A patient-centered view of symptoms, functional impact, and priorities in post-COVID-19 syndrome: Cross-sectional results from the Québec Action Post-COVID cohort
First Author: Mayo, Nancy
Reviewed: Jun 2, 2023
|
Mayo, Nancy
|
Jun 2, 2023
|
|
A turning point in COVID-19 severity and fatality during the pandemic: A national cohort study in Qatar
First Author: Chemaitelly, Hiam
Reviewed: Jun 2, 2023
|
Chemaitelly, Hiam
|
Jun 2, 2023
|
|
Adding Nitazoxanide to standard triple therapy improves eradication rate of Helicobacter Pylori in post covid-19 antibiotic resistant era: a single center open-label randomized controlled trial
First Author: Hassan, Amro M.
Reviewed: Jun 2, 2023
|
Hassan, Amro M.
|
Jun 2, 2023
|
|
Analysing the psychosocial and health impacts of Long COVID in Pakistan: A cross sectional study
First Author: Khan, Madeeha
Reviewed: Jun 2, 2023
|
Khan, Madeeha
|
Jun 2, 2023
|
|
Comparative analysis of symptom profile and risk of death associated with infection by SARS-CoV-2 and its variants in Hong Kong
First Author: Kwok, Kin On
Reviewed: Jun 2, 2023
|
Kwok, Kin On
|
Jun 2, 2023
|
|
Dichotomy of neutralizing antibody, B cell and T cell responses to SARS-CoV-2 vaccination and protection in healthy adults
First Author: Carr, Edward J
Reviewed: Jun 2, 2023
|
Carr, Edward J
|
Jun 2, 2023
|
|
Effectiveness of BNT162b2 mRNA vaccine third doses and previous infection in protecting against SARS-CoV-2 infections during the Delta and Omicron variant waves; the UK SIREN cohort study September 2021 to February 2022
First Author: Hall, Victoria J
Reviewed: Jun 2, 2023
|
Hall, Victoria J
|
Jun 2, 2023
|
|
Long COVID and financial outcomes: Evidence from four longitudinal population surveys
First Author: Rhead, Rebecca
Reviewed: Jun 2, 2023
|
Rhead, Rebecca
|
Jun 2, 2023
|
|
Long-term recurrence interval of Vogt–Koyanagi–Harada disease post-COVID-19 vaccination: A case study
First Author: Muto, Tetsuya
Reviewed: Jun 2, 2023
|
Muto, Tetsuya
|
Jun 2, 2023
|
|
Multi-omic Profiling Reveals Early Immunological Indicators for Identifying COVID-19 Progressors
First Author: Drake, Katherine A.
Reviewed: Jun 2, 2023
|
Drake, Katherine A.
|
Jun 2, 2023
|
|
Omicron Variant Reinfection Risk Among Individuals with Previous SARS-CoV-2 Infections within One Year in Shanghai, China: A Cross-sectional Study
First Author: Ye, Chuchu
Reviewed: Jun 2, 2023
|
Ye, Chuchu
|
Jun 2, 2023
|
|
Persistence of Anti-S1 IgG against SARS-CoV-2 Eight Months after the Booster Dose of Vaccine in Non-infected Patients
First Author: Algarate, Sonia
Reviewed: Jun 2, 2023
|
Algarate, Sonia
|
Jun 2, 2023
|
|
Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features
First Author: Magaret, Craig
Reviewed: Jun 2, 2023
|
Magaret, Craig
|
Jun 2, 2023
|
|
Researching COVID to enhance recovery (RECOVER) adult study protocol: Rationale, objectives, and design
First Author: Horwitz, Leora I.
Reviewed: Jun 2, 2023
|
Horwitz, Leora I.
|
Jun 2, 2023
|
|
The Effect of Health Action Process Approach on Adherence to Infection Prevention and Control Measures Among Chinese Healthcare Workers in the Post-pandemic Period of COVID-19
First Author: Zhou, Ting
Reviewed: Jun 2, 2023
|
Zhou, Ting
|
Jun 2, 2023
|
|
The secretory IgA (sIgA) response in human milk against the SARS-CoV-2 Spike is highly durable and neutralizing for at least 1 year of lactation post-infection
First Author: Yang, Xiaoqi
Reviewed: Jun 2, 2023
|
Yang, Xiaoqi
|
Jun 2, 2023
|
|
Three Doses of COVID-19 Vaccines: A Retrospective Study Evaluating the Safety and the Immune Response in Patients with Multiple Sclerosis
First Author: Maniscalco, Giorgia Teresa
Reviewed: Jun 2, 2023
|
Maniscalco, Giorgia Teresa
|
Jun 2, 2023
|
|
Use of Rotavirus Vaccine as a Containment Measure for SARS- CoV-2 Coronavirus (COVID-19): A Study of Possible Cross and Trained Immunity
First Author: Ayan, Nuria Lorite -
Reviewed: Jun 2, 2023
|
Ayan, Nuria Lorite -
|
Jun 2, 2023
|
|
A case of fulminant myocarditis associated with a novel coronavirus infection
First Author: Yan, Bixia
Reviewed: May 31, 2023
|
Yan, Bixia
|
May 31, 2023
|
|
Adjuvant Oligonucleotide Vaccine Increases Survival of Transgenic Mice [B6.Cg-Tg (K18-ACE2)2]
First Author: Oberemok, Volodymyr
Reviewed: May 31, 2023
|
Oberemok, Volodymyr
|
May 31, 2023
|
|
ChAdOx1 COVID vaccines express RBD open prefusion SARS-CoV-2 spikes on the cell surface
First Author: Ni, Tao
Reviewed: May 31, 2023
|
Ni, Tao
|
May 31, 2023
|
|
COVID-19 and COVID-19 Vaccine in Japan—A Review from a General Physician's Perspective
First Author: Kusunoki, Hiroshi
Reviewed: May 31, 2023
|
Kusunoki, Hiroshi
|
May 31, 2023
|
|
Cross-Protection Induced by Highly Conserved Human B, CD4+, and CD8+ T Cell Epitopes-Based Coronavirus Vaccine Against Severe Infection, Disease, and Death Caused by Multiple SARS-CoV-2 Variants of Concern
First Author: Prakash, Swayam
Reviewed: May 31, 2023
|
Prakash, Swayam
|
May 31, 2023
|
|
Immunogenicity and pre-clinical efficacy of an OMV-based SARS-CoV-2 vaccine
First Author: Grandi, Alberto
Reviewed: May 31, 2023
|
Grandi, Alberto
|
May 31, 2023
|
|
Inflammation in the COVID-19 airway is due to inhibition of CFTR signaling by the SARS-CoV-2 Spike protein
First Author: Caohuy, Hung
Reviewed: May 31, 2023
|
Caohuy, Hung
|
May 31, 2023
|
|
Information bias of vaccine effectiveness estimation due to informed consent for national registration of COVID-19 vaccination: estimation and correction using a data augmentation model
First Author: van Werkhoven, C.H. (Henri)
Reviewed: May 31, 2023
|
van Werkhoven, C.H. (Henri)
|
May 31, 2023
|
|
Kinetics of COVID-19 mRNA primary and booster vaccine-associated neutralizing activity against SARS-CoV-2 variants of concern in long-term care facility residents: A prospective longitudinal study
First Author: Kakugawa, Tomoyuki
Reviewed: May 31, 2023
|
Kakugawa, Tomoyuki
|
May 31, 2023
|
|
Lockdowns and Vaccines: Did Covid-19 Interventions Help Reduce the Long-Term Health Economic Consequences in Ghana?
First Author: Crankson, Shirley
Reviewed: May 31, 2023
|
Crankson, Shirley
|
May 31, 2023
|
|
Primary Care Post-COVID syndrome Diagnosis and Referral Coding
First Author: Willans, Robert
Reviewed: May 31, 2023
|
Willans, Robert
|
May 31, 2023
|
|
Psychiatric hospital admissions and linkages to ambulatory services in the Western Cape Province of South Africa (2015-2022): trends, risk factors, the impact of the COVID-19 pandemic and possible opportunities for intervention
First Author: Hussey, Hannah
Reviewed: May 31, 2023
|
Hussey, Hannah
|
May 31, 2023
|
|
Safety of BNT162b2 mRNA COVID-19 Vaccine in children with chronic kidney disease: a national population study of South Korea
First Author: Choe, Young June
Reviewed: May 31, 2023
|
Choe, Young June
|
May 31, 2023
|
|
Spatiotemporal Variations of “Triple-demic” Outbreaks of Respiratory Infections in the United States in the Post-COVID-19 Era
First Author: Luo, Wei
Reviewed: May 31, 2023
|
Luo, Wei
|
May 31, 2023
|
|
Successful Treatment of Post-COVID-19 Severe ANCA-Associated Vasculitis: Case Report
First Author: Ural, Zeynep
Reviewed: May 31, 2023
|
Ural, Zeynep
|
May 31, 2023
|
|
Transitioning towards fit-for-purpose Public Health Surveillance Systems
First Author: Anastasiadou, Maria N.
Reviewed: May 31, 2023
|
Anastasiadou, Maria N.
|
May 31, 2023
|
|
Within-host SARS-CoV-2 viral kinetics informed by complex life course exposures reveals different intrinsic properties of Omicron and Delta variants
First Author: Russell, Timothy W.
Reviewed: May 31, 2023
|
Russell, Timothy W.
|
May 31, 2023
|
|
A Deep Dive into the Delta Wave: Forecasting SARS-CoV-2 Epidemic Dynamic in Poland with the pDyn Agent-Based Model
First Author: Niedzielewski, Karol
Reviewed: May 28, 2023
|
Niedzielewski, Karol
|
May 28, 2023
|
|
Antigenic Cartography Indicates That Omicron BA.1 and BA.4/BA.5 Variants Remain Antigenically Distant to Ancestral SARS-CoV-2 After Sputnik V Vaccination Followed by Homologous (Sputnik V) or Heterologous (Comirnaty) Revaccination
First Author: Astakhova, Ekaterina A
Reviewed: May 28, 2023
|
Astakhova, Ekaterina A
|
May 28, 2023
|
|
Assessment of Cardiac Adverse Events following COVID-19 Vaccination by Speckle Tracking Echocardiography
First Author: Chaichuum, Srisakul
Reviewed: May 28, 2023
|
Chaichuum, Srisakul
|
May 28, 2023
|
|
Association between antibody responses post-vaccination and severe COVID-19 outcomes: national population-based cohort study in Scotland
First Author: Macdonald, Calum
Reviewed: May 28, 2023
|
Macdonald, Calum
|
May 28, 2023
|
|
Breakthrough infections by SARS-CoV-2 variants boost cross-reactive hybrid immune responses in mRNA-vaccinated Golden Syrian Hamsters
First Author: Diego, Juan García-Bernalt
Reviewed: May 28, 2023
|
Diego, Juan García-Bernalt
|
May 28, 2023
|
|
COVID-19 Activity Risk Calculator as a Gamified Public Health
Intervention Tool
First Author: Natraj, Shreyasvi
Reviewed: May 28, 2023
|
Natraj, Shreyasvi
|
May 28, 2023
|
|
Defining the Subtypes of Long COVID and Risk Factors for Prolonged Disease
First Author: Resendez, Skyler
Reviewed: May 28, 2023
|
Resendez, Skyler
|
May 28, 2023
|
|
The COVID-19 mRNA vaccine Comirnaty induces anaphylactic shock in an anti-PEG hyperimmune large animal model: Role of complement activation in cardiovascular, hematological and inflammatory mediator changes
First Author: Barta, Bálint András
Reviewed: May 28, 2023
|
Barta, Bálint András
|
May 28, 2023
|
|
A novel multi-antigenic parapoxvirus-based vaccine demonstrates efficacy in protecting hamsters and non-human primates against SARS-CoV-2 challenge
First Author: Reguzova, Alena
Reviewed: May 24, 2023
|
Reguzova, Alena
|
May 24, 2023
|
|
A synthetic delivery vector for mucosal vaccination
First Author: Billet, Anne
Reviewed: May 24, 2023
|
Billet, Anne
|
May 24, 2023
|
|
Assessing the Prevalence and Predictors of COVID-19 Vaccine Hesitancy among Healthcare Workers in Infectious Disease Centers in Ghana
First Author: Dadzie, George
Reviewed: May 24, 2023
|
Dadzie, George
|
May 24, 2023
|
|
Biology and Behavior of SARS-COV-2 Contagion with Emphasis on Treatment Strategies, Risk Assessment, and Resilience
First Author: Baldwin, James
Reviewed: May 24, 2023
|
Baldwin, James
|
May 24, 2023
|
|
Changes in Transmission and Symptoms of SARS-CoV-2 in United States Households, April 2020–September 2022
First Author: Mellis, Alexandra M.
Reviewed: May 24, 2023
|
Mellis, Alexandra M.
|
May 24, 2023
|
|
COVID-19 mRNA vaccine-mediated antibodies in human breast milk and their association with breast milk microbiota composition
First Author: Zhao, Shilin
Reviewed: May 24, 2023
|
Zhao, Shilin
|
May 24, 2023
|
|
Evolution of collective SARS-CoV-2 humoral immunity among the population of the Republic of Belarus
First Author: Popova, Anna Y.
Reviewed: May 24, 2023
|
Popova, Anna Y.
|
May 24, 2023
|
|
Factors influencing staff attitudes to COVID-19 vaccination in care homes in England: A qualitative study
First Author: Friedrich, Bettina
Reviewed: May 24, 2023
|
Friedrich, Bettina
|
May 24, 2023
|
|
Identification of Age-Related Characteristic Genes Involved in Severe COVID-19 Infection Among Elderly Patients using Machine Learning and Immune Cell Infiltration Analysis
First Author: Li, Huan
Reviewed: May 24, 2023
|
Li, Huan
|
May 24, 2023
|
|
Immunoglobulin A as a key immunological molecular signature of post-COVID-19 conditions
First Author: Sousa, Graziele F.
Reviewed: May 24, 2023
|
Sousa, Graziele F.
|
May 24, 2023
|
|
Incidence of anti-platelet factor4/polyanionic antibodies, thrombocytopenia, and thrombosis after COVID-19 vaccination with ChAdOx1 nCoV-19 in Thais
First Author: Boonyawat, Kochawan
Reviewed: May 24, 2023
|
Boonyawat, Kochawan
|
May 24, 2023
|
|
Knee osteonecrosis after SARS-CoV-2 infection: a systematic case-based review
First Author: Za, Pierangelo
Reviewed: May 24, 2023
|
Za, Pierangelo
|
May 24, 2023
|
|
Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights Into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges
First Author: Tsilingiris, Dimitrios
Reviewed: May 24, 2023
|
Tsilingiris, Dimitrios
|
May 24, 2023
|
|
Long COVID is primarily a Spike protein Induced Thrombotic Vasculitis
First Author: Kerr, Robin
Reviewed: May 24, 2023
|
Kerr, Robin
|
May 24, 2023
|
|
Long COVID: Plasma levels of neurofilament light chain in mild COVID-19 patients with neurocognitive symptoms
First Author: Gutman, Elisa
Reviewed: May 24, 2023
|
Gutman, Elisa
|
May 24, 2023
|
|
Longitudinal analysis of memory T follicular helper cells and antibody response following CoronaVac vaccination
First Author: Zhou, Pengcheng
Reviewed: May 24, 2023
|
Zhou, Pengcheng
|
May 24, 2023
|
|
Mechanism Underlying the Immune Responses of a Sublingual Vaccine for SARS-CoV-2 with RBD Antigen and Adjuvant, Poly(I:C) or AddaS03, in Non-human Primates
First Author: Yamamoto, Tetsuro
Reviewed: May 24, 2023
|
Yamamoto, Tetsuro
|
May 24, 2023
|
|
Mycophenolate Interruption Restores Anti-SARS-CoV-2 Vaccine Immunogenicity in Unresponsive Liver Transplant Recipients
First Author: Toniutto, Pierluigi
Reviewed: May 24, 2023
|
Toniutto, Pierluigi
|
May 24, 2023
|
|
Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses
First Author: Michael, Benedict
Reviewed: May 24, 2023
|
Michael, Benedict
|
May 24, 2023
|
|
Persistent endothelial dysfunction in post-COVID-19 syndrome and its associations with symptom severity and chronic inflammation
First Author: Kuchler, Timon
Reviewed: May 24, 2023
|
Kuchler, Timon
|
May 24, 2023
|
|
Post-Covid Condition and clinic characteristics associated with SARS-CoV-2 infection: A 2-year follow up to Brazilian cases
First Author: Silva, Nayara Sousa da
Reviewed: May 24, 2023
|
Silva, Nayara Sousa da
|
May 24, 2023
|
|
SARS-CoV-2 antibodies recognize 23 distinct epitopic sites on the receptor binding domain
First Author: Jiang, Jiansheng
Reviewed: May 24, 2023
|
Jiang, Jiansheng
|
May 24, 2023
|
|
Seroprevalence of SARS-CoV-2 and humoral immune responses to mRNA vaccines among people who use drugs - In the light of tailored mitigating strategies
First Author: Wüsthoff, Linda
Reviewed: May 24, 2023
|
Wüsthoff, Linda
|
May 24, 2023
|
|
Single-cycle SARS-CoV-2 vaccine elicits high protection and sterilizing immunity in hamsters
First Author: Lett, Martin Joseph
Reviewed: May 24, 2023
|
Lett, Martin Joseph
|
May 24, 2023
|
|
The Renin-Angiotensin-System in COVID-19: Can Long COVID Be Predicted?
First Author: K�nig, Simone
Reviewed: May 24, 2023
|
K�nig, Simone
|
May 24, 2023
|
|
Understanding COVID-19 Vaccine Uptake and Hesitancy Among People With HIV in Freetown, Sierra Leone: A Cross-sectional Study
First Author: Cummings, Peterlyn E.
Reviewed: May 24, 2023
|
Cummings, Peterlyn E.
|
May 24, 2023
|
|
Work engagement of healthcare workers in maternal and child health institutions in the post-COVID-19 era: an online cross-sectional study.�
First Author: Zhu, Hongjin
Reviewed: May 24, 2023
|
Zhu, Hongjin
|
May 24, 2023
|
|
"There is no one who helps you with it." Experiences of people with long COVID regarding medical care, therapeutic measures, and barriers in the German healthcare system: results of a qualitative study with four focus groups
First Author: Schmachtenberg, Tim
Reviewed: May 20, 2023
|
Schmachtenberg, Tim
|
May 20, 2023
|
|
A service provider's experience providing telehealth services during the COVID-19 pandemic in a community-based opioid substitution clinic in Bangladesh
First Author: SHAFIQ, TANVEER KHAN IBNE
Reviewed: May 20, 2023
|
SHAFIQ, TANVEER KHAN IBNE
|
May 20, 2023
|
|
Age Profiles for SARS-CoV-2 Variants in England and Wales and States of the USA (2020 to 2022): Impact on All-Cause Mor-Tality
First Author: Jones, Rodney P
Reviewed: May 20, 2023
|
Jones, Rodney P
|
May 20, 2023
|
|
Case Report: An Unusual Case of High-Risk Pulmonary Embolism in a Post-COVID 19 Female Under Hormonal Contraception
First Author: Sonaglioni, Andrea
Reviewed: May 20, 2023
|
Sonaglioni, Andrea
|
May 20, 2023
|
|
Cohort Profile: Post-hospitalisation COVID-19 study (PHOSP-COVID)
First Author: Elneima, Omer
Reviewed: May 20, 2023
|
Elneima, Omer
|
May 20, 2023
|
|
COVID-associated complications after reconstructive breast surgery – a retrospective cohort study
First Author: Bubberman, J.M.
Reviewed: May 20, 2023
|
Bubberman, J.M.
|
May 20, 2023
|
|
Effectiveness of SARS‐CoV‐2 vaccines used in Malaysia: A systematic review and meta‐analysis
First Author: Thantry, Anita Devi Krishnan
Reviewed: May 20, 2023
|
Thantry, Anita Devi Krishnan
|
May 20, 2023
|
|
Has the COVID-19 Pandemic Changed Parental Attitudes and Beliefs Regarding Vaccinating their Children against the Flu?
First Author: Shmueli, Liora
Reviewed: May 20, 2023
|
Shmueli, Liora
|
May 20, 2023
|
|
Immunogenicity of NVX-CoV2373 in PREVENT-19: A Phase 3, Randomized, Placebo-Controlled Trial in Adults in the United States and Mexico
First Author: Áñez, Germán
Reviewed: May 20, 2023
|
Áñez, Germán
|
May 20, 2023
|
|
Increasing Rates of Herpes Zoster Ophthalmicus and the COVID-19 Pandemic
First Author: Snyder, Alexander J.
Reviewed: May 20, 2023
|
Snyder, Alexander J.
|
May 20, 2023
|
|
Lipid metabolism of plasma-derived small extracellular in COVID-19 convalescent patients
First Author: Wenjing, Xiao
Reviewed: May 20, 2023
|
Wenjing, Xiao
|
May 20, 2023
|
|
Living with Long COVID: Implementing a living approach to the NICE guideline on managing the long-term effects of COVID-19
First Author: Sharp, Steve
Reviewed: May 20, 2023
|
Sharp, Steve
|
May 20, 2023
|
|
Persistent humoral immunity in children and adolescents throughout the COVID-19 pandemic (June 2020 to July 2022): a prospective school-based cohort study (Ciao Corona) in Switzerland
First Author: Raineri, Alessia
Reviewed: May 20, 2023
|
Raineri, Alessia
|
May 20, 2023
|
- Pediatrics/Adolescents
- Immunological
|
Recent functional decline and outpatient follow-up after hospital discharge: A cohort study
First Author: Bogler, Orly
Reviewed: May 20, 2023
|
Bogler, Orly
|
May 20, 2023
|
|
SARS-CoV-2 induced B cells generate an anticipatory memory against new virus variants and re-engage in COVID-19 vaccine responses
First Author: Kalinke, Ulrich
Reviewed: May 20, 2023
|
Kalinke, Ulrich
|
May 20, 2023
|
|
SARS-CoV-2 introductions to the island of Ireland
First Author: Rice, Alan M.
Reviewed: May 20, 2023
|
Rice, Alan M.
|
May 20, 2023
|
|
Symptom patterns of long COVID and chronic illness: a cross-sectional analysis of the SulCovid-19 Study
First Author: Gonzalez, Tatiane Nogueira
Reviewed: May 20, 2023
|
Gonzalez, Tatiane Nogueira
|
May 20, 2023
|
|
Telerehabilitation intervention in transitional care for people with COVID-19: Pre-post study with a non-equivalent control group
First Author: Reis, Neuza
Reviewed: May 20, 2023
|
Reis, Neuza
|
May 20, 2023
|
|
The New Normal: Delayed Peak SARS-CoV-2 Viral Loads Relative to Symptom Onset and Implications for COVID-19 Testing Programs
First Author: Frediani, Jennifer K.
Reviewed: May 20, 2023
|
Frediani, Jennifer K.
|
May 20, 2023
|
|
“Broad-Spectrum Heavily Mutated Monoclonal Antibody Isolated from COVID-19 Convalescent Vaccinee with Capacity to Neutralize SARS-CoV2 Variants Ranging from B.1 to BQ.1.1.”
First Author: Choudhary, Alok
Reviewed: May 14, 2023
|
Choudhary, Alok
|
May 14, 2023
|
|
A bivalent ChAd nasal vaccine protects against SARS-CoV-2 BQ.1.1 and XBB.1.5 infection and disease in mice and hamsters
First Author: Ying, Baoling
Reviewed: May 14, 2023
|
Ying, Baoling
|
May 14, 2023
|
|
A multiadjuvant polysaccharide-amino acid-lipid (PAL) subunit nanovaccine generates robust systemic and lung-specific mucosal immune responses against SARS-CoV-2 in mice
First Author: Pandey, Bhawana
Reviewed: May 14, 2023
|
Pandey, Bhawana
|
May 14, 2023
|
|
Association of Seizure with COVID-19 Vaccines in Persons with Epilepsy: A Systematic Review and Meta-analysis
First Author: Rafati, Ali
Reviewed: May 14, 2023
|
Rafati, Ali
|
May 14, 2023
|
|
Bivalent and Monovalent SARS-CoV-2 Variant Vaccine Boosters Improve coverage of the known Antigenic Landscape: Results of the COVID-19 Variant Immunologic Landscape (COVAIL) Trial
First Author: Branche, Angela
Reviewed: May 14, 2023
|
Branche, Angela
|
May 14, 2023
|
|
Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartography
First Author: Rössler, Annika
Reviewed: May 14, 2023
|
Rössler, Annika
|
May 14, 2023
|
|
Deep immunological imprinting due to the ancestral spike in the current bivalent COVID-19 vaccine
First Author: Wang, Qian
Reviewed: May 14, 2023
|
Wang, Qian
|
May 14, 2023
|
|
Determinant Factors of Voluntary or Mandatory Vaccination against COVID-19. A Survey Study among Students at Albanian University
First Author: Kongo, Elona
Reviewed: May 14, 2023
|
Kongo, Elona
|
May 14, 2023
|
|
Development of an MTB39A protein-based Mycobacterium tuberculosis nanoparticle vaccine candidate
First Author: Wang, Pu
Reviewed: May 14, 2023
|
Wang, Pu
|
May 14, 2023
|
|
Examining Temporalities on Stance Detection towards COVID-19 Vaccination
First Author: Mu, Yida
Reviewed: May 14, 2023
|
Mu, Yida
|
May 14, 2023
|
|
Human airway ex vivo models: new tools to study the airway epithelial cell response to SARS-CoV-2 infection
First Author: Assou, Said
Reviewed: May 14, 2023
|
Assou, Said
|
May 14, 2023
|
|
Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 and golden Syrian hamster upon SARS-CoV-2 infection.
First Author: Carrillo, Jorge
Reviewed: May 14, 2023
|
Carrillo, Jorge
|
May 14, 2023
|
|
In silico clinical studies for the design of optimal COVID-19 vaccination schedules in patients with cancer
First Author: Jain, Rakesh
Reviewed: May 14, 2023
|
Jain, Rakesh
|
May 14, 2023
|
|
Mobilizing faith-based COVID-19 health ambassadors to address COVID-19 health disparities among African American older adults in under-resourced communities: A hybrid, community-based participatory intervention
First Author: Adinkrah, Edward K.
Reviewed: May 14, 2023
|
Adinkrah, Edward K.
|
May 14, 2023
|
|
Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal tissue
First Author: Shi, Guoli
Reviewed: May 14, 2023
|
Shi, Guoli
|
May 14, 2023
|
|
Omicron variant BA.1, BA.5, BQ.1.1, and XBB.1.5 Neutralizing Antibodies Following BNT162b2 BA.4/5 versus mRNA-1273 BA.1 Bivalent Vaccination
First Author: Hladunewich, Michelle
Reviewed: May 14, 2023
|
Hladunewich, Michelle
|
May 14, 2023
|
|
Omicron-Specific and Bivalent Omicron-Containing Vaccine Candidates Elicit Potent Virus Neutralisation in the Animal Model
First Author: Abdoli, Asghar
Reviewed: May 14, 2023
|
Abdoli, Asghar
|
May 14, 2023
|
|
On factor copula-based mixed regression models
First Author: Krupskii, Pavel
Reviewed: May 14, 2023
|
Krupskii, Pavel
|
May 14, 2023
|
|
Ongoing symptoms and functional impairment 12 weeks after testing positive to SARS-CoV-2 or influenza in Australia: an observational cohort study
First Author: Brown, Matthew
Reviewed: May 14, 2023
|
Brown, Matthew
|
May 14, 2023
|
|
Persistence of SARS-Cov-2 Igg Antibody Response among South African Adults: A Prospective Cohort Study
First Author: Adeniyi, Oladele Vincent
Reviewed: May 14, 2023
|
Adeniyi, Oladele Vincent
|
May 14, 2023
|
|
Revisiting assumptions in test-negative studies for estimating vaccine effectiveness: the need for a clinical case definition
First Author: Sullivan, Sheena
Reviewed: May 14, 2023
|
Sullivan, Sheena
|
May 14, 2023
|
|
Risk of new-onset Long Covid following reinfection with SARS-CoV-2: community-based cohort study
First Author: Bosworth, Matthew L.
Reviewed: May 14, 2023
|
Bosworth, Matthew L.
|
May 14, 2023
|
|
SARS-CoV-2 infection during pregnancy and the risk of adverse maternal outcomes in the Republic of Georgia: a national birth registry-based cohort study
First Author: Skhvitaridze, Natia
Reviewed: May 14, 2023
|
Skhvitaridze, Natia
|
May 14, 2023
|
|
SARS-CoV-2 specific cellular and humoral immunity after bivalent BA.4/5 COVID-19 vaccination in previously infected and non-infected individuals
First Author: Urschel, Rebecca
Reviewed: May 14, 2023
|
Urschel, Rebecca
|
May 14, 2023
|
|
Symptom persistence and biomarkers in post-COVID-19/chronic fatigue syndrome – results from a prospective observational cohort
First Author: Legler, A. F.
Reviewed: May 14, 2023
|
Legler, A. F.
|
May 14, 2023
|
|
Vaccine effectiveness of BNT162b2 mRNA Covid-19 Vaccine in Children below 5 Years in German Primary Care
First Author: Strumann, Christoph
Reviewed: May 14, 2023
|
Strumann, Christoph
|
May 14, 2023
|
|
Vaccinia Virus Strain Mva Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Glycoprotein Induces Robust Protection and Prevents Brain Infection in Mouse and Hamster Models
First Author: Lorenzo, María M
Reviewed: May 14, 2023
|
Lorenzo, María M
|
May 14, 2023
|
|
What can neutralizing antibodies tell us about the quality of immunity in COVID-19 convalescents and vaccinees?
First Author: Halassy, Beata
Reviewed: May 14, 2023
|
Halassy, Beata
|
May 14, 2023
|
|
A Bayesian approach to identify changepoints in spatio-temporal ordered
categorical data: An application to COVID-19 data
First Author: Rawat, Siddharth
Reviewed: May 10, 2023
|
Rawat, Siddharth
|
May 10, 2023
|
|
SARS Cov2 Infection and Preeclampsia. How an Infection Can Help Us To Know More About an Obstetric Condition
First Author: Gonzalez, Otilia
Reviewed: May 10, 2023
|
Gonzalez, Otilia
|
May 10, 2023
|
|
DeCom: Deep Coupled-Factorization Machine for Post COVID-19 Respiratory
Syncytial Virus Prediction with Nonpharmaceutical Interventions Awareness
First Author: Li, Xinyan
Reviewed: May 8, 2023
|
Li, Xinyan
|
May 8, 2023
|
|
“I'll meet you at our bench”: Adaptation, Innovation and Resilience among VCSE organisations who supported marginalised and minoritised communities during the COVID-19 pandemic in Northern England – A Qualitative Focus Group Study
First Author: Scott, Steph
Reviewed: May 6, 2023
|
Scott, Steph
|
May 6, 2023
|
|
Association between BNT162b2 vaccination and health-related quality of life up to 18 months post-SARS-CoV-2 infection in Israel: A cross sectional survey
First Author: Edelstein, Michael
Reviewed: May 6, 2023
|
Edelstein, Michael
|
May 6, 2023
|
|
Pathology Outlines of Post-COVID-19 Pulmonary Fibrosis Comparative with Idiopathic Pulmonary Fibrosis
First Author: Cîrjaliu, Roxana-Elena
Reviewed: May 6, 2023
|
Cîrjaliu, Roxana-Elena
|
May 6, 2023
|
|
Researching COVID to enhance recovery (RECOVER) pediatric study protocol: Rationale, objectives and design
First Author: Gross, Rachel
Reviewed: May 6, 2023
|
Gross, Rachel
|
May 6, 2023
|
|
Cohort Profile: A longitudinal Victorian COVID-19 cohort (COVID PROFILE)
First Author: Eriksson, Emily M.
Reviewed: May 3, 2023
|
Eriksson, Emily M.
|
May 3, 2023
|
|
Novel Antiviral Therapeutic Against SARS-CoV-2 and its Variants: Recent Developments and Future Perspectives
First Author: Gupta, Amit
Reviewed: May 3, 2023
|
Gupta, Amit
|
May 3, 2023
|
|
Population immunity of natural infection, primary-series vaccination, and booster vaccination in Qatar during the COVID-19 pandemic: An observational study
First Author: Qassim, Suelen H.
Reviewed: May 3, 2023
|
Qassim, Suelen H.
|
May 3, 2023
|
|
Prevalence and factors associated with flares following COVID-19 mRNA vaccination in patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: a national cohort study
First Author: Fong, Warren
Reviewed: May 3, 2023
|
Fong, Warren
|
May 3, 2023
|
|
A systematic review of the prevalence of persistent gastrointestinal symptoms and incidence of new gastrointestinal illness after acute SARS-CoV-2 infection
First Author: Hawkings, Michael J.
Reviewed: May 1, 2023
|
Hawkings, Michael J.
|
May 1, 2023
|
|
Anxiety due to Long COVID is partially driven by activation of the tryptophan catabolite (TRYCAT) pathway
First Author: Al-Hakeim, Hussein Kadhem
Reviewed: May 1, 2023
|
Al-Hakeim, Hussein Kadhem
|
May 1, 2023
|
|
Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variants
First Author: Springer, David N.
Reviewed: May 1, 2023
|
Springer, David N.
|
May 1, 2023
|
|
Broadly neutralizing antibodies targeting a conserved silent face of spike RBD resist extreme SARS-CoV-2 antigenic drift
First Author: Song, Ge
Reviewed: May 1, 2023
|
Song, Ge
|
May 1, 2023
|
|
Changes in Antigen-Reactive Antibody Level at Various Time Spans after COVID-19 Vaccination Using Machine Learning
First Author: Ma, QingLan
Reviewed: May 1, 2023
|
Ma, QingLan
|
May 1, 2023
|
|
Chasing SARS-CoV-2 XBB.1.16 Recombinant Lineage in India and the Clinical Profile of XBB.1.16 cases in Maharashtra, India
First Author: Karyakarte, Rajesh P.
Reviewed: May 1, 2023
|
Karyakarte, Rajesh P.
|
May 1, 2023
|
|
Comparative Cohort Study of Post-Acute Covid-19 Infection with a Nested, Randomized Controlled Trial of Ivabradine for Those With Postural Orthostatic Tachycardia Syndrome (The COVIVA Study)
First Author: Saunders, David
Reviewed: May 1, 2023
|
Saunders, David
|
May 1, 2023
|
|
Covid-19 Vaccine Booster Cadence by Immunocompromised Status
First Author: Yechezkel, Matan
Reviewed: May 1, 2023
|
Yechezkel, Matan
|
May 1, 2023
|
|
Durability of immunity and clinical protection in nursing home residents following bivalent SARS-CoV-2 vaccination
First Author: Gravenstein, Stefan
Reviewed: May 1, 2023
|
Gravenstein, Stefan
|
May 1, 2023
|
|
Effect of water-based vs. land-based exercise intervention (postCOVIDkids) on exercise capacity, fatigue and quality of life in children with post COVID-19 condition: a randomized controlled trial
First Author: Ogonowska-Slodownik, Anna
Reviewed: May 1, 2023
|
Ogonowska-Slodownik, Anna
|
May 1, 2023
|
|
High-throughput SARS-CoV-2 antiviral testing method using the Celigo Image Cytometer
First Author: Clair, Laura A. St
Reviewed: May 1, 2023
|
Clair, Laura A. St
|
May 1, 2023
|
|
Influencing factors of COVID-19 vaccination hesitancy among adults in Taiwan, China: a cross-sectional study
First Author: Huang, Chun-Lian
Reviewed: May 1, 2023
|
Huang, Chun-Lian
|
May 1, 2023
|
|
LONG-TERM PHYSICAL AND MENTAL HEALTH IMPACT OF COVID-19 ON ADULTS IN ENGLAND: FOLLOW UP OF A LARGE RANDOM COMMUNITY SAMPLE
First Author: Atchison, Christina J
Reviewed: May 1, 2023
|
Atchison, Christina J
|
May 1, 2023
|
|
Post-acute COVID-19 in three doses vaccinated autoimmune rheumatic diseases patients: frequency and pattern of this condition
First Author: Silva, Clovis Artur Almeida da
Reviewed: May 1, 2023
|
Silva, Clovis Artur Almeida da
|
May 1, 2023
|
|
Researching COVID to enhance recovery (RECOVER) pregnancy study: Rationale, objectives and design
First Author: Metz, Torri D.
Reviewed: May 1, 2023
|
Metz, Torri D.
|
May 1, 2023
|
|
Risks of digestive diseases in long COVID: Evidence from a large-scale cohort study
First Author: Ma, Yuying
Reviewed: May 1, 2023
|
Ma, Yuying
|
May 1, 2023
|
|
The enigma of the SARS-CoV-2 microcirculation dysfunction: evidence for modified endothelial junctions
First Author: Bouillet, L
Reviewed: May 1, 2023
|
Bouillet, L
|
May 1, 2023
|
|
Using extracted data from Kaplan-Meier curves to compare COVID-19 vaccine efficacy
First Author: Tansawet, Amarit
Reviewed: May 1, 2023
|
Tansawet, Amarit
|
May 1, 2023
|
|
Bivalent COVID-19 booster vaccines induce cross-reactive but not BA.5-specific antibodies in polyclonal serum
First Author: Carreño, Juan Manuel
Reviewed: Apr 29, 2023
|
Carreño, Juan Manuel
|
Apr 29, 2023
|
|
Prevention of cyclical resurgences of COVID-19-like pandemics in the long term: What are the trade-offs?
First Author: Nakamoto, Ichiro
Reviewed: Apr 29, 2023
|
Nakamoto, Ichiro
|
Apr 29, 2023
|
|
The beneficial role of Candida intermedia and Saccharomyces boulardii yeasts on the immune response of mice vaccinated with a SARS-CoV-2 experimental vaccine
First Author: Piraine, Renan Eugênio Araujo
Reviewed: Apr 29, 2023
|
Piraine, Renan Eugênio Araujo
|
Apr 29, 2023
|
|
An in vitro experimental pipeline to characterize the binding specificity of SARS-CoV-2 neutralizing antibodies
First Author: Atanasoff, Kristina E.
Reviewed: Apr 26, 2023
|
Atanasoff, Kristina E.
|
Apr 26, 2023
|
|
Contribution of infection and vaccination to population-level seroprevalence through two COVID waves in Tamil Nadu, India
First Author: TS, Selvavinayagam
Reviewed: Apr 26, 2023
|
TS, Selvavinayagam
|
Apr 26, 2023
|
|
Distinct intrathecal inflammatory signatures following relapse and anti- COVID-19 mRNA vaccination in Multiple Sclerosis. A cross-sectional study.
First Author: Bruno, Antonio
Reviewed: Apr 26, 2023
|
Bruno, Antonio
|
Apr 26, 2023
|
|
Effects of previous infection, vaccination, and hybrid immunity against symptomatic Alpha, Beta, and Delta infections
First Author: Altarawneh, Heba N.
Reviewed: Apr 26, 2023
|
Altarawneh, Heba N.
|
Apr 26, 2023
|
|
Health disparities in COVID-19: Immune and vascular changes are linked to disease severity and persist in a high-risk population in Riverside County, California
First Author: Bergersen, Kristina V.
Reviewed: Apr 26, 2023
|
Bergersen, Kristina V.
|
Apr 26, 2023
|
|
Smartphone- and Cloud-based Artificial Intelligence Quantitative Analysis System (SCAISY) for SARS-CoV-2-specific IgG Antibody Lateral Flow Assays
First Author: Kumar, Samir
Reviewed: Apr 26, 2023
|
Kumar, Samir
|
Apr 26, 2023
|
|
A single-dose of intranasal vaccination with a live-attenuated SARS-CoV-2 vaccine candidate promotes protective mucosal and systemic immunity
First Author: Adam, Awadalkareem
Reviewed: Apr 25, 2023
|
Adam, Awadalkareem
|
Apr 25, 2023
|
|
An ex vivo human precision-cut lung slice platform provides insight into SARS-CoV-2 pathogenesis and antiviral drug efficacy
First Author: Pechous, Roger D.
Reviewed: Apr 25, 2023
|
Pechous, Roger D.
|
Apr 25, 2023
|
|
Biochemical, inflammatory and oxidative stress biomarkers in obese patients after COVID-19
First Author: Dyakov, Denis
Reviewed: Apr 25, 2023
|
Dyakov, Denis
|
Apr 25, 2023
|
|
Bivalent mRNA-1273.214 vaccine effectiveness in Qatar
First Author: Chemaitelly, Hiam
Reviewed: Apr 25, 2023
|
Chemaitelly, Hiam
|
Apr 25, 2023
|
|
COVID-19 illness severity and 2-year prevalence of physical symptoms: an observational study in Iceland, Sweden, Norway and Denmark
First Author: Shen, Qing
Reviewed: Apr 25, 2023
|
Shen, Qing
|
Apr 25, 2023
|
|
Growth Hormone Accelerates Recovery From Acetaminophen-Induced Murine Liver Injury
First Author: Everton, Elissa
Reviewed: Apr 25, 2023
|
Everton, Elissa
|
Apr 25, 2023
|
|
Loss-of-function mutation in Omicron variants reduces spike protein expression and attenuates SARS-CoV-2 infection
First Author: Vu, Michelle N.
Reviewed: Apr 25, 2023
|
Vu, Michelle N.
|
Apr 25, 2023
|
|
Post-COVID-19 syndrome and insulin resistance 20 months after a mild COVID-19
First Author: Fierro, Patricia
Reviewed: Apr 25, 2023
|
Fierro, Patricia
|
Apr 25, 2023
|
|
Vaccination compartmental epidemiological models for the delta and
omicron SARS-CoV-2 variants
First Author: Cuevas-Maraver, J.
Reviewed: Apr 25, 2023
|
Cuevas-Maraver, J.
|
Apr 25, 2023
|
|
A broadly protective CHO cell expressed recombinant spike protein subunit vaccine (IMT-CVAX) against SARS-CoV-2
First Author: Jitender
Reviewed: Apr 24, 2023
|
Jitender
|
Apr 24, 2023
|
|
Cross sectional study of knowledge, attitude and practice among general population towards COVID19 vaccines in Duhok province, Kurdistan region of Iraq
First Author: Elyas, Ramis Imad
Reviewed: Apr 24, 2023
|
Elyas, Ramis Imad
|
Apr 24, 2023
|
|
Knowledge of COVID-19 Symptoms, Transmission, and Prevention: Evidence from Health and Demographic Surveillance in Southern Mozambique
First Author: Nhacolo, Ariel
Reviewed: Apr 24, 2023
|
Nhacolo, Ariel
|
Apr 24, 2023
|
|
Longitudinal study of humoral immunity against SARS-CoV-2 of health professionals in Brazil: the impact of booster dose and reinfection on antibody dynamics
First Author: Franco-Luiz, Ana Paula Moreira
Reviewed: Apr 24, 2023
|
Franco-Luiz, Ana Paula Moreira
|
Apr 24, 2023
|
|
Aggravation of Psoriasis Following Covid-19: A Study of 105 Patients
First Author: Aktas, Meryem
Reviewed: Apr 20, 2023
|
Aktas, Meryem
|
Apr 20, 2023
|
|
Colour discrimination in post-COVID-19 observers assessed by the Farnsworth-Munsell 100-Hue test
First Author: Paramei, Galina V.
Reviewed: Apr 20, 2023
|
Paramei, Galina V.
|
Apr 20, 2023
|
|
Faster functional performance recovery after individualized nutrition therapy combined with a patient-tailored physical rehabilitation program versus standard physiotherapy in patients with long COVID: a pilot study for a randomized, controlled single-center trial.
First Author: Roggeman, Stijn
Reviewed: Apr 20, 2023
|
Roggeman, Stijn
|
Apr 20, 2023
|
|
Field Tested: Assessing the Transferability of Behavioral Interventions
First Author: Saccardo, Silvia
Reviewed: Apr 20, 2023
|
Saccardo, Silvia
|
Apr 20, 2023
|
|
Initiation of neutralizing antibody response probed using synthetic virus-like structures
First Author: Wholey, Wei-Yun
Reviewed: Apr 20, 2023
|
Wholey, Wei-Yun
|
Apr 20, 2023
|
|
Poor immune response to inactivated COVID-19 vaccine in patients with hypertension
First Author: Yang, Lei
Reviewed: Apr 20, 2023
|
Yang, Lei
|
Apr 20, 2023
|
|
Post COVID-19 Condition, Work Ability and Occupational Changes: Results from a Population-based Cohort
First Author: Kerksieck, Philipp
Reviewed: Apr 20, 2023
|
Kerksieck, Philipp
|
Apr 20, 2023
|
|
SARS-CoV-2 spike antigen-specific B cell and antibody responses in pre-vaccination period COVID-19 convalescent males and females with or without post-covid condition
First Author: Limoges, Marc-André
Reviewed: Apr 20, 2023
|
Limoges, Marc-André
|
Apr 20, 2023
|
|
Autoantibody production is enhanced after mild SARS-CoV-2 infection despite vaccination in individuals with and without long COVID
First Author: Visvabharathy, L
Reviewed: Apr 19, 2023
|
Visvabharathy, L
|
Apr 19, 2023
|
|
Comparison of Antibody Persistence Up to 6 Months After Additional Booster Vaccination With ChAdOx1 nCoV-19 Vaccine.
First Author: Suwanwattana, Pawita
Reviewed: Apr 19, 2023
|
Suwanwattana, Pawita
|
Apr 19, 2023
|
|
Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination
First Author: Zhou, Zhao-Hua
Reviewed: Apr 19, 2023
|
Zhou, Zhao-Hua
|
Apr 19, 2023
|
|
Potential Mechanism of Curcumin and Resveratrol against SARS-CoV-2
First Author: Wu, Wei
Reviewed: Apr 19, 2023
|
Wu, Wei
|
Apr 19, 2023
|
|
A methodological framework for assessing the benefit of SARS-CoV-2 vaccination following previous infection: case study of five to eleven year olds in the UK
First Author: Pagel, Christina
Reviewed: Apr 16, 2023
|
Pagel, Christina
|
Apr 16, 2023
|
|
Acute Necrotizing Encephalopathy Post SARS-CoV-2 Infection in an Adult Patient: Case Report
First Author: Hernandez-Dehesa, Itzel Ariadna
Reviewed: Apr 16, 2023
|
Hernandez-Dehesa, Itzel Ariadna
|
Apr 16, 2023
|
|
Antibodies that neutralize all current SARS-CoV-2 variants of concern by conformational locking
First Author: Liu, Lihong
Reviewed: Apr 16, 2023
|
Liu, Lihong
|
Apr 16, 2023
|
|
Comprehensive analysis of nasal IgA antibodies induced by intranasal administration of the SARS-CoV-2 spike protein
First Author: Waki, Kentarou
Reviewed: Apr 16, 2023
|
Waki, Kentarou
|
Apr 16, 2023
|
|
Effect of Age, Sex, and COVID-19 Vaccination History on All-Cause Mortality: Unexpected Outcomes in a Complex Biological and Social System
First Author: Jones, Rodney P
Reviewed: Apr 16, 2023
|
Jones, Rodney P
|
Apr 16, 2023
|
|
Effectiveness of mRNA COVID-19 monovalent and bivalent vaccine booster doses against Omicron severe outcomes among adults aged ≥50 years in Ontario, Canada
First Author: Grewal, Ramandip
Reviewed: Apr 16, 2023
|
Grewal, Ramandip
|
Apr 16, 2023
|
|
Evaluation of Epigallocatechin-3-Gallate-Palmitate (EC16) in Nasal Formulations Against Human Coronavirus
First Author: Frank, Nicolette
Reviewed: Apr 16, 2023
|
Frank, Nicolette
|
Apr 16, 2023
|
|
Infants and young children generate more durable antibody responses to SARS-CoV-2 infection than adults
First Author: Joshi, Devyani
Reviewed: Apr 16, 2023
|
Joshi, Devyani
|
Apr 16, 2023
|
|
Post-COVID-19 Pulmonary Complications among recovered COVID-19 patients: A cross-sectional study from Addis Ababa, Ethiopia
First Author: Seyoum, Abebaw Bekele
Reviewed: Apr 16, 2023
|
Seyoum, Abebaw Bekele
|
Apr 16, 2023
|
|
Post-infection functional gastrointestinal disorders following coronavirus disease-19: A Prospective follow-up cohort study
First Author: Zhang, Daya
Reviewed: Apr 16, 2023
|
Zhang, Daya
|
Apr 16, 2023
|
|
Pupillographic Analysis of COVID-19 Patients: Early and Late Results After Recovery
First Author: Gunduz, Gamze Ucan
Reviewed: Apr 16, 2023
|
Gunduz, Gamze Ucan
|
Apr 16, 2023
|
|
Repurposing niclosamide as a novel anti-SARS-Cov-2 drug by restricting entry protein CD147
First Author: Yang, Zhe
Reviewed: Apr 16, 2023
|
Yang, Zhe
|
Apr 16, 2023
|
|
SARS-CoV-2’s evolutionary capacity is mostly driven by host antiviral molecules
First Author: Lamb, Kieran D.
Reviewed: Apr 16, 2023
|
Lamb, Kieran D.
|
Apr 16, 2023
|
|
Silymarin Inhibits In Vitro SARS-CoV-2 Infection In Vero E6 Cells
First Author: Nnadi, Nnaemeka Emmanuel
Reviewed: Apr 16, 2023
|
Nnadi, Nnaemeka Emmanuel
|
Apr 16, 2023
|
|
Unbiased spectral cytometry immunome characterization predicts COVID-19 mRNA vaccine failure in older adults and patients with lymphoid malignancies
First Author: H-Vazquez, Juan
Reviewed: Apr 16, 2023
|
H-Vazquez, Juan
|
Apr 16, 2023
|
|
A community effort to discover small molecule SARS-CoV-2 inhibitors
First Author: Schimunek, Johannes
Reviewed: Apr 13, 2023
|
Schimunek, Johannes
|
Apr 13, 2023
|
|
Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines in Immunocompromised Individuals: A Systematic Review and Meta-Analysis Using the GRADE Framework
First Author: Wang, Xuan
Reviewed: Apr 13, 2023
|
Wang, Xuan
|
Apr 13, 2023
|
|
Early Treatment with Hydroxychloroquine and Azithromycin: A ‘Real-Life’ Monocentric Retrospective Cohort Study of 30,423 COVID-19 Patients
First Author: Million, Matthieu
Reviewed: Apr 13, 2023
|
Million, Matthieu
|
Apr 13, 2023
|
|
Experiment aversion among clinicians and the public — an obstacle to evidence-based medicine and public health
First Author: Vogt, Randi L.
Reviewed: Apr 13, 2023
|
Vogt, Randi L.
|
Apr 13, 2023
|
|
Formulation development and comparability studies with an aluminum-salt adjuvanted SARS-CoV-2 Spike ferritin nanoparticle vaccine antigen produced from two different cell lines
First Author: Kumru, Ozan S.
Reviewed: Apr 13, 2023
|
Kumru, Ozan S.
|
Apr 13, 2023
|
|
Humoral profiles of toddlers and young children following SARS-CoV-2 mRNA vaccination
First Author: Nziza, Nadege
Reviewed: Apr 13, 2023
|
Nziza, Nadege
|
Apr 13, 2023
|
|
Longitudinal Analysis of Humoral and Cellular Immune Response Following SARS-CoV-2 Vaccination Supports Utilizing Point-Of-Care Tests to Enhance COVID-19 Booster Uptake
First Author: Mallory, Michael
Reviewed: Apr 13, 2023
|
Mallory, Michael
|
Apr 13, 2023
|
|
Pre-infection neutralizing antibodies, Omicron BA.5 breakthrough infection, and long COVID: a propensity score-matched analysis
First Author: Yamamoto, Shohei
Reviewed: Apr 13, 2023
|
Yamamoto, Shohei
|
Apr 13, 2023
|
|
Prenatal maternal inactivated COVID-19 vaccination: the maternal and neonatal outcomes, a retrospective cohort study
First Author: Cai, Yaoyao
Reviewed: Apr 13, 2023
|
Cai, Yaoyao
|
Apr 13, 2023
|
|
Superior antibody and membrane protein-specific T cell responses to CoronaVac by intradermal versus intramuscular routes in adolescents
First Author: Rosa Duque, Jaime S.
Reviewed: Apr 13, 2023
|
Rosa Duque, Jaime S.
|
Apr 13, 2023
|
|
The role of N-glycosylation in spike antigenicity for the SARS-CoV-2 Gamma variant
First Author: Pegg, Cassandra L.
Reviewed: Apr 13, 2023
|
Pegg, Cassandra L.
|
Apr 13, 2023
|
|
Association between SARS-CoV-2 variants and post COVID-19 condition: findings from a longitudinal cohort study in the Belgian adult population
First Author: Nguyen, Huyen Thi Khanh
Reviewed: Apr 10, 2023
|
Nguyen, Huyen Thi Khanh
|
Apr 10, 2023
|
|
Blood biomarkers-defined subgroups show heterogeneity in post-acute COVID-19 syndrome: a rationale for precision medicine
First Author: Charvet, Benjamin
Reviewed: Apr 10, 2023
|
Charvet, Benjamin
|
Apr 10, 2023
|
|
Characterization and predictive risk scoring of long COVID in a South Indian cohort after breakthrough COVID infection; a prospective single centre study
First Author: Nair, Pranav
Reviewed: Apr 10, 2023
|
Nair, Pranav
|
Apr 10, 2023
|
|
Incidence of Symptoms Associated with Post-Acute Sequelae of SARS-CoV-2 infection in Non-Hospitalized Vaccinated Patients Receiving Nirmatrelvir-Ritonavir
First Author: Patel, Rushin
Reviewed: Apr 10, 2023
|
Patel, Rushin
|
Apr 10, 2023
|
|
Interruption of viral interference by anti-SARS-CoV-2 vaccination
First Author: Gyöngyösi, Mariann
Reviewed: Apr 10, 2023
|
Gyöngyösi, Mariann
|
Apr 10, 2023
|
|
Long-term outcomes of COVID-19 infection in children and young people: a systematic review and meta-analysis
First Author: Twohig, Helen
Reviewed: Apr 10, 2023
|
Twohig, Helen
|
Apr 10, 2023
|
|
Lower prevalence of Post-Covid-19 Condition following Omicron SARS-CoV-2 infection
First Author: de Bruijn, Siméon
Reviewed: Apr 10, 2023
|
de Bruijn, Siméon
|
Apr 10, 2023
|
|
Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses
First Author: Michael, Benedict D.
Reviewed: Apr 10, 2023
|
Michael, Benedict D.
|
Apr 10, 2023
|
|
Prevalence and Characterization of Long Covid-19 Symptoms in Health Care Professionals- A Need of the Hour
First Author: Srin, Mote
Reviewed: Apr 10, 2023
|
Srin, Mote
|
Apr 10, 2023
|
|
SARS-CoV-2 infection and post-acute risk of non-Covid-19 infectious disease hospitalizations: a nationwide cohort study of Danish adults aged ≥50 years
First Author: Andersson, Niklas Worm
Reviewed: Apr 10, 2023
|
Andersson, Niklas Worm
|
Apr 10, 2023
|
|
SARS-CoV-2 Spike Protein Accumulation in the Skull-Meninges-Brain Axis: Potential Implications for Long-Term Neurological Complications in post-COVID-19
First Author: Rong, Zhouyi
Reviewed: Apr 10, 2023
|
Rong, Zhouyi
|
Apr 10, 2023
|
|
Seclusion and mechanical restraint in the wake of the COVID-19 pandemic: an increased use in mental health settings
First Author: Goulet, Marie-Hélène
Reviewed: Apr 10, 2023
|
Goulet, Marie-Hélène
|
Apr 10, 2023
|
|
A Case Series of Acute Symptomatic Hyponatremia due to SIADH in mild COVID-19 Infection
First Author: Devaraja, Vanusha
Reviewed: Apr 7, 2023
|
Devaraja, Vanusha
|
Apr 7, 2023
|
|
Broad and potent neutralizing mAbs are elicited in vaccinated individuals following Delta/BA.1 breakthrough infection
First Author: Seow, Jeffrey
Reviewed: Apr 7, 2023
|
Seow, Jeffrey
|
Apr 7, 2023
|
|
Comparative Effectiveness of Alternative Intervals between First and Second Doses of the mRNA COVID-19 Vaccines: a Trial Emulation Approach
First Author: Shioda, Kayoko
Reviewed: Apr 7, 2023
|
Shioda, Kayoko
|
Apr 7, 2023
|
|
Deep repertoire mining uncovers ultra-broad coronavirus neutralizing antibodies targeting multiple spike epitopes
First Author: Hurtado, Jonathan
Reviewed: Apr 7, 2023
|
Hurtado, Jonathan
|
Apr 7, 2023
|
|
Development of Fully Human, Bispecific Antibodies that Effectively Block Omicron Variant Pseudovirus Infections
First Author: Allen, Jason
Reviewed: Apr 7, 2023
|
Allen, Jason
|
Apr 7, 2023
|
|
Engineering Immunosuppressive Drug Resistant Armored (IDRA) SARS-CoV-2 T cells for cell therapy
First Author: Bertoletti, Antonio
Reviewed: Apr 7, 2023
|
Bertoletti, Antonio
|
Apr 7, 2023
|
|
Explicit Modelling of Antibody Levels for Infectious Disease Simulations in the Context of SARS-CoV-2
First Author: Müller, Sebastian A.
Reviewed: Apr 7, 2023
|
Müller, Sebastian A.
|
Apr 7, 2023
|
|
Forecasting the trajectory of the COVID-19 pandemic into 2023 under plausible variant and intervention scenarios: a global modelling study
First Author: COVID-19 Forecasting Team
Reviewed: Apr 7, 2023
|
COVID-19 Forecasting Team
|
Apr 7, 2023
|
|
Humoral immunity improves with a booster dose of SARS-CoV-2 vaccine in patients with inflammatory bowel disease on immunosuppressants
First Author: Pereira, Magno Luis Costa
Reviewed: Apr 7, 2023
|
Pereira, Magno Luis Costa
|
Apr 7, 2023
|
|
Impact of vaccinations, boosters and lockdowns on COVID-19 waves in French Polynesia
First Author: Chapman, Lloyd
Reviewed: Apr 7, 2023
|
Chapman, Lloyd
|
Apr 7, 2023
|
|
Improving mRNA vaccine safety and efficiency with cationized lipid nanoparticle formula
First Author: Peng, Xu
Reviewed: Apr 7, 2023
|
Peng, Xu
|
Apr 7, 2023
|
|
International Vaccine Allocation: An Optimization Framework
First Author: Holleran, Abraham
Reviewed: Apr 7, 2023
|
Holleran, Abraham
|
Apr 7, 2023
|
|
Lasting first impression: Pre-existing immunity restricts mucosal antibody responses during Omicron breakthrough
First Author: Selva, Kevin John
Reviewed: Apr 7, 2023
|
Selva, Kevin John
|
Apr 7, 2023
|
|
Long-term duration of protection of ancestral-strain monovalent vaccines and effectiveness of the bivalent BA.1 boosters against COVID-19 hospitalisation during a period of BA.5, BQ.1, CH.1.1. and XBB.1.5 circulation in England
First Author: Møller Kirsebom, Freja Cordelia
Reviewed: Apr 7, 2023
|
Møller Kirsebom, Freja Cordelia
|
Apr 7, 2023
|
|
Robust immunogenicity of a third BNT162b2 vaccination against SARS-CoV-2 Omicron variant in a naïve New Zealand cohort
First Author: Lavender, Brittany
Reviewed: Apr 7, 2023
|
Lavender, Brittany
|
Apr 7, 2023
|
|
Serological Response to SARS-CoV-2 after COVID-19 Vaccination in Lung Cancer patients: Short Review
First Author: Rodilla, Ananda
Reviewed: Apr 7, 2023
|
Rodilla, Ananda
|
Apr 7, 2023
|
|
State-Level Excess Mortality in US Adults During the Delta and Omicron Waves of COVID-19
First Author: Renton, Benjamin
Reviewed: Apr 7, 2023
|
Renton, Benjamin
|
Apr 7, 2023
|
|
The Breadth of the Neutralizing Antibody Response to Original SARS-CoV-2 Infection is Linked to the Presence of Long COVID Symptoms
First Author: Buck, Amanda M.
Reviewed: Apr 7, 2023
|
Buck, Amanda M.
|
Apr 7, 2023
|
|
Trends in Antibody Titers after SARS-CoV-2 Vaccination - Insights from a Self-Paid Tests at a General Internal Medicine Clinic
First Author: Kusunoki, Hiroshi
Reviewed: Apr 7, 2023
|
Kusunoki, Hiroshi
|
Apr 7, 2023
|
|
Viral kinetics of sequential SARS-CoV-2 infections
First Author: Kissler, Stephen M
Reviewed: Apr 7, 2023
|
Kissler, Stephen M
|
Apr 7, 2023
|
|
Analysis of blood and nasal epithelial transcriptomes to identify mechanisms associated with control of SARS-CoV-2 viral load in the upper respiratory tract
First Author: Marjaneh, Mahdi Moradi
Reviewed: Apr 5, 2023
|
Marjaneh, Mahdi Moradi
|
Apr 5, 2023
|
|
Boosting human capacities: How vaccination behavior and intention relates to attitudes toward vaccination, Human Enhancement, and naturalness
First Author: Döbler, Niklas Alexander
Reviewed: Apr 5, 2023
|
Döbler, Niklas Alexander
|
Apr 5, 2023
|
|
Comparison of Capillary Blood Self-Collection using the Tasso-SST Device with Venous Phlebotomy for anti-SARS-CoV-2 Antibody Measurement
First Author: King, Elise R.
Reviewed: Apr 5, 2023
|
King, Elise R.
|
Apr 5, 2023
|
|
Deep physico-chemical characterization of individual serum antibody responses against SARS-CoV-2 RBD using a dual titration microspot assay
First Author: Kovács, Ágnes
Reviewed: Apr 5, 2023
|
Kovács, Ágnes
|
Apr 5, 2023
|
|
Effectiveness of the Coronavirus Disease 2019 (COVID-19) Bivalent Vaccine
First Author: Shrestha, Nabin K.
Reviewed: Apr 5, 2023
|
Shrestha, Nabin K.
|
Apr 5, 2023
|
|
How have mathematical models contributed to understanding the transmission and control of SARS-CoV-2 in healthcare settings? A systematic search and review
First Author: Smith, David R M
Reviewed: Apr 5, 2023
|
Smith, David R M
|
Apr 5, 2023
|
|
Index Cases First Identified by Nasal-Swab Rapid COVID-19 Tests Had More Transmission to Household Contacts Than Cases Identified by Other Test Types
First Author: Ji, Jenny
Reviewed: Apr 5, 2023
|
Ji, Jenny
|
Apr 5, 2023
|
|
Lyophilization process optimization and molecular dynamics simulation of mRNA-LNPs for SARS-CoV-2 vaccine
First Author: Yu, Peng
Reviewed: Apr 5, 2023
|
Yu, Peng
|
Apr 5, 2023
|
|
Protection against symptomatic SARS-CoV-2 BA.5 infection conferred by the Pfizer-BioNTech Original/BA.4-5 bivalent vaccine compared to the mRNA Original (ancestral) monovalent vaccines – a matched cohort study in France
First Author: Auvigne, Vincent
Reviewed: Apr 5, 2023
|
Auvigne, Vincent
|
Apr 5, 2023
|
|
Seroprevalence of SARS-CoV-2 anti-nucleocapsid total Ig, anti-RBD IgG antibodies, and infection in Thailand: A cross-sectional survey from October 2022 to January 2023
First Author: Chansaenroj, Jira
Reviewed: Apr 5, 2023
|
Chansaenroj, Jira
|
Apr 5, 2023
|
|
Socio-demographic characteristics associated with COVID-19 vaccination uptake in Switzerland: longitudinal analysis of the CoMix study
First Author: Reichmuth, Martina L
Reviewed: Apr 5, 2023
|
Reichmuth, Martina L
|
Apr 5, 2023
|
|
Virus-response proteinuria underlies rapid changes in kidney filtration barrier function in COVID-19
First Author: Reiser, Jochen
Reviewed: Apr 5, 2023
|
Reiser, Jochen
|
Apr 5, 2023
|
|
Immunometabolic rewiring in long COVID patients with chronic headache
First Author: Foo, Suan-Sin
Reviewed: Mar 30, 2023
|
Foo, Suan-Sin
|
Mar 30, 2023
|
|
Integrative single-cell transcriptome analysis reveals new insights into post-COVID-19 pulmonary fibrosis and potential therapeutic targets
First Author: Kim, Yumin
Reviewed: Mar 30, 2023
|
Kim, Yumin
|
Mar 30, 2023
|
|
Myocardial Infarction across COVID-19 Pandemic Phases: Insights from the Veterans Health Affairs System
First Author: Yong, Celina
Reviewed: Mar 30, 2023
|
Yong, Celina
|
Mar 30, 2023
|
|
Phenome-wide association study to explore the long-term symptoms after infection with novel coronavirus in the UK Biobank
First Author: Zhang, Kai
Reviewed: Mar 30, 2023
|
Zhang, Kai
|
Mar 30, 2023
|
|
Physical activity before, during, and after COVID-19 pandemic: a smartphone-tracking study of university students in Egypt and Saudi Arabia
First Author: Aly, Mohamed
Reviewed: Mar 30, 2023
|
Aly, Mohamed
|
Mar 30, 2023
|
|
Post-COVID-19 syndrome and related dysautonomia reduce quality of life, and increase anxiety and depressive symptoms: evidence from Greece
First Author: Galanis, Petros
Reviewed: Mar 30, 2023
|
Galanis, Petros
|
Mar 30, 2023
|
|
Predictors of mortality among post-COVID-19 discharged patients in Northern India
First Author: Arjun
Reviewed: Mar 30, 2023
|
Arjun
|
Mar 30, 2023
|
|
Risk Factors and Predictive Modeling for Post-Acute Sequelae of SARS-CoV-2 Infection: Findings from EHR Cohorts of the RECOVER Initiative
First Author: Zang, Chengxi
Reviewed: Mar 30, 2023
|
Zang, Chengxi
|
Mar 30, 2023
|
|
Comparison of Vaccination and Booster Rates and Their Impact on Excess Mortality During the COVID-19 Pandemic in European Countries
First Author: Matveeva, Olga
Reviewed: Mar 29, 2023
|
Matveeva, Olga
|
Mar 29, 2023
|
|
Coverage of state-initiated contact-tracing during COVID-19 and factors influencing it: evidence from real-world data
First Author: Mongin, Denis
Reviewed: Mar 29, 2023
|
Mongin, Denis
|
Mar 29, 2023
|
|
COVID-19 Resulted in Classrooms Without Walls: What can Pedagogical and Content Knowledge (PCK) Offer?
First Author: Bedeker, Michelle
Reviewed: Mar 29, 2023
|
Bedeker, Michelle
|
Mar 29, 2023
|
|
Dynamics of upper respiratory tract infections before, during, and after the COVID-19 pandemic in Germany: a cross-sectional study of 2,167,453 outpatients
First Author: Loosen, Sven H.
Reviewed: Mar 29, 2023
|
Loosen, Sven H.
|
Mar 29, 2023
|
|
Employment outcomes of people with Long Covid symptoms: community-based cohort study
First Author: Ayoubkhani, Daniel
Reviewed: Mar 29, 2023
|
Ayoubkhani, Daniel
|
Mar 29, 2023
|
|
Impact of COVID-19 Infection on Cardiorespiratory Fitness, Sleep, and Psychology of Endurance Athletes– CAESAR Study
First Author: Śliż, Daniel
Reviewed: Mar 29, 2023
|
Śliż, Daniel
|
Mar 29, 2023
|
|
Nanograms of SARS-CoV-2 Spike Protein Delivered by Exosomes Induce Potent Neutralization of Both Delta and Omicron Variants
First Author: Cacciottolo, Mafalda
Reviewed: Mar 29, 2023
|
Cacciottolo, Mafalda
|
Mar 29, 2023
|
|
Statistical Computational Analysis in Luxury hotels in the era of COVID-19 : The Cretan case
First Author: Asmargiannakis, Petros
Reviewed: Mar 29, 2023
|
Asmargiannakis, Petros
|
Mar 29, 2023
|
|
Transient Plasma Viral Rebound After Sars-cov-2 Vaccination in an Exceptional Hiv-1 Elite Controller Woman
First Author: Girolamo, Laura Di
Reviewed: Mar 29, 2023
|
Girolamo, Laura Di
|
Mar 29, 2023
|
|
Cerebral Venous Sinus Thrombosis After a Third Dose of mRNA COVID-19 Vaccine in an Adolescent: A case report
First Author: Mizuno, Shinsuke
Reviewed: Mar 26, 2023
|
Mizuno, Shinsuke
|
Mar 26, 2023
|
|
Computable Phenotypes for Post-acute sequelae of SARS-CoV-2: A National COVID Cohort Collaborative Analysis
First Author: Pungitore, Sarah
Reviewed: Mar 26, 2023
|
Pungitore, Sarah
|
Mar 26, 2023
|
|
Enhanced protective efficacy of a novel, thermostable, RBD-S2 fusion immunogen against SARS-CoV-2 and its variants
First Author: Mittal, Nidhi
Reviewed: Mar 26, 2023
|
Mittal, Nidhi
|
Mar 26, 2023
|
|
Immunogenicity and safety of NVX-CoV2373 as a homologous or heterologous booster: A phase 3 randomized clinical trial in adults
First Author: Raiser, Fritz
Reviewed: Mar 26, 2023
|
Raiser, Fritz
|
Mar 26, 2023
|
|
NVX-CoV2373 Vaccine Efficacy Against Hospitalization: A post hoc analysis of the PREVENT-19 phase 3, randomized, placebo-controlled trial
First Author: Marchese, Anthony M.
Reviewed: Mar 26, 2023
|
Marchese, Anthony M.
|
Mar 26, 2023
|
|
Reduced control of SARS-CoV-2 infection is associated with lower mucosal antibody responses in pregnant women
First Author: Clair, Laura A. St
Reviewed: Mar 26, 2023
|
Clair, Laura A. St
|
Mar 26, 2023
|
|
Right and Left Ventricular Cardiac Magnetic Resonance Imaging Derived Peak Systolic Strain is Abnormal in Children with Myocarditis
First Author: Rhee, Elisa
Reviewed: Mar 26, 2023
|
Rhee, Elisa
|
Mar 26, 2023
|
|
Statistical analysis plan for the Identification and Treatment of Hypoxemic Respiratory Failure (HRF) and ARDS with Protection, Paralysis, and Proning: a type-1 hybrid stepped-wedge cluster randomized effectiveness-implementation study
First Author: Parhar, Ken Kuljit S.
Reviewed: Mar 26, 2023
|
Parhar, Ken Kuljit S.
|
Mar 26, 2023
|
|
The effects of COVID-19 on cognitive performance in a community-based cohort: A COVID Symptom Study Biobank observational study
First Author: Cheetham, Nathan J.
Reviewed: Mar 26, 2023
|
Cheetham, Nathan J.
|
Mar 26, 2023
|
|
The impact of COVID-19-related restrictions on pregnancy and abortion rates in the Republic of Georgia
First Author: Khachidze, Nia
Reviewed: Mar 26, 2023
|
Khachidze, Nia
|
Mar 26, 2023
|
|
Thrombosis of Transverse Cerebral Venous Sinus Secondary to Vaccine ChAdOx1-S (Recombinant) First Report in Southamerica
First Author: Dulcey, Luis
Reviewed: Mar 26, 2023
|
Dulcey, Luis
|
Mar 26, 2023
|
|
Treatment of mental disorders and the course of COVID-19
First Author: Korzeniowska, Katarzyna
Reviewed: Mar 26, 2023
|
Korzeniowska, Katarzyna
|
Mar 26, 2023
|
|
Using Proportional Jaccard Indices to Identify Comorbidity Patterns of Heart Failure
First Author: Tang, Yueh
Reviewed: Mar 26, 2023
|
Tang, Yueh
|
Mar 26, 2023
|
|
A general computational design strategy for stabilizing viral class I fusion proteins
First Author: Gonzalez, Karen J.
Reviewed: Mar 23, 2023
|
Gonzalez, Karen J.
|
Mar 23, 2023
|
|
Antibodies generated in vitro and in vivo elucidate design of a thermostable ADDomer COVID-19 nasal nanoparticle vaccine
First Author: Buzas, Dora
Reviewed: Mar 23, 2023
|
Buzas, Dora
|
Mar 23, 2023
|
|
Assessment of Retrospective Collection of EQ-5D-5L in a US COVID-19 Population
First Author: Sun, Xiaowu
Reviewed: Mar 23, 2023
|
Sun, Xiaowu
|
Mar 23, 2023
|
|
Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection
First Author: Moyo-Gwete, Thandeka
Reviewed: Mar 23, 2023
|
Moyo-Gwete, Thandeka
|
Mar 23, 2023
|
|
Impact of COVID-19 and effects of booster vaccination with BNT162b2 on six-month long COVID symptoms, quality of life, work productivity and activity impairment during Omicron
First Author: Di Fusco, Manuela
Reviewed: Mar 23, 2023
|
Di Fusco, Manuela
|
Mar 23, 2023
|
|
Increased vaccine sensitivity of an emerging SARS-CoV-2 variant
First Author: Lewnard, Joseph A.
Reviewed: Mar 23, 2023
|
Lewnard, Joseph A.
|
Mar 23, 2023
|
|
Isolation of a pair of potent broadly neutralizing mAb binding to RBD and SD1 domains of SARS-CoV-2
First Author: Stuart, David
Reviewed: Mar 23, 2023
|
Stuart, David
|
Mar 23, 2023
|
|
Latin-American Registry of Cardiovascular Disease and COVID-19: Final Results
First Author: Gómez-Mesa, Juan Esteban
Reviewed: Mar 23, 2023
|
Gómez-Mesa, Juan Esteban
|
Mar 23, 2023
|
|
Modeling COVID-19 vaccination strategies in LMICs considering uncertainty in viral evolution and immunity
First Author: Klein, Daniel J.
Reviewed: Mar 23, 2023
|
Klein, Daniel J.
|
Mar 23, 2023
|
|
Modelling the impact of hybrid immunity on future COVID-19 epidemic waves
First Author: Le, Thao P.
Reviewed: Mar 23, 2023
|
Le, Thao P.
|
Mar 23, 2023
|
|
mRNA aggregates harness danger response for potent cancer immunotherapy
First Author: Mendez-Gomez, Hector R.
Reviewed: Mar 23, 2023
|
Mendez-Gomez, Hector R.
|
Mar 23, 2023
|
|
Multiple Roads to Success: A Latent Class Analysis on Successful Aging in Hong Kong Near-Centenarians and Centenarians (NCC) Amidst COVID-19
First Author: Shum, Eric Ngai-Yin
Reviewed: Mar 23, 2023
|
Shum, Eric Ngai-Yin
|
Mar 23, 2023
|
|
Post-COVID-19 syndrome and related dysautonomia affect patients’ life and work productivity
First Author: Galanis, Petros
Reviewed: Mar 23, 2023
|
Galanis, Petros
|
Mar 23, 2023
|
|
Relative vaccine effectiveness (rVE) of mRNA COVID-19 boosters in the UK vaccination programme, during the Spring-Summer (monovalent vaccine) and Autumn-Winter 2022 (bivalent vaccine) booster campaigns: a prospective test negative case-control study
First Author: Chatzilena, Anastasia
Reviewed: Mar 23, 2023
|
Chatzilena, Anastasia
|
Mar 23, 2023
|
|
Serial SARS-CoV-2 antibody titers in vaccinated dialysis patients: prevalence of unrecognized infection and duration of seroresponse
First Author: Hsu, Caroline M.
Reviewed: Mar 23, 2023
|
Hsu, Caroline M.
|
Mar 23, 2023
|
|
The incidence of positive bloodstream and urine cultures in five Australian hospitals during the COVID-19 pandemic
First Author: Mitchell, Brett G
Reviewed: Mar 23, 2023
|
Mitchell, Brett G
|
Mar 23, 2023
|
|
Treatment of Long COVID symptoms with triple anticoagulant therapy
First Author: Laubshder, Gert
Reviewed: Mar 23, 2023
|
Laubshder, Gert
|
Mar 23, 2023
|
|
Tryptophan catabolites, inflammation, and insulin resistance as determinants of chronic fatigue syndrome and affective symptoms in Long COVID
First Author: Al-Hakeim, Hussein Kadhem
Reviewed: Mar 23, 2023
|
Al-Hakeim, Hussein Kadhem
|
Mar 23, 2023
|
|
‘Which severe COVID-19 patients could benefit from High dose dexamethasone? A Bayesian reanalysis of a randomized clinical trial
First Author: Sylvie, Chevret
Reviewed: Mar 21, 2023
|
Sylvie, Chevret
|
Mar 21, 2023
|
|
How long is the long COVID? a retrospective analysis of football players in two major European Championships
First Author: Miccinilli, Sandra
Reviewed: Mar 21, 2023
|
Miccinilli, Sandra
|
Mar 21, 2023
|
|
Inhibition of SARS-CoV-2 3CLpro in vitro by chemically modified tyrosinase from Agaricus bisporus
First Author: Aguilera, David
Reviewed: Mar 21, 2023
|
Aguilera, David
|
Mar 21, 2023
|
|
Longitudinal SARS-CoV-2 neutralization of Omicron BA.1, BA.5 and BQ.1.1 after four vaccinations and the impact of break-through infections in hemodialysis patients
First Author: Platen, Louise
Reviewed: Mar 21, 2023
|
Platen, Louise
|
Mar 21, 2023
|
|
Murine Alveolar Macrophages Rapidly Accumulate Intranasally Administered SARS-CoV-2 Spike Protein leading to Neutrophil Recruitment and Damage
First Author: Park, Chung
Reviewed: Mar 21, 2023
|
Park, Chung
|
Mar 21, 2023
|
|
Post COVID-19 conditions in Children and Adolescents at 3 months following a Delta outbreak in Australia: a cohort study
First Author: Britton, Philip N
Reviewed: Mar 21, 2023
|
Britton, Philip N
|
Mar 21, 2023
|
- Pediatrics/Adolescents
- Long COVID
|
Proteomic Characterization of Acute Kidney Injury in Patients Hospitalized with SARS-CoV2 Infection
First Author: Nadkarni, Girish
Reviewed: Mar 21, 2023
|
Nadkarni, Girish
|
Mar 21, 2023
|
|
Strategies for the Management of Spike Protein-Related Pathology
First Author: Halma, Matthew T.J.
Reviewed: Mar 21, 2023
|
Halma, Matthew T.J.
|
Mar 21, 2023
|
|
Structuring the relationship between subjective well-being and psychological factors in Japan and the United States
First Author: Kitashima, Chiho
Reviewed: Mar 21, 2023
|
Kitashima, Chiho
|
Mar 21, 2023
|
|
Tetravalent SARS-CoV-2 S1 Subunit Protein Vaccination Elicits Robust Humoral and Cellular Immune Responses in SIV-Infected Rhesus Macaque Controllers
First Author: Khan, Muhammad S.
Reviewed: Mar 21, 2023
|
Khan, Muhammad S.
|
Mar 21, 2023
|
|
The cost of primary care consultations associated with long COVID in non-hospitalised adults: a retrospective cohort study using UK primary care data
First Author: Tufts, Jake
Reviewed: Mar 21, 2023
|
Tufts, Jake
|
Mar 21, 2023
|
|
Urine proteomic characterization of active and recovered COVID-19 patients
First Author: Sun, Jianping
Reviewed: Mar 21, 2023
|
Sun, Jianping
|
Mar 21, 2023
|
|
A standardised protocol for assessment of relative SARS-CoV-2 variant
severity, with application to severity risk for COVID-19 cases infected with
Omicron BA.1 compared to Delta variants in six European countries
First Author: Nyberg, Tommy
Reviewed: Mar 18, 2023
|
Nyberg, Tommy
|
Mar 18, 2023
|
|
Characterization of Long COVID among U.S. Medicare Beneficiaries using Claims Data
First Author: Lu, Yun
Reviewed: Mar 18, 2023
|
Lu, Yun
|
Mar 18, 2023
|
|
Dosing of convalescent plasma and hyperimmune anti-SARS-CoV-2 immunoglobulins: a phase I/II dose finding study
First Author: Huygens, Sammy
Reviewed: Mar 18, 2023
|
Huygens, Sammy
|
Mar 18, 2023
|
|
Hybrid immunity elicits potent cross-variant ADCC against SARS-CoV-2 through a combination of anti-S1 and S2 antibodies
First Author: Grant, Michael D.
Reviewed: Mar 18, 2023
|
Grant, Michael D.
|
Mar 18, 2023
|
|
No immunological interference or safety concerns when adjuvanted recombinant zoster vaccine is coadministered with a COVID-19 mRNA-1273 booster vaccine in adults aged 50 years and older: A randomized trial
First Author: Naficy, Abdi
Reviewed: Mar 18, 2023
|
Naficy, Abdi
|
Mar 18, 2023
|
|
Post-acute sequelae SARS-CoV-2 (PASC) infection and molecular signaling - A quasi-experimental study evaluating a natural supplement
First Author: Sigamani, Alben
Reviewed: Mar 18, 2023
|
Sigamani, Alben
|
Mar 18, 2023
|
|
T cell immunity of the nonadjuvanted HLA-restricted peptide COVID-19 vaccine
First Author: Lee, Yi-Ru
Reviewed: Mar 18, 2023
|
Lee, Yi-Ru
|
Mar 18, 2023
|
|
The burden of long COVID: a multinational cohort analysis of Spanish and UK data including SARS-CoV-2 infections, reinfections, and matched contemporaneous test negative controls
First Author: Prieto-Alhambra, Daniel
Reviewed: Mar 18, 2023
|
Prieto-Alhambra, Daniel
|
Mar 18, 2023
|
|
The Relationship of Depression, Anxiety, Stress and Post-Traumatic Stress Disorder with Professional Quality of Life Among Healthcare Workers During the COVID-19 Pandemic in Turkey
First Author: GÖRGÜN, Ceren TÜRKDOĞAN
Reviewed: Mar 18, 2023
|
GÖRGÜN, Ceren TÜRKDOĞAN
|
Mar 18, 2023
|
|
A Bayesian spatio-temporal study of meteorological factors affecting the spread of COVID-19
First Author: Mullineaux, Jamie
Reviewed: Mar 15, 2023
|
Mullineaux, Jamie
|
Mar 15, 2023
|
|
A large-scale and PCR-referenced vocal audio dataset for COVID-19
First Author: Budd, Jobie
Reviewed: Mar 15, 2023
|
Budd, Jobie
|
Mar 15, 2023
|
|
A single C-terminal residue controls SARS-CoV-2 spike trafficking and virion assembly
First Author: Dey, Debajit
Reviewed: Mar 15, 2023
|
Dey, Debajit
|
Mar 15, 2023
|
|
Assessing the utility of COVID-19 case reports as a leading indicator for hospitalization forecasting in the United States
First Author: Reich, Nicholas G
Reviewed: Mar 15, 2023
|
Reich, Nicholas G
|
Mar 15, 2023
|
|
Cause of Death by Race and Ethnicity in Minnesota Before and During the COVID-19 Pandemic, 2019-2020
First Author: Blake, Madelyn J.
Reviewed: Mar 15, 2023
|
Blake, Madelyn J.
|
Mar 15, 2023
|
|
Clinical performance of a chemiluminescence SARS-CoV-2 antibody assay in a cohort of healthcare workers, blood donors and COVID-19 patients
First Author: Rangel, Giselle
Reviewed: Mar 15, 2023
|
Rangel, Giselle
|
Mar 15, 2023
|
|
COVID-19 Detection Using Segmentation, Region Extraction and Classification Pipeline
First Author: Morani, Kenan
Reviewed: Mar 15, 2023
|
Morani, Kenan
|
Mar 15, 2023
|
|
Cross-device Federated Learning for Mobile Health Diagnostics: A First Study on COVID-19 Detection
First Author: Xia, Tong
Reviewed: Mar 15, 2023
|
Xia, Tong
|
Mar 15, 2023
|
|
Diversity of symptom phenotypes in SARS-CoV-2 community infections observed in multiple large datasets
First Author: Fyles, Martyn
Reviewed: Mar 15, 2023
|
Fyles, Martyn
|
Mar 15, 2023
|
|
Early proximal tubular injury in COVID-19 related ARDS: the URICOV study
First Author: Bobot, Mickaël
Reviewed: Mar 15, 2023
|
Bobot, Mickaël
|
Mar 15, 2023
|
|
Endemic infectious states below the epidemic threshold and beyond herd immunity
First Author: Aguilar, Javier
Reviewed: Mar 15, 2023
|
Aguilar, Javier
|
Mar 15, 2023
|
|
Enhancing COVID-19 Severity Analysis through Ensemble Methods
First Author: Thyagachandran, Anand
Reviewed: Mar 15, 2023
|
Thyagachandran, Anand
|
Mar 15, 2023
|
|
Evaluating targeted COVID-19 vaccination strategies with agent-based modeling
First Author: Hladish, Thomas J.
Reviewed: Mar 15, 2023
|
Hladish, Thomas J.
|
Mar 15, 2023
|
|
IL-6 and IL-17 may provide a potential link between hypertension and long-COVID sequelae in hemodialysis patients: A multicenter cross-sectional study
First Author: Stepanova, Natalia
Reviewed: Mar 15, 2023
|
Stepanova, Natalia
|
Mar 15, 2023
|
|
Impaired potency of neutralizing antibodies against cell-cell fusion mediated by SARS-CoV-2
First Author: Wang, Qian
Reviewed: Mar 15, 2023
|
Wang, Qian
|
Mar 15, 2023
|
|
Integrated analyses of single-cell RNA-seq public data reveal the gene regulatory network landscape of respiratory epithelial and peripheral immune cells in COVID-19 patients
First Author: Zhang, Lin
Reviewed: Mar 15, 2023
|
Zhang, Lin
|
Mar 15, 2023
|
|
Is Smart Working Beneficial for Workers' Well-being? A Longitudinal Investigation of Smart Working, Workload and Hair Cortisol/Dehydroepiandrosterone Sulfate during the COVID-19 Pandemic
First Author: Falco, Alessandra
Reviewed: Mar 15, 2023
|
Falco, Alessandra
|
Mar 15, 2023
|
|
Long-term monitoring of COVID 19 prevalence in raw and treated wastewater in Salvador, a largest capital of Brazilian Northeast
First Author: Rolo, Carolina Araújo
Reviewed: Mar 15, 2023
|
Rolo, Carolina Araújo
|
Mar 15, 2023
|
|
Medium-term scenarios of COVID-19 as a function of immune uncertainties and chronic disease
First Author: Saad-Roy, Chadi M.
Reviewed: Mar 15, 2023
|
Saad-Roy, Chadi M.
|
Mar 15, 2023
|
|
Molecular pathology of acute respiratory distress syndrome, mechanical ventilation and abnormal coagulation in severe COVID-19
First Author: Soulé, Antoine
Reviewed: Mar 15, 2023
|
Soulé, Antoine
|
Mar 15, 2023
|
|
Observational Causal Inference in Novel Diseases: A Case Study of COVID-19
First Author: Peysakhovich, Alexander
Reviewed: Mar 15, 2023
|
Peysakhovich, Alexander
|
Mar 15, 2023
|
|
Prevalence of IgG and IgM to SARS-CoV-2 and other human coronaviruses in The Democratic Republic of Congo, Sierra Leone and Uganda: A Longitudinal Study
First Author: Lawal, Bolarinde J.
Reviewed: Mar 15, 2023
|
Lawal, Bolarinde J.
|
Mar 15, 2023
|
|
Rational design of highly potent SARS-CoV-2 nsp14 methyltransferase inhibitors
First Author: Stefek, Milan
Reviewed: Mar 15, 2023
|
Stefek, Milan
|
Mar 15, 2023
|
|
Real-world effectiveness of sotrovimab for the treatment of SARS-CoV-2 infection during Omicron BA.2 subvariant predominance: a systematic literature review
First Author: Drysdale, Myriam
Reviewed: Mar 15, 2023
|
Drysdale, Myriam
|
Mar 15, 2023
|
|
Relationship between sarcopenia and cachexia with prognostic markers of middle-aged and older inpatients with COVID-19: a case-control study
First Author: Júnior, José Reginaldo Alves de Queiroz
Reviewed: Mar 15, 2023
|
Júnior, José Reginaldo Alves de Queiroz
|
Mar 15, 2023
|
|
SARS-CoV-2 Positivity and Viral Load during Three Viral Waves in Mumbai, India
First Author: Nikam, Chaitali
Reviewed: Mar 15, 2023
|
Nikam, Chaitali
|
Mar 15, 2023
|
|
SARS-CoV-2 protein structure and sequence mutations: evolutionary analysis and effects on virus variants
First Author: Lomoio, Ugo
Reviewed: Mar 15, 2023
|
Lomoio, Ugo
|
Mar 15, 2023
|
|
Sequence analysis of hot spot regions of spike and RNA‑dependent‑RNA polymerase (RdRp) genes of SARS-CoV-2 in Kerman, Iran
First Author: Arefinia, Nasir
Reviewed: Mar 15, 2023
|
Arefinia, Nasir
|
Mar 15, 2023
|
|
Sociodemographic inequity in COVID-19 vaccine uptake among youth in Zimbabwe
First Author: Larsson, Leyla
Reviewed: Mar 15, 2023
|
Larsson, Leyla
|
Mar 15, 2023
|
|
Spatio-temporal distributions of COVID-19 vaccine doses uptake in the Netherlands: A Bayesian ecological modelling analysis
First Author: Wang, Haoyi
Reviewed: Mar 15, 2023
|
Wang, Haoyi
|
Mar 15, 2023
|
|
Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that bind a conserved membrane proximal epitope of the spike
First Author: De Cae, Sieglinde
Reviewed: Mar 15, 2023
|
De Cae, Sieglinde
|
Mar 15, 2023
|
|
Use of Personal Protective Equipment in General Practice and Ambulance settings: a rapid review
First Author: Needham, Antonia
Reviewed: Mar 15, 2023
|
Needham, Antonia
|
Mar 15, 2023
|
|
Adaptation of a community health outreach model during the COVID-19 pandemic: The case of the Mexican Consulates in the United States of America
First Author: Gaitán-Rossi, Pablo
Reviewed: Mar 13, 2023
|
Gaitán-Rossi, Pablo
|
Mar 13, 2023
|
|
Age and Sex-Related Comparison of Telemedicine Service Utilization During the COVID-19 Pandemic: A Retrospective Analysis
First Author: Wong, Hubert
Reviewed: Mar 13, 2023
|
Wong, Hubert
|
Mar 13, 2023
|
|
Analysis of SARS-CoV-2 mutations associated with resistance to therapeutic monoclonal antibodies that emerge after treatment
First Author: Focosi, Daniele
Reviewed: Mar 13, 2023
|
Focosi, Daniele
|
Mar 13, 2023
|
|
Assessment of neutralization susceptibility of Omicron subvariants XBB.1.5 and BQ.1.1 against broad-spectrum neutralizing antibodies through epitopes mapping
First Author: Shah, Masaud
Reviewed: Mar 13, 2023
|
Shah, Masaud
|
Mar 13, 2023
|
|
Association between spironolactone use and COVID-19 outcomes in population-scale claims data: a retrospective cohort study
First Author: Cousins, Henry C.
Reviewed: Mar 13, 2023
|
Cousins, Henry C.
|
Mar 13, 2023
|
|
Association of Nirmatrelvir/Ritonavir Treatment with Long COVID Symptoms in an Online Cohort of Non-Hospitalized Individuals Experiencing Breakthrough SARS-CoV-2 Infection in the Omicron Era
First Author: Durstenfeld, Matthew S.
Reviewed: Mar 13, 2023
|
Durstenfeld, Matthew S.
|
Mar 13, 2023
|
|
Association of SARS-CoV-2 Nucleocapsid Protein Mutations with Patient Demographic and Clinical Characteristics during the Delta and Omicron Waves
First Author: Alsuwairi, Feda A.
Reviewed: Mar 13, 2023
|
Alsuwairi, Feda A.
|
Mar 13, 2023
|
|
Bivalent booster effectiveness against severe COVID-19 outcomes in Finland, September 2022 — January 2023
First Author: Poukka, Eero
Reviewed: Mar 13, 2023
|
Poukka, Eero
|
Mar 13, 2023
|
|
Campus Sewage Water Surveillance based dynamics and infection trends of SARS-CoV-2 variants during third wave of COVID-19 in Pune, India
First Author: Malik, Vinita
Reviewed: Mar 13, 2023
|
Malik, Vinita
|
Mar 13, 2023
|
|
Combining models to generate a consensus effective reproduction number R for the COVID-19 epidemic status in England
First Author: Park, Josie
Reviewed: Mar 13, 2023
|
Park, Josie
|
Mar 13, 2023
|
|
COVID-19 caused by either Omicron sub-variants or Delta in non-hospitalised adults associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history
First Author: Townsley, Hermaleigh
Reviewed: Mar 13, 2023
|
Townsley, Hermaleigh
|
Mar 13, 2023
|
|
COVID-19 or seasonal influenza? How to distinguish in people younger than 65 years old — — A retrospective observational cohort study comparing the 2009 pandemic influenza A H1N1 with 2022 SARS-CoV-2 Omicron BA.2 outbreaks in China
First Author: Zhong, Wen
Reviewed: Mar 13, 2023
|
Zhong, Wen
|
Mar 13, 2023
|
|
COVID-19 vaccination coverage and linkages with public willingness to receive vaccination prior to vaccine roll-out: Evidence from Rwanda
First Author: Ndishimye, Pacifique
Reviewed: Mar 13, 2023
|
Ndishimye, Pacifique
|
Mar 13, 2023
|
|
Decline in prevalence of tuberculosis following an intensive case-finding campaign and the COVID-19 pandemic in an urban Ugandan community
First Author: Kendall, Emily A
Reviewed: Mar 13, 2023
|
Kendall, Emily A
|
Mar 13, 2023
|
|
Detection of SARS-CoV-2 in Schools Using Built Environment Testing in Ottawa, Canada: A Multi-Facility Prospective Surveillance Study
First Author: Thampi, Nisha
Reviewed: Mar 13, 2023
|
Thampi, Nisha
|
Mar 13, 2023
|
|
Determinants of COVID-19 vaccine uptake among Nigerians: evidence from a cross- sectional national survey
First Author: OJO, Temitope Olumuyiwa
Reviewed: Mar 13, 2023
|
OJO, Temitope Olumuyiwa
|
Mar 13, 2023
|
|
Effectiveness of successive booster vaccine doses against SARS-CoV-2 related mortality in residents of Long-Term Care Facilities in the VIVALDI study
First Author: Stirrup, Oliver
Reviewed: Mar 13, 2023
|
Stirrup, Oliver
|
Mar 13, 2023
|
|
Estimating vaccine-preventable COVID-19 deaths under counterfactual vaccination scenarios in the United States
First Author: Zhong, Ming
Reviewed: Mar 13, 2023
|
Zhong, Ming
|
Mar 13, 2023
|
|
How much did the Covid-19 shielding policy cost in Wales? A Retrospective Cost analysis within the EVITE Immunity study
First Author: Sewell, Bernadette
Reviewed: Mar 13, 2023
|
Sewell, Bernadette
|
Mar 13, 2023
|
|
Impact of the COVID-19 Pandemic Crisis on Turnover Intention Among Nurses in Emergency Departments in Thailand: A Cross Sectional Study
First Author: Sungbun, Songwut
Reviewed: Mar 13, 2023
|
Sungbun, Songwut
|
Mar 13, 2023
|
|
Is soluble urokinase plasminogen activator receptor levels still a prognostic biomarker of COVID-19 in the Omicron era?
First Author: Holub, Michal
Reviewed: Mar 13, 2023
|
Holub, Michal
|
Mar 13, 2023
|
|
Major depressive disorders and the risk of susceptibility to COVID-19 infection and hospitalization: findings from the Employees’ Health Cohort Study of Iran (EHCSIR)
First Author: Nasirpour, Nastaran
Reviewed: Mar 13, 2023
|
Nasirpour, Nastaran
|
Mar 13, 2023
|
|
Management of Risk Factors for Health Care Workers After Initial Contact with Patients Infected with SARS-COV-2 in Niamey, The Center of the Epidemic in Niger
First Author: Ramatoulaye, Hamidou Lazoumar
Reviewed: Mar 13, 2023
|
Ramatoulaye, Hamidou Lazoumar
|
Mar 13, 2023
|
|
Mental health during COVID-19: an evaluation of an academic university’s contribution to existing research
First Author: Tawil, Samah
Reviewed: Mar 13, 2023
|
Tawil, Samah
|
Mar 13, 2023
|
|
Modelling the association between neutralizing antibody levels and SARS-CoV-2 viral dynamics : implications to define correlates of protection against infection
First Author: Lingas, Guillaume
Reviewed: Mar 13, 2023
|
Lingas, Guillaume
|
Mar 13, 2023
|
|
Molnupiravir’s real-world effectiveness in COVID-19 non-hospitalized patients at high risk of severe disease: a single-center study
First Author: Gmizic, I
Reviewed: Mar 13, 2023
|
Gmizic, I
|
Mar 13, 2023
|
|
Phase I Clinical Trial. Safety of Baricitinib to prevent respiratory insufficiency in oncohematological patients affected by Coronavirus Disease-19: BARCOVID19 study
First Author: Sanz-Linares, Gabriela
Reviewed: Mar 13, 2023
|
Sanz-Linares, Gabriela
|
Mar 13, 2023
|
|
Polygenic regression uncovers trait-relevant cellular contexts through pathway activation transformation of single-cell RNA sequencing data
First Author: Ma, Yunlong
Reviewed: Mar 13, 2023
|
Ma, Yunlong
|
Mar 13, 2023
|
|
Potential relationships between uveitis and COVID-19: a bioinformatic study based on CEO database
First Author: Li, Chen
Reviewed: Mar 13, 2023
|
Li, Chen
|
Mar 13, 2023
|
|
Predicting the feasibility of targeting a conserved region on the S2 domain of the SARS-CoV-2 spike protein
First Author: Garg, Pranav
Reviewed: Mar 13, 2023
|
Garg, Pranav
|
Mar 13, 2023
|
|
Real-time Dissection and Forecast of Infection Dynamics during a Pandemic
First Author: Schulz, Steven
Reviewed: Mar 13, 2023
|
Schulz, Steven
|
Mar 13, 2023
|
|
Risk of cardiovascular events following COVID-19 in people with and without pre-existing chronic respiratory disease
First Author: Whittaker, Hannah
Reviewed: Mar 13, 2023
|
Whittaker, Hannah
|
Mar 13, 2023
|
|
SARS-CoV-2 ORF3c suppresses immune activation by inhibiting innate sensing
First Author: Müller, Martin
Reviewed: Mar 13, 2023
|
Müller, Martin
|
Mar 13, 2023
|
|
SARS-CoV-2 post-vaccine surveillance studies in Australian children and adults with cancer: SerOzNET Quality of Life, Toxicity and Vaccine Beliefs Substudy Statistical Analysis Plan
First Author: Donoghue, Mark W
Reviewed: Mar 13, 2023
|
Donoghue, Mark W
|
Mar 13, 2023
|
|
SARS-CoV-2 post-vaccine surveillance studies in Australian children and adults with cancer: SerOzNET Statistical Analysis Plan
First Author: Body, Amy
Reviewed: Mar 13, 2023
|
Body, Amy
|
Mar 13, 2023
|
|
Shedding of SARS-CoV-2 genome in wastewater after COVID-19 outbreaks at nursing care homes in Japan: An ad-hoc survey
First Author: Yoshida, Hiromu
Reviewed: Mar 13, 2023
|
Yoshida, Hiromu
|
Mar 13, 2023
|
|
Spatially-resolved wastewater-based surveillance enables COVID-19 case localization across a university campus, and confirms lower SARS-CoV-2 RNA burden relative to the surrounding community
First Author: Lee, Jangwoo
Reviewed: Mar 13, 2023
|
Lee, Jangwoo
|
Mar 13, 2023
|
|
Stakeholder perspectives on the impact of Covid-19 on Oncology services: A qualitative study
First Author: Butow, Phyllis
Reviewed: Mar 13, 2023
|
Butow, Phyllis
|
Mar 13, 2023
|
|
Systematic analyses of the resistance potential of drugs targeting SARS-CoV-2 main protease
First Author: Flynn, Julia M.
Reviewed: Mar 13, 2023
|
Flynn, Julia M.
|
Mar 13, 2023
|
|
The risk of hospitalization for psychotic disorders following hospitalization for COVID-19: a French nationwide longitudinal study
First Author: Pignon, Baptiste
Reviewed: Mar 13, 2023
|
Pignon, Baptiste
|
Mar 13, 2023
|
|
The Second CACHE Challenge - Targeting the RNA-Binding Pocket of the SARS-CoV2 Nonstructural Protein 13 via a consensus-scoring method and FITTED templated docking.
First Author: Nivedha, Anita K.
Reviewed: Mar 13, 2023
|
Nivedha, Anita K.
|
Mar 13, 2023
|
|
Third and fourth vaccine doses broaden and prolong immunity to SARS-CoV-2 in immunocompromised adult patients
First Author: Cheung, Michelle W
Reviewed: Mar 13, 2023
|
Cheung, Michelle W
|
Mar 13, 2023
|
|
Virological evidence of the impact of non-pharmaceutical interventions against COVID-19 in a resource-limited setting
First Author: Moreira-Soto, Andres
Reviewed: Mar 13, 2023
|
Moreira-Soto, Andres
|
Mar 13, 2023
|
|
Efficacy of COVID-19 Vaccines Against the Omicron Variant of SARS-CoV-2
First Author: Rajsri, Kritika Srinivasan
Reviewed: Mar 9, 2023
|
Rajsri, Kritika Srinivasan
|
Mar 9, 2023
|
|
Impact of Timing and Combination of different BNT162b2 and ChAdOx1-S Covid-19 Basic and Booster Vaccinations on Humoral Immunogenicity and Reactogenicity in Adults
First Author: Dedroogh, Simon
Reviewed: Mar 9, 2023
|
Dedroogh, Simon
|
Mar 9, 2023
|
|
Progressive multifocal leukoencephalopathy in a patient with B-cell chronic lymphocytic leukemia after Covid 19 vaccination, complicated with Covid-19 and mucormycosis: a case report
First Author: Amirifard, Hamed
Reviewed: Mar 9, 2023
|
Amirifard, Hamed
|
Mar 9, 2023
|
|
The infectivity of SARS-CoV-2 progeny virions requires the activity of host cell N-myristoyltransferases and it is severely compromised by their inhibition
First Author: Saber, Saber H.
Reviewed: Mar 9, 2023
|
Saber, Saber H.
|
Mar 9, 2023
|
|
A Landscape on Disorders Following Different COVID-19 Vaccination: A Systematic Review of Iranian Case Reports
First Author: Larijani, Mona Sadat
Reviewed: Mar 7, 2023
|
Larijani, Mona Sadat
|
Mar 7, 2023
|
|
A novel approach for estimating vaccine efficacy for infections with multiple disease outcomes: application to a COVID-19 vaccine trial
First Author: Williams, Lucy R
Reviewed: Mar 7, 2023
|
Williams, Lucy R
|
Mar 7, 2023
|
|
A survey and antibody test following the surge of SARS-CoV-2 Omicron infection in China
First Author: Yao, Yichuan
Reviewed: Mar 7, 2023
|
Yao, Yichuan
|
Mar 7, 2023
|
|
Bulk RNA-Sequencing of small airway cell cultures from IPF and post-COVID lung fibrosis patients illustrates disease signatures and differential responses to TGF-β1 treatment
First Author: Uhl, Katie
Reviewed: Mar 7, 2023
|
Uhl, Katie
|
Mar 7, 2023
|
|
COVID-19 adenoviral vector vaccination elicits a robust memory B cell response with the capacity to recognize Omicron BA.2 and BA.5 variants
First Author: Fryer, Holly A.
Reviewed: Mar 7, 2023
|
Fryer, Holly A.
|
Mar 7, 2023
|
|
Cutaneous jet-injection of naked mRNA vaccine induces robust immune responses without systemic vaccine spillage
First Author: Abbasi, Saed
Reviewed: Mar 7, 2023
|
Abbasi, Saed
|
Mar 7, 2023
|
|
Engineered Immunogens to Expose Conserved Epitopes Targeted by Broad Coronavirus Antibodies
First Author: Kapingidza, Brenda
Reviewed: Mar 7, 2023
|
Kapingidza, Brenda
|
Mar 7, 2023
|
|
Genomic perspectives of SARS CoV-2 in liver disease patients with its clinical correlation: A single centre retrospective study
First Author: Bhugra, Arjun
Reviewed: Mar 7, 2023
|
Bhugra, Arjun
|
Mar 7, 2023
|
|
IgG4 serum levels are not elevated in cases of Post-COVID syndrome
First Author: Abel, Jonas
Reviewed: Mar 7, 2023
|
Abel, Jonas
|
Mar 7, 2023
|
|
Immune response to COVID-19 vaccines in people with immunodeficiencies
First Author: Ricotta, Emily
Reviewed: Mar 7, 2023
|
Ricotta, Emily
|
Mar 7, 2023
|
|
Initial multiple sclerosis presentation as optic neuritis following COVID-19 vaccination: A case report
First Author: Hashim, Ahmed Shamil
Reviewed: Mar 7, 2023
|
Hashim, Ahmed Shamil
|
Mar 7, 2023
|
|
Neutralizing antibody levels and epidemiological information of patients with breakthrough COVID-19 infection in Toyama, Japan
First Author: Tani, Hideki
Reviewed: Mar 7, 2023
|
Tani, Hideki
|
Mar 7, 2023
|
|
The gray swan: model-based assessment of the risk of sudden failure of hybrid immunity to SARS-CoV-2
First Author: Stoddard, Madison
Reviewed: Mar 7, 2023
|
Stoddard, Madison
|
Mar 7, 2023
|
|
The impact of early anti-SARS-CoV-2 antibody production on the length of hospitalization stay among COVID-19 patients
First Author: de Almeida, Dalziza Victalina
Reviewed: Mar 7, 2023
|
de Almeida, Dalziza Victalina
|
Mar 7, 2023
|
|
The relationship between mental health, sleep quality, and the immunogenicity of COVID-19 vaccinations
First Author: Wagenhäuser, Isabell
Reviewed: Mar 7, 2023
|
Wagenhäuser, Isabell
|
Mar 7, 2023
|
|
Deep learning for COVID-19 topic modelling via Twitter: Alpha, Delta and
Omicron
First Author: Lande, Janhavi
Reviewed: Mar 3, 2023
|
Lande, Janhavi
|
Mar 3, 2023
|
|
Evaluation of the Haematological Patterns from up to 985 Days of Long COVID: A Cross-Sectional Study
First Author: Gal�cio, Vanessa Costa Alves
Reviewed: Mar 1, 2023
|
Gal�cio, Vanessa Costa Alves
|
Mar 1, 2023
|
|
Genomic Determinants of Long COVID
First Author: Corpas, Manuel
Reviewed: Mar 1, 2023
|
Corpas, Manuel
|
Mar 1, 2023
|
|
Safety and immunogenicity of SCB-2019, an adjuvanted, recombinant SARS-CoV-2 trimeric S-protein subunit COVID-19 vaccine in healthy 12–17 year-old adolescents
First Author: Lopez, Pio
Reviewed: Mar 1, 2023
|
Lopez, Pio
|
Mar 1, 2023
|
|
Safety of Cov2-Bio COVID-19 Vaccine in Healthy Populations Aged 18 years and Above in Indonesia
First Author: Koesnoe, Sukamto
Reviewed: Mar 1, 2023
|
Koesnoe, Sukamto
|
Mar 1, 2023
|
|
Safety of the NVX-CoV2373 COVID-19 Vaccine in Randomized Placebo-Controlled Clinical Trials
First Author: Smith, Katherine
Reviewed: Mar 1, 2023
|
Smith, Katherine
|
Mar 1, 2023
|
|
Task shifting healthcare services in the post-COVID world: A scoping review
First Author: Das, Shukanto
Reviewed: Mar 1, 2023
|
Das, Shukanto
|
Mar 1, 2023
|
|
A comprehensive survey on the beliefs, perceptions, and clinical manifestations of pre and post Covid-19 vaccinations among physiotherapy students in the United Arab Emirates
First Author: Almheiri, Shaikha
Reviewed: Feb 28, 2023
|
Almheiri, Shaikha
|
Feb 28, 2023
|
|
A third vaccine dose equalizes the levels of effectiveness and immunogenicity of heterologous or homologous COVID-19 vaccine regimens
First Author: Guibert, Nicolas
Reviewed: Feb 28, 2023
|
Guibert, Nicolas
|
Feb 28, 2023
|
|
A unique cytotoxic CD4+ T cells signature defines critical COVID-19
First Author: Baird, Sarah
Reviewed: Feb 28, 2023
|
Baird, Sarah
|
Feb 28, 2023
|
|
Age-Associated B cells predict impaired humoral immunity after COVID-19 vaccination in patients receiving immune checkpoint blockade
First Author: Yam-Puc, Juan Carlos
Reviewed: Feb 28, 2023
|
Yam-Puc, Juan Carlos
|
Feb 28, 2023
|
|
An empirical analysis of lay media coverage on influenza prevention pre- and post-COVID 19: Mask recommendations were previously rare, now ubiquitous
First Author: Prasad, Vinay
Reviewed: Feb 28, 2023
|
Prasad, Vinay
|
Feb 28, 2023
|
|
Analysis of the SARS-CoV-2 spike protein revealed that blocked receptor-binding domain antigenicity decreases the production of neutralizing antibodies in vivo
First Author: Mei, Ya-Fang
Reviewed: Feb 28, 2023
|
Mei, Ya-Fang
|
Feb 28, 2023
|
|
Bivalent COVID-19 vaccine antibody responses to Omicron variants suggest that responses to divergent variants would be improved with matched vaccine antigens
First Author: Wang, Wei
Reviewed: Feb 28, 2023
|
Wang, Wei
|
Feb 28, 2023
|
|
BRIEF COMMUNICATION: High level of Anti SARS-Co-V2 RBD Antibody one year post booster vaccine hospital workers in Indonesia; Was second booster needed?
First Author: Muslimah, Amila Hanifan
Reviewed: Feb 28, 2023
|
Muslimah, Amila Hanifan
|
Feb 28, 2023
|
|
Changes in SARS-CoV-2 seroprevalence and population immunity in Finland, 2020–2022
First Author: Solastie, Anna
Reviewed: Feb 28, 2023
|
Solastie, Anna
|
Feb 28, 2023
|
|
Durable reprogramming of neutralising antibody responses following breakthrough Omicron infection
First Author: Lee, Wen Shi
Reviewed: Feb 28, 2023
|
Lee, Wen Shi
|
Feb 28, 2023
|
|
Event Rate and Predictors of Post-Acute COVID-19 Sequalae and the Average Time to Diagnosis in General Population
First Author: John Muthuka, K.
Reviewed: Feb 28, 2023
|
John Muthuka, K.
|
Feb 28, 2023
|
|
Evidence of Leaky Protection Following COVID-19 Vaccination and SARS-CoV-2 Infection in a US Correctional Facility Population
First Author: Lind, Margaret L
Reviewed: Feb 28, 2023
|
Lind, Margaret L
|
Feb 28, 2023
|
|
Excess burden of respiratory and abdominal conditions following COVID-19 infections during the ancestral and Delta variant periods in the United States: An EHR-based cohort study from the RECOVER Program
First Author: Varma, Jay K.
Reviewed: Feb 28, 2023
|
Varma, Jay K.
|
Feb 28, 2023
|
|
Immune response to SARS-CoV-2 mRNA vaccination in multiple sclerosis patients after rituximab treatment interruption
First Author: Gröning, Remigius
Reviewed: Feb 28, 2023
|
Gröning, Remigius
|
Feb 28, 2023
|
|
Intrinsic and effective severity of COVID-19 cases infected with the ancestral strain and Omicron BA.2 variant in Hong Kong
First Author: Wong, Jessica Y.
Reviewed: Feb 28, 2023
|
Wong, Jessica Y.
|
Feb 28, 2023
|
|
Longitudinal Humoral and Cell-Mediated Immune Responses in a Population-Based Cohort in Zurich, Switzerland between March and June 2022 - Evidence for Protection against Omicron SARS-CoV-2 Infection by Neutralizing Antibodies and Spike-specific T cell responses
First Author: Zens, K.D.
Reviewed: Feb 28, 2023
|
Zens, K.D.
|
Feb 28, 2023
|
|
Poor sleep quality, insomnia, and short sleep duration before infection predict long-term symptoms after COVID-19
First Author: Salfi, Federico
Reviewed: Feb 28, 2023
|
Salfi, Federico
|
Feb 28, 2023
|
|
Possible Role of P-selectin Adhesion in Long-COVID: A Case of Recovery After Long-COVID
First Author: Tarasev, Michael
Reviewed: Feb 28, 2023
|
Tarasev, Michael
|
Feb 28, 2023
|
|
REAL-WORLD EFFECTIVENESS OF NIRMATRELVIR/RITONAVIR ON COVID-19-ASSOCIATED HOSPITALIZATION PREVENTION: A POPULATION-BASED COHORT STUDY IN THE PROVINCE OF QUÉBEC, CANADA
First Author: Kabore, J.L.
Reviewed: Feb 28, 2023
|
Kabore, J.L.
|
Feb 28, 2023
|
|
Single shot dendritic cell targeting SARS-CoV-2 vaccine candidate induces broad and durable systemic and mucosal immune responses
First Author: Zhi Cheang, Nicholas You
Reviewed: Feb 28, 2023
|
Zhi Cheang, Nicholas You
|
Feb 28, 2023
|
|
Vaccine-induced correlate of protection against fatal COVID-19 in the old and frail during waves of neutralization resistant variants of concern
First Author: Vikström, Linnea
Reviewed: Feb 28, 2023
|
Vikström, Linnea
|
Feb 28, 2023
|
|
Identification of the pathogenic relationship between Long COVID and Alzheimer's disease by bioinformatics methods
First Author: Ren, Hui
Reviewed: Feb 25, 2023
|
Ren, Hui
|
Feb 25, 2023
|
|
Rapid screening methods for universal binding peptide aptamers against SARS-CoV-2 variant spikes, including omicron variants, and their application to diagnostic and therapeutic agents.
First Author: Hayashi, Nakanobu
Reviewed: Feb 25, 2023
|
Hayashi, Nakanobu
|
Feb 25, 2023
|
|
Comparative Effectiveness of BNT162b2 and NVX-CoV2373 Vaccines in Korean Adults
First Author: Park, Seon Kyeong
Reviewed: Feb 22, 2023
|
Park, Seon Kyeong
|
Feb 22, 2023
|
|
Modeling of pyrolysis reactions of polypropylene using a six-lump model and simulation of pyrolysis process using Aspen
First Author: Pluemprasit, Panyawut
Reviewed: Feb 22, 2023
|
Pluemprasit, Panyawut
|
Feb 22, 2023
|
|
Protective effect of plasma neutralization from prior SARS-CoV-2 Omicron infection against BA.5 subvariant symptomatic reinfection
First Author: Chen, Xiaosu
Reviewed: Feb 22, 2023
|
Chen, Xiaosu
|
Feb 22, 2023
|
|
Antibody prevalence after 3 or more COVID-19 vaccine doses in 23,000 immunosuppressed individuals: a cross-sectional study from MELODY
First Author: Pearce, Fiona A
Reviewed: Feb 21, 2023
|
Pearce, Fiona A
|
Feb 21, 2023
|
|
CD4+ and CD8+ T cell and antibody correlates of protection against Delta vaccine breakthrough infection: A nested case-control study within the PITCH study
First Author: Neale, Isabel
Reviewed: Feb 21, 2023
|
Neale, Isabel
|
Feb 21, 2023
|
|
Characterizing the use of the ICD-10 Code for Long COVID in 3 US Healthcare Systems
First Author: Zhang, Harrison G
Reviewed: Feb 21, 2023
|
Zhang, Harrison G
|
Feb 21, 2023
|
|
COVID-19 Vaccine Acceptance in Nigeria: A Rapid Systematic Review and Meta-Analysis
First Author: Nnaemeka, Victory Chizaram
Reviewed: Feb 21, 2023
|
Nnaemeka, Victory Chizaram
|
Feb 21, 2023
|
|
Development and characterization of a multimeric recombinant protein based on the spike protein receptor binding domain of SARS-CoV-2 that can neutralize virus infection
First Author: de Lima, Veronica Aparecida
Reviewed: Feb 21, 2023
|
de Lima, Veronica Aparecida
|
Feb 21, 2023
|
|
Effectiveness of SARS-CoV-2 Vaccines against Omicron Infection and Severe Events: A Systematic Review and Meta-Analysis of Test-Negative Design Studies
First Author: Song, Shangchen
Reviewed: Feb 21, 2023
|
Song, Shangchen
|
Feb 21, 2023
|
|
Effectiveness of voice therapy after recovery from COVID-19 infection: A Rare Case Report
First Author: Aghadoost, Samira
Reviewed: Feb 21, 2023
|
Aghadoost, Samira
|
Feb 21, 2023
|
|
Impacts of Testing, Vaccination, and Immunity on COVID-19 Cases in Schools
First Author: Branch-Elliman, Westyn
Reviewed: Feb 21, 2023
|
Branch-Elliman, Westyn
|
Feb 21, 2023
|
|
Long term vaccination strategies to mitigate the impact of SARS-CoV-2 transmission: a modelling study
First Author: Hogan, Alexandra B
Reviewed: Feb 21, 2023
|
Hogan, Alexandra B
|
Feb 21, 2023
|
|
Low Antibody Titers Demonstrate Significantly Increased Rate of SARS-CoV-2 Infection in a Highly Vaccinated Population from the National Basketball Association
First Author: Tai, Caroline G.
Reviewed: Feb 21, 2023
|
Tai, Caroline G.
|
Feb 21, 2023
|
|
Neurological manifestations of Multisystem Inflammatory Syndrome in children (MIS-C) associated with SARS-CoV-2 infection: A clinico-demographic profile with short-term outcome in patients admitted to a tertiary care hospital in Eastern India.
First Author: Roy, Santanu
Reviewed: Feb 21, 2023
|
Roy, Santanu
|
Feb 21, 2023
|
|
Post-COVID syndrome is associated with capillary alterations, macrophage infiltration and distinct transcriptomic signatures in skeletal muscles
First Author: Aschman, Tom
Reviewed: Feb 21, 2023
|
Aschman, Tom
|
Feb 21, 2023
|
|
Predicting the antigenic evolution of SARS-COV-2 with deep learning
First Author: Han, Wenkai
Reviewed: Feb 21, 2023
|
Han, Wenkai
|
Feb 21, 2023
|
|
Rapidly Adaptable Multiplexed Yeast Surface Display Serological Assay for Immune Escape Screening of SARS-CoV-2 Variants
First Author: Lopez-Morales, Joanan
Reviewed: Feb 21, 2023
|
Lopez-Morales, Joanan
|
Feb 21, 2023
|
|
SARS-CoV-2 Neutralizing Antibodies After Bivalent vs. Monovalent Booster
First Author: Wang, Qian
Reviewed: Feb 21, 2023
|
Wang, Qian
|
Feb 21, 2023
|
|
Self-Reported Adverse Events after Primary COVID-19 Vaccination in Bulgarian Healthcare Workers
First Author: Rangelova, Vanya
Reviewed: Feb 21, 2023
|
Rangelova, Vanya
|
Feb 21, 2023
|
|
The role of serum brain injury biomarkers in individuals with a mild-to-moderate COVID infection and Long-COVID - results from the prospective population-based COVI-GAPP study
First Author: Telser, Julia
Reviewed: Feb 21, 2023
|
Telser, Julia
|
Feb 21, 2023
|
|
Epidemiological drivers of transmissibility and severity of SARS-CoV-2 in England
First Author: Perez-Guzman, Pablo N
Reviewed: Feb 18, 2023
|
Perez-Guzman, Pablo N
|
Feb 18, 2023
|
|
Impact of COVID-19 Outbreak on Healthcare Workers in a Tertiary Healthcare Center in India - A cross sectional study
First Author: Mirza, Shahzad
Reviewed: Feb 18, 2023
|
Mirza, Shahzad
|
Feb 18, 2023
|
|
In silico prediction of immune-escaping hot spots for future COVID-19 vaccine design
First Author: Huang, Sing-Hang
Reviewed: Feb 18, 2023
|
Huang, Sing-Hang
|
Feb 18, 2023
|
|
Recruitment of plasma cells to the bone marrow in primary and secondary immune reactions
First Author: Mashreghi, Mir-Farzin
Reviewed: Feb 18, 2023
|
Mashreghi, Mir-Farzin
|
Feb 18, 2023
|
|
Relative effectiveness of BNT162b2, mRNA-1273, and Ad26.COV2.S vaccines and homologous boosting in preventing COVID-19 in adults in the US
First Author: Nguyen, Van Hung
Reviewed: Feb 18, 2023
|
Nguyen, Van Hung
|
Feb 18, 2023
|
|
The imprinting effect of COVID-19 vaccines: an expected selection bias in observational studies
First Author: Monge, Susana
Reviewed: Feb 18, 2023
|
Monge, Susana
|
Feb 18, 2023
|
|
A Phase 2, Randomized, Double-blind, Placebo-controlled Study of oral RP7214, a DHODH inhibitor, in Patients with Symptomatic Mild SARS-CoV-2 Infection
First Author: Nair, Ajit
Reviewed: Feb 15, 2023
|
Nair, Ajit
|
Feb 15, 2023
|
|
Autoantigen profiling reveals a shared post-COVID signature in fully recovered and Long COVID patients
First Author: Bodansky, Aaron
Reviewed: Feb 15, 2023
|
Bodansky, Aaron
|
Feb 15, 2023
|
|
Estimating serum cross-neutralizing responses to SARS-CoV-2 Omicron sub-lineages elicited by pre-Omicron or Omicron breakthrough infection with exposure interval compensation modeling
First Author: Miyamoto, Sho
Reviewed: Feb 15, 2023
|
Miyamoto, Sho
|
Feb 15, 2023
|
|
Factors Associated with Stroke after COVID-19 Vaccination: A Statewide Analysis
First Author: Nahab, Fadi
Reviewed: Feb 15, 2023
|
Nahab, Fadi
|
Feb 15, 2023
|
|
Machine-learning-aided multiplexed nanobiosensor for COVID-19 population immunity profiling
First Author: Beisenova, Aidana
Reviewed: Feb 15, 2023
|
Beisenova, Aidana
|
Feb 15, 2023
|
|
Resilience and social support improve mental health and quality of life in patients with post-COVID-19 syndrome
First Author: Galanis, Petros
Reviewed: Feb 15, 2023
|
Galanis, Petros
|
Feb 15, 2023
|
|
Seroprevalence of IgG Antibody against SARS-CoV-2 Nucleocapsid protein and Associated Risk Factors
First Author: Chowdhury, Yeamin Farabi
Reviewed: Feb 15, 2023
|
Chowdhury, Yeamin Farabi
|
Feb 15, 2023
|
|
A COVID-19 DNA Vaccine Candidate Elicits Broadly Neutralizing Antibodies Against Multiple SARS-CoV-2 Variants Including the Currently Circulating Omicron BF.5, BF.7, BQ.1 and XBB
First Author: Ding, Yuan
Reviewed: Feb 10, 2023
|
Ding, Yuan
|
Feb 10, 2023
|
|
A SARS-CoV-2 vaccine designed for manufacturability results in unexpected potency and non-waning humoral response
First Author: Campbell, Elliot
Reviewed: Feb 10, 2023
|
Campbell, Elliot
|
Feb 10, 2023
|
|
Associations of COVID-19 Symptoms with Omicron Subvariants BA.2 and BA.5, Host Status, and Clinical Outcomes: A Registry-Based Observational Study in Sapporo, Japan
First Author: Nakakubo, Sho
Reviewed: Feb 10, 2023
|
Nakakubo, Sho
|
Feb 10, 2023
|
|
Cellular immunity reflects the persistent symptoms among COVID-19 recovered patients in Japan
First Author: Miyata, Yoshiharu
Reviewed: Feb 10, 2023
|
Miyata, Yoshiharu
|
Feb 10, 2023
|
|
Exploring the Cognitive Dynamics of Artificial Intelligence in the
Post-COVID-19 and Learning 3.0 Era: A Case Study of ChatGPT
First Author: Luan, Lingfei
Reviewed: Feb 10, 2023
|
Luan, Lingfei
|
Feb 10, 2023
|
|
Heterologous inactivated virus/mRNA vaccination response to BF.7, BQ.1.1, and XBB.1
First Author: Zuo, Fanglei
Reviewed: Feb 10, 2023
|
Zuo, Fanglei
|
Feb 10, 2023
|
|
Impact of Immune Evasion, Waning and Boosting on Dynamics of Population Mixing Between a Vaccinated Majority and Unvaccinated Minority
First Author: Fisman, David N.
Reviewed: Feb 10, 2023
|
Fisman, David N.
|
Feb 10, 2023
|
|
Longitudinal changes in IgG-type SARS-CoV-2 antibody titers after COVID-19 vaccination and, prominent increase in antibody titers when infected after vaccination
First Author: Kusunoki, Hiroshi
Reviewed: Feb 10, 2023
|
Kusunoki, Hiroshi
|
Feb 10, 2023
|
|
Neutralization of SARS-CoV-2 BQ.1.1 and XBB.1.5 by Breakthrough Infection Sera from Previous and Current Waves in China
First Author: Wang, Xun
Reviewed: Feb 10, 2023
|
Wang, Xun
|
Feb 10, 2023
|
|
SARS-CoV-2 Disease Severity in the Golden Syrian Hamster Model of Infection is Related to the Volume of Intranasal Inoculum.
First Author: Handley, Alastair
Reviewed: Feb 10, 2023
|
Handley, Alastair
|
Feb 10, 2023
|
|
Vaccine coverage and effectiveness against laboratory-confirmed symptomatic and severe Covid-19 in indigenous people in Brazil: a cohort study
First Author: Pescarini, Julia M.
Reviewed: Feb 10, 2023
|
Pescarini, Julia M.
|
Feb 10, 2023
|
|
Both humoral and cellular immune responses to SARS-CoV-2 are essential to prevent infection: a prospective study in a working vaccinated population from southern France
First Author: Graça, Daisy
Reviewed: Feb 9, 2023
|
Graça, Daisy
|
Feb 9, 2023
|
|
Disease severity of unvaccinated SARS-CoV-2 positive adults less than 65 years old without comorbidity, in the Omicron period and pre-Omicron periods
First Author: Wahlström, Erik
Reviewed: Feb 9, 2023
|
Wahlström, Erik
|
Feb 9, 2023
|
|
Liver Function in Patients Up to 20 Months of Long COVID: A Cross-Sectional Study
First Author: Lima, Igor Costa de
Reviewed: Feb 9, 2023
|
Lima, Igor Costa de
|
Feb 9, 2023
|
|
Prior vaccination enhances immune responses during SARS-CoV-2 breakthrough infection with early activation of memory T cells followed by production of potent neutralizing antibodies
First Author: Painter, Mark M.
Reviewed: Feb 9, 2023
|
Painter, Mark M.
|
Feb 9, 2023
|
|
Recent Advances in the Lipid Nanoparticle-Mediated Delivery of mRNA Vaccines
First Author: Swetha, K
Reviewed: Feb 9, 2023
|
Swetha, K
|
Feb 9, 2023
|
|
The intersection of biological sex and gender in adverse events following seasonal influenza vaccination in older adults
First Author: Shapiro, Janna R.
Reviewed: Feb 9, 2023
|
Shapiro, Janna R.
|
Feb 9, 2023
|
|
Characterization of COVID-19 Vaccine Clinical Trial Discussions on the Social Question-and-Answer Site Quora
First Author: Xu, Qing
Reviewed: Feb 8, 2023
|
Xu, Qing
|
Feb 8, 2023
|
|
Management of severe cerebral venous sinus thrombosis after post-vaccination breakthrough COVID-19 infection: a case report and review of the literature
First Author: Giammello, Fabrizio
Reviewed: Feb 8, 2023
|
Giammello, Fabrizio
|
Feb 8, 2023
|
|
Headache following vaccination against COVID-19 among healthcare workers with a history of COVID-19 infection: A cross-sectional study in Iran with a meta-analytic review of the literature
First Author: Nasergivehchi, Somayeh
Reviewed: Feb 7, 2023
|
Nasergivehchi, Somayeh
|
Feb 7, 2023
|
|
Markov-modulated model for landing flow dynamics: An ordinal analysis
validation
First Author: Olivares, Felipe
Reviewed: Feb 7, 2023
|
Olivares, Felipe
|
Feb 7, 2023
|
|
sciCSR infers B cell state transition and predicts class-switch recombination dynamics using single-cell transcriptomic data
First Author: Ng, Joseph CF
Reviewed: Feb 7, 2023
|
Ng, Joseph CF
|
Feb 7, 2023
|
|
Attributable Causes of Death Among US Veteran Patients within 30-90 days following SARS-CoV-2 Infection: A Nationwide Cohort Study
First Author: La, Jennifer
Reviewed: Feb 6, 2023
|
La, Jennifer
|
Feb 6, 2023
|
|
Building an inpatient addiction medicine consult service in Sudbury, Canada: preliminary data and lessons learned in the era of COVID-19
First Author: Leary, Tara
Reviewed: Feb 6, 2023
|
Leary, Tara
|
Feb 6, 2023
|
|
Clinical Characteristics and Long-term Symptomology of Post-COVID-19 Olfactory and Gustatory Dysfunction
First Author: Boyd, Amelia
Reviewed: Feb 6, 2023
|
Boyd, Amelia
|
Feb 6, 2023
|
|
Correlates of symptomatic remission among individuals with post-COVID-19 condition
First Author: Perlis, Roy H.
Reviewed: Feb 6, 2023
|
Perlis, Roy H.
|
Feb 6, 2023
|
|
High number of SARS-CoV-2 persistent infections uncovered through genetic analysis of samples from a large community-based surveillance study
First Author: Ghafari, Mahan
Reviewed: Feb 6, 2023
|
Ghafari, Mahan
|
Feb 6, 2023
|
|
Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: randomised, active-controlled, observer-blinded, phase 3 trial
First Author: Song, Joon Young
Reviewed: Feb 6, 2023
|
Song, Joon Young
|
Feb 6, 2023
|
|
Immunogenicity of the BA.1 and BA.4/5 Bivalent Boosts: A Brief Report of Preliminary Results from the COVAIL Randomized Clinical Trial
First Author: Branche, Angela R
Reviewed: Feb 6, 2023
|
Branche, Angela R
|
Feb 6, 2023
|
|
Investigating Autonomic Nervous System Dysfunction among Patients with Post- Covid Condition and Prolonged Cardiovascular Symptoms
First Author: Silva, Fernanda Stábile da
Reviewed: Feb 6, 2023
|
Silva, Fernanda Stábile da
|
Feb 6, 2023
|
|
Long Covid and Neurodegenerative Disease
First Author: Chambers, Patrick
Reviewed: Feb 6, 2023
|
Chambers, Patrick
|
Feb 6, 2023
|
|
Minimal mRNA uptake and inflammatory response to COVID-19 mRNA vaccine exposure in human placental explants
First Author: Gonzalez, Veronica
Reviewed: Feb 6, 2023
|
Gonzalez, Veronica
|
Feb 6, 2023
|
|
Older age, lack of vaccination and infection with variants other than Omicron associated with severity of COVID-19 and in-hospital mortality in Pakistan
First Author: Mushtaq, Muhammad Zain
Reviewed: Feb 6, 2023
|
Mushtaq, Muhammad Zain
|
Feb 6, 2023
|
|
Real-Time Epidemiology and Acute Care Need Monitoring and Forecasting for COVID-19 via Bayesian Sequential Monte Carlo-leveraged Transmission Models
First Author: Li, Xiaoyan
Reviewed: Feb 6, 2023
|
Li, Xiaoyan
|
Feb 6, 2023
|
|
Road networks to explore COVID-19 infection
First Author: Uddin, Shahadat
Reviewed: Feb 6, 2023
|
Uddin, Shahadat
|
Feb 6, 2023
|
|
The clinical course and outcomes of SARS-CoV-2 infection in children: A 24-week follow-up study in Sulaimaniyah, Iraq
First Author: Sedik, Rozhan Nabaz Mohammed
Reviewed: Feb 6, 2023
|
Sedik, Rozhan Nabaz Mohammed
|
Feb 6, 2023
|
|
The emergence of SARS-CoV-2 lineages and associated antibody responses among asymptomatic individuals in a large university community
First Author: Merling, Marlena R.
Reviewed: Feb 6, 2023
|
Merling, Marlena R.
|
Feb 6, 2023
|
|
A Perturbative Approach to the Analysis of Many-Compartment Models
Characterized by the Presence of Waning Immunity
First Author: Elgart, Shoshana
Reviewed: Feb 4, 2023
|
Elgart, Shoshana
|
Feb 4, 2023
|
|
Agent-based modeling and phylogenetic analysis suggests that COVID-19 will remain a low-severity albeit highly transmissible disease
First Author: Toledo-Roy, Juan C.
Reviewed: Feb 4, 2023
|
Toledo-Roy, Juan C.
|
Feb 4, 2023
|
|
Beta-variant recombinant SARS CoV-2 vaccine induces durable cross-reactive antibodies against Omicron variants
First Author: Launay, Odile
Reviewed: Feb 4, 2023
|
Launay, Odile
|
Feb 4, 2023
|
|
Breakthrough infection with Omicron subvariant BF.7 induces broadly neutralizing antibodies to SARS-CoV-2 variants including XBB lineage
First Author: Zhang, Linqi
Reviewed: Feb 4, 2023
|
Zhang, Linqi
|
Feb 4, 2023
|
|
Design and synthesis of Diphenyl-1H-imidazole analogs towards SARS CoV-2 3CLpro inhibition for the treatment of COVID-19
First Author: Kanhed, Ashish M.
Reviewed: Feb 4, 2023
|
Kanhed, Ashish M.
|
Feb 4, 2023
|
|
Dosing Schedule Modification of COVID-19 Vaccine in Immunosuppressed and Cancer Patient: A Review of Current Suggestions
First Author: Rahman, Mohd Turzo
Reviewed: Feb 4, 2023
|
Rahman, Mohd Turzo
|
Feb 4, 2023
|
|
Early risk-assessment of pathogen genomic variants emergence
First Author: Susswein, Zachary
Reviewed: Feb 4, 2023
|
Susswein, Zachary
|
Feb 4, 2023
|
|
Evaluating COVID-19 vaccine allocation policies using Bayesian $m$-top
exploration
First Author: Cimpean, Alexandra
Reviewed: Feb 4, 2023
|
Cimpean, Alexandra
|
Feb 4, 2023
|
|
Impact of the gut microbiome on immunological responses to COVID-19 vaccination in healthy controls and people living with HIV
First Author: Ray, Shilpa
Reviewed: Feb 4, 2023
|
Ray, Shilpa
|
Feb 4, 2023
|
|
Impact of vaccination and risk factors on COVID-19 mortality amid delta wave in Libya: a single centre cohort study
First Author: Alhudiri, Inas
Reviewed: Feb 4, 2023
|
Alhudiri, Inas
|
Feb 4, 2023
|
|
Longitudinal home self-collection of capillary blood using homeRNA correlates interferon and innate viral defense pathways with SARS-CoV-2 viral clearance
First Author: Lim, Fang Yun
Reviewed: Feb 4, 2023
|
Lim, Fang Yun
|
Feb 4, 2023
|
|
Long-term changes in human mobility responses to COVID-19-related information in Japan
First Author: Fukui, Shinya
Reviewed: Feb 4, 2023
|
Fukui, Shinya
|
Feb 4, 2023
|
|
Modeling opinion polarization on social media: application to Covid-19
vaccination hesitancy in Italy
First Author: Franceschi, Jonathan
Reviewed: Feb 4, 2023
|
Franceschi, Jonathan
|
Feb 4, 2023
|
|
Novel Designs of Cytotoxic T Cell Assays for Point-of-Care and Laboratory measurements of related Host specific Adaptive Responses to Pathogens and Vaccines
First Author: WAYENGERA, Misaki
Reviewed: Feb 4, 2023
|
WAYENGERA, Misaki
|
Feb 4, 2023
|
|
Omicron BA.1 breakthrough infection drives long-term remodeling of the memory B cell repertoire in vaccinated individuals
First Author: Sokal, Aurélien
Reviewed: Feb 4, 2023
|
Sokal, Aurélien
|
Feb 4, 2023
|
|
Omicron BA.1/BA.2 infections in triple-vaccinated individuals enhance a diverse repertoire of mucosal and blood immune responses
First Author: Hornsby, Hailey
Reviewed: Feb 4, 2023
|
Hornsby, Hailey
|
Feb 4, 2023
|
|
Short- and longer-term all-cause mortality among SARS-CoV-2-infected persons and the pull-forward phenomenon in Qatar
First Author: Chemaitelly, Hiam
Reviewed: Feb 4, 2023
|
Chemaitelly, Hiam
|
Feb 4, 2023
|
|
Target-directed dynamic combinatorial chemistry affords inhibitors of Nsp10 as potential antivirals against SARS-CoV-2
First Author: Jumde, Ravindra P.
Reviewed: Feb 4, 2023
|
Jumde, Ravindra P.
|
Feb 4, 2023
|
|
The impact of vaccination frequency on COVID-19 public health outcomes: A model-based analysis
First Author: Stoddard, Madison
Reviewed: Feb 4, 2023
|
Stoddard, Madison
|
Feb 4, 2023
|
|
Updated beliefs and shaken confidence: Evidence from vaccine hesitancy caused by experiencing "COVID arm"
First Author: Fukai, Taiyo
Reviewed: Feb 4, 2023
|
Fukai, Taiyo
|
Feb 4, 2023
|
|
Vaccine-elicited B and T cell immunity to SARS-CoV-2 is impaired in chronic lung disease patients
First Author: Liu, Haolin
Reviewed: Feb 4, 2023
|
Liu, Haolin
|
Feb 4, 2023
|
|
A Randomized Trial Comparing Omicron-Containing Boosters with the Original Covid-19 Vaccine mRNA-1273
First Author: Lee, Ivan T.
Reviewed: Feb 2, 2023
|
Lee, Ivan T.
|
Feb 2, 2023
|
|
Acute tubulointerstitial nephritis with or without uveitis: a novel form of post-acute COVID-19 syndrome in children
First Author: Avramescu, Marina
Reviewed: Feb 2, 2023
|
Avramescu, Marina
|
Feb 2, 2023
|
|
Antibody escape, the risk of serotype formation, and rapid immune waning: modeling the implications of SARS-CoV-2 immune evasion
First Author: Albright, Catherine
Reviewed: Feb 2, 2023
|
Albright, Catherine
|
Feb 2, 2023
|
|
At the crossroads of epidemiology and biology: bridging the gap between SARS-CoV-2 viral strain properties and epidemic wave characteristics
First Author: Poydenot, Florian
Reviewed: Feb 2, 2023
|
Poydenot, Florian
|
Feb 2, 2023
|
|
COVID-19 in Pakistan: A national analysis of five pandemic waves
First Author: Ahmad, Taimoor
Reviewed: Feb 2, 2023
|
Ahmad, Taimoor
|
Feb 2, 2023
|
|
COVID-19 Vaccine Uptake among Recipients in Saskatchewan: A Patient-Oriented Realist Evaluation
First Author: Azizian, Amir Reza
Reviewed: Feb 2, 2023
|
Azizian, Amir Reza
|
Feb 2, 2023
|
|
Estimations of SARS-CoV-2 endemic characteristics
First Author: Nesteruk, Igor
Reviewed: Feb 2, 2023
|
Nesteruk, Igor
|
Feb 2, 2023
|
|
Incident autoimmune diseases in association with a SARS-CoV-2 infection: A matched cohort study
First Author: Tesch, Falko
Reviewed: Feb 2, 2023
|
Tesch, Falko
|
Feb 2, 2023
|
|
Long-term respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccination
First Author: Mitsi, Elena
Reviewed: Feb 2, 2023
|
Mitsi, Elena
|
Feb 2, 2023
|
|
Multimodal characterization of antigen-specific CD8+ T cells across SARS-CoV-2 vaccination and infection
First Author: Zhang, Bingjie
Reviewed: Feb 2, 2023
|
Zhang, Bingjie
|
Feb 2, 2023
|
|
Natural history of long-COVID in a nationwide, population cohort study
First Author: Pell, Jill
Reviewed: Feb 2, 2023
|
Pell, Jill
|
Feb 2, 2023
|
|
Perceptions and Intention of Healthcare Workers’ to Vaccinate Their Children Aged <18 Years against COVID-19 from A Tertiary Care Institute of Eastern Uttar Pradesh (U.P.), India
First Author: Khan, Imran Ahmed
Reviewed: Feb 2, 2023
|
Khan, Imran Ahmed
|
Feb 2, 2023
|
|
Polyethylene glycol (PEG)-associated immune responses triggered by clinically relevant lipid nanoparticles
First Author: Wang, Haiyang
Reviewed: Feb 2, 2023
|
Wang, Haiyang
|
Feb 2, 2023
|
|
Post-COVID-19 rhinocerebral mucormycosis, a life-threatening event in the background of immunosuppressive condition: A case report
First Author: Tajik, Fatemeh
Reviewed: Feb 2, 2023
|
Tajik, Fatemeh
|
Feb 2, 2023
|
|
RAMEN identifies effective indicators for severe COVID and Long COVID patients
First Author: Xiong, Yiwei
Reviewed: Feb 2, 2023
|
Xiong, Yiwei
|
Feb 2, 2023
|
|
Real-world effectiveness of molnupiravir, nirmatrelvir-ritonavir, and sotrovimab on preventing hospital admission among higher-risk patients with COVID-19 in Wales: a retrospective cohort study
First Author: Evans, Andrew
Reviewed: Feb 2, 2023
|
Evans, Andrew
|
Feb 2, 2023
|
|
Second monovalent SARS-CoV-2 mRNA booster restores Omicron-specific neutralizing activity in both nursing home residents and health care workers
First Author: Nugent, Clare
Reviewed: Feb 2, 2023
|
Nugent, Clare
|
Feb 2, 2023
|
|
Immunogenicity and safety of Biological E’s CORBEVAX™ vaccine as a heterologous booster dose in adult volunteers previously vaccinated with two doses of either COVISHIELD™ or COVAXIN: A Prospective double-blind randomised phase III clinical study
First Author: Thuluva, Subhash
Reviewed: Jan 30, 2023
|
Thuluva, Subhash
|
Jan 30, 2023
|
|
Impaired humoral immunity to BQ.1.1 in convalescent and vaccinated patients
First Author: Dewald, Felix
Reviewed: Jan 30, 2023
|
Dewald, Felix
|
Jan 30, 2023
|
|
Prediction of SARS-CoV-2 spike protein mutations using Sequence-to-Sequence and Transformer models
First Author: Ahmadi, Hamed
Reviewed: Jan 27, 2023
|
Ahmadi, Hamed
|
Jan 27, 2023
|
|
Waning Immunity Against XBB.1.5 Following Bivalent mRNA Boosters
First Author: Lasrado, Ninaad
Reviewed: Jan 27, 2023
|
Lasrado, Ninaad
|
Jan 27, 2023
|
|
A Qualitative Study Exploring Motivators and Barriers to COVID-19 Vaccine Uptake among Adults in South Africa and Zimbabw
First Author: Nellie Myburgh
Reviewed: Jan 26, 2023
|
Nellie Myburgh
|
Jan 26, 2023
|
|
Early induction of anti-Spike binding antibodies and T cells confer protection against COVID-19 in children during an Omicron wave
First Author: Zhong, Youjia
Reviewed: Jan 26, 2023
|
Zhong, Youjia
|
Jan 26, 2023
|
|
Evaluation of Potential Adverse Events Following COVID-19 mRNA Vaccination Among Adults Aged 65 Years and Older: A Self-Controlled Study in the U.S
First Author: Shoaibi, Azadeh
Reviewed: Jan 26, 2023
|
Shoaibi, Azadeh
|
Jan 26, 2023
|
|
Safety of bivalent omicron-containing mRNA-booster vaccines: a nationwide cohort study
First Author: Andersson, Niklas Worm
Reviewed: Jan 26, 2023
|
Andersson, Niklas Worm
|
Jan 26, 2023
|
|
Tumor-nonspecific vaccines improve the efficacy of CD3 bispecific antibody therapy in solid tumors
First Author: Middelburg, Jim
Reviewed: Jan 26, 2023
|
Middelburg, Jim
|
Jan 26, 2023
|
|
Elective Surgery Before, During and After the COVID-19 Pandemic in England 2015 - 2022: A Database Study
First Author: Remsing, Sandra
Reviewed: Jan 24, 2023
|
Remsing, Sandra
|
Jan 24, 2023
|
|
Frequency and Clinical Characteristics of Breakthrough Cases Post COVID-19 Vaccine and Predictive Risk Factors in College Students
First Author: Abdulrazaq, Manal Khudder
Reviewed: Jan 24, 2023
|
Abdulrazaq, Manal Khudder
|
Jan 24, 2023
|
|
Immunogenicity, Safety and Effectiveness of COVID-19 Pfizer-BioNTech (BNT162b2) mRNA Vaccination in Immunocompromised Adolescents and Young Adults: A systematic Review and Meta-Analyses
First Author: Katoto, Patrick Dmc
Reviewed: Jan 24, 2023
|
Katoto, Patrick Dmc
|
Jan 24, 2023
|
|
Induction of SARS-CoV-2 N-specific CD8+ T cell immunity in lungs by engineered extracellular vesicles associates with strongly impaired viral replication
First Author: Manfredi, Francesco
Reviewed: Jan 24, 2023
|
Manfredi, Francesco
|
Jan 24, 2023
|
|
Assessment of Retrospective Collection of EQ-5D-5L in US Patients with COVID-19
First Author: Sun, Xiaowu
Reviewed: Jan 23, 2023
|
Sun, Xiaowu
|
Jan 23, 2023
|
|
Comparative effectiveness of the bivalent BA.4-5 and BA.1 mRNA-booster vaccines in the Nordic countries
First Author: Andersson, Niklas Worm
Reviewed: Jan 23, 2023
|
Andersson, Niklas Worm
|
Jan 23, 2023
|
|
Determinants of protection against SARS-CoV-2 Omicron BA.1 and Delta infections in fully vaccinated outpatients
First Author: Roy, Alvaro
Reviewed: Jan 23, 2023
|
Roy, Alvaro
|
Jan 23, 2023
|
|
Development of a Novel Medium Throughput Flow-Cytometry Based Micro-Neutralisation Test for SARS-CoV-2 with Applications in Clinical Vaccine Trials and Antibody Screening
First Author: O Reilly, Sophie
Reviewed: Jan 23, 2023
|
O Reilly, Sophie
|
Jan 23, 2023
|
|
Effectiveness of Vaccination and Previous Infection Against Omicron Infection and Severe Outcomes in Children Under 12 Years of Age
First Author: Lin, Dan Yu
Reviewed: Jan 23, 2023
|
Lin, Dan Yu
|
Jan 23, 2023
|
|
Immune response to the mRNA COVID-19 vaccine in hemodialysis patients: cohort study
First Author: Chang, Yi Shin
Reviewed: Jan 23, 2023
|
Chang, Yi Shin
|
Jan 23, 2023
|
|
Long COVID brain fog and muscle pain are associated with longer time to clearance of SARS-CoV-2 RNA from the upper respiratory tract during acute infection
First Author: Antar, Annukka A R
Reviewed: Jan 23, 2023
|
Antar, Annukka A R
|
Jan 23, 2023
|
|
Occipital neuralgia after COVID-19 vaccination: a report of two cases
First Author: Malheiro, Sofia
Reviewed: Jan 23, 2023
|
Malheiro, Sofia
|
Jan 23, 2023
|
|
Post-marketing active surveillance of Guillan Barré Syndrome following vaccination with anti-COVID-19 vaccines in persons aged ≥12 years in Italy: a multi-database self-controlled case series study
First Author: Morciano, Cristina
Reviewed: Jan 23, 2023
|
Morciano, Cristina
|
Jan 23, 2023
|
|
Post-pandemic modeling of COVID-19: Waning immunity determines recurrence frequency
First Author: Calvetti, D
Reviewed: Jan 23, 2023
|
Calvetti, D
|
Jan 23, 2023
|
|
Prediction of Long COVID Based on Severity of Initial COVID-19 Infection: Differences in predictive feature sets between hospitalized versus non-hospitalized index infections
First Author: Socia, Damien
Reviewed: Jan 23, 2023
|
Socia, Damien
|
Jan 23, 2023
|
|
Significance of Conserved Regions in Coronavirus Spike Protein for Developing a Novel Vaccine against SARS-Cov-2 Infection
First Author: Titus A Olukitibi
Reviewed: Jan 23, 2023
|
Titus A Olukitibi
|
Jan 23, 2023
|
|
The fourth dose of mRNA COVID-19 vaccine following 12 different three-dose regimens: Safety and immunogenicity to Omicron BA.4/BA.5
First Author: Kanokudom, Sitthichai
Reviewed: Jan 23, 2023
|
Kanokudom, Sitthichai
|
Jan 23, 2023
|
|
An assessment on the interplay of digital proximity app use and vaccine uptake for SARS-CoV-2 transmission mitigation in Switzerland
First Author: Daniore, Paola
Reviewed: Jan 20, 2023
|
Daniore, Paola
|
Jan 20, 2023
|
|
Long-term cardiac symptoms following COVID-19: a systematic review and meta-analysis
First Author: Guo, Boya
Reviewed: Jan 20, 2023
|
Guo, Boya
|
Jan 20, 2023
|
|
Maintained imbalance of triglycerides, apolipoproteins, energy metabolites and cytokines in long-term COVID-19 syndrome (LTCS) patients
First Author: Berezhnoy, Georgy
Reviewed: Jan 20, 2023
|
Berezhnoy, Georgy
|
Jan 20, 2023
|
|
Natural evolution of SARS-CoV-2 variants in K18-ACE2 mice gives rise to more virulent virus and variant alleles associated with treatment resistance
First Author: Willett, Julian Daniel Sunday
Reviewed: Jan 20, 2023
|
Willett, Julian Daniel Sunday
|
Jan 20, 2023
|
|
Redistribution and activation of CD16brightCD56dim NK cell subset to fight against Omicron subvariant BA.2 after COVID-19 vaccination
First Author: Liu, Yang
Reviewed: Jan 20, 2023
|
Liu, Yang
|
Jan 20, 2023
|
|
Satisfaction and Self-Confidence among Nursing Students with Simulation Learning During COVID-19
First Author: Alsadi, Mohammad
Reviewed: Jan 20, 2023
|
Alsadi, Mohammad
|
Jan 20, 2023
|
|
Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variants
First Author: Addetia, Amin
Reviewed: Jan 20, 2023
|
Addetia, Amin
|
Jan 20, 2023
|
|
TRACE-Omicron: Policy Counterfactuals to Inform Mitigation of COVID-19
Spread in the United States
First Author: O Gara, David
Reviewed: Jan 20, 2023
|
O Gara, David
|
Jan 20, 2023
|
|
Anthracyclines inhibit SARS-CoV-2 infection
First Author: Wang, Zhen
Reviewed: Jan 18, 2023
|
Wang, Zhen
|
Jan 18, 2023
|
|
Effectiveness of early-treatment interventions on self-reported long COVID: A multi-arm, multi-stage adaptive platform control trial
First Author: Reis, Gilmar
Reviewed: Jan 18, 2023
|
Reis, Gilmar
|
Jan 18, 2023
|
|
Global prevalence of coronavirus disease 2019 reinfection: a systematic review and meta-analysis
First Author: Joyeuse, Ukwishaka
Reviewed: Jan 18, 2023
|
Joyeuse, Ukwishaka
|
Jan 18, 2023
|
|
Long-term systemic and mucosal SARS-CoV-2 IgA response and its association with persistent smell and taste disorders
First Author: Denis, Jessica
Reviewed: Jan 18, 2023
|
Denis, Jessica
|
Jan 18, 2023
|
|
Annual COVID-19 Booster Vaccine Acceptance among Healthcare workers: the role of Anti-Vaccination Attitudes and Burnout
First Author: Maraqa, Beesan
Reviewed: Jan 17, 2023
|
Maraqa, Beesan
|
Jan 17, 2023
|
|
Burden, Causation, and Particularities of long-COVID in African populations: A rapid systematic review
First Author: Nyasulu, Peter S
Reviewed: Jan 17, 2023
|
Nyasulu, Peter S
|
Jan 17, 2023
|
|
Effectiveness of Paxlovid - a review
First Author: Paltra, Sydney
Reviewed: Jan 17, 2023
|
Paltra, Sydney
|
Jan 17, 2023
|
|
Real-world data concerning the efficacy of molnupiravir in patients vaccinated against COVID-19 during the Omicron surge in Japan
First Author: Inaba, Satoshi
Reviewed: Jan 17, 2023
|
Inaba, Satoshi
|
Jan 17, 2023
|
|
The COVID-19 antibody responses, isotypes and glycosylation: Why SARS-CoV-2 Spike protein complex binding of IgG3 is potentiated in some and immuno-pathologies manifest
First Author: Iles, Raymond Kruse
Reviewed: Jan 17, 2023
|
Iles, Raymond Kruse
|
Jan 17, 2023
|
|
Did COVID-19 or COVID-19 vaccines influence the patterns of Dengue in 2021: An exploratory analysis of two observational studies from North India
First Author: Kaur, Upinder
Reviewed: Jan 16, 2023
|
Kaur, Upinder
|
Jan 16, 2023
|
|
Did the COVID-19 pandemic impact the dietary intake of individuals living with and beyond breast, prostate, and colorectal cancer and who was most likely to experience change?
First Author: Taylor, Katie S
Reviewed: Jan 16, 2023
|
Taylor, Katie S
|
Jan 16, 2023
|
|
Effectiveness of second booster compared to first booster and protection conferred by previous SARS CoV-2 infection against symptomatic Omicron BA.2 and BA.4/5 in France
First Author: Tamandjou, Cynthia
Reviewed: Jan 16, 2023
|
Tamandjou, Cynthia
|
Jan 16, 2023
|
|
Exosome based multivalent vaccine: achieving potent immunization, broaden reactivity and T cell response with nanograms of proteins without any adjuvant
First Author: Cacciottolo, Mafalda
Reviewed: Jan 16, 2023
|
Cacciottolo, Mafalda
|
Jan 16, 2023
|
|
Fully Quantitative Measurements of Differential Antibody Binding to a Spectrum of SARS-CoV-2 Spike Proteins: Wuhan, Alpha, Beta, Gamma, Delta, Omicron BA.1, BA.4, BA.5, BA.2.75 and BA.2.12.1
First Author: James Pemberton, Philip H
Reviewed: Jan 16, 2023
|
James Pemberton, Philip H
|
Jan 16, 2023
|
|
Plasma Proteome of Long-covid Patients Indicates Hypoxia-mediated Vasculo-proliferative Disease With Impact on Brain and Heart Function
First Author: Iosef, Cristiana
Reviewed: Jan 16, 2023
|
Iosef, Cristiana
|
Jan 16, 2023
|
|
Prior SARS-CoV-2 Infection and COVID-19 Vaccine Effectiveness against Outpatient Illness during Widespread Circulation of SARS-CoV-2 Omicron Variant, US Flu VE Network
First Author: Tartof, Sara Y
Reviewed: Jan 16, 2023
|
Tartof, Sara Y
|
Jan 16, 2023
|
|
Recombinant SARS-CoV-2 Spike Protein and its Receptor Binding Domain stimulate release of different pro-inflammatory mediators via activation of distinct receptors on human microglia cells
First Author: Tsilioni, Irene
Reviewed: Jan 16, 2023
|
Tsilioni, Irene
|
Jan 16, 2023
|
|
Safety, tolerability, and immunogenicity of a new SARS-CoV-2 recombinant Gamma variant RBD-based protein adjuvanted vaccine, used as heterologous booster in healthy adults: a Phase 1 interim report
First Author: Pasquevich, Karina A
Reviewed: Jan 16, 2023
|
Pasquevich, Karina A
|
Jan 16, 2023
|
|
The role of SARS-CoV-2 variants of concern in children and adolescents with COVID-19: a systematic review
First Author: Wiedenmann, Margarethe
Reviewed: Jan 16, 2023
|
Wiedenmann, Margarethe
|
Jan 16, 2023
|
|
Vaccine effectiveness against SARS-CoV-2 Delta and Omicron infection and infectiousness within households in the Netherlands between July 2021 and August 2022
First Author: Hoeve, Christina E
Reviewed: Jan 16, 2023
|
Hoeve, Christina E
|
Jan 16, 2023
|
|
Vectored Immunoprophylaxis and Treatment of SARS-CoV-2 Infection
First Author: Tada, Takuya
Reviewed: Jan 16, 2023
|
Tada, Takuya
|
Jan 16, 2023
|
|
A Gamma-adapted recombinant subunit vaccine induces broadly neutralizing antibodies against SARS-CoV-2 variants and protects mice from infection
First Author: Coria, Lorena M
Reviewed: Jan 15, 2023
|
Coria, Lorena M
|
Jan 15, 2023
|
|
A Phase 2/3 observer-blind, randomized, controlled study to determine the safety and immunogenicity of SARS-CoV-2 recombinant spike protein vaccine in Indian children and adolescents aged 2 to 17 years
First Author: Gunale, Bhagwat
Reviewed: Jan 15, 2023
|
Gunale, Bhagwat
|
Jan 15, 2023
|
- Pediatrics/Adolescents
- Immunological
|
A prospective cross-sectional study on post COVID-19 hair loss at a tertiary care hospital
First Author: Wadhwa, Dhaarna
Reviewed: Jan 15, 2023
|
Wadhwa, Dhaarna
|
Jan 15, 2023
|
|
Analysis of vaccine-induced immune responses according to the immunization sequences of mRNA and protein vaccines
First Author: Nam, Jae Hwan
Reviewed: Jan 15, 2023
|
Nam, Jae Hwan
|
Jan 15, 2023
|
|
Attitudes towards booster, testing and isolation, and their impact on COVID-19 response in winter 2022/2023 in France, Belgium, and Italy
First Author: Meijere, Giulia De
Reviewed: Jan 15, 2023
|
Meijere, Giulia De
|
Jan 15, 2023
|
|
Bivalent mRNA vaccine improves antibody-mediated neutralization of many SARS-CoV-2 Omicron lineage variants
First Author: Jiang, Nannan
Reviewed: Jan 15, 2023
|
Jiang, Nannan
|
Jan 15, 2023
|
|
Can Koreans be ‘FREE’ from mask wearing?: Advanced mathematical model can suggest the idea
First Author: Ko, Youngsuk
Reviewed: Jan 15, 2023
|
Ko, Youngsuk
|
Jan 15, 2023
|
|
CASCADIA: A prospective community-based study protocol for assessing SARS-CoV-2 vaccine effectiveness in children and adults utilizing a remote nasal swab collection and web-based survey design
First Author: Babu, Tara M
Reviewed: Jan 15, 2023
|
Babu, Tara M
|
Jan 15, 2023
|
|
Challenges in estimating waning effectiveness of two doses of BNT162b2 and ChAdOx1 COVID-19 vaccines beyond six months: an OpenSAFELY cohort study using linked electronic health records
First Author: Horne, Elsie Mf
Reviewed: Jan 15, 2023
|
Horne, Elsie Mf
|
Jan 15, 2023
|
|
Clinical Characteristics and Outcomes of Laboratory-Confirmed SARS-CoV-2 Cases Infected with Omicron subvariants and XBB recombinant variant
First Author: Karyakarte, Rajesh
Reviewed: Jan 15, 2023
|
Karyakarte, Rajesh
|
Jan 15, 2023
|
|
Comparison of SARS-CoV-2 entry inhibitors based on ACE2 receptor or engineered Spike-binding peptides
First Author: Llewellyn, George N
Reviewed: Jan 15, 2023
|
Llewellyn, George N
|
Jan 15, 2023
|
|
Comparison of target antigen and immunoglobulin isotypes in anti-SARS-CoV-2 antibodies from natural infection and vaccination
First Author: Kim, Jeong Hui
Reviewed: Jan 15, 2023
|
Kim, Jeong Hui
|
Jan 15, 2023
|
|
Covid-19 and Dynamic Changes in Learning Environment: A Perceptional Study
First Author: Amin, Venkatesh S
Reviewed: Jan 15, 2023
|
Amin, Venkatesh S
|
Jan 15, 2023
|
|
Critical review of conformational B-cell epitope prediction methods
First Author: Cia, Gabriel
Reviewed: Jan 15, 2023
|
Cia, Gabriel
|
Jan 15, 2023
|
|
Degree of immunoglobulin kappa light chain glycosylation of anti-spike SARS CoV-2 antibodies correlates with COVID-19 severity
First Author: Grigaite, Raminta
Reviewed: Jan 15, 2023
|
Grigaite, Raminta
|
Jan 15, 2023
|
|
Diminished responses to mRNA-based SARS-CoV-2 vaccines in individuals with rheumatoid arthritis on immune modifying therapies
First Author: Klebanoff, Samuel D
Reviewed: Jan 15, 2023
|
Klebanoff, Samuel D
|
Jan 15, 2023
|
|
Down-regulation of MALAT1 is a hallmark of tissue and peripheral proliferative T cells in COVID-19
First Author: Dey, Shoumit
Reviewed: Jan 15, 2023
|
Dey, Shoumit
|
Jan 15, 2023
|
|
Effectiveness of inactivated COVID-19 vaccines against SARS-CoV-2 infections among healthcare personnel in Pakistan: a test-negative, case-control study
First Author: Khan, Unab I
Reviewed: Jan 15, 2023
|
Khan, Unab I
|
Jan 15, 2023
|
|
Effects of Variants of Concern Mutations on the Force-Stability of the SARS-CoV-2:ACE2 Interface and Virus Transmissibility
First Author: Bauer, Magnus S
Reviewed: Jan 15, 2023
|
Bauer, Magnus S
|
Jan 15, 2023
|
|
Estimating long-term vaccine effectiveness against SARS-CoV-2 variants: a model-based approach
First Author: Hogan, Alexandra B
Reviewed: Jan 15, 2023
|
Hogan, Alexandra B
|
Jan 15, 2023
|
|
Genomic characterization and molecular evolution of SARS-CoV-2 in Rio Grande do Sul State, Brazil
First Author: Mayer, Amanda De Menezes
Reviewed: Jan 15, 2023
|
Mayer, Amanda De Menezes
|
Jan 15, 2023
|
|
Heterologous booster vaccines reduce severity and mortality in COVID-19 during BA.2 and BA.4/BA.5 omicron predominance in Thailand
First Author: Intawong, Kannikar
Reviewed: Jan 15, 2023
|
Intawong, Kannikar
|
Jan 15, 2023
|
|
HOGVAX: Exploiting Peptide Overlaps to Maximize Population Coverage in Vaccine Design with Application to SARS-CoV-2
First Author: Schulte, Sara C
Reviewed: Jan 15, 2023
|
Schulte, Sara C
|
Jan 15, 2023
|
|
Identification of differences in the magnitude and specificity of SARS-CoV-2 nucleocapsid antibody responses in naturally infected and vaccinated individuals
First Author: Pushpakumara, Pradeep D
Reviewed: Jan 15, 2023
|
Pushpakumara, Pradeep D
|
Jan 15, 2023
|
|
Identification of druggable host dependency factors shared by multiple SARS-CoV-2 variants of concern
First Author: Frasson, Ilaria
Reviewed: Jan 15, 2023
|
Frasson, Ilaria
|
Jan 15, 2023
|
|
Impaired B cell recall memory and reduced antibody avidity but robust T cell response in CVID patients after COVID-19 vaccination
First Author: Steiner, Sophie
Reviewed: Jan 15, 2023
|
Steiner, Sophie
|
Jan 15, 2023
|
|
Interim results from comparison of immune responses elicited by an inactivated and a vectored SARS-CoV-2 vaccine in seronegative and seropositive participants in India
First Author: Asokan, Mangaiarkarasi
Reviewed: Jan 15, 2023
|
Asokan, Mangaiarkarasi
|
Jan 15, 2023
|
|
Long Covid symptoms and diagnosis in primary care: a cohort study using structured and unstructured data in The Health Improvement Network primary care database
First Author: Shah, Anoop D
Reviewed: Jan 15, 2023
|
Shah, Anoop D
|
Jan 15, 2023
|
|
Longitudinal IgA and IgG Response, and ACE2 Binding Blockade, to Full-length SARS-CoV-2 Spike Protein Variants in a Population of Black PLWH Vaccinated with ChAdOx1 nCoV-19
First Author: Muneerah Smith
Reviewed: Jan 15, 2023
|
Muneerah Smith
|
Jan 15, 2023
|
|
Lower COVID-19 incidence in Bulgaria in 2022 can be attributed to the Delta variant's belated intense spread.
First Author: Getsova, Zhivka
Reviewed: Jan 15, 2023
|
Getsova, Zhivka
|
Jan 15, 2023
|
|
Nanoparticle-Conjugated TLR9 Agonists Improve the Potency, Durability, and Breadth of COVID-19 Vaccines
First Author: Ou, Ben S
Reviewed: Jan 15, 2023
|
Ou, Ben S
|
Jan 15, 2023
|
|
Neuromyelitis Optica Spectrum Disorder After BIBP COVID-19 Vaccine: A Case Report
First Author: Gutierrez, Cristiam
Reviewed: Jan 15, 2023
|
Gutierrez, Cristiam
|
Jan 15, 2023
|
|
Observational study on antibody response to COVID-19 Vaccines in pAtients with gastro-entero-panCreatic Cancers and neuroendocrIne NeoplAsms on systemic TreatmEnts (VACCINATE).
First Author: Alice Laffi
Reviewed: Jan 15, 2023
|
Alice Laffi
|
Jan 15, 2023
|
|
Patients with Post-COVID-19 Vaccination Myocarditis Have More Favorable Strain in Cardiac Magnetic Resonance Than Those With Viral Myocarditis
First Author: Vaiyani, Danish
Reviewed: Jan 15, 2023
|
Vaiyani, Danish
|
Jan 15, 2023
|
|
Persistently high platelet factor 4 levels in an adolescent with recurrent late thrombotic complications after SARS-CoV-2 mRNA vaccination: A case report
First Author: Haga, Yoichi
Reviewed: Jan 15, 2023
|
Haga, Yoichi
|
Jan 15, 2023
|
|
Poor neutralizing antibody responses against SARS-CoV-2 Omicron BQ.1.1 and XBB in Norway in October 2022
First Author: Vikse, Elisabeth Lea
Reviewed: Jan 15, 2023
|
Vikse, Elisabeth Lea
|
Jan 15, 2023
|
|
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity
First Author: Dam, Koos Van
Reviewed: Jan 15, 2023
|
Dam, Koos Van
|
Jan 15, 2023
|
|
SARS-CoV-2 wastewater concentration and linked longitudinal seroprevalence: a spatial analysis of strain mutation, post-COVID-19 vaccination effect, and hospitalization burden forecasting
First Author: Holm, Rochelle H
Reviewed: Jan 15, 2023
|
Holm, Rochelle H
|
Jan 15, 2023
|
|
Systemic and mucosal adaptive immunity to SARS-CoV-2 during the Omicron wave in patients with chronic lymphocytic leukemia
First Author: Ingelman Sundberg, Hanna
Reviewed: Jan 15, 2023
|
Ingelman Sundberg, Hanna
|
Jan 15, 2023
|
|
Targets and cross-reactivity of human T cell recognition of Common Cold Coronaviruses
First Author: Tarke, Alison
Reviewed: Jan 15, 2023
|
Tarke, Alison
|
Jan 15, 2023
|
|
The edible tomato COVID-19 vaccine, TOMAVAC, induces neutralising IgGs
First Author: Abdurakhmonov, Ibrokhim
Reviewed: Jan 15, 2023
|
Abdurakhmonov, Ibrokhim
|
Jan 15, 2023
|
|
The effect of previous SARS-CoV-2 infection and COVID-19 vaccination on SARS-CoV-2 Omicron infection and relation with serological response – a prospective cohort study
First Author: Gier, Brechje De
Reviewed: Jan 15, 2023
|
Gier, Brechje De
|
Jan 15, 2023
|
|
The incidence of COVID-19-related hospitalisation in migrants in the UK: Findings from the Virus Watch prospective community cohort study
First Author: Fong, Wing Lam Erica
Reviewed: Jan 15, 2023
|
Fong, Wing Lam Erica
|
Jan 15, 2023
|
|
The interplay between pre-season population susceptibility and the effectiveness of the rolled out vaccination control the timing and size of an emerging seasonal influenza wave in England
First Author: Van Leeuwen, E
Reviewed: Jan 15, 2023
|
Van Leeuwen, E
|
Jan 15, 2023
|
|
The time between vaccination and infection impacts immunity against SARS-CoV-2 variants
First Author: Bates, Timothy A
Reviewed: Jan 15, 2023
|
Bates, Timothy A
|
Jan 15, 2023
|
|
The trinomial health, safety and happiness promote rural tourism.
First Author: Castellano Alvarez, 3 Javier
Reviewed: Jan 15, 2023
|
Castellano Alvarez, 3 Javier
|
Jan 15, 2023
|
|
Vaccine effectiveness against severe COVID-19 during the Omicron wave in Germany: Results from the COViK study
First Author: Stoliaroff Pepin, Anna
Reviewed: Jan 15, 2023
|
Stoliaroff Pepin, Anna
|
Jan 15, 2023
|
|
Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection in the Netherlands from 12 July 2021 to 6 June 2022: a prospective cohort study
First Author: Huiberts, Anne J
Reviewed: Jan 15, 2023
|
Huiberts, Anne J
|
Jan 15, 2023
|
|
Waning vaccine response to severe COVID-19 outcomes during omicron predominance in Thailand
First Author: Intawong, Kannikar
Reviewed: Jan 15, 2023
|
Intawong, Kannikar
|
Jan 15, 2023
|
|
Who Gets Long COVID and Suffers its Mental Health and Socioeconomic Consequences in the United States? Preliminary Findings from a Large Nationwide Study
First Author: Kim, Daniel
Reviewed: Jan 15, 2023
|
Kim, Daniel
|
Jan 15, 2023
|
|
A machine learning-based phenotype for long COVID in children: an EHR-based study from the RECOVER program
First Author: Lorman, Vitaly
Reviewed: Jan 12, 2023
|
Lorman, Vitaly
|
Jan 12, 2023
|
|
Characterization of Oral Bacterial and Fungal Microbiome in Recovered COVID-19 Patients
First Author: Wei, Nana
Reviewed: Jan 12, 2023
|
Wei, Nana
|
Jan 12, 2023
|
|
Efficacy of CytoSorb® - A Metaanalysis
First Author: Becker, Soren
Reviewed: Jan 12, 2023
|
Becker, Soren
|
Jan 12, 2023
|
|
Ethnic inequalities in incidence, nature, determinants, and duration of long COVID among hospitalised adults in the Netherlands: A retrospective cohort study
First Author: Chilunga, Felix
Reviewed: Jan 12, 2023
|
Chilunga, Felix
|
Jan 12, 2023
|
|
Impairments following COVID-19 infection: Manifestations and investigations of related factors
First Author: Badinlou, Farzaneh
Reviewed: Jan 12, 2023
|
Badinlou, Farzaneh
|
Jan 12, 2023
|
|
Longitudinal Assessment of Plasma Syndecan-1 Predicts 60-Day Mortality in Patients with COVID-19
First Author: Quan Zhang
Reviewed: Jan 12, 2023
|
Quan Zhang
|
Jan 12, 2023
|
|
Outpatient treatment of Covid-19 with metformin, ivermectin, and fluvoxamine and the development of Long Covid over 10-month follow-up
First Author: Bramante, Carolyn T
Reviewed: Jan 12, 2023
|
Bramante, Carolyn T
|
Jan 12, 2023
|
|
Pre and Post COVID-19: Qualifications of Medical Students who Matched into Dermatology
First Author: Jacobs, Jennifer
Reviewed: Jan 12, 2023
|
Jacobs, Jennifer
|
Jan 12, 2023
|
|
Prevalence of and relevant factors for depression and anxiety symptoms among pregnant women on the eastern seaboard of China in the post-COVID-19 era
First Author: Yang, Haidong
Reviewed: Jan 12, 2023
|
Yang, Haidong
|
Jan 12, 2023
|
|
Reduced Olfactory Bulb Volume Accompanies Olfactory Dysfunction After Mild SARS-CoV-2 Infection: The Hamburg City Health Study COVID Program
First Author: Petersen, Marvin
Reviewed: Jan 12, 2023
|
Petersen, Marvin
|
Jan 12, 2023
|
|
Risk factors for long COVID among healthcare workers, Brazil, 2020–2022
First Author: Marra, Alexandre R
Reviewed: Jan 12, 2023
|
Marra, Alexandre R
|
Jan 12, 2023
|
|
SARS-CoV-2 Reinfection is Preceded by Unique Biomarkers and Related to Initial Infection Timing and Severity: an N3C RECOVER EHR-Based Cohort Study
First Author: Hadley, Emily
Reviewed: Jan 12, 2023
|
Hadley, Emily
|
Jan 12, 2023
|
|
The prospect of universal coronavirus immunity: a characterization of reciprocal and non-reciprocal T cell responses against SARS-CoV2 and common human coronaviruses
First Author: Soni, Mithil
Reviewed: Jan 12, 2023
|
Soni, Mithil
|
Jan 12, 2023
|
|
The SARS-CoV-2 Spike protein induces long-term transcriptional perturbations of mitochondrial metabolic genes, causes cardiac fibrosis, and reduces myocardial contractile in obese mice
First Author: Cao, Xiaoling
Reviewed: Jan 12, 2023
|
Cao, Xiaoling
|
Jan 12, 2023
|
|
“Side effects of Vero cell vaccination against Covid-19 among medical students of Nepalgunj Medical College”-A Post Vaccination survey
First Author: Rupak, K C
Reviewed: Jan 8, 2023
|
Rupak, K C
|
Jan 8, 2023
|
|
Clinical Virology and Effect of Vaccination and Monoclonal Antibodies against SARS-CoV-2 Omicron Sub Variant BF.7 (BA.5.2.1.7) : A systematic review
First Author: Chenchula, Santenna
Reviewed: Jan 8, 2023
|
Chenchula, Santenna
|
Jan 8, 2023
|
|
Common dandelion (Taraxacum officinale) leaf extract efficiently inhibits SARS-CoV-2 Omicron infection in vitro
First Author: Tran, Hoai Thi Thu
Reviewed: Jan 8, 2023
|
Tran, Hoai Thi Thu
|
Jan 8, 2023
|
|
Comparative effectiveness of four COVID-19 vaccines, BNT162b2 mRNA, mRNA-1273, ChAdOx1 nCov-19 and NVX-CoV2373 against SARS-CoV-2 B.1.1.529 (Omicron) infection
First Author: Liu, Bette
Reviewed: Jan 8, 2023
|
Liu, Bette
|
Jan 8, 2023
|
|
COVID-19 Vaccine Hesitancy, Adverse Events Following Immunization, and Associated Factors among Ethiopian General Population During Early Phase of COVID-19 Vaccination Program
First Author: Tadesse, Tamrat Assefa
Reviewed: Jan 8, 2023
|
Tadesse, Tamrat Assefa
|
Jan 8, 2023
|
|
Designing epitope-focused vaccines via antigen reorientation
First Author: Xu, Duo
Reviewed: Jan 8, 2023
|
Xu, Duo
|
Jan 8, 2023
|
|
EFFECTIVENESS OF CASIRIVIMAB-IMDEVIMAB AND SOTROVIMAB MONOCLONAL ANTIBODY TREATMENT AMONG HIGH-RISK PATIENTS WITH SARS-CoV-2 INFECTION: A REAL-WORLD EXPERIENCE
First Author: Murugapandian, Sangeetha
Reviewed: Jan 8, 2023
|
Murugapandian, Sangeetha
|
Jan 8, 2023
|
|
Effectiveness of Sotrovimab in Preventing COVID-19-related Hospitalizations or Deaths Among U.S. Veterans
First Author: Young Xu, Yinong
Reviewed: Jan 8, 2023
|
Young Xu, Yinong
|
Jan 8, 2023
|
|
ESCRT recruitment to mRNA-encoded SARS-CoV-2 spike induces virus-like particles and enhanced antibody responses
First Author: Hoffmann, Magnus A G
Reviewed: Jan 8, 2023
|
Hoffmann, Magnus A G
|
Jan 8, 2023
|
|
Evaluation of the molecular diversity of Brazilian strains of the B.1.1 variant of SARS-CoV-2 used in vaccines
First Author: Nascimento, Iasmin Auta Do
Reviewed: Jan 8, 2023
|
Nascimento, Iasmin Auta Do
|
Jan 8, 2023
|
|
Impact of BA.1, BA.2, and BA.4/BA.5 Omicron Mutations on Therapeutic Monoclonal Antibodies
First Author: Jawad, Bahaa
Reviewed: Jan 8, 2023
|
Jawad, Bahaa
|
Jan 8, 2023
|
|
Impact of comorbidities on the serological response to COVID-19 vaccination in Taiwan
First Author: Huang, Chung Feng
Reviewed: Jan 8, 2023
|
Huang, Chung Feng
|
Jan 8, 2023
|
|
Is it possible to flatten-the-curve after the initial outbreak of Covid-19? A data-driven modeling analysis for Omicron pandemic in China
First Author: Sun, Jiaqi
Reviewed: Jan 8, 2023
|
Sun, Jiaqi
|
Jan 8, 2023
|
|
Lipid Nanoparticle Composition Drives mRNA Delivery to the Placenta
First Author: Young, Rachel E
Reviewed: Jan 8, 2023
|
Young, Rachel E
|
Jan 8, 2023
|
|
Literature analysis of the efficacy of COVID-19 vaccinations
First Author: Hulsen, Tim
Reviewed: Jan 8, 2023
|
Hulsen, Tim
|
Jan 8, 2023
|
|
Methodological approaches to optimize multiplex oral fluid SARS-CoV-2 IgG assay performance and correlation with serologic and neutralizing antibody responses
First Author: Pisanic, Nora
Reviewed: Jan 8, 2023
|
Pisanic, Nora
|
Jan 8, 2023
|
|
Modelling of outbreaks of SARS-CoV-2 Omicron variants after easing Dynamic Zero-COVID strategy in mainland China
First Author: Song, Fujian
Reviewed: Jan 8, 2023
|
Song, Fujian
|
Jan 8, 2023
|
|
Prior infection- and/or vaccine-induced protection against Omicron BA.1, BA.2 and BA.4/BA.5-related hospitalisations in older adults: a test-negative case-control study in Quebec, Canada
First Author: Carazo, Sara
Reviewed: Jan 8, 2023
|
Carazo, Sara
|
Jan 8, 2023
|
|
Safety and Effectiveness of SA58 Nasal Spray against COVID-19 Infection in Medical Personnel:An Open-label, Blank-controlled Study
First Author: Si, Shujie
Reviewed: Jan 8, 2023
|
Si, Shujie
|
Jan 8, 2023
|
|
Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial
First Author: Corominas, Julia
Reviewed: Jan 8, 2023
|
Corominas, Julia
|
Jan 8, 2023
|
|
SARS-CoV-2 seroprevalence and longitudinal antibody response following natural infection in pregnancy: a prospective cohort study
First Author: Drake, Alison L
Reviewed: Jan 8, 2023
|
Drake, Alison L
|
Jan 8, 2023
|
|
Seroprevalence of anti-SARS-CoV-2 antibodies before and after implementation of anti-COVID-19 vaccination among hospital staff in Bangui, Central African Republic
First Author: Manirakiza, Alexandre
Reviewed: Jan 8, 2023
|
Manirakiza, Alexandre
|
Jan 8, 2023
|
|
Seroprevalence of SARS-CoV-2 Antibodies in French Polynesia and Perspective for Vaccine Strategies
First Author: Maite Aubry
Reviewed: Jan 8, 2023
|
Maite Aubry
|
Jan 8, 2023
|
|
The kinetics of humoral and cellular responses after the booster dose of COVID-19 vaccine in inflammatory arthritis patients
First Author: Wronski, Jakub
Reviewed: Jan 8, 2023
|
Wronski, Jakub
|
Jan 8, 2023
|
|
The level of Knowledge, Attitudes, and Practices concerning Covid-19 Vaccination and their Determinants in Chittagong District (Bangladesh)
First Author: Akter, Sahin
Reviewed: Jan 8, 2023
|
Akter, Sahin
|
Jan 8, 2023
|
|
The response to BTN62b2 booster doses demonstrates that serum antibodies do not predict the establishment of immune B-cell memory in common variable immune deficiencies
First Author: Piano Mortari, E
Reviewed: Jan 8, 2023
|
Piano Mortari, E
|
Jan 8, 2023
|
|
Addiction to medical websites post COVID-19 pandemic: A predictor of Illness Anxiety Disorder among Arabian youth
First Author: Hamid, Mohamed
Reviewed: Dec 24, 2022
|
Hamid, Mohamed
|
Dec 24, 2022
|
|
An approach to rapid distributed manufacturing of broad spectrum anti-viral griffithsin using cell-free systems to mitigate pandemics
First Author: Borhani, Shayan G
Reviewed: Dec 24, 2022
|
Borhani, Shayan G
|
Dec 24, 2022
|
|
An oral vaccine for SARS-CoV-2 RBD mRNA-bovine milk-derived exosomes induces a neutralizing antibody response in vivo
First Author: Zhang, Quan
Reviewed: Dec 24, 2022
|
Zhang, Quan
|
Dec 24, 2022
|
|
Analysis of uptake, effectiveness and safety of COVID-19 vaccinations in pregnancy using the QResearch® database: research protocol and statistical analysis plan
First Author: Copland, Emma
Reviewed: Dec 24, 2022
|
Copland, Emma
|
Dec 24, 2022
|
|
Association between SARS-CoV-2 Infection and Select Symptoms and Conditions 31 to 150 Days After Testing among Children and Adults
First Author: Zhang, Yongkang
Reviewed: Dec 24, 2022
|
Zhang, Yongkang
|
Dec 24, 2022
|
|
Association of Heart Rate Variability with Pulmonary Function Impairment and Symptomatology Post-COVID-19 Hospitalization
First Author: Estelle A.M.C. Adang
Reviewed: Dec 24, 2022
|
Estelle A.M.C. Adang
|
Dec 24, 2022
|
|
Booster Vaccination with SARS-CoV-2 mRNA Vaccines and Myocarditis Risk in Adolescents and Young Adults: A Nordic Cohort Study of 8.9 Million Residents
First Author: Hviid, Anders
Reviewed: Dec 24, 2022
|
Hviid, Anders
|
Dec 24, 2022
|
|
Comparison of the mucosal and systemic antibody responses in Covid-19 recovered patients with one dose of mRNA vaccine and unexposed subjects with three doses of mRNA vaccines
First Author: Liu, Shaojun
Reviewed: Dec 24, 2022
|
Liu, Shaojun
|
Dec 24, 2022
|
|
COVID-19 non-vaccination among older adults in China: a nationwide survey based on the China Health and Retirement Longitudinal Study (CHARLS)
First Author: Zhao, Yaohui
Reviewed: Dec 24, 2022
|
Zhao, Yaohui
|
Dec 24, 2022
|
|
Critical assessment of the impact of vaccines and waning/boosting of immunity on the burden of COVID-19 in the U.S
First Author: Ngonghala, Calistus N
Reviewed: Dec 24, 2022
|
Ngonghala, Calistus N
|
Dec 24, 2022
|
|
Evaluation of bivalent Omicron BA.1 booster vaccination after different priming regimens in healthcare workers (SWITCH ON): a randomized controlled trial
First Author: Tan, Ngoc H
Reviewed: Dec 24, 2022
|
Tan, Ngoc H
|
Dec 24, 2022
|
|
Humoral responses against BQ.1.1 elicited after breakthrough infection and SARS-CoV-2 mRNA vaccination
First Author: Tauzin, Alexandra
Reviewed: Dec 24, 2022
|
Tauzin, Alexandra
|
Dec 24, 2022
|
|
Identification of broad, potent antibodies to functionally constrained regions of SARS-CoV-2 spike following a breakthrough infection
First Author: Guenthoer, Jamie
Reviewed: Dec 24, 2022
|
Guenthoer, Jamie
|
Dec 24, 2022
|
|
Immunogenicity and reactogenicity of mRNA COVID-19 vaccine booster administered by intradermal or intramuscular route in Thai Older adults
First Author: Assantachai, Prasert
Reviewed: Dec 24, 2022
|
Assantachai, Prasert
|
Dec 24, 2022
|
|
Neurophenotypes of COVID-19: risk factors and recovery trajectories
First Author: Prabhakaran, Divya
Reviewed: Dec 24, 2022
|
Prabhakaran, Divya
|
Dec 24, 2022
|
|
Number of COVID-19 hospitalisations averted by vaccination: Estimates for the Netherlands, January 6, 2021 through August 30, 2022
First Author: Iersel, Senna C J L Van
Reviewed: Dec 24, 2022
|
Iersel, Senna C J L Van
|
Dec 24, 2022
|
|
SARS-CoV-2 mRNA vaccination exposes progressive adaptive immune dysfunction in patients with chronic lymphocytic leukemia
First Author: Qin, Kai
Reviewed: Dec 24, 2022
|
Qin, Kai
|
Dec 24, 2022
|
|
Sex difference in the cytokine profile among patients hospitalized for COVID-19 and during their recovery: predominance of females in adhesion molecules and males in oxidative stress
First Author: Mitrovic Ajtic, Olivera
Reviewed: Dec 24, 2022
|
Mitrovic Ajtic, Olivera
|
Dec 24, 2022
|
|
Surface-modified measles vaccines encoding oligomeric, fusion-stabilized SARS-CoV-2 spike glycoproteins bypass measles seropositivity, boosting neutralizing antibody responses to omicron and historical variants
First Author: Munoz Alia, Miguel A
Reviewed: Dec 24, 2022
|
Munoz Alia, Miguel A
|
Dec 24, 2022
|
|
The Long-term impact of Covid-19 on student mental health
First Author: Catling, Jon C
Reviewed: Dec 24, 2022
|
Catling, Jon C
|
Dec 24, 2022
|
|
Amelioration of myocarditis after COVID-19 vaccination by low-dose booster
First Author: Miyazaki, Koji
Reviewed: Dec 22, 2022
|
Miyazaki, Koji
|
Dec 22, 2022
|
|
Depression and its associated factors among COVID-19 survivors in a middle income country
First Author: Moy, Foong Ming
Reviewed: Dec 22, 2022
|
Moy, Foong Ming
|
Dec 22, 2022
|
|
Difference in presentation, outcomes, and hospital epidemiologic trend of COVID-19 among first, second, and third waves in Dhaka Medical College
First Author: Mahmud, Reaz
Reviewed: Dec 22, 2022
|
Mahmud, Reaz
|
Dec 22, 2022
|
|
Estimating measures to reduce the transmission of SARS-CoV-2 in Australia to guide a ‘National Plan’ to reopening
First Author: Ryan, Gerard E
Reviewed: Dec 22, 2022
|
Ryan, Gerard E
|
Dec 22, 2022
|
|
Long COVID prevalence, follow-up and use of resources in Primary Care: a confirmed case series study
First Author: Rogero Blanco, Eloisa
Reviewed: Dec 22, 2022
|
Rogero Blanco, Eloisa
|
Dec 22, 2022
|
|
Long-term neutralizing antibody dynamics against SARS-CoV-2 in symptomatic and asymptomatic infections: a systematic review and meta-analysis
First Author: Lu, Wanying
Reviewed: Dec 22, 2022
|
Lu, Wanying
|
Dec 22, 2022
|
|
Milk antibody response after 3rd dose of COVID-19 mRNA vaccine and SARS-CoV-2 breakthrough infection and implications for infant protection
First Author: Golan, Yarden
Reviewed: Dec 22, 2022
|
Golan, Yarden
|
Dec 22, 2022
|
|
Modelling the adjustment of COVID-19 response and exit from dynamic zero-COVID in China
First Author: Leung, Kathy
Reviewed: Dec 22, 2022
|
Leung, Kathy
|
Dec 22, 2022
|
|
Prevalence of salivary anti-SARS-CoV-2 IgG antibodies in vaccinated children
First Author: Badano, Maria Noel
Reviewed: Dec 22, 2022
|
Badano, Maria Noel
|
Dec 22, 2022
|
|
Progressive loss of conserved spike protein neutralizing antibody sites in Omicron sublineages is balanced by preserved T-cell recognition epitopes
First Author: Muik, Alexander
Reviewed: Dec 22, 2022
|
Muik, Alexander
|
Dec 22, 2022
|
|
Robust SARS-CoV-2 antibody and T cell immunity following three COVID-19 vaccine doses in inflammatory bowel disease patients receiving anti-TNF or alternative treatments
First Author: Zhang, Eva
Reviewed: Dec 22, 2022
|
Zhang, Eva
|
Dec 22, 2022
|
|
SARS-CoV-2 vaccine-breakthrough infections (VBIs) by Omicron (B.1.1.529) variant and consequences in structural and functional impact
First Author: Abduljaleel, Zainularifeen
Reviewed: Dec 22, 2022
|
Abduljaleel, Zainularifeen
|
Dec 22, 2022
|
|
The association between menstrual cycle abnormalities and the COVID-19 vaccine
First Author: Khalil, Asma
Reviewed: Dec 22, 2022
|
Khalil, Asma
|
Dec 22, 2022
|
|
The estimated disease burden of COVID-19 in Japan from 2020 to 2021
First Author: Tsuzuki, Shinya
Reviewed: Dec 22, 2022
|
Tsuzuki, Shinya
|
Dec 22, 2022
|
|
Towards carbon neutral scientific societies: A case study with the
International Adsorption Society
First Author: Streb, Anne
Reviewed: Dec 22, 2022
|
Streb, Anne
|
Dec 22, 2022
|
|
Understanding COVID-19 Vaccine Effectiveness Against Death Using a Novel Measure: COVID Excess Mortality Percentage
First Author: Yuan, Andy
Reviewed: Dec 22, 2022
|
Yuan, Andy
|
Dec 22, 2022
|
|
Broad and Durable Humoral Responses Following Single Hydrogel Immunization of SARS-CoV-2 Subunit Vaccine
First Author: Ou, Ben S
Reviewed: Dec 19, 2022
|
Ou, Ben S
|
Dec 19, 2022
|
|
Functional and microstructural brain abnormalities, fatigue, and cognitive dysfunction after mild COVID-19
First Author: Scardua Silva, Lucas
Reviewed: Dec 19, 2022
|
Scardua Silva, Lucas
|
Dec 19, 2022
|
|
Long COVID: G Protein-Coupled Receptors (GPCRs) responsible for persistent post-COVID symptoms
First Author: Das, Sanisha
Reviewed: Dec 19, 2022
|
Das, Sanisha
|
Dec 19, 2022
|
|
Long term anti-SARS-CoV-2 antibody kinetics and correlate of protection against Omicron BA.1/BA.2 infection
First Author: Perez Saez, Javier
Reviewed: Dec 19, 2022
|
Perez Saez, Javier
|
Dec 19, 2022
|
|
Longitudinal Assessment of Left Ventricular Function in Patients with Myopericarditis after mRNA COVID-19 Vaccination
First Author: Barresi, Nicholas V
Reviewed: Dec 19, 2022
|
Barresi, Nicholas V
|
Dec 19, 2022
|
|
Safety and Immunogenicity of Omicron BA.4/BA.5 Bivalent Vaccine Against Covid-19
First Author: Chalkias, Spyros
Reviewed: Dec 19, 2022
|
Chalkias, Spyros
|
Dec 19, 2022
|
|
The effect of vaccination on transmission of SARS-CoV-2 (COVID-19): a rapid review
First Author: Williams, Jessica
Reviewed: Dec 19, 2022
|
Williams, Jessica
|
Dec 19, 2022
|
|
Analysis and comparison of SARS-CoV-2 variant antibodies and neutralizing activity for 6 months after a booster mRNA vaccine in a healthcare worker population
First Author: Khan, Saahir
Reviewed: Dec 15, 2022
|
Khan, Saahir
|
Dec 15, 2022
|
|
Exploring B and T-cell epitopes for constructing a Novel Multiepitope vaccine to combat emerging Monkeypox infection: A Reverse Vaccinology approach
First Author: Yousaf, Hassan
Reviewed: Dec 15, 2022
|
Yousaf, Hassan
|
Dec 15, 2022
|
|
Identification of genomic signatures and multiple lineage markers from the second and third wave samples of COVID-19 in Western Rajasthan, India
First Author: Bokolia, Naveen Prakash
Reviewed: Dec 15, 2022
|
Bokolia, Naveen Prakash
|
Dec 15, 2022
|
|
Musculoskeletal Manifestations, Post-COVID Syndrome, Relationship with Laboratory Parameters in Hospitalized Patients Infected with COVID-19
First Author: Kuculmez, Ozlem
Reviewed: Dec 15, 2022
|
Kuculmez, Ozlem
|
Dec 15, 2022
|
|
Understanding pediatric long COVID using a tree-based scan statistic approach: An EHR-based cohort study from the RECOVER Program
First Author: Lorman, Vitaly
Reviewed: Dec 14, 2022
|
Lorman, Vitaly
|
Dec 14, 2022
|
- Pediatrics/Adolescents
- Long COVID
|
Determinants for detection of infection with SARS-CoV-2 Omicron variants of concern in health care workers by rapid antigen tests
First Author: Wettengel, Jochen M
Reviewed: Dec 13, 2022
|
Wettengel, Jochen M
|
Dec 13, 2022
|
|
Effect of BNT162b2 antigen dosage on protection against SARS-CoV-2 omicron infection
First Author: Chemaitelly, Hiam
Reviewed: Dec 13, 2022
|
Chemaitelly, Hiam
|
Dec 13, 2022
|
|
Emergence and antibody evasion of BQ and BA.2.75 SARS-CoV-2 sublineages in the face of maturing antibody breadth at the population level
First Author: Akerman, Anouschka
Reviewed: Dec 13, 2022
|
Akerman, Anouschka
|
Dec 13, 2022
|
|
Lack of effectiveness of Bebtelovimab Monoclonal Antibody Among High-Risk Patients with SARS-Cov-2 Omicron During BA.2, BA.2.12.1 and BA.5 Subvariants Dominated Era
First Author: Sridhara, Srilekha
Reviewed: Dec 13, 2022
|
Sridhara, Srilekha
|
Dec 13, 2022
|
|
Long-COVID symptom risk among COVID-19 patients and its relationship to COVID-19 vaccination; a prospective cohort study
First Author: Hamdah, Bayan Abu
Reviewed: Dec 13, 2022
|
Hamdah, Bayan Abu
|
Dec 13, 2022
|
|
Pandemic-Resiliency and Flexibility Assessment of Dormitory Buildings in the Post-Covid-19 Era
First Author: Disli, Gulsen
Reviewed: Dec 13, 2022
|
Disli, Gulsen
|
Dec 13, 2022
|
|
Reduced SARS-CoV-2 mRNA vaccine immunogenicity and protection in mice with diet-induced obesity and insulin resistance
First Author: O Meara, Timothy R
Reviewed: Dec 13, 2022
|
O Meara, Timothy R
|
Dec 13, 2022
|
|
Sample average treatment effect on the treated analysis using counterfactual explanation identifies BMT and SARS-CoV-2 vaccination as protective risk factors associated with COVID-19 severity and survival in patients with multiple myeloma
First Author: Mitra, Amit Kumar
Reviewed: Dec 13, 2022
|
Mitra, Amit Kumar
|
Dec 13, 2022
|
|
SARS-CoV-2 Breakthrough Infections after Third Doses Boost IgG Specific Salivary and Blood Antibodies
First Author: Maria Noel Badano
Reviewed: Dec 13, 2022
|
Maria Noel Badano
|
Dec 13, 2022
|
|
Serious harms of the COVID-19 vaccines: a systematic review
First Author: Gotzsche, Peter C
Reviewed: Dec 13, 2022
|
Gotzsche, Peter C
|
Dec 13, 2022
|
|
Time Series Analysis in American Stock Market Recovering in Post
COVID-19 Pandemic Period
First Author: Fu, Weilin
Reviewed: Dec 13, 2022
|
Fu, Weilin
|
Dec 13, 2022
|
|
Apixaban following discharge in hospitalised adults with COVID-19: Preliminary results from a multicentre, open-label, randomised controlled platform clinical trial
First Author: Toshner, Mark R
Reviewed: Dec 12, 2022
|
Toshner, Mark R
|
Dec 12, 2022
|
|
Effectiveness of COVID-19 treatment with nirmatrelvir-ritonavir or molnupiravir among U.S. Veterans: target trial emulation studies with one-month and six-month outcomes
First Author: Bajema, Kristina L
Reviewed: Dec 12, 2022
|
Bajema, Kristina L
|
Dec 12, 2022
|
|
Increased migratory/activated CD8+ T cell and low avidity SARS-CoV-2 reactive cellular response in post-acute COVID-19 syndrome
First Author: Paniskaki, Krystallenia
Reviewed: Dec 12, 2022
|
Paniskaki, Krystallenia
|
Dec 12, 2022
|
|
Involvement of fatigue in the effect of transcranial magnetic stimulation (TMS) on depression following COVID-19 and COVID-19 vaccination: a before-after study
First Author: Kamamuta, Ayane
Reviewed: Dec 12, 2022
|
Kamamuta, Ayane
|
Dec 12, 2022
|
|
Physical and mental health disability associated with long-COVID: Baseline results from a US nationwide cohort
First Author: Lau, Bryan
Reviewed: Dec 12, 2022
|
Lau, Bryan
|
Dec 12, 2022
|
|
What is the impact of post-COVID-19 syndrome on health-related quality of life and associated factors: a cross-sectional analysis
First Author: Mastrorosa, Ilaria
Reviewed: Dec 12, 2022
|
Mastrorosa, Ilaria
|
Dec 12, 2022
|
|
A Binary RNA and DNA Self-Amplifying Platform for Next Generation Vaccines and Therapeutics
First Author: Jefferies, Wilfred A
Reviewed: Dec 9, 2022
|
Jefferies, Wilfred A
|
Dec 9, 2022
|
|
Antibody Affinity Maturation to SARS-CoV-2 Omicron Variants in a Teachers Cohort
First Author: James Pemberton, Philip H
Reviewed: Dec 9, 2022
|
James Pemberton, Philip H
|
Dec 9, 2022
|
|
Are fewer cases of diabetes mellitus diagnosed in the months after SARS-CoV-2 infection?
First Author: Reddy, Neha V
Reviewed: Dec 9, 2022
|
Reddy, Neha V
|
Dec 9, 2022
|
|
BENEFIT-RISK ASSESSMENT OF COVID-19 VACCINE, MRNA (MRNA-1273) FOR MALES AGE 18-64 YEARS
First Author: Yogurtcu, Osman N
Reviewed: Dec 9, 2022
|
Yogurtcu, Osman N
|
Dec 9, 2022
|
|
Convergent evolution in SARS-CoV-2 Spike creates a variant soup that causes new COVID-19 waves
First Author: Focosi, Daniele
Reviewed: Dec 9, 2022
|
Focosi, Daniele
|
Dec 9, 2022
|
|
Durability of immune responses to the booster mRNA vaccination against COVID-19
First Author: Arunachalam, Prabhu S
Reviewed: Dec 9, 2022
|
Arunachalam, Prabhu S
|
Dec 9, 2022
|
|
Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 Protein Vaccine
First Author: Dayan, Gustavo H
Reviewed: Dec 9, 2022
|
Dayan, Gustavo H
|
Dec 9, 2022
|
|
Enhanced Protection from SARS-CoV-2 Variants by MVA-Based Vaccines Expressing Matched or Mismatched S Proteins Administered Intranasally to hACE2 Mice
First Author: Cotter, Catherine A
Reviewed: Dec 9, 2022
|
Cotter, Catherine A
|
Dec 9, 2022
|
|
Epidemiology and outcomes of SARS-CoV-2 infection associated with anti-nucleocapsid seropositivity in Cape Town, South Africa
First Author: Hussey, Hannah
Reviewed: Dec 9, 2022
|
Hussey, Hannah
|
Dec 9, 2022
|
|
Evaluating primary and booster vaccination prioritization strategies for COVID-19 by age and high-contact employment status using data from contact surveys
First Author: Roubenoff, Ethan
Reviewed: Dec 9, 2022
|
Roubenoff, Ethan
|
Dec 9, 2022
|
|
Factors Associated with Long Covid Symptoms in an Online Cohort Study
First Author: Durstenfeld, Matthew S
Reviewed: Dec 9, 2022
|
Durstenfeld, Matthew S
|
Dec 9, 2022
|
|
Heterologous boosting of neutralizing activity against Delta and Omicron SARS-CoV-2 variants in CoronaVac-primed adults; a randomized study with SCB-2019 vaccine
First Author: Roa, Camilo C
Reviewed: Dec 9, 2022
|
Roa, Camilo C
|
Dec 9, 2022
|
|
High resolution cryo-EM structures of two potently SARS-CoV-2 neutralizing monoclonal antibodies of same donor origin that vary in neutralizing Omicron variants
First Author: Rencilin, Clayton Fernando
Reviewed: Dec 9, 2022
|
Rencilin, Clayton Fernando
|
Dec 9, 2022
|
|
Impact Factors of COVID-19 Vaccination Hesitancy in patients after lung cancer surgery: an outpatients-based cross-sectional study
First Author: Qu, Can
Reviewed: Dec 9, 2022
|
Qu, Can
|
Dec 9, 2022
|
|
Impact of Social Capital on Chinese Migrant Workers' Poverty during COVID-19: The Mediation of Social Protection
First Author: Chen, Chen
Reviewed: Dec 9, 2022
|
Chen, Chen
|
Dec 9, 2022
|
|
Increased insulin resistance due to Long COVID is associated with depressive symptoms and partly predicted by the inflammatory response during acute infection
First Author: Al Hakeim, Hussein Kadhem
Reviewed: Dec 9, 2022
|
Al Hakeim, Hussein Kadhem
|
Dec 9, 2022
|
|
Infection and vaccine induced Spike antibody responses against SARS-CoV-2 Variants of concern in immune naïve children and adults
First Author: Pillay, Aleha
Reviewed: Dec 9, 2022
|
Pillay, Aleha
|
Dec 9, 2022
|
- Pediatrics/Adolescents
- Immunological
|
Inhalable SARS-CoV-2 vaccines for single-dose dry-powder aerosol immunization and orchestrated mucosal/systemic immune responses
First Author: Ye, Tong
Reviewed: Dec 9, 2022
|
Ye, Tong
|
Dec 9, 2022
|
|
Low-Dose Interferon I and Iii-Based Nasal Sprays: A Good-Looking Covid-19 Vaccine Candidate?
First Author: Theodor-Nicolae Carp
Reviewed: Dec 9, 2022
|
Theodor-Nicolae Carp
|
Dec 9, 2022
|
|
New insights into the structure of Comirnaty Covid-19 vaccine: A theory on soft nanoparticles with mRNA-lipid supercoils stabilized by hydrogen bonds
First Author: Szebeni, Janos
Reviewed: Dec 9, 2022
|
Szebeni, Janos
|
Dec 9, 2022
|
|
Optimizing COVID-19 testing strategies on college campuses: evaluation of the health and economic costs
First Author: Johnson, Kaitlyn E
Reviewed: Dec 9, 2022
|
Johnson, Kaitlyn E
|
Dec 9, 2022
|
|
Protection of hybrid immunity against SARS-CoV-2 reinfection and severe COVID-19 during periods of Omicron variant predominance in Mexico
First Author: Montes Gonzalez, Jose Antonio
Reviewed: Dec 9, 2022
|
Montes Gonzalez, Jose Antonio
|
Dec 9, 2022
|
|
Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines
First Author: Bruyn, Guy De
Reviewed: Dec 9, 2022
|
Bruyn, Guy De
|
Dec 9, 2022
|
|
SARS-CoV-2 infection- induced seroprevalence among children and associated risk factors during pre- and omicron-dominant wave, from January 2021 through November 2022, Thailand: Longitudinal study
First Author: Suntronwong, Nungruthai
Reviewed: Dec 9, 2022
|
Suntronwong, Nungruthai
|
Dec 9, 2022
|
|
Viral burdens are associated with age and viral variant in a population-representative study of SARS-CoV-2 that accounts for time-since-infection related sampling bias
First Author: Fryer, Helen R
Reviewed: Dec 9, 2022
|
Fryer, Helen R
|
Dec 9, 2022
|
|
BBIBP-CorV (Sinopharm) vaccination- induced immunity is affected by age, gender and prior COVID-19 and activates responses to spike and other antigens
First Author: Hasan, Zahra
Reviewed: Dec 8, 2022
|
Hasan, Zahra
|
Dec 8, 2022
|
|
Characteristics and outcomes of patients with COVID-19 at high-risk of disease progression receiving sotrovimab, oral antivirals or no treatment in England
First Author: Patel, Vishal
Reviewed: Dec 8, 2022
|
Patel, Vishal
|
Dec 8, 2022
|
|
Clinical, imaging, serological, and histopathological features of pulmonary post-acute sequelae after mild COVID-19 (PASC)
First Author: Gagiannis, D
Reviewed: Dec 8, 2022
|
Gagiannis, D
|
Dec 8, 2022
|
|
Comparative effectiveness of heterologous booster schedules with AZD1222, BNT162b2, or mRNA-1273 vaccines against COVID-19 during omicron predominance in the Nordic countries
First Author: Andersson, Niklas Worm
Reviewed: Dec 8, 2022
|
Andersson, Niklas Worm
|
Dec 8, 2022
|
|
Correlates of protection against SARS-CoV-2 Omicron variant and anti-spike antibody responses after a third/booster vaccination or breakthrough infection in the UK general population
First Author: Wei, Jia
Reviewed: Dec 8, 2022
|
Wei, Jia
|
Dec 8, 2022
|
|
Deep Evolutionary Forecasting identifies highly-mutated SARS-CoV-2 variants via functional sequence-landscape enumeration
First Author: Bahl, Christopher
Reviewed: Dec 8, 2022
|
Bahl, Christopher
|
Dec 8, 2022
|
|
Mental Health, Substance Use, and the Importance of Religion during the COVID-19 Pandemic
First Author: Park, Ji Yeun
Reviewed: Dec 8, 2022
|
Park, Ji Yeun
|
Dec 8, 2022
|
|
Performance of antigen lateral flow devices in the United Kingdom during the Alpha, Delta, and Omicron waves of the SARS-CoV-2 pandemic
First Author: Eyre, David
Reviewed: Dec 8, 2022
|
Eyre, David
|
Dec 8, 2022
|
|
Persistent alveolar type 2 dysfunction and lung structural derangement in post-acute COVID-19
First Author: Rendeiro, Andre F
Reviewed: Dec 8, 2022
|
Rendeiro, Andre F
|
Dec 8, 2022
|
|
Pilot Study Demonstrates Benefits of Nursing Home Air Purification on COVID-19 Outcomes
First Author: Jutkowitz, Eric
Reviewed: Dec 8, 2022
|
Jutkowitz, Eric
|
Dec 8, 2022
|
|
SARS-CoV-2 Antibody response to the Sputnik Vaccine in previous infected Patients and non-infected one
First Author: Abdulsammad, Mohamed
Reviewed: Dec 8, 2022
|
Abdulsammad, Mohamed
|
Dec 8, 2022
|
|
SARS-CoV-2 Vaccine Booster Elicits Robust Prolonged Maternal Antibody Responses and Passive Transfer Via The Placenta And Breastmilk
First Author: Marshall, Nicole E
Reviewed: Dec 8, 2022
|
Marshall, Nicole E
|
Dec 8, 2022
|
|
Severe acute infection and chronic pulmonary disease are risk factors for developing post-COVID-19 conditions
First Author: Ghosh, Pritha
Reviewed: Dec 8, 2022
|
Ghosh, Pritha
|
Dec 8, 2022
|
|
The influence of COVID-19 risk perception and vaccination status on the number of social contacts across Europe: insights from the CoMix study
First Author: Wambua, James
Reviewed: Dec 8, 2022
|
Wambua, James
|
Dec 8, 2022
|
|
The Role of National Brand “Bangga Buatan Indonesia” to Support MSME Resilience in COVID-19 Crisis
First Author: Wibowo, Joshi
Reviewed: Dec 8, 2022
|
Wibowo, Joshi
|
Dec 8, 2022
|
|
Vaccine hesitancy, reactogenicity and immunogenicity of BNT162b2 and CoronaVac in pediatric patients with neuromuscular diseases
First Author: Yu, Michael Kwan Leung
Reviewed: Dec 8, 2022
|
Yu, Michael Kwan Leung
|
Dec 8, 2022
|
|
A 6-week time period may not be sufficient to identify potential adverse events following COVID-19 vaccination
First Author: Banoun, Helene
Reviewed: Dec 5, 2022
|
Banoun, Helene
|
Dec 5, 2022
|
|
Factors associated with negative conversion of viral RNA in hospitalized children infected with SARS-CoV-2 Omicron Variant in Shanghai, China:a retrospective analysis
First Author: Yang, Yan
Reviewed: Dec 5, 2022
|
Yang, Yan
|
Dec 5, 2022
|
|
Fcγ receptor-dependent antibody effector functions are required for vaccine protection against infection by antigenic variants of SARS-CoV-2
First Author: Mackin, Samantha R
Reviewed: Dec 5, 2022
|
Mackin, Samantha R
|
Dec 5, 2022
|
|
Monoclonal antibody levels and protection from COVID-19
First Author: Stadler, Eva
Reviewed: Dec 5, 2022
|
Stadler, Eva
|
Dec 5, 2022
|
|
Structural and Computational Design of a SARS-2 Spike Antigen with Increased Receptor Binding Domain Exposure and Improved Immunogenicity
First Author: Williams, James A
Reviewed: Dec 5, 2022
|
Williams, James A
|
Dec 5, 2022
|
|
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants
First Author: Wang, Qian
Reviewed: Dec 1, 2022
|
Wang, Qian
|
Dec 1, 2022
|
|
Hospital and post-discharge mortality in COVID-19 patients with a preexisting cancer diagnosis in Iran
First Author: Seyyedsalehi, Monireh Sadat
Reviewed: Dec 1, 2022
|
Seyyedsalehi, Monireh Sadat
|
Dec 1, 2022
|
|
Human neutralizing antibodies to cold linear epitopes and to subdomain 1 of SARS-CoV-2
First Author: Bianchini, Filippo
Reviewed: Dec 1, 2022
|
Bianchini, Filippo
|
Dec 1, 2022
|
|
Immunogenicity and durability against Omicron BA.1, BA.2 and BA.4/5 variants at 3 to 4 months after a heterologous COVID-19 booster vaccine in healthy adults with a two-doses CoronaVac vaccination
First Author: Assawakosri, Suvichada
Reviewed: Dec 1, 2022
|
Assawakosri, Suvichada
|
Dec 1, 2022
|
|
Long-term immune protection against SARS-CoV-2 escape variants upon a single vaccination with murine cytomegalovirus expressing the spike protein
First Author: Kim, Yeonsu
Reviewed: Dec 1, 2022
|
Kim, Yeonsu
|
Dec 1, 2022
|
|
Plasma after both SARS-CoV-2 boosted vaccination and COVID-19 potently neutralizes BQ1.1 and XBB
First Author: Sullivan, David J
Reviewed: Dec 1, 2022
|
Sullivan, David J
|
Dec 1, 2022
|
|
Prolonged T-cell activation and long COVID symptoms independently associate with severe disease at 3 months in a UK cohort of hospitalized COVID-19 patients
First Author: Santopaolo, Marianna
Reviewed: Dec 1, 2022
|
Santopaolo, Marianna
|
Dec 1, 2022
|
|
SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse Effects
First Author: Boschi, Celine
Reviewed: Dec 1, 2022
|
Boschi, Celine
|
Dec 1, 2022
|
|
The Global Dynamic Transmissibility of COVID-19 and its Influencing Factors: an Analysis of Control Measures from 176 Countries
First Author: Wang, Hongjian
Reviewed: Dec 1, 2022
|
Wang, Hongjian
|
Dec 1, 2022
|
|
Transcriptional changes of tissue-specific genes in multiple endocrine organs: a study of lethal COVID-19 cases
First Author: Poma, Anello Marcello
Reviewed: Dec 1, 2022
|
Poma, Anello Marcello
|
Dec 1, 2022
|
|
Transmission prevention behaviors in US households with SARS-CoV-2 cases in 2020
First Author: Rubinstein, Rebecca
Reviewed: Dec 1, 2022
|
Rubinstein, Rebecca
|
Dec 1, 2022
|
|
Descriptive Study of the Adverse Events Following Immunization (AEFIs) Surveillance System in Zimbabwe
First Author: Nyambayo, Priscilla P M
Reviewed: Nov 29, 2022
|
Nyambayo, Priscilla P M
|
Nov 29, 2022
|
|
Modelling plausible scenarios for the Omicron SARS-CoV-2 variant from
early-stage surveillance
First Author: Banks, Christopher J
Reviewed: Nov 29, 2022
|
Banks, Christopher J
|
Nov 29, 2022
|
|
Prediction of Covid-19 vaccine effectiveness in adult populations and in clinically-vulnerable subgroups
First Author: Volkov, Oleg
Reviewed: Nov 29, 2022
|
Volkov, Oleg
|
Nov 29, 2022
|
|
Substance use, psychiatric symptoms, personal mastery, and social support among COVID-19 long haulers: A compensatory model
First Author: Tam, Cheuk Chi
Reviewed: Nov 29, 2022
|
Tam, Cheuk Chi
|
Nov 29, 2022
|
|
An Early SARS-CoV-2 Omicron Outbreak in a Dormitory in Saint-Petersburg, Russia
First Author: Klink, Galya V
Reviewed: Nov 28, 2022
|
Klink, Galya V
|
Nov 28, 2022
|
|
An FcRn-targeted mucosal vaccine against SARS-CoV-2 infection and transmission
First Author: Li, Weizhong
Reviewed: Nov 28, 2022
|
Li, Weizhong
|
Nov 28, 2022
|
|
Assessment of Attitude and Hesitancy Towards Covid-19 Vaccine among Hepatitis B and C Patients in Pakistan
First Author: Shafiq, Farheen
Reviewed: Nov 28, 2022
|
Shafiq, Farheen
|
Nov 28, 2022
|
|
Autonomic Function Recovery in Post-Covid-19 Young Adults After Immunization: An Observational Follow up Case-control Study
First Author: Ana Paula Coelho Figueira Freire
Reviewed: Nov 28, 2022
|
Ana Paula Coelho Figueira Freire
|
Nov 28, 2022
|
|
Molecular and cellular similarities in the brain of SARS-CoV-2 and Alzheimer’s disease individuals
First Author: Griggs, Elizabeth
Reviewed: Nov 28, 2022
|
Griggs, Elizabeth
|
Nov 28, 2022
|
|
Cardiac Arrhythmia after COVID-19 Vaccination versus Non–COVID-19 Vaccination: A Systematic Review and Meta-Analysis
First Author: Shi, Ao
Reviewed: Nov 25, 2022
|
Shi, Ao
|
Nov 25, 2022
|
|
Inability to work following COVID-19 vaccination among healthcare workers - an important aspect for future booster vaccinations
First Author: Reusch, Julia
Reviewed: Nov 25, 2022
|
Reusch, Julia
|
Nov 25, 2022
|
|
Predictive efficacies of vaccine dose fractionation using neutralizing antibody levels
First Author: Du, Zhanwei
Reviewed: Nov 25, 2022
|
Du, Zhanwei
|
Nov 25, 2022
|
|
Safety and immunogenicity of SARS-CoV-2 self-amplifying RNA vaccine expressing anchored RBD: a randomised, observer-blind, phase 1 study
First Author: Akahata, Wataru
Reviewed: Nov 25, 2022
|
Akahata, Wataru
|
Nov 25, 2022
|
|
Safety, Tolerability, and Immunogenicity of PIKA-Adjuvanted Recombinant SARS-CoV-2 Spike (S) Protein Subunit Vaccine in Healthy Adults: Interim results of an open-label and randomised Phase 1 clinical trial
First Author: Liu, Yuan
Reviewed: Nov 25, 2022
|
Liu, Yuan
|
Nov 25, 2022
|
|
Susceptibility-Weighted Magnetic Resonance Imaging Highlights Brain Alterations in COVID Recovered Patients
First Author: Mishra, Sapna S
Reviewed: Nov 25, 2022
|
Mishra, Sapna S
|
Nov 25, 2022
|
|
A multispecific antibody prevents immune escape and confers pan-SARS-CoV-2 neutralization
First Author: Misasi, John
Reviewed: Nov 24, 2022
|
Misasi, John
|
Nov 24, 2022
|
|
BMI across adulthood, COVID-19 and long COVID in two British birth cohorts
First Author: Staatz, Charis Bridger
Reviewed: Nov 24, 2022
|
Staatz, Charis Bridger
|
Nov 24, 2022
|
|
Elevated circulating monocytes and monocyte activation in pulmonary post-acute sequelae of SARS-CoV-2 infection
First Author: Park, Juwon
Reviewed: Nov 24, 2022
|
Park, Juwon
|
Nov 24, 2022
|
|
Glycemia and New-onset Diabetes among COVID-19 Patients with Prediabetes: A Follow-up Study in India
First Author: Thirunavukkarasu Sathish
Reviewed: Nov 24, 2022
|
Thirunavukkarasu Sathish
|
Nov 24, 2022
|
|
Novel mRNA vaccines encoding Monkeypox virus M1R and A35R protect mice from a lethal virus challenge
First Author: Hou, Fujun
Reviewed: Nov 24, 2022
|
Hou, Fujun
|
Nov 24, 2022
|
|
Prevalence and Risk Factors of Anxious and Depressive Symptoms in First-trimester Females and Their Partners: a study in the post-pandemic era of COVID-19 in China
First Author: Qin, Xuemei
Reviewed: Nov 24, 2022
|
Qin, Xuemei
|
Nov 24, 2022
|
|
SARS-CoV-2 variant transition dynamics are associated with vaccination rates, number of co-circulating variants, and natural immunity
First Author: Beesley, Lauren J
Reviewed: Nov 24, 2022
|
Beesley, Lauren J
|
Nov 24, 2022
|
|
Changes in population immunity against infection and severe disease from SARS-CoV-2 Omicron variants in the United States between December 2021 and November 2022
First Author: Klaassen, Fayette
Reviewed: Nov 23, 2022
|
Klaassen, Fayette
|
Nov 23, 2022
|
|
Coronavirus spike protein-specific antibodies indicate frequent infections and reinfections in infancy and among BNT162b2-vaccinated healthcare workers
First Author: Kolehmainen, Pekka
Reviewed: Nov 23, 2022
|
Kolehmainen, Pekka
|
Nov 23, 2022
|
|
Evaluation of T cell responses with the QuantiFERON SARS-CoV-2 assay in individuals with 3 doses of BNT162b2 vaccine, SARS-CoV-2 infection, or hybrid immunity
First Author: Dourdouna, Maria Myrto
Reviewed: Nov 23, 2022
|
Dourdouna, Maria Myrto
|
Nov 23, 2022
|
|
Immunogenicity and safety of a 4th homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a phase 2, randomized, placebo-controlled trial
First Author: Alves, Katia
Reviewed: Nov 23, 2022
|
Alves, Katia
|
Nov 23, 2022
|
|
Inference of an Epidemic Driven by Random Transmission Rate: Explaining the Dynamics of COVID-19 in Bogotá
First Author: Rios Gutierrez, Andres
Reviewed: Nov 23, 2022
|
Rios Gutierrez, Andres
|
Nov 23, 2022
|
|
Running ahead of evolution - AI based simulation for predicting future high-risk SARS-CoV-2 variants
First Author: Chen, Jie
Reviewed: Nov 23, 2022
|
Chen, Jie
|
Nov 23, 2022
|
|
Serologic Responses to COVID-19 Vaccination in Children with History of Multisystem Inflammatory Syndrome (MIS-C)
First Author: Perez, Maria A
Reviewed: Nov 23, 2022
|
Perez, Maria A
|
Nov 23, 2022
|
- Pediatrics/Adolescents
- Immunological
|
A single-centre, observational study to evaluate immune response to Covid-19 vaccines in immunocompromised patients with haematological disorders (COVAC-IC)
First Author: COVAC-IC investigators
Reviewed: Nov 22, 2022
|
COVAC-IC investigators
|
Nov 22, 2022
|
|
Bitcoin price fluctuation by Twitter sentiment analysis pre- and post- COVID- 19 pandemic
First Author: Japar, Izzati Izyani
Reviewed: Nov 22, 2022
|
Japar, Izzati Izyani
|
Nov 22, 2022
|
|
Comparative effectiveness of two- and three-dose schedules involving AZD1222 and BNT162b2 in people with kidney disease: a linked OpenSAFELY and UK Renal Registry cohort study
First Author: The OpenSAFELY Collaborative
Reviewed: Nov 22, 2022
|
The OpenSAFELY Collaborative
|
Nov 22, 2022
|
|
COVID-19 patients in the COVID-19 Recovery and Engagement (CORE) Clinics in the Bronx
First Author: Darrell, Megan
Reviewed: Nov 22, 2022
|
Darrell, Megan
|
Nov 22, 2022
|
|
Factors associated with release relief of Long COVID symptoms at 12-Months and their impact on daily life
First Author: Salmon, Dominique
Reviewed: Nov 22, 2022
|
Salmon, Dominique
|
Nov 22, 2022
|
|
Human Early Syncytiotrophoblasts Are Highly Susceptible to SARS-CoV-2 Infection
First Author: Ruan, Degong
Reviewed: Nov 22, 2022
|
Ruan, Degong
|
Nov 22, 2022
|
|
Metabolic Profile of Patients With Long Covid: a Cross-sectional Study
First Author: Menezes, Daniel
Reviewed: Nov 22, 2022
|
Menezes, Daniel
|
Nov 22, 2022
|
|
Molecularly distinct memory CD4+ T cells are induced by SARS-CoV-2 infection and mRNA vaccination
First Author: Gray Gaillard, Sophie L
Reviewed: Nov 22, 2022
|
Gray Gaillard, Sophie L
|
Nov 22, 2022
|
|
Neutralizing antibodies to Omicron after the fourth SARS-CoV-2 mRNA vaccine dose in immunocompromised patients highlight the need of additional boosters
First Author: Rescigno, Maria
Reviewed: Nov 22, 2022
|
Rescigno, Maria
|
Nov 22, 2022
|
|
Observational methods for COVID-19 vaccine effectiveness research: a trial emulation and empirical evaluation
First Author: Catala, Marti
Reviewed: Nov 22, 2022
|
Catala, Marti
|
Nov 22, 2022
|
|
Research Letter: Association between long COVID symptoms and employment status
First Author: Perlis, Roy H
Reviewed: Nov 22, 2022
|
Perlis, Roy H
|
Nov 22, 2022
|
|
Serial Viral Load Analysis by Ddpcr to Evaluate Fnc Efficacy and Safety in the Treatment of Mild Cases of Covid-19
First Author: Cabral, Paula
Reviewed: Nov 22, 2022
|
Cabral, Paula
|
Nov 22, 2022
|
|
Severe COVID-19 associated hyperglycaemia is caused by beta cell dysfunction: a prospective cohort study
First Author: Gojda, Jan
Reviewed: Nov 22, 2022
|
Gojda, Jan
|
Nov 22, 2022
|
|
A computer simulation-based study on the intervention of active ingredients of Mongolian medicine into the S-protein of SARS-CoV-2-associated variant Omicron
First Author: Bao, Lidao
Reviewed: Nov 21, 2022
|
Bao, Lidao
|
Nov 21, 2022
|
|
A randomized controlled trial of adjuvant inhalable sodium bicarbonate role in treatment of COVID-19
First Author: El Badrawy, Mohammad
Reviewed: Nov 21, 2022
|
El Badrawy, Mohammad
|
Nov 21, 2022
|
|
A rise in social media use in adolescents during the COVID-19 pandemic: the French validation of the Bergen Social Media Addiction Scale in a Canadian cohort
First Author: Dufort Rouleau, Raphael
Reviewed: Nov 21, 2022
|
Dufort Rouleau, Raphael
|
Nov 21, 2022
|
|
A stochastic agent-based model to evaluate COVID-19 transmission
influenced by human mobility
First Author: Chen, Kejie
Reviewed: Nov 21, 2022
|
Chen, Kejie
|
Nov 21, 2022
|
|
Anxiety, depression and perceived social support among covid-19 patients admitted to a Covid Care Centre in Uttarakhand, India
First Author: Khan, Mohd Najmul Aqib
Reviewed: Nov 21, 2022
|
Khan, Mohd Najmul Aqib
|
Nov 21, 2022
|
|
Application of radical mastectomy in ambulatory surgery centres under COVID-19
First Author: Zhou, Jiao
Reviewed: Nov 21, 2022
|
Zhou, Jiao
|
Nov 21, 2022
|
|
Cardiac Autonomic Function in Long COVID-19 Using Heart Rate Variability: An Observational Cross-Sectional Study
First Author: Antonio da Silva Menezes Junior
Reviewed: Nov 21, 2022
|
Antonio da Silva Menezes Junior
|
Nov 21, 2022
|
|
Characterization of tungiasis infection and morbidity in Kenya reveals increase in disease burden during COVID-19 school closures.
First Author: Elson, Lynne
Reviewed: Nov 21, 2022
|
Elson, Lynne
|
Nov 21, 2022
|
|
Combining Influenza and COVID-19 Booster Vaccination Strategy to Improve Vaccination Uptake Necessary for Managing the Health Pandemic: A Systematic Review and Meta-Analysis
First Author: Nikolaos Tzenios
Reviewed: Nov 21, 2022
|
Nikolaos Tzenios
|
Nov 21, 2022
|
|
Comparison of psycho-sexual factors and the quality of life between breastfeeding and non- breastfeeding women during the COVID-19 pandemic: A cross-sectional study
First Author: Damabi, Negin Mirzaei
Reviewed: Nov 21, 2022
|
Damabi, Negin Mirzaei
|
Nov 21, 2022
|
|
Diagnostic delay in multiple myeloma: the legacy of the COVID-19 pandemic.
First Author: Carmichael, Jonathan
Reviewed: Nov 21, 2022
|
Carmichael, Jonathan
|
Nov 21, 2022
|
|
Early alveolar epithelial cell necrosis is a potential driver of COVID-19-induced acute respiratory distress syndrome
First Author: Tojo, Kentaro
Reviewed: Nov 21, 2022
|
Tojo, Kentaro
|
Nov 21, 2022
|
|
Efficacy of the wild-type/Omicron BA.1 bivalent vaccine as the second booster dose against Omicron BA.2 and BA.5
First Author: Kawasuji, Hitoshi
Reviewed: Nov 21, 2022
|
Kawasuji, Hitoshi
|
Nov 21, 2022
|
|
Environmental predictors of SARS-CoV-2 infection incidence in Catalonia (northwestern Mediterranean)
First Author: Morato, Jesus Planella
Reviewed: Nov 21, 2022
|
Morato, Jesus Planella
|
Nov 21, 2022
|
|
Family physicians partnering for system change: A multiple-case study of Ontario Health Teams in development
First Author: Grady, Colleen
Reviewed: Nov 21, 2022
|
Grady, Colleen
|
Nov 21, 2022
|
|
Growing a Peritoneal Dialysis Program in Palestine from Zero to 178 Patients in 5 Years: A Single-Center Experience
First Author: Taher, Ameed
Reviewed: Nov 21, 2022
|
Taher, Ameed
|
Nov 21, 2022
|
|
Impact of Nutrition Education on Knowledge and Beliefs about Dietary supplements/Herbal foods: A pre - post intervention study
First Author: Kalkuz, Seyma
Reviewed: Nov 21, 2022
|
Kalkuz, Seyma
|
Nov 21, 2022
|
|
Improved Neutralization of Omicron BA.4/5, BA.4.6, BA.2.75.2, BQ.1.1, and XBB.1 with Bivalent BA.4/5 Vaccine
First Author: Zou, Jing
Reviewed: Nov 21, 2022
|
Zou, Jing
|
Nov 21, 2022
|
|
Incidence and clinical characteristics of adverse neurological events and stroke-like syndrome associated with immune stress-related response after COVID-19 vaccination
First Author: Sirisuk, Wikawee
Reviewed: Nov 21, 2022
|
Sirisuk, Wikawee
|
Nov 21, 2022
|
|
Innate immune response to SARS-CoV-2 infection contributes to neuronal damage in human iPSC-derived peripheral neurons
First Author: Passos, Vania
Reviewed: Nov 21, 2022
|
Passos, Vania
|
Nov 21, 2022
|
|
Large libraries of single-chain trimer peptide-MHCs enable rapid antigen-specific CD8+ T cell discovery and analysis
First Author: Heath, James
Reviewed: Nov 21, 2022
|
Heath, James
|
Nov 21, 2022
|
|
MAP3K19 regulatory variation in populations with African ancestry is associated with severe COVID-19
First Author: Cheng, Zhong Shan
Reviewed: Nov 21, 2022
|
Cheng, Zhong Shan
|
Nov 21, 2022
|
|
Population confidence in federal entities’ governance to face the COVID-19 pandemic in Brazil and its associated factors: Evidence from the Social Thermometer Project – COVID-19
First Author: Moura, Heriederson Savio Dias
Reviewed: Nov 21, 2022
|
Moura, Heriederson Savio Dias
|
Nov 21, 2022
|
|
Predictors of Long-term Muscle Weakness in Survivors of Covid-19 Acute Respiratory Distress Syndrome
First Author: Benedini, Marco
Reviewed: Nov 21, 2022
|
Benedini, Marco
|
Nov 21, 2022
|
|
Predictors of Severe COVID-19 among Healthcare Workers in Sabah, Malaysia
First Author: Joo, Lim Kai
Reviewed: Nov 21, 2022
|
Joo, Lim Kai
|
Nov 21, 2022
|
|
Preventable deaths involving opioids in England and Wales, 2013-2022: a systematic case series of coroners’ reports
First Author: Dernie, Francesco
Reviewed: Nov 21, 2022
|
Dernie, Francesco
|
Nov 21, 2022
|
|
Relapse of Monoclonal Gammopathy of Renal Significance after mRNA Covid-19 vaccination: a case report
First Author: Tsaftaridis, Nikolaos
Reviewed: Nov 21, 2022
|
Tsaftaridis, Nikolaos
|
Nov 21, 2022
|
|
Resistance of Omicron subvariants BA.2.75.2, BA.4.6 and BQ.1.1 to neutralizing antibodies
First Author: Planas, Delphine
Reviewed: Nov 21, 2022
|
Planas, Delphine
|
Nov 21, 2022
|
|
Safety-Critical Control of Compartmental Epidemiological Models with
Measurement Delays
First Author: Molnar, Tamas G
Reviewed: Nov 21, 2022
|
Molnar, Tamas G
|
Nov 21, 2022
|
|
STRENGTH OF ASSOCIATION BETWEEN GENERALIZED/NONSPECIFIC COVID-19 SIGNS & SYMPTOMS WITH SARS-COV 2 SPECIFIC ORF, N, E GENES IDENTIFIED THROUGH REAL TIME PCR
First Author: Arif, Muhammad
Reviewed: Nov 21, 2022
|
Arif, Muhammad
|
Nov 21, 2022
|
|
Time to intubation, ventilatory mechanics and outcome in COVID-19 patients with acute respiratory distress syndrome: A single-centre study.
First Author: Aretha, Diamanto
Reviewed: Nov 21, 2022
|
Aretha, Diamanto
|
Nov 21, 2022
|
|
Trajectories of child mental health, physical activity and screen-time during the COVID-19 pandemic considering different family situations: results from a longitudinal birth cohort.
First Author: Kurz, Deborah
Reviewed: Nov 21, 2022
|
Kurz, Deborah
|
Nov 21, 2022
|
|
3D-Printed Microfluidic Device for High-Throughput Production of Lipid Nanoparticles Incorporating SARS-CoV-2 Spike Protein mRNA
First Author: Lin, Wan Zhen
Reviewed: Nov 20, 2022
|
Lin, Wan Zhen
|
Nov 20, 2022
|
|
A C57BL/6 Mouse model of SARS-CoV-2 infection recapitulates age- and sex-based differences in human COVID-19 disease and recovery
First Author: Davis, Michael
Reviewed: Nov 20, 2022
|
Davis, Michael
|
Nov 20, 2022
|
|
A Digital Biomarker for Identifying Changes in Daily Activity Patterns
First Author: Fletcher Lloyd, Nan
Reviewed: Nov 20, 2022
|
Fletcher Lloyd, Nan
|
Nov 20, 2022
|
|
A longitudinal study of children with COVID-19 in outpatient centers in terms of clinical manifestations, hospitalization, antibiotic prescription, and the number of COVID-19 times
First Author: Hosseininasab, Ali
Reviewed: Nov 20, 2022
|
Hosseininasab, Ali
|
Nov 20, 2022
|
|
A Multisite Exploration of the Association between Critical Care Implementation Factors and Clinical Outcomes during the COVID-19 Pandemic
First Author: Silver, Santana
Reviewed: Nov 20, 2022
|
Silver, Santana
|
Nov 20, 2022
|
|
A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signaling
First Author: Hackney, Jason A
Reviewed: Nov 20, 2022
|
Hackney, Jason A
|
Nov 20, 2022
|
|
A Tale of Two Waves: Diverse Genomic and Transmission Landscapes Over 15 Months of the COVID-19 Pandemic in Pune, India
First Author: Niveditha, Divya
Reviewed: Nov 20, 2022
|
Niveditha, Divya
|
Nov 20, 2022
|
|
AIMP1 is a novel potential biomarker for LUAD and is associated with improved prognosis
First Author: Wei, Qishuang
Reviewed: Nov 20, 2022
|
Wei, Qishuang
|
Nov 20, 2022
|
|
Analysis of mental health status and influencing factors of medical staff during static management of the COVID-19 epidemic: a cross-sectional study
First Author: Liu, Jiawei
Reviewed: Nov 20, 2022
|
Liu, Jiawei
|
Nov 20, 2022
|
|
Antiviral innate immunity is diminished in the upper respiratory tract of severe COVID-19 patients
First Author: Ramos Benitez, Marcos J
Reviewed: Nov 20, 2022
|
Ramos Benitez, Marcos J
|
Nov 20, 2022
|
|
Are SARS-CoV-2 self-tests used for their intended purpose? The experience in Belgium.
First Author: Lafort, Yves
Reviewed: Nov 20, 2022
|
Lafort, Yves
|
Nov 20, 2022
|
|
Assessing the spatial-temporal risks of SARS-CoV-2 infection for healthcare-workers in the hospital using behavioural indices from routine data
First Author: Wilson Aggarwal, Jared
Reviewed: Nov 20, 2022
|
Wilson Aggarwal, Jared
|
Nov 20, 2022
|
|
Assessment of level of depression and associated factors among covid-19 recovered patients: a cross sectional study
First Author: Khatun, Mst Khadeza
Reviewed: Nov 20, 2022
|
Khatun, Mst Khadeza
|
Nov 20, 2022
|
|
Cancer Patients’ Health Related Quality of Life (HRQoL) and Its Predictor Factors during the COVID-19 Pandemic: A Cross-sectional Survey Study in China
First Author: Sun, Lingyun
Reviewed: Nov 20, 2022
|
Sun, Lingyun
|
Nov 20, 2022
|
|
Chronic Anti-Coagulation Therapy Reduced Mortality In Patients With High Cardiovascular Risk Early In COVID-19 Pandemic
First Author: Zaghloul, Mohamed S
Reviewed: Nov 20, 2022
|
Zaghloul, Mohamed S
|
Nov 20, 2022
|
|
Circular Economy of Medical Waste: Novel Intelligent Medical Waste Management Framework Based on Extension Linear Diophantine Fuzzy FDOSM and Neural Network Approach
First Author: Chew, Xin Ying
Reviewed: Nov 20, 2022
|
Chew, Xin Ying
|
Nov 20, 2022
|
|
Colorectal Surgery Travelling Fellowships: Historical Perspective and Future Direction
First Author: Badrek Alamoudi, Ahmed H
Reviewed: Nov 20, 2022
|
Badrek Alamoudi, Ahmed H
|
Nov 20, 2022
|
|
Combined COVID-19 vaccination and hepatitis C virus screening intervention in marginalised populations in Spain
First Author: Lazarus, Jeffrey
Reviewed: Nov 20, 2022
|
Lazarus, Jeffrey
|
Nov 20, 2022
|
|
Cotranslational formation of disulfides guides folding of the SARS COV-2 receptor binding domain
First Author: Bitran, Amir
Reviewed: Nov 20, 2022
|
Bitran, Amir
|
Nov 20, 2022
|
|
COVID Seq as Laboratory Developed Test (LDT) for diagnosis of SARS-CoV-2 Variants of Concern (VOC)
First Author: Carpenter, Rob E
Reviewed: Nov 20, 2022
|
Carpenter, Rob E
|
Nov 20, 2022
|
|
Covid-19 in Brazil: A Cross-Sectional Immuno-Epidemical and Genomic Evaluation in a Pre-Omicron Era
First Author: Rodrigues, Sarah De Oliveira
Reviewed: Nov 20, 2022
|
Rodrigues, Sarah De Oliveira
|
Nov 20, 2022
|
|
Deep Learning-based Network Pharmacology for Exploring the Mechanism of Licorice for the Treatment of COVID-19
First Author: Fu, Yu
Reviewed: Nov 20, 2022
|
Fu, Yu
|
Nov 20, 2022
|
|
Detection of infectious SARS-CoV-2 in frozen aerosol samples collected from hospital rooms of patients with COVID-19
First Author: Fortin, Audray
Reviewed: Nov 20, 2022
|
Fortin, Audray
|
Nov 20, 2022
|
|
Detection of SARS-CoV 2 receptor binding domain using fluorescence probe and DNA flowers enabled by rolling circle amplification
First Author: Zhang, Man
Reviewed: Nov 20, 2022
|
Zhang, Man
|
Nov 20, 2022
|
|
Dyad orientation-dependent regulation of
SARS-CoV 2 protease: towards informed
structure-based drug discovery
First Author: Abdel Maksoud, Khaled
Reviewed: Nov 20, 2022
|
Abdel Maksoud, Khaled
|
Nov 20, 2022
|
|
Early prone positioning does not improve the outcome of patients with mild pneumonia due to SARS-CoV-2: results from an open-label, randomized controlled trial (the EPCoT Study)
First Author: Fezzi, Miriam
Reviewed: Nov 20, 2022
|
Fezzi, Miriam
|
Nov 20, 2022
|
|
Effect of home exercise on post-stroke sensorimotor dysfunction during the long-term COVID-19 epidemic lockdown: a retrospective single-center cohort study
First Author: Wei, Dong
Reviewed: Nov 20, 2022
|
Wei, Dong
|
Nov 20, 2022
|
|
Epidemiology and molecular characteristics of respiratory syncytial virus (RSV) among Italian community-dwelling adults, 2021/22 season
First Author: Panatto, Donatella
Reviewed: Nov 20, 2022
|
Panatto, Donatella
|
Nov 20, 2022
|
|
Exploration of wastewater surveillance for Monkeypox virus
First Author: Mejia, Edgard M
Reviewed: Nov 20, 2022
|
Mejia, Edgard M
|
Nov 20, 2022
|
|
Gallium-68 labelled RGD PET/CT imaging of endothelial activation in COVID-19 patients
First Author: Genugten, Evelien A J Van
Reviewed: Nov 20, 2022
|
Genugten, Evelien A J Van
|
Nov 20, 2022
|
|
Genetic and structural data on the SARS-CoV-2 Omicron BQ.1 variant reveal its low potential for epidemiological expansion
First Author: Scarpa, Fabio
Reviewed: Nov 20, 2022
|
Scarpa, Fabio
|
Nov 20, 2022
|
|
How People Prioritize Health Issues During the COVID-19 Pandemic: Evidence from Seven Developing Countries
First Author: Whittington, Dale
Reviewed: Nov 20, 2022
|
Whittington, Dale
|
Nov 20, 2022
|
|
Long-standing COVID-19 disease in immunedeficient patients; case reports and literature review
First Author: Mortaz, Esmaeil
Reviewed: Nov 20, 2022
|
Mortaz, Esmaeil
|
Nov 20, 2022
|
|
Long-term COVID-19 booster effectiveness by infection history and clinical vulnerability and immune imprinting
First Author: Chemaitelly, Hiam
Reviewed: Nov 20, 2022
|
Chemaitelly, Hiam
|
Nov 20, 2022
|
|
Normalized Semi-Covariance Co-Efficiency Analysis of Spike Proteins from SARS-CoV-2 variant Omicron and Other Coronaviruses for their Infectivity and Virulence
First Author: Xu, Tong
Reviewed: Nov 20, 2022
|
Xu, Tong
|
Nov 20, 2022
|
|
Pandemic modelling for regions implementing an elimination strategy
First Author: Hurford, Amy
Reviewed: Nov 20, 2022
|
Hurford, Amy
|
Nov 20, 2022
|
|
Perinatal anxiety and depression amidst the COVID-19 pandemic
First Author: Tambawala, Zenab Yusuf
Reviewed: Nov 20, 2022
|
Tambawala, Zenab Yusuf
|
Nov 20, 2022
|
|
Primary Cardiac Angiosarcoma With Pulmonary Metastasis in a Young Female: A Case Report and Review of Literature
First Author: Kordjazy, Nastaran
Reviewed: Nov 20, 2022
|
Kordjazy, Nastaran
|
Nov 20, 2022
|
|
Protection conferred by Delta and BA.1/BA.2 infection against BA.4/BA.5 infection and hospitalization: A Retrospective Cohort Study
First Author: Winchester, Nicole E
Reviewed: Nov 20, 2022
|
Winchester, Nicole E
|
Nov 20, 2022
|
|
Requirements to minimize airborne infections related to virus aerosol contamination at indoor cultural events
First Author: Salthammer, Tunga
Reviewed: Nov 20, 2022
|
Salthammer, Tunga
|
Nov 20, 2022
|
|
Risk of SARS-CoV-2 reinfection is time- and variant-dependant, France, January 2021 to August 2022
First Author: Auvigne, Vincent
Reviewed: Nov 20, 2022
|
Auvigne, Vincent
|
Nov 20, 2022
|
|
Safety, reactogenicity, immunogenicity, and effectiveness of COVID-19 vaccines for pregnant persons: A protocol for a living systematic review and meta-analysis
First Author: Ciapponi, Agustin
Reviewed: Nov 20, 2022
|
Ciapponi, Agustin
|
Nov 20, 2022
|
|
Sensible Long-lead Forecast of COVID-19 Epidemic Outcomes
First Author: Yang, Wan
Reviewed: Nov 20, 2022
|
Yang, Wan
|
Nov 20, 2022
|
|
Serology assays used in SARS-CoV-2 seroprevalence surveys worldwide: a systematic review and meta-analysis of assay features, testing algorithms, and performance
First Author: Ma, Xiaomeng
Reviewed: Nov 20, 2022
|
Ma, Xiaomeng
|
Nov 20, 2022
|
|
Seroprevalence of four endemic human coronaviruses antibodies among Filipino children and their cross-reactivity and neutralization capacity against SARS-CoV-2
First Author: Sayama, Yusuke
Reviewed: Nov 20, 2022
|
Sayama, Yusuke
|
Nov 20, 2022
|
- Pediatrics/Adolescents
- Immunological
|
Short-term exposure to Air Pollution and COVID-19 in India: A Spatio-temporal analysis of Relative Risk from 20 Metropolitan cities
First Author: Prasad, Peri Subrahmanya Hari
Reviewed: Nov 20, 2022
|
Prasad, Peri Subrahmanya Hari
|
Nov 20, 2022
|
|
Socially Distanced: An Exploratory Study of the Relationships Between Delusional Ideation and Social Imagery Under the Lens of the COVID-19 Pandemic
First Author: Robertson, Kennedy
Reviewed: Nov 20, 2022
|
Robertson, Kennedy
|
Nov 20, 2022
|
|
Successful Detection of Delta and Omicron Variants of SARS-CoV-2 by Veterinary Diagnostic Laboratory Participants in an Interlaboratory Comparison Exercise
First Author: Deng, Kaiping
Reviewed: Nov 20, 2022
|
Deng, Kaiping
|
Nov 20, 2022
|
|
Symptoms and risk factors of depression and PTSD in the prolonged COVID-19 pandemic: A longitudinal survey conducted from 2020 to 2022 in Japan
First Author: Fukase, Yuko
Reviewed: Nov 20, 2022
|
Fukase, Yuko
|
Nov 20, 2022
|
|
Synthesis, structure, hirshfeld surface analysis, non-covalent interaction, and in silico studies of 4-hydroxy-1-[(4-nitrophenyl)sulphonyl]pyrrolidine-2-carboxyllic acid
First Author: Ugwu, David Izuchukwu
Reviewed: Nov 20, 2022
|
Ugwu, David Izuchukwu
|
Nov 20, 2022
|
|
The government of masks in sentinel territories against Covid-19: Dakar and Seine-Saint-Denis
First Author: Keck, Frederic
Reviewed: Nov 20, 2022
|
Keck, Frederic
|
Nov 20, 2022
|
|
The Paxlovid Rebound Study: A Prospective Cohort Study to Evaluate Viral and Symptom Rebound Differences Between Paxlovid and Untreated COVID-19 Participants
First Author: Pandit, Jay A
Reviewed: Nov 20, 2022
|
Pandit, Jay A
|
Nov 20, 2022
|
|
The Research Interest, Capacity and Culture of NHS Staff in South East Scotland and Changes in Attitude to Research Following the Pandemic: a Cross-Sectional Survey
First Author: Chinn, David J
Reviewed: Nov 20, 2022
|
Chinn, David J
|
Nov 20, 2022
|
|
Using Genome Sequence Data to Predict SARS-CoV-2 Detection Cycle Threshold Values
First Author: Duesterwald, Lea
Reviewed: Nov 20, 2022
|
Duesterwald, Lea
|
Nov 20, 2022
|
|
Viral shedding among symptomatic COVID-19 cases infected with the ancestral strain and Omicron BA.2
First Author: Wu, Peng
Reviewed: Nov 20, 2022
|
Wu, Peng
|
Nov 20, 2022
|
|
Vital Measurements of Hospitalized COVID-19 Patients as a Predictor of
Long COVID: An EHR-based Cohort Study from the RECOVER Program in N3C
First Author: Jiang, Sihang
Reviewed: Nov 20, 2022
|
Jiang, Sihang
|
Nov 20, 2022
|
|
Wastewater as a back door to serology?
First Author: Agan, Marie Little Fawn
Reviewed: Nov 20, 2022
|
Agan, Marie Little Fawn
|
Nov 20, 2022
|
|
Whole Genome CRISPR Screening Strategy for Identification of Host Genes Contributing to Envelope Mediated Entry of SARS-CoV-2 Spike and VSV-G
First Author: Hossain, Md Saddam
Reviewed: Nov 20, 2022
|
Hossain, Md Saddam
|
Nov 20, 2022
|
|
Year-round RSV Transmission in the Netherlands Following the COVID-19 Pandemic - A Prospective Nationwide Observational and Modeling Study
First Author: Lowensteyn, Yvette N
Reviewed: Nov 20, 2022
|
Lowensteyn, Yvette N
|
Nov 20, 2022
|
|
Acute and Post-Acute COVID-19 Outcomes Among Immunologically Naïve Adults During Delta Versus Omicron Waves
First Author: Doll, Margaret K
Reviewed: Nov 17, 2022
|
Doll, Margaret K
|
Nov 17, 2022
|
|
Bispecific antibodies combine breadth, potency, and avidity of parental antibodies to neutralize sarbecoviruses
First Author: Radic, Laura
Reviewed: Nov 17, 2022
|
Radic, Laura
|
Nov 17, 2022
|
|
Conceptualising the Episodic Nature of Disability among Adults Living with Long COVID: A Qualitative Study
First Author: O Brien, Kelly K
Reviewed: Nov 17, 2022
|
O Brien, Kelly K
|
Nov 17, 2022
|
|
Endemic Oscillations for SARS-CoV-2 Omicron -- A SIRS model analysis
First Author: Nill, Florian
Reviewed: Nov 17, 2022
|
Nill, Florian
|
Nov 17, 2022
|
|
Immune response of primary and booster immunity of SARS-CoV-2 vaccination among patients with chronic liver disease: a real-world study
First Author: Song, Ruixin
Reviewed: Nov 17, 2022
|
Song, Ruixin
|
Nov 17, 2022
|
|
Increased Interleukin-6 is Associated with Long COVID-19: Evidence from a Systematic Review and Meta-analysis
First Author: Yin, Jing Xian
Reviewed: Nov 17, 2022
|
Yin, Jing Xian
|
Nov 17, 2022
|
|
Protection against infection with the Omicron BA.5 subvariant among people with previous SARS-CoV-2 infection - surveillance results from southern Sweden, June to August 2022
First Author: Kahn, Fredrik
Reviewed: Nov 17, 2022
|
Kahn, Fredrik
|
Nov 17, 2022
|
|
Risk factors and symptom clusters for Long Covid: analysis of United Kingdom symptom tracker app data
First Author: Ford, Elizabeth
Reviewed: Nov 17, 2022
|
Ford, Elizabeth
|
Nov 17, 2022
|
|
Severity and Symptom Characteristics between Omicron and Delta SARS-CoV-2 Variant Infections in the Australian Capital Territory: A Cross-Sectional Study
First Author: Gomez, Algreg
Reviewed: Nov 17, 2022
|
Gomez, Algreg
|
Nov 17, 2022
|
|
Site Specific N- and O-glycosylation mapping of the Spike Proteins of SARS-CoV-2 Variants of Concern
First Author: Shajahan, Asif
Reviewed: Nov 17, 2022
|
Shajahan, Asif
|
Nov 17, 2022
|
|
A broad-spectrum macrocyclic peptide inhibitor of the SARS-CoV-2 spike protein
First Author: Thijssen, Vito
Reviewed: Nov 16, 2022
|
Thijssen, Vito
|
Nov 16, 2022
|
|
A rapid evidence map of womens health
First Author: Edwards, Deborah
Reviewed: Nov 16, 2022
|
Edwards, Deborah
|
Nov 16, 2022
|
|
Arrayed Imaging Reflectometry monitoring of anti-viral antibody production throughout vaccination and breakthrough Covid-19
First Author: Klose, Alanna M
Reviewed: Nov 16, 2022
|
Klose, Alanna M
|
Nov 16, 2022
|
|
Association of vaccine-induced or hybrid immunity with COVID-19-related mortality during the Omicron wave -- a retrospective observational study in
elderly Bavarians
First Author: Weigert, Maximilian
Reviewed: Nov 16, 2022
|
Weigert, Maximilian
|
Nov 16, 2022
|
|
Attenuated humoral responses in HIV infection after SARS-CoV-2 vaccination are linked to global B cell defects and cellular immune profiles
First Author: Touizer, Emma
Reviewed: Nov 16, 2022
|
Touizer, Emma
|
Nov 16, 2022
|
|
Clinical and experimental evidence suggest omicron SARS-CoV-2 is inherently less pathogenic than delta independent of previous immunity
First Author: Thiruvengadam, Ramachandran
Reviewed: Nov 16, 2022
|
Thiruvengadam, Ramachandran
|
Nov 16, 2022
|
|
Cohort profile: A Québec-based plasma donor biobank to study COVID-19 immunity (PlasCoV)
First Author: Germain, Marc
Reviewed: Nov 16, 2022
|
Germain, Marc
|
Nov 16, 2022
|
|
COVID-19 progression and convalescence in common variable immunodeficiency patients shows incomplete adaptive responses and persistent inflammasome activation
First Author: Rodriguez Ubreva, Javier
Reviewed: Nov 16, 2022
|
Rodriguez Ubreva, Javier
|
Nov 16, 2022
|
|
Dysmenorrhea, intermenstrual bleeding, and irregularities post COVID-19 vaccination and associated factors: a retrospective observational study
First Author: Khan, Ghadeer
Reviewed: Nov 16, 2022
|
Khan, Ghadeer
|
Nov 16, 2022
|
|
Health, socioeconomic and genetic predictors of COVID-19 vaccination uptake: a nationwide machine-learning study
First Author: Hartonen, Tuomo
Reviewed: Nov 16, 2022
|
Hartonen, Tuomo
|
Nov 16, 2022
|
|
Nationwide analysis of COVID-19 death rate throughout the pandemic in Italy
First Author: Mattiuzzi, Camilla
Reviewed: Nov 16, 2022
|
Mattiuzzi, Camilla
|
Nov 16, 2022
|
|
Perceived Risks and Perceptions of Covid–19 Vaccination in Patients with Autoimmune Skin Diseases Attending a Tertiary Care Centre in South India – A Questionnaire Based Study
First Author: Lomine Karain, R
Reviewed: Nov 16, 2022
|
Lomine Karain, R
|
Nov 16, 2022
|
|
Selection of long COVID symptoms influences prevalence estimates in a prospective cohort
First Author: Wynberg, Elke
Reviewed: Nov 16, 2022
|
Wynberg, Elke
|
Nov 16, 2022
|
|
An intranasal self-amplifying RNA SARS-CoV-2 vaccine produces durable respiratory and systemic immunity
First Author: Jennewein, Madeleine F
Reviewed: Nov 15, 2022
|
Jennewein, Madeleine F
|
Nov 15, 2022
|
|
Assessing the Effect of Selective Serotonin Reuptake Inhibitors in the Prevention of Post-Acute Sequelae of COVID-19
First Author: Sidky, Hythem
Reviewed: Nov 15, 2022
|
Sidky, Hythem
|
Nov 15, 2022
|
|
Clinical accuracy of SARS-CoV-2 rapid antigen testing in screening children and adolescents in comparison to RT-qPCR, November 2020 to September 2022
First Author: Krone, Manuel
Reviewed: Nov 15, 2022
|
Krone, Manuel
|
Nov 15, 2022
|
|
Comparison of the reactogenicity and immunogenicity between two-dose mRNA COVID-19 vaccine and inactivated followed by an mRNA vaccine in children aged 5 - 11 years
First Author: Wanlapakorn, Nasamon
Reviewed: Nov 15, 2022
|
Wanlapakorn, Nasamon
|
Nov 15, 2022
|
- Pediatrics/Adolescents
- Immunological
|
Cross-neutralization and viral fitness of SARS-CoV-2 Omicron sublineages
First Author: Xia, Hongjie
Reviewed: Nov 15, 2022
|
Xia, Hongjie
|
Nov 15, 2022
|
|
Evasive spike variants elucidate the preservation of T cell immune response to the SARS-CoV-2 omicron variant
First Author: Solanki, Arnav
Reviewed: Nov 15, 2022
|
Solanki, Arnav
|
Nov 15, 2022
|
|
Galectin approach to lower covid transmission - Drug Development for clinical use
First Author: Sigamani, Alben
Reviewed: Nov 15, 2022
|
Sigamani, Alben
|
Nov 15, 2022
|
|
Longitudinal efficacy and toxicity of SARS-CoV-2 vaccination in cancer patients treated with immunotherapy
First Author: Spiliopoulou, Pavlina
Reviewed: Nov 15, 2022
|
Spiliopoulou, Pavlina
|
Nov 15, 2022
|
|
Neurologic sequalae of COVID-19 are determined by immunologic imprinting from previous Coronaviruses
First Author: Spatola, Marianna
Reviewed: Nov 15, 2022
|
Spatola, Marianna
|
Nov 15, 2022
|
|
The Significant Contribution of Pasteur Institute of Iran to COVID-19 Pandemic Control: A Successful Map over the Obstacles
First Author: Larijani, Mona Sadat
Reviewed: Nov 15, 2022
|
Larijani, Mona Sadat
|
Nov 15, 2022
|
|
Tucaresol: A Unique Oral Candidate Drug Ideally Accessible for Treatment of COVID-19 Disease
First Author: Christopher Penney
Reviewed: Nov 15, 2022
|
Christopher Penney
|
Nov 15, 2022
|
|
Use of home pulse oximetry to enhance remote COVID-19 monitoring: Evaluating a single centre experience
First Author: France, Megan W
Reviewed: Nov 15, 2022
|
France, Megan W
|
Nov 15, 2022
|
|
Vaccination of SARS-CoV-2-infected individuals expands a broad range of clonally diverse affinity-matured B cell lineages
First Author: Chernyshev, Mark
Reviewed: Nov 15, 2022
|
Chernyshev, Mark
|
Nov 15, 2022
|
|
Bivalent BNT162b2mRNA original/Omicron BA.4-5 booster vaccination: adverse reactions and inability to work compared to the monovalent COVID-19 booster
First Author: Wagenhauser, Isabell
Reviewed: Nov 12, 2022
|
Wagenhauser, Isabell
|
Nov 12, 2022
|
|
Durability and determinants of anti-SARS-CoV-2 spike antibodies following the second and third doses of mRNA COVID-19 vaccine
First Author: Yamamoto, Shohei
Reviewed: Nov 12, 2022
|
Yamamoto, Shohei
|
Nov 12, 2022
|
|
Enhanced stability of the SARS CoV-2 spike glycoprotein trimer following modification of an alanine cavity in the protein core
First Author: Poumbourios, Pantelis
Reviewed: Nov 12, 2022
|
Poumbourios, Pantelis
|
Nov 12, 2022
|
|
Knowledge, beliefs, attitudes and perceived risk about COVID-19 vaccine and determinants of COVID-19 vaccine acceptance in Bangladesh
First Author: Mahmud, Sultan
Reviewed: Nov 12, 2022
|
Mahmud, Sultan
|
Nov 12, 2022
|
|
Real-world data on bio-clinical follow-up after vaccination with Pfizer-BioNT162b2 mRNA COVID-19 in 216 patients with hematological malignancies
First Author: Rossi, Jean Francois
Reviewed: Nov 12, 2022
|
Rossi, Jean Francois
|
Nov 12, 2022
|
|
Persistent Myocardial Dysfunction Assessed by Global Myocardial Strain in Covid-19 Recovered Patients with Cardiovascular Comorbidities at 3 Months after Acute Infection
First Author: Tanto, Ines Vidal
Reviewed: Nov 10, 2022
|
Tanto, Ines Vidal
|
Nov 10, 2022
|
|
Systematic review of the clinical effectiveness of Tixagevimab/Cilgavimab for prophylaxis of COVID-19 in immunocompromised patients
First Author: Suribhatla, Rhea
Reviewed: Nov 10, 2022
|
Suribhatla, Rhea
|
Nov 10, 2022
|
|
Systematic review of the prevalence of Long Covid
First Author: Woodrow, Mirembe
Reviewed: Nov 10, 2022
|
Woodrow, Mirembe
|
Nov 10, 2022
|
|
Three-month Antibody Persistence of a Bivalent Omicron-containing Booster Vaccine Against COVID-19
First Author: Chalkias, Spyros
Reviewed: Nov 10, 2022
|
Chalkias, Spyros
|
Nov 10, 2022
|
|
Characteristics of suicidal emergency room patients before and during the COVID-19 pandemic in Japan
First Author: Otani, Kyohei
Reviewed: Nov 9, 2022
|
Otani, Kyohei
|
Nov 9, 2022
|
|
Impact of SARS-CoV-2 infection on disease trajectory in youth with T1D: An EHR-based cohort study from the RECOVER program
First Author: Prahalad, Priya
Reviewed: Nov 9, 2022
|
Prahalad, Priya
|
Nov 9, 2022
|
|
Modeling post-holiday surge in COVID-19 cases in Pennsylvania counties
First Author: Ren, Benny
Reviewed: Nov 9, 2022
|
Ren, Benny
|
Nov 9, 2022
|
|
Nicotine exposure decreases likelihood of SARS-CoV-2 RNA expression and neuropathology in the hACE2 mouse brain but not moribundity
First Author: Letsinger, Ayland C
Reviewed: Nov 9, 2022
|
Letsinger, Ayland C
|
Nov 9, 2022
|
|
Nirmatrelvir and the Risk of Post-Acute Sequelae of COVID-19
First Author: Xie, Yan
Reviewed: Nov 9, 2022
|
Xie, Yan
|
Nov 9, 2022
|
|
Post-COVID Endocrine Disorders: Putative Role of Molecular Mimicry and Some Pathomorphological Correlates
First Author: Muslimbek Ghulomovich Normatov
Reviewed: Nov 9, 2022
|
Muslimbek Ghulomovich Normatov
|
Nov 9, 2022
|
|
Rehabilitation in Survivors of COVID-19 (RE2SCUE): a non-randomized, controlled and open study
First Author: Campos, Maria Cristine
Reviewed: Nov 9, 2022
|
Campos, Maria Cristine
|
Nov 9, 2022
|
|
A cohort study of Post COVID-19 Condition across the Beta, Delta and Omicron waves in South Africa: 6-month follow up of hospitalised and non-hospitalised participants
First Author: Jassat, Waasila
Reviewed: Nov 8, 2022
|
Jassat, Waasila
|
Nov 8, 2022
|
|
BIOLOGICAL RHYTHMS IN COVID-19 VACCINE EFFECTIVENESS
First Author: Hazan, Guy
Reviewed: Nov 8, 2022
|
Hazan, Guy
|
Nov 8, 2022
|
|
COVID-19 primary series and booster vaccination and immune imprinting
First Author: Chemaitelly, Hiam
Reviewed: Nov 8, 2022
|
Chemaitelly, Hiam
|
Nov 8, 2022
|
|
Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes
First Author: Grewal, Ramandip
Reviewed: Nov 8, 2022
|
Grewal, Ramandip
|
Nov 8, 2022
|
|
Evaluation of real and perceived risk to health care workers caring for patients with the Omicron variant of the SARS-CoV-2 virus in surgery and obstetrics
First Author: Nair, Chaithanya
Reviewed: Nov 8, 2022
|
Nair, Chaithanya
|
Nov 8, 2022
|
|
Evaluation of Serological Tests to Determine Postvaccinal Immunity to SARS-Cov-2 by Mrna Vaccines
First Author: Graciela Iglesias García
Reviewed: Nov 8, 2022
|
Graciela Iglesias García
|
Nov 8, 2022
|
|
Longitudinal proteomic investigation of COVID-19 vaccination
First Author: Wang, Yingrui
Reviewed: Nov 8, 2022
|
Wang, Yingrui
|
Nov 8, 2022
|
|
Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1, and XBB.1 by 4 doses of parental mRNA vaccine or a BA.5-bivalent booster
First Author: Kurhade, Chaitanya
Reviewed: Nov 8, 2022
|
Kurhade, Chaitanya
|
Nov 8, 2022
|
|
mRNA bivalent booster enhances neutralization against BA.2.75.2 and BQ.1.1
First Author: Davis Gardner, Meredith E
Reviewed: Nov 8, 2022
|
Davis Gardner, Meredith E
|
Nov 8, 2022
|
|
Population-based sero-epidemiological estimates of real-world vaccine effectiveness against Omicron infection in an infection-naive population, Hong Kong, January to July 2022
First Author: Lau, Jonathan J
Reviewed: Nov 8, 2022
|
Lau, Jonathan J
|
Nov 8, 2022
|
|
Post-COVID Phenotypic Manifestations are Associated with New-Onset Psychiatric Disease: Findings from the NIH N3C and RECOVER Studies
First Author: Coleman, Ben
Reviewed: Nov 8, 2022
|
Coleman, Ben
|
Nov 8, 2022
|
|
Safety and Immunogenicity of a Booster SARS-Cov-2 Vaccination in Patients with Chronic Liver Disease
First Author: Qianqian, Li
Reviewed: Nov 8, 2022
|
Qianqian, Li
|
Nov 8, 2022
|
|
SARS-CoV-2 antibody prevalence among industrial livestock operation workers and nearby community residents, North Carolina, USA, 2021-2022
First Author: Gigot, Carolyn
Reviewed: Nov 8, 2022
|
Gigot, Carolyn
|
Nov 8, 2022
|
|
Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody to antigenically distinct omicron SARS-CoV-2 subvariants
First Author: Changrob, Siriruk
Reviewed: Nov 8, 2022
|
Changrob, Siriruk
|
Nov 8, 2022
|
|
Substantial Neutralization Escape by the SARS-CoV-2 Omicron Variant BQ.1.1
First Author: Miller, Jessica
Reviewed: Nov 8, 2022
|
Miller, Jessica
|
Nov 8, 2022
|
|
The Course of Glaucoma in Recovered COVID-19 Patients
First Author: Sevimli, Neslihan
Reviewed: Nov 8, 2022
|
Sevimli, Neslihan
|
Nov 8, 2022
|
|
The interaction of transmission intensity, mortality, and the economy: a retrospective analysis of the COVID-19 pandemic
First Author: Morgenstern, Christian
Reviewed: Nov 8, 2022
|
Morgenstern, Christian
|
Nov 8, 2022
|
|
Tracing the origin of SARS-CoV-2 Omicron-like Spike sequences detected in wastewater
First Author: Shafer, Martin M
Reviewed: Nov 8, 2022
|
Shafer, Martin M
|
Nov 8, 2022
|
|
Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
First Author: Efstathios S. Giotis
Reviewed: Nov 8, 2022
|
Efstathios S. Giotis
|
Nov 8, 2022
|
|
A Polyvalent Nano-Lectin Potently Neutralizes SARS-CoV-2 by Targeting Glycans on the Viral Spike Protein
First Author: Budhadev, Darshita
Reviewed: Nov 2, 2022
|
Budhadev, Darshita
|
Nov 2, 2022
|
|
Application of a Multiplicative Cascade Model to Detect the Early Signs of SARS-CoV-2 Infection Using Heart Rate Data
First Author: Heath, Rachel
Reviewed: Nov 2, 2022
|
Heath, Rachel
|
Nov 2, 2022
|
|
Energy System Analysis with a Focus on Future Energy Demand Projections: the case of Norway
First Author: Malka, Lorenc
Reviewed: Nov 2, 2022
|
Malka, Lorenc
|
Nov 2, 2022
|
|
Epidemiological characteristics of patients from fever clinics with COVID-19 epidemic in 2022 in Shanghai, China.
First Author: Zhang, Yuanjing
Reviewed: Nov 2, 2022
|
Zhang, Yuanjing
|
Nov 2, 2022
|
|
Long COVID Classification: Findings from a Clustering Analysis in the Predi-COVID Cohort Study
First Author: Aurélie Fischer
Reviewed: Nov 2, 2022
|
Aurélie Fischer
|
Nov 2, 2022
|
|
Potential risk polarization for acute myocardial infarction during the COVID-19 pandemic: Single-center experiences in Osaka, Japan
First Author: Furui, Masato
Reviewed: Nov 2, 2022
|
Furui, Masato
|
Nov 2, 2022
|
|
Preliminary report: Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, KD-414, in healthy adult participants: a non-randomized, open-label phase 2/3 clinical study in Japan
First Author: Kido, Keishi
Reviewed: Nov 2, 2022
|
Kido, Keishi
|
Nov 2, 2022
|
|
Results of safety monitoring of BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine in U.S. children aged 5-17 years
First Author: Hu, Mao
Reviewed: Nov 2, 2022
|
Hu, Mao
|
Nov 2, 2022
|
|
Seroprevalence, seroconversion, and seroreversion of infection-induced SARS-CoV-2 antibodies among a cohort of children and adolescents in Montreal, Canada
First Author: Zinszer, Kate
Reviewed: Nov 2, 2022
|
Zinszer, Kate
|
Nov 2, 2022
|
|
Single-domain antibody delivery using an mRNA platform protects against lethal doses of botulinum neurotoxin A
First Author: Panova, Eugenia A
Reviewed: Nov 2, 2022
|
Panova, Eugenia A
|
Nov 2, 2022
|
|
The interaction of transmission intensity, mortality, and the economy: a
retrospective analysis of the COVID-19 pandemic
First Author: Morgenstern, Christian
Reviewed: Nov 2, 2022
|
Morgenstern, Christian
|
Nov 2, 2022
|
|
The SARS-CoV-2 cellular receptor ACE2 is expressed in oropharyngeal cells and is modulated in vitro by the bacterial lysate Lantigen B
First Author: Pizzimenti, Caterina
Reviewed: Nov 2, 2022
|
Pizzimenti, Caterina
|
Nov 2, 2022
|
|
A Review of Recycling and Waste Management Systems Through the Lens of the COVID-19 Pandemic
First Author: Titus Kim
Reviewed: Nov 1, 2022
|
Titus Kim
|
Nov 1, 2022
|
|
An IgM-like Inhalable ACE2 fusion protein broadly neutralizes SARS-CoV-2
First Author: Li, Wenhui
Reviewed: Nov 1, 2022
|
Li, Wenhui
|
Nov 1, 2022
|
|
Bell’s Palsy Following SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis
First Author: Rafati, Ali
Reviewed: Nov 1, 2022
|
Rafati, Ali
|
Nov 1, 2022
|
|
Contribution of genetics and lifestyle to the risk of major cardiovascular and thromboembolic complications following COVID-19
First Author: Xie, Junqing
Reviewed: Nov 1, 2022
|
Xie, Junqing
|
Nov 1, 2022
|
|
Covid-19 pandemic has polarized the society toward negative and positive traits depending on a person’s resilience and certain predispositions
First Author: Attary, Taraneh
Reviewed: Nov 1, 2022
|
Attary, Taraneh
|
Nov 1, 2022
|
|
Development of criteria for cognitive dysfunction in post-COVID syndrome: the IC-CoDi-COVID approach
First Author: Matias Guiu, Jordi A
Reviewed: Nov 1, 2022
|
Matias Guiu, Jordi A
|
Nov 1, 2022
|
|
Experiences in the use of multiple doses of convalescent plasma in critically ill patients with COVID-19
First Author: Aguilar, Ricardo
Reviewed: Nov 1, 2022
|
Aguilar, Ricardo
|
Nov 1, 2022
|
|
Immunogenicity of the BA.5 Bivalent mRNA Vaccine Boosters
First Author: Collier, Ai Ris Y
Reviewed: Nov 1, 2022
|
Collier, Ai Ris Y
|
Nov 1, 2022
|
|
Impact of vaccination on the presence and severity of symptoms of hospitalised patients with an infection by the Omicron variant (B.1.1.529) of the SARS-CoV-2 (subvariant BA.1)
First Author: Beraud, Guillaume
Reviewed: Nov 1, 2022
|
Beraud, Guillaume
|
Nov 1, 2022
|
|
Molecular basis of SARS-CoV-2 Omicron variant evasion from shared neutralizing antibody response
First Author: Patel, Anamika
Reviewed: Nov 1, 2022
|
Patel, Anamika
|
Nov 1, 2022
|
|
Molecular recognition of SARS-CoV-2 spike protein with three essential partners: exploring possible immune escape mechanisms of viarl mutants
First Author: Cheng, Yan
Reviewed: Nov 1, 2022
|
Cheng, Yan
|
Nov 1, 2022
|
|
Natural heteroclitic-like peptides are generated by SARS-CoV-2 mutations
First Author: Tiezzi, Camilla
Reviewed: Nov 1, 2022
|
Tiezzi, Camilla
|
Nov 1, 2022
|
|
Antibody responses to Omicron BA.4/BA.5 bivalent mRNA vaccine booster shot
First Author: Wang, Qian
Reviewed: Oct 31, 2022
|
Wang, Qian
|
Oct 31, 2022
|
|
Evaluation of the risk of SARS-CoV-2 Infection and Hospitalization in Vaccinated and Previously Infected Subjects Based on Real World Data.
First Author: Rossi, Maicol Andrea
Reviewed: Oct 31, 2022
|
Rossi, Maicol Andrea
|
Oct 31, 2022
|
|
Misleading assertions, unjustified assumptions, and additional
limitations of a study by Patone et al., described in the article "Risk of
Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2
Infection by Age and Sex"
First Author: Bourdon, Paul S
Reviewed: Oct 31, 2022
|
Bourdon, Paul S
|
Oct 31, 2022
|
|
Phenotypic alteration of low-density granulocytes in people with pulmonary post-acute sequalae of SARS-CoV-2 infection
First Author: Dean, Logan S
Reviewed: Oct 31, 2022
|
Dean, Logan S
|
Oct 31, 2022
|
|
Vaccine- and BTI-elicited pre-Omicron immunity more effectively neutralizes Omicron sublineages BA.1, BA.2, BA.4 and BA.5 than pre-Omicron infection alone
First Author: Silva, Eveline Santos Da
Reviewed: Oct 31, 2022
|
Silva, Eveline Santos Da
|
Oct 31, 2022
|
|
A systems approach evaluating the impact of SARS-CoV-2 variant of concern mutations on CD8+ T cell responses
First Author: Buckley, Paul R
Reviewed: Oct 28, 2022
|
Buckley, Paul R
|
Oct 28, 2022
|
|
Association of viral variant and vaccination status with the occurrence of symptoms compatible with post-acute sequelae after primary SARS-CoV-2 infection
First Author: Kahlert, Christian R
Reviewed: Oct 28, 2022
|
Kahlert, Christian R
|
Oct 28, 2022
|
|
Characterizing and Predicting Post-Acute Sequelae of SARS CoV-2 infection (PASC) in a Large Academic Medical Center in the US
First Author: Fritsche, Lars G
Reviewed: Oct 28, 2022
|
Fritsche, Lars G
|
Oct 28, 2022
|
|
Deep reinforcement learning framework for controlling infectious disease outbreaks in the context of multi-jurisdictions
First Author: Khatami, Seyedeh Nazanin
Reviewed: Oct 28, 2022
|
Khatami, Seyedeh Nazanin
|
Oct 28, 2022
|
|
Effectiveness of COVID-19 Vaccines at Preventing Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompromised Adults: An Observational Study of Real-World Data Across 10 US States from August-December 2021
First Author: Embi, Peter J
Reviewed: Oct 28, 2022
|
Embi, Peter J
|
Oct 28, 2022
|
|
Efficacy of Linear Regression Modelling of SARS-CoV-2 cases based on local wastewater surveillance
First Author: Lehmann, Martin
Reviewed: Oct 28, 2022
|
Lehmann, Martin
|
Oct 28, 2022
|
|
Impact of the COVID-19 pandemic on the circulation of other pathogens in England
First Author: Hayes, Lauren
Reviewed: Oct 28, 2022
|
Hayes, Lauren
|
Oct 28, 2022
|
|
Long- COVID and General Health Status in Hospitalized COVID-19 Survivors: A Prospective Cohort Study
First Author: Mohtasham Amiri, Zahra
Reviewed: Oct 28, 2022
|
Mohtasham Amiri, Zahra
|
Oct 28, 2022
|
|
Novavax NVX-COV2373 triggers potent neutralization of Omicron sub-lineages
First Author: Bhiman, Jinal N
Reviewed: Oct 28, 2022
|
Bhiman, Jinal N
|
Oct 28, 2022
|
|
Safety and effectiveness of COVID-19 mRNA vaccination and risk factors for hospitalisation caused by the omicron variant in 0.8 million adolescents: A nationwide cohort study in Sweden
First Author: Nordstrom, Peter
Reviewed: Oct 28, 2022
|
Nordstrom, Peter
|
Oct 28, 2022
|
|
Socioeconomic inequalities of Long COVID: findings from a population-based survey in the United Kingdom
First Author: Shabnam, Sharmin
Reviewed: Oct 28, 2022
|
Shabnam, Sharmin
|
Oct 28, 2022
|
|
Why Do You Feel This Way? Summarizing Triggers of Emotions in Social
Media Posts
First Author: Zhan, Hongli
Reviewed: Oct 28, 2022
|
Zhan, Hongli
|
Oct 28, 2022
|
|
Detection of Risk Predictors of COVID-19 Mortality with Classifier Machine Learning Models Operated with Routine Laboratory Biomarkers
First Author: Huyut, Mehmet Tahir
Reviewed: Oct 25, 2022
|
Huyut, Mehmet Tahir
|
Oct 25, 2022
|
|
Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose
First Author: Belik, Milja
Reviewed: Oct 25, 2022
|
Belik, Milja
|
Oct 25, 2022
|
|
A collaborative approach to improve representation in viral genomic surveillance
First Author: Kim, Paul Y
Reviewed: Oct 24, 2022
|
Kim, Paul Y
|
Oct 24, 2022
|
|
Acceptance of an annual COVID-19 booster vaccine by healthcare workers: the effect of burnout and anti-vaccination attitudes
First Author: Maraqa, Beesan
Reviewed: Oct 24, 2022
|
Maraqa, Beesan
|
Oct 24, 2022
|
|
Ancestral SARS-CoV-2 driven antibody repertoire diversity in an unvaccinated individual correlates with expanded neutralization breadth
First Author: Deshpande, Suprit
Reviewed: Oct 24, 2022
|
Deshpande, Suprit
|
Oct 24, 2022
|
|
Antibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titers
First Author: Schmidt, Pete
Reviewed: Oct 24, 2022
|
Schmidt, Pete
|
Oct 24, 2022
|
|
Assessment of COVID-19 vaccines side effects among Health workers in Damascus Hospital: cross-sectional study
First Author: Bibars, Marwa
Reviewed: Oct 24, 2022
|
Bibars, Marwa
|
Oct 24, 2022
|
|
Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients
First Author: Rouet, Romain
Reviewed: Oct 24, 2022
|
Rouet, Romain
|
Oct 24, 2022
|
|
De novo design of anti-variant COVID vaccine with T-cell memory
First Author: Goswami, Arpita
Reviewed: Oct 24, 2022
|
Goswami, Arpita
|
Oct 24, 2022
|
|
Diet Induced Obesity and Diabetes Enhance Mortality and Reduces Vaccine Efficacy for SARS-CoV-2
First Author: Johnson, Robert M
Reviewed: Oct 24, 2022
|
Johnson, Robert M
|
Oct 24, 2022
|
|
Distinct Neutralizing Antibody Escape of SARS-CoV-2 Omicron Subvariants BQ.1, BQ.1.1, BA.4.6, BF.7 and BA.2.75.2
First Author: Qu, Panke
Reviewed: Oct 24, 2022
|
Qu, Panke
|
Oct 24, 2022
|
|
Effectiveness of Coronavac and ChAdOx1 COVID-19 vaccines against severe illness in Thailand: A retrospective cohort study
First Author: Promlek, Thanyarat
Reviewed: Oct 24, 2022
|
Promlek, Thanyarat
|
Oct 24, 2022
|
|
Fatigue presentation, severity, and related outcomes 12 weeks post-COVID-19 hospitalization
First Author: Magel, Tianna
Reviewed: Oct 24, 2022
|
Magel, Tianna
|
Oct 24, 2022
|
|
Immunity induced by vaccination with recombinant influenza B virus neuraminidase protein breaks viral transmission chains in guinea pigs in an exposure intensity-dependent manner
First Author: Mcmahon, Meagan
Reviewed: Oct 24, 2022
|
Mcmahon, Meagan
|
Oct 24, 2022
|
|
Interim Analysis of a Phase I Randomized Clinical Trial on the Safety and Immunogenicity of the mRNA-1283 SARS-CoV-2 Vaccine in Adults
First Author: Yassini, Patrick
Reviewed: Oct 24, 2022
|
Yassini, Patrick
|
Oct 24, 2022
|
|
Intra-host viral populations of SARS-CoV-2 in immunosuppressed patients with hematologic cancers
First Author: Fournelle, Dominique
Reviewed: Oct 24, 2022
|
Fournelle, Dominique
|
Oct 24, 2022
|
|
Investigating the role of binding free energy, binding affinity and antibody escape in the evolution of SARS-CoV-2 spike protein
First Author: Young, Matthew
Reviewed: Oct 24, 2022
|
Young, Matthew
|
Oct 24, 2022
|
|
Safety and status report of SARS-CoV-2 vaccination in patients with Wilson's disease.
First Author: Han, Hui
Reviewed: Oct 24, 2022
|
Han, Hui
|
Oct 24, 2022
|
|
The humoral and cellular immune response of a third dose adenoviral-based vectored vaccine after a single or 2 shots of inactivated COVID-19 vaccine in healthy adults
First Author: Suparak, Supaporn
Reviewed: Oct 24, 2022
|
Suparak, Supaporn
|
Oct 24, 2022
|
|
Tissue Injury and Leukocyte Changes in Post-Acute Sequelae of SARS-CoV-2: Review of 2833 Post-acute Patient Outcomes per Immune Dysregulation and Microbial Translocation in Long COVID
First Author: Md Sahidul Islam
Reviewed: Oct 24, 2022
|
Md Sahidul Islam
|
Oct 24, 2022
|
|
Viral infectivity in pediatric SARS-CoV-2 clinical samples does not vary by age
First Author: Schmidt, Madaline M
Reviewed: Oct 24, 2022
|
Schmidt, Madaline M
|
Oct 24, 2022
|
|
COVID-19 Vaccine Effectiveness against Symptomatic and Asymptomatic SARS-CoV-2 Infections with the Delta Variant among a Cohort of Children Aged ≥ 12 Years and Adults in Utah
First Author: Mohanty, Sarita
Reviewed: Oct 23, 2022
|
Mohanty, Sarita
|
Oct 23, 2022
|
|
Development of hybrid immunity during a period of high incidence of infections with Omicron subvariants: A prospective population based multi-region cohort study
First Author: Frei, Anja
Reviewed: Oct 23, 2022
|
Frei, Anja
|
Oct 23, 2022
|
|
Impact of the COVID-19 pandemic: Effects of High Intensity Exercise on Physiological Indicators of Recovery Period by Wearing Face Masks of Elite Athletes
First Author: Kwon, Hyeong Tae
Reviewed: Oct 23, 2022
|
Kwon, Hyeong Tae
|
Oct 23, 2022
|
|
Making use of an App (Tawakkalna) to track and reduce COVID transmission in KSA
First Author: Bisanzio, Donal
Reviewed: Oct 23, 2022
|
Bisanzio, Donal
|
Oct 23, 2022
|
|
No evidence that analgesic use after COVID-19 vaccination negatively impacts antibody responses
First Author: Lafleur, Bonnie J
Reviewed: Oct 23, 2022
|
Lafleur, Bonnie J
|
Oct 23, 2022
|
|
SARS-CoV-2 multi-antigen protein microarray for detailed characterization of antibody responses in COVID-19 patients
First Author: Celikgil, Alev
Reviewed: Oct 23, 2022
|
Celikgil, Alev
|
Oct 23, 2022
|
|
SARS-CoV-2 Omicron (B.1.1.529) Variant: A Challenge with Covid-19
First Author: Zeinab Mohseni Afshar
Reviewed: Oct 23, 2022
|
Zeinab Mohseni Afshar
|
Oct 23, 2022
|
|
Seroprevalence against SARS-CoV-2 in health workers: evaluation 6 months after the complete scheme and reinfections
First Author: Cureno Diaz, Monica Alethia
Reviewed: Oct 23, 2022
|
Cureno Diaz, Monica Alethia
|
Oct 23, 2022
|
|
Broad SARS-CoV-2 Neutralization by Monoclonal and Bispecific Antibodies Derived from a Gamma-infected Individual
First Author: Guerra, Denise
Reviewed: Oct 20, 2022
|
Guerra, Denise
|
Oct 20, 2022
|
|
Emerging dominant SARS-CoV-2 variants
First Author: Chen, Jiahui
Reviewed: Oct 20, 2022
|
Chen, Jiahui
|
Oct 20, 2022
|
|
Evaluation of Pulmonary Arterial Stiffness in Mild COVID-19 Patients: A Pilot Prospective Study
First Author: Korkmaz, Yetkin
Reviewed: Oct 20, 2022
|
Korkmaz, Yetkin
|
Oct 20, 2022
|
|
Impact of COVID-19 Pandemic on Emergency Medical System and Management Strategies in Patients With Acute Coronary Syndrome
First Author: Saiin, Kohei
Reviewed: Oct 20, 2022
|
Saiin, Kohei
|
Oct 20, 2022
|
|
Insights into the Dynamics of SARS-CoV-2 viral-Host interaction and Immune Response
First Author: Mbogo, Rachel Waema
Reviewed: Oct 20, 2022
|
Mbogo, Rachel Waema
|
Oct 20, 2022
|
|
Maternal SARS-CoV-2 Vaccination and Infant Protection Against SARS-CoV-2 During the First 6 Months of Life
First Author: Zerbo, Ousseny
Reviewed: Oct 20, 2022
|
Zerbo, Ousseny
|
Oct 20, 2022
|
|
Role of spike in the pathogenic and antigenic behavior of SARS-CoV-2 BA.1 Omicron
First Author: Chen, Da Yuan
Reviewed: Oct 20, 2022
|
Chen, Da Yuan
|
Oct 20, 2022
|
|
Stability of SARS-CoV-2 spike antigens against mutations
First Author: Fuente, Ildefonso M De La
Reviewed: Oct 20, 2022
|
Fuente, Ildefonso M De La
|
Oct 20, 2022
|
|
Vancomycin resistant Enterococci Faecium: A sinister cause of Necrotizing Pneumonia in Post COVID patient
First Author: Gupta, Chhavi
Reviewed: Oct 20, 2022
|
Gupta, Chhavi
|
Oct 20, 2022
|
|
Anti-SARS-CoV-2 antibody containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19 via increased neutralizing antibody activity – a randomized clinical trial
First Author: Denkinger, C M
Reviewed: Oct 19, 2022
|
Denkinger, C M
|
Oct 19, 2022
|
|
Atypical B cells and impaired SARS-CoV-2 neutralisation following booster vaccination in the elderly
First Author: Ferreira, Isabella A T M
Reviewed: Oct 19, 2022
|
Ferreira, Isabella A T M
|
Oct 19, 2022
|
|
Identifying Contextual and Spatial Risk Factors for Post-Acute Sequelae of SARS-CoV-2 Infection: An EHR-based Cohort Study from the RECOVER Program
First Author: Zhang, Yongkang
Reviewed: Oct 19, 2022
|
Zhang, Yongkang
|
Oct 19, 2022
|
|
Inducing long lasting B cell and T cell immunity against multiple variants of SARS-CoV-2 through mutant bacteriophage Qβ – receptor binding domain conjugate
First Author: Tan, Zibin
Reviewed: Oct 19, 2022
|
Tan, Zibin
|
Oct 19, 2022
|
|
Innate immune sensing of self-derived double-stranded RNA by RIG-I-MAVS-TNF-α regulates the survival and senescence fate of SARS-2-S syncytia
First Author: Wan, Luming
Reviewed: Oct 19, 2022
|
Wan, Luming
|
Oct 19, 2022
|
|
Mutation and SARS-CoV-2 strain competition under vaccination in a
modified SIR model
First Author: Ahumada, M
Reviewed: Oct 19, 2022
|
Ahumada, M
|
Oct 19, 2022
|
|
Occurence of pulmonary fibrosis in COVID-19
First Author: Rasheed, Modar Haj
Reviewed: Oct 19, 2022
|
Rasheed, Modar Haj
|
Oct 19, 2022
|
|
Post-acute symptoms four months after SARS-CoV-2 infection during the Omicron period: a nationwide Danish questionnaire study
First Author: Spiliopoulos, Lampros
Reviewed: Oct 19, 2022
|
Spiliopoulos, Lampros
|
Oct 19, 2022
|
|
Quantifying changes in the IFR and IHR over 23 months of the SARS-CoV-2 pandemic in England
First Author: Eales, Oliver
Reviewed: Oct 19, 2022
|
Eales, Oliver
|
Oct 19, 2022
|
|
Risk of Myocarditis and Pericarditis Following Coronavirus Disease 2019 Messenger RNA Vaccination—A Nationwide Study
First Author: Su, Wei Ju
Reviewed: Oct 19, 2022
|
Su, Wei Ju
|
Oct 19, 2022
|
|
Robust and rapid pipeline for the development of mRNA vaccine for the fast-emerging SARS-CoV-2 variants
First Author: Soni, Garima
Reviewed: Oct 19, 2022
|
Soni, Garima
|
Oct 19, 2022
|
|
Study of pulmonary fibrosis as a complication in COVID-19
First Author: Rasheed, Modar Haj
Reviewed: Oct 19, 2022
|
Rasheed, Modar Haj
|
Oct 19, 2022
|
|
The Coming of Age of Nucleic Acid Vaccines during COVID-19
First Author: Rando, Halie M
Reviewed: Oct 19, 2022
|
Rando, Halie M
|
Oct 19, 2022
|
|
A Third Dose COVID-19 Vaccination in Allogeneic Hematopoietic Stem Cell Transplantation Patients
First Author: Watanabe, Marika
Reviewed: Oct 18, 2022
|
Watanabe, Marika
|
Oct 18, 2022
|
|
Associations Between Reported Post-COVID-19 Symptoms and Subjective Well-Being, Israel, July 2021 -April 2022
First Author: Gorelik, Yanay
Reviewed: Oct 18, 2022
|
Gorelik, Yanay
|
Oct 18, 2022
|
|
Cohort Profile: The Danish National Cohort Study of Effectiveness and Safety of SARS-CoV-2 vaccines (ENFORCE)
First Author: Staerke, Nina Breinholt
Reviewed: Oct 18, 2022
|
Staerke, Nina Breinholt
|
Oct 18, 2022
|
|
COVID-19 immunity after vaccination in the population of the Portuguese province Beira Baixa
First Author: Ribeiro, Ines
Reviewed: Oct 18, 2022
|
Ribeiro, Ines
|
Oct 18, 2022
|
|
Genomic tracking of SARS-COV-2 variants in Myanmar
First Author: Oo, Khine Zaw
Reviewed: Oct 18, 2022
|
Oo, Khine Zaw
|
Oct 18, 2022
|
|
GRAd-COV2 vaccine provides potent and durable immunity in randomised placebo-controlled phase 2 trial (COVITAR)
First Author: Capone, Stefania
Reviewed: Oct 18, 2022
|
Capone, Stefania
|
Oct 18, 2022
|
|
Immune response after SARS-CoV-2 infection with residual post COVID symptoms
First Author: Pongkunakorn, Tanyaporn
Reviewed: Oct 18, 2022
|
Pongkunakorn, Tanyaporn
|
Oct 18, 2022
|
|
Impact of the COVID-19 Vaccination Program on Case Incidence, Emergency Department Visits, and Hospital Admissions among Children Aged 5–17 Years during the Delta and Omicron Periods —United States, December 2020 to April 2022
First Author: Topf, Katherine G
Reviewed: Oct 18, 2022
|
Topf, Katherine G
|
Oct 18, 2022
|
|
Psychophysiologic symptom relief therapy (PSRT) for post-acute sequelae of COVID-19: a non-randomized interventional study
First Author: Donnino, Michael
Reviewed: Oct 18, 2022
|
Donnino, Michael
|
Oct 18, 2022
|
|
Rehabilitation in Survivors of COVID-19 (RE2SCUE): a non-randomized, controlled and open study
First Author: Campos, Maria Cristine
Reviewed: Oct 18, 2022
|
Campos, Maria Cristine
|
Oct 18, 2022
|
|
SARS-CoV-2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February-June 2022
First Author: Kagucia, E W
Reviewed: Oct 18, 2022
|
Kagucia, E W
|
Oct 18, 2022
|
|
Sensitivity of endemic behaviour of Covid-19 under a multi-dose vaccination regime, to various biological parameters and control variables
First Author: Dagpunar, John
Reviewed: Oct 18, 2022
|
Dagpunar, John
|
Oct 18, 2022
|
|
Acceptance of COVID-19 vaccination among parents of children with autism and other neurodevelopmental disorders in Saudi Arabia.
First Author: Saad, Ali Jawad Al
Reviewed: Oct 13, 2022
|
Saad, Ali Jawad Al
|
Oct 13, 2022
|
|
An alternative mechanism for skeletal muscle dysfunction in long-term post-viral lung disease
First Author: Martin, Ryan A
Reviewed: Oct 13, 2022
|
Martin, Ryan A
|
Oct 13, 2022
|
|
COVID-19 monoclonal antibody treatment impact on symptoms and post-COVID conditions among high-risk patients at a Federally Qualified Health Center
First Author: Vawter, Natalie L
Reviewed: Oct 13, 2022
|
Vawter, Natalie L
|
Oct 13, 2022
|
|
COVID-19: impact of original, Gamma, Delta, and Omicron variants of SARS-CoV-2 in vaccinated and unvaccinated pregnant and postpartum women
First Author: Serra, Fabiano Elisei
Reviewed: Oct 13, 2022
|
Serra, Fabiano Elisei
|
Oct 13, 2022
|
|
Evolution of acquired humoral immunity after full vaccination against SARS-CoV-2. IgG levels in healthcare workers at 6 and 9 months
First Author: Delicado Useros, Maria Victoria
Reviewed: Oct 13, 2022
|
Delicado Useros, Maria Victoria
|
Oct 13, 2022
|
|
Impact of vaccination on post-acute sequelae of SARS CoV-2 infection in patients with rheumatic diseases
First Author: Patel, Naomi J
Reviewed: Oct 13, 2022
|
Patel, Naomi J
|
Oct 13, 2022
|
|
Long COVID Risk and Pre-COVID Vaccination: An EHR-Based Cohort Study from the RECOVER Program
First Author: Daniel Brannock, M
Reviewed: Oct 13, 2022
|
Daniel Brannock, M
|
Oct 13, 2022
|
|
Mental health outcomes following COVID-19 infection: impacts of post-COVID impairments and fatigue on depression, anxiety, and insomnia
First Author: Badinlou, Farzaneh
Reviewed: Oct 13, 2022
|
Badinlou, Farzaneh
|
Oct 13, 2022
|
|
Neutralization of SARS-CoV-2 Omicron BA.4/BA.5 subvariant by a booster dose of bivalent adjuvanted subunit vaccine containing Omicron BA.4/BA.5 and BA.1 subvariants
First Author: Kuo, Tsun Yung
Reviewed: Oct 13, 2022
|
Kuo, Tsun Yung
|
Oct 13, 2022
|
|
The clinical symptoms in post COVID condition among Syrian population
First Author: Alshami, Sara
Reviewed: Oct 13, 2022
|
Alshami, Sara
|
Oct 13, 2022
|
|
The Incidence of Immune Mediated Inflammatory Diseases Following COVID-19: a Matched Cohort Study in UK Primary Care
First Author: Syed, Umer
Reviewed: Oct 13, 2022
|
Syed, Umer
|
Oct 13, 2022
|
|
Triggering type 1 diabetes post-covid: molecular mimicry?
First Author: Andrade, Luis Jesuino De Oliveira
Reviewed: Oct 13, 2022
|
Andrade, Luis Jesuino De Oliveira
|
Oct 13, 2022
|
|
A randomized, placebo-controlled trial of a nasal spray solution containing broadly potent neutralizing antibodies against SARS-CoV-2 variants in healthy volunteers
First Author: Imsuwansri, Thanarath
Reviewed: Oct 12, 2022
|
Imsuwansri, Thanarath
|
Oct 12, 2022
|
|
A scoping review of regulatory T cell dynamics in convalescent COVID-19 patients – Implications for Long COVID?
First Author: Haunhorst, Simon
Reviewed: Oct 12, 2022
|
Haunhorst, Simon
|
Oct 12, 2022
|
|
Age-dependent impairment in antibody responses elicited by a homologous CoronaVac booster dose
First Author: Filardi, Bruno Andraus
Reviewed: Oct 12, 2022
|
Filardi, Bruno Andraus
|
Oct 12, 2022
|
|
Association between COVID-19 mRNA vaccination and COVID-19 illness and severity during Omicron BA.4 and BA.5 sublineage periods
First Author: Link Gelles, Ruth
Reviewed: Oct 12, 2022
|
Link Gelles, Ruth
|
Oct 12, 2022
|
|
CD8+ T cell clonotypes from prior SARS-CoV-2 infection predominate during the cellular immune response to mRNA vaccination
First Author: Ford, Emily S
Reviewed: Oct 12, 2022
|
Ford, Emily S
|
Oct 12, 2022
|
|
Effectiveness and duration of a second COVID-19 vaccine booster
First Author: Jara, Alejandro
Reviewed: Oct 12, 2022
|
Jara, Alejandro
|
Oct 12, 2022
|
|
Elasomeran (mRNA1273) Vaccine: The Journey from Preclinical Research to Clinical Trials, Authorization, and FDA Approval
First Author: Khehra, Nimrat
Reviewed: Oct 12, 2022
|
Khehra, Nimrat
|
Oct 12, 2022
|
|
Evolution to increased positive charge on the viral spike protein may be part of the adaptation of SARS-CoV-2 to human transmission
First Author: Cotten, Matthew
Reviewed: Oct 12, 2022
|
Cotten, Matthew
|
Oct 12, 2022
|
|
Fatal cases after Omicron BA.1 and BA.2 infection: Diffuse alveolar damage occurs only in a minority – results of an autopsy study
First Author: Markl, Bruno
Reviewed: Oct 12, 2022
|
Markl, Bruno
|
Oct 12, 2022
|
|
Immune responses of the third dose of AZD1222 vaccine or BNT162b2 mRNA vaccine after two doses of CoronaVac vaccines against Delta and Omicron variants
First Author: Niyomnaitham, Suvimol
Reviewed: Oct 12, 2022
|
Niyomnaitham, Suvimol
|
Oct 12, 2022
|
|
Impact of vaccination on COVID-19-associated admissions to critical care in England: a population cohort study of linked data
First Author: Harrison, David A
Reviewed: Oct 12, 2022
|
Harrison, David A
|
Oct 12, 2022
|
|
Logical Analysis of Response of Health Officials’ Worldwide, to Cost-Effective Early Remedies for COVID19
First Author: Sunil J. Wimalawansa
Reviewed: Oct 12, 2022
|
Sunil J. Wimalawansa
|
Oct 12, 2022
|
|
Long-term systemic and mucosal humoral response in SARS- CoV-2 vaccinated post-Covid-19 infected patients
First Author: Sengupta, Anirban
Reviewed: Oct 12, 2022
|
Sengupta, Anirban
|
Oct 12, 2022
|
|
Plasma cytokine levels reveal deficiencies in IL-8 and gamma interferon in Long-COVID
First Author: Williams, Elizabeth S C P
Reviewed: Oct 12, 2022
|
Williams, Elizabeth S C P
|
Oct 12, 2022
|
|
Population-level relative effectiveness of the COVID-19 vaccines and the contribution of naturally acquired immunity
First Author: Shioda, Kayoko
Reviewed: Oct 12, 2022
|
Shioda, Kayoko
|
Oct 12, 2022
|
|
Potential use of Immunodaat® (Botanical extract of Elderberry -Sambucus Nigra L.) in the management of Post Covid-19 symptoms- a comparative, multi-centric, randomized, clinical study
First Author: Deshpande, Shailesh
Reviewed: Oct 12, 2022
|
Deshpande, Shailesh
|
Oct 12, 2022
|
|
Protective effectiveness of prior SARS-CoV-2 infection and hybrid immunity against Omicron infection and severe disease: a systematic review and meta-regression
First Author: Bobrovitz, Niklas
Reviewed: Oct 12, 2022
|
Bobrovitz, Niklas
|
Oct 12, 2022
|
|
Relevance of the viral Spike protein/cellular Estrogen Receptor-α interaction for endothelial-based coagulopathy induced by SARS-CoV-2
First Author: Barbieri, Silvia
Reviewed: Oct 12, 2022
|
Barbieri, Silvia
|
Oct 12, 2022
|
|
Role of anti-polyethylene glycol (PEG) antibodies in the allergic reactions and immunogenicity of PEG-containing Covid-19 vaccines
First Author: Kozma, Gergely Tibor
Reviewed: Oct 12, 2022
|
Kozma, Gergely Tibor
|
Oct 12, 2022
|
|
Vaccines alone cannot slow the evolution of SARS-CoV-2
First Author: Egeren, Debra Van
Reviewed: Oct 12, 2022
|
Egeren, Debra Van
|
Oct 12, 2022
|
|
A New Set-up of Vanishing Antibodies: A Biennial Follow-up of Three Different Clients’ Humoral Responses Against Sars-Cov-2 After Systemic Vaccination in an Oncology Hospital in Poland
First Author: Piotr Kosiorek
Reviewed: Oct 10, 2022
|
Piotr Kosiorek
|
Oct 10, 2022
|
|
Analyzing historical diagnosis code data from NIH N3C and RECOVER
Programs using deep learning to determine risk factors for Long Covid
First Author: Sengupta, Saurav
Reviewed: Oct 10, 2022
|
Sengupta, Saurav
|
Oct 10, 2022
|
|
COVID-19 vaccination and SARS-CoV-2 infection in early pregnancy and the risk of major congenital anomalies: a national population-based cohort study
First Author: Wood, Rachael
Reviewed: Oct 10, 2022
|
Wood, Rachael
|
Oct 10, 2022
|
|
COVID-19 vaccine antibody response is associated with side-effects, chronic health conditions, and vaccine type in a large Northern California cohort
First Author: Solomon, Olivia
Reviewed: Oct 10, 2022
|
Solomon, Olivia
|
Oct 10, 2022
|
|
Covid-19 Vaccine Recommendation Opinions of Nursing/midwifery Students to Women of Reproductive Age
First Author: Vayisoglu, Sumbule Koksoy
Reviewed: Oct 10, 2022
|
Vayisoglu, Sumbule Koksoy
|
Oct 10, 2022
|
|
Effectiveness and Duration of Protection of a Fourth Dose of COVID-19 mRNA Vaccine among Long-Term Care Residents in Ontario, Canada
First Author: Grewal, Ramandip
Reviewed: Oct 10, 2022
|
Grewal, Ramandip
|
Oct 10, 2022
|
|
Effectiveness of mRNA-1273 against infection and COVID-19 hospitalization with SARS-CoV-2 Omicron subvariants: BA.1, BA.2, BA.2.12.1, BA.4, and BA.5
First Author: Tseng, Hung Fu
Reviewed: Oct 10, 2022
|
Tseng, Hung Fu
|
Oct 10, 2022
|
|
Intranasal delivery of NS1-deleted influenza virus vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response
First Author: Zhang, Liang
Reviewed: Oct 10, 2022
|
Zhang, Liang
|
Oct 10, 2022
|
|
Is there a role for RDTs as we live with COVID? An assessment of different strategies
First Author: Bonnet, Gabrielle
Reviewed: Oct 10, 2022
|
Bonnet, Gabrielle
|
Oct 10, 2022
|
|
Prediction of Post COVID-19 Impact on Indian people using Machine Learning Techniques
First Author: Pathak, Peeyush Kumar
Reviewed: Oct 10, 2022
|
Pathak, Peeyush Kumar
|
Oct 10, 2022
|
|
Reduction in circulating monocytes correlates with persistent post-COVID pulmonary fibrosis in multi-omic comparison of long-haul COVID and IPF
First Author: Bingham, Grace C
Reviewed: Oct 10, 2022
|
Bingham, Grace C
|
Oct 10, 2022
|
|
The impact of a home-based personalized computerized training program on cognitive dysfunction associated with Long COVID: a before-and-after feasibility study
First Author: Dunabeitia, Jon Andoni
Reviewed: Oct 10, 2022
|
Dunabeitia, Jon Andoni
|
Oct 10, 2022
|
|
A case of an adolescent with antiphospholipid syndrome and persistently high PF4 levels with recurrent late thrombotic complications after mRNA SARS-CoV-2 vaccine
First Author: Haga, Yoichi
Reviewed: Oct 6, 2022
|
Haga, Yoichi
|
Oct 6, 2022
|
|
A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta
First Author: Carter, Brandon
Reviewed: Oct 6, 2022
|
Carter, Brandon
|
Oct 6, 2022
|
|
Long COVID and Associated Factors in Individuals From Southern Brazil: A Population-based Study on COVID
First Author: Saes, Mirelle De Oliveira
Reviewed: Oct 6, 2022
|
Saes, Mirelle De Oliveira
|
Oct 6, 2022
|
|
Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape
First Author: Marzi, Roberta
Reviewed: Oct 6, 2022
|
Marzi, Roberta
|
Oct 6, 2022
|
|
Real-world clinical outcomes of treatment with molnupiravir for patients with mild- to-moderate coronavirus disease 2019 during the Omicron variant pandemic
First Author: Suzuki, Yasuhito
Reviewed: Oct 6, 2022
|
Suzuki, Yasuhito
|
Oct 6, 2022
|
|
Relationship between cognition and emotions caused by the COVID-19 infection, and depression and anxiety
First Author: Hazumi, Megumi
Reviewed: Oct 6, 2022
|
Hazumi, Megumi
|
Oct 6, 2022
|
|
Binding and neutralizing IgG responses to SARS-CoV-2 after natural infection or vaccination
First Author: Olds, Kaylan M
Reviewed: Oct 5, 2022
|
Olds, Kaylan M
|
Oct 5, 2022
|
|
Characterizing Longitudinal Antibody Responses in Recovered Individuals Following COVID-19 Infection and Single-Dose Vaccination in British Columbia, Canada: a Prospective Cohort Study
First Author: Olmstead, Andrea D
Reviewed: Oct 5, 2022
|
Olmstead, Andrea D
|
Oct 5, 2022
|
|
Populational analysis of the immunoglobulin G response to different COVID-19 vaccines in Brazil
First Author: Paula, Nigella M
Reviewed: Oct 5, 2022
|
Paula, Nigella M
|
Oct 5, 2022
|
|
Dimensional Structure of one-year Post-COVID-19 Neuropsychiatric and Somatic Sequelae and Association with Role Impairment
First Author: Leung, Owen N W
Reviewed: Oct 4, 2022
|
Leung, Owen N W
|
Oct 4, 2022
|
|
IgG3 subclass antibodies recognize antigenically drifted influenza viruses and SARS-CoV-2 variants through efficient bivalent binding
First Author: Bolton, Marcus J
Reviewed: Oct 4, 2022
|
Bolton, Marcus J
|
Oct 4, 2022
|
|
Reducing COVID-19 Vaccine Fatigue: Results of Two Conjoint Experiments
First Author: Stamm, Tanja
Reviewed: Oct 4, 2022
|
Stamm, Tanja
|
Oct 4, 2022
|
|
Stigma Experienced by Patients Who Recovered from COVID-19 in the Post- Vaccination Period: Prevalence, Severity and Associated Factors
First Author: Techapoonpon, Kamolvisa
Reviewed: Oct 4, 2022
|
Techapoonpon, Kamolvisa
|
Oct 4, 2022
|
|
Healthcare system overstretch and in-hospital mortality of intubated COVID-19 patients in Greece: an updated analysis, September 2020 to April 2022
First Author: Lytras, Theodore
Reviewed: Oct 3, 2022
|
Lytras, Theodore
|
Oct 3, 2022
|
|
Impact of cross-coronavirus immunity in post-acute sequelae of COVID-19
First Author: Herman, Jonathan D
Reviewed: Oct 3, 2022
|
Herman, Jonathan D
|
Oct 3, 2022
|
|
Impact of the COVID-19 restrictions on the epidemiology of Cryptosporidium spp. in England and Wales, 2015-2021 A time-series analysis
First Author: Adamson, J P
Reviewed: Oct 3, 2022
|
Adamson, J P
|
Oct 3, 2022
|
|
Molnupiravir Use and Severe Covid-19 Outcomes During the Omicron Surge
First Author: Arbel, Ronen
Reviewed: Oct 3, 2022
|
Arbel, Ronen
|
Oct 3, 2022
|
|
Older adults access to mental health and social care services during COVID-19 restrictions in Western Australia
First Author: Adams, Claire
Reviewed: Oct 3, 2022
|
Adams, Claire
|
Oct 3, 2022
|
|
Post COVID-19 condition after Wildtype, Delta, and Omicron variant SARS-CoV-2 infection and vaccination: pooled analysis of two population-based cohorts
First Author: Ballouz, Tala
Reviewed: Oct 3, 2022
|
Ballouz, Tala
|
Oct 3, 2022
|
|
Post-Concussion Assessment as a diagnostic and mechanistic framework for treating patients with Long COVID
First Author: Davidson, Bradley S
Reviewed: Oct 3, 2022
|
Davidson, Bradley S
|
Oct 3, 2022
|
|
Protection of homologous and heterologous boosters after primary schemes of rAd26-rAd5, ChAdOx1 nCoV-19 and BBIBP-CorV during the Omicron outbreak in adults of 50 years and older in Argentina: a test-negative case-control study
First Author: Gonzalez, Soledad
Reviewed: Oct 3, 2022
|
Gonzalez, Soledad
|
Oct 3, 2022
|
|
Resurgence of Omicron BA.2 in SARS-CoV-2 infection-naive Hong Kong
First Author: Xie, Ruopeng
Reviewed: Oct 3, 2022
|
Xie, Ruopeng
|
Oct 3, 2022
|
|
What is the impact of nicotine on the Post-COVID-19 syndrome - a severe impairment of acetylcholine-orchestrated neuromodulation: A case series
First Author: Leitzke, Marco
Reviewed: Oct 3, 2022
|
Leitzke, Marco
|
Oct 3, 2022
|
|
A multi-population-based genomic analysis uncovers unique haplotype variants and crucial mutant genes in SARS-CoV-2
First Author: Sheikh, Afzal
Reviewed: Sep 30, 2022
|
Sheikh, Afzal
|
Sep 30, 2022
|
|
A novel biopolymer for mucosal adjuvant against respiratory pathogens
First Author: Hoover, Ashley R
Reviewed: Sep 30, 2022
|
Hoover, Ashley R
|
Sep 30, 2022
|
|
A phase 3, randomised, double-blind, placebo-controlled clinical trial for adult evaluation of the efficacy and safety of a SARS-CoV-2 recombinant spike RBD protein vaccine (ABDALA-3 Study)
First Author: Hernandez Bernal, Francisco
Reviewed: Sep 30, 2022
|
Hernandez Bernal, Francisco
|
Sep 30, 2022
|
|
A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but elicits a skewed CD4+ T cell profile
First Author: Sannier, Geremy
Reviewed: Sep 30, 2022
|
Sannier, Geremy
|
Sep 30, 2022
|
|
An Early and Preliminary Assessment of the Clinical Severity of the Emerging SARS-CoV-2 Omicron Variants in Maharashtra, India
First Author: Karyakarte, Rajesh
Reviewed: Sep 30, 2022
|
Karyakarte, Rajesh
|
Sep 30, 2022
|
|
Cold Supply Chain Planning including Smart Contracts: An Intelligent
Blockchain-based approach
First Author: Goodarzi, Soroush
Reviewed: Sep 30, 2022
|
Goodarzi, Soroush
|
Sep 30, 2022
|
|
Controllable self-replicating RNA vaccine delivered intradermally elicits predominantly cellular immunity
First Author: Amano, Tomokazu
Reviewed: Sep 30, 2022
|
Amano, Tomokazu
|
Sep 30, 2022
|
|
Distinct immune signatures discriminate SARS-CoV-2 vaccine combinations
First Author: Nunez, Nicolas Gonzalo
Reviewed: Sep 30, 2022
|
Nunez, Nicolas Gonzalo
|
Sep 30, 2022
|
|
Effectiveness of BNT162b2 and CoronaVac against pediatric COVID-19-associated hospitalization and moderate-to-severe disease
First Author: Duque, Jaime S Rosa
Reviewed: Sep 30, 2022
|
Duque, Jaime S Rosa
|
Sep 30, 2022
|
|
Effectiveness of inactivated and Ad5-nCoV COVID-19 vaccines against SARS-CoV-2 Omicron BA. 2 variant infection, severe illness, and death
First Author: Huang, Zhuoying
Reviewed: Sep 30, 2022
|
Huang, Zhuoying
|
Sep 30, 2022
|
|
Heterologous boost with mRNA vaccines against SARS-CoV-2 Delta/Omicron variants following an inactivated whole-virus vaccine
First Author: Lu, Changrui
Reviewed: Sep 30, 2022
|
Lu, Changrui
|
Sep 30, 2022
|
|
Image-based & machine learning-guided multiplexed serology test for SARS-CoV-2
First Author: Pietiainen, Vilja
Reviewed: Sep 30, 2022
|
Pietiainen, Vilja
|
Sep 30, 2022
|
|
Immune dynamics at single cell protein level after delta/omicron infection in COVID-19 vaccinated convalescent individuals
First Author: Bajaj, Rimpi
Reviewed: Sep 30, 2022
|
Bajaj, Rimpi
|
Sep 30, 2022
|
|
Mucosal vaccination for SARS-CoV-2 elicits superior systemic T central memory function and cross-neutralizing antibodies against variants of concern
First Author: O Neill, Aled
Reviewed: Sep 30, 2022
|
O Neill, Aled
|
Sep 30, 2022
|
|
MultiOMICs landscape of SARS-CoV-2-induced host responses in human lung epithelial cells
First Author: Pinto, Sneha M
Reviewed: Sep 30, 2022
|
Pinto, Sneha M
|
Sep 30, 2022
|
|
Nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
First Author: Liew, Felicity
Reviewed: Sep 30, 2022
|
Liew, Felicity
|
Sep 30, 2022
|
|
Novel deterministic epidemic model considering mass vaccination and lockdown against coronavirus disease 2019 spread in Israel: A numerical study
First Author: Utamura, Motoaki
Reviewed: Sep 30, 2022
|
Utamura, Motoaki
|
Sep 30, 2022
|
|
Optimization and deoptimization of codons in SARS-CoV-2 and the implications for vaccine development
First Author: Wu, Xinkai
Reviewed: Sep 30, 2022
|
Wu, Xinkai
|
Sep 30, 2022
|
|
Resistance of SARS-CoV-2 Omicron Subvariant BA.4.6 to Antibody Neutralization
First Author: Wang, Qian
Reviewed: Sep 30, 2022
|
Wang, Qian
|
Sep 30, 2022
|
|
Safety and immunogenicity of a broad-spectrum mosaic vaccine as a booster dose against SARS-CoV-2 Omicron and other circulating variants
First Author: Kaabi, Nawal Al
Reviewed: Sep 30, 2022
|
Kaabi, Nawal Al
|
Sep 30, 2022
|
|
Safety and immunogenicity of a third dose of COVID-19 protein subunit vaccine (Covovax™) after homologous and heterologous two-dose regimens
First Author: Kanokudom, Sitthichai
Reviewed: Sep 30, 2022
|
Kanokudom, Sitthichai
|
Sep 30, 2022
|
|
SARS-CoV-2 seroprevalence on the north coast of Peru: A cross-sectional study after the first wave
First Author: Moyano, Luz M
Reviewed: Sep 30, 2022
|
Moyano, Luz M
|
Sep 30, 2022
|
|
Serial cross-sectional estimation of vaccine and infection-induced SARS-CoV-2 sero-prevalence in children and adults, British Columbia, Canada: March 2020 to August 2022
First Author: Skowronski, Danuta M
Reviewed: Sep 30, 2022
|
Skowronski, Danuta M
|
Sep 30, 2022
|
|
THE EFFECT OF THE MEASLES, MUMPS AND RUBELLA VACCINE ON INNATE AND ADAPTIVE IMMUNE RESPONSES IN PERSONS RECEIVING A SARS-COV-2 mRNA VACCINE
First Author: Toit, Leon Du
Reviewed: Sep 30, 2022
|
Toit, Leon Du
|
Sep 30, 2022
|
|
Use of the particle agglutination/particle agglutination-inhibition test for antigenic analysis of SARS-CoV-2
First Author: Kobayashi, Jun
Reviewed: Sep 30, 2022
|
Kobayashi, Jun
|
Sep 30, 2022
|
|
A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA (BNT162b2/mRNA-1273) and adenovirus vectored vaccines (ChAdOx1-S) after the first, second and third doses
First Author: Ryan, Feargal J
Reviewed: Sep 28, 2022
|
Ryan, Feargal J
|
Sep 28, 2022
|
|
Comparative epidemic expansion of SARS-CoV-2 variants Delta and Omicron in Amazonas, a Brazilian setting with high levels of hybrid immunity
First Author: Arantes, Ighor
Reviewed: Sep 28, 2022
|
Arantes, Ighor
|
Sep 28, 2022
|
|
Comprehensive analysis of immune responses in CLL patients after heterologous COVID-19 vaccination
First Author: Lee, Hye Kyung
Reviewed: Sep 28, 2022
|
Lee, Hye Kyung
|
Sep 28, 2022
|
|
COVID-19 Vaccines: The Impact on Pregnancy Outcomes and Menstrual Function
First Author: James A. Thorp
Reviewed: Sep 28, 2022
|
James A. Thorp
|
Sep 28, 2022
|
|
Determination of SARS-CoV-2 Variants and Seroprevalence in Accra, Ghana during the Delta-Omicron Waves
First Author: Irene Owusu Donkor
Reviewed: Sep 28, 2022
|
Irene Owusu Donkor
|
Sep 28, 2022
|
|
Dose of approved COVID-19 vaccines is based on weak evidence: a review of early-phase, dose-finding trials
First Author: Dunn, David
Reviewed: Sep 28, 2022
|
Dunn, David
|
Sep 28, 2022
|
|
Effects of SARS-CoV-2 Infection on Attention, Memory, and Sensorimotor Performance
First Author: O Connor, Erin E
Reviewed: Sep 28, 2022
|
O Connor, Erin E
|
Sep 28, 2022
|
|
Efficacy and safety of ensitrelvir in patients with mild-to-moderate COVID-19: a protocol for a multicenter, randomized, double-blind, placebo-controlled, phase 3 study (the SCORPIO-SR trial)
First Author: Yotsuyanagi, Hiroshi
Reviewed: Sep 28, 2022
|
Yotsuyanagi, Hiroshi
|
Sep 28, 2022
|
|
Evolution of antibody immunity following Omicron BA.1 breakthrough infection
First Author: Kaku, Chengzi I
Reviewed: Sep 28, 2022
|
Kaku, Chengzi I
|
Sep 28, 2022
|
|
Fully Quantitative Measurements of Differential Antibody Binding to Spike Proteins from Wuhan, Alpha, Beta, Gamma, Delta and Omicron BA.1 variants of SARS-CoV-2: Antibody Immunity Endotypes
First Author: James Pemberton, Philip H
Reviewed: Sep 28, 2022
|
James Pemberton, Philip H
|
Sep 28, 2022
|
|
Higher risk of SARS-CoV-2 Omicron BA.4/5 infection than of BA.2 infection after previous BA.1 infection, the Netherlands, 2 May to 24 July 2022
First Author: Andeweg, Stijn P
Reviewed: Sep 28, 2022
|
Andeweg, Stijn P
|
Sep 28, 2022
|
|
LitCovid in 2022: an information resource for the COVID-19 literature
First Author: Chen, Qingyu
Reviewed: Sep 28, 2022
|
Chen, Qingyu
|
Sep 28, 2022
|
|
Post-COVID-19 syndrome: retinal microcirculation as a potential marker for chronic fatigue
First Author: Schlick, Sarah
Reviewed: Sep 28, 2022
|
Schlick, Sarah
|
Sep 28, 2022
|
|
Prevalence of SARS-CoV-2 Antibodies after the Omicron Surge, Kingston, Jamaica, 2022
First Author: Anzinger, Joshua J
Reviewed: Sep 28, 2022
|
Anzinger, Joshua J
|
Sep 28, 2022
|
|
Reconstructing the SARS-CoV-2 epidemic in eastern Uganda through longitudinal serosurveillance in a malaria cohort
First Author: Briggs, Jessica
Reviewed: Sep 28, 2022
|
Briggs, Jessica
|
Sep 28, 2022
|
|
Safety, Immunogenicity and Efficacy of NVX-CoV2373 in Adolescents in PREVENT-19: A Randomized, Phase 3 Trial
First Author: Anez, German
Reviewed: Sep 28, 2022
|
Anez, German
|
Sep 28, 2022
|
- Pediatrics/Adolescents
- Immunological
|
SARS-CoV-2 - The Role of Natural Immunity: A Narrative Review
First Author: Sara Diani
Reviewed: Sep 28, 2022
|
Sara Diani
|
Sep 28, 2022
|
|
SARS-CoV-2 Immunity following different combinations of vaccination and breakthrough infection
First Author: Pusnik, Jernej
Reviewed: Sep 28, 2022
|
Pusnik, Jernej
|
Sep 28, 2022
|
|
SARS-CoV-2 Omicron boosting induces de novo B cell response in humans
First Author: Alsoussi, Wafaa B
Reviewed: Sep 28, 2022
|
Alsoussi, Wafaa B
|
Sep 28, 2022
|
|
Triple COVID-19 vaccination induces humoral and cellular immunity to SARS-CoV-2 with cross-recognition of the Omicron variant and IgA secretion
First Author: Ruhl, Louisa
Reviewed: Sep 28, 2022
|
Ruhl, Louisa
|
Sep 28, 2022
|
|
Acceptance and Attitude towards the Traditional Chinese Medicine among Asymptomatic COVID-19 Patients: A cross-sectional study in Shanghai Fangcang hospital
First Author: Pan, Bo
Reviewed: Sep 26, 2022
|
Pan, Bo
|
Sep 26, 2022
|
|
Acute disseminated encephalomyelitis following inactivated COVID-19 vaccine: A case report
First Author: Sazgarnejad, Saharnaz
Reviewed: Sep 26, 2022
|
Sazgarnejad, Saharnaz
|
Sep 26, 2022
|
|
Blood-brain barrier disruption in Long COVID-associated cognitive impairment
First Author: Campbell, Matthew
Reviewed: Sep 26, 2022
|
Campbell, Matthew
|
Sep 26, 2022
|
|
Depression and Anxiety among nursing students in the post COVID-19 pandemic in Inner Mongolia: An online cross-sectional survey
First Author: Bai, Xue
Reviewed: Sep 26, 2022
|
Bai, Xue
|
Sep 26, 2022
|
|
Is the Sars-CoV-2 virus a possible trigger agent for the development of achalasia?
First Author: Furuzawa Carballeda, Janette
Reviewed: Sep 26, 2022
|
Furuzawa Carballeda, Janette
|
Sep 26, 2022
|
|
The impact of prior COVID-19 on vaccine response and the resultant hybrid immunity are age-dependent
First Author: Nakagama, Sachie
Reviewed: Sep 26, 2022
|
Nakagama, Sachie
|
Sep 26, 2022
|
|
Comprehensive identification of Long Covid articles with
human-in-the-loop machine learning
First Author: Leaman, Robert
Reviewed: Sep 24, 2022
|
Leaman, Robert
|
Sep 24, 2022
|
|
Estimation of mRNA COVID-19 Vaccination Effectiveness in Tokyo for Omicron Variants BA.2 and BA.5 -Effect of Social Behavior-
First Author: Kodera, Sachiko
Reviewed: Sep 24, 2022
|
Kodera, Sachiko
|
Sep 24, 2022
|
|
How did COVID-19 Pandemic Impact Safety on a Construction Project? A Case Study Comparing Pre and Post COVID-19 Influence on Safety at an Australian Construction Site.
First Author: Roberta Selleck
Reviewed: Sep 24, 2022
|
Roberta Selleck
|
Sep 24, 2022
|
|
Mathematical modeling identifies optimal dosing schedules for COVID-19 vaccines to minimize breakthrough infections
First Author: Dogra, Prashant
Reviewed: Sep 24, 2022
|
Dogra, Prashant
|
Sep 24, 2022
|
|
Neutralizing antibodies following three doses of BNT162b2 vaccine, breakthrough infection, and symptoms during the Omicron predominant wave
First Author: Yamamoto, Shohei
Reviewed: Sep 24, 2022
|
Yamamoto, Shohei
|
Sep 24, 2022
|
|
Post-vaccination neutralization responses to Omicron sub-variants
First Author: Jacobsen, Henning
Reviewed: Sep 24, 2022
|
Jacobsen, Henning
|
Sep 24, 2022
|
|
Prevalence and risk factors for long COVID after mild disease: a longitudinal study with a symptomatic control group
First Author: Ceron, Ana Beatriz Caze
Reviewed: Sep 24, 2022
|
Ceron, Ana Beatriz Caze
|
Sep 24, 2022
|
|
Real World Effectiveness of Tixagevimab/cilgavimab (Evusheld) in the Omicron Era
First Author: Chen, Benjamin
Reviewed: Sep 24, 2022
|
Chen, Benjamin
|
Sep 24, 2022
|
|
SARS-CoV-2 mRNA vaccination elicits broad and potent Fc effector functions to VOCs in vulnerable populations
First Author: Hederman, Andrew P
Reviewed: Sep 24, 2022
|
Hederman, Andrew P
|
Sep 24, 2022
|
- Immunological
- Not Of Interest
|
A cross-sectional study of quantitative CT measurements associated with the diffusion capacity of the lung in recovered COVID-19 patients with normalised chest CT
First Author: Wen, Han
Reviewed: Sep 22, 2022
|
Wen, Han
|
Sep 22, 2022
|
|
Alterations of the Antioxidant and Inflammatory Response of the Peripheral Blood Granulocytes to SARS-CoV-2 Infection in the Deceased COVID-19 Patients
First Author: Neven Zarkovic
Reviewed: Sep 22, 2022
|
Neven Zarkovic
|
Sep 22, 2022
|
|
IFN-γ mediated-cellular immunity is essential to the vaccine-induced protection against SARS-CoV-2
First Author: Wang, Xiao Lei
Reviewed: Sep 22, 2022
|
Wang, Xiao Lei
|
Sep 22, 2022
|
|
Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution
First Author: Cao, Yunlong
Reviewed: Sep 22, 2022
|
Cao, Yunlong
|
Sep 22, 2022
|
|
Rationale, Design, and Baseline Characteristics of the VALIANT (COVID-19 in Older Adults: A Longitudinal Assessment) Cohort
First Author: Cohen, Andrew B
Reviewed: Sep 22, 2022
|
Cohen, Andrew B
|
Sep 22, 2022
|
|
SARS-CoV-2 and HSV-1 Induce Amyloid Aggregation in Human CSF
First Author: Christ, Wanda
Reviewed: Sep 22, 2022
|
Christ, Wanda
|
Sep 22, 2022
|
|
SARS-CoV-2 infection of human neurons requires endosomal cell entry and can be blocked by inhibitors of host phosphoinositol-5 kinase
First Author: Kettunen, Pinja
Reviewed: Sep 22, 2022
|
Kettunen, Pinja
|
Sep 22, 2022
|
|
Severe fatigue as symptom of long COVID is characterized by increased expression of inflammatory genes in monocytes, increased serum pro-inflammatory cytokines, and increased CD8+ T-lymphocytes: A putative dysregulation of the immune-brain axis, the coagulation process, and auto-inflammation to explain the diversity of long COVID symptoms
First Author: Berentschot, Julia C
Reviewed: Sep 22, 2022
|
Berentschot, Julia C
|
Sep 22, 2022
|
|
Systematic Down-Selection of Repurposed Drug Candidates for COVID-19
First Author: Christopher A. MacRaild
Reviewed: Sep 22, 2022
|
Christopher A. MacRaild
|
Sep 22, 2022
|
|
Cognitive status and rehabilitation outcomes of patients in acute rehabilitation post Covid-19
First Author: Vahtra, Madli
Reviewed: Sep 20, 2022
|
Vahtra, Madli
|
Sep 20, 2022
|
|
Covid-19 vaccination hesitancy in Mexico City among healthy adults and adults with chronic diseases
First Author: Gonzalez Block, Miguel
Reviewed: Sep 20, 2022
|
Gonzalez Block, Miguel
|
Sep 20, 2022
|
|
Effects of Covid-19 Vaccines on the Menstrual Cycle: A Cross-Sectional Study.
First Author: Gopaul, Chavin
Reviewed: Sep 20, 2022
|
Gopaul, Chavin
|
Sep 20, 2022
|
|
Humoral and Cellular Immunogenicity and Safety of 3 Doses of CoronaVac and BNT162b2 in Young Children and Adolescents with Kidney Diseases
First Author: Leung, Daniel
Reviewed: Sep 20, 2022
|
Leung, Daniel
|
Sep 20, 2022
|
|
Increasing Cases of SARS-CoV-2 Omicron Reinfection Reveals Ineffective Post-COVID-19 Immunity in Denmark and Conveys the Need for Continued Next-Generation Sequencing
First Author: Burkholz, Scott
Reviewed: Sep 20, 2022
|
Burkholz, Scott
|
Sep 20, 2022
|
|
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Post-COVID Syndrome: A Common Neuroimmune Ground?
First Author: Varvara A. Ryabkova
Reviewed: Sep 20, 2022
|
Varvara A. Ryabkova
|
Sep 20, 2022
|
|
Real-World Effectiveness of Nirmatrelvir/Ritonavir in Preventing Hospitalization Among Patients With COVID-19 at High Risk for Severe Disease in the United States: A Nationwide Population-Based Cohort Study
First Author: Zhou, Xiaofeng
Reviewed: Sep 20, 2022
|
Zhou, Xiaofeng
|
Sep 20, 2022
|
|
Real-world Use of Nirmatrelvir-Ritonavir in COVID-19 Outpatients During the Emergence of Omicron Variants BA.2/BA2.12.1
First Author: Aggarwal, Neil R
Reviewed: Sep 20, 2022
|
Aggarwal, Neil R
|
Sep 20, 2022
|
|
Simulation and application of COVID-19 compartment model using
physics-informed neural network
First Author: Ke, Jinhuan
Reviewed: Sep 20, 2022
|
Ke, Jinhuan
|
Sep 20, 2022
|
|
The Effects of Long COVID-19, its Severity, and the Need for Immediate Attention: Analysis of Clinical Trials and Twitter data
First Author: Bhattacharyya, Arinjita
Reviewed: Sep 20, 2022
|
Bhattacharyya, Arinjita
|
Sep 20, 2022
|
|
The epidemiology of long COVID in US adults two years after the start of the US SARS-CoV-2 pandemic
First Author: Robertson, Mckaylee M
Reviewed: Sep 20, 2022
|
Robertson, Mckaylee M
|
Sep 20, 2022
|
|
A Systematic Review and Quality Evaluation of Studies on Long-Term Sequelae of COVID-19
First Author: Jorge Vásconez González
Reviewed: Sep 19, 2022
|
Jorge Vásconez González
|
Sep 19, 2022
|
|
Association of Prior COVID-19 Infection With Newly Diagnosed Erectile Dysfunction: Evaluation of 42,406 COVID-19 Recovered Men
First Author: Hebert, Kevin
Reviewed: Sep 19, 2022
|
Hebert, Kevin
|
Sep 19, 2022
|
|
Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant
First Author: Scheaffer, Suzanne M
Reviewed: Sep 19, 2022
|
Scheaffer, Suzanne M
|
Sep 19, 2022
|
|
Comparative multi-OMICS single cell atlas of five COVID-19 (rAdVV and mRNA) vaccines describe unique and distinct mechanisms of action
First Author: Singh, Yogesh
Reviewed: Sep 19, 2022
|
Singh, Yogesh
|
Sep 19, 2022
|
|
Design, structure and plasma binding of ancestral β-CoV scaffold antigens
First Author: Syren, Per Olof
Reviewed: Sep 19, 2022
|
Syren, Per Olof
|
Sep 19, 2022
|
|
Efficacy of Probiotic Treatment as Post-Exposure Prophylaxis for COVID-19: A Double-Blind, Placebo Controlled Randomized Trial
First Author: Wischmeyer, Paul E
Reviewed: Sep 19, 2022
|
Wischmeyer, Paul E
|
Sep 19, 2022
|
|
Epidemiological and Clinical Features of SARS-CoV-2 Variants Circulating between April-December 2021 in Italy
First Author: Alessia Lai
Reviewed: Sep 19, 2022
|
Alessia Lai
|
Sep 19, 2022
|
|
Molecular engineering of a cryptic epitope in Spike RBD improves manufacturability and neutralizing breadth against SARS-CoV-2 variants
First Author: Rodriguez Aponte, Sergio A
Reviewed: Sep 19, 2022
|
Rodriguez Aponte, Sergio A
|
Sep 19, 2022
|
|
Parents in Taiwan are hesitant to have their children vaccinated against COVID-19 and its influencing factors
First Author: Deng, Jing Shan
Reviewed: Sep 19, 2022
|
Deng, Jing Shan
|
Sep 19, 2022
|
|
Preclinical evaluation of safety and immunogenicity of a primary series intranasal COVID-19 vaccine candidate (BBV154), and humoral immunogenicity evaluation of a heterologous prime-boost strategy with COVAXIN (BBV152)
First Author: Vadrevu, Krishna
Reviewed: Sep 19, 2022
|
Vadrevu, Krishna
|
Sep 19, 2022
|
|
Prevalence and predictors of long COVID among non-hospitalised adolescents and young adults: a prospective controlled cohort study
First Author: Wyller, Vegard
Reviewed: Sep 19, 2022
|
Wyller, Vegard
|
Sep 19, 2022
|
|
Serum Glucose and Electrolyte Levels in Children with and without Febrile Seizures: A case-control study
First Author: Mohamed, Zakaria Ahmed
Reviewed: Sep 19, 2022
|
Mohamed, Zakaria Ahmed
|
Sep 19, 2022
|
|
Spontaneous, persistent T-cell dependent IFN-γ release in patients who progress to Long COVID
First Author: Krishna, Benjamin A
Reviewed: Sep 19, 2022
|
Krishna, Benjamin A
|
Sep 19, 2022
|
|
The SARS-CoV-2 Spike Protein Mutation Explorer: Using an Interactive Application to Improve the Public Understanding of SARS-CoV-2 Variants of Concern
First Author: Iannucci, Sarah
Reviewed: Sep 19, 2022
|
Iannucci, Sarah
|
Sep 19, 2022
|
|
Trans-synaptic dwelling of SARS-CoV-2 particles perturbs neural synapse organization and function
First Author: Partiot, Emma
Reviewed: Sep 19, 2022
|
Partiot, Emma
|
Sep 19, 2022
|
|
Vaccination Status and Long COVID Symptoms in Patients Discharged from Hospital
First Author: Nascimento, Teresa Cristina D C
Reviewed: Sep 19, 2022
|
Nascimento, Teresa Cristina D C
|
Sep 19, 2022
|
|
What is New in Prophylaxis and Treatment of Covid- 19 in Renal Transplant Patients?
First Author: Maurizio Salvadori
Reviewed: Sep 19, 2022
|
Maurizio Salvadori
|
Sep 19, 2022
|
|
What Proportion of Population has achieved Cellular Immunity against SARS-CoV-2 after Booster Vaccination: A Cross-sectional Study
First Author: Tani, Yuta
Reviewed: Sep 19, 2022
|
Tani, Yuta
|
Sep 19, 2022
|
|
An Engineered T7 RNA Polymerase for efficient co-transcriptional capping with reduced dsRNA byproducts in mRNA synthesis
First Author: Miller, Mathew
Reviewed: Sep 16, 2022
|
Miller, Mathew
|
Sep 16, 2022
|
|
Assessment of adverse events following vaccination with AstraZeneca Coronavirus Disease 2019 vaccine in Greater Kampala, Uganda, March-April 2021
First Author: Komakech, Allan
Reviewed: Sep 16, 2022
|
Komakech, Allan
|
Sep 16, 2022
|
|
Impact of COVID-19 and Effects of Vaccination with BNT162b2 on Patient-Reported Health-Related Quality of Life, Symptoms, and Work Productivity Among US Adult Outpatients with SARS-CoV-2
First Author: Fusco, Manuela Di
Reviewed: Sep 16, 2022
|
Fusco, Manuela Di
|
Sep 16, 2022
|
|
Predictors of COVID-19 Vaccine Acceptance among Healthcare Workers in Nigeria
First Author: Victory Nnaemeka
Reviewed: Sep 16, 2022
|
Victory Nnaemeka
|
Sep 16, 2022
|
|
SARS-CoV-2 Infection in Unvaccinated High Risk Pregnant Women in the Bronx, NY is Associated with Placental Abnormalities, Shorter Gestation and Lower Apgar Scores
First Author: Sandra Reznik
Reviewed: Sep 16, 2022
|
Sandra Reznik
|
Sep 16, 2022
|
|
Shifts in COVID-19 Vaccine acceptance rates among African countries: A systematic review and Meta-analysis
First Author: Kim, Yejoon
Reviewed: Sep 16, 2022
|
Kim, Yejoon
|
Sep 16, 2022
|
|
Spatial analysis of COVID-19 booster vaccine uptake in Scotland, and projection of future distributions
First Author: Wood, A J
Reviewed: Sep 16, 2022
|
Wood, A J
|
Sep 16, 2022
|
|
Investigation of potential tea polyphenols against SARS-CoV-2 targets: A Computational approach
First Author: Vinayagan, Nadana
Reviewed: Sep 15, 2022
|
Vinayagan, Nadana
|
Sep 15, 2022
|
|
A Phase I, Prospective, Randomized, Open-labeled Study to Evaluate the Safety, Tolerability, and Immunogenicity of Booster Dose with MVC-COV1901 or MVC-COV1901(Beta) SARS-CoV-2 Vaccine in Adults
First Author: Lien, Chia En
Reviewed: Sep 13, 2022
|
Lien, Chia En
|
Sep 13, 2022
|
|
Characterising Long Covid: a living systematic review update with controlled studies
First Author: Michelen, Melina
Reviewed: Sep 13, 2022
|
Michelen, Melina
|
Sep 13, 2022
|
|
Effectiveness of endurance training rehabilitation after hospitalisation in intensive care for COVID-19-related acute respiratory distress syndrome on dyspnoea (RECOVER): a randomised controlled, open-label multicentre trial
First Author: Romanet, Christophe
Reviewed: Sep 13, 2022
|
Romanet, Christophe
|
Sep 13, 2022
|
|
Impact of HLA divergence on humoral response to SARS-CoV-2 and HBV vaccines in the liver transplantation setting
First Author: Feray, Cyrille
Reviewed: Sep 13, 2022
|
Feray, Cyrille
|
Sep 13, 2022
|
|
Polygenic Risk Scores for Asthma and Allergic Disease Predict COVID-19 Severity in 9/11 Responders
First Author: Waszczuk, Monika A
Reviewed: Sep 13, 2022
|
Waszczuk, Monika A
|
Sep 13, 2022
|
|
Trends in risk factors and symptoms associated with SARS-CoV-2 and Rhinovirus test positivity in King County, Washington: A Test-Negative Design Study of the Greater Seattle Coronavirus Assessment Network
First Author: Hansen, Chelsea L
Reviewed: Sep 13, 2022
|
Hansen, Chelsea L
|
Sep 13, 2022
|
|
UB-612 Multitope Vaccine Targeting SARS-CoV-2 Spike and Non-Spike Proteins Provides Broad and Durable Immune Responses
First Author: Wang, Chang Yi
Reviewed: Sep 13, 2022
|
Wang, Chang Yi
|
Sep 13, 2022
|
|
Appropriate Human Serum Albumin Fluid Therapy and the Alleviation COVID-19 Vulnerabilities; An Explanation of the Hsa Lymphatic Nutrient Pump
First Author: Andrew S. Johnson
Reviewed: Sep 9, 2022
|
Andrew S. Johnson
|
Sep 9, 2022
|
|
Determinants of Parents’ Motive to Vaccinate their 12–17 Years Old Children against COVID-19 in North Kivu (DRC)
First Author: Stephane Hans Bateyi Mustafa
Reviewed: Sep 8, 2022
|
Stephane Hans Bateyi Mustafa
|
Sep 8, 2022
|
|
Topological AI forecasting of future dominating viral variants
First Author: Wei, Guo Wei
Reviewed: Sep 8, 2022
|
Wei, Guo Wei
|
Sep 8, 2022
|
|
A Novel Dry-Stabilized Whole Blood Microsampling and Protein Extraction Method for Testing of SARS-CoV-2 Antibody Titres
First Author: Mccarthy, Patrick
Reviewed: Sep 7, 2022
|
Mccarthy, Patrick
|
Sep 7, 2022
|
|
Effectiveness of the COVID-19 vaccines against severe disease with Omicron sub-lineages BA.4 and BA.5 in England
First Author: Kirsebom, Freja C M
Reviewed: Sep 7, 2022
|
Kirsebom, Freja C M
|
Sep 7, 2022
|
|
Expert Review of Global Real-World Data on COVID-19 Vaccine Booster Effectiveness & Safety During the Omicron-dominant Phase of the Pandemic
First Author: Solante, Rontgene
Reviewed: Sep 7, 2022
|
Solante, Rontgene
|
Sep 7, 2022
|
|
Heterogeneity in vaccinal immunity to SARS-CoV-2 can be addressed by a personalized booster strategy
First Author: Stoddard, Madison
Reviewed: Sep 7, 2022
|
Stoddard, Madison
|
Sep 7, 2022
|
|
Heterologous booster immunization with SARS-CoV-2 spike protein after mRNA vaccine elicits durable and broad antibody responses
First Author: Takano, Tomohiro
Reviewed: Sep 7, 2022
|
Takano, Tomohiro
|
Sep 7, 2022
|
|
Machine Learning for Control Systems Security of Industrial Robots: a Post-covid-19 Overview
First Author: Gueye, Thierno
Reviewed: Sep 7, 2022
|
Gueye, Thierno
|
Sep 7, 2022
|
|
Microfluidic immuno-serology assay revealed a limited diversity of protection against COVID-19 in patients with altered immunity
First Author: Kim, Dongjoo
Reviewed: Sep 7, 2022
|
Kim, Dongjoo
|
Sep 7, 2022
|
|
Novel monoclonal antibodies showing broad neutralizing activity for SARS-CoV-2 variants including Omicrons BA.5 and BA.2.75
First Author: Ishimaru, Hanako
Reviewed: Sep 7, 2022
|
Ishimaru, Hanako
|
Sep 7, 2022
|
|
Prophylactic Treatment of COVID-19 in Care Homes Trial (PROTECT-CH)
First Author: Bath, Philip M
Reviewed: Sep 7, 2022
|
Bath, Philip M
|
Sep 7, 2022
|
|
Real-World COVID-19 Vaccine Protection Rates against Infection in the Delta and Omicron Eras
First Author: Zhu, Yuru
Reviewed: Sep 7, 2022
|
Zhu, Yuru
|
Sep 7, 2022
|
|
Recent SARS-CoV-2 infection abrogates antibody and B-cell responses to booster vaccination
First Author: Buckner, Clarisa M
Reviewed: Sep 7, 2022
|
Buckner, Clarisa M
|
Sep 7, 2022
|
|
SARS-CoV-2 nucleocapsid protein inhibits the stress response through RNA-binding domain N2b
First Author: Aloise, Chiara
Reviewed: Sep 7, 2022
|
Aloise, Chiara
|
Sep 7, 2022
|
|
T-cell Response and Antibody Production by Booster COVID-19 Vaccination in Japanese Patients with Chronic Kidney Disease Treated with Hemodialysis
First Author: Ayumi Yoshifuji
Reviewed: Sep 7, 2022
|
Ayumi Yoshifuji
|
Sep 7, 2022
|
|
The CSHQ-DE Questionnaire Uncovers Relevant Sleep Disorders in Children and Adolescents with Long COVID-19
First Author: Sarah Werner
Reviewed: Sep 7, 2022
|
Sarah Werner
|
Sep 7, 2022
|
|
Zero-COVID policy or Living-with-COVID policy? Analysis Based on Percent Excess Mortality
First Author: Cao, Xiaohan
Reviewed: Sep 7, 2022
|
Cao, Xiaohan
|
Sep 7, 2022
|
|
A Beta-containing bivalent SARS-CoV-2 spike protein vaccine candidate with AS03 elicits durable and broad neutralization of variants including Omicron in macaques and confers protection in hamsters
First Author: Berry, Catherine
Reviewed: Sep 6, 2022
|
Berry, Catherine
|
Sep 6, 2022
|
|
A Case Report: Acute Myocardial Infarction, Coronal Arteritis and Myocarditis after BNT162b2 mRNA Vaccination against Covid-19
First Author: Michael Mörz
Reviewed: Sep 6, 2022
|
Michael Mörz
|
Sep 6, 2022
|
|
Harnessing Nasal Immunity with Iga to Prevent Respiratory Infections
First Author: John Joseph
Reviewed: Sep 6, 2022
|
John Joseph
|
Sep 6, 2022
|
|
Low prevalence of current and past SARS-CoV-2 infections among visitors and staff members of homelessness services in Amsterdam at the end of the second wave of infections in the Netherlands
First Author: Generaal, Ellen
Reviewed: Sep 6, 2022
|
Generaal, Ellen
|
Sep 6, 2022
|
|
Molecular fate-mapping of serum antibodies reveals the effects of antigenic imprinting on repeated immunization
First Author: Schiepers, Arien
Reviewed: Sep 6, 2022
|
Schiepers, Arien
|
Sep 6, 2022
|
|
Receptor binding domain (RBD) antibodies contribute more to SARS-CoV-2 neutralization when target cells express high levels of ACE2
First Author: Farrell, Ariana Ghez
Reviewed: Sep 6, 2022
|
Farrell, Ariana Ghez
|
Sep 6, 2022
|
|
Cancer survivors present physical and psychological sequelae after COVID-19 hospitalization: a prospective and longitudinal cross-sectional study assessing post-acute sequelae of SARS-CoV-2 infection (PASC) in cancer patients
First Author: Leite, Victor Figueiredo
Reviewed: Sep 2, 2022
|
Leite, Victor Figueiredo
|
Sep 2, 2022
|
|
Niacinamide enhances cathelicidin mediated SARS-CoV-2 membrane disruption
First Author: Bhatt, Tanay
Reviewed: Sep 2, 2022
|
Bhatt, Tanay
|
Sep 2, 2022
|
|
Vaccine Side Effects Following COVID-19 Vaccination with Inactivated Vaccines in Zimbabwe
First Author: Azure Tariro Makadzange
Reviewed: Sep 2, 2022
|
Azure Tariro Makadzange
|
Sep 2, 2022
|
|
Infectious Complications Following Car-T Cell Therapy for B Cell Non-Hodgkin Lymphoma: A Single-Center Experience and Review of the Literature
First Author: Mercadal, Santiago
Reviewed: Aug 31, 2022
|
Mercadal, Santiago
|
Aug 31, 2022
|
|
Quantifying the Role of Interest Rates, the Dollar and Covid in Oil
Prices
First Author: Kohlscheen, Emanuel
Reviewed: Aug 31, 2022
|
Kohlscheen, Emanuel
|
Aug 31, 2022
|
|
Residents’ Willingness to Pay for Domestic Nature-Based Tourism in Botswana
First Author: Mogomotsi, Patricia Kefilwe
Reviewed: Aug 31, 2022
|
Mogomotsi, Patricia Kefilwe
|
Aug 31, 2022
|
|
STUDY PROTOCOL
A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): A trial conducted within the VACCELERATE network
First Author: Neuhann, Julia Maria
Reviewed: Aug 31, 2022
|
Neuhann, Julia Maria
|
Aug 31, 2022
|
|
Antigen presentation dynamics shape the response to emergent variants like SARS-CoV-2 Omicron strain after multiple vaccinations with wild type strain
First Author: Yang, Leerang
Reviewed: Aug 30, 2022
|
Yang, Leerang
|
Aug 30, 2022
|
|
Assessing Vulnerability to COVID-19 in High-Risk Populations: The Role of SARS-CoV-2 Spike-Targeted Serology
First Author: Kaufman, Harvey W
Reviewed: Aug 30, 2022
|
Kaufman, Harvey W
|
Aug 30, 2022
|
|
Comparing the Safety and Immunogenicity of homologous (Sputnik V) and heterologous (BNT162B2) COVID-19 prime-boost vaccination
First Author: Al Madhi, Marwa
Reviewed: Aug 30, 2022
|
Al Madhi, Marwa
|
Aug 30, 2022
|
|
Continuous population-level monitoring of SARS-CoV-2 seroprevalence in a large metropolitan region
First Author: Emmenegger, Marc
Reviewed: Aug 30, 2022
|
Emmenegger, Marc
|
Aug 30, 2022
|
|
Correlation of patient serum IgG, IgA and IgM antigen binding with COVID-19 disease severity using multiplexed SARS-CoV-2 antigen microarray and maintained relative IgA and IgM antigen binding over time
First Author: Berre, Marie Le
Reviewed: Aug 30, 2022
|
Berre, Marie Le
|
Aug 30, 2022
|
|
Dynamics of anti-S IgG antibodies titers after the second dose of COVID 19 mRNA and non-mRNA vaccines in the manual and craft worker population of Qatar
First Author: Bansal, Devendra
Reviewed: Aug 30, 2022
|
Bansal, Devendra
|
Aug 30, 2022
|
|
Homologous and heterologous boosting with CoronaVac and BNT162b2: a randomized trial (the Cobovax study)
First Author: Leung, Nancy H L
Reviewed: Aug 30, 2022
|
Leung, Nancy H L
|
Aug 30, 2022
|
|
Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults
First Author: Melo Gonzalez, Felipe
Reviewed: Aug 30, 2022
|
Melo Gonzalez, Felipe
|
Aug 30, 2022
|
|
Immune protection against SARS-CoV-2 re-reinfection and immune imprinting
First Author: Chemaitelly, Hiam
Reviewed: Aug 30, 2022
|
Chemaitelly, Hiam
|
Aug 30, 2022
|
|
Long Covid active case finding: a co-produced community-based pilot within the STIMULATE-ICP study (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways)
First Author: Alwan, Nisreen A
Reviewed: Aug 30, 2022
|
Alwan, Nisreen A
|
Aug 30, 2022
|
|
Mathematical modeling of the waning of anti-RBD IgG SARS-CoV-2 antibody titers after a two-dose BNT162b2 mRNA vaccination
First Author: Torres, Javier
Reviewed: Aug 30, 2022
|
Torres, Javier
|
Aug 30, 2022
|
|
NEURO-COVAX: An Italian Population-Based Study of Neurological Complications After COVID-19 Vaccines
First Author: Salsone, Maria
Reviewed: Aug 30, 2022
|
Salsone, Maria
|
Aug 30, 2022
|
|
Nirmatrelvir/ritonavir and molnuipiravir in the treatment of mild/moderate COVID-19: results of a real-life study
First Author: Gentile, Ivan
Reviewed: Aug 30, 2022
|
Gentile, Ivan
|
Aug 30, 2022
|
|
Omicron B.1.1.529 variant infections associated with severe disease are uncommon in a COVID-19 under-vaccinated, high SARS-CoV-2 seroprevalence population in Malawi
First Author: Mseka, Upendo L
Reviewed: Aug 30, 2022
|
Mseka, Upendo L
|
Aug 30, 2022
|
|
Post-COVID syndrome prevalence and risk factors in children and adolescents: A population-based serological study
First Author: Dumont, Roxane
Reviewed: Aug 30, 2022
|
Dumont, Roxane
|
Aug 30, 2022
|
|
Prevention of cholera and COVID-19 pandemics in Uganda: understanding vaccine coverage survey Plus
First Author: Bwire, Godfrey
Reviewed: Aug 30, 2022
|
Bwire, Godfrey
|
Aug 30, 2022
|
|
Public health interventions successfully mitigated multiple incursions of SARS-CoV-2 Delta variant in the Australian Capital Territory
First Author: Hall, Robyn
Reviewed: Aug 30, 2022
|
Hall, Robyn
|
Aug 30, 2022
|
|
Rates of COVID-19-Associated Hospitalization in Immunocompromised Individuals in Omicron-era: A Population-Based Observational Study Using Surveillance Data in British Columbia, Canada
First Author: Bahremand, Taraneh
Reviewed: Aug 30, 2022
|
Bahremand, Taraneh
|
Aug 30, 2022
|
|
Susceptibility and infectiousness of SARS-CoV-2 in children versus adults, by variant (wild-type, Alpha, Delta): a systematic review and meta-analysis of household contact studies
First Author: Uthman, Olalekan A
Reviewed: Aug 30, 2022
|
Uthman, Olalekan A
|
Aug 30, 2022
|
- Adults
- Pediatrics/Adolescents
|
T cell responses to SARS-CoV-2 vaccination in people with multiple sclerosis differ between disease-modifying therapies
First Author: Wolf, Asia Sophia
Reviewed: Aug 30, 2022
|
Wolf, Asia Sophia
|
Aug 30, 2022
|
|
The Impact of SARS-CoV-2 Vaccine Dose Separation and Dose Targeting on Hospital Admissions and Deaths from COVID-19 in England
First Author: Keeling, Matt J
Reviewed: Aug 30, 2022
|
Keeling, Matt J
|
Aug 30, 2022
|
|
The Role of Modelling and Analytics in South African COVID-19 Planning and Budgeting
First Author: Meyer Rath, Gesine
Reviewed: Aug 30, 2022
|
Meyer Rath, Gesine
|
Aug 30, 2022
|
|
Trained Immunity as a Prospective Tool against Emerging Respiratory Pathogens
First Author: John Joseph
Reviewed: Aug 30, 2022
|
John Joseph
|
Aug 30, 2022
|
|
TRENDS IN CASES, HOSPITALISATION AND MORTALITY RELATED TO THE OMICRON BA.4/BA.5 SUB-VARIANTS IN SOUTH AFRICA
First Author: Jassat, Waasila
Reviewed: Aug 30, 2022
|
Jassat, Waasila
|
Aug 30, 2022
|
|
Use of whole genome sequencing to estimate the contribution of immune evasion and waning immunity to decreasing COVID-19 vaccine effectiveness during alpha and delta variant waves
First Author: Lind, Margaret L
Reviewed: Aug 30, 2022
|
Lind, Margaret L
|
Aug 30, 2022
|
|
Variability in mRNA SARS-CoV-2 BNT162b2 vaccine immunogenicity is associated with differences in the gut microbiome and habitual dietary fibre intake
First Author: Healey, Genelle R
Reviewed: Aug 30, 2022
|
Healey, Genelle R
|
Aug 30, 2022
|
|
Analysis of the experiences of patients in the rehabilitation period related to the COVID-19 disease and assessment of the impact of this disease on the disability in convalescents
First Author: Migala, Mariusz
Reviewed: Aug 27, 2022
|
Migala, Mariusz
|
Aug 27, 2022
|
|
Antibody and T cell responses against wild-type and Omicron SARS-CoV-2 after the third dose of BNT162b2 in healthy adolescents
First Author: Lau, Yu Lung
Reviewed: Aug 27, 2022
|
Lau, Yu Lung
|
Aug 27, 2022
|
- Pediatrics/Adolescents
- Immunological
|
Central nervous system biomarkers GFAp and NfL associate with post-acute cognitive impairment and fatigue following critical COVID-19
First Author: Bark, Lovisa
Reviewed: Aug 27, 2022
|
Bark, Lovisa
|
Aug 27, 2022
|
|
Effectiveness of fourth dose COVID-19 vaccine against the Omicron variant compared to no vaccination
First Author: Zeng, Jessie
Reviewed: Aug 27, 2022
|
Zeng, Jessie
|
Aug 27, 2022
|
|
Hospital Admission and Hospital Course Predictors of Severity of Post-covid-19 Condition
First Author: Tran, Karen C
Reviewed: Aug 27, 2022
|
Tran, Karen C
|
Aug 27, 2022
|
|
Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients
First Author: Kemlin, D
Reviewed: Aug 27, 2022
|
Kemlin, D
|
Aug 27, 2022
|
|
Increased adverse events following third dose of BNT162b2/Pfizer vaccine in those with previous COVID-19, but not with concurrent influenza vaccine
First Author: Raw, Rachael K
Reviewed: Aug 27, 2022
|
Raw, Rachael K
|
Aug 27, 2022
|
|
Neutralizing Antibody to Omicron BA.1, BA.2 and BA.5 in COVID-19 Patients
First Author: Linderman, Susanne L
Reviewed: Aug 27, 2022
|
Linderman, Susanne L
|
Aug 27, 2022
|
|
Protection against symptomatic disease with the delta and omicron BA.1/BA.2 variants of SARS-CoV-2 after infection and vaccination in adolescents: national observational test-negative case control study, August 2021 to March 2022, England
First Author: Powell, Annabel A
Reviewed: Aug 27, 2022
|
Powell, Annabel A
|
Aug 27, 2022
|
- Pediatrics/Adolescents
- Waning Over Time
|
Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa
First Author: Sun, Kaiyuan
Reviewed: Aug 27, 2022
|
Sun, Kaiyuan
|
Aug 27, 2022
|
|
Single-cell RNA sequencing highlights a reduced function of natural killer and cytotoxic T cell in recovered COVID-19 pregnant women
First Author: Aziz, Nor Haslinda Abd
Reviewed: Aug 27, 2022
|
Aziz, Nor Haslinda Abd
|
Aug 27, 2022
|
|
Symptom presentation among SARS-CoV-2 positive cases and the impact of COVID-19 vaccination; three prospective household cohorts
First Author: Westerhof, Ilse
Reviewed: Aug 27, 2022
|
Westerhof, Ilse
|
Aug 27, 2022
|
- Adults
- Pediatrics/Adolescents
|
Phylogeny analysis of Pakistani SARS-CoV2 strains and screening of a list of natural compounds as the antiviral targets for viral M pro protein
First Author: Javaid, Anum
Reviewed: Aug 25, 2022
|
Javaid, Anum
|
Aug 25, 2022
|
|
PLCG2 variant p.P522R - associated with healthy aging- may reduce the aging of the human immune system
First Author: Diks, Annieck M
Reviewed: Aug 25, 2022
|
Diks, Annieck M
|
Aug 25, 2022
|
|
The prevalence of mental ill-health in women during pregnancy and after childbirth during the Covid-19 pandemic: a Systematic Review and Meta- analysis
First Author: Delanerolle, Gayathri
Reviewed: Aug 25, 2022
|
Delanerolle, Gayathri
|
Aug 25, 2022
|
|
Analysis of critical protein-protein interactions of SARS-CoV-2 capping and proofreading molecular machineries towards designing dual target inhibitory peptides
First Author: Arabi Jeshvaghani, Fatemeh
Reviewed: Aug 24, 2022
|
Arabi Jeshvaghani, Fatemeh
|
Aug 24, 2022
|
|
Use of Rotavirus Vaccine as a Containment Measure for SARS-CoV-2 Coronavirus (COVID-19): A Study of Possible Cross and Trained Immunity
First Author: Nuria Lorite - Ayan
Reviewed: Aug 24, 2022
|
Nuria Lorite - Ayan
|
Aug 24, 2022
|
|
A replicon RNA vaccine induces durable protective immunity from SARS-CoV-2 in nonhuman primates after neutralizing antibodies have waned
First Author: O Connor, Megan A
Reviewed: Aug 23, 2022
|
O Connor, Megan A
|
Aug 23, 2022
|
|
Enhancing antibody responses by multivalent antigen display on thymus-independent DNA origami scaffolds
First Author: Wamhoff, Eike Christian
Reviewed: Aug 23, 2022
|
Wamhoff, Eike Christian
|
Aug 23, 2022
|
|
Hyperbaric Oxygen Therapy for Long COVID (HOT-LoCO), an interim safety report from a randomised controlled trial
First Author: Kjellberg, Anders
Reviewed: Aug 23, 2022
|
Kjellberg, Anders
|
Aug 23, 2022
|
|
Antigen Specific T Cells in People with Obesity at Five Months Following ChAdOx1 COVID-19 Vaccination
First Author: Kelly, Neil E Wrigley
Reviewed: Aug 22, 2022
|
Kelly, Neil E Wrigley
|
Aug 22, 2022
|
|
BNT162b2 induced neutralizing and non-neutralizing antibody functions against SARSCoV-2 diminish with age
First Author: Bates, Timothy A
Reviewed: Aug 22, 2022
|
Bates, Timothy A
|
Aug 22, 2022
|
|
Brain imaging and neuropsychological assessment of individuals recovered from mild COVID-19
First Author: Petersen, Marvin
Reviewed: Aug 22, 2022
|
Petersen, Marvin
|
Aug 22, 2022
|
|
COVID-19 plasma exosomes promote pro-inflammatory immune responses in peripheral blood mononuclear cells
First Author: Chen, Lechuang
Reviewed: Aug 22, 2022
|
Chen, Lechuang
|
Aug 22, 2022
|
|
Dynamics of SARS-CoV-2 VOC neutralization and novel mAb reveal protection against Omicron
First Author: Hao, Linhui
Reviewed: Aug 22, 2022
|
Hao, Linhui
|
Aug 22, 2022
|
|
Long COVID at Low and High Altitude: A Countrywide Epidemiological Analysis of Self-Reported Long-Term Persisting Symptoms in Ecuador
First Author: Juan S. Izquiero-Condoy
Reviewed: Aug 22, 2022
|
Juan S. Izquiero-Condoy
|
Aug 22, 2022
|
|
Maternal COVID-19 Vaccine May Reduce the Risk of MIS-C in Infants: A Narrative Review
First Author: Chetna Mangat
Reviewed: Aug 22, 2022
|
Chetna Mangat
|
Aug 22, 2022
|
|
Natural variations within the glycan shield of SARS-CoV-2 impact viral spike dynamics
First Author: Newby, Maddy L
Reviewed: Aug 22, 2022
|
Newby, Maddy L
|
Aug 22, 2022
|
|
QCovid 4 - Predicting risk of death or hospitalisation from COVID-19 in adults testing positive for SARS-CoV-2 infection during the Omicron wave in England
First Author: Hippisley Cox, Julia
Reviewed: Aug 22, 2022
|
Hippisley Cox, Julia
|
Aug 22, 2022
|
|
Risk Factors Associated with Post-Acute Sequelae of SARS-CoV-2 in an EHR Cohort: A National COVID Cohort Collaborative (N3C) Analysis as part of the NIH RECOVER program
First Author: Hill, Elaine
Reviewed: Aug 22, 2022
|
Hill, Elaine
|
Aug 22, 2022
|
|
Structural epitope profiling identifies antibodies associated with critical COVID-19 and long COVID
First Author: Kearns, Patrick K A
Reviewed: Aug 22, 2022
|
Kearns, Patrick K A
|
Aug 22, 2022
|
|
The COVID HOME study research protocol: Prospective cohort study of non-hospitalised COVID-19 patients
First Author: Tami, A
Reviewed: Aug 22, 2022
|
Tami, A
|
Aug 22, 2022
|
|
The effect of COVID-19 vaccination and booster on maternal-fetal outcomes: a retrospective multicenter cohort study
First Author: Piekos, Samantha N
Reviewed: Aug 22, 2022
|
Piekos, Samantha N
|
Aug 22, 2022
|
- Adults
- Pediatrics/Adolescents
|
Comparison of antibody responses to SARS-CoV-2 variants in Australian children
First Author: Toh, Zheng Quan
Reviewed: Aug 19, 2022
|
Toh, Zheng Quan
|
Aug 19, 2022
|
- Pediatrics/Adolescents
- Immunological
|
Covid-19 Vaccination and Mental Stress within Diverse Socio-demographic Groups
First Author: Wasiq Khan
Reviewed: Aug 19, 2022
|
Wasiq Khan
|
Aug 19, 2022
|
|
Evasion of Neutralizing Antibody Response by the SARS-CoV-2 BA.2.75 Variant
First Author: Qu, Panke
Reviewed: Aug 19, 2022
|
Qu, Panke
|
Aug 19, 2022
|
|
HLA-A*01:01 allele vanishing in COVID-19 patients population associated with non-structural epitope abundance in CD8+ T-cell repertoire
First Author: Shkurnikov, Maxim
Reviewed: Aug 19, 2022
|
Shkurnikov, Maxim
|
Aug 19, 2022
|
|
Individuals with recent prior SARS-CoV-2 infection are at reduced risk of Omicron infection and associated hospitalization
First Author: Nadig, Mihika
Reviewed: Aug 19, 2022
|
Nadig, Mihika
|
Aug 19, 2022
|
|
Memory B cell responses to Omicron subvariants after SARS-CoV-2 mRNA breakthrough infection
First Author: Wang, Zijun
Reviewed: Aug 19, 2022
|
Wang, Zijun
|
Aug 19, 2022
|
|
Safety and Immunogenicity of a Recombinant Protein RBD Fusion Heterodimer Vaccine against SARS-CoV-2: preliminary results of a phase 1-2a dose-escalating, randomized, double-blind clinical trial
First Author: Leal, Lorna
Reviewed: Aug 19, 2022
|
Leal, Lorna
|
Aug 19, 2022
|
|
The P681H mutation in the Spike glycoprotein escapes IFITM restriction and is necessary for type I interferon resistance in the SARS-CoV-2 alpha variant
First Author: Lista, Maria Jose
Reviewed: Aug 19, 2022
|
Lista, Maria Jose
|
Aug 19, 2022
|
|
A retrospective study of the safety and immunogenicity of MVC-COV1901 vaccine for people living with HIV
First Author: Cheng, Shu Hsing
Reviewed: Aug 18, 2022
|
Cheng, Shu Hsing
|
Aug 18, 2022
|
|
PrEP knowledge and HIV testing preferences among street-based female sex workers in the United States: Implications post-COVID-19
First Author: Bouey, Jennifer Z H
Reviewed: Aug 18, 2022
|
Bouey, Jennifer Z H
|
Aug 18, 2022
|
|
Rapid Detection of SARS-CoV-2 Variants by Molecular Clamping Technology Based RT-qPCR
First Author: Shen, Shuo
Reviewed: Aug 18, 2022
|
Shen, Shuo
|
Aug 18, 2022
|
|
Relative hypercoagulopathy of the SARS-CoV-2 Beta and Delta variants when compared to the less severe Omicron variants is related to TEG parameters, the extent of fibrin amyloid microclots, and the severity of clinical illness.
First Author: Grobbelaar, Lize M
Reviewed: Aug 18, 2022
|
Grobbelaar, Lize M
|
Aug 18, 2022
|
|
The change in pediatric subject symptoms during the COVID-19 pandemic in China
First Author: Tang, Yaqi
Reviewed: Aug 18, 2022
|
Tang, Yaqi
|
Aug 18, 2022
|
|
Time course of adverse reactions after BNT162b2 vaccination in healthy and allergic disease individuals aged 5–11 years: an observational and historical cohort study
First Author: Yoshida, Makoto
Reviewed: Aug 18, 2022
|
Yoshida, Makoto
|
Aug 18, 2022
|
|
A single-administration therapeutic interfering particle reduces SARS-CoV-2 viral shedding and pathogenesis in hamsters
First Author: Chaturvedi, Sonali
Reviewed: Aug 17, 2022
|
Chaturvedi, Sonali
|
Aug 17, 2022
|
|
Adjusted booster schedules disperse age-dependent differences in antibody titers benefitting risk populations
First Author: Muller, Lisa
Reviewed: Aug 16, 2022
|
Muller, Lisa
|
Aug 16, 2022
|
|
Anakinra in hospitalized COVID-19 patients guided by baseline soluble urokinase plasminogen receptor plasma levels: a real world, retrospective cohort study
First Author: Segala, Francesco Vladimiro
Reviewed: Aug 16, 2022
|
Segala, Francesco Vladimiro
|
Aug 16, 2022
|
|
Analysis of differences in lymphocyte subsets and CD4+ T cells immune activation between re-detectable positive and non-re-detectable positive COVID-19 convalescent patients
First Author: Huang, Zhimin
Reviewed: Aug 16, 2022
|
Huang, Zhimin
|
Aug 16, 2022
|
|
Antibody feedback regulation of memory B cell development in SARS-CoV-2 mRNA vaccination
First Author: Schaefer Babajew, Dennis
Reviewed: Aug 16, 2022
|
Schaefer Babajew, Dennis
|
Aug 16, 2022
|
|
BRIEF REPORT: Impact of age and SARS-CoV-2 breakthrough infection on humoral immune responses after three doses of COVID-19 mRNA vaccine
First Author: Mwimanzi, Francis
Reviewed: Aug 16, 2022
|
Mwimanzi, Francis
|
Aug 16, 2022
|
|
Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccine
First Author: Deliyannis, Georgia
Reviewed: Aug 16, 2022
|
Deliyannis, Georgia
|
Aug 16, 2022
|
|
Clinical effectiveness of SARS-CoV-2 booster vaccine against Omicron infection in residents and staff of Long-Term Care Facilities: a prospective cohort study (VIVALDI)
First Author: Stirrup, Oliver
Reviewed: Aug 16, 2022
|
Stirrup, Oliver
|
Aug 16, 2022
|
|
Distinguishing features of Long COVID identified through immune profiling
First Author: Klein, Jon
Reviewed: Aug 16, 2022
|
Klein, Jon
|
Aug 16, 2022
|
|
Estimating COVID-19 Vaccine Efficacy via Dynamic Epidemiological Models–A Study of Ten Countries
First Author: Zhu, Yuru
Reviewed: Aug 16, 2022
|
Zhu, Yuru
|
Aug 16, 2022
|
|
Function and Cryo-EM structures of broadly potent bispecific antibodies against multiple SARS-CoV-2 Omicron sublineages
First Author: Ren, Ping
Reviewed: Aug 16, 2022
|
Ren, Ping
|
Aug 16, 2022
|
|
Genomic Benefits and Potential Harms of COVID-19 Vaccines Indicated from High-Performance Genomic Biomarkers
First Author: Zhang, Zhengjun
Reviewed: Aug 16, 2022
|
Zhang, Zhengjun
|
Aug 16, 2022
|
|
Humoral immune responses remain quantitatively impaired but improve qualitatively in anti-CD20 treated patients with multiple sclerosis after three or four COVID-19 vaccinations
First Author: Otto, Carolin
Reviewed: Aug 16, 2022
|
Otto, Carolin
|
Aug 16, 2022
|
|
Immunogenicity of an additional mRNA-1273 SARS-CoV-2 vaccination in people living with HIV with hyporesponse after primary vaccination
First Author: Jongkees, Marlou J
Reviewed: Aug 16, 2022
|
Jongkees, Marlou J
|
Aug 16, 2022
|
|
Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave
First Author: Tan, Sophia T
Reviewed: Aug 16, 2022
|
Tan, Sophia T
|
Aug 16, 2022
|
|
Long-Term Care Workers’ Experiences and Their Views About Support During the COVID-19 Pandemic: A Scoping Review
First Author: Sheila A. Boamah
Reviewed: Aug 16, 2022
|
Sheila A. Boamah
|
Aug 16, 2022
|
|
Metabolomic and gut microbiome profiles across the spectrum of community-based COVID and non-COVID disease: A COVID-19 Biobank study
First Author: Osterdahl, Marc F
Reviewed: Aug 16, 2022
|
Osterdahl, Marc F
|
Aug 16, 2022
|
|
Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the pre-hairpin intermediate of the spike protein
First Author: Yang, Kailu
Reviewed: Aug 16, 2022
|
Yang, Kailu
|
Aug 16, 2022
|
|
Outcome of COVID-19 in hospitalised immunocompromised patients: an analysis of the WHO ISARIC CCP-UK prospective cohort study
First Author: Turtle, Lance
Reviewed: Aug 16, 2022
|
Turtle, Lance
|
Aug 16, 2022
|
|
Persistent Presence of Spike protein and Viral RNA in the Circulation of Individuals with Post-Acute Sequelae of COVID-19
First Author: Craddock, Vaughn
Reviewed: Aug 16, 2022
|
Craddock, Vaughn
|
Aug 16, 2022
|
|
Post-acute sequelae of SARS-CoV-2 (PASC) impact quality of life at 6, 12 and 18 months post-infection
First Author: Demko, Zoe O
Reviewed: Aug 16, 2022
|
Demko, Zoe O
|
Aug 16, 2022
|
|
Quantifying the impact of delaying the second COVID-19 vaccine dose in England: a mathematical modelling study
First Author: Imai, Natsuko
Reviewed: Aug 16, 2022
|
Imai, Natsuko
|
Aug 16, 2022
|
|
Safety and Immunogenicity of Intradermal Administration of Fractional Dose CoronaVac®, ChAdOx1 nCoV-19 and BNT162b2 as Primary Series Vaccination
First Author: Chatsiricharoenkul, Somruedee
Reviewed: Aug 16, 2022
|
Chatsiricharoenkul, Somruedee
|
Aug 16, 2022
|
|
Spike-specific CXCR3+ TFH cells play a dominant functional role in supporting antibody responses in SARS-CoV-2 infection and vaccination
First Author: Zhang, Jian
Reviewed: Aug 16, 2022
|
Zhang, Jian
|
Aug 16, 2022
|
|
Twice evasions of Omicron variants explain the temporal patterns in six Asia and Oceania countries
First Author: Chen, Boqiang
Reviewed: Aug 16, 2022
|
Chen, Boqiang
|
Aug 16, 2022
|
|
Waning of humoral immunity and affecting factors after BNT162b2 vaccination: a cohort study with latent growth curve model in Fukushima
First Author: Kobashi, Yurie
Reviewed: Aug 16, 2022
|
Kobashi, Yurie
|
Aug 16, 2022
|
|
An Effective mRNA-LNP Vaccine Against the Lethal Plague Bacterium
First Author: Kon, Edo
Reviewed: Aug 15, 2022
|
Kon, Edo
|
Aug 15, 2022
|
|
Assessing Covid 19 Vaccine Side Effects among Syrian Private University Staff and Students
First Author: Othman, Kassem
Reviewed: Aug 15, 2022
|
Othman, Kassem
|
Aug 15, 2022
|
|
Attitude towards COVID-19 vaccination among healthcare workers: A cross-sectional study from Egypt
First Author: Tharwat, Samar
Reviewed: Aug 15, 2022
|
Tharwat, Samar
|
Aug 15, 2022
|
|
Differential immune response induced by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial
First Author: Galvez, Nicolas Ms
Reviewed: Aug 15, 2022
|
Galvez, Nicolas Ms
|
Aug 15, 2022
|
|
Early Side Effects after Administration of the 1st Dose of Oxford-AstraZeneca Vaccine
First Author: Singh, Pramod
Reviewed: Aug 15, 2022
|
Singh, Pramod
|
Aug 15, 2022
|
|
Healthcare resilience - A meta-narrative systematic review and synthesis
First Author: Tan, Mark Zy
Reviewed: Aug 15, 2022
|
Tan, Mark Zy
|
Aug 15, 2022
|
|
Heterologous vaccination as a strategy to minimize inequity in COVID-19 vaccine access: A modeling study in Thailand
First Author: Anupong, Suparinthon
Reviewed: Aug 15, 2022
|
Anupong, Suparinthon
|
Aug 15, 2022
|
|
Human immune and gut microbial parameters associated with inter-individual variations in COVID-19 mRNA vaccine-induced immunity
First Author: Hirota, Masato
Reviewed: Aug 15, 2022
|
Hirota, Masato
|
Aug 15, 2022
|
|
Immune Response and Clinical Outcomes of BNT162b2 and mRNA1273 Fourth Dose COVID-19 Vaccines; Three Months Follow-up
First Author: Canetti, Michal
Reviewed: Aug 15, 2022
|
Canetti, Michal
|
Aug 15, 2022
|
- Adults
- Waning Over Time
- Immunological
|
mRNA vaccines and hybrid immunity use different B cell germlines to neutralize Omicron BA.4 and BA.5
First Author: Andreano, Emanuele
Reviewed: Aug 15, 2022
|
Andreano, Emanuele
|
Aug 15, 2022
|
|
Self-Managing Symptoms of Long COVID: an Education and Strategies Research Protocol
First Author: Green, Robin
Reviewed: Aug 15, 2022
|
Green, Robin
|
Aug 15, 2022
|
|
Severity Predictors of COVID-19 in SARS-CoV-2 Variant, Delta and Omicron Period; Single Center Study
First Author: Ogawa, Fumihiro
Reviewed: Aug 15, 2022
|
Ogawa, Fumihiro
|
Aug 15, 2022
|
|
The effect of Omicron breakthrough infection and extended BNT162b2 booster dosing on neutralization breadth against SARS-CoV-2 variants of concern
First Author: Graham, Carl
Reviewed: Aug 15, 2022
|
Graham, Carl
|
Aug 15, 2022
|
|
Virological characteristics of the SARS-CoV-2 Omicron BA.2.75
First Author: Saito, Akatsuki
Reviewed: Aug 15, 2022
|
Saito, Akatsuki
|
Aug 15, 2022
|
|
Within-host diversity of SARS-CoV-2 lineages and effect of vaccination
First Author: Poon, Leo
Reviewed: Aug 15, 2022
|
Poon, Leo
|
Aug 15, 2022
|
|
A Description of Experiences of Women and Significant others in Accessing Comprehensive Healthcare in the First 1000 Days of Life Post-conception During COVID-19 in Rural Uganda
First Author: Nakate, Mary Grace
Reviewed: Aug 12, 2022
|
Nakate, Mary Grace
|
Aug 12, 2022
|
|
Reinfection risk and vaccination effectiveness against Omicron
First Author: Du, Jiaxing
Reviewed: Aug 12, 2022
|
Du, Jiaxing
|
Aug 12, 2022
|
|
Systematic investigation of selected bio-molecules, potentially effective in inhibiting SARS-CoV-2/COVID-19 via in-silico analysis
First Author: Vanzara, Akash
Reviewed: Aug 12, 2022
|
Vanzara, Akash
|
Aug 12, 2022
|
|
Antibody response to variants during Omicron outbreak after BNT162b2 booster in Korean healthcare workers
First Author: Lim, Sung Hee
Reviewed: Aug 10, 2022
|
Lim, Sung Hee
|
Aug 10, 2022
|
|
A COVID-19 model incorporating variants, vaccination, waning immunity, and population behavior
First Author: La Joie, Zachary
Reviewed: Aug 9, 2022
|
La Joie, Zachary
|
Aug 9, 2022
|
|
Assessment of antibody responses against SARS-CoV-2 in unvaccinated individuals and vaccinees from Omicron-BA.2 infection in Zhaoqing, Guangdong Province, China
First Author: Zhang, Huan
Reviewed: Aug 9, 2022
|
Zhang, Huan
|
Aug 9, 2022
|
|
Cardiovascular Effects of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents
First Author: Suyanee Mansanguan
Reviewed: Aug 9, 2022
|
Suyanee Mansanguan
|
Aug 9, 2022
|
|
Design of a Novel Recombinant Protein Vaccine Based on BA.4 and BA.5 subvariants of SARS-CoV-2: An immunoinformatic and structural approach
First Author: Atapour, Amir
Reviewed: Aug 9, 2022
|
Atapour, Amir
|
Aug 9, 2022
|
|
A long interval between priming and boosting SARS-CoV-2 mRNA vaccine doses enhances B cell responses with limited impact on T cell immunity
First Author: Nicolas, Alexandre
Reviewed: Aug 8, 2022
|
Nicolas, Alexandre
|
Aug 8, 2022
|
|
An integrated epidemiologic and economic model to assess optimal COVID-19 pandemic policy
First Author: Szanyi, Joshua
Reviewed: Aug 8, 2022
|
Szanyi, Joshua
|
Aug 8, 2022
|
|
Antibody Response Following COVID-19 Boosters During the Omicron Wave in the United States: A Decentralized, Digital Health, Real-World Study
First Author: Doornek, Tosha
Reviewed: Aug 8, 2022
|
Doornek, Tosha
|
Aug 8, 2022
|
|
Antigen evolution from D614, to G614, to Delta, and to Omicron subtype of SARS-CoV-2
First Author: Zuo, Peijun
Reviewed: Aug 8, 2022
|
Zuo, Peijun
|
Aug 8, 2022
|
|
Association of SARS-CoV-2 BA.4/BA.5 Omicron lineages with immune escape and clinical outcome
First Author: Lewnard, Joseph A
Reviewed: Aug 8, 2022
|
Lewnard, Joseph A
|
Aug 8, 2022
|
|
cardiovascular safety of COVID-19 vaccines in real-world studies: a systematic review and meta-analysis
First Author: Chang, Yafei
Reviewed: Aug 8, 2022
|
Chang, Yafei
|
Aug 8, 2022
|
|
Cellular and humoral immunity towards parental SARS-CoV-2 and variants of concern after two doses of the NVX-CoV2373-vaccine in comparison to homologous BNT162b and mRNA1273 regimens
First Author: Hielscher, Franziska
Reviewed: Aug 8, 2022
|
Hielscher, Franziska
|
Aug 8, 2022
|
|
Changes in COVID-19-related mortality across key demographic and clinical subgroups: an observational cohort study using the OpenSAFELY platform on 18 million adults in England
First Author: The OpenSAFELY Collaborative
Reviewed: Aug 8, 2022
|
The OpenSAFELY Collaborative
|
Aug 8, 2022
|
|
COVID-19 convalescent plasma for the treatment of immunocompromised patients: a systematic review
First Author: Senefeld, Jonathon W
Reviewed: Aug 8, 2022
|
Senefeld, Jonathon W
|
Aug 8, 2022
|
|
Covid-19 Vaccination Efficacy, Reported Side Effects, and Hesitancy Among the Syrian Population
First Author: Najjar, Michel
Reviewed: Aug 8, 2022
|
Najjar, Michel
|
Aug 8, 2022
|
|
DNA Origami Presenting the Receptor Binding Domain of SARS-CoV-2 Elicit Robust Protective Immune Response
First Author: Oktay, Esra
Reviewed: Aug 8, 2022
|
Oktay, Esra
|
Aug 8, 2022
|
|
Double-dose mRNA vaccination to SARS-CoV-2 progressively increases recognition of variants-of-concern by Spike RBD-specific memory B cells
First Author: Hartley, Gemma E
Reviewed: Aug 8, 2022
|
Hartley, Gemma E
|
Aug 8, 2022
|
|
Epitranscriptomic N6-methyladenosine profile of SARS-CoV-2-infected human lung epithelial cells
First Author: Phillips, Stacia
Reviewed: Aug 8, 2022
|
Phillips, Stacia
|
Aug 8, 2022
|
|
Immunoinformatics and MD-simulation data suggest that Omicron spike epitopes are more interacting to IgG via better MHC class-II recognition than Delta variant.
First Author: Sarkar, Aniket
Reviewed: Aug 8, 2022
|
Sarkar, Aniket
|
Aug 8, 2022
|
|
Impact of age-structure and vaccine prioritization on COVID-19 in West Africa
First Author: Taboe, Hemaho B
Reviewed: Aug 8, 2022
|
Taboe, Hemaho B
|
Aug 8, 2022
|
|
InterClone: Store, Search and Cluster Adaptive Immune Receptor Repertoires
First Author: Wilamowski, Jan
Reviewed: Aug 8, 2022
|
Wilamowski, Jan
|
Aug 8, 2022
|
|
Longitudinal analyses after COVID-19 recovery or prolonged infection reveal unique immunological signatures after repeated vaccinations
First Author: Hisamatsu, Daisuke
Reviewed: Aug 8, 2022
|
Hisamatsu, Daisuke
|
Aug 8, 2022
|
|
Memory B cells and memory T cells induced by SARS-CoV-2 booster vaccination or infection show different dynamics and efficacy to the Omicron variant
First Author: Mise Omata, Setsuko
Reviewed: Aug 8, 2022
|
Mise Omata, Setsuko
|
Aug 8, 2022
|
|
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is common in post-acute sequelae of SARS-CoV-2 infection (PASC): Results from a post-COVID-19 multidisciplinary clinic
First Author: Bonilla, H
Reviewed: Aug 8, 2022
|
Bonilla, H
|
Aug 8, 2022
|
|
Neutralization sensitivity of the SARS-CoV-2 Omicron BA.2.75 sublineage
First Author: Gruell, Henning
Reviewed: Aug 8, 2022
|
Gruell, Henning
|
Aug 8, 2022
|
|
Omicron BA.2 breakthrough infection enhances cross-neutralization of BA.2.12.1 and BA.4/BA.5
First Author: Muik, Alexander
Reviewed: Aug 8, 2022
|
Muik, Alexander
|
Aug 8, 2022
|
|
Pangenome analysis of SARS-CoV2 strains to Identify Potential vaccine targets by Reverse Vaccinology
First Author: Haseeb, Muhammad
Reviewed: Aug 8, 2022
|
Haseeb, Muhammad
|
Aug 8, 2022
|
|
Phenotype-driven identification of drug targets for post-COVID-19 anosmia
First Author: Catterson, Victoria M
Reviewed: Aug 8, 2022
|
Catterson, Victoria M
|
Aug 8, 2022
|
|
Phenotypes and Functions of Dendritic Cells in SARS-CoV-2 Vaccine-derived Humoral Immunity
First Author: Cui, An
Reviewed: Aug 8, 2022
|
Cui, An
|
Aug 8, 2022
|
|
Real-world uptake of COVID-19 vaccination among individuals expressing vaccine hesitancy: a registry-linkage study
First Author: Andrejko, Kristin L
Reviewed: Aug 8, 2022
|
Andrejko, Kristin L
|
Aug 8, 2022
|
|
Safety and Tolerability Study of Sotrovimab (VIR-7831) Prophylaxis Against COVID-19 Infection in Immunocompromised Individuals with Impaired SARS-CoV-2 Humoral Immunity
First Author: Gonzalez Bocco, Isabel H
Reviewed: Aug 8, 2022
|
Gonzalez Bocco, Isabel H
|
Aug 8, 2022
|
|
SARS-CoV-2 BA.4/5 Spike recognition and neutralization elicited after the third dose of mRNA vaccine
First Author: Tauzin, Alexandra
Reviewed: Aug 8, 2022
|
Tauzin, Alexandra
|
Aug 8, 2022
|
|
Spatio-temporal characteristics of the SARS-CoV-2 Omicron variant spread at fine geographical scales, and comparison to earlier variants
First Author: Wood, A J
Reviewed: Aug 8, 2022
|
Wood, A J
|
Aug 8, 2022
|
|
The frequency of defective genomes in Omicron differs from that of the Alpha, Beta and Delta variants
First Author: Campos, Carolina
Reviewed: Aug 8, 2022
|
Campos, Carolina
|
Aug 8, 2022
|
|
The health impact of long COVID during the 2021-2022 Omicron wave in Australia: a quantitative burden of disease study
First Author: Howe, Samantha
Reviewed: Aug 8, 2022
|
Howe, Samantha
|
Aug 8, 2022
|
|
The speed of vaccination rollout and the risk of pathogen adaptation
First Author: Gandon, Sylvain
Reviewed: Aug 8, 2022
|
Gandon, Sylvain
|
Aug 8, 2022
|
|
Use of a Self-Care and Educational Mobile App to Improve Outcomes of Patients with Acute Decompensated Heart Failure during the COVID-19 Pandemic
First Author: Essa, Hani
Reviewed: Aug 8, 2022
|
Essa, Hani
|
Aug 8, 2022
|
|
Comparative effectiveness of BNT162b2 versus mRNA-1273 boosting in England: a cohort study in OpenSAFELY-TPP
First Author: Hulme, William J
Reviewed: Aug 4, 2022
|
Hulme, William J
|
Aug 4, 2022
|
|
COVID-19 vaccination responses with different vaccine platforms in patients with inborn errors of immunity
First Author: Erra, Lorenzo
Reviewed: Aug 4, 2022
|
Erra, Lorenzo
|
Aug 4, 2022
|
|
COVID-19 Vaccine Hesitancy Among Parents of Children Under Five Years in the United States
First Author: Celia B. Fisher
Reviewed: Aug 4, 2022
|
Celia B. Fisher
|
Aug 4, 2022
|
|
Evaluation of the safety and immunogenicity of fractional intradermal COVID-19 vaccines as a booster: A pilot study
First Author: Niyomnaitham, Suvimol
Reviewed: Aug 4, 2022
|
Niyomnaitham, Suvimol
|
Aug 4, 2022
|
|
Evolution of SARS-CoV-2 Shedding in Exhaled Breath Aerosols
First Author: Lai, Jianyu
Reviewed: Aug 4, 2022
|
Lai, Jianyu
|
Aug 4, 2022
|
|
Induction of poxviral immunity by synthetic MVA-based dual-antigen COVID-19 vaccine COH04S1
First Author: Chiuppesi, Flavia
Reviewed: Aug 4, 2022
|
Chiuppesi, Flavia
|
Aug 4, 2022
|
|
Multifractal cross-correlations of bitcoin and ether trading
characteristics in the post-COVID-19 time
First Author: Watorek, Marcin
Reviewed: Aug 4, 2022
|
Watorek, Marcin
|
Aug 4, 2022
|
|
Neutralization of SARS-CoV-2 Omicron sublineages by 4 doses of mRNA vaccine
First Author: Xie, Xuping
Reviewed: Aug 4, 2022
|
Xie, Xuping
|
Aug 4, 2022
|
|
SARS-CoV-2 infection is associated with anti-desmoglein 2 autoantibody detection
First Author: Ward, Kerensa E
Reviewed: Aug 4, 2022
|
Ward, Kerensa E
|
Aug 4, 2022
|
|
Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA.2 wave in Geneva, Switzerland
First Author: Zaballa, Maria Eugenia
Reviewed: Aug 4, 2022
|
Zaballa, Maria Eugenia
|
Aug 4, 2022
|
|
Technology-Enabled Virtual Ward for COVID Management of the Elderly and Immunocompromised in Singapore: A Descriptive Cohort
First Author: Ko, Stephanie Q
Reviewed: Aug 4, 2022
|
Ko, Stephanie Q
|
Aug 4, 2022
|
|
The association between dysnatraemia during hospitalisation and post COVID-19 mental fatigue
First Author: Salvato, Gerardo
Reviewed: Aug 4, 2022
|
Salvato, Gerardo
|
Aug 4, 2022
|
|
The COVID-19 pandemic impact on continuity of care provision on rare brain diseases and on Ataxia, Dystonia and PKU. A scoping review protocol
First Author: Cannizzo, Sara
Reviewed: Aug 4, 2022
|
Cannizzo, Sara
|
Aug 4, 2022
|
|
Antibody Persistence and Safety through 6 Months after Heterologous Orally Aerosolised Ad5-nCoV in individuals primed with two-dose CoronaVac previously
First Author: Jin, Lairun
Reviewed: Aug 3, 2022
|
Jin, Lairun
|
Aug 3, 2022
|
|
Correlates of protection for booster doses of the BNT162b2 vaccine
First Author: Hertz, Tomer
Reviewed: Aug 3, 2022
|
Hertz, Tomer
|
Aug 3, 2022
|
|
Correlation of post-vaccination fever with specific antibody response to SARS-CoV-2 BNT162b2 booster and no significant influence of antipyretic medication
First Author: Tani, Naoki
Reviewed: Aug 3, 2022
|
Tani, Naoki
|
Aug 3, 2022
|
|
Effect of Delta and Omicron mutations on the RBD-SD1 domain of the Spike protein in SARS-CoV-2 and the Omicron mutations on RBD-ACE2 interface complex
First Author: Ching, Wai Yim
Reviewed: Aug 3, 2022
|
Ching, Wai Yim
|
Aug 3, 2022
|
|
Effectiveness of the BNT162b2 vaccine against SARS-CoV-2 infection among children and adolescents in Qatar
First Author: Chemaitelly, Hiam
Reviewed: Aug 3, 2022
|
Chemaitelly, Hiam
|
Aug 3, 2022
|
|
Estimation of the Odds Ratio in Vaccinated Individuals and Determination of Vaccine Efficacy against Sars-Cov-2 Infection in Angola – Part I
First Author: Santland Sebastião Alberto De Lemos
Reviewed: Aug 3, 2022
|
Santland Sebastião Alberto De Lemos
|
Aug 3, 2022
|
- Adults
- Pediatrics/Adolescents
|
Frailty and Age Impact Immune Responses to Moderna COVID-19 mRNA Vaccine
First Author: Semelka, Charles T
Reviewed: Aug 3, 2022
|
Semelka, Charles T
|
Aug 3, 2022
|
|
Humoral response and safety of the BNT162b2 and mRNA-1273 COVID-19 vaccines in allogeneic hematopoietic stem cell transplant recipients: an observational study
First Author: Shimomura, Yoshimitsu
Reviewed: Aug 3, 2022
|
Shimomura, Yoshimitsu
|
Aug 3, 2022
|
|
Hybrid immunity at 6 months after SARS-CoV-2 exposure in individuals from the community treatment program
First Author: Chevaisrakul, Parawee
Reviewed: Aug 3, 2022
|
Chevaisrakul, Parawee
|
Aug 3, 2022
|
|
Molecular basis for antiviral activity of pediatric neutralizing antibodies targeting SARS-CoV-2 Spike receptor binding domain
First Author: Chen, Yaozong
Reviewed: Aug 3, 2022
|
Chen, Yaozong
|
Aug 3, 2022
|
|
Primary Omicron infection elicits weak antibody response but robust cellular immunity in children
First Author: Dowell, Alexander C
Reviewed: Aug 3, 2022
|
Dowell, Alexander C
|
Aug 3, 2022
|
|
Reduced quality of life, more technical challenges, and less study motivation among paramedic students after one year of the COVID-19 pandemic – a survey study
First Author: Haikio, K
Reviewed: Aug 3, 2022
|
Haikio, K
|
Aug 3, 2022
|
|
Risk of BA.5 infection in individuals exposed to prior SARS-CoV-2 variants
First Author: Malato, Joao
Reviewed: Aug 3, 2022
|
Malato, Joao
|
Aug 3, 2022
|
|
Safety and Immunogenicity of SARS-Cov-2 Vaccine MVC-COV1901– Do Elderly Need a Higher Dose?
First Author: Lien, Chia En
Reviewed: Aug 3, 2022
|
Lien, Chia En
|
Aug 3, 2022
|
|
Comorbidity genetic risk and pathways impact SARS-CoV-2 infection outcomes
First Author: Jaros, Rachel
Reviewed: Jul 29, 2022
|
Jaros, Rachel
|
Jul 29, 2022
|
|
A distinct symptom pattern emerges for COVID-19 Long-Haul: A nationwide study
First Author: Downs, Charles A
Reviewed: Jul 28, 2022
|
Downs, Charles A
|
Jul 28, 2022
|
|
A Randomised -Controlled Phase 2 trial of Molnupiravir in Unvaccinated and Vaccinated Individuals with Early SARS-CoV-2
First Author: Khoo, Saye H
Reviewed: Jul 28, 2022
|
Khoo, Saye H
|
Jul 28, 2022
|
|
Active safety surveillance of COVID-19 mRNA vaccines in children aged 5-15 years in Australia
First Author: Wood, Nicholas
Reviewed: Jul 28, 2022
|
Wood, Nicholas
|
Jul 28, 2022
|
|
An Evaluation of the Safety and Immunogenicity of MVC-COV1901: Results of an interim analysis of a phase III, parallel group, randomized, double-blind, active-controlled study
First Author: Torales, Julio
Reviewed: Jul 28, 2022
|
Torales, Julio
|
Jul 28, 2022
|
|
Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without Omicron breakthrough infection
First Author: Planas, Delphine
Reviewed: Jul 28, 2022
|
Planas, Delphine
|
Jul 28, 2022
|
|
Effect of COVID-19 vaccine on long-COVID: A 2-year follow-up observational study from hospitals in north India
First Author: Budhiraja, Sandeep
Reviewed: Jul 28, 2022
|
Budhiraja, Sandeep
|
Jul 28, 2022
|
|
Evaluation of Seropositivity after Standard Doses of Vaccination against SARS-CoV-2 in Early Breast Cancer Patients Receiving Adjuvant Treatment
First Author: Kim, Jinyong
Reviewed: Jul 28, 2022
|
Kim, Jinyong
|
Jul 28, 2022
|
|
High titre neutralizing antibodies in response to SARS-CoV-2 infection require RBD-specific CD4 T cells that include proliferative memory cells
First Author: Phetsouphanh, Chansavath
Reviewed: Jul 28, 2022
|
Phetsouphanh, Chansavath
|
Jul 28, 2022
|
|
Immunogenicity of BNT162b2 mRNA-Based Vaccine against SARS-CoV-2 in People with Cystic Fibrosis
First Author: Gianfranco Alicandro
Reviewed: Jul 28, 2022
|
Gianfranco Alicandro
|
Jul 28, 2022
|
|
Impact of Pre-Existing Chronic Viral Infection and Reactivation on the Development of Long COVID
First Author: Peluso, Michael J
Reviewed: Jul 28, 2022
|
Peluso, Michael J
|
Jul 28, 2022
|
|
Intent among Parents to Vaccinate Children before Pediatric Vaccine Recommendations, Minnesota and Los Angeles County, California--May-September 2021
First Author: Kara A. Suvada
Reviewed: Jul 28, 2022
|
Kara A. Suvada
|
Jul 28, 2022
|
|
Predicting intention to vaccinate against COVID-19 in older Syrian refugees in Lebanon: findings from a multi-wave study
First Author: Salibi, Noura
Reviewed: Jul 28, 2022
|
Salibi, Noura
|
Jul 28, 2022
|
|
The Effect of SARS-COV-2 Variant on Respiratory Features and Mortality Among Vaccinated and Non-Fully Vaccinated Patients
First Author: Hughes, Thomas D
Reviewed: Jul 28, 2022
|
Hughes, Thomas D
|
Jul 28, 2022
|
|
The impact of cyclin-dependent kinases 4 and 6 inhibitors in the immune response to mRNA SARS-CoV-2 vaccine in women with breast cancer.
First Author: Saavedra, Cristina
Reviewed: Jul 28, 2022
|
Saavedra, Cristina
|
Jul 28, 2022
|
|
The Potential Clinical Impact of Implementing Different COVID-19 Boosters in Fall 2022 in the United States
First Author: Kohli, Michele A
Reviewed: Jul 28, 2022
|
Kohli, Michele A
|
Jul 28, 2022
|
|
A linear DNA vaccine candidate encoding the SARS-CoV-2 Receptor Binding Domain elicits protective immunity in domestic cats
First Author: Conforti, Antonella
Reviewed: Jul 27, 2022
|
Conforti, Antonella
|
Jul 27, 2022
|
|
Acute and preventive treatment of COVID-19 related headache: A series of 100 patients
First Author: Garcia Azorin, David
Reviewed: Jul 27, 2022
|
Garcia Azorin, David
|
Jul 27, 2022
|
|
Comparison the effects and side effects of Covid-19 vaccination in patients with inflammatory bowel disease (IBD); A systematic scoping review
First Author: Tabesh, Elham
Reviewed: Jul 27, 2022
|
Tabesh, Elham
|
Jul 27, 2022
|
|
Durability of the Neutralizing Antibody Response to mRNA Booster Vaccination Against SARS-CoV-2 BA.2.12.1 and BA.4/5 Variants
First Author: Qu, Panke
Reviewed: Jul 27, 2022
|
Qu, Panke
|
Jul 27, 2022
|
|
Effectiveness of BNT162b2 and CoronaVac in children and adolescents against SARS-CoV-2 infection during Omicron BA.2 wave in Hong Kong
First Author: Lau, Yu Lung
Reviewed: Jul 27, 2022
|
Lau, Yu Lung
|
Jul 27, 2022
|
|
Effectiveness of BNT162b2 mRNA COVID-19 third vaccines during pregnancy: A national observational study in Israel
First Author: Guedalia, Joshua
Reviewed: Jul 27, 2022
|
Guedalia, Joshua
|
Jul 27, 2022
|
|
Enhancing COVID Rehabilitation with Technology (ECORT): Protocol for an open-label, single site randomized controlled trial evaluating the effectiveness of electronic case management for individuals with persistent COVID-19 symptoms.
First Author: Hatcher, Simon
Reviewed: Jul 27, 2022
|
Hatcher, Simon
|
Jul 27, 2022
|
|
Evasion of neutralizing antibodies by Omicron sublineage BA.2.75
First Author: Sheward, Daniel J
Reviewed: Jul 27, 2022
|
Sheward, Daniel J
|
Jul 27, 2022
|
|
Generalizable Long COVID Subtypes: Findings from the NIH N3C and RECOVER Programs
First Author: Reese, Justin T
Reviewed: Jul 27, 2022
|
Reese, Justin T
|
Jul 27, 2022
|
|
Has COVID-19 pandemic worsened quality of life of patients with Inflammatory Bowel Disease? A longitudinal disease activity-controlled study
First Author: Rosa, Ilenia
Reviewed: Jul 27, 2022
|
Rosa, Ilenia
|
Jul 27, 2022
|
|
Learning from pre-pandemic data to forecast viral antibody escape
First Author: Thadani, Nicole N
Reviewed: Jul 27, 2022
|
Thadani, Nicole N
|
Jul 27, 2022
|
|
Mathematical assessment of the role of waning and boosting immunity against the BA.1 Omicron variant in the United States
First Author: Safdar, Salman
Reviewed: Jul 27, 2022
|
Safdar, Salman
|
Jul 27, 2022
|
|
Mental Health among Children with Long COVID during the COVID- 19 Pandemic
First Author: Shachar Lavie, Iris
Reviewed: Jul 27, 2022
|
Shachar Lavie, Iris
|
Jul 27, 2022
|
|
Molecular Mimicry between SARS-CoV-2 and Human Endocrinocytes: A Prerequisite of Post-COVID Endocrine Autoimmunity
First Author: Leonid P. Churilov
Reviewed: Jul 27, 2022
|
Leonid P. Churilov
|
Jul 27, 2022
|
|
Prevalence and Factors Associated with Mental Illness Symptoms among School Students Post Lockdown of the COVID-19 Pandemic in the United Arab Emirates: A Cross-Sectional National Study
First Author: Ghader, Nariman Ali
Reviewed: Jul 27, 2022
|
Ghader, Nariman Ali
|
Jul 27, 2022
|
|
Risk factors for severe COVID-19 among HIV-infected and-uninfected individuals in South Africa, April 2020- March 2022 – data from sentinel surveillance
First Author: Walaza, Sibongile
Reviewed: Jul 27, 2022
|
Walaza, Sibongile
|
Jul 27, 2022
|
|
Safety and biodistribution of Nanoligomers™ targeting SARS-CoV-2 genome for treatment of COVID-19
First Author: Mccollum, Colleen R
Reviewed: Jul 27, 2022
|
Mccollum, Colleen R
|
Jul 27, 2022
|
|
STIMULATE-ICP: A pragmatic, multi-centre, cluster randomised trial of an integrated care pathway with a nested, Phase III, open label, adaptive platform randomised drug trial in individuals with Long COVID: a structured protocol
First Author: Forshaw, Denise
Reviewed: Jul 27, 2022
|
Forshaw, Denise
|
Jul 27, 2022
|
|
Treatment of Long COVID with nirmatrelvir/ritonavir and tocilizumab in a patient with rheumatoid arthritis and SARS-CoV-2 antigen persistence: a case report
First Author: Visvabharathy, Lavanya
Reviewed: Jul 27, 2022
|
Visvabharathy, Lavanya
|
Jul 27, 2022
|
|
Development of long-covid, or prevalent complaints in general?
First Author: Magnusson, Karin
Reviewed: Jul 20, 2022
|
Magnusson, Karin
|
Jul 20, 2022
|
|
Immunogenicity and safety of the CoronaVac inactivated SARS-CoV-2 vaccine in people with underlying medical conditions in China: a retrospective study
First Author: Li, Chunmei
Reviewed: Jul 20, 2022
|
Li, Chunmei
|
Jul 20, 2022
|
|
Omicron SARS-CoV-2 Neutralization by Immunoglobulin Preparations Manufactured from Plasma Collected in the US and Europe
First Author: Farcet, Maria R
Reviewed: Jul 20, 2022
|
Farcet, Maria R
|
Jul 20, 2022
|
|
SARS-CoV-2 Antibody Responses to AZD1222 Vaccination in West Africa
First Author: Abdullahi, Adam
Reviewed: Jul 20, 2022
|
Abdullahi, Adam
|
Jul 20, 2022
|
|
The relationship between nosocomial infections and coronavirus disease 2019 in the neurosurgery unit: Clinical characteristics and outcome
First Author: Pan, Shuang Jun
Reviewed: Jul 20, 2022
|
Pan, Shuang Jun
|
Jul 20, 2022
|
|
Type 1 diabetes mellitus post-COVID-19: a trigger or a coincidence? A case report
First Author: Deen, Nashwan Zainal
Reviewed: Jul 20, 2022
|
Deen, Nashwan Zainal
|
Jul 20, 2022
|
|
An Immunostimulatory Glycolipid That Blocks SARS-CoV-2, RSV, and Influenza Infections In Vivo
First Author: Ho, David
Reviewed: Jul 19, 2022
|
Ho, David
|
Jul 19, 2022
|
|
Antibody responses 8-20 weeks after two doses of SARS-CoV-2 vaccine (CoronaVac) in hemodialysis patients: Results of a single center in northeast Turkey
First Author: Erdogdu, Halil Ibrahim
Reviewed: Jul 19, 2022
|
Erdogdu, Halil Ibrahim
|
Jul 19, 2022
|
|
Association of COVID-19 with Diabetes: A Systematic Review and Meta-Analysis
First Author: Ssentongo, Paddy
Reviewed: Jul 19, 2022
|
Ssentongo, Paddy
|
Jul 19, 2022
|
|
Comparison of the immunological and T-cell responses in vaccinated people positive and negative to SARS-CoV-2 employing FTIR spectroscopy
First Author: Mata Miranda, Monica M
Reviewed: Jul 19, 2022
|
Mata Miranda, Monica M
|
Jul 19, 2022
|
|
COVID-19 booster vaccine willingness among patients with chronic kidney disease in Taizhou, China
First Author: Chen, He Dan
Reviewed: Jul 19, 2022
|
Chen, He Dan
|
Jul 19, 2022
|
|
Defining post-acute COVID-19 syndrome (PACS) by an epigenetic biosignature in peripheral blood mononuclear cells
First Author: Nikesjo, Frida
Reviewed: Jul 19, 2022
|
Nikesjo, Frida
|
Jul 19, 2022
|
|
Designing a Conventional Two-dose mRNA Vaccine for Tuberculosis Comprised of Dormancy-associated Proteins, ESAT6 and a Vault- liposome Vector System
First Author: Kovacic, Dzenan
Reviewed: Jul 19, 2022
|
Kovacic, Dzenan
|
Jul 19, 2022
|
|
Enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants BA.4 and BA.5
First Author: Reuschl, Ann Kathrin
Reviewed: Jul 19, 2022
|
Reuschl, Ann Kathrin
|
Jul 19, 2022
|
|
Estimating immunity with mathematical models for SARS-CoV-2 after COVID-19 vaccination
First Author: Sato, Yasunori
Reviewed: Jul 19, 2022
|
Sato, Yasunori
|
Jul 19, 2022
|
|
Homologous or Heterologous COVID-19 Boosters Regimens Significantly Impact Sero-neutralization of SARS-CoV-2 Virus and Variants
First Author: Rome Buathong
Reviewed: Jul 19, 2022
|
Rome Buathong
|
Jul 19, 2022
|
|
Impact of Covid-19 on Gastrointestinal Cancer Surgery: A National Survey
First Author: Parray, Amir M
Reviewed: Jul 19, 2022
|
Parray, Amir M
|
Jul 19, 2022
|
|
Mild Facial Paresis in a recipient of Gam-COVID-Vac Vaccine: A Case Report.
First Author: Hamidabad, Negin Mahmoudi
Reviewed: Jul 19, 2022
|
Hamidabad, Negin Mahmoudi
|
Jul 19, 2022
|
|
Potential Benefit of Early Treatment with Sotrovimab in Patients With High Risk for Severe COVID-19 Carrying BA.2 Infection
First Author: Melania Degli Antoni
Reviewed: Jul 19, 2022
|
Melania Degli Antoni
|
Jul 19, 2022
|
|
SARS-CoV-2 S1 Protein Persistence in SARS-CoV-2 Negative Post-Vaccination Individuals with Long COVID/ PASC-Like Symptoms
First Author: Bruce
Reviewed: Jul 19, 2022
|
Bruce
|
Jul 19, 2022
|
|
Tuberculosis treatment adherence in the era of COVID-19
First Author: Lippincott, Christopher
Reviewed: Jul 19, 2022
|
Lippincott, Christopher
|
Jul 19, 2022
|
|
HEART rate variability biofeedback for LOng Covid symptoms (HEARTLOC): protocol for a feasibility study
First Author: Corrado, J
Reviewed: Jul 18, 2022
|
Corrado, J
|
Jul 18, 2022
|
|
A Bivalent Omicron-containing Booster Vaccine Against Covid-19
First Author: Chalkias, Spyros
Reviewed: Jul 11, 2022
|
Chalkias, Spyros
|
Jul 11, 2022
|
|
A cell-based, spike protein binding assay highlights differences in antibody neutralising capacity for SARS-CoV-2 variants
First Author: Harrison, Neale
Reviewed: Jul 11, 2022
|
Harrison, Neale
|
Jul 11, 2022
|
|
Anamnestic Humoral Correlates of Immunity Across SARS-CoV-2 Variants of Concern
First Author: Mcnamara, Ryan P
Reviewed: Jul 11, 2022
|
Mcnamara, Ryan P
|
Jul 11, 2022
|
|
Association between Bisphosphonate use and COVID-19 related outcomes: a retrospective cohort study
First Author: Thompson, Jeffrey
Reviewed: Jul 11, 2022
|
Thompson, Jeffrey
|
Jul 11, 2022
|
|
COVID-19 vaccine booster strategies in light of emerging viral variants: Frequency, timing, and target groups
First Author: Kelly, Sherrie L
Reviewed: Jul 11, 2022
|
Kelly, Sherrie L
|
Jul 11, 2022
|
|
COVID-19 vaccine breakthrough infections among fully vaccinated Health Care Workers in Lagos, Nigeria
First Author: Oladele, David A
Reviewed: Jul 11, 2022
|
Oladele, David A
|
Jul 11, 2022
|
|
Effect of hybrid immunity, school reopening, and the Omicron variant on trajectory of COVID-19 epidemic in India: A modelling study
First Author: Mozaffer, Farhina
Reviewed: Jul 11, 2022
|
Mozaffer, Farhina
|
Jul 11, 2022
|
|
Effectiveness of Subcutaneous Casirivimab and Imdevimab Relative to no COVID-19 Antibody Treatment Among Patients Diagnosed With COVID-19 in the Ambulatory Setting
First Author: Jalbert, Jessica J
Reviewed: Jul 11, 2022
|
Jalbert, Jessica J
|
Jul 11, 2022
|
|
Effectiveness of vaccination against SARS-CoV-2 Omicron variant infection, symptomatic disease, and hospitalisation: a systematic review and meta-analysis
First Author: Meggiolaro, Angela
Reviewed: Jul 11, 2022
|
Meggiolaro, Angela
|
Jul 11, 2022
|
|
Humanized antibody potently neutralizes all SARS-CoV-2 variants by a novel mechanism
First Author: Luo, Sai
Reviewed: Jul 11, 2022
|
Luo, Sai
|
Jul 11, 2022
|
|
Humoral Responses in the Omicron Era following Three-Dose SARS-CoV-2 Vaccine Series in Kidney Transplant Recipients
First Author: Mcevoy, Caitriona M
Reviewed: Jul 11, 2022
|
Mcevoy, Caitriona M
|
Jul 11, 2022
|
|
Immune Correlates Analysis of the PREVENT-19 COVID-19 Vaccine Efficacy Clinical Trial
First Author: Fong, Youyi
Reviewed: Jul 11, 2022
|
Fong, Youyi
|
Jul 11, 2022
|
|
Immunogenicity and safety of COVID-19 vaccine in lung cancer patients receiving anticancer treatment: A prospective multicenter cohort study
First Author: Nakashima, Kei
Reviewed: Jul 11, 2022
|
Nakashima, Kei
|
Jul 11, 2022
|
|
Improved SARS-CoV-2 neutralization of Delta and Omicron variants of concern after fourth vaccination in hemodialysis patients
First Author: Cheng, Cho Chin
Reviewed: Jul 11, 2022
|
Cheng, Cho Chin
|
Jul 11, 2022
|
|
In vivo virological efficacy of monoclonal antibodies and direct antiviral agents against the SARS-CoV-2 BA.1 and BA.2 Omicron sublineages
First Author: Mazzotta, V
Reviewed: Jul 11, 2022
|
Mazzotta, V
|
Jul 11, 2022
|
|
Kinetics of neutralising antibodies against Omicron variant in Vietnamese healthcare workers after primary immunisation with ChAdOx1-S and booster with BNT162b2
First Author: Chau, Nguyen Van Vinh
Reviewed: Jul 11, 2022
|
Chau, Nguyen Van Vinh
|
Jul 11, 2022
|
|
Long-term immune persistence induced by two-dose BBIBP-CorV vaccine with different intervals, and immunogenicity and safety of a homologous booster dose in high-risk occupational population Secondary Study Based on a Randomized Clinical Trial
First Author: Yao, Tian
Reviewed: Jul 11, 2022
|
Yao, Tian
|
Jul 11, 2022
|
|
Natural and hybrid immunity following four COVID-19 waves in a South African cohort
First Author: Zar, Heather J
Reviewed: Jul 11, 2022
|
Zar, Heather J
|
Jul 11, 2022
|
|
Naturally-acquired Immunity Dynamics against SARS-CoV-2 in Children and Adolescents
First Author: Patalon, Tal
Reviewed: Jul 11, 2022
|
Patalon, Tal
|
Jul 11, 2022
|
|
Pre-Omicron vaccine breakthrough infection induces superior cross-neutralization against SARS-CoV-2 Omicron BA.1 than primo infection
First Author: Silva, Eveline Santos Da
Reviewed: Jul 11, 2022
|
Silva, Eveline Santos Da
|
Jul 11, 2022
|
|
Probing the biophysical constraints of SARS-CoV-2 spike N-terminal domain using deep mutational scanning
First Author: Ouyang, Wenhao O
Reviewed: Jul 11, 2022
|
Ouyang, Wenhao O
|
Jul 11, 2022
|
|
SARS-CoV-2 breakthrough infection during the Delta-dominant epidemic and neutralizing antibodies against Omicron in comparison with the third dose of BNT162b2: a matched analysis
First Author: Yamamoto, Shohei
Reviewed: Jul 11, 2022
|
Yamamoto, Shohei
|
Jul 11, 2022
|
|
SARS-CoV-2 vaccine breakthrough by Omicron and Delta variants: comparative assessments with New York State genomic surveillance data
First Author: Keyel, Alexander C
Reviewed: Jul 11, 2022
|
Keyel, Alexander C
|
Jul 11, 2022
|
|
SEMA: Antigen B-cell conformational epitope prediction using deep transfer learning
First Author: Shashkova, Tatiana I
Reviewed: Jul 11, 2022
|
Shashkova, Tatiana I
|
Jul 11, 2022
|
|
A strong association between the VDR gene markers and SARS-CoV-2 variants
First Author: Mamurova, Begimai
Reviewed: Jul 7, 2022
|
Mamurova, Begimai
|
Jul 7, 2022
|
|
Factors associated with COVID-19 booster vaccine willingness among migrants from the Eastern Mediterranean living in Australia: a cross-sectional study
First Author: Allen, Keeley
Reviewed: Jul 7, 2022
|
Allen, Keeley
|
Jul 7, 2022
|
|
The impact of COVID-19 vaccination on renal function in patients with chronic kidney disease
First Author: Chuang, Tzung Fang
Reviewed: Jul 7, 2022
|
Chuang, Tzung Fang
|
Jul 7, 2022
|
|
B cell response six months after SARS-CoV-2 mRNA vaccination in people living with HIV under antiretroviral therapy
First Author: Polvere, Jacopo
Reviewed: Jul 6, 2022
|
Polvere, Jacopo
|
Jul 6, 2022
|
|
Chronic fatigue, depression and anxiety symptoms in Long COVID are strongly predicted by neuroimmune and neuro-oxidative pathways which are caused by the inflammation during acute infection
First Author: Al Hakeim, Hussein Kadhem
Reviewed: Jul 6, 2022
|
Al Hakeim, Hussein Kadhem
|
Jul 6, 2022
|
|
Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron, sublineages BA.1, BA.1.1, BA.2 and impact of mutational patterns in critically ill French patients with COVID-19
First Author: Fourati, Slim
Reviewed: Jul 6, 2022
|
Fourati, Slim
|
Jul 6, 2022
|
|
Comparison of the Safety and Immunogenicity of the BNT-162b2 Vaccine and the ChAdOx1 Vaccine for Solid Organ Transplant Recipients: A Prospective Study
First Author: Ajlan, Aziza A
Reviewed: Jul 6, 2022
|
Ajlan, Aziza A
|
Jul 6, 2022
|
|
COVID-19 vaccines breakthrough infection and adverse reactions in medical students: A nationwide survey in Iran
First Author: Allahgholipour, Amirreza
Reviewed: Jul 6, 2022
|
Allahgholipour, Amirreza
|
Jul 6, 2022
|
|
DIFFERENTIAL SARS-COV-2 ANTIGEN SPECIFICITY OF THE HUMORAL RESPONSE IN INACTIVATED VIRUS-VACCINATED, CONVALESCENT, AND BREAKTHROUGH SUBJECTS
First Author: Duarte, Luisa F
Reviewed: Jul 6, 2022
|
Duarte, Luisa F
|
Jul 6, 2022
|
|
Effectiveness of vaccines in preventing hospitalization due to COVID-19: A multicenter hospital-based case-control study, Germany, June 2021 to January 2022
First Author: Stoliaroff Pepin, Anna
Reviewed: Jul 6, 2022
|
Stoliaroff Pepin, Anna
|
Jul 6, 2022
|
|
Injection of Platelet Rich Plasma in the Olfactory Cleft for COVID-19 Patients with Persistent Olfactory Dysfunction: Description of the Technique
First Author: Jerome R Lechien
Reviewed: Jul 6, 2022
|
Jerome R Lechien
|
Jul 6, 2022
|
|
Priming conditions shape breadth of neutralizing antibody responses to sarbecoviruses
First Author: Jia, Janice
Reviewed: Jul 6, 2022
|
Jia, Janice
|
Jul 6, 2022
|
|
Protection from Omicron infection in residents of nursing and retirement homes in Ontario, Canada
First Author: Breznik, Jessica A
Reviewed: Jul 6, 2022
|
Breznik, Jessica A
|
Jul 6, 2022
|
|
Real World Evidence of Effectiveness of COVID-19 Vaccines and Anti SARS-CoV-2 Monoclonal Antibodies Against Post-Acute Sequelae of SARS-CoV-2 Infection
First Author: Tannous, Jonika
Reviewed: Jul 6, 2022
|
Tannous, Jonika
|
Jul 6, 2022
|
|
SARS-CoV-2 antibody seroprevalence in Togo, May-June 2021: a cross-sectional, nationally representative, age-stratified serosurvey
First Author: Konu, Yao Rodion
Reviewed: Jul 6, 2022
|
Konu, Yao Rodion
|
Jul 6, 2022
|
|
Severity of Omicron (B.1.1.529) and Delta (B.1.1.617.2) SARS-CoV-2 infection among hospitalised adults: a prospective cohort study
First Author: Hyams, Catherine
Reviewed: Jul 6, 2022
|
Hyams, Catherine
|
Jul 6, 2022
|
|
The decline of COVID-19 severity and lethality over two years of pandemic
First Author: Marziano, Valentina
Reviewed: Jul 6, 2022
|
Marziano, Valentina
|
Jul 6, 2022
|
|
Trapping virus-loaded aerosols using granular protein nanofibrils and iron oxyhydroxides nanoparticles
First Author: Armanious, Antonius
Reviewed: Jul 6, 2022
|
Armanious, Antonius
|
Jul 6, 2022
|
|
Acceptance of COVID-19 Booster in the adult population of Pakistan: A cross sectional study
First Author: Amjad, Fatima
Reviewed: Jul 4, 2022
|
Amjad, Fatima
|
Jul 4, 2022
|
|
Age-varying susceptibility to the Omicron variant (B.1.1.529) of SARS-CoV-2
First Author: Chun, June Young
Reviewed: Jul 4, 2022
|
Chun, June Young
|
Jul 4, 2022
|
|
BNT162b2 effectiveness against Delta & Omicron variants in teens by dosing interval and duration
First Author: Ionescu, Iulia G
Reviewed: Jul 4, 2022
|
Ionescu, Iulia G
|
Jul 4, 2022
|
|
Capturing the SARS-CoV-2 infection pyramid within the municipality of Rotterdam using longitudinal sewage surveillance
First Author: Graaf, Miranda De
Reviewed: Jul 4, 2022
|
Graaf, Miranda De
|
Jul 4, 2022
|
|
COVID-19 vaccination trends and side effects among Egyptian hemodialysis patients: a multicenter survey study
First Author: Nassar, Mohammed Kamal
Reviewed: Jul 4, 2022
|
Nassar, Mohammed Kamal
|
Jul 4, 2022
|
|
Effectiveness of heterologous 3rd and 4th dose COVID-19 vaccine schedules for SARS-CoV-2 infection during delta and omicron predominance in Thailand.
First Author: Chariyalertsak, Suwat
Reviewed: Jul 4, 2022
|
Chariyalertsak, Suwat
|
Jul 4, 2022
|
|
Efficacy of SARS-CoV-2 primary and booster vaccine doses in CAR-T recipients
First Author: Abid, Muhammad Bilal
Reviewed: Jul 4, 2022
|
Abid, Muhammad Bilal
|
Jul 4, 2022
|
|
Factors Associated with Receipt and Parental Intent for COVID-19 Vaccination of Children Ages 5–11 years
First Author: Santibanez, Tammy A
Reviewed: Jul 4, 2022
|
Santibanez, Tammy A
|
Jul 4, 2022
|
|
Humoral Immune Response to Inactivated COVID-19 Vaccination at the 3rd Month among People Living with HIV
First Author: Wu, Songjie
Reviewed: Jul 4, 2022
|
Wu, Songjie
|
Jul 4, 2022
|
|
Hybrid and vaccine-induced immunity against SARS-CoV-2 in MS patients on different disease-modifying therapies
First Author: Kister, Ilya
Reviewed: Jul 4, 2022
|
Kister, Ilya
|
Jul 4, 2022
|
|
Increasing SARS-CoV2 cases, hospitalizations and deaths among the vaccinated elderly populations during the Omicron (B.1.1.529) variant surge in UK
First Author: Emani, Venkata R
Reviewed: Jul 4, 2022
|
Emani, Venkata R
|
Jul 4, 2022
|
|
Modeling vaccine allocation and equity implications of COVID-19 containment strategies
First Author: Nakamoto, Ichiro
Reviewed: Jul 4, 2022
|
Nakamoto, Ichiro
|
Jul 4, 2022
|
|
Monoclonal Antibody Treatment of COVID-19 in a Pregnant Woman with Common Variable Immunodeficiency
First Author: Aberumand, Babak
Reviewed: Jul 4, 2022
|
Aberumand, Babak
|
Jul 4, 2022
|
|
Neutralizing monoclonal antibodies elicited by mosaic RBD nanoparticles bind conserved sarbecovirus epitopes
First Author: Fan, Chengcheng
Reviewed: Jul 4, 2022
|
Fan, Chengcheng
|
Jul 4, 2022
|
|
Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province, South Africa
First Author: Davies, Mary Ann
Reviewed: Jul 4, 2022
|
Davies, Mary Ann
|
Jul 4, 2022
|
|
Patients with Inflammatory Bowel Disease on anti-Tumor Necrosis Factor Therapy Might be Predisposed to SARS-CoV-2 Variants Infection Even after Receiving a Third mRNA Vaccine Dose
First Author: Paola López-Marte
Reviewed: Jul 4, 2022
|
Paola López-Marte
|
Jul 4, 2022
|
|
Points-Based Models for Predicting Severe Disease related to Covid-19 with the SARS-CoV-2 Omicron Variant
First Author: Shlomo, Yatir Ben
Reviewed: Jul 4, 2022
|
Shlomo, Yatir Ben
|
Jul 4, 2022
|
|
Post-Acute COVID-19 syndrome (PACS) right atrioventricular and vena cava thrombus on top of a myxoma. A Case report
First Author: Alrifae, Ghaliya Mohammed Hasan
Reviewed: Jul 4, 2022
|
Alrifae, Ghaliya Mohammed Hasan
|
Jul 4, 2022
|
|
Pre-existing immunity modulates responses to mRNA boosters
First Author: Dangi, Tanushree
Reviewed: Jul 4, 2022
|
Dangi, Tanushree
|
Jul 4, 2022
|
|
Protection against Omicron BA.2 reinfection conferred by primary Omicron or pre-Omicron infection with and without mRNA vaccination
First Author: Carazo, Sara
Reviewed: Jul 4, 2022
|
Carazo, Sara
|
Jul 4, 2022
|
|
SARS-CoV-2 breakthrough infections induce somatically hypermutated broadly neutralizing antibodies against heterologous variants
First Author: Xiong, Xiaoli
Reviewed: Jul 4, 2022
|
Xiong, Xiaoli
|
Jul 4, 2022
|
|
Strong correlations between the binding antibodies against wild type and neutralizing antibodies against omicron BA.1 and BA.2 variants of SARS-CoV-2 in individuals following booster (third dose) vaccination
First Author: Suntronwong, Nungruthai
Reviewed: Jul 4, 2022
|
Suntronwong, Nungruthai
|
Jul 4, 2022
|
|
The effects of vaccination on the disease severity and factors for viral clearance and hospitalization in Omicron-infected patients :A retrospective observational cohort study from recent regional outbreaks in China
First Author: Li, Hongru
Reviewed: Jul 4, 2022
|
Li, Hongru
|
Jul 4, 2022
|
|
Transition to Endemic: Acceptance of Additional COVID-19 Vaccine Doses Among Canadian Adults in A National Cross-Sectional Survey
First Author: Reifferscheid, Laura
Reviewed: Jul 4, 2022
|
Reifferscheid, Laura
|
Jul 4, 2022
|
|
Use of Chinese herbs to treat symptoms likely related to COVID-19: Survey analysis of licensed acupuncturists in the United States
First Author: Anderson, Belinda J
Reviewed: Jul 4, 2022
|
Anderson, Belinda J
|
Jul 4, 2022
|
|
Versatile live attenuated SARS-CoV-2 vaccine platform applicable to variants induces protective immunity
First Author: Yoshida, Akiho
Reviewed: Jul 4, 2022
|
Yoshida, Akiho
|
Jul 4, 2022
|
|
A Case Report: Multifocal Necrotizing Encephalitis and Myocarditis after BNT162b2 mRNA Vaccination against Covid-19
First Author: Michael Mörz
Reviewed: Jun 27, 2022
|
Michael Mörz
|
Jun 27, 2022
|
|
A flexible compartment model for simulation specific to COVID-19
First Author: Ohmori, Hiroo
Reviewed: Jun 27, 2022
|
Ohmori, Hiroo
|
Jun 27, 2022
|
|
A patient-centric characterization of systemic recovery from SARS-CoV-2 infection
First Author: Ruffieux, Helene
Reviewed: Jun 27, 2022
|
Ruffieux, Helene
|
Jun 27, 2022
|
|
Change in Effectiveness of Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 Outpatients During the Omicron Phase
First Author: Aggarwal, Neil R
Reviewed: Jun 27, 2022
|
Aggarwal, Neil R
|
Jun 27, 2022
|
|
Characterising patterns of COVID-19 and long COVID symptoms: Evidence from nine UK longitudinal studies
First Author: Bowyer, Ruth C E
Reviewed: Jun 27, 2022
|
Bowyer, Ruth C E
|
Jun 27, 2022
|
|
Cohort Profile: Longitudinal population-based study of COVID-19 in UK adults (COVIDENCE UK)
First Author: Holt, Hayley
Reviewed: Jun 27, 2022
|
Holt, Hayley
|
Jun 27, 2022
|
|
Deciphering inhibitory mechanism of coronavirus replication through host miRNAs-RNA-dependent RNA polymerase (RdRp) interactome
First Author: Morenikeji, Olanrewaju B
Reviewed: Jun 27, 2022
|
Morenikeji, Olanrewaju B
|
Jun 27, 2022
|
|
Evidence of Exhausted Lymphocytes after the Third anti-SARS-CoV-2 Vaccine Dose in Cancer Patients
First Author: Fuentes, Javier David Benitez
Reviewed: Jun 27, 2022
|
Fuentes, Javier David Benitez
|
Jun 27, 2022
|
|
Post-viral fatigue following SARS-CoV-2 infection during pregnancy: a longitudinal comparative study
First Author: Oliveira, Ana Maria Da Silva Sousa
Reviewed: Jun 27, 2022
|
Oliveira, Ana Maria Da Silva Sousa
|
Jun 27, 2022
|
|
Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: From the first wave to Omicron
First Author: Kawano, Yumeko
Reviewed: Jun 27, 2022
|
Kawano, Yumeko
|
Jun 27, 2022
|
|
The imaging and clinical characteristics of patients with immune breakthrough Omicron-variant infected patients, Tianjin China: Is the vaccine effective?
First Author: Chang, Junqi
Reviewed: Jun 27, 2022
|
Chang, Junqi
|
Jun 27, 2022
|
|
A pilot randomized controlled trial of supervised, at-home, self-administered transcutaneous auricular vagus nerve stimulation (taVNS) to manage long COVID symptoms
First Author: Badran, Bashar W
Reviewed: Jun 23, 2022
|
Badran, Bashar W
|
Jun 23, 2022
|
|
Association between immunosuppressants and antibody responses to SARS-CoV-2 vaccines in patients with autoimmune liver diseases
First Author: Li, Hu
Reviewed: Jun 23, 2022
|
Li, Hu
|
Jun 23, 2022
|
|
Effect of age and prior COVID-19 on BBIBP-CorV (Sinopharm) vaccination- induced antibody responses in a region with high seroprevalence
First Author: Hasan, Zahra
Reviewed: Jun 23, 2022
|
Hasan, Zahra
|
Jun 23, 2022
|
|
Evaluation of a novel fully automated and ELISA- based assays for detecting anti- SARS- CoV-2 neutralizing antibodies
First Author: Zedan, Hadeel T
Reviewed: Jun 23, 2022
|
Zedan, Hadeel T
|
Jun 23, 2022
|
|
Immunogenicity following two doses of BBIBP-CorV vaccine and a third booster dose with viral vector and Mrna COVID-19 vaccines against delta and omicron variants in prime immunized adults with two doses of BBIBP-CorV vaccine
First Author: Chansaenroj, Jira
Reviewed: Jun 23, 2022
|
Chansaenroj, Jira
|
Jun 23, 2022
|
|
Predicting SARS-CoV-2 variant spread in a completely seropositive population using semi-quantitative antibody measurements in blood donors
First Author: Buss, Lewis F
Reviewed: Jun 23, 2022
|
Buss, Lewis F
|
Jun 23, 2022
|
|
The prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-up
First Author: Adriaenssens, Niels
Reviewed: Jun 23, 2022
|
Adriaenssens, Niels
|
Jun 23, 2022
|
|
A Systematic Review on COVID-19 Vaccine preferences using Discrete Choice Experiments
First Author: Amani, Adidja
Reviewed: Jun 22, 2022
|
Amani, Adidja
|
Jun 22, 2022
|
|
Cardiopulmonary exercise testing to evaluate post-acute sequelae of COVID-19 (“Long COVID”): a systematic review and meta-analysis
First Author: Durstenfeld, Matthew S
Reviewed: Jun 22, 2022
|
Durstenfeld, Matthew S
|
Jun 22, 2022
|
|
COVID-19 Vaccine Hesitancy and Confidence in the Philippines and Malaysia: A Cross-sectional Study of Sociodemographic Factors and Information-Seeking
First Author: Brackstone, K
Reviewed: Jun 22, 2022
|
Brackstone, K
|
Jun 22, 2022
|
|
Cycle threshold values in symptomatic COVID-19 cases in England
First Author: Funk, Sebastian
Reviewed: Jun 22, 2022
|
Funk, Sebastian
|
Jun 22, 2022
|
|
Effectiveness of mRNA COVID-19 vaccine boosters against infection, hospitalization and death: a target trial emulation in the omicron (B.1.1.529) variant era
First Author: Ioannou, George N
Reviewed: Jun 22, 2022
|
Ioannou, George N
|
Jun 22, 2022
|
|
Global estimates of the fitness advantage of SARS-CoV-2 variant Omicron
First Author: Dorp, Christiaan Van
Reviewed: Jun 22, 2022
|
Dorp, Christiaan Van
|
Jun 22, 2022
|
|
Knowledge, attitudes, practices and epidemiological profile of Muslim faithful receiving Covid-19 vaccines in Yaounde,Cameroon
First Author: Amani, Adidja
Reviewed: Jun 22, 2022
|
Amani, Adidja
|
Jun 22, 2022
|
|
Sensitivity of rapid antigen tests for COVID-19 during the Omicron variant outbreak
First Author: Murakami, Michio
Reviewed: Jun 22, 2022
|
Murakami, Michio
|
Jun 22, 2022
|
|
Titers and capacity of neutralizing antibodies against SARS-CoV-2 variants after heterologous booster vaccination in health care workers primed with two doses of ChAdOx1 nCov-19: a single-blinded, randomized clinical trial
First Author: Chuang, Chih Hsien
Reviewed: Jun 22, 2022
|
Chuang, Chih Hsien
|
Jun 22, 2022
|
|
Accelerated waning of the humoral response to SARS-CoV-2 vaccines in obesity
First Author: Klaauw, Agatha A Van Der
Reviewed: Jun 20, 2022
|
Klaauw, Agatha A Van Der
|
Jun 20, 2022
|
|
American Covid: An Econometric Analysis of Variants
First Author: Mcintosh, James
Reviewed: Jun 20, 2022
|
Mcintosh, James
|
Jun 20, 2022
|
|
An outbreak of SARS-CoV-2 among residents of a senior housing apartment building in Massachusetts
First Author: Selser, Victoria M
Reviewed: Jun 20, 2022
|
Selser, Victoria M
|
Jun 20, 2022
|
|
Assessing COVID-19 vaccination strategies in varied demographics using an individual-based model
First Author: Ben Zuk, Noam
Reviewed: Jun 20, 2022
|
Ben Zuk, Noam
|
Jun 20, 2022
|
|
Association of Lung Fibrotic Changes and Cardiological Dysfunction with Hypertension in Long COVID-19 cohort
First Author: Tauekelova, Ainur
Reviewed: Jun 20, 2022
|
Tauekelova, Ainur
|
Jun 20, 2022
|
|
Casirivimab and Imdevimab Treatment in Seropositive, Hospitalized COVID-19 Patients With Non-neutralizing or Borderline Neutralizing Antibodies
First Author: Hooper, Andrea T
Reviewed: Jun 20, 2022
|
Hooper, Andrea T
|
Jun 20, 2022
|
|
COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn (DMID 21-0004)
First Author: Munoz, Flor M
Reviewed: Jun 20, 2022
|
Munoz, Flor M
|
Jun 20, 2022
|
- Pediatrics/Adolescents
- Immunological
|
COVID-19 vaccination uptake and safety profile among germline BRCA1 and BRCA2 pathogenic variant carriers in Singapore
First Author: Zhang, Zewen
Reviewed: Jun 20, 2022
|
Zhang, Zewen
|
Jun 20, 2022
|
|
Effects of the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine on immune-related adverse events and disease outcomes in cancer patients receiving immune checkpoint inhibitors
First Author: Nelli, Fabrizio
Reviewed: Jun 20, 2022
|
Nelli, Fabrizio
|
Jun 20, 2022
|
|
Evaluation of anti-SARS-CoV-2 antibody response to COVID-19 vaccine deployment in the Bono Region, Ghana
First Author: Gyasi, Samuel Fosu
Reviewed: Jun 20, 2022
|
Gyasi, Samuel Fosu
|
Jun 20, 2022
|
|
Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapy
First Author: Sand, Ilana Katz
Reviewed: Jun 20, 2022
|
Sand, Ilana Katz
|
Jun 20, 2022
|
|
Glaucoma cases reported post-COVID-19 vaccination : A VAERS database analysis
First Author: Singh, Rohan Bir
Reviewed: Jun 20, 2022
|
Singh, Rohan Bir
|
Jun 20, 2022
|
|
HIV skews the SARS-CoV-2 B cell response toward an extrafollicular maturation pathway
First Author: Krause, Robert
Reviewed: Jun 20, 2022
|
Krause, Robert
|
Jun 20, 2022
|
|
Immunogenicity and safety of coadministration of COVID-19 and influenza vaccination among healthcare workers
First Author: Wagenhauser, Isabell
Reviewed: Jun 20, 2022
|
Wagenhauser, Isabell
|
Jun 20, 2022
|
|
Immunosuppression as a hub for SARS-CoV-2 mutational drift
First Author: Shapira, Guy
Reviewed: Jun 20, 2022
|
Shapira, Guy
|
Jun 20, 2022
|
|
Impaired Neutralization of SARS-CoV-2 Including Omicron Variants after COVID-19 mRNA Booster Immunization under Methotrexate Therapy
First Author: Habermann, Elisa
Reviewed: Jun 20, 2022
|
Habermann, Elisa
|
Jun 20, 2022
|
|
Neutralising antibodies predict protection from severe COVID-19
First Author: Cromer, Deborah
Reviewed: Jun 20, 2022
|
Cromer, Deborah
|
Jun 20, 2022
|
|
Optimized intramuscular immunization with VSV-vectored spike protein triggers a superior protective humoral immune response to SARS-CoV-2
First Author: Taddeo, Adriano
Reviewed: Jun 20, 2022
|
Taddeo, Adriano
|
Jun 20, 2022
|
|
Outcomes of SARS-CoV-2 Reinfection
First Author: Al Aly, Ziyad
Reviewed: Jun 20, 2022
|
Al Aly, Ziyad
|
Jun 20, 2022
|
|
Risk of myocarditis after two doses of COVID-19 mRNA vaccines in the US, 2020-2022: a self- controlled case series study
First Author: Lai, Daoyuan
Reviewed: Jun 20, 2022
|
Lai, Daoyuan
|
Jun 20, 2022
|
|
Stratifying elicited antibody dynamics after two doses of SARS-CoV-2 vaccine in a community-based cohort in Fukushima, Japan
First Author: Nakamura, Naotoshi
Reviewed: Jun 20, 2022
|
Nakamura, Naotoshi
|
Jun 20, 2022
|
|
Two ligand-binding sites on SARS-CoV-2 non-structural protein 1 revealed by fragment-based x-ray screening
First Author: Ma, Shumeng
Reviewed: Jun 20, 2022
|
Ma, Shumeng
|
Jun 20, 2022
|
|
Vaccine Effectiveness of Primary Series and Booster Doses against Omicron Variant COVID-19-Associated Hospitalization in the United States
First Author: Adams, Katherine
Reviewed: Jun 20, 2022
|
Adams, Katherine
|
Jun 20, 2022
|
|
SARS-CoV-2 infection of human brain microvascular endothelial cells leads to inflammatory activation through NF-κB non-canonical pathway and mitochondrial remodeling
First Author: Torices, Silvia
Reviewed: Jun 17, 2022
|
Torices, Silvia
|
Jun 17, 2022
|
|
A cross-sectional national investigation of COVID-19 outbreaks in nurseries during rapid spread of the Alpha (B.1.1.7) variant of SARS- CoV-2 in England
First Author: Aiano, Felicity
Reviewed: Jun 16, 2022
|
Aiano, Felicity
|
Jun 16, 2022
|
|
A high-throughput assay for identifying diverse antagonists of the binding interaction between the ACE2 receptor and the dynamic spike proteins of SARS-CoV-2
First Author: Sammons, Rachel
Reviewed: Jun 16, 2022
|
Sammons, Rachel
|
Jun 16, 2022
|
|
Acceptance, Hesitancy, and Refusal in anti-COVID-19 vaccination. A cluster analysis aiming at the typology behind these three concepts
First Author: Cristea, Darie
Reviewed: Jun 16, 2022
|
Cristea, Darie
|
Jun 16, 2022
|
|
ARF6 is an important host factor for SARS-CoV-2 infection in vitro
First Author: Mirabelli, C
Reviewed: Jun 16, 2022
|
Mirabelli, C
|
Jun 16, 2022
|
|
COVID-19 Vaccine Hesitancy Prospectively Predicts Booster Vaccination Side-effects Six Months Later: Implications of this Psychosomatic Nocebo Component
First Author: Hoffman, Yaakov S G
Reviewed: Jun 16, 2022
|
Hoffman, Yaakov S G
|
Jun 16, 2022
|
|
COVIDHunter: COVID-19 pandemic wave prediction and mitigation via
seasonality-aware modeling
First Author: Alser, Mohammed
Reviewed: Jun 16, 2022
|
Alser, Mohammed
|
Jun 16, 2022
|
|
Designing of multiple diagnostic primers for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) Omicron variant (B.1.1.529/BA)
First Author: Gupta, Amit Kumar
Reviewed: Jun 16, 2022
|
Gupta, Amit Kumar
|
Jun 16, 2022
|
|
Discovery of all-D-peptide inhibitors of SARS CoV 2 3C-like protease
First Author: Eberle, Raphael
Reviewed: Jun 16, 2022
|
Eberle, Raphael
|
Jun 16, 2022
|
|
Disruptions caused in Pakistan by the COVID-19 Pandemic and their Wireless Technology Based Solutions
First Author: Rafique, Ayesha
Reviewed: Jun 16, 2022
|
Rafique, Ayesha
|
Jun 16, 2022
|
|
Early-phase pandemic in Italy: Covid-19 spread determinant factors
First Author: Urso, Patrizia
Reviewed: Jun 16, 2022
|
Urso, Patrizia
|
Jun 16, 2022
|
|
Efficacy and safety of nitazoxanide in treating SARS-CoV-2 infection: A systematic review and meta-analysis of blinded, placebo- controlled, randomized clinical trials
First Author: Martins Filho, Paulo Ricardo
Reviewed: Jun 16, 2022
|
Martins Filho, Paulo Ricardo
|
Jun 16, 2022
|
|
Electrogenic Staphylococcus epidermidis colonizes nasal cavities and alleviates IL-6 progression induced by SARS-CoV-2 nucleocapsid phosphoprotein
First Author: Zayabaatar, Enkhbat
Reviewed: Jun 16, 2022
|
Zayabaatar, Enkhbat
|
Jun 16, 2022
|
|
Environmental circulation of adenovirus 40/41 and SARS-CoV-2 in the context of the emergence of acute hepatitis of unknown origin
First Author: Wollants, Elke
Reviewed: Jun 16, 2022
|
Wollants, Elke
|
Jun 16, 2022
|
|
Evolutionary trajectory of the physicochemical mechanism of interaction of SARS-CoV-2 spike protein with ACE2
First Author: Planchais, Cyril
Reviewed: Jun 16, 2022
|
Planchais, Cyril
|
Jun 16, 2022
|
|
Favipiravir and/or Nitazoxanide: a randomized, double-blind, 2x2 design, placebo-controlled trial of early therapy in COVID-19 (FANTAZE).
First Author: Smith, Tania A
Reviewed: Jun 16, 2022
|
Smith, Tania A
|
Jun 16, 2022
|
|
Hybrid immunity shifts the Fc-effector quality of SARS-CoV-2 mRNA vaccine-induced immunity
First Author: Bowman, Kathryn A
Reviewed: Jun 16, 2022
|
Bowman, Kathryn A
|
Jun 16, 2022
|
|
In silico studies of Mpro and PLpro from SARS-CoV-2 and a new class of Cephalosporin drugs containing 1,2,4-thiadiazole
First Author: Delgado, Cassia Pereira
Reviewed: Jun 16, 2022
|
Delgado, Cassia Pereira
|
Jun 16, 2022
|
|
Ivermectin for Treatment of Mild-to-Moderate COVID-19 in the Outpatient Setting: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial
First Author: Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)-6 Study Group
Reviewed: Jun 16, 2022
|
Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)-6 Study Group
|
Jun 16, 2022
|
|
Molecular dynamic simulation suggests stronger in-silico docking of Omicron spike on ACE2 than Wild but weaker than Delta SARS-CoV-2 variants can be blocked by engineered S1-RBD fraction
First Author: Santra, Dipannita
Reviewed: Jun 16, 2022
|
Santra, Dipannita
|
Jun 16, 2022
|
|
Motives for COVID-19 vaccine hesitancy amongst marginalized groups, including homeless persons and migrants, in France: a mixed-methods study.
First Author: Ducarroz, Simon
Reviewed: Jun 16, 2022
|
Ducarroz, Simon
|
Jun 16, 2022
|
|
Quality of life in the cirrhosis registry during the SARS-CoV-2 lockdown in Slovakia
First Author: Skladany, Lubomir
Reviewed: Jun 16, 2022
|
Skladany, Lubomir
|
Jun 16, 2022
|
|
Risk Factors for COVID-19 Mortality in Pediatric Populations: A Scoping Review
First Author: Wijaya, Jane Theophillia
Reviewed: Jun 16, 2022
|
Wijaya, Jane Theophillia
|
Jun 16, 2022
|
|
SARS-CoV-2 minor variant genomes at the start of the pandemic contained markers of VoCs
First Author: Dong, Xiaofeng
Reviewed: Jun 16, 2022
|
Dong, Xiaofeng
|
Jun 16, 2022
|
|
SARS-CoV-2 RdRp Follows Asynchronous Translocation Pathway for Viral Transcription and Replication
First Author: Wang, Xiaowei
Reviewed: Jun 16, 2022
|
Wang, Xiaowei
|
Jun 16, 2022
|
|
SARS-CoV-2 spike protein induces TLR-4-mediated long-term cognitive dysfunction recapitulating post-COVID syndrome
First Author: Fontes Dantas, Fabricia L
Reviewed: Jun 16, 2022
|
Fontes Dantas, Fabricia L
|
Jun 16, 2022
|
|
SARS-CoV-2 type I Interferon modulation by nonstructural proteins 1 and 2
First Author: Lacasse, Emile
Reviewed: Jun 16, 2022
|
Lacasse, Emile
|
Jun 16, 2022
|
|
Seroprevalence of SARS-CoV-2 and risk factors in Bantul Regency, Yogyakarta, Indonesia
First Author: Ahmad, Riris Andono
Reviewed: Jun 16, 2022
|
Ahmad, Riris Andono
|
Jun 16, 2022
|
|
The Fc-effector function of COVID-19 convalescent plasma contributes to SARS-CoV-2 treatment efficacy in mice
First Author: Ullah, Irfan
Reviewed: Jun 16, 2022
|
Ullah, Irfan
|
Jun 16, 2022
|
|
The pathway to the development and maintenance of PTSD among healthcare workers in the first five months of the Covid-19 pandemic in Ekiti State, Nigeria.
First Author: Yarseah, Dogbahgen Alphonso
Reviewed: Jun 16, 2022
|
Yarseah, Dogbahgen Alphonso
|
Jun 16, 2022
|
|
The Peruvian COVID-19 Immunization Program: lessons learned from a policy evaluation
First Author: Quispe, Antonio
Reviewed: Jun 16, 2022
|
Quispe, Antonio
|
Jun 16, 2022
|
|
Vaccination against SARS-CoV-2 and mortality in hemodialysis patients: three is good…
First Author: Yavuz, Demet
Reviewed: Jun 16, 2022
|
Yavuz, Demet
|
Jun 16, 2022
|
|
Ventilatory ratio and pre-ICU management delay as early predictors of mortality in invasively ventilated COVID-19-related ARDS patients. A retrospective observational cohort study.
First Author: Toumi, Radhouane
Reviewed: Jun 16, 2022
|
Toumi, Radhouane
|
Jun 16, 2022
|
|
What is the impact of COVID-19 pandemic era 2020 on JSSK-JANANI-SHISHU SURAKSHA KARYAKRAM (mother-child protection program) services utilization in India – A cross-sectional comparative research study?
First Author: Kumar, Piyush
Reviewed: Jun 16, 2022
|
Kumar, Piyush
|
Jun 16, 2022
|
|
A high-resolution melt curve toolkit to identify lineage-defining SARS-CoV-2 mutations
First Author: Fraser, Alice
Reviewed: Jun 15, 2022
|
Fraser, Alice
|
Jun 15, 2022
|
|
A study protocol for a double-blind randomised placebo-controlled trial evaluating the efficacy of carrageenan nasal and throat spray for COVID-19 prophylaxis � ICE COVID
First Author: Jessop, Zita
Reviewed: Jun 15, 2022
|
Jessop, Zita
|
Jun 15, 2022
|
|
A study protocol for a double-blind randomised placebo-controlled trial evaluating the efficacy of carrageenan nasal and throat spray for COVID-19 prophylaxis – ICE COVID
First Author: Jessop, Zita
Reviewed: Jun 15, 2022
|
Jessop, Zita
|
Jun 15, 2022
|
|
Multisystem inflammatory syndrome in adult with longitudinally extensive transverse myelitis following SARS-CoV-2 vaccination: Case report
First Author: Gupta, Anirban
Reviewed: Jun 15, 2022
|
Gupta, Anirban
|
Jun 15, 2022
|
|
Multisystem inflammatory syndrome in adult with longitudinally extensive transverse myelitis following SARS-CoV-2 vaccination:�Case report
First Author: Gupta, Anirban
Reviewed: Jun 15, 2022
|
Gupta, Anirban
|
Jun 15, 2022
|
|
Preclinical mouse studies of vector immunity and long-term responses to CORAVAX, a Rabies virus-vectored COVID-19 vaccine
First Author: Schnell, Matthias
Reviewed: Jun 15, 2022
|
Schnell, Matthias
|
Jun 15, 2022
|
|
Implementation of the eCDC/WHO Recommendation for Molecular Diagnosis of SARS-CoV-2 Omicron Subvariants and Its Challenges
First Author: Sin Hang Lee
Reviewed: Jun 14, 2022
|
Sin Hang Lee
|
Jun 14, 2022
|
|
When SARS CoV-2 meets thyroid - short-term and long-term patients’ outcomes
First Author: Zrilic, Anamarija
Reviewed: Jun 14, 2022
|
Zrilic, Anamarija
|
Jun 14, 2022
|
|
A cellular assay for spike/ACE2 fusion: quantification of fusion-inhibitory antibodies after COVID-19 and vaccination
First Author: Abdul, Fabien
Reviewed: Jun 13, 2022
|
Abdul, Fabien
|
Jun 13, 2022
|
|
Analysis and comparison of anti-RBD neutralizing antibodies from AZD-1222, Sputnik V, Sinopharm and Covaxin vaccines and its relationship with age and gender among health care workers
First Author: Zare, Hamed
Reviewed: Jun 13, 2022
|
Zare, Hamed
|
Jun 13, 2022
|
|
Development of an Escape-resistant SARS CoV-2 Neutralizing Synthetic Nanobody
First Author: Dormeshkin, Dmitri
Reviewed: Jun 13, 2022
|
Dormeshkin, Dmitri
|
Jun 13, 2022
|
|
Efficacy of Parainfluenza Virus 5 (PIV5)-vectored Intranasal COVID-19 Vaccine as a Single Dose Vaccine and as a Booster against SARS-CoV-2 Variants
First Author: Beavis, Ashley C
Reviewed: Jun 13, 2022
|
Beavis, Ashley C
|
Jun 13, 2022
|
|
Evolution of long-term hybrid immunity in healthcare workers after different COVID-19 vaccination regimens: a longitudinal observational cohort study
First Author: Moore, Shona C
Reviewed: Jun 13, 2022
|
Moore, Shona C
|
Jun 13, 2022
|
|
Investigating the causal inference of vaccine on COVID-19 disease propagation based on Bayesian approach
First Author: Ling, Lu
Reviewed: Jun 13, 2022
|
Ling, Lu
|
Jun 13, 2022
|
|
Neutralization of Omicron sublineages and Deltacron SARS-CoV-2 by 3 doses of BNT162b2 vaccine or BA.1 infection
First Author: Kurhade, Chaitanya
Reviewed: Jun 13, 2022
|
Kurhade, Chaitanya
|
Jun 13, 2022
|
|
Non-pharmacological therapies for post-viral syndromes, including Long COVID: A systematic review
First Author: Chandan, Joht Singh
Reviewed: Jun 13, 2022
|
Chandan, Joht Singh
|
Jun 13, 2022
|
|
Post-acute COVID-19 cognitive impairment and decline uniquely associate with kynurenine pathway activation: a longitudinal observational study
First Author: Cysique, Lucette A
Reviewed: Jun 13, 2022
|
Cysique, Lucette A
|
Jun 13, 2022
|
|
Safety of the fourth COVID-19 BNT162b2 mRNA (second booster) vaccine
First Author: Yechezkel, Matan
Reviewed: Jun 13, 2022
|
Yechezkel, Matan
|
Jun 13, 2022
|
|
SARS-CoV-2-neutralizing humoral IgA response occurs earlier but modest and diminishes faster compared to IgG response
First Author: Takamatsu, Yuki
Reviewed: Jun 13, 2022
|
Takamatsu, Yuki
|
Jun 13, 2022
|
|
Validity of self-testing at home with rapid SARS-CoV-2 antibody detection by lateral flow immunoassay
First Author: Atchison, Christina J
Reviewed: Jun 13, 2022
|
Atchison, Christina J
|
Jun 13, 2022
|
|
Development and application of an uncapped mRNA platform
First Author: Liu, Biao
Reviewed: Jun 10, 2022
|
Liu, Biao
|
Jun 10, 2022
|
|
Investigation of Anti-Epithelial-Mesenchymal Transition and Anti-Inflammation effects of Qing Fei Hua Xian Decotion on Pulmonary Fibrosis via Network Pharmacology and Experimental Verification
First Author: Yu, Chao Chao
Reviewed: Jun 10, 2022
|
Yu, Chao Chao
|
Jun 10, 2022
|
|
COVID-19 the Gateway for Future learning: The Impact of Online Teaching on the Future Learning Environment
First Author: Alharbi, Badr A
Reviewed: Jun 9, 2022
|
Alharbi, Badr A
|
Jun 9, 2022
|
|
Development of a Novel SARS-CoV-2 Immune Complex Vaccine Candidate (CRCx) with Broad Immune Responses: A Preclinical Trial in Animal Model.
First Author: Zayed, Khalid
Reviewed: Jun 9, 2022
|
Zayed, Khalid
|
Jun 9, 2022
|
|
The occurrence of hyperactivated platelets and fibrinaloid microclots in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
First Author: Nunes, Massimo
Reviewed: Jun 9, 2022
|
Nunes, Massimo
|
Jun 9, 2022
|
|
COVID-19 Endemic Plan: Impact of Vaccination and Non-pharmaceutical Interventions with Viral Variants and Waning Immunity Using an Agent-Based Simulation
First Author: Lee, Serin
Reviewed: Jun 8, 2022
|
Lee, Serin
|
Jun 8, 2022
|
|
Inhibiting Property of Phytoconstituents of ‘Aconitum Heterophyllum’ Against Omicron Variant of SARS-CoV-2: Molecular Docking, Molecular Dynamic and MM-GBSA approach
First Author: Lakhera, Shradha
Reviewed: Jun 8, 2022
|
Lakhera, Shradha
|
Jun 8, 2022
|
|
In-silico design of a multi-epitope recombinant vaccine against SARS-CoV-2 targeting the receptor-binding domain
First Author: Pande, Harshawardhan
Reviewed: Jun 8, 2022
|
Pande, Harshawardhan
|
Jun 8, 2022
|
|
Long COVID is associated with extensive in-vivo neuroinflammation on [18F]DPA-714 PET
First Author: Visser, Denise
Reviewed: Jun 8, 2022
|
Visser, Denise
|
Jun 8, 2022
|
|
Metagenomic assessment of gut microbial communities and risk of severe COVID-19
First Author: Lai, Peggy
Reviewed: Jun 8, 2022
|
Lai, Peggy
|
Jun 8, 2022
|
|
Preclinical Immunogenicity and Efficacy of a Multiple Antigen-Presenting System (Maps) Sars Cov-2 Vaccine
First Author: Cieslewicz Brian
Reviewed: Jun 8, 2022
|
Cieslewicz Brian
|
Jun 8, 2022
|
|
Protectivity of Covid-19 Vaccines and Its Relationship with Immune Response and Vaccination Strategy: a One-Year Cohort Study
First Author: Ferdi Tanir
Reviewed: Jun 8, 2022
|
Ferdi Tanir
|
Jun 8, 2022
|
|
A flexible, efficient, and scalable platform to produce circular RNAs as new therapeutics
First Author: Chen, Chuyun
Reviewed: Jun 7, 2022
|
Chen, Chuyun
|
Jun 7, 2022
|
|
An Environmentally Responsible Synthesis of the SARS-CoV-2 Mpro Inhibitor Nirmatrelvir (PF‑07321332), the Active Ingredient in Paxlovid
First Author: Kincaid, Joseph R A
Reviewed: Jun 7, 2022
|
Kincaid, Joseph R A
|
Jun 7, 2022
|
|
Antiviral immune responses, cellular metabolism and adhesion are differentially modulated by SARS-CoV-2 ORF7a or ORF7b
First Author: Garcia Garcia, Transito
Reviewed: Jun 7, 2022
|
Garcia Garcia, Transito
|
Jun 7, 2022
|
|
Applying machine-learning to rapidly analyse large qualitative text datasets to inform the COVID-19 pandemic response: Comparing human and machine-assisted topic analysis techniques
First Author: Towler, Lauren
Reviewed: Jun 7, 2022
|
Towler, Lauren
|
Jun 7, 2022
|
|
Artificial intelligence tool for the study of COVID-19 microdroplet spread across the human diameter and airborne space
First Author: Alsaadi, Hesham H
Reviewed: Jun 7, 2022
|
Alsaadi, Hesham H
|
Jun 7, 2022
|
|
Asymptotic analysis of optimal vaccination policies
First Author: Penn, Matthew J
Reviewed: Jun 7, 2022
|
Penn, Matthew J
|
Jun 7, 2022
|
|
Atomic-scale Quantum Chemical Calculation of Omicron Mutations Near Cleavage Sites of the Spike Protein
First Author: Adhikari, Puja
Reviewed: Jun 7, 2022
|
Adhikari, Puja
|
Jun 7, 2022
|
|
Characterization of entry pathways, species-specific ACE2 residues determining entry, and antibody neutralization evasion of Omicron BA.1, BA.1.1, BA.2, and BA.3 variants
First Author: Neerukonda, Sabari Nath
Reviewed: Jun 7, 2022
|
Neerukonda, Sabari Nath
|
Jun 7, 2022
|
|
Close kin influence COVID-19 precautionary behaviors and vaccine acceptance of older individuals
First Author: Arpino, Bruno
Reviewed: Jun 7, 2022
|
Arpino, Bruno
|
Jun 7, 2022
|
|
Comprehensive characterization of the transcriptional response to COVID-19 in multiple organs reveals shared signatures across tissues
First Author: The COVID Tissue Atlas Consortium
Reviewed: Jun 7, 2022
|
The COVID Tissue Atlas Consortium
|
Jun 7, 2022
|
|
COVID-19 is not an Independent Cause of Death
First Author: Castro, Marcia C
Reviewed: Jun 7, 2022
|
Castro, Marcia C
|
Jun 7, 2022
|
|
COVID-19 vaccination acceptance in underserved urban areas of Islamabad and Rawalpindi: Results from a cross-sectional survey
First Author: Kazmi, Twangar
Reviewed: Jun 7, 2022
|
Kazmi, Twangar
|
Jun 7, 2022
|
|
COVID-19 vaccine hesitancy and attitudes in Pakistan: A cross-sectional phone survey of major urban cities
First Author: Khan, Adnan Ahmad
Reviewed: Jun 7, 2022
|
Khan, Adnan Ahmad
|
Jun 7, 2022
|
|
Delays in COVID-19 Diagnosis and Hospitalization and Outcomes — New York City, New York, USA, October 2020–November 2021
First Author: Graf, Laura E
Reviewed: Jun 7, 2022
|
Graf, Laura E
|
Jun 7, 2022
|
|
Development and Validation of Multivariable Prediction Models of Serological Response to SARS-CoV-2 Vaccination in Kidney Transplant Recipients
First Author: Osmanodja, Bilgin
Reviewed: Jun 7, 2022
|
Osmanodja, Bilgin
|
Jun 7, 2022
|
|
Diagnostic accuracy of the Panbio™ COVID-19 Antigen rapid test device for SARS-CoV-2 detection in Kenya, 2021: A field evaluation
First Author: Karuga, Irungu
Reviewed: Jun 7, 2022
|
Karuga, Irungu
|
Jun 7, 2022
|
|
Discovery of host-directed modulators of virus infection by probing the SARS-CoV-2-host protein-protein interaction network
First Author: Ravindran, Vandana
Reviewed: Jun 7, 2022
|
Ravindran, Vandana
|
Jun 7, 2022
|
|
Distinct smell and taste disorder phenotype of post-acute COVID-19 sequelae
First Author: Rass, Verena
Reviewed: Jun 7, 2022
|
Rass, Verena
|
Jun 7, 2022
|
|
Do you take off your mask correctly?a survey study during large-scale COVID-19 nucleic acid detection in China
First Author: Ma, Jingjing
Reviewed: Jun 7, 2022
|
Ma, Jingjing
|
Jun 7, 2022
|
|
Does procalcitonin play a role as a predictor of in-hospital mortality among Covid-19 patients admitted to intensive care unit?
First Author: Zakeri, Anahita
Reviewed: Jun 7, 2022
|
Zakeri, Anahita
|
Jun 7, 2022
|
|
Electrical Impedance Tomography Imaging of Oxygen Therapy with High Flow Nasal Cannula in Patients with COVID-19 Acute Respiratory Distress Syndrome
First Author: Oner, Ozlem
Reviewed: Jun 7, 2022
|
Oner, Ozlem
|
Jun 7, 2022
|
|
English dictionaries, gold and silver standard corpora for biomedical
natural language processing related to SARS-CoV-2 and COVID-19
First Author: Rashed, Salma Kazemi
Reviewed: Jun 7, 2022
|
Rashed, Salma Kazemi
|
Jun 7, 2022
|
|
Exploring the challenges faced by Kurdish migrant workers during the Covid-19 pandemic
First Author: Khazaee Pool, Maryam
Reviewed: Jun 7, 2022
|
Khazaee Pool, Maryam
|
Jun 7, 2022
|
|
Factors Influencing COVID-19 Vaccination: A Case of Smallscale Farmers in Zambia’s Southern Province Practicing Climate-Smart Agricultural Technologies.
First Author: Somanje, Albert Novas
Reviewed: Jun 7, 2022
|
Somanje, Albert Novas
|
Jun 7, 2022
|
|
Global French Spine Surgery Activity: Executive Report of Demographics Data and Trends
First Author: Chapon, Renan
Reviewed: Jun 7, 2022
|
Chapon, Renan
|
Jun 7, 2022
|
|
Global research trends on diseases in the elderly population: a visualization analysis
First Author: Zhao, Lei
Reviewed: Jun 7, 2022
|
Zhao, Lei
|
Jun 7, 2022
|
|
Has the COVID-19 influenced the patient presentations and therapeutic options for urolithiasis?
First Author: Luo, Yijia
Reviewed: Jun 7, 2022
|
Luo, Yijia
|
Jun 7, 2022
|
|
Heterogeneous evolution of SARS-CoV-2 seroprevalence in school-age children: Results from the Ciao Corona study in November-December 2021 in the canton of Zurich
First Author: Haile, Sarah R
Reviewed: Jun 7, 2022
|
Haile, Sarah R
|
Jun 7, 2022
|
|
Homologous and heterologous boosting of the ChAdOx1-S1-S COVID-19 vaccine with the SCB-2019 vaccine candidate: a randomized, observer-blinded, controlled, phase 2 study
First Author: Clemens, Sue Ann Costa
Reviewed: Jun 7, 2022
|
Clemens, Sue Ann Costa
|
Jun 7, 2022
|
|
Immunity response against mild-to-moderate breakthrough COVID-19
First Author: Mongkolsucharitkul, Pichanun
Reviewed: Jun 7, 2022
|
Mongkolsucharitkul, Pichanun
|
Jun 7, 2022
|
|
Impact of the Pandemic: Screening for Social Risk Factors in the Intensive Care Unit
First Author: Ge, Derek
Reviewed: Jun 7, 2022
|
Ge, Derek
|
Jun 7, 2022
|
|
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
First Author: Young Jun Park
Reviewed: Jun 7, 2022
|
Young Jun Park
|
Jun 7, 2022
|
|
Incorporating Mass Vaccination into Compartment Models for Infectious Diseases
First Author: Ledder, Glenn
Reviewed: Jun 7, 2022
|
Ledder, Glenn
|
Jun 7, 2022
|
|
Indian Female Migrants Face Greater Barriers to Post-Covid Recovery than Males: Evidence from a Panel Study
First Author: Allard, Jenna
Reviewed: Jun 7, 2022
|
Allard, Jenna
|
Jun 7, 2022
|
|
Interactions between carbon nanotubes and external structures of SARS-CoV-2 using molecular docking and molecular dynamics
First Author: Lobato, Julio Cesar Mendes
Reviewed: Jun 7, 2022
|
Lobato, Julio Cesar Mendes
|
Jun 7, 2022
|
|
Interview survey on the role of occupational physicians in the workplace during the COVID-19 pandemic in Japan
First Author: Igarashi, Yu
Reviewed: Jun 7, 2022
|
Igarashi, Yu
|
Jun 7, 2022
|
|
Lineage BA.2 dominated the Omicron SARS-CoV-2 epidemic wave in the Philippines
First Author: Li, Yao Tsun
Reviewed: Jun 7, 2022
|
Li, Yao Tsun
|
Jun 7, 2022
|
|
Longitudinal profiles of plasma gelsolin, cytokines and antibody expression predict COVID-19 severity and hospitalization outcomes
First Author: Asare Werehene, Meshach
Reviewed: Jun 7, 2022
|
Asare Werehene, Meshach
|
Jun 7, 2022
|
|
Major amputation needed to treat purulent tenosynovitis and necrotizing fasciitis in a patient diagnosed with severe COVID-19: a case report
First Author: Toga, Akira
Reviewed: Jun 7, 2022
|
Toga, Akira
|
Jun 7, 2022
|
|
Meteorological Factors Facilitated Increased Legionnaires’ Disease Notifications and Mortality Pre-COVID-19 and COVID-19 in Hong Kong
First Author: Zhang, Yin
Reviewed: Jun 7, 2022
|
Zhang, Yin
|
Jun 7, 2022
|
|
Multilocular thymic cyst in a HIV positive adult man detected during COVID-19 treatment: A case report and literature review
First Author: Hatano, Hiroto
Reviewed: Jun 7, 2022
|
Hatano, Hiroto
|
Jun 7, 2022
|
|
On How, and Why, and When, We Grow Old
First Author: Citti, Luca
Reviewed: Jun 7, 2022
|
Citti, Luca
|
Jun 7, 2022
|
|
One Million and Counting: Estimates of Deaths in the United States from Ancestral SARS-CoV-2 and Variants
First Author: Walker, Jo
Reviewed: Jun 7, 2022
|
Walker, Jo
|
Jun 7, 2022
|
|
OpenSAFELY NHS Service Restoration Observatory 2: changes in primary care activity across six clinical areas during the COVID-19 pandemic
First Author: Curtis, Helen J
Reviewed: Jun 7, 2022
|
Curtis, Helen J
|
Jun 7, 2022
|
|
Oral Nirmatrelvir and Severe Covid-19 Outcomes During the Omicron Surge
First Author: Arbel, Ronen
Reviewed: Jun 7, 2022
|
Arbel, Ronen
|
Jun 7, 2022
|
|
OxoScan-MS: Oxonium ion scanning mass spectrometry facilitates plasma glycoproteomics in large scale
First Author: White, Matthew E H
Reviewed: Jun 7, 2022
|
White, Matthew E H
|
Jun 7, 2022
|
|
Perception of risk and compliance with COVID-19 safety guidelines among healthcare workers in Ghana: a cross-sectional study
First Author: Kayi, Esinam Afi
Reviewed: Jun 7, 2022
|
Kayi, Esinam Afi
|
Jun 7, 2022
|
|
Potent and pan-neutralization of SARS-CoV-2 variants of concern by DARPins
First Author: Chonira, Vikas
Reviewed: Jun 7, 2022
|
Chonira, Vikas
|
Jun 7, 2022
|
|
Potential inhibitors for blocking the interaction of the coronavirus SARS-CoV-2 spike protein and its host cell receptor ACE2
First Author: Li, Changzhi
Reviewed: Jun 7, 2022
|
Li, Changzhi
|
Jun 7, 2022
|
|
Pregnancy during COVID-19: social contact patterns and vaccine coverage of pregnant women from CoMix in 19 European countries
First Author: Wong, Kerry Lm
Reviewed: Jun 7, 2022
|
Wong, Kerry Lm
|
Jun 7, 2022
|
|
Proteomic analysis of cardiometabolic biomarkers and predictive modeling of severe outcomes in patients hospitalized with COVID-19
First Author: Schroeder, Philip
Reviewed: Jun 7, 2022
|
Schroeder, Philip
|
Jun 7, 2022
|
|
Psychometric Evaluation of the Fear of COVID-19 Scale Among Syrian Population
First Author: Khadour, Fater
Reviewed: Jun 7, 2022
|
Khadour, Fater
|
Jun 7, 2022
|
|
Response of Wastewater-Based Epidemiology Predictor for the Second Wave of COVID-19 in Ahmedabad, India: A Long-term Data Perspective
First Author: Kumar, Manish
Reviewed: Jun 7, 2022
|
Kumar, Manish
|
Jun 7, 2022
|
|
Safety and superior immunogenicity of heterologous boosting with an RBD-based SARS-CoV-2 mRNA vaccine in Chinese adults
First Author: Liu, Xiaoqiang
Reviewed: Jun 7, 2022
|
Liu, Xiaoqiang
|
Jun 7, 2022
|
|
SARS-COV-2 Delta and Omicron community transmission networks
First Author: Murray, John M
Reviewed: Jun 7, 2022
|
Murray, John M
|
Jun 7, 2022
|
|
SARS-CoV-2 genomic surveillance in Rwanda: Introductions and local transmission of the B.1.617.2 (Delta) variant of concern
First Author: Butera, Yvan
Reviewed: Jun 7, 2022
|
Butera, Yvan
|
Jun 7, 2022
|
|
SARS-CoV-2 Variant Spike and accessory gene mutations alter pathogenesis
First Author: Mcgrath, M E
Reviewed: Jun 7, 2022
|
Mcgrath, M E
|
Jun 7, 2022
|
|
Selection for immune evasion in SARS-CoV-2 revealed by high-resolution epitope mapping combined with genome sequence analysis
First Author: N Guessan, Arnaud
Reviewed: Jun 7, 2022
|
N Guessan, Arnaud
|
Jun 7, 2022
|
|
Severe acute respiratory syndrome coronavirus 2 breakthrough infections in healthcare workers vaccinees with BNT162b2 (Pfizer-BioNtech) in Bogotá, Colombia
First Author: Tavera Rodriguez, Pilar
Reviewed: Jun 7, 2022
|
Tavera Rodriguez, Pilar
|
Jun 7, 2022
|
|
Shared genetic etiology and causality between COVID-19 and venous thromboembolism: evidence from genome-wide cross trait analysis and bi-directional Mendelian randomization study
First Author: Huang, Xin
Reviewed: Jun 7, 2022
|
Huang, Xin
|
Jun 7, 2022
|
|
SNSMiner_COVAC: Analyzing COVID-19 vaccination for safety surveillance
First Author: Lee, Seunghee
Reviewed: Jun 7, 2022
|
Lee, Seunghee
|
Jun 7, 2022
|
|
Societal COVID-19 epidemic counter measures and activities associated with SARS-CoV-2 infection in an adult unvaccinated population – a case-control study in Denmark, June 2021
First Author: Munch, Pernille Kold
Reviewed: Jun 7, 2022
|
Munch, Pernille Kold
|
Jun 7, 2022
|
|
Structural basis of a two-antibody cocktail exhibiting highly potent and broadly neutralizing activities against SARS-CoV-2 variants including diverse Omicron sublineages
First Author: Li, Xiaoman
Reviewed: Jun 7, 2022
|
Li, Xiaoman
|
Jun 7, 2022
|
|
SUMOylation of SARS-CoV-2 Nucleocapsid protein enhances its interaction affinity and plays a critical role for its nuclear translocation
First Author: Madahar, Vipul
Reviewed: Jun 7, 2022
|
Madahar, Vipul
|
Jun 7, 2022
|
|
Symptom variation, correlations, and relationship to physical activity in Long Covid: intensive longitudinal study
First Author: Burton, Christopher
Reviewed: Jun 7, 2022
|
Burton, Christopher
|
Jun 7, 2022
|
|
Targeted reduction of airborne viral transmission risk in residential aged care
First Author: Brass, Amanda
Reviewed: Jun 7, 2022
|
Brass, Amanda
|
Jun 7, 2022
|
|
The cost of the COVID-19 pandemic vs the cost-effectiveness of mitigation strategies in the EU/UK/EEA and OECD countries: a systematic review
First Author: Vardavas, Constantine
Reviewed: Jun 7, 2022
|
Vardavas, Constantine
|
Jun 7, 2022
|
|
The Frequency and Patterns of Post-COVID-19 Vaccination Syndrome Reveal Initially Mild and Potentially Immunocytopenic Signs in Primarily Young Saudi Women
First Author: Kamaleldin B. Said
Reviewed: Jun 7, 2022
|
Kamaleldin B. Said
|
Jun 7, 2022
|
|
The impact of COVID-19 pandemic on influenza surveillance: a systematic review and meta-analysis
First Author: Sabeena, Sasidharanpillai
Reviewed: Jun 7, 2022
|
Sabeena, Sasidharanpillai
|
Jun 7, 2022
|
|
The interplay between the airway epithelium and tissue macrophages during the SARS-CoV-2 infection
First Author: Lenart, Marzena
Reviewed: Jun 7, 2022
|
Lenart, Marzena
|
Jun 7, 2022
|
|
The mediating role of fear of COVID-19 in the association between COVID-19-related work stressors and subjective well-being: cross-sectional evidence in the child care sector across three samples
First Author: Gritzka, Susan
Reviewed: Jun 7, 2022
|
Gritzka, Susan
|
Jun 7, 2022
|
|
The Nucleocapsid Protein Of SARS-CoV-2, Combined With ODN-39M, Is A Potential Component For An Intranasal Bivalent Pancorona Vaccine
First Author: Lobaina, Yadira
Reviewed: Jun 7, 2022
|
Lobaina, Yadira
|
Jun 7, 2022
|
|
The relationship between lung fibrosis, epidermal growth factor receptor and disease outcomes in Covid-19 pneumonia: A postmortem evaluation
First Author: Dulger, Seyhan Us
Reviewed: Jun 7, 2022
|
Dulger, Seyhan Us
|
Jun 7, 2022
|
|
The salivary and nasopharyngeal microbiomes are associated with SARS-CoV-2 infection and disease severity
First Author: Kim, Josh G
Reviewed: Jun 7, 2022
|
Kim, Josh G
|
Jun 7, 2022
|
|
The spread of infectious diseases from a physics perspective
First Author: Brabers, J H V J
Reviewed: Jun 7, 2022
|
Brabers, J H V J
|
Jun 7, 2022
|
|
Trends in SARS-CoV-2 infection prevalence during England’s roadmap out of lockdown, January to July 2021
First Author: Eales, Oliver
Reviewed: Jun 7, 2022
|
Eales, Oliver
|
Jun 7, 2022
|
|
U.S. CDC support to international SARS-CoV-2 seroprevalence surveys, May 2020–February 2022
First Author: Hamida, Amen Ben
Reviewed: Jun 7, 2022
|
Hamida, Amen Ben
|
Jun 7, 2022
|
|
Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha (B.1.1.7), Delta (B.1.617.2) or Omicron (B.1.1.529) dominance: A Danish nationwide study
First Author: Nielsen, Katrine Finderup
Reviewed: Jun 7, 2022
|
Nielsen, Katrine Finderup
|
Jun 7, 2022
|
|
Validation of a Deep Learning Model to aid in COVID-19 Detection from Digital Chest Radiographs
First Author: Ajmera, Pranav
Reviewed: Jun 7, 2022
|
Ajmera, Pranav
|
Jun 7, 2022
|
|
Viral Load Rebound in Placebo and Nirmatrelvir-Ritonavir Treated COVID-19 Patients is not Associated with Recurrence of Severe Disease or Mutations
First Author: Soares, Holly
Reviewed: Jun 7, 2022
|
Soares, Holly
|
Jun 7, 2022
|
|
Waning of two-dose BNT162b2 and mRNA-1273 vaccine effectiveness against symptomatic SARS-CoV-2 infection is robust to depletion-of-susceptibles bias
First Author: Andrejko, Kristin L
Reviewed: Jun 7, 2022
|
Andrejko, Kristin L
|
Jun 7, 2022
|
|
Whole Genome DNA and RNA Sequencing of Whole Blood Elucidates the Genetic Architecture of Gene Expression Underlying a Wide Range of Diseases
First Author: Liu, Chunyu
Reviewed: Jun 7, 2022
|
Liu, Chunyu
|
Jun 7, 2022
|
|
Anti-Ad26 humoral immunity does not compromise neutralizing antibody responses following Ad26-based booster vaccination with Gam-COVID-Vac
First Author: Filatov, Alexander
Reviewed: Jun 6, 2022
|
Filatov, Alexander
|
Jun 6, 2022
|
|
A global systematic analysis of the occurrence, severity, and recovery pattern of long COVID in 2020 and 2021
First Author: Hanson, Sarah Wulf
Reviewed: Jun 3, 2022
|
Hanson, Sarah Wulf
|
Jun 3, 2022
|
|
A robust, highly multiplexed mass spectrometry assay to identify SARS-CoV-2 variants
First Author: Hernandez, Matthew M
Reviewed: Jun 3, 2022
|
Hernandez, Matthew M
|
Jun 3, 2022
|
|
CMV seropositivity in older adults changes T cell functionality, but does not prevent antibody or cellular SARS-CoV-2 vaccine responses
First Author: Breznik, Jessica A
Reviewed: Jun 3, 2022
|
Breznik, Jessica A
|
Jun 3, 2022
|
|
Development of a Novel SARS-CoV-2 Immune Complex Vaccine Candidate (CRCx) with Broad Immune Responses: A Preclinical Trial in Animal Model
First Author: Salah, Sherif
Reviewed: Jun 3, 2022
|
Salah, Sherif
|
Jun 3, 2022
|
|
Effective antiviral regimens to reduce COVID-19 hospitalizations: a systematic comparison of randomized controlled trials
First Author: Sullivan, David J
Reviewed: Jun 3, 2022
|
Sullivan, David J
|
Jun 3, 2022
|
|
Facing the Omicron variant – How well do vaccines protect against mild and severe COVID-19? Third interim analysis of a living systematic review
First Author: Kulper Schiek, Wiebe
Reviewed: Jun 3, 2022
|
Kulper Schiek, Wiebe
|
Jun 3, 2022
|
|
Gam-COVID-Vac, EpiVacCorona, and CoviVac effectiveness against lung injury during Delta and Omicron variant surges in St. Petersburg, Russia: test-negative case-control study
First Author: Barchuk, Anton
Reviewed: Jun 3, 2022
|
Barchuk, Anton
|
Jun 3, 2022
|
|
Immunogenicity and Safety of Beta Adjuvanted Recombinant Booster Vaccine
First Author: Launay, Odile
Reviewed: Jun 3, 2022
|
Launay, Odile
|
Jun 3, 2022
|
|
Impact of a blood-stage vaccine on Plasmodium vivax malaria
First Author: Hou, Mimi M
Reviewed: Jun 3, 2022
|
Hou, Mimi M
|
Jun 3, 2022
|
|
Incidence of Post-Covid Syndrome and Associated Symptoms in Outpatient Care in Bavaria, Germany
First Author: Donnachie, Ewan
Reviewed: Jun 3, 2022
|
Donnachie, Ewan
|
Jun 3, 2022
|
|
Increased ambulance attendances related to suicide and self-injury in response to the pandemic in Australia
First Author: John, James
Reviewed: Jun 3, 2022
|
John, James
|
Jun 3, 2022
|
|
Neurophysiological Examination in Patients With Suspected Polyneuropathy Associated With Sars-CoV-2 Infection
First Author: Moure, Jorge De Francisco
Reviewed: Jun 3, 2022
|
Moure, Jorge De Francisco
|
Jun 3, 2022
|
|
Omicron reactive multi protein specific CD4 T cells defines cellular immune response induced by inactivated virus vaccines
First Author: Lim, Joey Ming Er
Reviewed: Jun 3, 2022
|
Lim, Joey Ming Er
|
Jun 3, 2022
|
|
Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency
First Author: Walz, Juliane
Reviewed: Jun 3, 2022
|
Walz, Juliane
|
Jun 3, 2022
|
|
Potentiating the cross-reactive IFN-γ T cell and polyfunctional T cell responses by heterologous GX-19N DNA booster in mice primed with either a COVID-19 mRNA vaccine or inactivated vaccine
First Author: Seo, Yong Bok
Reviewed: Jun 3, 2022
|
Seo, Yong Bok
|
Jun 3, 2022
|
|
Profiling of immune responses to COVID-19 and vaccination uncovers potent adjuvant capacities of SARS CoV-2 infection to vaccination leading to memory T cell responses with a Th17 signature in cancer patients
First Author: Echaide, Miriam
Reviewed: Jun 3, 2022
|
Echaide, Miriam
|
Jun 3, 2022
|
|
Protection against Omicron conferred by mRNA primary vaccine series, boosters, and prior infection
First Author: Chin, Elizabeth T
Reviewed: Jun 3, 2022
|
Chin, Elizabeth T
|
Jun 3, 2022
|
|
Respiratory mucosal vaccination of peptide-poloxamine-DNA nanoparticles provides complete protection against lethal SARS-CoV-2 challenge
First Author: Sun, Si
Reviewed: Jun 3, 2022
|
Sun, Si
|
Jun 3, 2022
|
|
RNA polymerase inaccuracy underlies SARS-CoV-2 variants and vaccine heterogeneity
First Author: Herman, Christophe
Reviewed: Jun 3, 2022
|
Herman, Christophe
|
Jun 3, 2022
|
|
SARS-CoV-2 neutralising antibody activity in a highly vaccinated population: Longitudinal serology studies in Singapore
First Author: Clapham, Hannah E
Reviewed: Jun 3, 2022
|
Clapham, Hannah E
|
Jun 3, 2022
|
|
Spike mutation resilient scFv76 antibody counteracts SARS-CoV-2 lung damage upon aerosol delivery
First Author: Milazzo, Ferdinando M
Reviewed: Jun 3, 2022
|
Milazzo, Ferdinando M
|
Jun 3, 2022
|
|
Tixagevimab/Cilgavimab for Prevention of COVID-19 during the Omicron Surge: Retrospective Analysis of National VA Electronic Data
First Author: Young Xu, Yinong
Reviewed: Jun 3, 2022
|
Young Xu, Yinong
|
Jun 3, 2022
|
|
Immune Escape Associated with RBD Omicron Mutations and SARS-CoV-2 Evolution Dynamics
First Author: Alexander Kudryavtsev
Reviewed: Jun 2, 2022
|
Alexander Kudryavtsev
|
Jun 2, 2022
|
|
Mortality and its determinants after an outbreak of post COVID-19 associated Rhino - Orbito - Cerebral mucormycosis in India
First Author: Nagarkar, Nitin M
Reviewed: Jun 2, 2022
|
Nagarkar, Nitin M
|
Jun 2, 2022
|
|
Ocular Symptoms In COVID-19 Infection: A Survey Study
First Author: Mcharg, Matthew
Reviewed: Jun 2, 2022
|
Mcharg, Matthew
|
Jun 2, 2022
|
|
Predictors of Willingness of the General Public to Receive a Second COVID-19 Booster Dose or a New COVID-19 Vaccine: A Cross-Sectional Study in Greece
First Author: Petros Galanis
Reviewed: Jun 2, 2022
|
Petros Galanis
|
Jun 2, 2022
|
|
The patterns and changes of general surgical presentations during the first wave COVID-19 pandemic at a metropolitan Sydney hospital
First Author: Diab, Jason
Reviewed: Jun 2, 2022
|
Diab, Jason
|
Jun 2, 2022
|
|
The SARS-CoV-2 S1 Spike Protein Promotes MAPK and NF-kB Activation and Inflammatory Cytokine Production In Human Lung and Intestinal Epithelial Cells
First Author: Christopher B Forsyth
Reviewed: Jun 2, 2022
|
Christopher B Forsyth
|
Jun 2, 2022
|
|
Backward bifurcation, basic reinfection number and robustness of a SEIRE
epidemic model with reinfection
First Author: Wang, Shaoli
Reviewed: Jun 1, 2022
|
Wang, Shaoli
|
Jun 1, 2022
|
|
COVID-19 can initiate and trigger henoch-schoenlein purpura; a case series
First Author: Nabavizadeh, Seyed Hesamedin
Reviewed: Jun 1, 2022
|
Nabavizadeh, Seyed Hesamedin
|
Jun 1, 2022
|
|
Efficacy and impact of SARS-CoV-2 vaccination on cancer treatment for breast cancer patients: A multi-center prospective observational study
First Author: Terada, Mitsuo
Reviewed: Jun 1, 2022
|
Terada, Mitsuo
|
Jun 1, 2022
|
|
Empathetic, old, and disgust-sensitive vs. comfort-seeking, misinformed, and rationalizing: Predictors and motives for mask-wearing behavior and vaccination intention during the COVID-19 pandemic
First Author: Binter, Jakub
Reviewed: Jun 1, 2022
|
Binter, Jakub
|
Jun 1, 2022
|
|
Etiology Model for Clinical Studies’ Intramuscular Injection of Saline Solution Control Driving Innate Immune Response Associated Adverse Events in Volunteers
First Author: Darrell O Ricke, Ph D
Reviewed: Jun 1, 2022
|
Darrell O Ricke, Ph D
|
Jun 1, 2022
|
|
Inhaled corticosteroids do not affect the antibody titer against the SARS-CoV-2 spike protein in BNT162b2 mRNA vaccinated patients
First Author: Nakajima, Takeo
Reviewed: Jun 1, 2022
|
Nakajima, Takeo
|
Jun 1, 2022
|
|
Mid- to long-term cardiac magnetic resonance findings in elite athletes recovered from COVID-19 - results from one German Olympic medical center
First Author: Schneeweis, Christopher
Reviewed: Jun 1, 2022
|
Schneeweis, Christopher
|
Jun 1, 2022
|
|
Retrospective cohort study of the effectiveness of the Sputnik V and EpiVacCorona vaccines against the SARS-CoV-2 Delta variant in Moscow (June-July 2021)
First Author: Matveeva, Olga
Reviewed: Jun 1, 2022
|
Matveeva, Olga
|
Jun 1, 2022
|
|
The SARS-CoV-2 spike protein binds and modulates estrogen receptors
First Author: Solis, Oscar
Reviewed: Jun 1, 2022
|
Solis, Oscar
|
Jun 1, 2022
|
|
Distinct antigenic properties of the SARS-CoV-2 Omicron lineages BA.4 and BA.5
First Author: Willett, Brian J
Reviewed: May 30, 2022
|
Willett, Brian J
|
May 30, 2022
|
|
Explore the attitudes of children and adolescent parents towards the vaccination of COVID-19 in China
First Author: Wang, Lin
Reviewed: May 30, 2022
|
Wang, Lin
|
May 30, 2022
|
|
Facilitators and barriers to COVID-19 vaccination among healthcare workers and the general population in Guinea
First Author: Toure, Almamy Amara
Reviewed: May 30, 2022
|
Toure, Almamy Amara
|
May 30, 2022
|
|
Incidence, determinants and serological correlates of reactive symptoms following SARS-CoV-2 vaccination: a population-based longitudinal study (COVIDENCE UK)
First Author: Holt, Hayley
Reviewed: May 30, 2022
|
Holt, Hayley
|
May 30, 2022
|
|
Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology
First Author: Hemmi, Takuya
Reviewed: May 30, 2022
|
Hemmi, Takuya
|
May 30, 2022
|
|
SARS-CoV-2 Omicron BA.2.12.1, BA.4, and BA.5 subvariants evolved to extend antibody evasion
First Author: Wang, Qian
Reviewed: May 30, 2022
|
Wang, Qian
|
May 30, 2022
|
|
Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors
First Author: Cheetham, Nathan J
Reviewed: May 27, 2022
|
Cheetham, Nathan J
|
May 27, 2022
|
|
Anti-chemokine antibodies after SARS-CoV-2 infection correlate with favorable disease course
First Author: Muri, Jonathan
Reviewed: May 27, 2022
|
Muri, Jonathan
|
May 27, 2022
|
|
Assessment of subtle cognitive impairments in patients with post-COVID syndrome with the tablet-based Oxford Cognitive Screen-Plus (OCS-Plus)
First Author: Kozik, V
Reviewed: May 27, 2022
|
Kozik, V
|
May 27, 2022
|
|
Association of results of four lateral flow antibody tests with subsequent SARS-CoV-2 infection
First Author: Findlater, Lucy
Reviewed: May 27, 2022
|
Findlater, Lucy
|
May 27, 2022
|
|
Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe COVID-19 outcomes in non-hospitalised patients: an observational cohort study using the OpenSAFELY platform
First Author: Zheng, Bang
Reviewed: May 27, 2022
|
Zheng, Bang
|
May 27, 2022
|
|
COVID-19 symptoms and duration of direct antigen test positivity at a community testing and surveillance site, January 2021-2022
First Author: Marquez, Carina
Reviewed: May 27, 2022
|
Marquez, Carina
|
May 27, 2022
|
|
Further antibody escape by Omicron BA.4 and BA.5 from vaccine and BA.1 serum
First Author: Tuekprakhon, Aekkachai
Reviewed: May 27, 2022
|
Tuekprakhon, Aekkachai
|
May 27, 2022
|
|
Incidence of Glomerulonephritis after SARS-CoV-2 mRNA Vaccination
First Author: Diebold, Matthias
Reviewed: May 27, 2022
|
Diebold, Matthias
|
May 27, 2022
|
|
In-Vitro results of EG-Covimab-H (Lab cultivated Human polyclonal antibodies) for neutralizing SARSCoV-2 Virus & safety on tissues.
First Author: Mohammed, Alaa Abdelkarim
Reviewed: May 27, 2022
|
Mohammed, Alaa Abdelkarim
|
May 27, 2022
|
|
Machine Learning for Identifying Data-Driven Subphenotypes of Incident Post-Acute SARS-CoV-2 Infection Conditions with Large Scale Electronic Health Records: Findings from the RECOVER Initiative
First Author: Zhang, Hao
Reviewed: May 27, 2022
|
Zhang, Hao
|
May 27, 2022
|
|
Modeling suggests that multiple immunizations or infections will reveal the benefits of updating SARS-CoV-2 vaccines
First Author: Desikan, Rajat
Reviewed: May 27, 2022
|
Desikan, Rajat
|
May 27, 2022
|
|
Omicron and vaccines: An analysis on the decline in COVID-19 mortality
First Author: Larrauri, Blas J
Reviewed: May 27, 2022
|
Larrauri, Blas J
|
May 27, 2022
|
|
Reduced Neutralization of SARS-CoV-2 Omicron Variant in Sera from SARS-CoV-1 Survivors after 3-dose of Vaccination
First Author: Zhao, Xuesen
Reviewed: May 27, 2022
|
Zhao, Xuesen
|
May 27, 2022
|
|
Safety of the BNT162b2 mRNA COVID-19 Vaccine in Children below 5 Years (CoVacU5) – an Investigator-Initiated Retrospective Cohort Study
First Author: Topfner, Nicole
Reviewed: May 27, 2022
|
Topfner, Nicole
|
May 27, 2022
|
|
The Effect of Cash Transfer on Maternal and Child Health Outcomes: A Systematic Review in Sub-Saharan Africa
First Author: Ngamasana, Emery L
Reviewed: May 27, 2022
|
Ngamasana, Emery L
|
May 27, 2022
|
|
Understanding Post-Acute Sequelae of SARS-CoV-2 Infection through Data-Driven Analysis with Longitudinal Electronic Health Records: Findings from the RECOVER Initiative
First Author: Zang, Chengxi
Reviewed: May 27, 2022
|
Zang, Chengxi
|
May 27, 2022
|
|
A generic model for pandemics in networks of communities and the role of
vaccination
First Author: Antonopoulos, Chris G
Reviewed: May 26, 2022
|
Antonopoulos, Chris G
|
May 26, 2022
|
|
ChAdOx1-S and BBV152 vaccines – Effectiveness on post-vaccination and COVID-19 outcomes.
First Author: Agrawal, Ruchi
Reviewed: May 26, 2022
|
Agrawal, Ruchi
|
May 26, 2022
|
|
B cells, BAFF and interferons in MIS-C
First Author: Klocperk, Adam
Reviewed: May 25, 2022
|
Klocperk, Adam
|
May 25, 2022
|
|
BNT162b2 induces robust cross-variant SARS-CoV-2 immunity in children
First Author: Bartsch, Yannic C
Reviewed: May 25, 2022
|
Bartsch, Yannic C
|
May 25, 2022
|
|
Cross-sectional analysis of the humoral response after SARS-CoV-2 vaccination in Sardinian Multiple Sclerosis patients, a follow-up study
First Author: Idda, Maria Laura
Reviewed: May 25, 2022
|
Idda, Maria Laura
|
May 25, 2022
|
|
Early experience with modified dose nirmatrelvir/ritonavir in dialysis patients with coronavirus disease-2019
First Author: Brown, Pierre Antoine
Reviewed: May 25, 2022
|
Brown, Pierre Antoine
|
May 25, 2022
|
|
Evaluation of anti-spike glycoprotein antibody and neutralizing antibody response of different vaccine platforms. A protocol of systematic review and meta-analysis of COVID-19 vaccine clinical trial studies
First Author: Mirzakhani, Mohammad
Reviewed: May 25, 2022
|
Mirzakhani, Mohammad
|
May 25, 2022
|
|
Fear of Infection and Sufficient Vaccine Reservation Information Might Drive Rapid Coronavirus Disease 2019 Vaccination in Japan: Evidence from Twitter Analysis
First Author: Niu, Qian
Reviewed: May 25, 2022
|
Niu, Qian
|
May 25, 2022
|
|
Hyperbaric Oxygen for Treatment of Long COVID Syndrome (HOT-LoCO); Protocol for a Randomised, Placebo-Controlled, Double-Blind, Phase II Clinical Trial
First Author: Kjellberg, Anders
Reviewed: May 25, 2022
|
Kjellberg, Anders
|
May 25, 2022
|
|
Levels and determinants of COVID-19 vaccine hesitancy among sub-Saharan African adolescents
First Author: Wang, Dongqing
Reviewed: May 25, 2022
|
Wang, Dongqing
|
May 25, 2022
|
|
Long-COVID in Scotland Study: a nationwide, population cohort study
First Author: Pell, Jill
Reviewed: May 25, 2022
|
Pell, Jill
|
May 25, 2022
|
|
Neutralization Escape by the SARS-CoV-2 Omicron Variants BA.2.12.1 and BA.4/BA.5
First Author: Hachmann, Nicole P
Reviewed: May 25, 2022
|
Hachmann, Nicole P
|
May 25, 2022
|
|
Preceding anti-spike IgG levels predicted risk and severity of COVID-19 during the Omicron-dominant wave in Santa Fe city, Argentina
First Author: Eberhardt, Ayelen T
Reviewed: May 25, 2022
|
Eberhardt, Ayelen T
|
May 25, 2022
|
|
Real-World Effectiveness of Casirivimab and Imdevimab Among Patients Diagnosed With COVID-19 in the Ambulatory Setting: A Retrospective Cohort Study Using a Large Claims Database
First Author: Hussein, Mohamed
Reviewed: May 25, 2022
|
Hussein, Mohamed
|
May 25, 2022
|
|
Real-world effectiveness of molnupiravir and nirmatrelvir/ritonavir among COVID-19 inpatients during Hong Kong’s Omicron BA.2 wave: an observational study
First Author: Wong, Carlos K H
Reviewed: May 25, 2022
|
Wong, Carlos K H
|
May 25, 2022
|
|
Reduced antibody acquisition with increasing age following vaccination with BNT162b2: results from a large study performed in the general population aged 12 to 92 years
First Author: Hoogen, Lotus L Van Den
Reviewed: May 25, 2022
|
Hoogen, Lotus L Van Den
|
May 25, 2022
|
|
Reduced Exercise Capacity, Chronotropic Incompetence, Inflammation and Symptoms in Post-Acute COVID-19
First Author: Durstenfeld, Matthew S
Reviewed: May 25, 2022
|
Durstenfeld, Matthew S
|
May 25, 2022
|
|
Self-medication practices and associated factors among COVID-19 recovered patients to prevent future infections: A web-based survey in Bangladesh
First Author: Sujan, Md Safaet Hossain
Reviewed: May 25, 2022
|
Sujan, Md Safaet Hossain
|
May 25, 2022
|
|
Sequence Proven Reinfections with SARS-CoV-2 at a Large Academic Center
First Author: Paul Morris, C
Reviewed: May 25, 2022
|
Paul Morris, C
|
May 25, 2022
|
|
Serial infection with SARS-CoV-2 Omicron BA.1 and BA.2 following three-dose COVID-19 vaccination
First Author: Lapointe, Hope R
Reviewed: May 25, 2022
|
Lapointe, Hope R
|
May 25, 2022
|
|
The negative impact of COVID-19 on working memory revealed using a rapid online quiz
First Author: Baseler, Heidi A
Reviewed: May 25, 2022
|
Baseler, Heidi A
|
May 25, 2022
|
|
Variant Allele of ALDH2, rs671 Associates with Attenuated Post-Vaccination Response in Anti-SARS-CoV-2 Spike Protein IgG: A Prospective Study in the Japanese General Population
First Author: Akiko Matsumoto
Reviewed: May 25, 2022
|
Akiko Matsumoto
|
May 25, 2022
|
|
Assessing the impact of non-pharmaceutical interventions (NPIs) and BCG vaccine cross-protection in the transmission dynamics of SARS-CoV-2 in eastern Africa
First Author: Kilonzo, Chelsea Mbeke
Reviewed: May 24, 2022
|
Kilonzo, Chelsea Mbeke
|
May 24, 2022
|
|
Association between Post-acute Sequelae of SARS-CoV-2 and Physical Inactivity: A Cohort Study of 614 COVID-19 survivors
First Author: Gil, Saulo
Reviewed: May 24, 2022
|
Gil, Saulo
|
May 24, 2022
|
|
Case of Conversion from Hypothyroidism to Hyperthyroidism and Back After Anti-SARS-CoV-2 Vaccination
First Author: Andrey, Ushakov
Reviewed: May 24, 2022
|
Andrey, Ushakov
|
May 24, 2022
|
|
Development and validation of a prognostic model for the early identification of COVID-19 patients at risk of developing common long COVID symptoms
First Author: Deforth, Manja
Reviewed: May 24, 2022
|
Deforth, Manja
|
May 24, 2022
|
|
Differential Evasion of Delta and Omicron Immunity and Enhanced Fusogenicity of SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants
First Author: Qu, Panke
Reviewed: May 24, 2022
|
Qu, Panke
|
May 24, 2022
|
|
Ivermectin compared with placebo in the clinical evolution of Mexican patients with asymptomatic and mild COVID-19: a randomized clinical trial
First Author: Rocha, Carmen De La
Reviewed: May 24, 2022
|
Rocha, Carmen De La
|
May 24, 2022
|
|
Molecular analysis of a public cross-neutralizing antibody response to SARS-CoV-2
First Author: Yuan, Meng
Reviewed: May 24, 2022
|
Yuan, Meng
|
May 24, 2022
|
|
ORFeome Phage Display Reveals a Major Immunogenic Epitope on the S2 Subdomain of SARS-Cov-2 Spike Protein
First Author: Rico Ballmann
Reviewed: May 24, 2022
|
Rico Ballmann
|
May 24, 2022
|
|
Predictive value of reactogenicity for anti-SARS-CoV-2 antibody response in mRNA-1273 recipients: a multicenter prospective cohort study
First Author: Choi, Min Joo
Reviewed: May 24, 2022
|
Choi, Min Joo
|
May 24, 2022
|
|
Prophylactic treatment of Glycyrrhiza glabra mitigates COVID-19 pathology through inhibition of pro-inflammatory cytokines in the hamster model and NETosis
First Author: Rizvi, Zaigham Abbas
Reviewed: May 24, 2022
|
Rizvi, Zaigham Abbas
|
May 24, 2022
|
|
Safety of inactivated COVID‑19 vaccine in pediatric patients with rheumatic diseases
First Author: Yi, Cuili
Reviewed: May 24, 2022
|
Yi, Cuili
|
May 24, 2022
|
|
SARS-CoV-2 Subunit Virus-Like Vaccine Demonstrates High Safety Profile and Protective Efficacy: Preclinical Study
First Author: Vakhrusheva, A V
Reviewed: May 24, 2022
|
Vakhrusheva, A V
|
May 24, 2022
|
|
Specific Cellular and Humoral Immune Responses to the Neoantigen S1 of SARS-CoV-2 in Patients with Primary and Secondary Immunodeficiency
First Author: Mohamed, Kauzar Mohamed
Reviewed: May 24, 2022
|
Mohamed, Kauzar Mohamed
|
May 24, 2022
|
|
Stress and Coping Issues in Management Students Post COVID-19 Lockdown
First Author: Chib, Shiney
Reviewed: May 24, 2022
|
Chib, Shiney
|
May 24, 2022
|
|
The ATLAS™ screening assay reveals distinct CD4+ and CD8+ SARS-CoV-2 antigen response profiles which have implications to Omicron cellular immunity
First Author: Foti, James J
Reviewed: May 24, 2022
|
Foti, James J
|
May 24, 2022
|
|
The gut microbiota and metabolome is associated with diminished COVID-19 vaccine-induced antibody responses in immunosuppressed inflammatory bowel disease patients
First Author: Alexander, James L
Reviewed: May 24, 2022
|
Alexander, James L
|
May 24, 2022
|
|
Tixagevimab/cilgavimab pre-exposure prophylaxis is associated with lower breakthrough infection risk in vaccinated solid organ transplant recipients during the Omicron wave
First Author: Jurdi, Ayman Al
Reviewed: May 24, 2022
|
Jurdi, Ayman Al
|
May 24, 2022
|
|
What are effective strategy to constrain COVID-19 pandemic crisis? lessons learned from a comparative policy analysis between Italian regions to cope with next pandemic impact
First Author: Coccia, Mario
Reviewed: May 24, 2022
|
Coccia, Mario
|
May 24, 2022
|
|
A live attenuated vaccine confers superior mucosal and systemic immunity to SARS-CoV-2 variants
First Author: Nouailles, Geraldine
Reviewed: May 20, 2022
|
Nouailles, Geraldine
|
May 20, 2022
|
|
A Phase1 Results of a Non-Stabilized Spike-Encoding mRNA Vaccine in Adults
First Author: Gatechompol, Sivaporn
Reviewed: May 20, 2022
|
Gatechompol, Sivaporn
|
May 20, 2022
|
|
Companies' Digitalization Challenges and Opportunities in a Post-COVID-19 World
First Author: Bhat, Aaqib Nisar
Reviewed: May 20, 2022
|
Bhat, Aaqib Nisar
|
May 20, 2022
|
|
COVID-19 vaccines effectiveness against SARS-CO-V-2 infection among persons attending RT-PCR centre at a Medical College Hospital in Telangana: A case control study
First Author: Veerapu, Nagapraveen
Reviewed: May 20, 2022
|
Veerapu, Nagapraveen
|
May 20, 2022
|
|
Design and baseline description of an observational population-based cohort study on COVID-19 vaccine effectiveness in the Netherlands - The VAccine Study COvid-19 (VASCO)
First Author: Huiberts, Anne J
Reviewed: May 20, 2022
|
Huiberts, Anne J
|
May 20, 2022
|
|
Humoral immune responses against SARS-CoV-2 Spike variants after mRNA vaccination in solid organ transplant recipients
First Author: Tauzin, Alexandra
Reviewed: May 20, 2022
|
Tauzin, Alexandra
|
May 20, 2022
|
|
Is Cancer significant Comorbid Condition in COVID 19 Infected Patients? -A Retrospective Analysis Experienced in a Tertiary Care Center in Eastern India
First Author: Mukherjee, Kalyan K
Reviewed: May 20, 2022
|
Mukherjee, Kalyan K
|
May 20, 2022
|
|
Long-COVID in immunocompromised children
First Author: Kuczborska, Karolina
Reviewed: May 20, 2022
|
Kuczborska, Karolina
|
May 20, 2022
|
|
Post COVID-19 condition of the Omicron variant of SARS-CoV-2
First Author: Morioka, Shinichiro
Reviewed: May 20, 2022
|
Morioka, Shinichiro
|
May 20, 2022
|
|
SARS-CoV-2 Omicron Variant Wave in India: Advent, Phylogeny and Evolution
First Author: Singh, Urvashi B
Reviewed: May 20, 2022
|
Singh, Urvashi B
|
May 20, 2022
|
|
Self-Reported SARS-CoV-2 Vaccination is Consistent with Electronic Health Record Data among the COVID-19 Community Research Partnership
First Author: Tjaden, Ashley H
Reviewed: May 20, 2022
|
Tjaden, Ashley H
|
May 20, 2022
|
|
A Comparative Analysis of a Self-Reported Adverse Events Analysis After Receiving one of the Available SARS-CoV-2 Vaccine Schemes in Ecuador
First Author: Esteban Ortiz-Prado
Reviewed: May 19, 2022
|
Esteban Ortiz-Prado
|
May 19, 2022
|
|
COVID-Net UV: An End-to-End Spatio-Temporal Deep Neural Network
Architecture for Automated Diagnosis of COVID-19 Infection from Ultrasound
Videos
First Author: Azimi, Hilda
Reviewed: May 19, 2022
|
Azimi, Hilda
|
May 19, 2022
|
|
Determination of Ki67 after SARS-CoV-2 infection by enzyme linked immunoassay
First Author: Kldiashvili, Ekaterina
Reviewed: May 19, 2022
|
Kldiashvili, Ekaterina
|
May 19, 2022
|
|
In silico designing of a novel epitope-based candidate vaccine against Streptococcus pneumoniae with introduction of a new domain of PepO as adjuvant
First Author: Bahadori, Zohreh
Reviewed: May 19, 2022
|
Bahadori, Zohreh
|
May 19, 2022
|
|
Personal risk or societal benefit? Investigating adults’ support for COVID-19 childhood vaccination
First Author: Melegaro, Alessia
Reviewed: May 19, 2022
|
Melegaro, Alessia
|
May 19, 2022
|
|
The estimated disease burden of acute COVID-19 in the Netherlands in 2020, in disability-adjusted life-years
First Author: Mcdonald, Scott A
Reviewed: May 19, 2022
|
Mcdonald, Scott A
|
May 19, 2022
|
|
A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern
First Author: Yuan, Mengqi
Reviewed: May 18, 2022
|
Yuan, Mengqi
|
May 18, 2022
|
|
Clinical characteristics of hospitalized patients in Binzhou, China during periods of the SARS-CoV-2 Omicron variant BA.2 predominance: a single-centered, retrospective, observational study
First Author: Xu, Haixiao
Reviewed: May 18, 2022
|
Xu, Haixiao
|
May 18, 2022
|
|
Delivery of Circular mRNA via Degradable Lipid Nanoparticles against SARS-CoV-2 Delta Variant
First Author: Huang, Ke
Reviewed: May 18, 2022
|
Huang, Ke
|
May 18, 2022
|
|
Effect on the conformations of spike protein of SARS-CoV-2 due to mutation
First Author: Gupta, Aayatti Mallick
Reviewed: May 18, 2022
|
Gupta, Aayatti Mallick
|
May 18, 2022
|
|
Elevated liver enzymes and bilirubin following SARS-CoV-2 infection in children under 10
First Author: Kendall, Ellen K
Reviewed: May 18, 2022
|
Kendall, Ellen K
|
May 18, 2022
|
|
Humoral immunity to SARS-CoV-2 elicited by combination COVID-19 vaccination regimens
First Author: Wang, Zijun
Reviewed: May 18, 2022
|
Wang, Zijun
|
May 18, 2022
|
|
Immune gene expression analysis indicates the potential of a self-amplifying Covid-19 mRNA vaccine
First Author: Ooi, Eng Eong
Reviewed: May 18, 2022
|
Ooi, Eng Eong
|
May 18, 2022
|
|
In-Silico Investigation of Inhibiting Property of Phytoconstituents of Medicinal Herb ‘Aconitum Heterophyllum’ Against Omicron Variant of SARS-CoV-2
First Author: Lakhera, Shradha
Reviewed: May 18, 2022
|
Lakhera, Shradha
|
May 18, 2022
|
|
Low immune response after 1.5 years of primary SARS-CoV-2 infection and Covishield vaccination lead to SARS-CoV-2 reinfection
First Author: Shete, Anita M
Reviewed: May 18, 2022
|
Shete, Anita M
|
May 18, 2022
|
|
Reactogenicity of mRNA and non-mRNA Based COVID-19 Vaccines Among Lactating Mother and Baby Dyads
First Author: Beth Jacob-Chow
Reviewed: May 18, 2022
|
Beth Jacob-Chow
|
May 18, 2022
|
|
The preliminary safety and immunogenicity results of a randomized, double-blind, placebo-controlled Phase I trial for a recombinant two-component subunit SARS-CoV-2 vaccine ReCOV
First Author: Wynne, Chris
Reviewed: May 18, 2022
|
Wynne, Chris
|
May 18, 2022
|
|
Three-doses of BNT162b2 COVID-19 mRNA vaccine establishes long-lasting CD8+ T cell immunity in CLL and MDS patients
First Author: Hernandez, Susana Patricia Amaya
Reviewed: May 18, 2022
|
Hernandez, Susana Patricia Amaya
|
May 18, 2022
|
|
Comprehensive Biotechnical System for Screening Risk-Based Diagnosis of COVID-19 and Post-COVID Syndrome
First Author: Vladimir Savostyanov
Reviewed: May 17, 2022
|
Vladimir Savostyanov
|
May 17, 2022
|
|
Factors Associated with Severe Covid-19 Despite Vaccination: A Nationwide, Retrospective Cohort Study
First Author: Vo, Austin D
Reviewed: May 17, 2022
|
Vo, Austin D
|
May 17, 2022
|
|
Using a physical model and aggregate data to estimate the spreading of
Covid-19 in Israel in the presence of waning immunity and competing variants
First Author: De Leon, Hilla
Reviewed: May 17, 2022
|
De Leon, Hilla
|
May 17, 2022
|
|
Adenovirus-Vectored SARS-CoV-2 Vaccine Expressing S1-N Fusion Protein
First Author: Khan, Muhammad S
Reviewed: May 16, 2022
|
Khan, Muhammad S
|
May 16, 2022
|
|
Assessing the impacts of timing on the health benefits, cost-effectiveness and relative affordability of COVID-19 vaccination programmes in 27 African Countries
First Author: Liu, Yang
Reviewed: May 16, 2022
|
Liu, Yang
|
May 16, 2022
|
|
BA.2 omicron differs immunologically from both BA.1 omicron and pre-omicron variants
First Author: Rossler, Annika
Reviewed: May 16, 2022
|
Rossler, Annika
|
May 16, 2022
|
|
Comparative epidemiology of ivermectin and vaccines against Delta variant based on real-world data and hypothesized mechanisms of ivermectin immunological action
First Author: Tanioka, Hisaya
Reviewed: May 16, 2022
|
Tanioka, Hisaya
|
May 16, 2022
|
|
COVID-19 mRNA third dose induces a unique hybrid immunity-like antibody response
First Author: Andreano, Emanuele
Reviewed: May 16, 2022
|
Andreano, Emanuele
|
May 16, 2022
|
|
COVID-19 vaccination in pregnancy: views and vaccination uptake rates in pregnancy, a mixed methods analysis from the Born In Wales study
First Author: Mhereeg, M
Reviewed: May 16, 2022
|
Mhereeg, M
|
May 16, 2022
|
|
COVID-19 Vaccine effectiveness against symptomatic infection and hospitalization in Belgium, July 2021-APRIL 2022
First Author: Braeye, Toon
Reviewed: May 16, 2022
|
Braeye, Toon
|
May 16, 2022
|
|
Delayed antigen-specific CD4+ T-cell induction correlates with impaired immune responses to SARS-COV-2 mRNA vaccination in the elderly
First Author: Jo, Norihide
Reviewed: May 16, 2022
|
Jo, Norihide
|
May 16, 2022
|
|
Genomic Surveillance of SARS-COV-2 reveals diverse circulating variant lineages in Nairobi and Kiambu County, Kenya
First Author: Kuja, Josiah O
Reviewed: May 16, 2022
|
Kuja, Josiah O
|
May 16, 2022
|
|
High but Short-lived anti-SARS-CoV2 neutralizing, IgM, IgA, and IgG levels among mRNA-vaccinees compared to naturally-infected participants
First Author: Abou Saleh, Haissam
Reviewed: May 16, 2022
|
Abou Saleh, Haissam
|
May 16, 2022
|
|
Influencing factors of Anti-SARS-CoV-2-Spike IgG antibody titres in healthcare workers – A cross-section study
First Author: Reusch, Julia
Reviewed: May 16, 2022
|
Reusch, Julia
|
May 16, 2022
|
|
Is large-scale vaccination sufficient for controlling the Covid-19 pandemic with uncertainties? A model-based study
First Author: Majumder, Abhijit
Reviewed: May 16, 2022
|
Majumder, Abhijit
|
May 16, 2022
|
|
mRNA-based COVID-19 booster vaccination is highly effective and cost-effective in Australia
First Author: Li, Rui
Reviewed: May 16, 2022
|
Li, Rui
|
May 16, 2022
|
|
Multicenter case-control study evaluating the safety of anti-SARS-CoV-2 vaccines in a cohort of patients with systemic vasculitis
First Author: Simoncelli, Edoardo
Reviewed: May 16, 2022
|
Simoncelli, Edoardo
|
May 16, 2022
|
|
Phase I study of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B
First Author: Orozco, Natalia Martin
Reviewed: May 16, 2022
|
Orozco, Natalia Martin
|
May 16, 2022
|
|
Preclinical evaluation of RQ3013, a broad-spectrum mRNA vaccine against SARS-CoV-2 variants
First Author: Tan, Shudan
Reviewed: May 16, 2022
|
Tan, Shudan
|
May 16, 2022
|
|
Three-dose vaccination-induced immune responses protect against SARS-CoV-2 Omicron-BA.2
First Author: Zhou, Runhong
Reviewed: May 16, 2022
|
Zhou, Runhong
|
May 16, 2022
|
|
An Optimal Control Model of transmission dynamics of COVID-19 in Ghana
First Author: Okyere, Samuel
Reviewed: May 13, 2022
|
Okyere, Samuel
|
May 13, 2022
|
|
Clinical and Virological Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants in Vaccinated and Unvaccinated Patients in Mexico City
First Author: Hernandez Teran, Alejandra
Reviewed: May 13, 2022
|
Hernandez Teran, Alejandra
|
May 13, 2022
|
|
Decreased cerebral blood flow in non-hospitalized adults who self-isolated due to COVID-19
First Author: Kim, William S H
Reviewed: May 13, 2022
|
Kim, William S H
|
May 13, 2022
|
|
Inferring selection effects in SARS-CoV-2 with Bayesian Viral Allele Selection
First Author: Jankowiak, Martin
Reviewed: May 13, 2022
|
Jankowiak, Martin
|
May 13, 2022
|
|
Persistent serum protein signatures define an inflammatory subset of long COVID
First Author: Talla, Aarthi
Reviewed: May 13, 2022
|
Talla, Aarthi
|
May 13, 2022
|
|
Potential antiviral effects of pantethine against SARS-CoV-2
First Author: Abou Hamdan, M
Reviewed: May 13, 2022
|
Abou Hamdan, M
|
May 13, 2022
|
|
A Mathematical Modeling Study of COVID-19 With Reference to Immigration
from Urban to Rural Population
First Author: Vamsi, D K K
Reviewed: May 12, 2022
|
Vamsi, D K K
|
May 12, 2022
|
|
A quasi-experimental cohort study evaluating a conditional economic incentive on first-dose COVID-19 vaccination rates among older adults in South Africa
First Author: Chetty Makkan, Candice M
Reviewed: May 12, 2022
|
Chetty Makkan, Candice M
|
May 12, 2022
|
|
ACE2 nanoparticles prevent cell entry of SARS-CoV-2
First Author: Sauvanet, Cecile
Reviewed: May 12, 2022
|
Sauvanet, Cecile
|
May 12, 2022
|
|
Antibody responses to AZD1222 vaccination in West Africa
First Author: Abdullahi, Adam
Reviewed: May 12, 2022
|
Abdullahi, Adam
|
May 12, 2022
|
|
Antibody responses to known and unknown SARS-CoV-2 infections after mRNA vaccine booster
First Author: Demonbreun, Alexis R
Reviewed: May 12, 2022
|
Demonbreun, Alexis R
|
May 12, 2022
|
|
Assessing the feasibility of sustaining a “Zero-COVID” policy in China in the era of highly transmissible variants
First Author: Wang, Yan
Reviewed: May 12, 2022
|
Wang, Yan
|
May 12, 2022
|
|
Covid-19 vaccine effectiveness against general SARS-CoV-2 infection from the omicron variant: A retrospective cohort study
First Author: Rennert, Lior
Reviewed: May 12, 2022
|
Rennert, Lior
|
May 12, 2022
|
|
COVID-19 vaccine effectiveness during a prison outbreak when the Omicron was the dominant circulating variant— Zambia, December 2021
First Author: Simwanza, John
Reviewed: May 12, 2022
|
Simwanza, John
|
May 12, 2022
|
|
Development and evaluation of low-volume tests to detect and characterise antibodies to SARS-CoV-2
First Author: Halliday, Alice
Reviewed: May 12, 2022
|
Halliday, Alice
|
May 12, 2022
|
|
Emotional Reaction to the First Dose of COVID-19 Vaccine: Post Vaccination Decline in Anxiety and Stress Among Anxious Individuals and Increase Among Individuals with Normal Anxiety Levels Pre Vaccination
First Author: Rasmieh Al-Amer
Reviewed: May 12, 2022
|
Rasmieh Al-Amer
|
May 12, 2022
|
|
Escape of SARS-CoV-2 variant Omicron to mucosal immunity in vaccinated subjects
First Author: Martinuzzi, Emanuela
Reviewed: May 12, 2022
|
Martinuzzi, Emanuela
|
May 12, 2022
|
|
Immunological findings in a group of individuals who were non-responders to standard two-dose SARS-CoV-2 vaccines
First Author: Zeng, Qiang
Reviewed: May 12, 2022
|
Zeng, Qiang
|
May 12, 2022
|
|
mRNA booster vaccination enhances antibody responses against SARS-CoV2 Omicron variant in individuals primed with mRNA or inactivated virus vaccines
First Author: Zhang, Biyan
Reviewed: May 12, 2022
|
Zhang, Biyan
|
May 12, 2022
|
|
Pathophysiology of COVID-19: SARS-CoV-2 mimics neoplastic cells and The Long COVID-19 Syndrome can be a Warburg Effect and ACE-2 internalization consequence
First Author: Zanella, Luiz Gonzaga Francisco De Assis Barros D Elia
Reviewed: May 12, 2022
|
Zanella, Luiz Gonzaga Francisco De Assis Barros D Elia
|
May 12, 2022
|
|
Post-acute health care burden after SARS-CoV-2 infection: A retrospective cohort study of long COVID among 530,892 adults
First Author: Mcnaughton, Candace D
Reviewed: May 12, 2022
|
Mcnaughton, Candace D
|
May 12, 2022
|
|
Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/ Post-Acute Sequelae of COVID-19 (PASC)
First Author: Pretorius, Etheresia
Reviewed: May 12, 2022
|
Pretorius, Etheresia
|
May 12, 2022
|
|
Reporting Rates for VAERS Death Reports Following COVID-19 Vaccination, December 14, 2020-November 17, 2021
First Author: Day, Brendan
Reviewed: May 12, 2022
|
Day, Brendan
|
May 12, 2022
|
|
SARS-CoV-2 evolution and patient immunological history shape the breadth and potency of antibody-mediated immunity
First Author: Manali, Maria
Reviewed: May 12, 2022
|
Manali, Maria
|
May 12, 2022
|
|
SARS-CoV-2 neutralizing antibodies in Chile after a vaccination campaign with five different schemes
First Author: Aguilera, Ximena
Reviewed: May 12, 2022
|
Aguilera, Ximena
|
May 12, 2022
|
|
Screening for safe opening of universities under Omicron and Delta variants of COVID-19: When less is more
First Author: Rabil, Marie Jeanne
Reviewed: May 12, 2022
|
Rabil, Marie Jeanne
|
May 12, 2022
|
|
Seroprevalence of SARS-CoV-2 Antibodies among vaccinated and non-vaccinated adults in the West Bank: Results of a repeated cross-sectional study
First Author: Awartani, Faisal
Reviewed: May 12, 2022
|
Awartani, Faisal
|
May 12, 2022
|
|
Short-lived booster effect and stable CD8+ T cell memory after 3rd COVID-19 vaccine dose
First Author: Thimme, Robert
Reviewed: May 12, 2022
|
Thimme, Robert
|
May 12, 2022
|
|
Simultaneous and sequential multi-species coronavirus vaccination
First Author: Peng, Lei
Reviewed: May 12, 2022
|
Peng, Lei
|
May 12, 2022
|
|
UB-612, a Multitope Universal Vaccine Eliciting a Balanced B and T Cell Immunity against SARS-CoV-2 Variants of Concern
First Author: Wang, Chang Yi
Reviewed: May 12, 2022
|
Wang, Chang Yi
|
May 12, 2022
|
|
A cross-sectional analysis from the PAC-19QoLReg on the association between Quality of Life (QoL) of long COVID-19 patients and their disease duration
First Author: Jandhyala, Ravi
Reviewed: May 10, 2022
|
Jandhyala, Ravi
|
May 10, 2022
|
|
A new polysaccharide platform constructs self-adjuvant nanovaccines to enhance immune responses
First Author: Chen, Sisi
Reviewed: May 10, 2022
|
Chen, Sisi
|
May 10, 2022
|
|
Analysis of Perception, Reasons, and Motivations for COVID-19 Vaccination in People with Diabetes across Sub-Saharan Africa: A Mixed-Method Approach
First Author: Uchechukwu Levi Osuagwu
Reviewed: May 10, 2022
|
Uchechukwu Levi Osuagwu
|
May 10, 2022
|
|
Bromhexine, for post exposure COVID-19 prophylaxis: A Randomized, Double-Blind, Placebo Control Trial
First Author: Tolouian, Ramin
Reviewed: May 10, 2022
|
Tolouian, Ramin
|
May 10, 2022
|
|
Immunogenicity and safety of the BNT162b2 mRNA Covid-19 vaccine in patients with melanoma treated with immunotherapy
First Author: Diamantopoulos, Panagiotis
Reviewed: May 10, 2022
|
Diamantopoulos, Panagiotis
|
May 10, 2022
|
|
Immunogenicity of BNT162b2 Vaccine Booster Dose in Patients with Inflammatory Bowel Disease Receiving Infliximab Combination Therapy: A Prospective Observational Study
First Author: Shehab, Mohammad
Reviewed: May 10, 2022
|
Shehab, Mohammad
|
May 10, 2022
|
|
Kidney Transplant Recipients and Omicron: Outcomes, effect of vaccines and the efficacy and safety of novel treatments
First Author: Gleeson, Sarah
Reviewed: May 10, 2022
|
Gleeson, Sarah
|
May 10, 2022
|
|
Protection from Omicron and other VOCs by Bivalent S-Trimer COVID-19 Vaccine
First Author: Su, Danmei
Reviewed: May 10, 2022
|
Su, Danmei
|
May 10, 2022
|
|
A Quantum Dot Biomimetic for SARS-CoV-2 to Interrogate Dysregulation of the Neurovascular Unit Relevant to Brain Inflammation
First Author: Chiang, Wesley
Reviewed: May 9, 2022
|
Chiang, Wesley
|
May 9, 2022
|
|
Analysis of economic recovery forecasts in the post-COVID-19 era - China as an example
First Author: Li, Xin
Reviewed: May 9, 2022
|
Li, Xin
|
May 9, 2022
|
|
Coding Long COVID: Characterizing a new disease through an ICD-10 lens
First Author: Pfaff, Emily R
Reviewed: May 9, 2022
|
Pfaff, Emily R
|
May 9, 2022
|
|
Pineapple Agro-Industrial Wastes to Produce Biomedical Applications Post-COVID-19 Pandemic: Biorefinery and the Circular Economy
First Author: Valeria Amores-Monge
Reviewed: May 9, 2022
|
Valeria Amores-Monge
|
May 9, 2022
|
|
Transcriptome and DNA methylome analysis of peripheral blood samples reveals incomplete restoration and transposable element activation after 3-month recovery of COVID-19
First Author: Yin, Ying
Reviewed: May 9, 2022
|
Yin, Ying
|
May 9, 2022
|
|
An analytical insight of discussions and sentiments of Indians on Omicron-driven third wave of COVID-19 using twitter data
First Author: Vatsa, Deepika Vatsa Deepika
Reviewed: May 6, 2022
|
Vatsa, Deepika Vatsa Deepika
|
May 6, 2022
|
|
An Efficient Approach for SARS-CoV-2 Monoclonal Antibody Production via Modified mRNA-LNP Immunization
First Author: Hsu, Fu Fei
Reviewed: May 6, 2022
|
Hsu, Fu Fei
|
May 6, 2022
|
|
An intranasal nanoparticle STING agonist has broad protective immunity against respiratory viruses and variants
First Author: Leekha, Ankita
Reviewed: May 6, 2022
|
Leekha, Ankita
|
May 6, 2022
|
|
Antibody Responses In Non-Severe SARS-CoV-2 Infections Are Driven By CD4+ T cells and Age
First Author: Murrell, Amelie E
Reviewed: May 6, 2022
|
Murrell, Amelie E
|
May 6, 2022
|
|
Anti-nucleocapsid antibodies following SARS-CoV-2 infection in the blinded phase of the mRNA-1273 Covid-19 vaccine efficacy clinical trial
First Author: Follmann, Dean
Reviewed: May 6, 2022
|
Follmann, Dean
|
May 6, 2022
|
|
Association between metabolic syndrome and humoral immune response to Pfizer–BioNTech vaccine in healthcare workers
First Author: Hoang, Dong Van
Reviewed: May 6, 2022
|
Hoang, Dong Van
|
May 6, 2022
|
|
Comparison of immunogenicity and safety of inactivated, adenovirus-vectored and heterologous adenovirus-vectored/mRNA vaccines in patients with systemic lupus erythematosus and rheumatoid arthritis: a prospective cohort study
First Author: Assawasaksakul, Theerada
Reviewed: May 6, 2022
|
Assawasaksakul, Theerada
|
May 6, 2022
|
|
COVID-19 Infection and Transmission Includes Complex Sequence Diversity
First Author: Chan, Ernest R
Reviewed: May 6, 2022
|
Chan, Ernest R
|
May 6, 2022
|
|
Determinants of SARS-CoV-2 anti-spike antibody levels following BNT162b2 vaccination: cross-sectional analysis of 6,000 SIREN study participants
First Author: Otter, Ashley David
Reviewed: May 6, 2022
|
Otter, Ashley David
|
May 6, 2022
|
|
Dynamics of anti-Spike IgG antibody titer after the third BNT162b2 COVID-19 vaccination in the Japanese health care workers
First Author: Ikezaki, Hiroaki
Reviewed: May 6, 2022
|
Ikezaki, Hiroaki
|
May 6, 2022
|
|
Effectiveness of BBIBP-CorV, BNT162b2 and mRNA-1273 vaccines against hospitalisations among children and adolescents during the Omicron outbreak in Argentina
First Author: Gonzalez, Soledad
Reviewed: May 6, 2022
|
Gonzalez, Soledad
|
May 6, 2022
|
|
Epidemiological impact and cost-effectiveness analysis of COVID-19 vaccination in Kenya
First Author: Orangi, Stacey
Reviewed: May 6, 2022
|
Orangi, Stacey
|
May 6, 2022
|
|
Estimating the distribution of COVID-19-susceptible, -recovered, and -vaccinated individuals in Germany up to April 2022
First Author: Maier, Benjamin F
Reviewed: May 6, 2022
|
Maier, Benjamin F
|
May 6, 2022
|
|
Estimating the risk of hospitalisation and death in England’s remaining unvaccinated population
First Author: Shingleton, Joseph
Reviewed: May 6, 2022
|
Shingleton, Joseph
|
May 6, 2022
|
|
High neutralizing activity against Omicron BA.2 can be induced by COVID-19 mRNA booster vaccination
First Author: Tjan, Lidya Handayani
Reviewed: May 6, 2022
|
Tjan, Lidya Handayani
|
May 6, 2022
|
|
Immune and pathophysiologic profiling of antenatal COVID-19 in the GIFT cohort: A Singaporean case-control study
First Author: Gu, Yue
Reviewed: May 6, 2022
|
Gu, Yue
|
May 6, 2022
|
|
Immune response to 2-dose BNT162b2 vaccination and risk of SARS-CoV-2 breakthrough infection: The Shieldvacc-2 study
First Author: Seekircher, Lisa
Reviewed: May 6, 2022
|
Seekircher, Lisa
|
May 6, 2022
|
|
Investigating Attitudes, Motivations and Key Influencers for vaccine uptake among late adopters of COVID-19 vaccination in Africa
First Author: Tariro Makadzange, A
Reviewed: May 6, 2022
|
Tariro Makadzange, A
|
May 6, 2022
|
|
Lab-on-a-chip multiplexed electrochemical sensor enables simultaneous detection of SARS-CoV-2 RNA and host antibodies
First Author: Najjar, Devora
Reviewed: May 6, 2022
|
Najjar, Devora
|
May 6, 2022
|
|
Monoclonal Antibodies for Treatment of SARS-CoV-2 Infection During Pregnancy
First Author: Mccreary, Erin K
Reviewed: May 6, 2022
|
Mccreary, Erin K
|
May 6, 2022
|
|
Occupational health hazards among healthcare providers and ancillary staff in Ghana: a scoping review
First Author: Tawiah, Philip Apraku
Reviewed: May 6, 2022
|
Tawiah, Philip Apraku
|
May 6, 2022
|
|
Pathogen- and type-specific changes in invasive bacterial disease epidemiology during the first year of the COVID-19 pandemic in the Netherlands
First Author: Steens, Anneke
Reviewed: May 6, 2022
|
Steens, Anneke
|
May 6, 2022
|
|
Pediatric nasal epithelial cells are less permissive to SARS-CoV-2 replication compared to adult cells
First Author: Zhu, Yanshan
Reviewed: May 6, 2022
|
Zhu, Yanshan
|
May 6, 2022
|
|
Peptide derived nanobody inhibits entry of SARS-CoV-2 variants
First Author: Mendon, Nivya
Reviewed: May 6, 2022
|
Mendon, Nivya
|
May 6, 2022
|
|
Predictors of COVID-19 vaccine uptake: An online longitudinal study of US Veterans and non-Veterans
First Author: Thorpe, Alistair
Reviewed: May 6, 2022
|
Thorpe, Alistair
|
May 6, 2022
|
|
Redox regulation of the SARS-CoV-2 main protease provides new opportunities for drug design
First Author: Funk, Lisa Marie
Reviewed: May 6, 2022
|
Funk, Lisa Marie
|
May 6, 2022
|
|
SARS-CoV-2 evolution and immune escape in immunocompromised patients treated with exogenous antibodies
First Author: Scherer, Erin M
Reviewed: May 6, 2022
|
Scherer, Erin M
|
May 6, 2022
|
|
SARS-CoV-2 testing of aircraft wastewater shows that mandatory tests and vaccination pass before boarding did not prevent massive importation of Omicron variant in Europe
First Author: Targa, Lorlane Le
Reviewed: May 6, 2022
|
Targa, Lorlane Le
|
May 6, 2022
|
|
Similar viral loads in Omicron infections regardless of vaccination status
First Author: Hirotsu, Yosuke
Reviewed: May 6, 2022
|
Hirotsu, Yosuke
|
May 6, 2022
|
|
Strong peak immunogenicity but rapid antibody waning following third vaccine dose in elderly residents of care homes
First Author: Tut, Gokhan
Reviewed: May 6, 2022
|
Tut, Gokhan
|
May 6, 2022
|
|
The COVID-19 Omicron wave in the framework of a new mathematical modeling in few European countriesand the right time for lifting restrictions
First Author: Petkov, Pavel
Reviewed: May 6, 2022
|
Petkov, Pavel
|
May 6, 2022
|
|
Uncovering the structural flexibility of SARS-CoV-2 glycoprotein spike variants
First Author: Arruda, Hiam R S
Reviewed: May 6, 2022
|
Arruda, Hiam R S
|
May 6, 2022
|
|
Vaccine effectiveness against SARS-CoV-2 infection and COVID-19-related hospitalization with the Alpha, Delta and Omicron SARS-CoV-2 variants: a nationwide Danish cohort study
First Author: Gram, Mie Agermose
Reviewed: May 6, 2022
|
Gram, Mie Agermose
|
May 6, 2022
|
|
Wastewater to clinical case (WC) ratio of COVID-19 identifies insufficient clinical testing, onset of new variants of concern and population immunity in urban communities
First Author: D Aoust, Patrick M
Reviewed: May 6, 2022
|
D Aoust, Patrick M
|
May 6, 2022
|
|
Effect of oral nirmatrelvir on Long COVID symptoms: a case series
First Author: Peluso, Michael J
Reviewed: May 5, 2022
|
Peluso, Michael J
|
May 5, 2022
|
|
First Identification of SARS-CoV-2 Omicron BA.4 Lineage in Italy: Genomic Comparison with Omicron Lineages
First Author: Cinzia Peronace
Reviewed: May 5, 2022
|
Cinzia Peronace
|
May 5, 2022
|
|
Relationship between the coronavirus 2019 disease (COVID-19) vaccines and the development of new lower urinary tract symptoms: A cross-sectional study on medical students.
First Author: Al Smadi, Jad Khaled
Reviewed: May 5, 2022
|
Al Smadi, Jad Khaled
|
May 5, 2022
|
|
A New Approach to Modelling Pre-symptomatic Incidence and Transmission Time of SARS-CoV-2 Variants
First Author: Chen, Sam Li Sheng
Reviewed: May 4, 2022
|
Chen, Sam Li Sheng
|
May 4, 2022
|
|
Long-COVID post-viral chronic fatigue and affective symptoms are associated with oxidative damage, lowered antioxidant defenses and inflammation: a proof of concept and mechanism study.
First Author: Al Hakeim, Hussein Kadhem
Reviewed: May 4, 2022
|
Al Hakeim, Hussein Kadhem
|
May 4, 2022
|
|
Safety and Immunogenicity of a Third Dose of SARS-CoV-2 mRNA Vaccine — An Interim Analysis
First Author: Anderson, Evan
Reviewed: May 4, 2022
|
Anderson, Evan
|
May 4, 2022
|
|
A bacteriophage-based, highly efficacious, needle and adjuvant-free, mucosal COVID-19 vaccine
First Author: Zhu, Jingen
Reviewed: May 3, 2022
|
Zhu, Jingen
|
May 3, 2022
|
|
BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron BA.1 infection
First Author: Xie, Xiaoliang
Reviewed: May 3, 2022
|
Xie, Xiaoliang
|
May 3, 2022
|
|
Investment strategy for blockchain technology in a shipping supply chain
First Author: Xin, Xu
Reviewed: May 3, 2022
|
Xin, Xu
|
May 3, 2022
|
|
Protection against Omicron re-infection conferred by prior heterologous SARS-CoV-2 infection, with and without mRNA vaccination
First Author: Carazo, Sara
Reviewed: May 3, 2022
|
Carazo, Sara
|
May 3, 2022
|
|
SARS-CoV-2 Omicron Variant is as Deadly as Previous Waves After Adjusting for Vaccinations, Demographics, and Comorbidities
First Author: Strasser, Zachary
Reviewed: May 3, 2022
|
Strasser, Zachary
|
May 3, 2022
|
|
The impact of COVID-19 pandemic on bronchiolitis (lower respiratory tract infection) due to respiratory syncytial virus: A systematic review and meta-analysis
First Author: Sabeena, Sasidharanpillai
Reviewed: May 3, 2022
|
Sabeena, Sasidharanpillai
|
May 3, 2022
|
|
First Author:
Reviewed: May 2, 2022
|
|
May 2, 2022
|
|
First Author:
Reviewed: May 2, 2022
|
|
May 2, 2022
|
|
A case of ANCA-associated vasculitis in a 16-year-old female following SARS-COV-2 infection and a systematic review of the literature
First Author: Bryant, Maria C
Reviewed: May 2, 2022
|
Bryant, Maria C
|
May 2, 2022
|
|
A feasibility study proposal of the predictive model to enable the
prediction of population susceptibility to COVID-19 by analysis of vaccine
utilization for advising deployment of a booster dose
First Author: Jittprasong, Chottiwatt
Reviewed: May 2, 2022
|
Jittprasong, Chottiwatt
|
May 2, 2022
|
|
A Pan-Coronavirus Vaccine Candidate: Nine Amino Acid Substitutions in the ORF1ab Gene Attenuate 99% of 365 Unique Coronaviruses: A Comparative Effectiveness Research Study
First Author: Luellen, Eric
Reviewed: May 2, 2022
|
Luellen, Eric
|
May 2, 2022
|
|
A Southeast Asia Expert Review of Global Real-World Vaccine Effectiveness Against SARS-CoV-2
First Author: Chuenkitmongkol, Sunate
Reviewed: May 2, 2022
|
Chuenkitmongkol, Sunate
|
May 2, 2022
|
|
Anti SARS-CoV2 seroprevalence in Zanzibar in 2021 before the Omicron wave
First Author: Salum, Salum Seif
Reviewed: May 2, 2022
|
Salum, Salum Seif
|
May 2, 2022
|
|
Antibody response and intra-host viral evolution after plasma therapy in COVID-19 patients pre-exposed or not to B-cell depleting agents
First Author: Gachoud, David
Reviewed: May 2, 2022
|
Gachoud, David
|
May 2, 2022
|
|
Anti-SARS-CoV-2 spike antibody titers and neutralizing antibodies in vaccinated rheumatoid arthritis patients.
First Author: Furukawa, Hiroshi
Reviewed: May 2, 2022
|
Furukawa, Hiroshi
|
May 2, 2022
|
|
Anti-SARS-Cov-2 S-RBD IgG formed after BNT162b2 vaccination can bind C1q and activate complement
First Author: Abu Humaidan, Anas H A
Reviewed: May 2, 2022
|
Abu Humaidan, Anas H A
|
May 2, 2022
|
|
Challenges of Equitable Vaccine Distribution in the COVID-19 Pandemic
First Author: Bae, Joseph
Reviewed: May 2, 2022
|
Bae, Joseph
|
May 2, 2022
|
|
Characterization of Autonomic Symptom Burden in Long COVID: A Global Survey of 2,314 Adults
First Author: Larsen, Nicholas W
Reviewed: May 2, 2022
|
Larsen, Nicholas W
|
May 2, 2022
|
|
Clinical characteristics and outcome of immunocompromised patients with COVID-19 caused by the Omicron variant: a prospective observational study
First Author: Reshwan K Malahe, S
Reviewed: May 2, 2022
|
Reshwan K Malahe, S
|
May 2, 2022
|
|
Cortical Grey Matter Volume Loss links to Neurological Sequelae in post COVID-19 “Long Haulers”
First Author: Rothstein, Ted L
Reviewed: May 2, 2022
|
Rothstein, Ted L
|
May 2, 2022
|
|
COVID-19 third wave experience in India, a survey of 5971 adults
First Author: Jayadevan, Rajeev
Reviewed: May 2, 2022
|
Jayadevan, Rajeev
|
May 2, 2022
|
|
Cytokine Hub Classification of PASC, ME-CFS and other PASC-like Conditions
First Author: Patterson, Bruce K
Reviewed: May 2, 2022
|
Patterson, Bruce K
|
May 2, 2022
|
|
Delayed booster dosing improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine
First Author: Nielsen, C M
Reviewed: May 2, 2022
|
Nielsen, C M
|
May 2, 2022
|
|
Effectiveness of Primary and Booster COVID-19 mRNA Vaccination against Omicron Variant SARS-CoV-2 Infection in People with a Prior SARS-CoV-2 Infection
First Author: Lind, Margaret L
Reviewed: May 2, 2022
|
Lind, Margaret L
|
May 2, 2022
|
|
Femoral head osteonecrosis post-COVID-19 infection, a prophecy coming true. A report of seven hips.
First Author: Mahran, Mohamed A
Reviewed: May 2, 2022
|
Mahran, Mohamed A
|
May 2, 2022
|
|
Higher contact among vaccinated can be a mechanism for negative vaccine effectiveness
First Author: Bodner, Korryn
Reviewed: May 2, 2022
|
Bodner, Korryn
|
May 2, 2022
|
|
Hospitalized patients with severe COVID-19 during the Omicron wave in Israel - benefits of a fourth vaccine dose
First Author: Brosh Nissimov, Tal
Reviewed: May 2, 2022
|
Brosh Nissimov, Tal
|
May 2, 2022
|
|
How Risky if China Moves Away from Its Zero-COVID Policy?
First Author: Ji-Ming Chen
Reviewed: May 2, 2022
|
Ji-Ming Chen
|
May 2, 2022
|
|
Immunogenicity, efficacy, and safety of SARS-CoV-2 vaccine dose fractionation: a systematic review and meta-analysis
First Author: Yang, Bingyi
Reviewed: May 2, 2022
|
Yang, Bingyi
|
May 2, 2022
|
|
Impact of the additional/booster dose of COVID-19 vaccine against severe disease during the epidemic phase characterized by the predominance of the Omicron variant in Italy, November 2021 - March 2022
First Author: Branda, Francesco
Reviewed: May 2, 2022
|
Branda, Francesco
|
May 2, 2022
|
|
Induction of neutralizing antibodies against SARS-CoV-2 variants by a multivalent mRNA-lipid nanoparticle vaccine encoding SARS-CoV-2/SARS-CoV Spike protein receptor-binding domains
First Author: Zhang, Qiong
Reviewed: May 2, 2022
|
Zhang, Qiong
|
May 2, 2022
|
|
Kinetics of immune responses elicited after three mRNA COVID-19 vaccine doses in predominantly antibody-deficient individuals.
First Author: Ainsua Enrich, Erola
Reviewed: May 2, 2022
|
Ainsua Enrich, Erola
|
May 2, 2022
|
|
Long-COVID post-viral chronic fatigue syndrome and affective symptoms are associated with oxidative damage, lowered antioxidant defenses and inflammation: a proof of concept and mechanism study
First Author: Al Hakeim, Hussein Kadhem
Reviewed: May 2, 2022
|
Al Hakeim, Hussein Kadhem
|
May 2, 2022
|
|
Mapping the emergence of SARS-CoV-2 Omicron variants on a university campus
First Author: Weil, Ana A
Reviewed: May 2, 2022
|
Weil, Ana A
|
May 2, 2022
|
|
Mobile Primary Healthcare for post-COVID Patients in Rural Areas: a Proof-of-Concept Study
First Author: Stallmach, Andreas
Reviewed: May 2, 2022
|
Stallmach, Andreas
|
May 2, 2022
|
|
Modelling the transmission dynamics of a multi-strain SARS-CoV-2 epidemic with vaccination for an emerging strain
First Author: Kayanja, Andrew
Reviewed: May 2, 2022
|
Kayanja, Andrew
|
May 2, 2022
|
|
Observed strong pervasive positive selection in the N-terminal domain, receptor-binding domain and furin-cleavage sites of SARS-CoV-2 Spike protein sampled from Zimbabwean COVID-19 patients
First Author: Kambarami, Milton S
Reviewed: May 2, 2022
|
Kambarami, Milton S
|
May 2, 2022
|
|
P681 mutations within the polybasic motif of spike dictate fusogenicity and syncytia formation of SARS CoV-2 variants
First Author: Kuzmina, Alona
Reviewed: May 2, 2022
|
Kuzmina, Alona
|
May 2, 2022
|
|
Percentages of Vaccination Coverage Required To Establish Herd Immunity Against SARS-Cov-2
First Author: Pedro Plans-Rubió
Reviewed: May 2, 2022
|
Pedro Plans-Rubió
|
May 2, 2022
|
|
Reactogenicity, Safety, and Serological and Cellular Immunogenicity of a Booster Dose of SARS-CoV-2 mRNA Prototype, Variant, and Bivalent Vaccines
First Author: Anderson, Evan J
Reviewed: May 2, 2022
|
Anderson, Evan J
|
May 2, 2022
|
|
Real-world study of the effectiveness of BBIBP-CorV (Sinopharm) COVID-19 vaccine in the Kingdom of Morocco
First Author: Zhang, Yaowen
Reviewed: May 2, 2022
|
Zhang, Yaowen
|
May 2, 2022
|
|
Regional replacement of SARS-CoV-2 variant BA.1 with BA.2 as observed through wastewater surveillance
First Author: Boehm, Alexandria B
Reviewed: May 2, 2022
|
Boehm, Alexandria B
|
May 2, 2022
|
|
Removal of Clinically Relevant SARS-CoV-2 Variants by An Affinity Resin Containing Galanthus nivalis Agglutinin
First Author: Gooldy, Melanie
Reviewed: May 2, 2022
|
Gooldy, Melanie
|
May 2, 2022
|
|
Safety, tolerability and immunogenicity of Biological E’s CORBEVAX™ vaccine in children and adolescents: A Prospective, Randomised, Double-blind, Placebo controlled, Phase-2/3 Study
First Author: Thuluva, Subhash
Reviewed: May 2, 2022
|
Thuluva, Subhash
|
May 2, 2022
|
|
Seasonal patterns of SARS-CoV-2 transmission in secondary schools: a modelling study
First Author: Pham, Thi Mui
Reviewed: May 2, 2022
|
Pham, Thi Mui
|
May 2, 2022
|
|
Shared N417-dependent epitope on the SARS-CoV-2 Omicron, Beta and Delta-plus variants
First Author: Moyo Gwete, Thandeka
Reviewed: May 2, 2022
|
Moyo Gwete, Thandeka
|
May 2, 2022
|
|
The Balancing Role of Distribution Speed against Varying Efficacy Levels of COVID-19 Vaccines under Variants
First Author: Kim, Daniel
Reviewed: May 2, 2022
|
Kim, Daniel
|
May 2, 2022
|
|
The green tea catechin EGCG provides proof-of-concept for a pan-coronavirus attachment inhibitor
First Author: Colpitts, Che C
Reviewed: May 2, 2022
|
Colpitts, Che C
|
May 2, 2022
|
|
The risk factors and outcomes for radiological abnormalities in early convalescence of COVID-19 patients caused by the SARS-CoV-2 Omicron variant in Tianjin, China: a retrospective, multicenter follow-up study
First Author: Wang, Hong
Reviewed: May 2, 2022
|
Wang, Hong
|
May 2, 2022
|
|
The SARS-CoV-2 Omicron Variant of Concern and its Rapid Spread throughout the Western Brazilian Amazon
First Author: Gabriella Sgorlon-Oliveira
Reviewed: May 2, 2022
|
Gabriella Sgorlon-Oliveira
|
May 2, 2022
|
|
The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA.1 phenotype
First Author: Barut, Tuba
Reviewed: May 2, 2022
|
Barut, Tuba
|
May 2, 2022
|
|
Vaccine effectiveness of CoronaVac against symptomatic and severe COVID-19 among children in Brazil during the Omicron period
First Author: Florentino, Pilar
Reviewed: May 2, 2022
|
Florentino, Pilar
|
May 2, 2022
|
|
A systematic review and meta-analysis of Long COVID symptoms
First Author: Natarajan, Arun
Reviewed: Apr 29, 2022
|
Natarajan, Arun
|
Apr 29, 2022
|
|
Acupuncture in multidisciplinary treatment of post-COVID-19 Syndrome: A Case Report
First Author: Trager, Robert J
Reviewed: Apr 29, 2022
|
Trager, Robert J
|
Apr 29, 2022
|
|
Acute and long-term impacts of COVID-19 on economic vulnerability: a population-based longitudinal study (COVIDENCE UK)
First Author: Williamson, Anne E
Reviewed: Apr 29, 2022
|
Williamson, Anne E
|
Apr 29, 2022
|
|
Blood group O and post-COVID-19 syndrome
First Author: Diaz Salazar, Sara
Reviewed: Apr 29, 2022
|
Diaz Salazar, Sara
|
Apr 29, 2022
|
|
Brain functional connectivity alterations associated with neuropsychological post-COVID syndrome
First Author: Voruz, Philippe
Reviewed: Apr 29, 2022
|
Voruz, Philippe
|
Apr 29, 2022
|
|
Collaborative Research for Long COVID Haulers in Greece (Characteristics, Clinical Assessment and Rehabilitation). Non-hospitalized and Hospitalized Long COVID Patients Share Similar Symptom Patterns
First Author: Martha Spyridoula Katsarou
Reviewed: Apr 29, 2022
|
Martha Spyridoula Katsarou
|
Apr 29, 2022
|
|
Development of a vocal biomarker for fatigue monitoring in people with COVID-19
First Author: Elbeji, Abir
Reviewed: Apr 29, 2022
|
Elbeji, Abir
|
Apr 29, 2022
|
|
Differential Impact of Quarantine Policies for Recovered COVID-19 Cases in England: A Case Cohort Study of Surveillance Data, June to December 2020
First Author: Merrick, Rachel
Reviewed: Apr 29, 2022
|
Merrick, Rachel
|
Apr 29, 2022
|
|
Differentiating between infectious and non-infectious influenza A virus and coronavirus RNA levels using long-range RT-qPCR
First Author: Juozapaite, Dovile
Reviewed: Apr 29, 2022
|
Juozapaite, Dovile
|
Apr 29, 2022
|
|
Effects of Long-Haul COVID on the Health-Related Quality of Life Among Recovered Hospitalized Patients
First Author: Trihandini, Indang
Reviewed: Apr 29, 2022
|
Trihandini, Indang
|
Apr 29, 2022
|
|
Evaluation of the Retina, Choroid and Optic Disc Vascular Structures In Individuals With a History of Covid-19
First Author: Gedik, Birumut
Reviewed: Apr 29, 2022
|
Gedik, Birumut
|
Apr 29, 2022
|
|
Feasibility of a Group-Based Telerehabilitation Intervention for Long COVID Management.
First Author: King, Meredith
Reviewed: Apr 29, 2022
|
King, Meredith
|
Apr 29, 2022
|
|
Functional Relationship of Interferon Regulator Factor-5, Interferon-γ, and Hypoxia-Induced Factor-1α with COVID-19 During Pregnancy Outcomes
First Author: Herkiloglu, Dilsad
Reviewed: Apr 29, 2022
|
Herkiloglu, Dilsad
|
Apr 29, 2022
|
|
High frequency and persistence of Anti-DSG2 antibodies in post COVID-19 serum samples
First Author: Lee, Edward
Reviewed: Apr 29, 2022
|
Lee, Edward
|
Apr 29, 2022
|
|
Higher Limbic and Basal Ganglia volumes in surviving COVID-negative patients and the relations to fatigue
First Author: Hafiz, Rakibul
Reviewed: Apr 29, 2022
|
Hafiz, Rakibul
|
Apr 29, 2022
|
|
Impact of long-term COVID on workers: a systematic review protocol
First Author: Prado, Camila Bruneli Do
Reviewed: Apr 29, 2022
|
Prado, Camila Bruneli Do
|
Apr 29, 2022
|
|
Impacts of COVID-19 on glycemia and risk of diabetic ketoacidosis
First Author: Sharma, Anukriti
Reviewed: Apr 29, 2022
|
Sharma, Anukriti
|
Apr 29, 2022
|
|
Interstitial lung damage following COVID-19 hospitalisation: an interim analysis of the UKILD Post-COVID study
First Author: I, Stewart
Reviewed: Apr 29, 2022
|
I, Stewart
|
Apr 29, 2022
|
|
Long COVID and its associated factors among COVID survivors in the community from a middle-income country – an online cross-sectional study
First Author: Moy, Foong Ming
Reviewed: Apr 29, 2022
|
Moy, Foong Ming
|
Apr 29, 2022
|
|
Long COVID and Symptom Trajectory in a Representative Sample of Americans
First Author: Wu, Qiao
Reviewed: Apr 29, 2022
|
Wu, Qiao
|
Apr 29, 2022
|
|
Long COVID in Children and Adolescents: A Systematic Review and Meta-analyses
First Author: Lopez Leon, Sandra
Reviewed: Apr 29, 2022
|
Lopez Leon, Sandra
|
Apr 29, 2022
|
|
Mid-term subclinical myocardial injury detection in patients recovered from COVID-19 according pulmonary lesion severity
First Author: Chamtouri, Ikram
Reviewed: Apr 29, 2022
|
Chamtouri, Ikram
|
Apr 29, 2022
|
|
Monocytosis in the Acute Phase of SARS-CoV-2 Infection Predicts the Presence of Anosognosia for Cognitive Deficits in the Chronic Phase
First Author: Nuber Champier, Anthony
Reviewed: Apr 29, 2022
|
Nuber Champier, Anthony
|
Apr 29, 2022
|
|
Multi-organ impairment and Long COVID: a 1-year prospective, longitudinal cohort study
First Author: Dennis, Andrea
Reviewed: Apr 29, 2022
|
Dennis, Andrea
|
Apr 29, 2022
|
|
Non-Coding RNA in Idiopathic Interstitial Pneumonia and Covid-19 Pulmonary Fibrosis
First Author: Ali, Mohammad Shadab
Reviewed: Apr 29, 2022
|
Ali, Mohammad Shadab
|
Apr 29, 2022
|
|
Patients at risk of pulmonary fibrosis Post Covid-19: Epidemiology, pulmonary sequelaes and humoral response
First Author: Porto, Miriam Hernandez
Reviewed: Apr 29, 2022
|
Porto, Miriam Hernandez
|
Apr 29, 2022
|
|
Physical Activity, Stress and Quality Of Life among Community-Dwelling Older Adults in Shenzhen during the Post-COVID-19 Pandemic Period
First Author: Zhang, Xiaoying
Reviewed: Apr 29, 2022
|
Zhang, Xiaoying
|
Apr 29, 2022
|
|
Possible Role of P-selectin Adhesion in Long-COVID: A Comparative Analysis of a Long-COVID Case Versus an Asymptomatic Post-COVID Case
First Author: Tarasev, Michael
Reviewed: Apr 29, 2022
|
Tarasev, Michael
|
Apr 29, 2022
|
|
Post COVID-19 Condition in South Africa: 3-month follow-up after hospitalisation with SARS-CoV-2
First Author: Dryden, Murray
Reviewed: Apr 29, 2022
|
Dryden, Murray
|
Apr 29, 2022
|
|
Prevalence, determinants, and impact on general health and working capacity of post-acute sequelae of COVID-19 six to 12 months after infection: a population-based retrospective cohort study from southern Germany
First Author: Peter, Raphael S
Reviewed: Apr 29, 2022
|
Peter, Raphael S
|
Apr 29, 2022
|
|
Reassessment of persistent symptoms, self-reported COVID-19 infection and SARS-CoV-2 serology in the SAPRIS-SERO cohort: identifying possible sub-syndromes of Long Covid
First Author: Spiers, Nicola
Reviewed: Apr 29, 2022
|
Spiers, Nicola
|
Apr 29, 2022
|
|
Retinal Findings and Pitfalls of Optical Coherence Tomography Evaluation of The Inner Retina in Covid-19 Patients
First Author: Sousa, Ednan Cardoso De
Reviewed: Apr 29, 2022
|
Sousa, Ednan Cardoso De
|
Apr 29, 2022
|
|
Risk factors and preventive interventions for post Covid-19 condition: systematic reviews
First Author: Pillay, Jennifer
Reviewed: Apr 29, 2022
|
Pillay, Jennifer
|
Apr 29, 2022
|
|
The changing characteristics of post-COVID-19 syndrome: Cross-sectional findings from 458 consultations using the Stanford Hall remote rehabilitation assessment tool
First Author: O Sullivan, Oliver
Reviewed: Apr 29, 2022
|
O Sullivan, Oliver
|
Apr 29, 2022
|
|
The modified COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm) patient-reported outcome measure for Long Covid or Post-COVID syndrome
First Author: Sivan, Manoj
Reviewed: Apr 29, 2022
|
Sivan, Manoj
|
Apr 29, 2022
|
|
Unilateral Diaphragm Paralysis Following COVID-19 Infection
First Author: Lowenkamp, Mikayla N
Reviewed: Apr 29, 2022
|
Lowenkamp, Mikayla N
|
Apr 29, 2022
|
|
Unique molecular signatures sustained in circulating monocytes and regulatory T cells in Convalescent COVID-19 patients
First Author: Hoffmann, Andrew D
Reviewed: Apr 29, 2022
|
Hoffmann, Andrew D
|
Apr 29, 2022
|
|
Validity of reported post-acute health outcomes in children with SARS-CoV-2 infection: a systematic review
First Author: Hirt, Julian
Reviewed: Apr 29, 2022
|
Hirt, Julian
|
Apr 29, 2022
|
|
Bilateral Aspergillosis endogenous endophthalmitis in post COVID-19 recovered patient; a clinical case report
First Author: Zia, Zahra
Reviewed: Apr 28, 2022
|
Zia, Zahra
|
Apr 28, 2022
|
|
Cardiac impairment in Long Covid 1-year post-SARS-CoV-2 infection
First Author: Roca Fernandez, Adriana
Reviewed: Apr 28, 2022
|
Roca Fernandez, Adriana
|
Apr 28, 2022
|
|
Clinical features, therapeutic outcomes and recovery period of long COVID
First Author: Takakura, Kazuki
Reviewed: Apr 28, 2022
|
Takakura, Kazuki
|
Apr 28, 2022
|
|
COVID-19-associated mucormycosis in Iran: A retrospective study on 52 patients
First Author: Tavakolpour, Soheil
Reviewed: Apr 28, 2022
|
Tavakolpour, Soheil
|
Apr 28, 2022
|
|
Dark-field Chest X-ray Imaging for the Assessment of COVID‑19‑Pneumonia
First Author: Frank, Manuela
Reviewed: Apr 28, 2022
|
Frank, Manuela
|
Apr 28, 2022
|
|
Developing a model for predicting impairing physical symptoms in children 3 months after a SARS-CoV-2 PCR-test: The CLoCk Study
First Author: Nugawela, Manjula D
Reviewed: Apr 28, 2022
|
Nugawela, Manjula D
|
Apr 28, 2022
|
|
Diagnostic guidance for patients with persistent pulmonary abnormalities after COVID-19 infection: the potential benefit of 68Ga-FAPI PET/CT
First Author: Sviridenko, Anna
Reviewed: Apr 28, 2022
|
Sviridenko, Anna
|
Apr 28, 2022
|
|
Does COVID-19 infection change thyroid hormone levels? A comparative cross-sectional study in Iran
First Author: Afshari, Poorandokht
Reviewed: Apr 28, 2022
|
Afshari, Poorandokht
|
Apr 28, 2022
|
|
Does pre-infection stress increase the risk of long COVID? Longitudinal associations between adversity worries and experiences in the month prior to COVID-19 infection and the development of long COVID and specific long COVID symptoms
First Author: Paul, Elise
Reviewed: Apr 28, 2022
|
Paul, Elise
|
Apr 28, 2022
|
|
Ethical and Social insights into Synthetic Biology: Bibliometric approach and predicting research fronts in POST-COVID-19 era
First Author: Wang, Gaofeng
Reviewed: Apr 28, 2022
|
Wang, Gaofeng
|
Apr 28, 2022
|
|
Evidence for positive long- and short-term effects of vaccinations
against COVID-19 in wearable sensor metrics -- Insights from the German
Corona Data Donation Project
First Author: Wiedermann, Marc
Reviewed: Apr 28, 2022
|
Wiedermann, Marc
|
Apr 28, 2022
|
|
Health behaviours the month prior to COVID-19 infection and the development of self-reported long COVID and specific long COVID symptoms: A longitudinal analysis of 1,811 UK adults
First Author: Paul, Elise
Reviewed: Apr 28, 2022
|
Paul, Elise
|
Apr 28, 2022
|
|
In Silico transcriptional analysis of asymptomatic and severe COVID-19 patients reveals the susceptibility of severe patients to other comorbidities and non-viral pathological conditions
First Author: Sen, Poonam
Reviewed: Apr 28, 2022
|
Sen, Poonam
|
Apr 28, 2022
|
|
Longitudinal lung function assessment of patients hospitalised with COVID-19 using 1H and 129Xe lung MRI
First Author: Saunders, Laura C
Reviewed: Apr 28, 2022
|
Saunders, Laura C
|
Apr 28, 2022
|
|
Long-term psychological consequences of long Covid: a propensity score matching analysis comparing trajectories of depression and anxiety symptoms before and after contracting long Covid vs short Covid
First Author: Fancourt, Daisy
Reviewed: Apr 28, 2022
|
Fancourt, Daisy
|
Apr 28, 2022
|
|
Lowered oxygen saturation and increased body temperature in acute COVID-19 largely predict chronic fatigue syndrome and affective symptoms due to LONG COVID: a precision nomothetic approach
First Author: Al Hadrawi, Dhurgham Shihab
Reviewed: Apr 28, 2022
|
Al Hadrawi, Dhurgham Shihab
|
Apr 28, 2022
|
|
Markers of Fungal Translocation Are Elevated During Post-Acute Sequelae of SARS-CoV-2 Infection and Induce NF-κB Triggered Inflammation
First Author: Giron, Leila B
Reviewed: Apr 28, 2022
|
Giron, Leila B
|
Apr 28, 2022
|
|
Neural Dysregulation in Post-COVID Fatigue
First Author: Baker, Anne M E
Reviewed: Apr 28, 2022
|
Baker, Anne M E
|
Apr 28, 2022
|
|
Outpatient and Home Pulmonary Rehabilitation Program Post COVID-19: A study protocol for clinical trial
First Author: Oliveira, Luis V F
Reviewed: Apr 28, 2022
|
Oliveira, Luis V F
|
Apr 28, 2022
|
|
Patients’ Perceptions and Experiences of the COVIDCare@Home Program: Insights from a Mixed Methods Study
First Author: Jeffs, Lianne
Reviewed: Apr 28, 2022
|
Jeffs, Lianne
|
Apr 28, 2022
|
|
Persistent post-COVID-19 smell loss is associated with inflammatory infiltration and altered olfactory epithelial gene expression
First Author: Finlay, John B
Reviewed: Apr 28, 2022
|
Finlay, John B
|
Apr 28, 2022
|
|
Post COVID-19 hyperinflammatory acute kidney injury and background ovarian insufficiency: Renal functional restoration after combined angiotensin-converting enzyme inhibitor with estrogen replacement
First Author: Scott Sills, E
Reviewed: Apr 28, 2022
|
Scott Sills, E
|
Apr 28, 2022
|
|
Post-acute sequelae of COVID-19 and adverse psychiatric outcomes: an etiology and risk systematic review protocol
First Author: Effiong, Andem
Reviewed: Apr 28, 2022
|
Effiong, Andem
|
Apr 28, 2022
|
|
Prediction of deterioration from COVID-19 in patients in skilled nursing facilities using wearable and contact-free devices: a feasibility study
First Author: Preyss Friedman, Sabine Von
Reviewed: Apr 28, 2022
|
Preyss Friedman, Sabine Von
|
Apr 28, 2022
|
|
Pulmonary and Renal Long COVID at Two-year Revisit
First Author: Guo, Tiannan
Reviewed: Apr 28, 2022
|
Guo, Tiannan
|
Apr 28, 2022
|
|
Receptor binding domain of SARS-CoV-2 is a functional αv-integrin agonist
First Author: Norris, Emma G
Reviewed: Apr 28, 2022
|
Norris, Emma G
|
Apr 28, 2022
|
|
Re-shaping Post-COVID-19 Teaching and Learning: A Blueprint of
Virtual-Physical Blended Classrooms in the Metaverse Era
First Author: Wang, Yuyang
Reviewed: Apr 28, 2022
|
Wang, Yuyang
|
Apr 28, 2022
|
|
Role of Local Governing Institutions in Community-Based Management of COVID-19 Pandemic in Two States of South-India: Mixed Method Cross-Sectional Study
First Author: Gafurjiwala, Seema M
Reviewed: Apr 28, 2022
|
Gafurjiwala, Seema M
|
Apr 28, 2022
|
|
SARS-CoV-2 hijacks host cell genome instability pathways
First Author: Victor, Joshua
Reviewed: Apr 28, 2022
|
Victor, Joshua
|
Apr 28, 2022
|
|
STIMULATE-ICP-Delphi (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways Delphi): Study Protocol
First Author: Feltz Cornelis, Christina M Van Der
Reviewed: Apr 28, 2022
|
Feltz Cornelis, Christina M Van Der
|
Apr 28, 2022
|
|
Symptoms, physical measures and cognitive tests after SARS-CoV-2 infection in a large population-based case-control study
First Author: Holm, Hilma
Reviewed: Apr 28, 2022
|
Holm, Hilma
|
Apr 28, 2022
|
|
The Brain Reacting to COVID-19: Analysis of the Cerebrospinal Fluid and Serum Proteome,Transcriptome and Inflammatory Proteins
First Author: Reinhold, Dirk
Reviewed: Apr 28, 2022
|
Reinhold, Dirk
|
Apr 28, 2022
|
|
A prospective observational study on BBV152 coronavirus vaccine use in adolescents and comparison with adults- first real-world safety analysis
First Author: Kaur, Upinder
Reviewed: Apr 26, 2022
|
Kaur, Upinder
|
Apr 26, 2022
|
|
Both COVID-19 infection and vaccination induce high-affinity cross-clade responses to SARS-CoV-2 variants
First Author: Emmenegger, Marc
Reviewed: Apr 26, 2022
|
Emmenegger, Marc
|
Apr 26, 2022
|
|
Clinical and Economic Impact of Differential COVID-19 Vaccine Effectiveness in the United States
First Author: Maschio, Michael
Reviewed: Apr 26, 2022
|
Maschio, Michael
|
Apr 26, 2022
|
|
Duration of COVID-19 mRNA Vaccine Effectiveness against Severe Disease
First Author: Bansal, Devendra
Reviewed: Apr 26, 2022
|
Bansal, Devendra
|
Apr 26, 2022
|
|
Effectiveness of 2 and 3 mRNA COVID-19 Vaccines Doses against Omicron and Delta-Related Outpatient Illness among Adults, October 2021 – February 2022
First Author: Kim, Sara S
Reviewed: Apr 26, 2022
|
Kim, Sara S
|
Apr 26, 2022
|
|
High rate of BA.1, BA.1.1 and BA.2 infection in triple vaccinated
First Author: Marking, Ulrika
Reviewed: Apr 26, 2022
|
Marking, Ulrika
|
Apr 26, 2022
|
|
Impact of SARS-CoV-2 vaccination on systemic immune responses in people living with HIV
First Author: Bessen, Clara
Reviewed: Apr 26, 2022
|
Bessen, Clara
|
Apr 26, 2022
|
|
Omicron BA.1 and BA.2 immune response in naïve and prior infected persons
First Author: Knabl, Ludwig
Reviewed: Apr 26, 2022
|
Knabl, Ludwig
|
Apr 26, 2022
|
|
Psychosocial predictors of COVID-19 vaccine uptake among pregnant women: a cross-sectional study in Greece
First Author: Galanis, Petros
Reviewed: Apr 26, 2022
|
Galanis, Petros
|
Apr 26, 2022
|
|
SARS-CoV-2 reinfections with BA.1 (Omicron) variant among fully vaccinated individuals in the northeast of Brazil
First Author: Neto, Francisco P F
Reviewed: Apr 26, 2022
|
Neto, Francisco P F
|
Apr 26, 2022
|
|
SARS-CoV-2 spike S375F mutation characterizes the Omicron BA.1 variant
First Author: Kimura, Izumi
Reviewed: Apr 26, 2022
|
Kimura, Izumi
|
Apr 26, 2022
|
|
Three-dose mRNA-1273 vaccination schedule: sufficient antibody response in majority of immunocompromised hematology patients
First Author: Haggenburg, Sabine
Reviewed: Apr 26, 2022
|
Haggenburg, Sabine
|
Apr 26, 2022
|
|
A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two doses
First Author: Tauzin, Alexandra
Reviewed: Apr 25, 2022
|
Tauzin, Alexandra
|
Apr 25, 2022
|
|
COVID-19 vaccine effectiveness against severe disease from the Omicron BA.1 and BA.2 subvariants – surveillance results from southern Sweden, December 2021 to March 2022
First Author: Bjork, Jonas
Reviewed: Apr 25, 2022
|
Bjork, Jonas
|
Apr 25, 2022
|
|
Effectiveness and waning of protection with different SARS-CoV-2 primary and booster vaccines during the Delta pandemic wave in 2021 in Hungary (HUN-VE 3 study)
First Author: Voko, Zoltan
Reviewed: Apr 25, 2022
|
Voko, Zoltan
|
Apr 25, 2022
|
|
Effectiveness of a Fourth Dose of COVID-19 Vaccine among Long-Term Care Residents in Ontario, Canada
First Author: Grewal, Ramandip
Reviewed: Apr 25, 2022
|
Grewal, Ramandip
|
Apr 25, 2022
|
|
Effectiveness of Four Vaccines in Preventing SARS-CoV-2 Infection in Kazakhstan
First Author: Nabirova, Dilyara
Reviewed: Apr 25, 2022
|
Nabirova, Dilyara
|
Apr 25, 2022
|
|
Genetic risk and incident venous thromboembolism in middle-aged and older adults following Covid-19 vaccination
First Author: Xie, Junqing
Reviewed: Apr 25, 2022
|
Xie, Junqing
|
Apr 25, 2022
|
|
Inhaled Aviptadil for the treatment of COVID-19 in patients at high risk for ARDS: Study protocol for a randomized, placebo controlled multicentre trial.
First Author: Boesing, Maria
Reviewed: Apr 25, 2022
|
Boesing, Maria
|
Apr 25, 2022
|
|
Multi-faceted analysis of COVID-19 epidemic in the Republic of Korea considering Omicron variant: Mathematical modeling-based study
First Author: Ko, Youngsuk
Reviewed: Apr 25, 2022
|
Ko, Youngsuk
|
Apr 25, 2022
|
|
Omicron Sublineages Current Status in Ecuador
First Author: Andrés Carrazco-Montalvo
Reviewed: Apr 25, 2022
|
Andrés Carrazco-Montalvo
|
Apr 25, 2022
|
|
PERMISSIVE OMICRON BREAKTHROUGH INFECTIONS IN INDIVIDUALS WITH BINDING OR NEUTRALIZING ANTIBODIES TO ANCESTRAL SARS-CoV-2
First Author: Williams, Erin
Reviewed: Apr 25, 2022
|
Williams, Erin
|
Apr 25, 2022
|
|
PhyloTransformer: A Self-supervised Discriminative Model for Mutation Prediction Based on a Multi-head Self-attention Mechanism
First Author: Wu, Yingying
Reviewed: Apr 25, 2022
|
Wu, Yingying
|
Apr 25, 2022
|
|
Previous SARS-CoV-2 infection or a third dose of vaccine elicited cross-variant neutralizing antibodies in vaccinated solid organ transplant recipients
First Author: Chang, Chih Chao
Reviewed: Apr 25, 2022
|
Chang, Chih Chao
|
Apr 25, 2022
|
|
The SARS-CoV-2 Omicron BA.1 spike G446S potentiates HLA-A*24:02-restricted T cell immunity
First Author: Motozono, Chihiro
Reviewed: Apr 25, 2022
|
Motozono, Chihiro
|
Apr 25, 2022
|
|
Characteristics of Patients with Hematologic Malignancies Without Seroconversion Post-COVID19 Third Vaccine Dosing
First Author: Hallmeyer, Sigrun
Reviewed: Apr 22, 2022
|
Hallmeyer, Sigrun
|
Apr 22, 2022
|
|
Crystal structure of the Rubella virus protease reveals a unique papain-like protease fold
First Author: Cheong, Ezekiel Ze Ken
Reviewed: Apr 22, 2022
|
Cheong, Ezekiel Ze Ken
|
Apr 22, 2022
|
|
Disease profile and plasma neutralizing activity of post-vaccination Omicron BA.1 infection in Tianjin, China: a retrospective study
First Author: Zheng, Hong
Reviewed: Apr 22, 2022
|
Zheng, Hong
|
Apr 22, 2022
|
|
Early-stage antibody kinetics after the third dose of BNT162b2 mRNA COVID-19 vaccination measured by a point-of-care fingertip whole blood testing
First Author: Hagiya, Hideharu
Reviewed: Apr 22, 2022
|
Hagiya, Hideharu
|
Apr 22, 2022
|
|
Effectiveness of ChAdOx1 nCoV-19 Corona Virus Vaccine (Covishield™) in preventing SARS-CoV2 infection, Chennai, Tamil Nadu, India, 2021
First Author: Murali, Sharan
Reviewed: Apr 22, 2022
|
Murali, Sharan
|
Apr 22, 2022
|
|
Effectiveness of COVID-19 mRNA vaccine booster dose relative to primary series during a period of Omicron circulation
First Author: Petrie, Joshua G
Reviewed: Apr 22, 2022
|
Petrie, Joshua G
|
Apr 22, 2022
|
|
Evaluation of isotype specific salivary antibody assays for detecting previous SARS-CoV-2 infection in children and adults
First Author: Thomas, Amy C
Reviewed: Apr 22, 2022
|
Thomas, Amy C
|
Apr 22, 2022
|
|
Heterologous Gam-COVID-Vac (Sputnik V) / mRNA-1273 (Moderna) vaccination induces a stronger humoral response than homologous Sputnik V in a real-world data analysis
First Author: Pereson, Matias J
Reviewed: Apr 22, 2022
|
Pereson, Matias J
|
Apr 22, 2022
|
|
Mathematical artificial intelligence design of mutation-proof COVID-19
monoclonal antibodies
First Author: Chen, Jiahui
Reviewed: Apr 22, 2022
|
Chen, Jiahui
|
Apr 22, 2022
|
|
mRNA-1273 but not BNT162b2 induces antibodies against polyethylene glycol (PEG) contained in mRNA-based vaccine formulations
First Author: Carreno, Juan Manuel
Reviewed: Apr 22, 2022
|
Carreno, Juan Manuel
|
Apr 22, 2022
|
|
Profile of Brazilian inpatients with COVID-19 vaccine breakthrough infection and risk factors for unfavorable outcome
First Author: Jesus, Matheus A S De
Reviewed: Apr 22, 2022
|
Jesus, Matheus A S De
|
Apr 22, 2022
|
|
Seroprevalence, correlates and kinetics of SARS-CoV-2 Nucleocapsid IgG antibody in healthcare workers at a tertiary hospital: A prevaccine census study
First Author: Maina, Daniel
Reviewed: Apr 22, 2022
|
Maina, Daniel
|
Apr 22, 2022
|
|
Using a real-world network to model the tradeoff between stay-at-home restriction, vaccination, social distancing and working hours on COVID-19 dynamics
First Author: Nashebi, Ramin
Reviewed: Apr 22, 2022
|
Nashebi, Ramin
|
Apr 22, 2022
|
|
Vaccine effectiveness of CanSino (Adv5-nCoV) COVID-19 vaccine among childcare workers – Mexico, March–December 2021
First Author: Richardson, Vesta L
Reviewed: Apr 22, 2022
|
Richardson, Vesta L
|
Apr 22, 2022
|
|
Safety and tolerability of COVID-19 vaccines in patients with cancer: a single center retrospective analysis
First Author: Nuzzo, Amedeo
Reviewed: Apr 21, 2022
|
Nuzzo, Amedeo
|
Apr 21, 2022
|
|
SARS-CoV-2 infection, vaccination and antibody response trajectories in adults: a cohort study in Catalonia
First Author: Karachaliou, Marianna
Reviewed: Apr 21, 2022
|
Karachaliou, Marianna
|
Apr 21, 2022
|
|
Ultrafast disinfection of SARS-CoV-2 viruses
First Author: Xu, Yang
Reviewed: Apr 21, 2022
|
Xu, Yang
|
Apr 21, 2022
|
|
Broadly neutralizing and protective nanobodies against diverse sarbecoviruses
First Author: Li, Mingxi
Reviewed: Apr 20, 2022
|
Li, Mingxi
|
Apr 20, 2022
|
|
Determinants of Spike Infectivity, Processing and Neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2
First Author: Pastorio, Chiara
Reviewed: Apr 20, 2022
|
Pastorio, Chiara
|
Apr 20, 2022
|
|
Epitope Mapping of SARS-CoV-2 Spike Protein Reveals Distinguishable Antibody Binding Activity of Vaccinated and Infected Individuals
First Author: Felbinger, Nathaniel
Reviewed: Apr 20, 2022
|
Felbinger, Nathaniel
|
Apr 20, 2022
|
|
SARS-CoV-2 Delta breakthrough infections in vaccinated patients
First Author: Zou, Jing
Reviewed: Apr 20, 2022
|
Zou, Jing
|
Apr 20, 2022
|
|
Understanding community level influences on COVID-19 prevalence in England: New insights from comparison over time and space
First Author: Joshi, Chaitanya
Reviewed: Apr 20, 2022
|
Joshi, Chaitanya
|
Apr 20, 2022
|
|
A high potent synthetic nanobody with broad-spectrum activity neutralizes SARS-Cov-2 virus and Omicron variant through a unique binding mode
First Author: Zhao, Dongping
Reviewed: Apr 19, 2022
|
Zhao, Dongping
|
Apr 19, 2022
|
|
Antibody- and T cell-dependent responses elicited by a SARS-CoV-2 adenoviral-based vaccine in a socially vulnerable cohort of elderly individuals
First Author: Moya, Martin
Reviewed: Apr 19, 2022
|
Moya, Martin
|
Apr 19, 2022
|
|
Broadly neutralizing antibodies target the coronavirus fusion peptide
First Author: Dacon, Cherrelle
Reviewed: Apr 19, 2022
|
Dacon, Cherrelle
|
Apr 19, 2022
|
|
Compact method of SARS-CoV-2 PCR detection enhances overall process of diagnosing Delta and Omicron variants
First Author: Kim, Jae Jong
Reviewed: Apr 19, 2022
|
Kim, Jae Jong
|
Apr 19, 2022
|
|
COVID-19 vaccine effectiveness against SARS-CoV-2 infection in the United States prior to the Delta and Omicron-associated surges: a retrospective cohort study of repeat blood donors
First Author: Grebe, Eduard
Reviewed: Apr 19, 2022
|
Grebe, Eduard
|
Apr 19, 2022
|
|
Effectiveness of COVID-19 vaccines against hospitalization and death in Canada: A multiprovincial test-negative design study
First Author: Nasreen, Sharifa
Reviewed: Apr 19, 2022
|
Nasreen, Sharifa
|
Apr 19, 2022
|
|
Effectiveness of the BNT162b vaccine fourth dose in reducing SARS-CoV-2 infection among healthcare workers in Israel, a multi-center cohort study
First Author: Cohen, Matan J
Reviewed: Apr 19, 2022
|
Cohen, Matan J
|
Apr 19, 2022
|
|
Genome wide screen of RNAi molecules against SARS-CoV-2 creates a broadly potent prophylaxis
First Author: Yogev, Ohad
Reviewed: Apr 19, 2022
|
Yogev, Ohad
|
Apr 19, 2022
|
|
Immune Correlates Analysis of a Single Ad26.COV2.S Dose in the ENSEMBLE COVID-19 Vaccine Efficacy Clinical Trial
First Author: Fong, Youyi
Reviewed: Apr 19, 2022
|
Fong, Youyi
|
Apr 19, 2022
|
|
Incidence of Guillain-Barré syndrome following SARS-CoV-2 immunization in Mexico: A nation-wide registry of seven COVID-19 vaccines
First Author: Garcia Grimshaw, Miguel
Reviewed: Apr 19, 2022
|
Garcia Grimshaw, Miguel
|
Apr 19, 2022
|
|
Intensity and longevity of SARS-CoV-2 vaccination response and efficacy of adjusted vaccination schedules in patients with immune-mediated inflammatory disease
First Author: Simon, David
Reviewed: Apr 19, 2022
|
Simon, David
|
Apr 19, 2022
|
|
Limited Neutralization of Omicron by Antibodies from the BNT162b2 Vaccination against SARS-CoV-2
First Author: Lanz, Tobias V
Reviewed: Apr 19, 2022
|
Lanz, Tobias V
|
Apr 19, 2022
|
|
Omicron neutralizing antibody response following booster vaccination compared with breakthrough infection
First Author: Curlin, Marcel E
Reviewed: Apr 19, 2022
|
Curlin, Marcel E
|
Apr 19, 2022
|
|
Quantifying protocols for safe school activities
First Author: Genari, Juliano
Reviewed: Apr 19, 2022
|
Genari, Juliano
|
Apr 19, 2022
|
|
Risk and severity of SARS-CoV-2 reinfections during 2020-2022 in Vojvodina, Serbia: a population-level study
First Author: Medic, Snezana
Reviewed: Apr 19, 2022
|
Medic, Snezana
|
Apr 19, 2022
|
|
Safety, Immunogenicity and Antibody Persistence of a Bivalent Beta-Containing Booster Vaccine
First Author: Chalkias, Spyros
Reviewed: Apr 19, 2022
|
Chalkias, Spyros
|
Apr 19, 2022
|
|
Testing and Quarantine Strategies for Travelers – An Evidence Based Analytic Model Using Bayesʼ Theorem
First Author: Lee, Fu Shiuan Whitney
Reviewed: Apr 19, 2022
|
Lee, Fu Shiuan Whitney
|
Apr 19, 2022
|
|
Human primary Omicron BA.1 and BA.2 infections result in sub-lineage-specific neutralization
First Author: Stiasny, Karin
Reviewed: Apr 15, 2022
|
Stiasny, Karin
|
Apr 15, 2022
|
|
Immunization and SARS-CoV-2 antibodies seroprevalence in a country with high vaccination coverage: Lessons from Chile
First Author: Aguilera, Ximena
Reviewed: Apr 15, 2022
|
Aguilera, Ximena
|
Apr 15, 2022
|
|
Retrospective cohort study of COVID-19 in patients of the Brazilian public health system with SARS-COV-2 Omicron variant infection
First Author: Murari, Thiago
Reviewed: Apr 15, 2022
|
Murari, Thiago
|
Apr 15, 2022
|
|
Hippo Signaling Pathway Activation during SARS-CoV-2 Infection Contributes to Host Antiviral Response
First Author: Garcia, Gustavo
Reviewed: Apr 14, 2022
|
Garcia, Gustavo
|
Apr 14, 2022
|
|
NVX-CoV2373 vaccination induces functional SARS-CoV-2–specific CD4+ and CD8+ T cell responses
First Author: Moderbacher, Carolyn Rydyznski
Reviewed: Apr 14, 2022
|
Moderbacher, Carolyn Rydyznski
|
Apr 14, 2022
|
|
Optimizing Vaccine Allocation Strategies in Pandemic Outbreaks: An
Optimal Control Approach
First Author: Tonkens, Sander
Reviewed: Apr 14, 2022
|
Tonkens, Sander
|
Apr 14, 2022
|
|
Plant-produced RBD and cocktail-based vaccine candidates are highly effective against SARS-CoV-2, independently of its emerging variants
First Author: Mamedov, Tarlan
Reviewed: Apr 14, 2022
|
Mamedov, Tarlan
|
Apr 14, 2022
|
|
QSAR of SARS-CoV-2 Main Protease Inhibitors Utilizing Theoretical Molecular Descriptors
First Author: Nandi, Sisir
Reviewed: Apr 14, 2022
|
Nandi, Sisir
|
Apr 14, 2022
|
|
SARS-CoV-2 mutations affect proteasome processing to alter CD8+ T cell responses
First Author: Wellington, Dannielle
Reviewed: Apr 14, 2022
|
Wellington, Dannielle
|
Apr 14, 2022
|
|
Seroprevalence study prior and post vaccination in Cancer patients in Principality of Andorra (COVONCO study)
First Author: Royo Cebrecos, Cristina
Reviewed: Apr 14, 2022
|
Royo Cebrecos, Cristina
|
Apr 14, 2022
|
|
The clinical characteristics of 541 fully vaccinated hospitalized COVID-19 patients in a Tertiary Care Hospital in Turkey
First Author: Toker, Aysin Kilinc
Reviewed: Apr 14, 2022
|
Toker, Aysin Kilinc
|
Apr 14, 2022
|
|
Willingness to accept COVID-19 vaccination among people living with HIV in a high HIV prevalence community
First Author: Govere Hwenje, Sabina
Reviewed: Apr 14, 2022
|
Govere Hwenje, Sabina
|
Apr 14, 2022
|
|
Changes in Preventive Behaviour After COVID-19 Vaccination in Thailand: A Cross-Sectional Study
First Author: Ngamchaliew, Pitchayanont
Reviewed: Apr 13, 2022
|
Ngamchaliew, Pitchayanont
|
Apr 13, 2022
|
|
Evidence-Based Evaluation of PCR Diagnostics for SARS-Cov-2 and The Omicron Variants by Sanger Sequencing
First Author: Sin Hang Lee
Reviewed: Apr 13, 2022
|
Sin Hang Lee
|
Apr 13, 2022
|
|
Immunoinformatics design of Bivalent Vaccine targeting S1-NTD and HA2 to simultaneously protect against SARS-CoV-2 and Influenza infections
First Author: Rezaei, Marzieh
Reviewed: Apr 13, 2022
|
Rezaei, Marzieh
|
Apr 13, 2022
|
|
mRNA vaccine induces cytotoxic CD8+ T-cell cross-reactivity against SARS-CoV-2 Omicron variant and regulates COVID-19 severity
First Author: Nogimori, Takuto
Reviewed: Apr 13, 2022
|
Nogimori, Takuto
|
Apr 13, 2022
|
|
Antibody Resistance of SARS-CoV-2 Omicron BA.1, BA.1.1, BA.2 and BA.3 Sub-lineages
First Author: Ai, Jingwen
Reviewed: Apr 12, 2022
|
Ai, Jingwen
|
Apr 12, 2022
|
|
Combined Infection Control Interventions Protect the Essential Workforce from Occupationally-Acquired SARS-CoV-2 during Produce Production, Harvesting and Processing Activities
First Author: Kane Cooper, D
Reviewed: Apr 12, 2022
|
Kane Cooper, D
|
Apr 12, 2022
|
|
Early SARS-CoV-2 reinfections within 60 days highlight the need to consider antigenic variations together with duration of immunity in defining retesting policies
First Author: Nevejan, Louis
Reviewed: Apr 12, 2022
|
Nevejan, Louis
|
Apr 12, 2022
|
|
Vaccine effectiveness of BNT162b2 against Omicron and Delta outcomes in adolescents
First Author: Buchan, Sarah A
Reviewed: Apr 12, 2022
|
Buchan, Sarah A
|
Apr 12, 2022
|
|
Analysis of immunization, adverse events, and efficacy of a fourth dose of BNT162b2 vaccine
First Author: Romero Ibarguengoitia, Maria Elena
Reviewed: Apr 11, 2022
|
Romero Ibarguengoitia, Maria Elena
|
Apr 11, 2022
|
|
Antibody responses to SARS-CoV-2 vaccination in patients with acute leukaemia and high risk MDS on active anti-cancer therapies
First Author: Chan, W Y
Reviewed: Apr 11, 2022
|
Chan, W Y
|
Apr 11, 2022
|
|
Anti-Spike Protein to Determine SARS-CoV-2 Antibody Levels: Is There a Specific Threshold Conferring Protection in Immunocompromised Patients?
First Author: Philippe Halfon
Reviewed: Apr 11, 2022
|
Philippe Halfon
|
Apr 11, 2022
|
|
Changing patterns of SARS-CoV-2 infection through Delta and Omicron waves by vaccination status, previous infection and neighbourhood deprivation: A cohort analysis of 2.7M people
First Author: Green, Mark A
Reviewed: Apr 11, 2022
|
Green, Mark A
|
Apr 11, 2022
|
|
Clinical Variables Correlate with Serum Neutralizing Antibody Titers after COVID-19 mRNA Vaccination in an Adult, US-based Population
First Author: Zhao, Min
Reviewed: Apr 11, 2022
|
Zhao, Min
|
Apr 11, 2022
|
|
Contribution of low population immunity to the severe Omicron BA.2 outbreak in Hong Kong
First Author: Chen, Lin Lei
Reviewed: Apr 11, 2022
|
Chen, Lin Lei
|
Apr 11, 2022
|
|
Delineating antibody escape from Omicron variants
First Author: Gruell, Henning
Reviewed: Apr 11, 2022
|
Gruell, Henning
|
Apr 11, 2022
|
|
Disinfectants Role in the Prevention of Spreading the COVID-19 and Other Infectious Diseases – The Need for Functional Polymers!
First Author: Farah, Shady
Reviewed: Apr 11, 2022
|
Farah, Shady
|
Apr 11, 2022
|
|
EFFECT OF THE THIRD DOSE OF ASTRAZENECA VACCINE ON THE ABILITY TO GENERATE ANTI-RBD ANTIBODIES WITHIN TWO AT-RISK POPULATIONS, GERIATRICS AND HEALTH PERSONNEL IN THE PROVINCE OF TUCUMÁN
First Author: Ruiz, Luis Medina
Reviewed: Apr 11, 2022
|
Ruiz, Luis Medina
|
Apr 11, 2022
|
|
Effectiveness of a nation-wide COVID-19 vaccination program in Mexico
First Author: Bello Chavolla, Omar Yaxmehen
Reviewed: Apr 11, 2022
|
Bello Chavolla, Omar Yaxmehen
|
Apr 11, 2022
|
|
Estimating the number of breakthrough COVID-19 deaths in the United States
First Author: Smith, Jinkinson
Reviewed: Apr 11, 2022
|
Smith, Jinkinson
|
Apr 11, 2022
|
|
Evaluation of Eight Lateral Flow Tests for the detection of anti-SARS-CoV-2 antibodies in a vaccinated population
First Author: Greenland Bews, Caitlin
Reviewed: Apr 11, 2022
|
Greenland Bews, Caitlin
|
Apr 11, 2022
|
|
Evaluation of the Roche SARS-CoV-2 Rapid Antibody Test in samples from vaccinated individuals
First Author: Hayer, Johannes
Reviewed: Apr 11, 2022
|
Hayer, Johannes
|
Apr 11, 2022
|
|
Evolution of Delta variant by non-Spike signature co-appearing mutations: trailblazer of COVID-19 disease outcome
First Author: Banerjee, Anindita
Reviewed: Apr 11, 2022
|
Banerjee, Anindita
|
Apr 11, 2022
|
|
High incidence of sotrovimab resistance and viral persistence after treatment of immunocompromised patients infected with the SARS-CoV-2 Omicron variant
First Author: Huygens, Sammy
Reviewed: Apr 11, 2022
|
Huygens, Sammy
|
Apr 11, 2022
|
|
Immunogenicity of BNT162b2 COVID-19 vaccine in New Zealand adults
First Author: Priddy, Frances H
Reviewed: Apr 11, 2022
|
Priddy, Frances H
|
Apr 11, 2022
|
|
Immunopharmacological evaluation of adjuvant efficacy of Monophosphoryl lipid-A and CpG ODN with SARS-CoV-2 RBD antigen
First Author: Sambyal, Shainy
Reviewed: Apr 11, 2022
|
Sambyal, Shainy
|
Apr 11, 2022
|
|
Impact of prior infection on SARS-CoV-2 antibody responses in vaccinated long-term care facility staff
First Author: Gallichotte, Emily N
Reviewed: Apr 11, 2022
|
Gallichotte, Emily N
|
Apr 11, 2022
|
|
Long- and short-term effects of cross-immunity in epidemic dynamics
First Author: Atienza Diez, Iker
Reviewed: Apr 11, 2022
|
Atienza Diez, Iker
|
Apr 11, 2022
|
|
Monitoring of SARS-CoV-2 variant dynamics in wastewater by digital RT-PCR : from Alpha to Omicron BA.2 VOC
First Author: Wurtzer, Sebastien
Reviewed: Apr 11, 2022
|
Wurtzer, Sebastien
|
Apr 11, 2022
|
|
Nanocell COVID-19 vaccine elicits iNKT-licensed dendritic cells to produce high affinity antibodies neutralizing Variants of Concern
First Author: Gao, Steven
Reviewed: Apr 11, 2022
|
Gao, Steven
|
Apr 11, 2022
|
|
Non-invasive transdermal delivery of biomacromolecules with fluorocarbon-modified chitosan for melanoma immunotherapy and transdermal vaccines
First Author: Zhu, Wenjun
Reviewed: Apr 11, 2022
|
Zhu, Wenjun
|
Apr 11, 2022
|
|
Predictors for Reactogenicity and Humoral Immunity to SARS-CoV-2 Following Infection and mRNA Vaccination: A Regularized Mixed-Effects Modelling Approach
First Author: Williams, Erin C
Reviewed: Apr 11, 2022
|
Williams, Erin C
|
Apr 11, 2022
|
|
Real World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 Outpatients
First Author: Aggarwal, Neil R
Reviewed: Apr 11, 2022
|
Aggarwal, Neil R
|
Apr 11, 2022
|
|
SARS-CoV-2 Omicron (BA.1 and BA.2) specific novel CD8+ and CD4+ T cell epitopes targeting spike protein
First Author: Parn, Simone
Reviewed: Apr 11, 2022
|
Parn, Simone
|
Apr 11, 2022
|
|
Screening of SARS-CoV-2 Antivirals Through a Cell-Based RNA-Dependent RNA Polymerase (RdRp) Reporter Assay
First Author: Uppal, Timsy
Reviewed: Apr 11, 2022
|
Uppal, Timsy
|
Apr 11, 2022
|
|
The new normal? Dynamics and scale of the SARS-CoV-2 variant Omicron epidemic in England
First Author: Eales, Oliver
Reviewed: Apr 11, 2022
|
Eales, Oliver
|
Apr 11, 2022
|
|
Third primary SARS-CoV-2 prophylactic mRNA vaccines enhances antibody responses in the majority of patients with haematological malignancies: Results from the MARCH study
First Author: Cook, Lucy
Reviewed: Apr 11, 2022
|
Cook, Lucy
|
Apr 11, 2022
|
|
Viral dynamics of Omicron and Delta SARS-CoV-2 variants with implications for timing of release from isolation: a longitudinal cohort study
First Author: Bouton, Tara C
Reviewed: Apr 11, 2022
|
Bouton, Tara C
|
Apr 11, 2022
|
|
Aggregating human judgment probabilistic predictions of COVID-19
transmission, burden, and preventative measures
First Author: Codi, Allison
Reviewed: Apr 8, 2022
|
Codi, Allison
|
Apr 8, 2022
|
|
Broad SARS-CoV-2 spike-specific CD4+ T-cell response preserves recognition of variants of concern
First Author: Long, Heather
Reviewed: Apr 8, 2022
|
Long, Heather
|
Apr 8, 2022
|
|
Immunogenicity evaluation after BNT162b2 booster vaccination in healthcare workers
First Author: Zurac, Sabina
Reviewed: Apr 8, 2022
|
Zurac, Sabina
|
Apr 8, 2022
|
|
When climate skeptics turn vaccine enthusiasts: An analysis of audience segments on climate change and COVID-19 in Australia
First Author: Richardson, Lucy M
Reviewed: Apr 8, 2022
|
Richardson, Lucy M
|
Apr 8, 2022
|
|
Antibody evolution to SARS-CoV-2 after single-dose Ad26.COV2.S vaccine
First Author: Cho, Alice
Reviewed: Apr 7, 2022
|
Cho, Alice
|
Apr 7, 2022
|
|
Convergence of immune escape strategies highlights plasticity of SARS-CoV-2 spike
First Author: Yu, Xiaodi
Reviewed: Apr 7, 2022
|
Yu, Xiaodi
|
Apr 7, 2022
|
|
COVID-19 vaccination coverage by company size and the effects of socioeconomic factors and workplace vaccination in Japan: a cohort study
First Author: Mori, Koji
Reviewed: Apr 7, 2022
|
Mori, Koji
|
Apr 7, 2022
|
|
Demonstration of antibodies against SARS-CoV-2, neutralizing or binding, in seroconversion panels after mRNA-1273, BNT-162b2 and Ad26.COV2.S vaccine administration
First Author: Belda, Francisco
Reviewed: Apr 7, 2022
|
Belda, Francisco
|
Apr 7, 2022
|
|
Does Pre-Existing Immunity Determine the Course of SARS-CoV-2 Infection in Health-Care Workers? Single-Center Experience
First Author: Laura, Luka
Reviewed: Apr 7, 2022
|
Laura, Luka
|
Apr 7, 2022
|
|
Immunogenicity of Pfizer-BioNTech COVID-19 mRNA Primary Vaccination Series in Recovered Individuals Depends on Symptoms at Initial Infection
First Author: Nantel, Sabryna
Reviewed: Apr 7, 2022
|
Nantel, Sabryna
|
Apr 7, 2022
|
|
Increased seroprevalence and improved antibody responses following third primary SARS-CoV-2 immunisation: an update from the COV-AD study
First Author: Shields, Adrian M
Reviewed: Apr 7, 2022
|
Shields, Adrian M
|
Apr 7, 2022
|
|
Modeling COVID-19 vaccine-induced immunological memory development and
its links to antibody level and infectiousness
First Author: Gao, Xin
Reviewed: Apr 7, 2022
|
Gao, Xin
|
Apr 7, 2022
|
|
Omicron breakthrough infection drives cross-variant neutralization and memory B cell formation
First Author: Quandt, Jasmin
Reviewed: Apr 7, 2022
|
Quandt, Jasmin
|
Apr 7, 2022
|
|
Recall of pre-existing cross-reactive B cell memory following Omicron breakthrough infection
First Author: Kaku, Chengzi I
Reviewed: Apr 7, 2022
|
Kaku, Chengzi I
|
Apr 7, 2022
|
|
Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: a phase 1/2, randomized, placebo-controlled, observer-blinded trial
First Author: Song, Joon Young
Reviewed: Apr 7, 2022
|
Song, Joon Young
|
Apr 7, 2022
|
|
A Wide-bandwidth Nanocomposite-Sensor Integrated Smart Mask for Tracking Multi-phase Respiratory Activities for COVID-19 Endemic
First Author: Suo, Jiao
Reviewed: Apr 6, 2022
|
Suo, Jiao
|
Apr 6, 2022
|
|
Brequinar and Dipyridamole in Combination Exhibits Synergistic Antiviral Activity Against SARS-CoV-2 in vitro: Rationale for a host-acting antiviral treatment strategy for COVID-19
First Author: Demarest, James F
Reviewed: Apr 6, 2022
|
Demarest, James F
|
Apr 6, 2022
|
|
Changing characteristics over time of individuals receiving COVID-19 vaccines in Denmark: A population-based descriptive study of vaccine uptake
First Author: Reilev, Mette
Reviewed: Apr 6, 2022
|
Reilev, Mette
|
Apr 6, 2022
|
|
Effect of vaccination rates on the prevalence and mortality of COVID-19
First Author: Westerhout, Jacob
Reviewed: Apr 6, 2022
|
Westerhout, Jacob
|
Apr 6, 2022
|
|
Effectiveness of an Inactivated Covid-19 Vaccine with Homologous and Heterologous Boosters against the Omicron (B.1.1.529) Variant
First Author: Ranzani, Otavio T
Reviewed: Apr 6, 2022
|
Ranzani, Otavio T
|
Apr 6, 2022
|
|
Effectiveness of COVID-19 vaccines against Omicron and Delta hospitalisation: test negative case-control study
First Author: Stowe, Julia
Reviewed: Apr 6, 2022
|
Stowe, Julia
|
Apr 6, 2022
|
|
Global Reports of Myocarditis Following COVID-19 Vaccination: A Systematic Review and Meta-Analysis
First Author: Ahmed, Sirwan Khalid
Reviewed: Apr 6, 2022
|
Ahmed, Sirwan Khalid
|
Apr 6, 2022
|
|
Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV: a nationwide prospective cohort study in the Netherlands
First Author: Hensley, Kathryn S
Reviewed: Apr 6, 2022
|
Hensley, Kathryn S
|
Apr 6, 2022
|
|
Interpretation of non-responders to SARS-CoV-2 vaccines using WHO International Standard
First Author: Zeng, Qiang
Reviewed: Apr 6, 2022
|
Zeng, Qiang
|
Apr 6, 2022
|
|
Necessity of COVID-19 Vaccination in Persons who have Already had COVID-19
First Author: Shrestha, Nabin K
Reviewed: Apr 6, 2022
|
Shrestha, Nabin K
|
Apr 6, 2022
|
|
Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): a single blind, randomized, non-inferiority trial
First Author: Pannus, Pieter
Reviewed: Apr 6, 2022
|
Pannus, Pieter
|
Apr 6, 2022
|
|
Boosting maternal and neonatal anti SARS-CoV-2 humoral immunity using a third mRNA vaccine dose
First Author: Cahen Peretz, Adva
Reviewed: Apr 5, 2022
|
Cahen Peretz, Adva
|
Apr 5, 2022
|
|
A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants
First Author: Zhang, Jing
Reviewed: Apr 4, 2022
|
Zhang, Jing
|
Apr 4, 2022
|
|
A study of the relationship between ABO blood group and Rh with the amount of IgG antibody titers in recovered corona-inflicted patients
First Author: Elahimanesh, Farideh
Reviewed: Apr 4, 2022
|
Elahimanesh, Farideh
|
Apr 4, 2022
|
|
Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July – November 2021
First Author: Starrfelt, Jostein
Reviewed: Apr 4, 2022
|
Starrfelt, Jostein
|
Apr 4, 2022
|
|
Convergent epitope specificities, V gene usage and public clones elicited by primary exposure to SARS-CoV-2 variants
First Author: Lima, Noemia S
Reviewed: Apr 4, 2022
|
Lima, Noemia S
|
Apr 4, 2022
|
|
Dynamics of Neutralizing Antibody and T-cell Responses to SARS-CoV-2 and Variants of Concern After Primary Immunization With CoronaVac and Booster With BNT162b2 or ChAdOx1 in Health Care Workers
First Author: Watsamon Jantarabenjakul
Reviewed: Apr 4, 2022
|
Watsamon Jantarabenjakul
|
Apr 4, 2022
|
|
Effect of COVID-19 vaccination on menstrual periods in a prospectively recruited cohort
First Author: Woon, Ee Von
Reviewed: Apr 4, 2022
|
Woon, Ee Von
|
Apr 4, 2022
|
|
Mobility was a Significant Determinant of Reported COVID-19 Incidence During the Omicron Surge in the Most Populous U.S. Counties
First Author: Harris, Jeffrey E
Reviewed: Apr 4, 2022
|
Harris, Jeffrey E
|
Apr 4, 2022
|
|
Multiplexed measurement of binding- and neutralizing antibodies to SARS-CoV-2 variants in 12.000 post-vaccine sera
First Author: Tran, Trung The
Reviewed: Apr 4, 2022
|
Tran, Trung The
|
Apr 4, 2022
|
|
Multisystem Inflammatory Syndrome in a Fully Vaccinated 18-Year-Old Without Known SARS-CoV-2 Infection
First Author: Liu, Andy
Reviewed: Apr 4, 2022
|
Liu, Andy
|
Apr 4, 2022
|
|
Nationwide Effectiveness of First and Second SARS-CoV2 Booster Vaccines during the Delta and Omicron Pandemic Waves in Hungary (HUN-VE 2 Study)
First Author: Kiss, Zoltan
Reviewed: Apr 4, 2022
|
Kiss, Zoltan
|
Apr 4, 2022
|
|
Neutralization of Omicron BA.1, BA.2, and BA.3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine
First Author: Kurhade, Chaitanya
Reviewed: Apr 4, 2022
|
Kurhade, Chaitanya
|
Apr 4, 2022
|
|
Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis
First Author: Johnson, Bryan A
Reviewed: Apr 4, 2022
|
Johnson, Bryan A
|
Apr 4, 2022
|
|
Persistent health issues, adverse events of significant concern, and effectiveness of COVID-19 vaccination- findings from a real-world cohort study of healthcare workers in north India
First Author: Kaur, Upinder
Reviewed: Apr 4, 2022
|
Kaur, Upinder
|
Apr 4, 2022
|
|
Psychosocial factors affecting COVID-19 vaccine uptake in the UK: a prospective cohort study (CoVAccS – wave 3)
First Author: Smith, Louise E
Reviewed: Apr 4, 2022
|
Smith, Louise E
|
Apr 4, 2022
|
|
Radiation Recall Pneumonitis Covid-19 Infection Induced After Adjuvant Breast Cancer Radiotherapy. A Known Phenomenon in a Unknown Pandemic Disease. A Case Report
First Author: Lazzari, Grazia
Reviewed: Apr 4, 2022
|
Lazzari, Grazia
|
Apr 4, 2022
|
|
SARS-CoV-2 Omicron neutralization and risk of infection among elderly after a booster dose of Pfizer vaccine
First Author: Bruel, Timothee
Reviewed: Apr 4, 2022
|
Bruel, Timothee
|
Apr 4, 2022
|
|
Serum C reactive protein predicts humoral response after BNT162b2 booster administration
First Author: Salvagno, Gian Luca
Reviewed: Apr 4, 2022
|
Salvagno, Gian Luca
|
Apr 4, 2022
|
|
Vaccine effectiveness against infection and COVID-19-associated hospitalisation with the Omicron (B.1.1.529) variant after vaccination with the BNT162b2 or mRNA-1273 vaccine: A nationwide Danish cohort study
First Author: Hansen, Christian
Reviewed: Apr 4, 2022
|
Hansen, Christian
|
Apr 4, 2022
|
|
1,3-Diphenylurea derivatives inhibit cellular entry of influenza A virus and SARS-CoV-2
First Author: Kumar, Nirmal
Reviewed: Apr 1, 2022
|
Kumar, Nirmal
|
Apr 1, 2022
|
|
AIRRscape: an interactive tool for exploring B-cell receptor repertoires and antibody responses
First Author: Waltari, Eric
Reviewed: Apr 1, 2022
|
Waltari, Eric
|
Apr 1, 2022
|
|
Analysis of humoral immunity against emerging SARS-CoV-2 variants: a population-based prevalence study in Yokohama, Japan
First Author: Goto, Atsushi
Reviewed: Apr 1, 2022
|
Goto, Atsushi
|
Apr 1, 2022
|
|
Characterization of antibody and T-cell response after second booster vaccination
First Author: Grikscheit, Katharina
Reviewed: Apr 1, 2022
|
Grikscheit, Katharina
|
Apr 1, 2022
|
|
Delayed acute onset of widespread macular lesions following COVID-19 booster vaccine case report
First Author: Kaszycki, Margaret
Reviewed: Apr 1, 2022
|
Kaszycki, Margaret
|
Apr 1, 2022
|
|
Dynamics of humoral and cellular immune responses after homologous and heterologous SARS-CoV-2 vaccination with ChAdOx1 nCoV-19 and BNT162b2
First Author: Vogel, Emanuel
Reviewed: Apr 1, 2022
|
Vogel, Emanuel
|
Apr 1, 2022
|
|
Evaluation of safety concerns for COVID-19 immunization of pregnant women: A systematic review of emerging evidence
First Author: Krishna, Hare
Reviewed: Apr 1, 2022
|
Krishna, Hare
|
Apr 1, 2022
|
|
Inconsistent directions of change in case severity across successive SARS-CoV-2 variant waves suggests an unpredictable future
First Author: Pascall, David J
Reviewed: Apr 1, 2022
|
Pascall, David J
|
Apr 1, 2022
|
|
Neutralization-activity of Sera/IgG Obtained from Fully BNT162b2- Vaccinated Individuals Against 10 Clinical SARS-CoV-2 isolates Including Various VOCs (Alpha/Beta/Gamma/Delta) and VUM (Kappa)
First Author: Amano, Masayuki
Reviewed: Apr 1, 2022
|
Amano, Masayuki
|
Apr 1, 2022
|
|
Serological Response to Three, Four and Five Doses of SARS-CoV-2 Vaccine in Kidney Transplant Recipients
First Author: Osmanodja, Bilgin
Reviewed: Apr 1, 2022
|
Osmanodja, Bilgin
|
Apr 1, 2022
|
|
A tracer gas study of ventilation and air movement to inform potential SARS-CoV-2 airborne transmission
First Author: Linge, Kathryn
Reviewed: Mar 31, 2022
|
Linge, Kathryn
|
Mar 31, 2022
|
|
COVID-19 testing: A qualitative study exploring enablers and barriers in the Greater Accra Region, Ghana
First Author: Ha, Solip
Reviewed: Mar 31, 2022
|
Ha, Solip
|
Mar 31, 2022
|
|
Immunity Escape of SARS-CoV-2 Variants: Omicron Leads the Way
First Author: Rupali Dhingra
Reviewed: Mar 31, 2022
|
Rupali Dhingra
|
Mar 31, 2022
|
|
Sotrovimab neutralizing SARS-CoV-2: Risk factors for post-infusion clinical events
First Author: Yoshida, Junichi
Reviewed: Mar 31, 2022
|
Yoshida, Junichi
|
Mar 31, 2022
|
|
A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability
First Author: Voigt, Emily A
Reviewed: Mar 30, 2022
|
Voigt, Emily A
|
Mar 30, 2022
|
|
Automated Thermal Screening for COVID-19 using Machine Learning
First Author: Katte, Pratik
Reviewed: Mar 30, 2022
|
Katte, Pratik
|
Mar 30, 2022
|
|
B cell receptor repertoire analysis unveils dynamic antibody response and severity markers in COVID-19 patients
First Author: Rao, Soumya
Reviewed: Mar 30, 2022
|
Rao, Soumya
|
Mar 30, 2022
|
|
Booster dose of BNT162b2 in a CoronaVac primary vaccination protocol improves neutralization of SARS-CoV-2 Omicron variant
First Author: Campos, Guilherme R F
Reviewed: Mar 30, 2022
|
Campos, Guilherme R F
|
Mar 30, 2022
|
|
Comprehensive immunovirological and environmental screening reveals risk factors for fatal COVID-19 during post-vaccination nursing home outbreaks
First Author: Cuypers, Lize
Reviewed: Mar 30, 2022
|
Cuypers, Lize
|
Mar 30, 2022
|
|
COVID-19 pandemic dynamics in South Africa and epidemiological characteristics of three variants of concern (Beta, Delta, and Omicron)
First Author: Yang, Wan
Reviewed: Mar 30, 2022
|
Yang, Wan
|
Mar 30, 2022
|
|
COVID-19 Vaccine Effectiveness against the Omicron BA.2 variant in England
First Author: Kirsebom, Freja C M
Reviewed: Mar 30, 2022
|
Kirsebom, Freja C M
|
Mar 30, 2022
|
|
Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2
First Author: Fang, Zhenhao
Reviewed: Mar 30, 2022
|
Fang, Zhenhao
|
Mar 30, 2022
|
|
Impact assessment of mobility restrictions, testing, and vaccination on the COVID-19 pandemic in India
First Author: Shin, Jeonghyun
Reviewed: Mar 30, 2022
|
Shin, Jeonghyun
|
Mar 30, 2022
|
|
Impact of Vaccination, Prior Infection, and Therapy on Delta and Omicron Variants
First Author: Wang, Xiaofeng
Reviewed: Mar 30, 2022
|
Wang, Xiaofeng
|
Mar 30, 2022
|
|
In silico analysis predicts a limited impact of SARS-CoV-2 variants on CD8 T cell recognition
First Author: Isaeva, Olga I
Reviewed: Mar 30, 2022
|
Isaeva, Olga I
|
Mar 30, 2022
|
|
Influenza infection in ferrets with SARS-CoV-2 infection history
First Author: Melo, Caroline Vilas Boas De
Reviewed: Mar 30, 2022
|
Melo, Caroline Vilas Boas De
|
Mar 30, 2022
|
|
Optimized infection control practices augment the robust protective effect of vaccination for ESRD patients during a hemodialysis facility SARS-CoV-2 outbreak
First Author: Meller, Megan E
Reviewed: Mar 30, 2022
|
Meller, Megan E
|
Mar 30, 2022
|
|
People with HIV receiving suppressive antiretroviral therapy show typical antibody durability after dual COVID-19 vaccination, and strong third dose responses
First Author: Lapointe, Hope R
Reviewed: Mar 30, 2022
|
Lapointe, Hope R
|
Mar 30, 2022
|
|
Pre-exposure prophylaxis with Evusheld™ elicits limited neutralizing activity against the omicron variant in kidney transplant patients
First Author: Benotmane, Ilies
Reviewed: Mar 30, 2022
|
Benotmane, Ilies
|
Mar 30, 2022
|
|
Readiness to take COVID-19 vaccines: a national cross-sectional survey in Vietnam
First Author: Hoang, Huong Thi Xuan
Reviewed: Mar 30, 2022
|
Hoang, Huong Thi Xuan
|
Mar 30, 2022
|
|
Relative Effectiveness of Four Doses Compared to Three Dose of the BNT162b2 Vaccine in Israel
First Author: Gazit, Sivan
Reviewed: Mar 30, 2022
|
Gazit, Sivan
|
Mar 30, 2022
|
|
The efficacy, safety and immunogenicity Nanocovax: results of a randomized, double-blind, placebo-controlled Phase 3 trial
First Author: Nguyen, Thuy P
Reviewed: Mar 30, 2022
|
Nguyen, Thuy P
|
Mar 30, 2022
|
|
The progress and promise of RNA medicine—an arsenal of targeted treatments
First Author: Zhou, Qiongqiong
Reviewed: Mar 30, 2022
|
Zhou, Qiongqiong
|
Mar 30, 2022
|
|
Universally available herbal teas based on sage and perilla elicit potent antiviral activity against SARS-CoV-2 variants of concern by HMOX-1 upregulation in human cells
First Author: Le Trilling, Vu Thuy Khanh
Reviewed: Mar 30, 2022
|
Le Trilling, Vu Thuy Khanh
|
Mar 30, 2022
|
|
Vaccine Effectiveness Against Hospitalization Among Adolescent and Pediatric SARS-CoV-2 Cases in Ontario, Canada
First Author: Simmons, Alison E
Reviewed: Mar 30, 2022
|
Simmons, Alison E
|
Mar 30, 2022
|
|
Vaccine effectiveness with BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine against reported SARS-CoV-2 Delta and Omicron infection among adolescents, Norway, August 2021 to January 2022
First Author: Veneti, Lamprini
Reviewed: Mar 30, 2022
|
Veneti, Lamprini
|
Mar 30, 2022
|
|
Viral load dynamics of SARS-CoV-2 Delta and Omicron variants following multiple vaccine doses and previous infection
First Author: Woodbridge, Yonatan
Reviewed: Mar 30, 2022
|
Woodbridge, Yonatan
|
Mar 30, 2022
|
|
Waning effectiveness of BNT162b2 and ChAdOx1 COVID-19 vaccines over six months since second dose: a cohort study using linked electronic health records
First Author: Horne, Elsie Mf
Reviewed: Mar 30, 2022
|
Horne, Elsie Mf
|
Mar 30, 2022
|
|
Aerosolized Ad5-nCoV booster vaccination elicited potent immune response against the SARS-CoV-2 Omicron variant after inactivated COVID-19 vaccine priming
First Author: Zhang, Zhe
Reviewed: Mar 29, 2022
|
Zhang, Zhe
|
Mar 29, 2022
|
|
Boosters protect against SARS-CoV-2 infections in young adults during an Omicron-predominant period
First Author: Wan, Jiayue
Reviewed: Mar 29, 2022
|
Wan, Jiayue
|
Mar 29, 2022
|
|
Case Report of Breakthrough Long COVID and the Use of Nirmatrelvir-Ritonavir
First Author: Geng, Linda N
Reviewed: Mar 29, 2022
|
Geng, Linda N
|
Mar 29, 2022
|
|
Community Engagement to support COVID-19 Vaccine Uptake: A living systematic review protocol
First Author: Gilmore, Brynne
Reviewed: Mar 29, 2022
|
Gilmore, Brynne
|
Mar 29, 2022
|
|
Impact of SARS-CoV-2 vaccination of children ages 5-11 years on COVID-19 disease burden and resilience to new variants in the United States, November 2021-March 2022: a multi-model study
First Author: Borchering, Rebecca K
Reviewed: Mar 29, 2022
|
Borchering, Rebecca K
|
Mar 29, 2022
|
|
Increase in SARS-CoV-2 RBD-specific IgA and IgG Antibodies in Human Milk from Lactating Women Following the COVID-19 Booster Vaccination
First Author: Henle, Andrea M
Reviewed: Mar 29, 2022
|
Henle, Andrea M
|
Mar 29, 2022
|
|
Nucleocapsid-specific humoral responses improve the control of SARS-CoV-2
First Author: Dangi, Tanushree
Reviewed: Mar 29, 2022
|
Dangi, Tanushree
|
Mar 29, 2022
|
|
Physical, psychological and cognitive profile of post-COVID condition in healthcare workers, Quebec, Canada
First Author: Carazo, Sara
Reviewed: Mar 29, 2022
|
Carazo, Sara
|
Mar 29, 2022
|
|
Quantifying the vaccine-induced humoral immune response to spike-receptor binding domain as a surrogate for neutralization testing following mRNA-1273 (Spikevax) vaccination against COVID-19
First Author: Kirste, Imke
Reviewed: Mar 29, 2022
|
Kirste, Imke
|
Mar 29, 2022
|
|
Safety and immunogenicity of a hybrid-type vaccine booster in BBIBP-CorV recipients: a randomized controlled phase 2 trial
First Author: Kaabi, Nawal Al
Reviewed: Mar 29, 2022
|
Kaabi, Nawal Al
|
Mar 29, 2022
|
|
SARS-CoV-2 genomic surveillance enables the identification of Delta/Omicron co-infections in Argentina
First Author: Pisano, Maria Belen
Reviewed: Mar 29, 2022
|
Pisano, Maria Belen
|
Mar 29, 2022
|
|
Severity of maternal SARS-CoV-2 infection and perinatal outcomes during the Omicron variant dominant period: UK Obstetric Surveillance System national cohort study
First Author: Engjom, Hilde Marie
Reviewed: Mar 29, 2022
|
Engjom, Hilde Marie
|
Mar 29, 2022
|
|
Short-term drop in antibody titer after the third dose of SARS-CoV-2 BNT162b2 vaccine in adults
First Author: Herzberg, Jonas
Reviewed: Mar 29, 2022
|
Herzberg, Jonas
|
Mar 29, 2022
|
|
The Acoustic Dissection of Cough: Diving into Machine Listening-based COVID-19 Analysis and Detection
First Author: Ren, Zhao
Reviewed: Mar 29, 2022
|
Ren, Zhao
|
Mar 29, 2022
|
|
Venous Thromboembolism in Ambulatory Covid-19 patients: Clinical and Genetic Determinants
First Author: Xie, J Q
Reviewed: Mar 29, 2022
|
Xie, J Q
|
Mar 29, 2022
|
|
15-month follow-up of anti-spike receptor binding domain (RBD) SARS-CoV-2 antibodies among healthcare workers in Boston, MA
First Author: Dodge, Maura C
Reviewed: Mar 28, 2022
|
Dodge, Maura C
|
Mar 28, 2022
|
|
A potent SARS-CoV-2 antibody neutralizes Omicron variant by disassembling the spike trimer
First Author: Zhan, Wuqiang
Reviewed: Mar 28, 2022
|
Zhan, Wuqiang
|
Mar 28, 2022
|
|
Acceptance of COVID-19 vaccine among healthcare workers in Katsina state, Northwest Nigeria
First Author: Abubakar, Ahmed Tijani
Reviewed: Mar 28, 2022
|
Abubakar, Ahmed Tijani
|
Mar 28, 2022
|
|
Binding affinity improvement analysis of multiple-mutant Omicron on 2019-nCov to human ACE2 by In-silico predictions
First Author: Li, Bo
Reviewed: Mar 28, 2022
|
Li, Bo
|
Mar 28, 2022
|
|
Effect of prior infection, vaccination, and hybrid immunity against symptomatic BA.1 and BA.2 Omicron infections and severe COVID-19 in Qatar
First Author: Altarawneh, Heba N
Reviewed: Mar 28, 2022
|
Altarawneh, Heba N
|
Mar 28, 2022
|
|
High neutralizing antibody levels against SARS-CoV-2 Omicron after UB-612 booster vaccination
First Author: Guirakhoo, Farshad
Reviewed: Mar 28, 2022
|
Guirakhoo, Farshad
|
Mar 28, 2022
|
|
Humoral and cellular immune memory to four COVID-19 vaccines
First Author: Zhang, Zeli
Reviewed: Mar 28, 2022
|
Zhang, Zeli
|
Mar 28, 2022
|
|
Immune and Clotting Dysfunction Detected in Saliva and Blood Plasma after COVID-19
First Author: Jang, Hyesun
Reviewed: Mar 28, 2022
|
Jang, Hyesun
|
Mar 28, 2022
|
|
Immunogenic superiority and safety of Biological E�s CORBEVAX� vaccine compared to COVISHIELD� (ChAdOx1 nCoV-19) vaccine studied in a phase III, single blind, multicenter, randomized clinical trial
First Author: Thuluva, Subhash
Reviewed: Mar 28, 2022
|
Thuluva, Subhash
|
Mar 28, 2022
|
|
Projecting the impact of the introduction of SARS-CoV-2 Omicron variant in China in the context of waning immunity after vaccination
First Author: Yu, Hongjie
Reviewed: Mar 28, 2022
|
Yu, Hongjie
|
Mar 28, 2022
|
|
Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern
First Author: Pollet, Jeroen
Reviewed: Mar 28, 2022
|
Pollet, Jeroen
|
Mar 28, 2022
|
|
Robust and durable prophylactic protection conferred by RNA interference in preclinical models of SARS-CoV-2
First Author: Anglero Rodriguez, Yesseinia I
Reviewed: Mar 28, 2022
|
Anglero Rodriguez, Yesseinia I
|
Mar 28, 2022
|
|
SARS-CoV-2 Omicron triggers cross-reactive neutralization and Fc effector functions in previously vaccinated, but not unvaccinated individuals
First Author: Richardson, Simone I
Reviewed: Mar 28, 2022
|
Richardson, Simone I
|
Mar 28, 2022
|
|
Second Booster Vaccine and Covid-19 Mortality in Adults 60 to 100 Years Old
First Author: Arbel, Ronen
Reviewed: Mar 28, 2022
|
Arbel, Ronen
|
Mar 28, 2022
|
|
Vaccine effectiveness of two and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong
First Author: Mcmenamin, Martina E
Reviewed: Mar 28, 2022
|
Mcmenamin, Martina E
|
Mar 28, 2022
|
|
Association of Periodic Fasting with Lower Severity of COVID-19 Outcomes in the SARS-CoV-2 Pre-Vaccine Era: An Observational Cohort from the INSPIRE Registry
First Author: Horne, Benjamin D
Reviewed: Mar 25, 2022
|
Horne, Benjamin D
|
Mar 25, 2022
|
|
Durable protection against SARS-CoV-2 Omicron induced by an adjuvanted subunit vaccine
First Author: Arunachalam, Prabhu S
Reviewed: Mar 25, 2022
|
Arunachalam, Prabhu S
|
Mar 25, 2022
|
|
High neutrophils and triglycerides lead to critical illness in COVID-19 and reveal CDK6 inhibitors as potential treatment
First Author: Schmidt, Marco F
Reviewed: Mar 25, 2022
|
Schmidt, Marco F
|
Mar 25, 2022
|
|
Immunoinformatics approach to epitope-based vaccine design against the SARS-CoV-2 in Bangladeshi patients
First Author: Akter, Shahina
Reviewed: Mar 25, 2022
|
Akter, Shahina
|
Mar 25, 2022
|
|
Peptidome Surveillance Across Evolving SARS-CoV-2 Lineages Reveals HLA Binding Conservation in Nucleocapsid Among Variants With Most Potential for T-Cell Epitope Loss In Spike
First Author: Wnuk, Kamil
Reviewed: Mar 25, 2022
|
Wnuk, Kamil
|
Mar 25, 2022
|
|
Potency and Breadth of Neutralization after 3 doses of mRNA vaccines in COVID-19 Convalescent and Naïve individuals
First Author: Luczkowiak, Joanna
Reviewed: Mar 25, 2022
|
Luczkowiak, Joanna
|
Mar 25, 2022
|
|
Variation of total anti-SARS-CoV-2 antibodies after primary BNT162b2 vaccination and homologous booster
First Author: Salvagno, Gian Luca
Reviewed: Mar 25, 2022
|
Salvagno, Gian Luca
|
Mar 25, 2022
|
|
Good recovery of immunization stress-related responses presenting as cluster of stroke-like events following CoronaVac and ChAdOx1 vaccinations
First Author: Apiwattanakul, Metha
Reviewed: Mar 24, 2022
|
Apiwattanakul, Metha
|
Mar 24, 2022
|
|
Polyphenolic Promiscuity, Inflammation-coupled Specificity:
Whether PAINs Filters Mask an Antiviral Asset
First Author: Sheridan, Rick
Reviewed: Mar 24, 2022
|
Sheridan, Rick
|
Mar 24, 2022
|
|
Potent and specific human monoclonal antibodies against SARS-CoV-2 Omicron variant by rapid mRNA immunization of humanized mice
First Author: Ren, Ping
Reviewed: Mar 24, 2022
|
Ren, Ping
|
Mar 24, 2022
|
|
Pre-exposure to mRNA-LNPs reprograms adaptive and innate immune responses in an inheritable fashion
First Author: Qin, Zhen
Reviewed: Mar 24, 2022
|
Qin, Zhen
|
Mar 24, 2022
|
|
SARS-CoV-2 Omicron potently neutralized by a novel antibody with unique Spike binding properties
First Author: Fenwick, Craig
Reviewed: Mar 24, 2022
|
Fenwick, Craig
|
Mar 24, 2022
|
|
“Effectiveness of whole virus COVID-19 vaccine at protecting health care personnel against SARS-CoV-2 infections in Lima, Peru”
First Author: Arriola, Carmen S
Reviewed: Mar 23, 2022
|
Arriola, Carmen S
|
Mar 23, 2022
|
|
A log-odds system for waning and boosting of COVID-19 vaccine effectiveness
First Author: Blakely, Tony
Reviewed: Mar 23, 2022
|
Blakely, Tony
|
Mar 23, 2022
|
|
Changes in Thrombosis-Related Parameters After AstraZeneca COVID-19 Vaccination in A Male Volunteer: A Case Report
First Author: Hong, Sae Yong
Reviewed: Mar 23, 2022
|
Hong, Sae Yong
|
Mar 23, 2022
|
|
Comparison of the 2021 COVID-19 ‘Roadmap’ Projections against Public Health Data
First Author: Keeling, Matt J
Reviewed: Mar 23, 2022
|
Keeling, Matt J
|
Mar 23, 2022
|
|
Humoral and cellular immune responses to CoronaVac assessed up to one year after vaccination
First Author: Costa, Priscilla Ramos
Reviewed: Mar 23, 2022
|
Costa, Priscilla Ramos
|
Mar 23, 2022
|
|
Protection of prior natural infection compared to mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar
First Author: Chemaitelly, Hiam
Reviewed: Mar 23, 2022
|
Chemaitelly, Hiam
|
Mar 23, 2022
|
|
Rational development of a combined mRNA vaccine against COVID-19 and influenza
First Author: Qin, Cheng Feng
Reviewed: Mar 23, 2022
|
Qin, Cheng Feng
|
Mar 23, 2022
|
|
Relative effectiveness of booster vs. 2-dose mRNA Covid-19 vaccination in the Veterans Health Administration: Self-controlled risk interval analysis
First Author: Korves, Caroline
Reviewed: Mar 23, 2022
|
Korves, Caroline
|
Mar 23, 2022
|
|
Serological Responses to the First Three Doses of SARS-CoV-2 Vaccination in Inflammatory Bowel Disease: A Prospective Cohort Study
First Author: Quan, Joshua
Reviewed: Mar 23, 2022
|
Quan, Joshua
|
Mar 23, 2022
|
|
Severe Acute Respiratory Coronavirus-2 Antibody and T cell response after a third vaccine dose in hemodialysis patients compared with healthy controls
First Author: Simon, Benedikt
Reviewed: Mar 23, 2022
|
Simon, Benedikt
|
Mar 23, 2022
|
|
Variant-specific burden of SARS-CoV-2 in Michigan: March 2020 through November 2021
First Author: Petrie, Joshua G
Reviewed: Mar 23, 2022
|
Petrie, Joshua G
|
Mar 23, 2022
|
|
Broad neutralization of SARS-CoV-2 variants by circular mRNA producing VFLIP-X spike in mice
First Author: Seephetdee, Chotiwat
Reviewed: Mar 22, 2022
|
Seephetdee, Chotiwat
|
Mar 22, 2022
|
|
Daily-activity-dependency of effective reproduction number in COVID-19
pandemic: direct modelling from GPS data
First Author: Ozaki, Jun Ichi
Reviewed: Mar 22, 2022
|
Ozaki, Jun Ichi
|
Mar 22, 2022
|
|
Pulmonary lesions following inoculation with the SARS-CoV-2 Omicron BA.1 (B.1.1.529) variant in Syrian golden hamsters
First Author: Rissmann, Melanie
Reviewed: Mar 22, 2022
|
Rissmann, Melanie
|
Mar 22, 2022
|
|
A broad and potent neutralization epitope in SARS-related coronaviruses
First Author: Yuan, Meng
Reviewed: Mar 21, 2022
|
Yuan, Meng
|
Mar 21, 2022
|
|
BNT162b2 mRNA Vaccinations in Israel: Understanding The Impact and Improving The Vaccination Policies by Redefining The Immunized Population
First Author: Ross, Chana
Reviewed: Mar 21, 2022
|
Ross, Chana
|
Mar 21, 2022
|
|
Broad Cross-reactive IgA and IgG Against Human Coronaviruses in Milk Induced by COVID-19 Vaccination and Infection
First Author: Wang, Jiong
Reviewed: Mar 21, 2022
|
Wang, Jiong
|
Mar 21, 2022
|
|
Comorbidities Diminish the Likelihood of Seropositivity After SARS-CoV-2 Vaccination
First Author: Amraotkar, Alok R
Reviewed: Mar 21, 2022
|
Amraotkar, Alok R
|
Mar 21, 2022
|
|
COVID-19 Vaccine Hesitancy among Marginalized Populations in the U.S. and Canada: Protocol for a Scoping Review
First Author: Newman, Peter A
Reviewed: Mar 21, 2022
|
Newman, Peter A
|
Mar 21, 2022
|
|
Development of a ferritin-based nanoparticle vaccine against the SARS-CoV-2 Omicron variant
First Author: Tai, Wanbo
Reviewed: Mar 21, 2022
|
Tai, Wanbo
|
Mar 21, 2022
|
|
Does the Rubella Immunoglobulin G affect the severity of COVID- 19? Rubella Immunoglobulin G and COVID- 19
First Author: Sahebi, Leyla
Reviewed: Mar 21, 2022
|
Sahebi, Leyla
|
Mar 21, 2022
|
|
Dynamic single-cell RNA sequencing reveals BCG vaccination curtails SARS-CoV-2 induced disease severity and lung inflammation
First Author: Singh, Alok K
Reviewed: Mar 21, 2022
|
Singh, Alok K
|
Mar 21, 2022
|
|
Immunization with recombinant accessory protein-deficient SARS-CoV-2 protects against lethal challenge and viral transmission
First Author: Ye, Chengjin
Reviewed: Mar 21, 2022
|
Ye, Chengjin
|
Mar 21, 2022
|
|
Immunogenicity of the third and fourth BNT162b2 mRNA COVID-19 boosters and factors associated with immune response in systemic lupus erythematosus and rheumatoid arthritis patients
First Author: Assawasaksakul, Theerada
Reviewed: Mar 21, 2022
|
Assawasaksakul, Theerada
|
Mar 21, 2022
|
|
Longitudinal determination of mRNA-vaccination induced strongly binding SARS-CoV-2 IgG antibodies in a cohort of Romanian healthcare workers
First Author: Korodi, Monika
Reviewed: Mar 21, 2022
|
Korodi, Monika
|
Mar 21, 2022
|
|
Lower Risk of Paediatric Inflammatory Multisystem Syndrome (PIMS-TS) with the Delta variant of SARS-CoV-2
First Author: Cohen, Jonathan M
Reviewed: Mar 21, 2022
|
Cohen, Jonathan M
|
Mar 21, 2022
|
|
Modelling the impact of rapid tests, tracing and distancing in lower-income countries suggest that optimal policies varies with rural-urban settings
First Author: Jiang, Xilin
Reviewed: Mar 21, 2022
|
Jiang, Xilin
|
Mar 21, 2022
|
|
Monocytes are the main source of STING-mediated IFN-α production
First Author: Congy Jolivet, Nicolas
Reviewed: Mar 21, 2022
|
Congy Jolivet, Nicolas
|
Mar 21, 2022
|
|
Neutralizing responses in fully vaccinated with BNT162b2, CoronaVac, ChAdOx1, and Ad26.COV2.S against SARS-CoV-2 lineages in Colombia, 2020-2021
First Author: Alvarez Diaz, Diego A
Reviewed: Mar 21, 2022
|
Alvarez Diaz, Diego A
|
Mar 21, 2022
|
|
Omicron BA.1 and BA.2 neutralizing activity elicited by a comprehensive panel of human vaccines
First Author: Bowen, John E
Reviewed: Mar 21, 2022
|
Bowen, John E
|
Mar 21, 2022
|
|
Safety and immunogenicity of SARS-CoV-2 vaccine MVC-COV1901 in adolescents in Taiwan: A double-blind, randomized, placebo-controlled phase 2 trial
First Author: Liu, Luke Tzu Chi
Reviewed: Mar 21, 2022
|
Liu, Luke Tzu Chi
|
Mar 21, 2022
|
- Pediatrics/Adolescents
- Immunological
|
SARS-CoV-2 infection during the Omicron surge among patients receiving dialysis: the role of circulating receptor-binding domain antibodies and vaccine doses
First Author: Montez Rath, Maria E
Reviewed: Mar 21, 2022
|
Montez Rath, Maria E
|
Mar 21, 2022
|
|
Selection of optimum formulation of RBD-based protein sub-unit covid19 vaccine (Corbevax) based on safety and immunogenicity in an open-label, randomized Phase-1 and 2 clinical studies
First Author: Thuluva, Subhash
Reviewed: Mar 21, 2022
|
Thuluva, Subhash
|
Mar 21, 2022
|
|
Shared Genomic Architectures of COVID-19 and Antisocial Behavior
First Author: Adams, Charleen D
Reviewed: Mar 21, 2022
|
Adams, Charleen D
|
Mar 21, 2022
|
|
Structural basis of Omicron immune evasion: A comparative computational study of Spike protein-Antibody interaction
First Author: Contractor, Darshan
Reviewed: Mar 21, 2022
|
Contractor, Darshan
|
Mar 21, 2022
|
|
The effect of waning on antibody levels and memory B cell recall following SARS-CoV-2 infection or vaccination
First Author: Forgacs, David
Reviewed: Mar 21, 2022
|
Forgacs, David
|
Mar 21, 2022
|
|
The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopes
First Author: Greaney, Allison J
Reviewed: Mar 21, 2022
|
Greaney, Allison J
|
Mar 21, 2022
|
|
Tracking SARS-CoV-2 Omicron diverse spike gene mutations identifies multiple inter-variant recombination events
First Author: Ou, Junxian
Reviewed: Mar 21, 2022
|
Ou, Junxian
|
Mar 21, 2022
|
|
Adverse effects of vaccinations against the Corona-virus SARS-CoV-2:
insights and hindsights from a statistical perspective
First Author: Schmidt Melchiors, Thomas
Reviewed: Mar 20, 2022
|
Schmidt Melchiors, Thomas
|
Mar 20, 2022
|
|
Analysis of immunization time, amplitude, and adverse events of seven different vaccines against SARS-CoV-2 across four different countries
First Author: Romero Ibarguengoitia, Maria Elena
Reviewed: Mar 20, 2022
|
Romero Ibarguengoitia, Maria Elena
|
Mar 20, 2022
|
|
Antibody-Positive Neuromyelitis Optica Spectrum Disorder After Second COVID-19 Vaccination: A Case Report.
First Author: Kuntz, Stephanie
Reviewed: Mar 20, 2022
|
Kuntz, Stephanie
|
Mar 20, 2022
|
|
Association of frailty, age, and biological sex with SARS-CoV-2 mRNA vaccine-induced immunity in older adults
First Author: Shapiro, Janna R
Reviewed: Mar 20, 2022
|
Shapiro, Janna R
|
Mar 20, 2022
|
|
Cellular and humoral immune response to a third dose of BNT162b2 COVID-19 vaccine – a prospective observational study
First Author: Herzberg, Jonas
Reviewed: Mar 20, 2022
|
Herzberg, Jonas
|
Mar 20, 2022
|
|
Characterizing the SARS-CoV-2 Omicron variant shedding and duration of RT-PCR and rapid antigen test positivity on vaccinated individuals.
First Author: Luna Muschi, Alessandra
Reviewed: Mar 20, 2022
|
Luna Muschi, Alessandra
|
Mar 20, 2022
|
|
Convalescent Blood Treatment for COVID-19: Are Local Donors Enough?
First Author: Douglas, Pamela K
Reviewed: Mar 20, 2022
|
Douglas, Pamela K
|
Mar 20, 2022
|
|
COVID-19 Vaccination in the Gaza Strip: a Cross-sectional Study of Vaccine Coverage, Hesitancy, and Associated Risk Factors Among Community Members and Healthcare Workers
First Author: Majer, Jennifer
Reviewed: Mar 20, 2022
|
Majer, Jennifer
|
Mar 20, 2022
|
|
Current epidemiological situation of COVID-19 in the Republic of Belarus: characteristics of the epidemic process, sanitary and anti-epidemic measures
First Author: Dashkevich, Ala M
Reviewed: Mar 20, 2022
|
Dashkevich, Ala M
|
Mar 20, 2022
|
|
Daily Rapid Antigen Testing in a University Setting to Inform COVID-19 Isolation Duration Policy
First Author: Earnest, Rebecca
Reviewed: Mar 20, 2022
|
Earnest, Rebecca
|
Mar 20, 2022
|
|
Disentangling the effect of measures, variants and vaccines on SARS-CoV-2 Infections in England: A dynamic intensity model
First Author: Boldea, Otilia
Reviewed: Mar 20, 2022
|
Boldea, Otilia
|
Mar 20, 2022
|
|
Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar
First Author: Chemaitelly, Hiam
Reviewed: Mar 20, 2022
|
Chemaitelly, Hiam
|
Mar 20, 2022
|
|
Duration of vaccine effectiveness against SARS-CoV2 infection, hospitalisation, and death in residents and staff of Long-Term Care Facilities (VIVALDI): a prospective cohort study, England, Dec 2020-Dec 2021
First Author: Shrotri, Madhumita
Reviewed: Mar 20, 2022
|
Shrotri, Madhumita
|
Mar 20, 2022
|
|
Effectiveness and safety of inactivated SARS-CoV2 vaccine (BBIBP-CorV) among healthcare workers: A seven-month follow-up study at fifteen hospitals
First Author: Ashmawy, Rasha
Reviewed: Mar 20, 2022
|
Ashmawy, Rasha
|
Mar 20, 2022
|
|
Effectiveness of CoronaVac in children 3 to 5 years during the omicron SARS-CoV-2 outbreak
First Author: Araos, Rafael
Reviewed: Mar 20, 2022
|
Araos, Rafael
|
Mar 20, 2022
|
|
High vaccine effectiveness against severe Covid-19 in the elderly in Finland before and after the emergence of Omicron
First Author: Baum, Ulrike
Reviewed: Mar 20, 2022
|
Baum, Ulrike
|
Mar 20, 2022
|
|
Immunogenicity and safety of a recombinant adenovirus type-5 COVID-19 vaccine in adults: data from a randomised, double-blind, placebo-controlled, single-dose, phase 3 trial in Russia
First Author: Lioznov, Dmitry
Reviewed: Mar 20, 2022
|
Lioznov, Dmitry
|
Mar 20, 2022
|
|
Increased receptor affinity and reduced recognition by specific antibodies contribute to immune escape of SARS-CoV-2 variant Omicron
First Author: Vogt, Anne Cathrine
Reviewed: Mar 20, 2022
|
Vogt, Anne Cathrine
|
Mar 20, 2022
|
|
Innate immune response and distinct metabolomic signatures together drive and shape the SARS-CoV-2-specific T cell response during COVID-19
First Author: Binayke, Akshay
Reviewed: Mar 20, 2022
|
Binayke, Akshay
|
Mar 20, 2022
|
|
Milder disease trajectory among COVID-19 patients hospitalised with the SARS-CoV-2 Omicron variant compared with the Delta variant in Norway
First Author: Stalcrantz, Jeanette
Reviewed: Mar 20, 2022
|
Stalcrantz, Jeanette
|
Mar 20, 2022
|
|
Modeling of Asymptotically Periodic Outbreaks: a long-term SIRW2
description of COVID-19?
First Author: Viguerie, Alex
Reviewed: Mar 20, 2022
|
Viguerie, Alex
|
Mar 20, 2022
|
|
Regional opening strategies with commuter testing and containment of new SARS-CoV-2 variants in Germany
First Author: Kuhn, Martin J
Reviewed: Mar 20, 2022
|
Kuhn, Martin J
|
Mar 20, 2022
|
|
Response to COVID-19 booster vaccinations in seronegative people with MS
First Author: Tallantyre, Emma C
Reviewed: Mar 20, 2022
|
Tallantyre, Emma C
|
Mar 20, 2022
|
|
Risk factors for SARS-CoV-2 infection after primary vaccination with ChAdOx1 nCoV-19 or BNT1262b2 and after booster vaccination with BNT1262b2 or mRNA-1273: a population-based cohort study (COVIDENCE UK)
First Author: Vivaldi, Giulia
Reviewed: Mar 20, 2022
|
Vivaldi, Giulia
|
Mar 20, 2022
|
|
Safety and Immunogenicity of COVID-19 BBIBP-CorV Vaccine in Children 3-12 Years Old
First Author: Khaled Greish
Reviewed: Mar 20, 2022
|
Khaled Greish
|
Mar 20, 2022
|
- Pediatrics/Adolescents
- Immunological
|
SARS-CoV-2 Omicron disease burden in Australia following border reopening: a modelling analysis
First Author: Milne, George J
Reviewed: Mar 20, 2022
|
Milne, George J
|
Mar 20, 2022
|
|
SARS-CoV-2 reinfections during the first three major COVID-19 waves in Bulgaria
First Author: Marinov, Georgi K
Reviewed: Mar 20, 2022
|
Marinov, Georgi K
|
Mar 20, 2022
|
|
SARS-CoV-2 seroconversion in response to infection and vaccination: A time series local study in Brazil
First Author: Huergo, Luciano F
Reviewed: Mar 20, 2022
|
Huergo, Luciano F
|
Mar 20, 2022
|
|
The changing impact of vaccines in the COVID-19 pandemic
First Author: Cohen, Jamie A
Reviewed: Mar 20, 2022
|
Cohen, Jamie A
|
Mar 20, 2022
|
|
The Omicron SARS-CoV-2 epidemic in England during February 2022
First Author: Chadeau Hyam, Marc
Reviewed: Mar 20, 2022
|
Chadeau Hyam, Marc
|
Mar 20, 2022
|
|
Using digital traces to build prospective and real-time county-level
early warning systems to anticipate COVID-19 outbreaks in the United States
First Author: Stolerman, Lucas M
Reviewed: Mar 20, 2022
|
Stolerman, Lucas M
|
Mar 20, 2022
|
|
Vaccination against SARS-CoV-2 in UK school-aged children and young people decreases infection rates and reduces COVID-19 symptoms
First Author: Molteni, Erika
Reviewed: Mar 20, 2022
|
Molteni, Erika
|
Mar 20, 2022
|
|
Vaccine-induced antibody level predicts the clinical course of breakthrough infection of COVID-19 caused by delta and omicron variants: a prospective observational cohort study
First Author: Kim, Min Hyung
Reviewed: Mar 20, 2022
|
Kim, Min Hyung
|
Mar 20, 2022
|
|
Would New SARS-CoV-2 Variants Change the War Against COVID-19?
First Author: Elrashdy M. Redwan
Reviewed: Mar 20, 2022
|
Elrashdy M. Redwan
|
Mar 20, 2022
|
|
Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause severe disease
First Author: Zhou, Panpan
Reviewed: Mar 14, 2022
|
Zhou, Panpan
|
Mar 14, 2022
|
|
Chimeric mRNA based COVID-19 vaccine elicits potent neutralizing antibodies and protection against Omicron and Delta
First Author: Hu, Qidong
Reviewed: Mar 14, 2022
|
Hu, Qidong
|
Mar 14, 2022
|
|
Clinical outcomes among patients infected with Omicron (B.1.1.529) SARS-CoV-2 variant in southern California
First Author: Lewnard, Joseph A
Reviewed: Mar 14, 2022
|
Lewnard, Joseph A
|
Mar 14, 2022
|
- Adults
- Pediatrics/Adolescents
|
Cost-effectiveness of a whole-area testing pilot of asymptomatic SARS-CoV-2 infections with lateral flow devices: A modelling and economic analysis study
First Author: Drakesmith, Mark
Reviewed: Mar 14, 2022
|
Drakesmith, Mark
|
Mar 14, 2022
|
|
Defining Factors that Influence vaccine-induced, cross-variant neutralizing antibodies for SARS-CoV-2 in Asians
First Author: Gu, Yue
Reviewed: Mar 14, 2022
|
Gu, Yue
|
Mar 14, 2022
|
|
Discovery of Potent Pyrazoline-Based Covalent SARS-CoV-2 Main Protease Inhibitors
First Author: Moon, Patrick
Reviewed: Mar 14, 2022
|
Moon, Patrick
|
Mar 14, 2022
|
|
Elevated levels of IL-6 in IgA nephropathy patients are induced by an epigenetically-driven mechanism triggered by viral and bacterial RNA
First Author: Fabio, Sallustio
Reviewed: Mar 14, 2022
|
Fabio, Sallustio
|
Mar 14, 2022
|
|
Extensive neutralization against SARS-CoV-2 variants elicited by Omicron-specific subunit vaccine booster
First Author: Peng, Pai
Reviewed: Mar 14, 2022
|
Peng, Pai
|
Mar 14, 2022
|
|
Geneticin shows selective antiviral activity against SARS-CoV-2 by targeting programmed -1 ribosomal frameshifting
First Author: Varricchio, Carmine
Reviewed: Mar 14, 2022
|
Varricchio, Carmine
|
Mar 14, 2022
|
|
Identification and Characterization of a Novel Cell Binding and Cross-reactive Region on Spike Protein of SARS-CoV-2
First Author: Wang, Hanlu
Reviewed: Mar 14, 2022
|
Wang, Hanlu
|
Mar 14, 2022
|
|
Identification of tumor antigens and immune subtypes of bladder cancer for mRNA vaccine development
First Author: Luo, Yongwen
Reviewed: Mar 14, 2022
|
Luo, Yongwen
|
Mar 14, 2022
|
|
In silico screening and testing of FDA approved small molecules to block SARS-CoV-2 entry to the host cell by inhibiting Spike protein cleavage
First Author: Sila Ozdemir, E
Reviewed: Mar 14, 2022
|
Sila Ozdemir, E
|
Mar 14, 2022
|
|
mRNA-based vaccine candidate COReNAPCIN® induces robust humoral and cellular immunity in mice and non-human primates
First Author: Alimohammadi, Reza
Reviewed: Mar 14, 2022
|
Alimohammadi, Reza
|
Mar 14, 2022
|
|
Potent universal-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibody
First Author: Piepenbrink, Michael S
Reviewed: Mar 14, 2022
|
Piepenbrink, Michael S
|
Mar 14, 2022
|
|
Protective antibodies and T cell responses to Omicron variant three months after the booster dose of BNT162b2 vaccine
First Author: Naaber, Paul
Reviewed: Mar 14, 2022
|
Naaber, Paul
|
Mar 14, 2022
|
|
Risk of myocarditis and pericarditis following BNT162b2 and ChAdOx1 COVID-19 vaccinations
First Author: Ip, Samantha
Reviewed: Mar 14, 2022
|
Ip, Samantha
|
Mar 14, 2022
|
|
Safety and Immunogenicity of a 100 μg mRNA-1273 Vaccine Booster for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
First Author: Chalkias, Spyros
Reviewed: Mar 14, 2022
|
Chalkias, Spyros
|
Mar 14, 2022
|
|
Severity of SARS-CoV-2 Infection in Pregnancy in Ontario: A Matched Cohort Analysis
First Author: Murison, Kiera R
Reviewed: Mar 14, 2022
|
Murison, Kiera R
|
Mar 14, 2022
|
|
Sociodemographic Differences in Population-Level Immunosenescence in Older Age
First Author: Noppert, Grace A
Reviewed: Mar 14, 2022
|
Noppert, Grace A
|
Mar 14, 2022
|
|
Three separate spike antigen exposures by COVID-19 vaccination or SARS-CoV-2 infection elicit strong humoral immune responses in healthcare workers
First Author: Brehm, Thomas Theo
Reviewed: Mar 14, 2022
|
Brehm, Thomas Theo
|
Mar 14, 2022
|
|
Tracking the national and regional COVID-19 epidemic status in the UK
using directed Principal Component Analysis
First Author: Swallow, Ben
Reviewed: Mar 14, 2022
|
Swallow, Ben
|
Mar 14, 2022
|
|
Development of a COVID-19 risk-assessment model for participants at an outdoor music festival: Evaluation of the validity and control measure effectiveness
First Author: Murakami, Michio
Reviewed: Mar 12, 2022
|
Murakami, Michio
|
Mar 12, 2022
|
|
Evaluation of the role of home rapid antigen testing to determine isolation period after infection with SARS-CoV-2
First Author: Cosimi, Lisa A
Reviewed: Mar 12, 2022
|
Cosimi, Lisa A
|
Mar 12, 2022
|
|
Glycaemic control is associated with SARS-CoV-2 breakthrough infections in vaccinated patients with type 2 diabetes: an observational study
First Author: Marfella, Raffaele
Reviewed: Mar 12, 2022
|
Marfella, Raffaele
|
Mar 12, 2022
|
|
Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac and ChAdOx1 and BNT162b2 plus heterologous BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults
First Author: Niyomnaitham, Suvimol
Reviewed: Mar 12, 2022
|
Niyomnaitham, Suvimol
|
Mar 12, 2022
|
|
Immunogenicity and Safety of Booster Dose of S-268019-b or Tozinameran in Japanese Participants: An Interim Report of Phase 2/3, Randomized, Observer-Blinded, Noninferiority Study
First Author: Shinkai, Masaharu
Reviewed: Mar 12, 2022
|
Shinkai, Masaharu
|
Mar 12, 2022
|
|
Open label phase I/II clinical trial and predicted efficacy of SARS-CoV-2 RBD protein vaccines SOBERANA 02 and SOBERANA Plus in children
First Author: Puga Gomez, Rinaldo
Reviewed: Mar 12, 2022
|
Puga Gomez, Rinaldo
|
Mar 12, 2022
|
|
Reasons underlying the intention to vaccinate children aged 5-11 against COVID-19: A cross-sectional study of parents in Israel, November 2021
First Author: Morozov, Nicole G
Reviewed: Mar 12, 2022
|
Morozov, Nicole G
|
Mar 12, 2022
|
|
Reevaluating COVID-19 Mandates using Tensor Completion
First Author: Auerbach, Jonathan
Reviewed: Mar 12, 2022
|
Auerbach, Jonathan
|
Mar 12, 2022
|
|
SARS-CoV-2 Omicron Variant Infection of Individuals with High Titer Neutralizing Antibodies Post-3rd mRNA Vaccine Dose
First Author: Roeder, Alexa J
Reviewed: Mar 12, 2022
|
Roeder, Alexa J
|
Mar 12, 2022
|
|
Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in three Kenyan referral hospitals: repeated cross-sectional surveys 2020-21
First Author: Lucinde, R
Reviewed: Mar 12, 2022
|
Lucinde, R
|
Mar 12, 2022
|
|
Spike mutations of the SARS-CoV-2 Omicron: more likely to occur in the epitopes
First Author: Li, Hu
Reviewed: Mar 12, 2022
|
Li, Hu
|
Mar 12, 2022
|
|
Zinc pyrithione is a potent inhibitor of PLPro and cathepsin L enzymes with ex vivo inhibition of SARS-CoV-2 entry and replication
First Author: Kladnik, Jerneja
Reviewed: Mar 12, 2022
|
Kladnik, Jerneja
|
Mar 12, 2022
|
|
An Immunoinformatic strategy to develop new Mycobacterium tuberculosis multi-epitope vaccine
First Author: Ghandadi, Morteza
Reviewed: Mar 10, 2022
|
Ghandadi, Morteza
|
Mar 10, 2022
|
|
Covid-19 Exposure Assessment Tool (CEAT): Easy-to-use tool to quantify exposure based on airflow, group behavior, and infection prevalence in the community
First Author: Schimmoller, Brian J
Reviewed: Mar 10, 2022
|
Schimmoller, Brian J
|
Mar 10, 2022
|
|
Detection of SARS-CoV-2 nucleocapsid, spike, and neutralizing antibodies in vaccinated Japanese.
First Author: Midorikawa, Rie
Reviewed: Mar 10, 2022
|
Midorikawa, Rie
|
Mar 10, 2022
|
|
Effect of BNT162b2 booster dose on anti-SARS-CoV-2 spike trimeric IgG antibodies in seronegative individuals
First Author: Salvagno, Gian Luca
Reviewed: Mar 10, 2022
|
Salvagno, Gian Luca
|
Mar 10, 2022
|
|
Immunogenicity and reactogenicity of SARS-CoV-2 mRNA and inactivated vaccines in healthy adolescents
First Author: Lau, Yu Lung
Reviewed: Mar 10, 2022
|
Lau, Yu Lung
|
Mar 10, 2022
|
- Pediatrics/Adolescents
- Immunological
|
Investigating the Structure-Activity Relationship of Marine Polycyclic Batzelladine Alkaloids as Promising Inhibitors for SARS-CoV-2 Main Protease (Mpro)
First Author: Elgohary, Alaa M
Reviewed: Mar 10, 2022
|
Elgohary, Alaa M
|
Mar 10, 2022
|
|
A Study of a Fractional-order Model of Coronavius Disease 2019(COVID-19) after Mass Caccination
First Author: Wang, Chunhua
Reviewed: Mar 9, 2022
|
Wang, Chunhua
|
Mar 9, 2022
|
|
Absence of Anti-RBD Antibodies in SARS-COV-2 Infected or Naive Individuals Prior to Vaccination With CoronaVac Leads to Short Protection of Only Four Months Duration
First Author: Camille F de Oliveira
Reviewed: Mar 9, 2022
|
Camille F de Oliveira
|
Mar 9, 2022
|
|
Acute Placental Insufficiency Two Weeks After an Asymptomatic COVID-19 Maternal Infection: The Deleterious Effects of The SARS-Cov-2 Placentitis Associated with B.1.617.2 (Delta) Variant. Report of Two Cases.
First Author: Chiaie, Loredana Delle
Reviewed: Mar 9, 2022
|
Chiaie, Loredana Delle
|
Mar 9, 2022
|
|
Adverse Events Following Immunization of ChAdOx1 nCoV- 19 Vaccine Among Health Care Workers of a Tertiary Care Hospital of North India
First Author: Dhamnetiya, Deepak
Reviewed: Mar 9, 2022
|
Dhamnetiya, Deepak
|
Mar 9, 2022
|
|
An observational study of the association between COVID-19 vaccination rates and participation in a vaccine lottery
First Author: Jun, Dajung
Reviewed: Mar 9, 2022
|
Jun, Dajung
|
Mar 9, 2022
|
|
Comparison of the reactogenicity and immunogenicity of a reduced and standard booster dose of the mRNA COVID-19 vaccine in healthy adults after two doses of inactivated vaccine
First Author: Kanokudom, Sitthichai
Reviewed: Mar 9, 2022
|
Kanokudom, Sitthichai
|
Mar 9, 2022
|
|
Determining the optimal SARS-CoV-2 mRNA vaccine dosing interval for maximum immunogenicity
First Author: Asamoah Boaheng, Michael
Reviewed: Mar 9, 2022
|
Asamoah Boaheng, Michael
|
Mar 9, 2022
|
|
Effects of BA.1/BA.2 subvariant, vaccination, and prior infection on infectiousness of SARS-CoV-2 Omicron infections
First Author: Qassim, Suelen H
Reviewed: Mar 9, 2022
|
Qassim, Suelen H
|
Mar 9, 2022
|
|
Genomic epidemiology offers high resolution estimates of serial intervals for COVID-19
First Author: Stockdale, Jessica E
Reviewed: Mar 9, 2022
|
Stockdale, Jessica E
|
Mar 9, 2022
|
|
Impact of Delta and Vaccination on SARS-CoV-2 transmission risk: Lessons for Emerging Breakthrough infections
First Author: Sriraman, Kalpana
Reviewed: Mar 9, 2022
|
Sriraman, Kalpana
|
Mar 9, 2022
|
|
Monitoring and understanding household clustering of SARS-CoV-2 cases using surveillance data in Fulton County, Georgia
First Author: Liu, Carol Y
Reviewed: Mar 9, 2022
|
Liu, Carol Y
|
Mar 9, 2022
|
|
Morning SARS-CoV-2 testing yields better detection of infection due to higher viral loads in saliva and nasal swabs upon waking
First Author: Winnett, Alexander Viloria
Reviewed: Mar 9, 2022
|
Winnett, Alexander Viloria
|
Mar 9, 2022
|
|
Optimal vaccination with time-varying based on immunity barrier in Hunan Province, China
First Author: Guo, Xiaohao
Reviewed: Mar 9, 2022
|
Guo, Xiaohao
|
Mar 9, 2022
|
|
Vaccine Breakthrough Infection with the SARS-CoV-2 Delta or Omicron (BA.1) Variant Leads to Distinct Profiles of Neutralizing Antibody Responses
First Author: Seaman, Michael S
Reviewed: Mar 9, 2022
|
Seaman, Michael S
|
Mar 9, 2022
|
|
Vaccine effectiveness and duration of protection against symptomatic and severe Covid-19 during the first year of vaccination in France
First Author: Castillo, Milena Suarez
Reviewed: Mar 9, 2022
|
Castillo, Milena Suarez
|
Mar 9, 2022
|
|
A strategy to optimize the peptide-based inhibitors against different mutants of the spike protein of SARS-CoV-2
First Author: Priya, Prerna
Reviewed: Mar 7, 2022
|
Priya, Prerna
|
Mar 7, 2022
|
|
Acceptability Of Covid-19 Vaccines And Vaccination In Cameroon: Challenges And Way Forward
First Author: Tambo, Ernest
Reviewed: Mar 7, 2022
|
Tambo, Ernest
|
Mar 7, 2022
|
|
An Immunobridging study to evaluate the neutralizing antibody titer in adults immunized with two doses of either ChAdOx1-nCov-19 (AstraZeneca) or MVC-COV1901
First Author: Estrada, Josue Antonio
Reviewed: Mar 7, 2022
|
Estrada, Josue Antonio
|
Mar 7, 2022
|
|
Decoding COVID-19 mRNA Vaccine Immunometabolism in Central Nervous System: human brain normal glial and glioma cells by Raman imaging
First Author: Abramczyk, H
Reviewed: Mar 7, 2022
|
Abramczyk, H
|
Mar 7, 2022
|
|
Descriptive and Narrative Study of Long Covid Cases in General Practice and Diagnostic Value of Single Photon Emission Computed Tomography (SPECT scan)
First Author: Jamoulle, Marc
Reviewed: Mar 7, 2022
|
Jamoulle, Marc
|
Mar 7, 2022
|
|
Development, Analysis, and Preclinical Evaluation of Inactivated Vaccine Candidate for Prevention of COVID-19 Disease
First Author: Onen, Engin Alp
Reviewed: Mar 7, 2022
|
Onen, Engin Alp
|
Mar 7, 2022
|
|
Duration of viable virus shedding in SARS-CoV-2 omicron variant infection
First Author: Boucau, Julie
Reviewed: Mar 7, 2022
|
Boucau, Julie
|
Mar 7, 2022
|
|
Effect of booster vaccination against Delta and Omicron variants in Iceland
First Author: Norddahl, Gudmundur L
Reviewed: Mar 7, 2022
|
Norddahl, Gudmundur L
|
Mar 7, 2022
|
|
Effectiveness of the BNT162b2 vaccine among children 5-11 and 12-17 years in New York after the Emergence of the Omicron Variant
First Author: Dorabawila, Vajeera
Reviewed: Mar 7, 2022
|
Dorabawila, Vajeera
|
Mar 7, 2022
|
|
High Viral Specific Antibody Convalescent Plasma Effectively Neutralizes SARS-CoV-2 Variants of Concern
First Author: Li, Maggie
Reviewed: Mar 7, 2022
|
Li, Maggie
|
Mar 7, 2022
|
|
Immunological memory to Common Cold Coronaviruses assessed longitudinally over a three-year period
First Author: Yu, Esther Dawen
Reviewed: Mar 7, 2022
|
Yu, Esther Dawen
|
Mar 7, 2022
|
|
Longitudinal monitoring of SARS-CoV-2 neutralizing antibody titers and its impact on employee personal wellness decisions
First Author: Vandergaast, Rianna
Reviewed: Mar 7, 2022
|
Vandergaast, Rianna
|
Mar 7, 2022
|
|
Myocarditis and Pericarditis following COVID-19 Vaccination: Evidence Syntheses on Incidence, Risk Factors, Natural History, and Hypothesized Mechanisms
First Author: Pillay, Jennifer
Reviewed: Mar 7, 2022
|
Pillay, Jennifer
|
Mar 7, 2022
|
|
Rapid hypermutation B cell trajectory recruits previously primed B cells upon third SARS-CoV-2 mRNA vaccination
First Author: Paschold, Lisa
Reviewed: Mar 7, 2022
|
Paschold, Lisa
|
Mar 7, 2022
|
|
Remdesivir, Zidovudine (AZT) and Nevirapine inhibit Chandipura virus replication through high energy interactions with the RdRp domain of the polymerase protein L
First Author: Mandal, Dibyakanti
Reviewed: Mar 7, 2022
|
Mandal, Dibyakanti
|
Mar 7, 2022
|
|
RK-33, a small molecule inhibitor of host RNA helicase DDX3, suppresses multiple variants of SARS-CoV-2
First Author: Vesuna, Farhad
Reviewed: Mar 7, 2022
|
Vesuna, Farhad
|
Mar 7, 2022
|
|
Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): a randomized, observer-blinded, placebo-controlled trial
First Author: Jin, Pengfei
Reviewed: Mar 7, 2022
|
Jin, Pengfei
|
Mar 7, 2022
|
|
SARS-CoV-2 mRNA Vaccination-Associated Myocarditis in Children Ages 12-17: A Stratified National Database Analysis
First Author: Hoeg, Tracy Beth
Reviewed: Mar 7, 2022
|
Hoeg, Tracy Beth
|
Mar 7, 2022
|
|
Serum Unconjugated Bilirubin as a Predictor of Specific Cellular Immunity Response in Kidney Transplant Recipients after Administration of SARS-CoV-2 Inactivated Vaccine
First Author: Zhang, Lei
Reviewed: Mar 7, 2022
|
Zhang, Lei
|
Mar 7, 2022
|
|
The Advantage of Inactivated Vaccine for Preventing the Omicron Outbreak
First Author: Xinbo Lian
Reviewed: Mar 7, 2022
|
Xinbo Lian
|
Mar 7, 2022
|
|
Vaccination and Variants: retrospective model for the evolution of Covid-19 in Italy
First Author: Fierro, Annalisa
Reviewed: Mar 7, 2022
|
Fierro, Annalisa
|
Mar 7, 2022
|
|
Variability in SARS-Cov-2 IgG Antibody Affinity To Omicron and Delta Variants in Convalescent and Community mRNA Vaccinated Individuals
First Author: Tu, Michael K
Reviewed: Mar 7, 2022
|
Tu, Michael K
|
Mar 7, 2022
|
|
BCG revaccination qualitatively and quantitatively enhances SARS-CoV-2 spike-specific neutralizing antibody and T cell responses induced by the COVISHIELDTM vaccine in SARS-CoV-2 seronegative young Indian adults
First Author: Rakshit, Srabanti
Reviewed: Mar 4, 2022
|
Rakshit, Srabanti
|
Mar 4, 2022
|
|
Changes in Blood Pressure After Pfizer/Biontech Sars-Cov-2 Vaccination
First Author: Ch Ng, Chin Chin
Reviewed: Mar 4, 2022
|
Ch Ng, Chin Chin
|
Mar 4, 2022
|
|
Effect of Heterologous Vaccination Strategy on Humoral Response against COVID-19 with CoronaVac Plus BNT162b2: A Prospective Cohort Study
First Author: Hakan Demirhindi
Reviewed: Mar 4, 2022
|
Hakan Demirhindi
|
Mar 4, 2022
|
|
Factors associated with the decay of anti-SARS-CoV-2 neutralizing antibodies among recipients of an adenoviral vector-based AZD1222 and a whole-virion inactivated (BBV152) vaccine in Chennai, India: a prospective, longitudinal, cohort study
First Author: Selvavinayagam, Sivaprakasam T
Reviewed: Mar 4, 2022
|
Selvavinayagam, Sivaprakasam T
|
Mar 4, 2022
|
|
Genomics of Post-Vaccination SARS-CoV-2 Infections During the Delta Dominated Second Wave of COVID-19 Pandemic, from Mumbai Metropolitan Region (MMR), India
First Author: Nilgiriwala, Kayzad
Reviewed: Mar 4, 2022
|
Nilgiriwala, Kayzad
|
Mar 4, 2022
|
|
Severity of Covid-19 Cases in the Months of Predominance of the Alpha Variant and the Role of Vaccination
First Author: Florensa, Didac
Reviewed: Mar 4, 2022
|
Florensa, Didac
|
Mar 4, 2022
|
|
Short-term improvement of mental health after a COVID-19 vaccination
First Author: Chourpiliadis, Charilaos
Reviewed: Mar 4, 2022
|
Chourpiliadis, Charilaos
|
Mar 4, 2022
|
|
Follow-up investigation and detailed mutational characterization of the SARS-CoV-2 Omicron variant lineages (BA.1, BA.2, BA.3 and BA.1.1)
First Author: Abbas, Qussai
Reviewed: Mar 3, 2022
|
Abbas, Qussai
|
Mar 3, 2022
|
|
The Efficacy of Casirivimab/Imdevimab in Solid Organ Transplant Recipients with Mild-To-Moderate COVID-19
First Author: Tagaya, Etsuko
Reviewed: Mar 3, 2022
|
Tagaya, Etsuko
|
Mar 3, 2022
|
|
Uveitis Including Vogt-Koyanagi-Harada Syndrome Following Inactive Covid-19 Vaccination: A Case Series
First Author: Shariati, Mehrdad Motamed
Reviewed: Mar 3, 2022
|
Shariati, Mehrdad Motamed
|
Mar 3, 2022
|
|
Vaccination, life expectancy, and trust: Patterns of COVID-19
vaccination rates around the world
First Author: Rughinis, Cosima
Reviewed: Mar 3, 2022
|
Rughinis, Cosima
|
Mar 3, 2022
|
|
‘True’ COVID-19 Vaccine Booster Hesitancy among Healthcare Workers: A Retrospective Observational Study in Singapore
First Author: Sky Wei Chee Koh
Reviewed: Mar 2, 2022
|
Sky Wei Chee Koh
|
Mar 2, 2022
|
|
A mixture model to estimate SARS-CoV-2 seroprevalence in Chennai, India
First Author: Hitchings, Matt D T
Reviewed: Mar 2, 2022
|
Hitchings, Matt D T
|
Mar 2, 2022
|
|
Booster protection against Omicron infection in a highly vaccinated cohort
First Author: Tai, Caroline G
Reviewed: Mar 2, 2022
|
Tai, Caroline G
|
Mar 2, 2022
|
|
Bounce backs amid continued losses: Life expectancy changes since COVID-19
First Author: Scholey, Jonas
Reviewed: Mar 2, 2022
|
Scholey, Jonas
|
Mar 2, 2022
|
|
Clinical and Virologic Factors associated with Outcomes of COVID-19 before and after Vaccination among Veterans: Retrospective Analysis from Six New England States
First Author: Lee, Megan
Reviewed: Mar 2, 2022
|
Lee, Megan
|
Mar 2, 2022
|
|
Cross-neutralizing activity against Omicron could be obtained in SARS-CoV-2 convalescent patients who received two doses of mRNA vaccination
First Author: Kurahashi, Yukiya
Reviewed: Mar 2, 2022
|
Kurahashi, Yukiya
|
Mar 2, 2022
|
|
Dynamics of the Delta and Omicron variants of SARS-CoV-2 in the United States: the battle of supremacy in the presence of vaccination, mask usage and antiviral treatment
First Author: Ngonghala, Calistus N
Reviewed: Mar 2, 2022
|
Ngonghala, Calistus N
|
Mar 2, 2022
|
|
Effectiveness of the third dose of BNT162b2 vaccine on neutralizing Omicron variant in the Japanese population
First Author: Kawasuji, Hitoshi
Reviewed: Mar 2, 2022
|
Kawasuji, Hitoshi
|
Mar 2, 2022
|
|
Evaluation of the Safety and Immunogenicity of Different COVID-19 Vaccine Combinations in Healthy Individuals: Study Protocol for a Randomized, Subject-blinded, Controlled Phase 3 Trial [PRIBIVAC]
First Author: Poh, Xuan Ying
Reviewed: Mar 2, 2022
|
Poh, Xuan Ying
|
Mar 2, 2022
|
|
Impact of Omicron variant on the response to SARS-CoV-2 mRNA Vaccination in multiple myeloma
First Author: Storti, Paola
Reviewed: Mar 2, 2022
|
Storti, Paola
|
Mar 2, 2022
|
|
Increase in SARS-CoV-2 RBD-specific IgA and IgG Antibodies in Breast Milk from Lactating Women Following the COVID-19 Booster Vaccination
First Author: Henle, Andrea M
Reviewed: Mar 2, 2022
|
Henle, Andrea M
|
Mar 2, 2022
|
|
Long-term Durable Humoral Immune Response to Heterologous Antigenic Exposure Post six months by Natural SARS-CoV-2 Infection and Vaccination
First Author: Batra, Gaurav
Reviewed: Mar 2, 2022
|
Batra, Gaurav
|
Mar 2, 2022
|
|
Mitoquinone mesylate targets SARS-CoV-2 and associated lung inflammation through host pathways
First Author: Petcherski, Anton
Reviewed: Mar 2, 2022
|
Petcherski, Anton
|
Mar 2, 2022
|
|
Omicron BA.1 and BA.2 are antigenically distinct SARS-CoV-2 variants
First Author: Mykytyn, Anna Z
Reviewed: Mar 2, 2022
|
Mykytyn, Anna Z
|
Mar 2, 2022
|
|
Preliminary Evidence of a Link between COVID-19 Vaccines and Otologic Symptoms
First Author: Woodcock, Ramsi A
Reviewed: Mar 2, 2022
|
Woodcock, Ramsi A
|
Mar 2, 2022
|
|
Presence of Symptoms 6 Weeks After COVID-19 Among Vaccinated and Unvaccinated U.S. Healthcare Personnel
First Author: Mohr, Nicholas M
Reviewed: Mar 2, 2022
|
Mohr, Nicholas M
|
Mar 2, 2022
|
|
Protection by vaccines and previous infection against the Omicron variant of SARS-CoV-2
First Author: Smid, Martin
Reviewed: Mar 2, 2022
|
Smid, Martin
|
Mar 2, 2022
|
|
Public Health Impact of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) in the first year of rollout in the United States
First Author: Fusco, Manuela Di
Reviewed: Mar 2, 2022
|
Fusco, Manuela Di
|
Mar 2, 2022
|
|
Risk of COVID-19 related deaths for SARS-CoV-2 Omicron (B.1.1.529) compared with Delta (B.1.617.2)
First Author: Ward, Isobel L
Reviewed: Mar 2, 2022
|
Ward, Isobel L
|
Mar 2, 2022
|
|
Risk of Long Covid in people infected with SARS-CoV-2 after two doses of a COVID-19 vaccine: community-based, matched cohort study
First Author: Ayoubkhani, Daniel
Reviewed: Mar 2, 2022
|
Ayoubkhani, Daniel
|
Mar 2, 2022
|
|
Safety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) Network study
First Author: Sadarangani, Manish
Reviewed: Mar 2, 2022
|
Sadarangani, Manish
|
Mar 2, 2022
|
|
SARS-CoV-2 Infection Breakthrough among the non-vaccinated and vaccinated: a Real World Evidence study based on Big Data
First Author: Perrella, A
Reviewed: Mar 2, 2022
|
Perrella, A
|
Mar 2, 2022
|
|
The impact of COVID passport mandates on the number of cases of and hospitalizations with COVID-19 in the UK: a difference-in-differences analysis
First Author: Lopez Guell, Kim
Reviewed: Mar 2, 2022
|
Lopez Guell, Kim
|
Mar 2, 2022
|
|
Third dose of COVID-19 vaccine, CVnCoV, increased neutralizing activity against SARS-CoV-2 wild-type and Delta variant
First Author: Wolz, Olaf Oliver
Reviewed: Mar 2, 2022
|
Wolz, Olaf Oliver
|
Mar 2, 2022
|
|
Three-month follow-up of heterologous vs homologous third vaccination in kidney transplant recipients
First Author: Heinzel, Andreas
Reviewed: Mar 2, 2022
|
Heinzel, Andreas
|
Mar 2, 2022
|
|
Waning Effectiveness of the Third Dose of the BNT162b2 mRNA COVID-19 Vaccine
First Author: Patalon, Tal
Reviewed: Mar 2, 2022
|
Patalon, Tal
|
Mar 2, 2022
|
|
A comparison of Ivermectin and Non Ivermectin based regimen for covid 19 in Abuja: effects on virus clearance, Days-to-Discharge and Mortality.
First Author: Thairu, Y
Reviewed: Feb 28, 2022
|
Thairu, Y
|
Feb 28, 2022
|
|
A novel intranasal administration adenoviral vector-based platform for rapid COVID-19 vaccine development
First Author: Yuan, Yifei
Reviewed: Feb 28, 2022
|
Yuan, Yifei
|
Feb 28, 2022
|
|
An inactivated SARS-CoV-2 vaccine is safe and induces humoral and cellular immunity against virus variants in healthy children and adolescents in Chile
First Author: Soto, Jorge A
Reviewed: Feb 28, 2022
|
Soto, Jorge A
|
Feb 28, 2022
|
- Pediatrics/Adolescents
- Immunological
|
Anti-SARS-CoV-2 IgG antibodies after recovery from COVID-19 or vaccination in Libyan population: comparison of four vaccines
First Author: Ebrahim, Fawzi
Reviewed: Feb 28, 2022
|
Ebrahim, Fawzi
|
Feb 28, 2022
|
|
At Least Three Doses of Leading Vaccines Essential for Neutralisation of SARS-CoV-2 Omicron Variant
First Author: Singanallur, Nagendrakumar Balasubramanian
Reviewed: Feb 28, 2022
|
Singanallur, Nagendrakumar Balasubramanian
|
Feb 28, 2022
|
|
Breakthrough SARS-CoV-2 infections in immune mediated disease patients undergoing B cell depleting therapy
First Author: Calabrese, Cassandra M
Reviewed: Feb 28, 2022
|
Calabrese, Cassandra M
|
Feb 28, 2022
|
|
Can individuals with low antibody responses to conventional antiviral vaccines acquire adequate antibody by the SARS-CoV-2 mRNA vaccine?
First Author: Ogura, Wataru
Reviewed: Feb 28, 2022
|
Ogura, Wataru
|
Feb 28, 2022
|
|
Cell-Mediated Immune Response after COVID 19 Vaccination in Patients with Inflammatory Bowel Disease
First Author: Caldera, Freddy
Reviewed: Feb 28, 2022
|
Caldera, Freddy
|
Feb 28, 2022
|
|
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2
First Author: Kawaoka, Yoshihiro
Reviewed: Feb 28, 2022
|
Kawaoka, Yoshihiro
|
Feb 28, 2022
|
|
Clinical severity of COVID-19 patients admitted to hospitals during the Omicron wave in South Africa
First Author: Jassat, Waasila
Reviewed: Feb 28, 2022
|
Jassat, Waasila
|
Feb 28, 2022
|
|
Effectiveness of Covid-19 vaccines against symptomatic and asymptomatic SARS-CoV-2 infections in an urgent care setting
First Author: Rane, Madhura S
Reviewed: Feb 28, 2022
|
Rane, Madhura S
|
Feb 28, 2022
|
|
Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine
First Author: Goel, Rishi R
Reviewed: Feb 28, 2022
|
Goel, Rishi R
|
Feb 28, 2022
|
|
Factors Associated with COVID-19 Vaccine Booster Hesitancy: a Retrospective Cohort Study, Fukushima Vaccination Community Survey
First Author: Makoto Yoshida
Reviewed: Feb 28, 2022
|
Makoto Yoshida
|
Feb 28, 2022
|
|
Favourable vaccine-induced SARS-CoV-2 specific T cell response profile in patients undergoing immune-modifying therapies
First Author: Qui, Martin
Reviewed: Feb 28, 2022
|
Qui, Martin
|
Feb 28, 2022
|
|
Four doses of the inactivated SARS-CoV-2 vaccine redistribute humoral immune responses away from the Receptor Binding Domain
First Author: Wang, Ji
Reviewed: Feb 28, 2022
|
Wang, Ji
|
Feb 28, 2022
|
|
Genomic monitoring unveils a high prevalence of SARS-CoV-2 Omicron variant in vaccine breakthrough cases
First Author: Campos, Gubio Soares
Reviewed: Feb 28, 2022
|
Campos, Gubio Soares
|
Feb 28, 2022
|
|
How the Development, Features and Roll-Out of a SARS-COV-2 Vaccine Shape Public Acceptance: A Conjoint Experiment in a Large Representative Sample of Danes
First Author: Jorgensen, Frederik Juhl
Reviewed: Feb 28, 2022
|
Jorgensen, Frederik Juhl
|
Feb 28, 2022
|
|
Identification of SARS-CoV-2 Variants Using Viral Sequencing for the Centers for Disease Control and Prevention Genomic U.S. Surveillance Program.
First Author: Goswami, Chirayu
Reviewed: Feb 28, 2022
|
Goswami, Chirayu
|
Feb 28, 2022
|
|
Impact of BNT162b2 mRNA Vaccination on the Development of Short and Long-term Vaccine-Related Adverse Events in Inflammatory Bowel Disease: A Multi-Center Prospective Study
First Author: Shehab, Mohammad
Reviewed: Feb 28, 2022
|
Shehab, Mohammad
|
Feb 28, 2022
|
|
Influenza vaccination reveals and partly reverses sex dimorphic immune imprints associated with prior mild COVID-19
First Author: Sparks, Rachel
Reviewed: Feb 28, 2022
|
Sparks, Rachel
|
Feb 28, 2022
|
|
Likelihood of infecting or getting infected with COVID-19 as a function of vaccination status, as investigated with a stochastic model for New Zealand (Aotearoa) for Delta and Omicron variants
First Author: Watson, Leighton M
Reviewed: Feb 28, 2022
|
Watson, Leighton M
|
Feb 28, 2022
|
|
Modular capsid decoration boosts adenovirus vaccine-induced humoral and cellular immunity against SARS-CoV-2
First Author: Dicks, Matthew D J
Reviewed: Feb 28, 2022
|
Dicks, Matthew D J
|
Feb 28, 2022
|
|
Mucosal Immunization of Cynomolgus Macaques with Adenoviral Vector Vaccine Elicits Neutralizing Nasal and Serum Antibody to Several SARS-CoV-2 Variants
First Author: Flitter, Becca A
Reviewed: Feb 28, 2022
|
Flitter, Becca A
|
Feb 28, 2022
|
|
Neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2
First Author: Xiong, Hua Long
Reviewed: Feb 28, 2022
|
Xiong, Hua Long
|
Feb 28, 2022
|
|
On the caveats of a multiplex test for SARS-CoV-2 to detect seroconversion after infection or vaccination
First Author: Fernandes Siqueira, Lorena
Reviewed: Feb 28, 2022
|
Fernandes Siqueira, Lorena
|
Feb 28, 2022
|
|
Potent Neutralizing Activity of Polyclonal Equine Antibodies against Omicron SARS-CoV-2
First Author: Luczkowiak, J
Reviewed: Feb 28, 2022
|
Luczkowiak, J
|
Feb 28, 2022
|
|
Scottish COVID CAncer iMmunity Prevalence (SCCAMP) - a longitudinal study of patients with cancer receiving active anti-cancer treatment during the COVID-19 pandemic
First Author: Purshouse, Karin
Reviewed: Feb 28, 2022
|
Purshouse, Karin
|
Feb 28, 2022
|
|
Using Best-Worst Scaling to investigate younger adult Canadians’ preferences for COVID-19 vaccination and public health measures: an observational study
First Author: Tatar, Ovidiu
Reviewed: Feb 28, 2022
|
Tatar, Ovidiu
|
Feb 28, 2022
|
|
Assessment of neutralizing antibody responses after natural SARS-CoV-2 infection and vaccination in Congolese individuals
First Author: Ntoumi, Francine
Reviewed: Feb 25, 2022
|
Ntoumi, Francine
|
Feb 25, 2022
|
|
Central Retinal Vein Occlusion Post ChAdOx1 nCoV-19 Vaccination – Can It Be Explained by the Two-hit Hypothesis?
First Author: Parakh, Shweta
Reviewed: Feb 25, 2022
|
Parakh, Shweta
|
Feb 25, 2022
|
|
COVID-19 Omicron variant-inhibitory in silico evidence for phytocompounds of an ancient Ayurvedic formulation
First Author: Sharanya, C S
Reviewed: Feb 25, 2022
|
Sharanya, C S
|
Feb 25, 2022
|
|
Differential escape of neutralizing antibodies by SARS-CoV-2 Omicron and pre-emergent sarbecoviruses
First Author: Wang, Lin Fa
Reviewed: Feb 25, 2022
|
Wang, Lin Fa
|
Feb 25, 2022
|
|
Kinetics of humoral immune response over 17 months of COVID-19 pandemic in a large cohort of healthcare workers in Spain: The ProHEpiC-19 study
First Author: Violan, Concepcion
Reviewed: Feb 25, 2022
|
Violan, Concepcion
|
Feb 25, 2022
|
|
Omicron BA.2 (B.1.1.529.2): high potential to becoming the next dominating variant
First Author: Chen, Jiahui
Reviewed: Feb 25, 2022
|
Chen, Jiahui
|
Feb 25, 2022
|
|
COVID-19 Breakthrough Infections among Patients with Cancer Receiving Sinopharm BIBP Vaccine
First Author: Manteghinejad, Amirreza
Reviewed: Feb 24, 2022
|
Manteghinejad, Amirreza
|
Feb 24, 2022
|
|
Immunomolecular Assay Based on Selective Virion Capture by Spike Antibody and Viral Nucleic Acid Amplification for Detecting Intact SARS-CoV-2 Particles
First Author: Wu, Xiaoli
Reviewed: Feb 24, 2022
|
Wu, Xiaoli
|
Feb 24, 2022
|
|
Real-time monitoring of the effectiveness of six COVID-19 vaccines in Hungary in 2021 using the screening method
First Author: Krisztina, Horvath J
Reviewed: Feb 24, 2022
|
Krisztina, Horvath J
|
Feb 24, 2022
|
|
Risk of SARS-CoV-2 reinfection 18 months after primary infection: population-level observational study
First Author: Flacco, Maria Elena
Reviewed: Feb 24, 2022
|
Flacco, Maria Elena
|
Feb 24, 2022
|
|
A mathematical model reveals the influence of NPIs and vaccination on SARS-CoV-2 Omicron Variant
First Author: Wang, Bin Guo
Reviewed: Feb 23, 2022
|
Wang, Bin Guo
|
Feb 23, 2022
|
|
An Assessment of Veterans Attitudes and Willingness to Receiving the COVID-19 Vaccine: A Mixed Methods Study
First Author: Gardner, Jessica
Reviewed: Feb 23, 2022
|
Gardner, Jessica
|
Feb 23, 2022
|
|
Mosaic receptor-binding domain nanoparticles induce protective immunity against SARS-CoV-2 challenges
First Author: Lee, Dan Bi
Reviewed: Feb 23, 2022
|
Lee, Dan Bi
|
Feb 23, 2022
|
|
Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern: A Perspective for Emerging more Transmissible and Vaccine-Resistant Strains
First Author: Anacleto S. de Souza
Reviewed: Feb 23, 2022
|
Anacleto S. de Souza
|
Feb 23, 2022
|
|
4th Dose COVID mRNA Vaccines’ Immunogenicity & Efficacy Against Omicron VOC
First Author: Regev Yochay, Gili
Reviewed: Feb 22, 2022
|
Regev Yochay, Gili
|
Feb 22, 2022
|
|
A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions
First Author: Liu, Yang
Reviewed: Feb 22, 2022
|
Liu, Yang
|
Feb 22, 2022
|
|
A novel consensus-based computational pipeline for rapid screening of antibody therapeutics for efficacy against SARS-CoV-2 variants of concern including omicron variant
First Author: Kumar, Naveen
Reviewed: Feb 22, 2022
|
Kumar, Naveen
|
Feb 22, 2022
|
|
A randomized clinical trial of a booster dose with low versus standard dose of AZD1222 in adult after 2 doses of inactivated vaccines
First Author: Nanthapisal, Sira
Reviewed: Feb 22, 2022
|
Nanthapisal, Sira
|
Feb 22, 2022
|
|
An extended SIR model with vaccine dynamics for SARS-CoV-2 adaptation rate
First Author: Horvat, R
Reviewed: Feb 22, 2022
|
Horvat, R
|
Feb 22, 2022
|
|
Beyond Vaccination Rates: A Synthetic Random Proxy Metric of Total
SARS-CoV-2 Immunity Seroprevalence in the Community
First Author: Si, Yajuan
Reviewed: Feb 22, 2022
|
Si, Yajuan
|
Feb 22, 2022
|
|
Bioinformatic analysis of B and T cell epitopes from SARS-CoV-2 Spike, Membrane and Nucleocapsid proteins as a strategy to assess possible cross-reactivity between emerging variants, including Omicron, and other human coronaviruses
First Author: Pacheco Olvera, Diana Laura
Reviewed: Feb 22, 2022
|
Pacheco Olvera, Diana Laura
|
Feb 22, 2022
|
|
Clinical and immunological features of SARS-CoV-2 breakthrough infections in vaccinated individuals requiring hospitalization
First Author: Lamacchia, Giulia
Reviewed: Feb 22, 2022
|
Lamacchia, Giulia
|
Feb 22, 2022
|
|
Comparative transmission of SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) variants and the impact of vaccination: national cohort study, England
First Author: Allen, Hester
Reviewed: Feb 22, 2022
|
Allen, Hester
|
Feb 22, 2022
|
|
Determinants of antibody responses to two doses of ChAdOx1 nCoV-19 or BNT162b2 and a subsequent booster dose of BNT162b2 or mRNA-1273: population-based cohort study (COVIDENCE UK)
First Author: Jolliffe, David A
Reviewed: Feb 22, 2022
|
Jolliffe, David A
|
Feb 22, 2022
|
|
Differential durability of humoral and T cell immunity after two and three BNT162b2 vaccinations in adults aged >80 years
First Author:
Reviewed: Feb 22, 2022
|
|
Feb 22, 2022
|
|
Effectiveness and durability of the mRNA vaccine-induced SARS-CoV-2-specific humoral and cellular immunity in severe asthma patients on biological therapy
First Author:
Reviewed: Feb 22, 2022
|
|
Feb 22, 2022
|
|
Increased household transmission and immune escape of the SARS-CoV-2 Omicron variant compared to the Delta variant: evidence from Norwegian contact tracing and vaccination data
First Author:
Reviewed: Feb 22, 2022
|
|
Feb 22, 2022
|
|
Increased Potency and Breadth of SARS-CoV-2 Neutralizing Antibodies After a Third mRNA Vaccine Dose
First Author:
Reviewed: Feb 22, 2022
|
|
Feb 22, 2022
|
|
Intramuscular mRNA BNT162b2 vaccine against SARS-CoV-2 induces robust neutralizing salivary IgA
First Author:
Reviewed: Feb 22, 2022
|
|
Feb 22, 2022
|
|
Milk of cow and goat, immunized by recombinant protein vaccine ZF-UZ-VAC2001(Zifivax), contains neutralizing antibodies against SARS-CoV-2 and remains active after standard milk pasteurization
First Author:
Reviewed: Feb 22, 2022
|
|
Feb 22, 2022
|
|
Omicron-Based Vaccine Candidate Elicits Potent Neutralizing Antibodies in the Animal Model
First Author:
Reviewed: Feb 22, 2022
|
|
Feb 22, 2022
|
|
Oral administration of S-217622, a SARS-CoV-2 main protease inhibitor, decreases viral load and accelerates recovery from clinical aspects of COVID-19
First Author:
Reviewed: Feb 22, 2022
|
|
Feb 22, 2022
|
|
Prior SARS-CoV2 infection in vaccinated solid organ transplant recipients induces potent neutralization responses against variants, including Omicron
First Author:
Reviewed: Feb 22, 2022
|
|
Feb 22, 2022
|
|
Quantitative, multiplexed, targeted proteomics for ascertaining variant specific SARS-CoV-2 antibody response
First Author:
Reviewed: Feb 22, 2022
|
|
Feb 22, 2022
|
|
Reduced antigenicity of Omicron lowers host serologic response
First Author:
Reviewed: Feb 22, 2022
|
|
Feb 22, 2022
|
|
Relative Virulence of SARS-CoV-2 Among Vaccinated and Unvaccinated Individuals Hospitalized with SARS-CoV-2
First Author:
Reviewed: Feb 22, 2022
|
|
Feb 22, 2022
|
|
SARS-CoV-2 Omicron-specific mRNA vaccine induces potent and broad antibody responses in vivo
First Author:
Reviewed: Feb 22, 2022
|
|
Feb 22, 2022
|
|
Serological responses and six-month trajectories to COVID-19 Comirnaty and Spikevax booster vaccine, September 2021 to January 2022, London, United Kingdom
First Author:
Reviewed: Feb 22, 2022
|
|
Feb 22, 2022
|
|
The BNT162b2 mRNA SARS-CoV-2 vaccine induces transient afucosylated IgG1 in naive but not antigen-experienced vaccinees
First Author:
Reviewed: Feb 22, 2022
|
|
Feb 22, 2022
|
|
The Influence of Time on the Sensitivity of SARS-CoV-2 Serological Testing
First Author:
Reviewed: Feb 22, 2022
|
|
Feb 22, 2022
|
|
Virological characteristics of SARS-CoV-2 BA.2 variant
First Author:
Reviewed: Feb 22, 2022
|
|
Feb 22, 2022
|
|
Application of a new mathematical description of Epidemics to the COVID-19 Omicron wave in few strongly affected countries by the beginning of 2022: USA, UK and France
First Author:
Reviewed: Feb 18, 2022
|
|
Feb 18, 2022
|
|
Beyond COVID-19 Pandemic: Topology-aware optimisation of vaccination
strategy for minimising virus spreading
First Author:
Reviewed: Feb 18, 2022
|
|
Feb 18, 2022
|
|
Coronavirus Disease 2019 (COVID-19) Vaccine Boosting in Persons Already Protected by Natural or Vaccine-Induced Immunity
First Author:
Reviewed: Feb 18, 2022
|
|
Feb 18, 2022
|
|
Correlation between post-vaccination titres of combined IgG, IgA, and IgM anti-Spike antibodies and protection against breakthrough SARS-CoV-2 infection: a population-based longitudinal study (COVIDENCE UK)
First Author:
Reviewed: Feb 18, 2022
|
|
Feb 18, 2022
|
|
Excess COVID-19 associated deaths among the unvaccinated population ≥18 years old in the US, May 30 – December 4, 2021
First Author:
Reviewed: Feb 18, 2022
|
|
Feb 18, 2022
|
|
Multiple sclerosis disease-modifying therapies and COVID-19 vaccines: A practical review and meta-analysis
First Author:
Reviewed: Feb 18, 2022
|
|
Feb 18, 2022
|
|
Persistence of SARS-CoV-2 immunity, Omicron’s footprints, and projections of epidemic resurgences in South African population cohorts
First Author:
Reviewed: Feb 18, 2022
|
|
Feb 18, 2022
|
|
A diagnostic strategy for adjusting Covid-19 vaccination to individual immune state
First Author:
Reviewed: Feb 16, 2022
|
|
Feb 16, 2022
|
|
Adolescent vaccination with BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine and effectiveness against COVID-19: national test-negative case-control study, England
First Author:
Reviewed: Feb 16, 2022
|
|
Feb 16, 2022
|
|
Anti-SARS-Cov-2 Iga And Igg In Human Milk From Vaccinated Mothers After Holder Pasteurization.
First Author:
Reviewed: Feb 16, 2022
|
|
Feb 16, 2022
|
|
Binding Interactions between RBD of Spike-Protein and Human ACE2 in Omicron variant
First Author:
Reviewed: Feb 16, 2022
|
|
Feb 16, 2022
|
|
Cell delivery peptides for small interfering RNAs targeting SARS-CoV-2 new variants through a bioinformatics and deep learning design
First Author:
Reviewed: Feb 16, 2022
|
|
Feb 16, 2022
|
|
COVID-19 vaccine: factual reporting, dynamic preferences, and gender hesitancy
First Author:
Reviewed: Feb 16, 2022
|
|
Feb 16, 2022
|
|
Distinct Core Glycan and O-Glycoform Utilization of SARS-CoV-2 Omicron Variant Spike Protein RBD Revealed by Top-Down Mass Spectrometry
First Author:
Reviewed: Feb 16, 2022
|
|
Feb 16, 2022
|
|
Efficacy of ChAdOx1 vaccines against SARS-CoV-2 Variants of Concern Beta, Delta and Omicron in the Syrian hamster model
First Author:
Reviewed: Feb 16, 2022
|
|
Feb 16, 2022
|
|
High antibody and reduced cellular response in children up to one year after SARS-CoV-2 infection
First Author:
Reviewed: Feb 16, 2022
|
|
Feb 16, 2022
|
|
Investigating trends in those who experience menstrual bleeding changes after SARS-CoV-2 vaccination
First Author:
Reviewed: Feb 16, 2022
|
|
Feb 16, 2022
|
|
Long-term antibody response to SARS-CoV-2 in children
First Author:
Reviewed: Feb 16, 2022
|
|
Feb 16, 2022
|
|
Lyophilized mRNA-lipid nanoparticles vaccine with long-term stability and high antigenicity against SARS-CoV-2
First Author:
Reviewed: Feb 16, 2022
|
|
Feb 16, 2022
|
|
Preclinical establishment of a divalent vaccine against SARS-CoV-2
First Author:
Reviewed: Feb 16, 2022
|
|
Feb 16, 2022
|
|
Predicting Epitope Candidates for SARS-CoV-2
First Author:
Reviewed: Feb 16, 2022
|
|
Feb 16, 2022
|
|
Remdesivir and GS-441524 retain antiviral activity against Delta, Omicron, and other emergent SARS-CoV-2 variants
First Author:
Reviewed: Feb 16, 2022
|
|
Feb 16, 2022
|
|
SARS-CoV-2 neutralization after mRNA vaccination and variant breakthrough infection
First Author:
Reviewed: Feb 16, 2022
|
|
Feb 16, 2022
|
|
Theoretical Analysis of SIRVVD Model to Provide Insight on the Target
Rate of COVID-19/SARS-CoV-2 Vaccination in Japan
First Author:
Reviewed: Feb 16, 2022
|
|
Feb 16, 2022
|
|
Topological data analysis identifies emerging adaptive mutations in
SARS-CoV-2
First Author:
Reviewed: Feb 16, 2022
|
|
Feb 16, 2022
|
|
A highly attenuated SARS-CoV-2 related pangolin coronavirus variant has a 104nt deletion at the 3′-terminus untranslated region
First Author:
Reviewed: Feb 14, 2022
|
|
Feb 14, 2022
|
|
Anatomy of Omicron neutralizing antibodies in COVID-19 mRNA vaccinees
First Author:
Reviewed: Feb 14, 2022
|
|
Feb 14, 2022
|
|
Antibody and memory B-cell immunity in a heterogeneously SARS-CoV-2 infected and vaccinated population
First Author:
Reviewed: Feb 14, 2022
|
|
Feb 14, 2022
|
|
Antibody Evasion Properties of SARS-CoV-2 Omicron Sublineages
First Author:
Reviewed: Feb 14, 2022
|
|
Feb 14, 2022
|
|
Antibody response after a single dose of BBV152 vaccine negatively correlates with pre-existing antibodies and induces a significant but low levels of neutralizing antibodies to Omicron variant
First Author:
Reviewed: Feb 14, 2022
|
|
Feb 14, 2022
|
|
Anti-spike antibody trajectories in individuals previously immunised with BNT162b2 or ChAdOx1 following a BNT162b2 booster dose
First Author:
Reviewed: Feb 14, 2022
|
|
Feb 14, 2022
|
|
Boosting with Omicron-matched or historical mRNA vaccines increases neutralizing antibody responses and protection against B.1.1.529 infection in mice
First Author:
Reviewed: Feb 14, 2022
|
|
Feb 14, 2022
|
|
Clinical outcomes in hospitalized vaccine-breakthrough COVID-19 cases compared with contemporary unvaccinated hospitalized adults
First Author:
Reviewed: Feb 14, 2022
|
|
Feb 14, 2022
|
|
Community vaccination can shorten the COVID-19 isolation period: an individual-based modeling approach
First Author:
Reviewed: Feb 14, 2022
|
|
Feb 14, 2022
|
|
Covalent narlaprevir- and boceprevir-derived hybrid inhibitors of SARS-CoV-2 main protease: room-temperature X-ray and neutron crystallography, binding thermodynamics, and antiviral activity
First Author:
Reviewed: Feb 14, 2022
|
|
Feb 14, 2022
|
|
COVID Testing in the Workplace: Return to Work Testing in an Occupational Cohort
First Author:
Reviewed: Feb 14, 2022
|
|
Feb 14, 2022
|
|
Differential aerosol shedding of SARS-CoV-2 Delta and Omicron variants during respiratory activities
First Author:
Reviewed: Feb 14, 2022
|
|
Feb 14, 2022
|
|
Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice
First Author:
Reviewed: Feb 14, 2022
|
|
Feb 14, 2022
|
|
Duration of protection of BNT162b2 and mRNA-1273 COVID-19 vaccines against symptomatic SARS-CoV-2 Omicron infection in Qatar
First Author:
Reviewed: Feb 14, 2022
|
|
Feb 14, 2022
|
|
Dynamics of Neutralizing Antibodies and Binding Antibodies to Domains of SARS-CoV-2 Spike Protein in COVID-19 Survivors
First Author:
Reviewed: Feb 14, 2022
|
|
Feb 14, 2022
|
|
Estimation of COVID-19 cases prevented by vaccination in California
First Author:
Reviewed: Feb 14, 2022
|
|
Feb 14, 2022
|
|
Evaluation of a Rapid and Accessible RT-qPCR Approach for SARS-CoV-2 Variant of Concern Identification
First Author:
Reviewed: Feb 14, 2022
|
|
Feb 14, 2022
|
|
History of SARS-CoV-2 infection, anti-spike IgG antibody kinetics and neutralization capacities following the second and third dose of BNT162b2 vaccine in nursing home residents
First Author:
Reviewed: Feb 14, 2022
|
|
Feb 14, 2022
|
|
Immune responses after twofold SARS-CoV-2 immunisation in elderly residents and Health Care Workers in nursing homes and homes with assisted living support - Proposal for a correlate of protection
First Author:
Reviewed: Feb 14, 2022
|
|
Feb 14, 2022
|
|
Increased household transmission and immune escape of the SARS-CoV-2 Omicron variant compared to the Delta variant: evidence from Norwegian contact tracing and vaccination data
First Author:
Reviewed: Feb 14, 2022
|
|
Feb 14, 2022
|
- Adults
- Pediatrics/Adolescents
|
Model-based estimates of deaths averted and cost per life saved by scaling-up mRNA COVID-19 vaccination in low and lower-middle income countries in the COVID-19 Omicron variant era
First Author:
Reviewed: Feb 14, 2022
|
|
Feb 14, 2022
|
|
Neutralization Of SARS-CoV-2 Variants By A Human Polyclonal Antibody Therapeutic (COVID-HIG, NP-028) With High Neutralizing Titers To SARS-CoV-2
First Author:
Reviewed: Feb 14, 2022
|
|
Feb 14, 2022
|
|
Post-marketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12-39 years in Italy: a multi-database, self-controlled case series study
First Author:
Reviewed: Feb 14, 2022
|
|
Feb 14, 2022
|
|
Quantifying the risks versus benefits of the Pfizer COVID-19 vaccine in Australia: a Bayesian network analysis
First Author:
Reviewed: Feb 14, 2022
|
|
Feb 14, 2022
|
|
Rapid, High-Throughput, Cost Effective Whole Genome Sequencing of SARS-CoV-2 Using a Condensed One Hour Library Preparation of the Illumina DNA Prep Kit
First Author:
Reviewed: Feb 14, 2022
|
|
Feb 14, 2022
|
|
Risk of sustained SARS-CoV-2 transmission in Queensland, Australia
First Author:
Reviewed: Feb 14, 2022
|
|
Feb 14, 2022
|
|
Safety and Efficacy of Preventative COVID Vaccines: The StopCoV Study
First Author:
Reviewed: Feb 14, 2022
|
|
Feb 14, 2022
|
|
Safety and efficacy of two immunization schedules with an inactivated SARS-CoV-2 vaccine in adults. A randomized non-inferiority clinical trial
First Author:
Reviewed: Feb 14, 2022
|
|
Feb 14, 2022
|
|
Safety and immunogenicity of a live recombinant Newcastle disease virus-based COVID-19 vaccine (Patria) administered via the intramuscular or intranasal route: Interim results of a non-randomized open label phase I trial in Mexico
First Author:
Reviewed: Feb 14, 2022
|
|
Feb 14, 2022
|
|
Safety and immunogenicity of inactivated whole virion vaccine CoviVac against COVID-19: a multicenter, randomized, double-blind, placebo-controlled phase I/II clinical trial
First Author:
Reviewed: Feb 14, 2022
|
|
Feb 14, 2022
|
|
Sero-prevalence of anti-SARS-CoV-2 antibodies in Chattogram Metropolitan Area, Bangladesh
First Author:
Reviewed: Feb 14, 2022
|
|
Feb 14, 2022
|
|
Symptoms and severity in vaccinated and unvaccinated patients hospitalised with SARS-CoV-2 delta (B.1.617.2) variant infection
First Author:
Reviewed: Feb 14, 2022
|
|
Feb 14, 2022
|
|
Targeted isolation of panels of diverse human protective broadly neutralizing antibodies against SARS-like viruses
First Author:
Reviewed: Feb 14, 2022
|
|
Feb 14, 2022
|
|
Time to reinfection and vaccine breakthrough SARS-CoV-2 infections: a retrospective cohort study
First Author:
Reviewed: Feb 14, 2022
|
|
Feb 14, 2022
|
|
A potent SARS-CoV-2 neutralizing antibody recognizing a conserved epitope with broad mutant variant and SARS-CoV activity
First Author:
Reviewed: Feb 11, 2022
|
|
Feb 11, 2022
|
|
A Suite of TMPRSS2 Assays for Screening Drug Repurposing Candidates as Potential Treatments of COVID-19
First Author:
Reviewed: Feb 11, 2022
|
|
Feb 11, 2022
|
|
An mRNA vaccine candidate for the SARS-CoV-2 Omicron variant
First Author:
Reviewed: Feb 11, 2022
|
|
Feb 11, 2022
|
|
Clinical Severity and mRNA Vaccine Effectiveness for Omicron, Delta, and Alpha SARS-CoV-2 Variants in the United States: A Prospective Observational Study
First Author:
Reviewed: Feb 11, 2022
|
|
Feb 11, 2022
|
|
Comparable Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants
First Author:
Reviewed: Feb 11, 2022
|
|
Feb 11, 2022
|
|
Comparative profiles of SARS-CoV-2 Spike-specific human milk antibodies elicited by mRNA- and adenovirus-based COVID-19 vaccines
First Author:
Reviewed: Feb 11, 2022
|
|
Feb 11, 2022
|
|
Comparison of two T cell assays to evaluate T cell responses to SARS-CoV-2 following vaccination in naïve and convalescent healthcare workers
First Author:
Reviewed: Feb 11, 2022
|
|
Feb 11, 2022
|
|
Comprehensive Epitope Mapping of Broad Sarbecovirus Neutralizing Antibodies
First Author:
Reviewed: Feb 11, 2022
|
|
Feb 11, 2022
|
|
Early genomic, epidemiological, and clinical description of the SARS-CoV-2 Omicron variant in Mexico City
First Author:
Reviewed: Feb 11, 2022
|
|
Feb 11, 2022
|
|
Effectiveness of Covid-19 Vaccines against the SARS-COV-2-Delta (B.1.617.2) in China-A Real World Study
First Author:
Reviewed: Feb 11, 2022
|
|
Feb 11, 2022
|
|
EMoMiS: A Pipeline for Epitope-based Molecular Mimicry Search in Protein Structures with Applications to SARS-CoV-2
First Author:
Reviewed: Feb 11, 2022
|
|
Feb 11, 2022
|
|
Estimating the risk reduction of isolation on COVID-19 non-household transmission and severe/critical illness in non-immune individuals: September to November 2021
First Author:
Reviewed: Feb 11, 2022
|
|
Feb 11, 2022
|
|
Increased household transmission and immune escape of the SARS-CoV-2 Omicron variant compared to the Delta variant: evidence from Norwegian contact tracing and vaccination data
First Author:
Reviewed: Feb 11, 2022
|
|
Feb 11, 2022
|
|
Mutations of Omicron variant at the interface of the receptor domain motif and human angiotensin-converting enzyme-2
First Author:
Reviewed: Feb 11, 2022
|
|
Feb 11, 2022
|
|
Omicron BA.2 (B.1.1.529.2): high potential to becoming the next
dominating variant
First Author:
Reviewed: Feb 11, 2022
|
|
Feb 11, 2022
|
|
Protection of COVID-19 vaccination and previous infection against Omicron BA.1 and Delta SARS-CoV-2 infections, the Netherlands, 22 November 2021- 19 January 2022
First Author:
Reviewed: Feb 11, 2022
|
|
Feb 11, 2022
|
|
SARS-CoV-2 mRNA vaccination fails to elicit humoral and cellular immune responses in multiple sclerosis patients receiving fingolimod
First Author:
Reviewed: Feb 11, 2022
|
|
Feb 11, 2022
|
|
Seroprevalence of immunoglobulin G antibodies against SARS-CoV-2 in Cyprus
First Author:
Reviewed: Feb 11, 2022
|
|
Feb 11, 2022
|
|
Single cell sequencing analysis uncovers genetics-influenced CD16+monocytes and memory CD8+T cells involved in severe COVID-19
First Author:
Reviewed: Feb 11, 2022
|
|
Feb 11, 2022
|
|
Transient production of Receptor-Binding Domain of SARS-CoV-2 in Nicotiana benthamiana plants induces specific antibodies in immunized mice
First Author:
Reviewed: Feb 11, 2022
|
|
Feb 11, 2022
|
|
Vaccine Protection Against the SARS-CoV-2 Omicron Variant in Macaques
First Author:
Reviewed: Feb 11, 2022
|
|
Feb 11, 2022
|
|
A computational approach for molecular characterization of Covaxin (BBV152) and its ingredients for assessing its efficacy against COVID-19
First Author:
Reviewed: Feb 10, 2022
|
|
Feb 10, 2022
|
|
Allergological Study in Patients Vaccinated Against COVID-19 with Suspected Allergic Reactions
First Author:
Reviewed: Feb 10, 2022
|
|
Feb 10, 2022
|
|
An assessment of the vaccination of school-aged children in England
First Author:
Reviewed: Feb 10, 2022
|
|
Feb 10, 2022
|
|
Attitudes Towards Coronavirus (COVID-19) Vaccine and Sources of Information Across Diverse Ethnic Groups in the UK: a Qualitative Study
First Author:
Reviewed: Feb 10, 2022
|
|
Feb 10, 2022
|
|
Comparative effectiveness of different primary vaccination courses on mRNA based booster vaccines against SARs-COV-2 infections: A time-varying cohort analysis using trial emulation in the Virus Watch community cohort
First Author:
Reviewed: Feb 10, 2022
|
|
Feb 10, 2022
|
|
Comparative study of immunogenicity and safety of Gam-COVID-Vac and Sinopharm BBIBP-CorV vaccines in Belarus
First Author:
Reviewed: Feb 10, 2022
|
|
Feb 10, 2022
|
|
Co-WIN: Really Winning? Analysing Inequity in India's Vaccination
Response
First Author:
Reviewed: Feb 10, 2022
|
|
Feb 10, 2022
|
|
Emulation of a target trial from observational data to compare effectiveness of Casirivimab/Imdevimab and Bamlanivimab/Etesevimab for early treatment of non-hospitalized patients with COVID-19
First Author:
Reviewed: Feb 10, 2022
|
|
Feb 10, 2022
|
|
Factors Influencing the Acceptance of COVID-19 Vaccines in a Country With a High Vaccination Rate
First Author:
Reviewed: Feb 10, 2022
|
|
Feb 10, 2022
|
|
MVA-CoV2-S vaccine candidate confers full protection from SARS-CoV-2 brain infection and damage in susceptible transgenic mice
First Author:
Reviewed: Feb 10, 2022
|
|
Feb 10, 2022
|
|
SARS-CoV-2 Omicron symptomatic infections in previously infected or vaccinated South African healthcare workers
First Author:
Reviewed: Feb 10, 2022
|
|
Feb 10, 2022
|
|
SARS-CoV-2 Testing Strategies for Outbreak Mitigation in Vaccinated Populations
First Author:
Reviewed: Feb 10, 2022
|
|
Feb 10, 2022
|
|
A community-based survey on COVID-19 Knowledge, Attitudes, Practices and Vaccination Hesitance in Moshi, Kilimanjaro Region, Northern Tanzania
First Author:
Reviewed: Feb 9, 2022
|
|
Feb 9, 2022
|
|
Bimodal Antibody-Titer Decline Following BNT162b2 Mrna Anti-SARS-Cov-2 Vaccination In Healthcare Workers of The INT – IRCCS “Fondazione Pascale” Cancer Center (Naples, Italy)
First Author:
Reviewed: Feb 9, 2022
|
|
Feb 9, 2022
|
|
COVID-19 infection enhances susceptibility to oxidative-stress induced parkinsonism
First Author:
Reviewed: Feb 9, 2022
|
|
Feb 9, 2022
|
|
COVID-19 Vaccine Uptake, Unmet Need and Reported Side Effect in Nigeria: an Online Cross-sectional Study
First Author:
Reviewed: Feb 9, 2022
|
|
Feb 9, 2022
|
|
Development and optimisation of a high-throughput screening assay for in vitro anti–SARS-CoV-2 activity: evaluation of 5676 phase 1 passed structures
First Author:
Reviewed: Feb 9, 2022
|
|
Feb 9, 2022
|
|
Effectiveness of the Inactivated COVID-19 Vaccine (CoronaVac) in Adult Population in Bali, Indonesia
First Author:
Reviewed: Feb 9, 2022
|
|
Feb 9, 2022
|
|
Humoral Antibody Kinetics with ChAdOx1-nCOV (CovishieldTM) and BBV-152 (CovaxinTM) Vaccine among Indian Healthcare workers: A 6-month Longitudinal Cross-sectional Coronavirus Vaccine-induced Antibody Titre (COVAT) Study
First Author:
Reviewed: Feb 9, 2022
|
|
Feb 9, 2022
|
|
Measles incidence in South Africa: a six-year review, 2015 - 2020
First Author:
Reviewed: Feb 9, 2022
|
|
Feb 9, 2022
|
|
Modeling Vaccinations, Virus Variants and Lockdown: Early guidance for Sars-Cov-2 health policies in India *
First Author:
Reviewed: Feb 9, 2022
|
|
Feb 9, 2022
|
|
Replicating RNA platform enables rapid response to the SARS-CoV-2 Omicron variant and elicits enhanced protection in naïve hamsters compared to ancestral vaccine
First Author:
Reviewed: Feb 9, 2022
|
|
Feb 9, 2022
|
|
Risk assessment of COVID-19 epidemic resurgence in relation to SARS-CoV-2 variants and vaccination passes
First Author:
Reviewed: Feb 9, 2022
|
|
Feb 9, 2022
|
|
Risk factors for severe COVID-19 differ by age: a retrospective study of hospitalized adults
First Author:
Reviewed: Feb 9, 2022
|
|
Feb 9, 2022
|
|
Risk of severe COVID-19 from the Delta and Omicron variants in relation to vaccination status, sex, age and comorbidities – surveillance results from southern Sweden
First Author:
Reviewed: Feb 9, 2022
|
|
Feb 9, 2022
|
|
Safety and Immunogenicity of An Egg-Based Inactivated Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomized, Placebo-Controlled, Phase 1/2 Trial in Vietnam
First Author:
Reviewed: Feb 9, 2022
|
|
Feb 9, 2022
|
|
Serious hospital events following symptomatic infection with Sars-CoV-2 Omicron and Delta variants: an exposed-unexposed cohort study in December 2021 from the COVID-19 surveillance databases in France
First Author:
Reviewed: Feb 9, 2022
|
|
Feb 9, 2022
|
|
Wastewater Surveillance of U.S. Coast Guard Installations and Seagoing Military Vessels to Mitigate the Risk of COVID-19 Outbreaks
First Author:
Reviewed: Feb 9, 2022
|
|
Feb 9, 2022
|
|
A pseudotyped lentivirus-based assay to titer SARS-CoV-2 neutralizing antibodies in Mexico
First Author:
Reviewed: Feb 7, 2022
|
|
Feb 7, 2022
|
|
Ablation of CD8+ T-cell recognition of an immunodominant epitope in SARS-CoV-2 Omicron
First Author:
Reviewed: Feb 7, 2022
|
|
Feb 7, 2022
|
|
An intranasal lentiviral booster broadens immune recognition of SARS-CoV-2 variants and reinforces the waning mRNA vaccine-induced immunity that it targets to lung mucosa
First Author:
Reviewed: Feb 7, 2022
|
|
Feb 7, 2022
|
|
Association study of HLA with the kinetics of SARS-CoV-2 spike specific IgG antibody responses to BNT162b2 mRNA vaccine
First Author:
Reviewed: Feb 7, 2022
|
|
Feb 7, 2022
|
|
At-home Testing and Risk Factors for Acquisition of SARS-CoV-2 Infection in a Major US Metropolitan Area
First Author:
Reviewed: Feb 7, 2022
|
|
Feb 7, 2022
|
|
BNT162b2, mRNA-1273, and Sputnik V vaccines induce comparable immune responses on a par with severe course of COVID-19
First Author:
Reviewed: Feb 7, 2022
|
|
Feb 7, 2022
|
|
Combating the SARS-CoV-2 Omicron variant with non-Omicron neutralizing antibodies
First Author:
Reviewed: Feb 7, 2022
|
|
Feb 7, 2022
|
|
Comparative complete scheme and booster effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infections with SARS-CoV-2 Omicron (BA.1) and Delta (B.1.617.2) variants
First Author:
Reviewed: Feb 7, 2022
|
|
Feb 7, 2022
|
|
Conserved Neutralizing Epitopes on the N-Terminal Domain of Variant SARS-CoV-2 Spike Proteins
First Author:
Reviewed: Feb 7, 2022
|
|
Feb 7, 2022
|
|
COVID-19 in Tunisia (North Africa): Seroprevalence of SARS-CoV-2 in the general population of the capital city Tunis
First Author:
Reviewed: Feb 7, 2022
|
|
Feb 7, 2022
|
|
COVID-19 Vaccination is Associated with Decreasing Cases, Hospitalizations, and Deaths Across Age Groups and Variants over 9 months in Switzerland
First Author:
Reviewed: Feb 7, 2022
|
|
Feb 7, 2022
|
|
Doubtful Clinical Benefit of Casirivimab-Imdevimab Treatment for Disease Severity Outcome of High-Risk Patients with SARS-CoV-2 Delta Variant Infection
First Author:
Reviewed: Feb 7, 2022
|
|
Feb 7, 2022
|
|
Durability of Omicron-neutralizing serum activity following mRNA booster immunization in elderly individuals
First Author:
Reviewed: Feb 7, 2022
|
|
Feb 7, 2022
|
|
Early immune responses have long-term associations with clinical, virologic, and immunologic outcomes in patients with COVID-19
First Author:
Reviewed: Feb 7, 2022
|
|
Feb 7, 2022
|
|
Efficacy and Safety of a Booster Regimen of Ad26.COV2.S Vaccine against Covid-19
First Author:
Reviewed: Feb 7, 2022
|
|
Feb 7, 2022
|
|
Epidemiological Assessment of Sars-Cov-2 Reinfection
First Author:
Reviewed: Feb 7, 2022
|
|
Feb 7, 2022
|
|
Estimating COVID-19 Vaccination Effectiveness Using Electronic Health Records of an Academic Medical Center in Michigan
First Author:
Reviewed: Feb 7, 2022
|
|
Feb 7, 2022
|
|
Evaluating the Efficacy of Facebook's Vaccine Misinformation Content
Removal Policies
First Author:
Reviewed: Feb 7, 2022
|
|
Feb 7, 2022
|
|
High Rates of Rapid Antigen Test Positivity After 5 days of Isolation for COVID-19
First Author:
Reviewed: Feb 7, 2022
|
|
Feb 7, 2022
|
|
Impact of SARS-CoV-2 variants on inpatient clinical outcome
First Author:
Reviewed: Feb 7, 2022
|
|
Feb 7, 2022
|
|
Increasing SARS-CoV-2 mutations against vaccination-acquired immunity
First Author:
Reviewed: Feb 7, 2022
|
|
Feb 7, 2022
|
|
Influenza virus-like particle-based hybrid vaccine containing RBD induces immunity against influenza and SARS-CoV-2 viruses
First Author:
Reviewed: Feb 7, 2022
|
|
Feb 7, 2022
|
|
Intracellular flow cytometry complements RT-qPCR detection of circulating SARS-CoV-2 variants of concern
First Author:
Reviewed: Feb 7, 2022
|
|
Feb 7, 2022
|
|
Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccine
First Author:
Reviewed: Feb 7, 2022
|
|
Feb 7, 2022
|
|
Neutralization profile of Omicron variant convalescent individuals
First Author:
Reviewed: Feb 7, 2022
|
|
Feb 7, 2022
|
|
Nucleocapsid and spike antibody responses post virologically confirmed SARS-CoV-2 infection: An observational analysis in the Virus Watch community cohort
First Author:
Reviewed: Feb 7, 2022
|
|
Feb 7, 2022
|
|
Omicron-specific mRNA vaccine induced potent neutralizing antibody against Omicron but not other SARS-CoV-2 variants
First Author:
Reviewed: Feb 7, 2022
|
|
Feb 7, 2022
|
|
Patterns of Volatility Across the Spike Protein Accurately Predict the Emergence of Mutations within SARS-CoV-2 Lineages
First Author:
Reviewed: Feb 7, 2022
|
|
Feb 7, 2022
|
|
Phytochemical Drug Discovery for COVID-19 Using High-resolution Computational Docking and Machine Learning Assisted Binder Prediction
First Author:
Reviewed: Feb 7, 2022
|
|
Feb 7, 2022
|
|
Quantitative risk assessment of COVID-19 and serious illness among spectators at mass gathering events with vaccine-testing package implementation
First Author:
Reviewed: Feb 7, 2022
|
|
Feb 7, 2022
|
|
Rapid, high throughput, automated detection of SARS-CoV-2 neutralizing antibodies against native-like vaccine and delta variant spike trimers
First Author:
Reviewed: Feb 7, 2022
|
|
Feb 7, 2022
|
|
Real-life performance of a COVID-19 rapid antigen detection test targeting the SARS-CoV-2 nucleoprotein for diagnosis of COVID-19 due to the Omicron variant
First Author:
Reviewed: Feb 7, 2022
|
|
Feb 7, 2022
|
|
SARS-CoV-2 RT-qPCR testing of pooled saliva samples: a case study of 824 asymptomatic individuals and a questionnaire survey in Japan
First Author:
Reviewed: Feb 7, 2022
|
|
Feb 7, 2022
|
|
SARS-COV-2 Vaccine Responses in Renal Patient Populations
First Author:
Reviewed: Feb 7, 2022
|
|
Feb 7, 2022
|
|
Side Effects of COVID-19 Vaccines and Perceptions about COVID-19 and Its Vaccines in Bangladesh
First Author:
Reviewed: Feb 7, 2022
|
|
Feb 7, 2022
|
|
The Impact of Vaccination on the Infection rate and the Severity of
Covid-19
First Author:
Reviewed: Feb 7, 2022
|
|
Feb 7, 2022
|
|
Dynamics of antibody responses, cellular immunity, and breakthrough infections among Japanese healthcare workers during the 6 months after receiving two doses of BNT162b2 mRNA vaccine
First Author:
Reviewed: Feb 4, 2022
|
|
Feb 4, 2022
|
|
Evaluation of the systemic and mucosal immune response induced by COVID-19 and the BNT162b2 mRNA vaccine for SARS-CoV-2
First Author:
Reviewed: Feb 4, 2022
|
|
Feb 4, 2022
|
|
Genome surveillance of SARS-CoV-2 variants and their role in pathogenesis focusing on second wave of COVID-19 in India
First Author:
Reviewed: Feb 4, 2022
|
|
Feb 4, 2022
|
|
Observed serial intervals of SARS-CoV-2 for the Omicron and Delta variants in Belgium based on contact tracing data, 19 November to 31 December 2021
First Author:
Reviewed: Feb 4, 2022
|
|
Feb 4, 2022
|
|
Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: a living systematic review and meta-analysis
First Author:
Reviewed: Feb 4, 2022
|
|
Feb 4, 2022
|
|
Serum Neutralizing Activity of mRNA-1273 Against the SARS-CoV-2 B.1.1.529 (Omicron) Variant: A Preliminary Report
First Author:
Reviewed: Feb 4, 2022
|
|
Feb 4, 2022
|
|
Transmission of SARS-CoV-2 Omicron VOC subvariants BA.1 and BA.2: Evidence from Danish Households
First Author:
Reviewed: Feb 4, 2022
|
|
Feb 4, 2022
|
|
A longitudinal seroconversion panel shows anti-SARS-CoV-2 antibody levels up to 6.5 months after vaccination with mRNA-1273 (Moderna)
First Author:
Reviewed: Feb 3, 2022
|
|
Feb 3, 2022
|
|
Antibody and T cell responses to SARS-CoV-2 mRNA vaccines during maintenance therapy for immune-mediated inflammatory diseases
First Author:
Reviewed: Feb 3, 2022
|
|
Feb 3, 2022
|
|
Application of Artificial Intelligence for Rapid Prevention of Epidemic Diseases (COVID-19)
First Author:
Reviewed: Feb 3, 2022
|
|
Feb 3, 2022
|
|
Breadth of SARS-CoV-2 Neutralization and Protection Induced by a Nanoparticle Vaccine
First Author:
Reviewed: Feb 3, 2022
|
|
Feb 3, 2022
|
|
Comparative effectiveness of COVID-19 vaccination against death and severe disease in an ongoing nationwide mass vaccination campaign
First Author:
Reviewed: Feb 3, 2022
|
|
Feb 3, 2022
|
|
Comparison of total and neutralizing SARS-CoV-2 spike antibodies against omicron and other variants in paired samples after two or three doses of mRNA vaccine
First Author:
Reviewed: Feb 3, 2022
|
|
Feb 3, 2022
|
|
Covaxin (BBV152) Vaccine Neutralizes SARS-CoV-2 Delta and Omicron variants
First Author:
Reviewed: Feb 3, 2022
|
|
Feb 3, 2022
|
|
COVID-19 self-testing in Nigeria: Stakeholders’ opinions and perspective on its value for case detection
First Author:
Reviewed: Feb 3, 2022
|
|
Feb 3, 2022
|
|
Detection of anti-SARS-CoV-2 S1 RBD-specific antibodies prior to and during the pandemic in 2011-2021 and Covid-19 observational study in 2019-2021
First Author:
Reviewed: Feb 3, 2022
|
|
Feb 3, 2022
|
|
Early introduction and rise of the Omicron SARS-CoV-2 variant in highly vaccinated university populations
First Author:
Reviewed: Feb 3, 2022
|
|
Feb 3, 2022
|
|
Effectiveness of a SARS-CoV-2 mRNA vaccine booster dose for prevention of infection, hospitalization or death in two nation-wide nursing home systems
First Author:
Reviewed: Feb 3, 2022
|
|
Feb 3, 2022
|
|
Evaluation of the CD4+ T cell response to SARS-CoV-2 infection and cross reactivity to beta variant in children of all ages
First Author:
Reviewed: Feb 3, 2022
|
|
Feb 3, 2022
|
|
Fifteen Days in December: Capture and Analysis of Omicron-Related Travel Restrictions
First Author:
Reviewed: Feb 3, 2022
|
|
Feb 3, 2022
|
|
Germinal center-derived broadly neutralizing antibodies adapt to SARS-CoV-2 antigenic drift
First Author:
Reviewed: Feb 3, 2022
|
|
Feb 3, 2022
|
|
Hybrid immunity from SARS-CoV-2 delta variant surge induced low to undetectable levels of neutralizing antibodies against Omicron variant
First Author:
Reviewed: Feb 3, 2022
|
|
Feb 3, 2022
|
|
Impact of various vaccine boosters on neutralization against Omicron following prime vaccinations with inactivated or adenovirus-vectored vaccine
First Author:
Reviewed: Feb 3, 2022
|
|
Feb 3, 2022
|
|
IMPACT OF WEEKNIGHT AND WEEKEND CURFEWS USING MOBILITY DATA: A CASE STUDY OF BENGALURU URBAN
First Author:
Reviewed: Feb 3, 2022
|
|
Feb 3, 2022
|
|
Mapping SARS-CoV-2 antigenic relationships and serological responses
First Author:
Reviewed: Feb 3, 2022
|
|
Feb 3, 2022
|
|
mRNA vaccine boosting enhances antibody responses against SARS-CoV-2 Omicron variant in patients with antibody deficiency syndromes
First Author:
Reviewed: Feb 3, 2022
|
|
Feb 3, 2022
|
|
Neutralizing Activities against the Omicron Variant after a Heterologous Booster in Healthy Adults Receiving Two Doses of CoronaVac Vaccination
First Author:
Reviewed: Feb 3, 2022
|
|
Feb 3, 2022
|
|
Omicron SARS-CoV-2 Variant of Concern: A Review on its Transmissibility, Immune Evasion, Reinfection, and Severity
First Author:
Reviewed: Feb 3, 2022
|
|
Feb 3, 2022
|
|
Persistently reduced humoral and cellular immune response following third SARS-CoV-2 mRNA vaccination in anti-CD20-treated multiple sclerosis patients
First Author:
Reviewed: Feb 3, 2022
|
|
Feb 3, 2022
|
|
Prevalence, Parents’ Hesitancy, and Determinants of COVID-19 Vaccination Among Children: A Multi-Country Study From the Eastern Mediterranean Region
First Author:
Reviewed: Feb 3, 2022
|
|
Feb 3, 2022
|
|
Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge
First Author:
Reviewed: Feb 3, 2022
|
|
Feb 3, 2022
|
|
SARS-CoV-2 third vaccine immune response in MS patients treated with ocrelizumab
First Author:
Reviewed: Feb 3, 2022
|
|
Feb 3, 2022
|
|
Screening for SARS-CoV-2 in close contacts of individuals with confirmed infection: performance and operational considerations
First Author:
Reviewed: Feb 3, 2022
|
|
Feb 3, 2022
|
|
Sputnik-V reactogenicity and immunogenicity in the blood and mucosa: a prospective cohort study
First Author:
Reviewed: Feb 3, 2022
|
|
Feb 3, 2022
|
|
‘Anatomy of SARS-CoV-2 outbreak of ‘vaccinated’: An observational case-control study of Covid-19 breakthrough infections in medical college students at Rural Medical College, India
First Author:
Reviewed: Feb 2, 2022
|
|
Feb 2, 2022
|
|
A Quick Displacement of the SARS-CoV-2 variant Delta with Omicron: Unprecedented Spike in COVID-19 Cases Associated with Fewer Admissions and Comparable Upper Respiratory Viral Loads
First Author:
Reviewed: Feb 2, 2022
|
|
Feb 2, 2022
|
|
Antibody response to SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases in Japan: Interim analysis of a multicenter cohort study
First Author:
Reviewed: Feb 2, 2022
|
|
Feb 2, 2022
|
|
Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity
First Author:
Reviewed: Feb 2, 2022
|
|
Feb 2, 2022
|
|
Comparative immunogenicity of heterologous versus homologous 3rd SARS-CoV-2 vaccine doses in kidney transplant recipients
First Author:
Reviewed: Feb 2, 2022
|
|
Feb 2, 2022
|
|
Comparison of vaccine effectiveness against the Omicron (B.1.1.529) variant in patients receiving haemodialysis
First Author:
Reviewed: Feb 2, 2022
|
|
Feb 2, 2022
|
|
Dynamics of SARS-CoV-2 and host immunity in infection and vaccine protection
First Author:
Reviewed: Feb 2, 2022
|
|
Feb 2, 2022
|
|
Efficacy and Safety of a Plant-Based Virus-Like Particle Vaccine for COVID-19 Adjuvanted with AS03
First Author:
Reviewed: Feb 2, 2022
|
|
Feb 2, 2022
|
|
EPIDEMIOLOGICAL CHARACTERISTICS AND SEVERITY OF OMICRON VARIANT CASES IN THE APHP CRITICAL CARE UNITS
First Author:
Reviewed: Feb 2, 2022
|
|
Feb 2, 2022
|
|
Estimates of the impact on COVID-19 deaths of unequal global allocations of vaccines
First Author:
Reviewed: Feb 2, 2022
|
|
Feb 2, 2022
|
|
How dangerous is omicron and how effective are vaccinations?
First Author:
Reviewed: Feb 2, 2022
|
|
Feb 2, 2022
|
|
Immune response to third SARS-CoV-2 vaccination in seronegative kidney transplant recipients: possible improvement by mycophenolate mofetil reduction
First Author:
Reviewed: Feb 2, 2022
|
|
Feb 2, 2022
|
|
Immunogenicity of COVID-19 mRNA Vaccines in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome
First Author:
Reviewed: Feb 2, 2022
|
|
Feb 2, 2022
|
|
Impact of voluntary risk-mitigation behaviour on transmission of the Omicron SARS-CoV-2 variant in England
First Author:
Reviewed: Feb 2, 2022
|
|
Feb 2, 2022
|
|
Kinetics and persistence of the cellular and humoral immune responses to BNT162b2 mRNA vaccine in SARS-CoV-2-naive and - experienced subjects
First Author:
Reviewed: Feb 2, 2022
|
|
Feb 2, 2022
|
|
Long term effectiveness of inactivated vaccine BBIBP-CorV (Vero Cells) against COVID-19 associated severe and critical hospitalization in Morocco
First Author:
Reviewed: Feb 2, 2022
|
|
Feb 2, 2022
|
|
Metal-Organic Frameworks (MOFs); A Promising Approach to Combat SARS-CoV-2
First Author:
Reviewed: Feb 2, 2022
|
|
Feb 2, 2022
|
|
Mucosal immunity against SARS-CoV-2 variants of concern including Omicron following vaccination
First Author:
Reviewed: Feb 2, 2022
|
|
Feb 2, 2022
|
|
Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants
First Author:
Reviewed: Feb 2, 2022
|
|
Feb 2, 2022
|
|
SARS-CoV-2 antigen exposure history shapes phenotypes and specificity of memory CD8 T cells
First Author:
Reviewed: Feb 2, 2022
|
|
Feb 2, 2022
|
|
SARS-CoV-2 anti-spike antibody levels following second dose of ChAdOx1 nCov-19 or BNT162b2 in residents of long-term care facilities in England (VIVALDI)
First Author:
Reviewed: Feb 2, 2022
|
|
Feb 2, 2022
|
|
Seroepidemiological and genomic investigation of COVID-19 spread in North East region of India
First Author:
Reviewed: Feb 2, 2022
|
|
Feb 2, 2022
|
|
South African Population Immunity and Severe Covid-19 with Omicron Variant
First Author:
Reviewed: Feb 2, 2022
|
|
Feb 2, 2022
|
|
The impacts of increased global vaccine sharing on the COVID-19 pandemic; a retrospective modelling study
First Author:
Reviewed: Feb 2, 2022
|
|
Feb 2, 2022
|
|
The inactivated NDV-HXP-S COVID-19 vaccine induces a significantly higher ratio of neutralizing to non-neutralizing antibodies in humans as compared to mRNA vaccines
First Author:
Reviewed: Feb 2, 2022
|
|
Feb 2, 2022
|
|
TNFα-producing CD4+ T cells dominate the SARS-CoV-2-specific T cell response in COVID-19 outpatients and are associated with durable antibodies
First Author:
Reviewed: Feb 2, 2022
|
|
Feb 2, 2022
|
|
Anti-SARS-CoV-2 swine glyco-humanized polyclonal antibody XAV-19 retains neutralizing activity against SARS-CoV-2 B.1.1.529 (Omicron)
First Author:
Reviewed: Feb 1, 2022
|
|
Feb 1, 2022
|
|
Biodistribution and Environmental Safety of a Live-attenuated YF17D-vectored SARS-CoV-2 Vaccine Candidate
First Author:
Reviewed: Feb 1, 2022
|
|
Feb 1, 2022
|
|
Comprehensive fitness landscape of SARS-CoV-2 Mpro reveals insights into viral resistance mechanisms
First Author:
Reviewed: Feb 1, 2022
|
|
Feb 1, 2022
|
|
Cytotoxic T lymphocytes targeting a conserved SARS-CoV-2 spike epitope are efficient serial killers
First Author:
Reviewed: Feb 1, 2022
|
|
Feb 1, 2022
|
|
Discovery of S-217622, a Non-Covalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19
First Author:
Reviewed: Feb 1, 2022
|
|
Feb 1, 2022
|
|
Lineage-mosaic and mutation-patched spike proteins for broad-spectrum COVID-19 vaccine
First Author:
Reviewed: Feb 1, 2022
|
|
Feb 1, 2022
|
|
Unadjuvanted intranasal spike vaccine booster elicits robust protective mucosal immunity against sarbecoviruses
First Author:
Reviewed: Feb 1, 2022
|
|
Feb 1, 2022
|
|
Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerability
First Author:
Reviewed: Feb 1, 2022
|
|
Feb 1, 2022
|
|
Acquired neutralizing breadth against SARS-CoV-2 variants including Omicron after three doses of mRNA COVID-19 vaccination and the vaccine efficacy
First Author:
Reviewed: Jan 31, 2022
|
|
Jan 31, 2022
|
|
Are allergic diseases a risk factor for systemic side effects after COVID-19 vaccines?
First Author:
Reviewed: Jan 31, 2022
|
|
Jan 31, 2022
|
|
Binding of Human ACE2 and RBD of Omicron Enhanced by Unique Interaction Patterns Among SARS-CoV-2 Variants of Concern
First Author:
Reviewed: Jan 31, 2022
|
|
Jan 31, 2022
|
|
Clinical evaluation of the Diagnostic Analyzer for Selective Hybridization (DASH): a point-of-care PCR test for rapid detection of SARS-CoV-2 infection
First Author:
Reviewed: Jan 31, 2022
|
|
Jan 31, 2022
|
|
Comparative performance of between-population vaccine allocation strategies with applications to SARS-CoV-2
First Author:
Reviewed: Jan 31, 2022
|
|
Jan 31, 2022
|
|
COVID-19 vaccination recruits and matures cross-reactive antibodies to conserved epitopes in endemic coronavirus Spike proteins
First Author:
Reviewed: Jan 31, 2022
|
|
Jan 31, 2022
|
|
COVID-19 vaccines effectiveness against symptomatic SARS-CoV-2 Delta variant infection: a population-based case-control study in St. Petersburg, Russia
First Author:
Reviewed: Jan 31, 2022
|
|
Jan 31, 2022
|
|
Design of immunogens for eliciting antibody responses that may protect against SARS-CoV-2 variants
First Author:
Reviewed: Jan 31, 2022
|
|
Jan 31, 2022
|
|
Dynamics of infection-elicited SARS-CoV-2 antibodies in children over time
First Author:
Reviewed: Jan 31, 2022
|
|
Jan 31, 2022
|
|
Effectiveness of BBV152 vaccine against SARS-CoV-2 infections, hospitalizations and deaths among healthcare workers in the setting of high delta variant transmission in New Delhi, India
First Author:
Reviewed: Jan 31, 2022
|
|
Jan 31, 2022
|
|
Effectiveness of Pfizer-BioNTech Vaccine Against COVID-19 Associated Hospitalizations among Lebanese Adults ≥75 years- Lebanon, April-May 2021
First Author:
Reviewed: Jan 31, 2022
|
|
Jan 31, 2022
|
|
Effects of 12 weeks of Multi-nutrient supplementation on the Immune and Musculoskeletal systems of Older Adults in Aged-Care (The Pomerium Study): Protocol for a Randomised Controlled Trial
First Author:
Reviewed: Jan 31, 2022
|
|
Jan 31, 2022
|
|
Establishment of human post-vaccination SARS-CoV-2 standard reference sera
First Author:
Reviewed: Jan 31, 2022
|
|
Jan 31, 2022
|
|
Forecasted trends of the new COVID-19 epidemic due to the Omicron variant in Thailand, 2022
First Author:
Reviewed: Jan 31, 2022
|
|
Jan 31, 2022
|
|
mRNA-1273 Vaccine-elicited Neutralization of SARS-CoV-2 Omicron in Adolescents and Children
First Author:
Reviewed: Jan 31, 2022
|
|
Jan 31, 2022
|
|
Mutations of SARS-CoV-2 variants of concern escaping Spike-specific T cells
First Author:
Reviewed: Jan 31, 2022
|
|
Jan 31, 2022
|
|
Nasally-delivered interferon-λ protects mice against upper and lower respiratory tract infection of SARS-CoV-2 variants including Omicron
First Author:
Reviewed: Jan 31, 2022
|
|
Jan 31, 2022
|
|
Omicron: a chimera of two early SARS-CoV-2 lineages
First Author:
Reviewed: Jan 31, 2022
|
|
Jan 31, 2022
|
|
Optimal control of the spatial allocation of COVID-19 vaccines: Italy as a case study
First Author:
Reviewed: Jan 31, 2022
|
|
Jan 31, 2022
|
|
Over- and under-estimation of vaccine effectiveness
First Author:
Reviewed: Jan 31, 2022
|
|
Jan 31, 2022
|
|
Projection of Healthcare Demand in Germany and Switzerland Urged by Omicron Wave (January-March 2022)
First Author:
Reviewed: Jan 31, 2022
|
|
Jan 31, 2022
|
|
Rapid emergence of SARS-CoV-2 Omicron variant is associated with an infection advantage over Delta in vaccinated persons
First Author:
Reviewed: Jan 31, 2022
|
|
Jan 31, 2022
|
|
SARS-CoV-2 antibody profile of naturally infected and vaccinated individuals detected using qualitative, semi-quantitative and multiplex immunoassays
First Author:
Reviewed: Jan 31, 2022
|
|
Jan 31, 2022
|
|
Should healthcare workers with SARS-CoV-2 household exposures work? A Cohort Study
First Author:
Reviewed: Jan 31, 2022
|
|
Jan 31, 2022
|
|
Structural changes in the SARS-CoV-2 spike E406W mutant escaping a clinical monoclonal antibody cocktail
First Author:
Reviewed: Jan 31, 2022
|
|
Jan 31, 2022
|
|
Substantial immune response in Omicron infected breakthrough and unvaccinated individuals against SARS-CoV-2 variants of concerns
First Author:
Reviewed: Jan 31, 2022
|
|
Jan 31, 2022
|
|
Systemic adverse effects induced by the BNT162b2 vaccine are associated with higher antibody titers from 3 to 6 months after vaccination
First Author:
Reviewed: Jan 31, 2022
|
|
Jan 31, 2022
|
|
The effect of COVID-19 mRNA vaccine on respiratory system: human lung carcinoma cells by means of Raman spectroscopy and imaging
First Author:
Reviewed: Jan 31, 2022
|
|
Jan 31, 2022
|
|
The Epidemiology of Hundreds of Individuals Infected with Omicron BA.1 in Middle-Eastern Jordan
First Author:
Reviewed: Jan 31, 2022
|
|
Jan 31, 2022
|
|
The MU Study of Seropositivity and Risk for SARS-CoV-2 and COVID-19: Crucial Behavioral and Immunological Data from Midwestern College Students
First Author:
Reviewed: Jan 31, 2022
|
|
Jan 31, 2022
|
|
A CRISPR-based ultrasensitive assay redefines “undetectable” SARS-CoV-2 antibodies in kidney transplant recipients after COVID-19 vaccination
First Author:
Reviewed: Jan 28, 2022
|
|
Jan 28, 2022
|
|
B.1.617.2 SARS-CoV-2 (Delta) variant is associated with increased risk of hospitalization and death compared with B.1.1.7 SARS-CoV-2 (Alpha) variant
First Author:
Reviewed: Jan 28, 2022
|
|
Jan 28, 2022
|
|
Comparison of the clinical features, viral shedding and immune response in vaccine breakthrough infection by the Omicron and Delta variants
First Author:
Reviewed: Jan 28, 2022
|
|
Jan 28, 2022
|
|
COVID-19, Vaccination Rates, Infection Rates, Death Rates, and Behavioral Interventions: It’s Time to Cut the Bull!
First Author:
Reviewed: Jan 28, 2022
|
|
Jan 28, 2022
|
|
Diminished neutralization responses towards SARS-CoV-2 Omicron VoC after mRNA or vector-based COVID-19 vaccinations
First Author:
Reviewed: Jan 28, 2022
|
|
Jan 28, 2022
|
|
Does a humoral correlate of protection exist for SARS-CoV-2? A systematic review
First Author:
Reviewed: Jan 28, 2022
|
|
Jan 28, 2022
|
|
Effectiveness of mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections during the Delta variant epidemic in Japan: Vaccine Effectiveness Real-time Surveillance for SARS-CoV-2 (VERSUS)
First Author:
Reviewed: Jan 28, 2022
|
|
Jan 28, 2022
|
|
ESTIMATING THE EFFECT OF VACCINATION ON THE CASE-FATALITY RATE FOR COVID-19
First Author:
Reviewed: Jan 28, 2022
|
|
Jan 28, 2022
|
|
Gene delivery of a single,structurally engineered Coronavirus vaccine antigen elicits SARS-CoV-2 Omicron and pan-Sarbecovirus neutralisation
First Author:
Reviewed: Jan 28, 2022
|
|
Jan 28, 2022
|
|
Hyperparameter Optimization for COVID-19 Chest X-Ray Classification
First Author:
Reviewed: Jan 28, 2022
|
|
Jan 28, 2022
|
|
Impact of accelerating booster vaccination amidst Omicron surge in the United States
First Author:
Reviewed: Jan 28, 2022
|
|
Jan 28, 2022
|
|
Neutralization of Omicron SARS-CoV-2 by 2 or 3 doses of BNT162b2 vaccine
First Author:
Reviewed: Jan 28, 2022
|
|
Jan 28, 2022
|
|
Omicron (BA.1) SARS-CoV-2 variant is associated with reduced risk of hospitalization and length of stay compared with Delta (B.1.617.2)
First Author:
Reviewed: Jan 28, 2022
|
|
Jan 28, 2022
|
|
Outcomes of SARS-CoV-2 Omicron infection in residents of Long-Term Care
First Author:
Reviewed: Jan 28, 2022
|
|
Jan 28, 2022
|
|
Quantifying post-vaccination protective anti-SARS-CoV-2 IgG antibodies in blood and saliva with a fully automated, high throughput digital immunoassay
First Author:
Reviewed: Jan 28, 2022
|
|
Jan 28, 2022
|
|
Serological study of CoronaVac vaccine and booster doses in Chile: immunogenicity and persistence of anti-SARS-CoV-2 S antibodies
First Author:
Reviewed: Jan 28, 2022
|
|
Jan 28, 2022
|
|
Waning of Vaccine-Conferred Protection against SARS-CoV-2 Infection: Matched Case-Control Test-Negative Design Study in Two High-Risk Populations
First Author:
Reviewed: Jan 28, 2022
|
|
Jan 28, 2022
|
|
A method for variant agnostic detection of SARS-CoV-2, rapid monitoring of circulating variants, detection of mutations of biological significance, and early detection of emergent variants such as Omicron
First Author:
Reviewed: Jan 27, 2022
|
|
Jan 27, 2022
|
|
A model of the transmission of SARS-Cov-2 (Covid-19) with an underlying
condition of Diabetes
First Author:
Reviewed: Jan 27, 2022
|
|
Jan 27, 2022
|
|
Anti-PEG antibodies boosted in humans by SARS-CoV-2 lipid nanoparticle mRNA vaccine
First Author:
Reviewed: Jan 27, 2022
|
|
Jan 27, 2022
|
|
Autoantibodies in COVID-19 correlate with anti-viral humoral responses and distinct immune signatures
First Author:
Reviewed: Jan 27, 2022
|
|
Jan 27, 2022
|
|
Durability and cross-reactivity of SARS-CoV-2 mRNA vaccine in adolescent children
First Author:
Reviewed: Jan 27, 2022
|
|
Jan 27, 2022
|
|
Egg-derived anti-SARS-CoV-2 immunoglobulin Y (IgY) with broad variant activity as intranasal prophylaxis against COVID-19: preclinical studies and randomized controlled phase 1 clinical trial
First Author:
Reviewed: Jan 27, 2022
|
|
Jan 27, 2022
|
|
Modelling COVID-19 Vaccine Breakthrough Infections in Highly Vaccinated Israel – the effects of waning immunity and third vaccination dose
First Author:
Reviewed: Jan 27, 2022
|
|
Jan 27, 2022
|
|
Protective effect of a first SARS-CoV-2 infection from reinfection: a matched retrospective cohort study using PCR testing data in England
First Author:
Reviewed: Jan 27, 2022
|
|
Jan 27, 2022
|
|
SARS-CoV-2 risk taxation model and validation based on large scale Dutch test-events
First Author:
Reviewed: Jan 27, 2022
|
|
Jan 27, 2022
|
|
“Effectiveness of COVID-19 Vaccines in preventing Infectiousness, Hospitalization and Mortality: A Historical Cohort Study Using Iranian Registration Data During Vaccination program”
First Author:
Reviewed: Jan 26, 2022
|
|
Jan 26, 2022
|
|
A booster dose of mRNA-based COVID-19 vaccines fosters the development of an immune response in immunosuppressed fragile patients
First Author:
Reviewed: Jan 26, 2022
|
|
Jan 26, 2022
|
|
A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection
First Author:
Reviewed: Jan 26, 2022
|
|
Jan 26, 2022
|
|
An expanded high throughput RT-PCR assay to rapidly identify all known SARS-CoV-2 variants of concern using melting temperature coding
First Author:
Reviewed: Jan 26, 2022
|
|
Jan 26, 2022
|
|
BNT162b2 vaccine boosts neutralizing antibodies to ancestral SARS-CoV-2 & Omicron variant in adults received 2-dose inactivated vaccine
First Author:
Reviewed: Jan 26, 2022
|
|
Jan 26, 2022
|
|
COVID-19 Status Forecasting Using New Viral variants and Vaccination
Effectiveness Models
First Author:
Reviewed: Jan 26, 2022
|
|
Jan 26, 2022
|
|
Effectiveness of BNT162b2 and mRNA-1273 COVID-19 boosters against SARS-CoV-2 Omicron (B.1.1.529) infection in Qatar
First Author:
Reviewed: Jan 26, 2022
|
|
Jan 26, 2022
|
|
In Silico Analysis of Ferrocenyl-analogues as the Potential Drugs Against Aggressive UK-based Strain of SARS-CoV-2 Virus
First Author:
Reviewed: Jan 26, 2022
|
|
Jan 26, 2022
|
|
Local SARS-CoV-2 Peptide-Specific Immune Responses in Lungs of Convalescent and Uninfected Human Subjects
First Author:
Reviewed: Jan 26, 2022
|
|
Jan 26, 2022
|
|
Monitoring SARS-CoV-2 genome evolution in a localized population
First Author:
Reviewed: Jan 26, 2022
|
|
Jan 26, 2022
|
|
mRNA-COVID19 vaccination can be considered safe and tolerable for frail patients
First Author:
Reviewed: Jan 26, 2022
|
|
Jan 26, 2022
|
|
One vaccine to counter many diseases? Modelling the economics of oral polio vaccine against child mortality and COVID-19
First Author:
Reviewed: Jan 26, 2022
|
|
Jan 26, 2022
|
|
Safety and immunogenicity of Pfizer/BioNTech SARS-CoV-2 mRNA third booster vaccine against SARS-CoV-2 Omicron variant in Japanese healthcare workers
First Author:
Reviewed: Jan 26, 2022
|
|
Jan 26, 2022
|
|
Safety Profile of Sinopharm COVID-19 Vaccine and Breakthrough Infections in Pakistan
First Author:
Reviewed: Jan 26, 2022
|
|
Jan 26, 2022
|
|
Sialic acid and fucose residues on the SARS-CoV-2 receptor binding domain modulate IgG reactivity
First Author:
Reviewed: Jan 26, 2022
|
|
Jan 26, 2022
|
|
Successful mRNA COVID-19 vaccination in a patient with a history of severe polyethylene glycol anaphylaxis
First Author:
Reviewed: Jan 26, 2022
|
|
Jan 26, 2022
|
|
Testing behaviour may bias observational studies of vaccine effectiveness
First Author:
Reviewed: Jan 26, 2022
|
|
Jan 26, 2022
|
|
Using Survey Data to Estimate the Impact of the Omicron Variant on Vaccine Efficacy against COVID-19 Infection
First Author:
Reviewed: Jan 26, 2022
|
|
Jan 26, 2022
|
|
Assessment of the effectiveness of Omicron transmission mitigation
strategies for European universities using an agent-based network model
First Author:
Reviewed: Jan 25, 2022
|
|
Jan 25, 2022
|
|
Competent immune responses to SARS-CoV-2 variants in older adults following mRNA vaccination
First Author:
Reviewed: Jan 25, 2022
|
|
Jan 25, 2022
|
|
Computation of Antigenicity Predicts SARS-CoV-2 Vaccine Breakthrough Variants
First Author:
Reviewed: Jan 25, 2022
|
|
Jan 25, 2022
|
|
Cross-sectional study to assess the efficacy of SARS-CoV-2 vaccination in patients with monoclonal gammopathies
First Author:
Reviewed: Jan 25, 2022
|
|
Jan 25, 2022
|
|
Discovery of a SARS-CoV-2 Broadly-Acting Neutralizing Antibody with Activity against Omicron and Omicron + R346K Variants
First Author:
Reviewed: Jan 25, 2022
|
|
Jan 25, 2022
|
|
Evaluation of the effects of vaccination regimes on the transmission dynamics of COVID-19 pandemic
First Author:
Reviewed: Jan 25, 2022
|
|
Jan 25, 2022
|
|
High activity of an affinity-matured ACE2 decoy against Omicron SARS-CoV-2 and pre-emergent coronaviruses
First Author:
Reviewed: Jan 25, 2022
|
|
Jan 25, 2022
|
|
Longitudinal Assessment of SARS-CoV-2 Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multi-Cytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity
First Author:
Reviewed: Jan 25, 2022
|
|
Jan 25, 2022
|
|
Long-Term Persistence of IgG Antibodies in recovered COVID-19 individuals at 18 months and the impact of two-dose BNT162b2 (Pfizer-BioNTech) mRNA vaccination on the antibody response
First Author:
Reviewed: Jan 25, 2022
|
|
Jan 25, 2022
|
|
Nirmatrelvir, an orally active Mpro inhibitor, is a potent inhibitor of SARS-CoV-2 Variants of Concern
First Author:
Reviewed: Jan 25, 2022
|
|
Jan 25, 2022
|
|
Nirmatrelvir, Molnupiravir, and Remdesivir maintain potent in vitro activity against the SARS-CoV-2 Omicron variant
First Author:
Reviewed: Jan 25, 2022
|
|
Jan 25, 2022
|
|
Non-Markovian modelling highlights the importance of age structure on Covid-19 epidemiological dynamics
First Author:
Reviewed: Jan 25, 2022
|
|
Jan 25, 2022
|
|
Peptide Nanoarray Scaffold Vaccine for SARS-COV-2 and Its Variants of Concerns
First Author:
Reviewed: Jan 25, 2022
|
|
Jan 25, 2022
|
|
Periodic travelling waves of Covid-19 epidemics and vaccination campaign
First Author:
Reviewed: Jan 25, 2022
|
|
Jan 25, 2022
|
|
Retention of Neutralizing response against SARS-CoV-2 Omicron variant in Sputnik V vaccinated individuals
First Author:
Reviewed: Jan 25, 2022
|
|
Jan 25, 2022
|
|
T cell response following anti COVID-19 BNT162b2 vaccination is maintained against the SARS-CoV-2 Omicron B.1.1.529 variant of concern
First Author:
Reviewed: Jan 25, 2022
|
|
Jan 25, 2022
|
|
Targeting SARS-CoV-2 infection through CAR T cells and bispecific T cell engagers
First Author:
Reviewed: Jan 25, 2022
|
|
Jan 25, 2022
|
|
The immunogenicity against variants of concern and reactogenicity of four COVID-19 booster vaccinations following CoronaVac or ChAdOx1 nCoV-19 primary series
First Author:
Reviewed: Jan 25, 2022
|
|
Jan 25, 2022
|
|
The spread of SARS-CoV-2 variant Omicron with the doubling time of 2.0–3.3 days can be explained by immune evasion
First Author:
Reviewed: Jan 25, 2022
|
|
Jan 25, 2022
|
|
Booster vaccination to curtail COVID-19 resurgence - population-level implications of the Israeli campaign
First Author:
Reviewed: Jan 24, 2022
|
|
Jan 24, 2022
|
|
COVID-19 breakthrough infection after inactivated vaccine induced robust antibody responses and cross-neutralization of SARS-CoV-2 variants, but less immunity against omicron
First Author:
Reviewed: Jan 24, 2022
|
|
Jan 24, 2022
|
|
Detection of SARS-CoV-2 variant Mu, Beta, Gamma, Lambda, Delta, Alpha, and Omicron in wastewater settled solids using mutation-specific assays is associated with regional detection of variants in clinical samples
First Author:
Reviewed: Jan 24, 2022
|
|
Jan 24, 2022
|
|
Development of an in-house Quantitative ELISA for the Evaluation of Different Covid-19 Vaccines in Human
First Author:
Reviewed: Jan 24, 2022
|
|
Jan 24, 2022
|
|
Effectiveness of mRNA COVID-19 Vaccines against Omicron among Veterans
First Author:
Reviewed: Jan 24, 2022
|
|
Jan 24, 2022
|
|
Immunokinetic Model for COVID-19 Patients
First Author:
Reviewed: Jan 24, 2022
|
|
Jan 24, 2022
|
|
Multisystemic inflammatory syndrome following COVID-19 mRNA vaccine in children: a national post-authorization pharmacovigilance study
First Author:
Reviewed: Jan 24, 2022
|
|
Jan 24, 2022
|
|
SARS-CoV-2 specific T cells induced by both SARS-CoV-2 infection and mRNA vaccination broadly cross-recognize omicron
First Author:
Reviewed: Jan 24, 2022
|
|
Jan 24, 2022
|
|
Short-term instantaneous prophylaxis and efficient treatment against SARS-CoV-2 in hACE2 mice conferred by an intranasal nanobody (Nb22)
First Author:
Reviewed: Jan 24, 2022
|
|
Jan 24, 2022
|
|
The value of vaccine booster doses to mitigate the global impact of the Omicron SARS-CoV-2 variant
First Author:
Reviewed: Jan 24, 2022
|
|
Jan 24, 2022
|
|
Influences of social media usage on public attitudes and behavior
towards COVID-19 vaccine in the Arab world
First Author:
Reviewed: Jan 21, 2022
|
|
Jan 21, 2022
|
|
Limited cross-variant immunity after infection with the SARS-CoV-2 Omicron variant without vaccination
First Author:
Reviewed: Jan 21, 2022
|
|
Jan 21, 2022
|
|
Novel universal SARS-CoV DNA vaccine inducing neutralizing antibodies to huCoV-19/WH01, Beta, Delta and Omicron variants and T cells to Bat-CoV
First Author:
Reviewed: Jan 21, 2022
|
|
Jan 21, 2022
|
|
Phylodynamic analysis of SARS-CoV-2 spread in Rio de Janeiro, Brazil, highlights how metropolitan areas act as dispersal hubs for new variants
First Author:
Reviewed: Jan 21, 2022
|
|
Jan 21, 2022
|
|
Real-world monitoring of BNT162b2 vaccine-induced SARS-CoV-2 B and T cell immunity in naive healthcare workers: a prospective single center study
First Author:
Reviewed: Jan 21, 2022
|
|
Jan 21, 2022
|
|
Relative Contagiousness of Emerging Virus Variants: An Analysis of the
Alpha, Delta, and Omicron SARS-CoV-2 Variants
First Author:
Reviewed: Jan 21, 2022
|
|
Jan 21, 2022
|
|
SARS-CoV-2 vaccination of convalescents boosts neutralization capacity against SARS-CoV-2 Delta and Omicron that can be predicted by anti-S antibody concentrations in serological assays
First Author:
Reviewed: Jan 21, 2022
|
|
Jan 21, 2022
|
|
Sensitivity of SARS-CoV-2 antigen-detecting rapid tests for Omicron variant
First Author:
Reviewed: Jan 21, 2022
|
|
Jan 21, 2022
|
|
Systematic review of spontaneous reports of myocarditis and pericarditis in transplant recipients and immunocompromised patients following COVID-19 mRNA vaccination
First Author:
Reviewed: Jan 21, 2022
|
|
Jan 21, 2022
|
|
The spatial-temporal distribution and aetiological characteristics of hand, foot, and mouth disease before and after the EV‑A71 vaccination and COVID-19 pandemic in Kunming, China, 2017–2020
First Author:
Reviewed: Jan 21, 2022
|
|
Jan 21, 2022
|
|
Tuftsin: a natural molecule against SARS-CoV-2 infection
First Author:
Reviewed: Jan 21, 2022
|
|
Jan 21, 2022
|
|
A national survey of early treatment seeking behavior among those with incident SARS-CoV-2 infection
First Author:
Reviewed: Jan 20, 2022
|
|
Jan 20, 2022
|
|
A prospective, single-center study to evaluate the clinical performance of Meril ABFind in individuals vaccinated against COVID-19
First Author:
Reviewed: Jan 20, 2022
|
|
Jan 20, 2022
|
|
Assessing the clinical severity of the Omicron variant in the Western Cape Province, South Africa, using the diagnostic PCR proxy marker of RdRp target delay to distinguish between Omicron and Delta infections – a survival analysis
First Author:
Reviewed: Jan 20, 2022
|
|
Jan 20, 2022
|
|
ATP6V1B2 and IFI27 and their intrinsic functional genomic characteristics associated with SARS-CoV-2
First Author:
Reviewed: Jan 20, 2022
|
|
Jan 20, 2022
|
|
Comparison of Antibody Response Durability of mRNA-1273, BNT162b2, and Ad26.COV2.S SARS-CoV-2 Vaccines in Healthcare Workers
First Author:
Reviewed: Jan 20, 2022
|
|
Jan 20, 2022
|
|
Development of an effective immune response in adults with Down Syndrome after SARS-CoV-2 vaccination
First Author:
Reviewed: Jan 20, 2022
|
|
Jan 20, 2022
|
|
Distinct Vaccine Efficacy Rates Among Health Care Workers During a COVID-19 Outbreak in Jordan
First Author:
Reviewed: Jan 20, 2022
|
|
Jan 20, 2022
|
|
Generation of novel SARS-CoV-2 variants on B.1.1.7 lineage in three patients with advanced HIV disease
First Author:
Reviewed: Jan 20, 2022
|
|
Jan 20, 2022
|
|
Immunosuppression impaired the immunogenicity of inactivated SARS-CoV-2 vaccine in non-dialysis kidney disease patients
First Author:
Reviewed: Jan 20, 2022
|
|
Jan 20, 2022
|
|
Mutations make pandemics worse or better: modeling SARS-CoV-2 variants
and imperfect vaccination
First Author:
Reviewed: Jan 20, 2022
|
|
Jan 20, 2022
|
|
Predicting the Number of COVID-19 Infections and Deaths in USA
First Author:
Reviewed: Jan 20, 2022
|
|
Jan 20, 2022
|
|
Resilient T cell responses to B.1.1.529 (Omicron) SARS-CoV-2 variant
First Author:
Reviewed: Jan 20, 2022
|
|
Jan 20, 2022
|
|
SARS-CoV-2 Omicron Neutralization After Heterologous Vaccine Boosting
First Author:
Reviewed: Jan 20, 2022
|
|
Jan 20, 2022
|
|
Students as Community Vaccinators: Implementation of a Service-Learning COVID-19 Vaccination Program
First Author:
Reviewed: Jan 20, 2022
|
|
Jan 20, 2022
|
|
Validation of a clinical and genetic model for predicting severe COVID-19
First Author:
Reviewed: Jan 20, 2022
|
|
Jan 20, 2022
|
|
Waning COVID-19 Vaccine Effectiveness for BNT162b2 and CoronaVac in Malaysia: An Observational Study
First Author:
Reviewed: Jan 20, 2022
|
|
Jan 20, 2022
|
|
Waning Effectiveness of SARS-CoV-2 mRNA Vaccines in Older Adults: A Rapid Review
First Author:
Reviewed: Jan 20, 2022
|
|
Jan 20, 2022
|
|
Antigenic evolution of SARS-CoV-2 in immunocompromised hosts
First Author:
Reviewed: Jan 19, 2022
|
|
Jan 19, 2022
|
|
COVID-19 vaccine booster induces a strong CD8+ T cell response against Omicron variant epitopes in HLA-A*02:01+ individuals
First Author:
Reviewed: Jan 19, 2022
|
|
Jan 19, 2022
|
|
Evidence of early community transmission of Omicron (B1.1.529) in Delhi- A city with very high seropositivity and past-exposure!
First Author:
Reviewed: Jan 19, 2022
|
|
Jan 19, 2022
|
|
Extremely potent monoclonal antibodies neutralize Omicron and other SARS-CoV-2 variants
First Author:
Reviewed: Jan 19, 2022
|
|
Jan 19, 2022
|
|
High Rate of Asymptomatic Carriage Associated with Variant Strain Omicron
First Author:
Reviewed: Jan 19, 2022
|
|
Jan 19, 2022
|
|
Humoral and T-cell immune response after three doses of mRNA SARS-CoV-2 vaccines in fragile patients: the Italian VAX4FRAIL study
First Author:
Reviewed: Jan 19, 2022
|
|
Jan 19, 2022
|
|
Immunity in Omicron SARS-CoV-2 breakthrough COVID-19 in vaccinated adults
First Author:
Reviewed: Jan 19, 2022
|
|
Jan 19, 2022
|
|
Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, beta, delta, and omicron variants
First Author:
Reviewed: Jan 19, 2022
|
|
Jan 19, 2022
|
|
Imprinted SARS-CoV-2-specific memory lymphocytes define hybrid immunity
First Author:
Reviewed: Jan 19, 2022
|
|
Jan 19, 2022
|
|
Incidence and Risk Factors of Immediate Hypersensitivity Reactions and Immunisation Stress-related Responses with COVID-19 mRNA Vaccine
First Author:
Reviewed: Jan 19, 2022
|
|
Jan 19, 2022
|
|
Large-scale cross-sectional seroepidemiologic study of COVID-19 in Japan: Acquisition of herd immunity and the vaccines’ efficacy
First Author:
Reviewed: Jan 19, 2022
|
|
Jan 19, 2022
|
|
Rapid and Accurate Identification of SARS-CoV-2 Omicron Variants Using Droplet Digital PCR (RT-ddPCR)
First Author:
Reviewed: Jan 19, 2022
|
|
Jan 19, 2022
|
|
SARS-CoV-2 pandemic: on its way to becoming an endemic disease?
First Author:
Reviewed: Jan 19, 2022
|
|
Jan 19, 2022
|
|
The SARS-CoV-2 Omicron (B.1.1.529) variant exhibits altered pathogenicity, transmissibility, and fitness in the golden Syrian hamster model
First Author:
Reviewed: Jan 19, 2022
|
|
Jan 19, 2022
|
|
Viral dynamics and duration of PCR positivity of the SARS-CoV-2 Omicron variant
First Author:
Reviewed: Jan 19, 2022
|
|
Jan 19, 2022
|
|
A single-cell atlas reveals shared and distinct immune responses and metabolism during SARS-CoV-2 and HIV-1 infections
First Author:
Reviewed: Jan 18, 2022
|
|
Jan 18, 2022
|
|
Cohort-specific serological recognition of SARS-CoV-2 variant RBD antigens
First Author:
Reviewed: Jan 18, 2022
|
|
Jan 18, 2022
|
|
COVID-19 adaptive humoral immunity models: weakly neutralizing versus antibody-disease enhancement scenarios
First Author:
Reviewed: Jan 18, 2022
|
|
Jan 18, 2022
|
|
Covid-19 disease dynamics with vaccination: The effect of uncertainty
First Author:
Reviewed: Jan 18, 2022
|
|
Jan 18, 2022
|
|
COVID-19 vaccination breakthrough infections in a real-world setting: Using community reporters to evaluate vaccine effectiveness
First Author:
Reviewed: Jan 18, 2022
|
|
Jan 18, 2022
|
|
EFFECT OF FULL VACCINATION AND POST-COVID OLFACTORY DYSFUNCTION IN RECOVERED COVID-19 PATIENT. A RETROSPECTIVE LONGITUDINAL STUDY WITH PROPENSITY MATCHING
First Author:
Reviewed: Jan 18, 2022
|
|
Jan 18, 2022
|
|
Healthcare workers’ views on mandatory SARS-CoV-2 vaccination in the United Kingdom: findings from the UK-REACH prospective longitudinal cohort study
First Author:
Reviewed: Jan 18, 2022
|
|
Jan 18, 2022
|
|
Household secondary attack rates of SARS-CoV-2 by variant and vaccination status: an updated systematic review and meta-analysis
First Author:
Reviewed: Jan 18, 2022
|
|
Jan 18, 2022
|
|
Immunologic response, Efficacy, and Safety of Vaccines Against COVID-19 Infection in Children and Adolescents Aged 2 – 21 years old: A Systematic Review
First Author:
Reviewed: Jan 18, 2022
|
|
Jan 18, 2022
|
|
Infectious viral load in unvaccinated and vaccinated patients infected with SARS-CoV-2 WT, Delta and Omicron
First Author:
Reviewed: Jan 18, 2022
|
|
Jan 18, 2022
|
|
Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa
First Author:
Reviewed: Jan 18, 2022
|
|
Jan 18, 2022
|
|
Real World Evidence of Neutralizing Monoclonal Antibodies for Preventing Hospitalization and Mortality in COVID-19 Outpatients
First Author:
Reviewed: Jan 18, 2022
|
|
Jan 18, 2022
|
|
Shift of lung macrophage composition is associated with COVID-19 disease severity and recovery
First Author:
Reviewed: Jan 18, 2022
|
|
Jan 18, 2022
|
|
Systematic review and meta-analysis of COVID-19 vaccines safety, tolerability, and efficacy among HIV-infected patients
First Author:
Reviewed: Jan 18, 2022
|
|
Jan 18, 2022
|
|
Circular RNA Vaccines against SARS-CoV-2 and Emerging Variants
First Author:
Reviewed: Jan 17, 2022
|
|
Jan 17, 2022
|
|
Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2
First Author:
Reviewed: Jan 17, 2022
|
|
Jan 17, 2022
|
|
Molecular basis of SARS-CoV-2 Omicron variant receptor engagement and antibody evasion and neutralization
First Author:
Reviewed: Jan 17, 2022
|
|
Jan 17, 2022
|
|
Molnupiravir combined with different repurposed drugs further inhibits SARS-CoV-2 infection in human nasal epithelium in vitro
First Author:
Reviewed: Jan 17, 2022
|
|
Jan 17, 2022
|
|
Rapid isolation and resolution immune evasion and viral fitness across contemporary SARS-CoV-2 variants
First Author:
Reviewed: Jan 14, 2022
|
|
Jan 14, 2022
|
|
Comparison of the Clinical and Laboratory Findings and Outcomes of Hospitalized COVID-19 Patients who Were Vaccinated with Coronavac or Unvaccinated: An Analytical, Cross Sectional Study
First Author:
Reviewed: Jan 13, 2022
|
|
Jan 13, 2022
|
|
Early and Strong Antibody Responses to SARS-CoV-2 Predict Disease Severity in COVID-19 Patients
First Author:
Reviewed: Jan 13, 2022
|
|
Jan 13, 2022
|
|
Immune response and safety to inactivated COVID-19 vaccine: A comparison between People Living with HIV and HIV-naive individuals
First Author:
Reviewed: Jan 13, 2022
|
|
Jan 13, 2022
|
|
Omicron favors neuropilin1 binding over ACE2: Increased infectivity and available drugs
First Author:
Reviewed: Jan 13, 2022
|
|
Jan 13, 2022
|
|
Real-world analysis of age-dependent efficacy of COVID-19 vaccination
First Author:
Reviewed: Jan 13, 2022
|
|
Jan 13, 2022
|
|
SARS-CoV-2 specific B cell memory drives improved class switching and tissue homing responses to single dose Ad26.COV2.S vaccination in previously infected recipients
First Author:
Reviewed: Jan 13, 2022
|
|
Jan 13, 2022
|
|
SARS-CoV-2 Vaccinated Breakthrough Infections With Fatal and Critical Outcomes in the Department of Antioquia, Colombia
First Author:
Reviewed: Jan 13, 2022
|
|
Jan 13, 2022
|
|
A decision support framework for optimal vaccine distribution across a
multi-tier cold chain network
First Author:
Reviewed: Jan 12, 2022
|
|
Jan 12, 2022
|
|
A single dose ChAdOx1 nCoV-19 vaccine elicits high antibody responses in individuals with prior SARS-CoV-2 infection comparable to that of double dose vaccinated SARS-CoV-2 infection naïve individuals
First Author:
Reviewed: Jan 12, 2022
|
|
Jan 12, 2022
|
|
BNT162b2 post-exposure-prophylaxis against COVID-19
First Author:
Reviewed: Jan 12, 2022
|
|
Jan 12, 2022
|
|
Comparison of Natural and BNT162b2 Vaccine-induced Immunity, with and without an Enhancer or Booster Dose, on the Risk of COVID-19-Related Hospitalization in Israel
First Author:
Reviewed: Jan 12, 2022
|
|
Jan 12, 2022
|
|
COVID-19 impact on routine immunisations for vaccine-preventable diseases: Projecting the effect of different routes to recovery
First Author:
Reviewed: Jan 12, 2022
|
|
Jan 12, 2022
|
|
COVID-19 vaccine effectiveness among healthcare workers in Portugal: results from a hospital-based cohort study, December 2020 to November 2021
First Author:
Reviewed: Jan 12, 2022
|
|
Jan 12, 2022
|
|
Effectiveness of mRNA-1273 against SARS-CoV-2 omicron and delta variants
First Author:
Reviewed: Jan 12, 2022
|
|
Jan 12, 2022
|
|
Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape
First Author:
Reviewed: Jan 12, 2022
|
|
Jan 12, 2022
|
|
Innate and adaptive immune defects associated with lower SARS-CoV-2 BNT162b2 mRNA vaccine response in elderly people
First Author:
Reviewed: Jan 12, 2022
|
|
Jan 12, 2022
|
|
Persistence of immunity and impact of a third (booster) dose of an inactivated SARS-CoV-2 vaccine, BBV152; a phase 2, double-blind, randomised controlled trial
First Author:
Reviewed: Jan 12, 2022
|
|
Jan 12, 2022
|
|
Political Endorsements by Scientific Organizations Reduce Trust in Scientific Expertise During COVID-19
First Author:
Reviewed: Jan 12, 2022
|
|
Jan 12, 2022
|
|
Safety and immunogenicity of the BBIBP-CorV vaccine in adolescents aged 12-17 years in Thai population, prospective cohort study
First Author:
Reviewed: Jan 12, 2022
|
|
Jan 12, 2022
|
|
SARS-CoV-2 Omicron Outbreak in a Dormitory in Saint-Petersburg, Russia
First Author:
Reviewed: Jan 12, 2022
|
|
Jan 12, 2022
|
|
SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern
First Author:
Reviewed: Jan 12, 2022
|
|
Jan 12, 2022
|
|
SARS-CoV-2 variants genome analysis of Indonesian isolates and their responses to available vaccines
First Author:
Reviewed: Jan 12, 2022
|
|
Jan 12, 2022
|
|
Temporary hold of mycophenolate boosts SARS-CoV-2 vaccination-specific humoral and cellular immunity in kidney transplant recipients
First Author:
Reviewed: Jan 12, 2022
|
|
Jan 12, 2022
|
|
VarLOCK - sequencing independent, rapid detection of SARS-CoV-2 variants of concern for point-of-care testing, qPCR pipelines and national wastewater surveillance
First Author:
Reviewed: Jan 12, 2022
|
|
Jan 12, 2022
|
|
Delta infection following vaccination elicits potent neutralizing immunity against the SARS-CoV-2 Omicron
First Author:
Reviewed: Jan 11, 2022
|
|
Jan 11, 2022
|
|
Effects of infection fatality ratio and social contact matrices on
vaccine prioritization strategies
First Author:
Reviewed: Jan 11, 2022
|
|
Jan 11, 2022
|
|
Neurotoxic Amyloidogenic Peptides in the Proteome of SARS-COV2: Potential Implications for Neurological Symptoms in COVID-19
First Author:
Reviewed: Jan 11, 2022
|
|
Jan 11, 2022
|
|
Should We Delay the Second COVID-19 Vaccine Dose in Order to Optimize Rollout? A Mathematical Perspective
First Author:
Reviewed: Jan 11, 2022
|
|
Jan 11, 2022
|
|
An elite broadly neutralizing antibody protects SARS-CoV-2 Omicron variant challenge
First Author:
Reviewed: Jan 10, 2022
|
|
Jan 10, 2022
|
|
An integrated lab-on-a-chip device for RNA extraction, amplification and CRISPR-Cas12a-assisted detection for COVID-19 screening in resource-limited settings
First Author:
Reviewed: Jan 10, 2022
|
|
Jan 10, 2022
|
|
Association between vaccination status and reported incidence of post-acute COVID-19 symptoms in Israel: a cross-sectional study of patients infected between March 2020 and November 2021
First Author:
Reviewed: Jan 10, 2022
|
|
Jan 10, 2022
|
|
Burden of SARS-CoV-2 and protection from symptomatic second infection in children
First Author:
Reviewed: Jan 10, 2022
|
|
Jan 10, 2022
|
|
Cell-mediated and humoral immune response to SARS-CoV-2 vaccination and booster dose in immunosuppressed patients
First Author:
Reviewed: Jan 10, 2022
|
|
Jan 10, 2022
|
|
Comparison of infectious SARS-CoV-2 from the nasopharynx of vaccinated and unvaccinated individuals
First Author:
Reviewed: Jan 10, 2022
|
|
Jan 10, 2022
|
|
Daily Lactobacillus Probiotic versus Placebo in COVID-19-Exposed Household Contacts (PROTECT-EHC): A Randomized Clinical Trial
First Author:
Reviewed: Jan 10, 2022
|
|
Jan 10, 2022
|
|
Diminished antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients
First Author:
Reviewed: Jan 10, 2022
|
|
Jan 10, 2022
|
|
Durability of Protection against COVID-19 Breakthrough Infections and Severe Disease by Vaccines in the United States
First Author:
Reviewed: Jan 10, 2022
|
|
Jan 10, 2022
|
|
Effect of Vaccination on Household Transmission of SARS-CoV-2 Delta VOC
First Author:
Reviewed: Jan 10, 2022
|
|
Jan 10, 2022
|
- Adults
- Pediatrics/Adolescents
|
Effects of vaccination efficacy on wealth distributionin kinetic
epidemic models
First Author:
Reviewed: Jan 10, 2022
|
|
Jan 10, 2022
|
|
Estimating the state of the Covid-19 epidemic curve in Mayotte during the period without vaccination
First Author:
Reviewed: Jan 10, 2022
|
|
Jan 10, 2022
|
|
Evaluation of Commercial Anti-SARS-CoV-2 Neutralizing Antibody Assays in seropositive subjects
First Author:
Reviewed: Jan 10, 2022
|
|
Jan 10, 2022
|
|
First Manifestation of AQP4-IgG-Positive Neuromyelitis Optica Spectrum Disorder Associated with the COVID-19 mRNA Vaccine BNT162b2
First Author:
Reviewed: Jan 10, 2022
|
|
Jan 10, 2022
|
|
Fully Vaccinated and Boosted Patients Requiring Hospitalization for COVID-19: an Observational Cohort Analysis
First Author:
Reviewed: Jan 10, 2022
|
|
Jan 10, 2022
|
|
Heterologous vaccination with inactivated and mRNA vaccines increases B and T cell responses to SARS-CoV-2
First Author:
Reviewed: Jan 10, 2022
|
|
Jan 10, 2022
|
|
High Sensitivity and NPV for BinaxNOW Rapid Antigen Test in Children at a Mass Testing Site During Prevalent Delta Variant
First Author:
Reviewed: Jan 10, 2022
|
|
Jan 10, 2022
|
|
Immune responses to inactivated and vector-based vaccines in individuals previously infected with SARS-CoV-2
First Author:
Reviewed: Jan 10, 2022
|
|
Jan 10, 2022
|
|
Older Adults Mount Less Durable Humoral Responses to a Two-dose COVID-19 mRNA Vaccine Regimen, but Strong Initial Responses to a Third Dose
First Author:
Reviewed: Jan 10, 2022
|
|
Jan 10, 2022
|
|
Performance evaluation of novel fluorescent-based lateral immune flow assay (LIFA) for rapid detection and quantitation of total anti-SARS-CoV-2 S-RBD binding antibodies in infected individuals
First Author:
Reviewed: Jan 10, 2022
|
|
Jan 10, 2022
|
|
Preliminary modeling estimates of the relative transmissibility and immune escape of the Omicron SARS-CoV-2 variant of concern in South Africa
First Author:
Reviewed: Jan 10, 2022
|
|
Jan 10, 2022
|
|
Reported Cases of Multisystem Inflammatory Syndrome in Children (MIS-C) Aged 12–20 Years in the United States Who Received COVID-19 Vaccine, December 2020 through August 2021
First Author:
Reviewed: Jan 10, 2022
|
|
Jan 10, 2022
|
|
Safety and immunogenicity of a heterologous boost with a recombinant vaccine, NVSI-06-07, in the inactivated vaccine recipients from UAE: a phase 2 randomised, double-blinded, controlled clinical trial
First Author:
Reviewed: Jan 10, 2022
|
|
Jan 10, 2022
|
|
Safety and immunogenicity of anti-SARS CoV-2 conjugate vaccine SOBERANA 02 in a two-dose or three-dose heterologous scheme in adults: Phase IIb Clinical Trial
First Author:
Reviewed: Jan 10, 2022
|
|
Jan 10, 2022
|
|
SARS-CoV-2 Genetic diversity and lineage dynamics of in Egypt
First Author:
Reviewed: Jan 10, 2022
|
|
Jan 10, 2022
|
|
Seroresponse to third doses of SARS-CoV-2 vaccine among patients receiving maintenance dialysis
First Author:
Reviewed: Jan 10, 2022
|
|
Jan 10, 2022
|
|
Structural basis of Omicron neutralization by affinity-matured public antibodies
First Author:
Reviewed: Jan 10, 2022
|
|
Jan 10, 2022
|
|
Sub-optimal Neutralisation of Omicron (B.1.1.529) Variant by Antibodies induced by Vaccine alone or SARS-CoV-2 Infection plus Vaccine (Hybrid Immunity) post 6-months
First Author:
Reviewed: Jan 10, 2022
|
|
Jan 10, 2022
|
|
T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all prior infected and vaccinated individuals
First Author:
Reviewed: Jan 10, 2022
|
|
Jan 10, 2022
|
|
The impact of vaccination on incidence and outcomes of SARS-CoV-2 infection in patients with kidney failure in Scotland
First Author:
Reviewed: Jan 10, 2022
|
|
Jan 10, 2022
|
|
Timing of Breakthrough Infection Risk After Vaccination Against SARS-CoV-2
First Author:
Reviewed: Jan 10, 2022
|
|
Jan 10, 2022
|
- Adults
- Pediatrics/Adolescents
|
Validation of a novel fluorescent lateral flow assay for rapid qualitative and quantitative assessment of total anti-SARS-CoV-2 S-RBD binding antibody units (BAU) from plasma or fingerstick whole-blood of COVID-19 vaccinees
First Author:
Reviewed: Jan 10, 2022
|
|
Jan 10, 2022
|
|
Waning Effectiveness of the BNT162b2 Vaccine Against Infection in Adolescents
First Author:
Reviewed: Jan 10, 2022
|
|
Jan 10, 2022
|
|
Analysis of SARS-CoV-2 Omicron Neutralization Data up to 2021-12-22
First Author:
Reviewed: Jan 7, 2022
|
|
Jan 7, 2022
|
|
Antibody response to SARS-CoV-2 mRNA vaccine in lung cancer patients: Reactivity to vaccine antigen and variants of concern
First Author:
Reviewed: Jan 7, 2022
|
|
Jan 7, 2022
|
|
Estimating protection afforded by prior infection in preventing reinfection: Applying the test-negative study design
First Author:
Reviewed: Jan 7, 2022
|
|
Jan 7, 2022
|
|
How Large Fraction of A Population Must be Vaccinated before A Disease is Controlled?
First Author:
Reviewed: Jan 7, 2022
|
|
Jan 7, 2022
|
|
Impairment of SARS-CoV-2 spike-glycoprotein maturation and fusion-activity by nitazoxanide: an effect independent of spike variants emergence
First Author:
Reviewed: Jan 7, 2022
|
|
Jan 7, 2022
|
|
In vitro evaluation of therapeutic antibodies against a SARS-CoV-2 Omicron B.1.1.529 isolate
First Author:
Reviewed: Jan 7, 2022
|
|
Jan 7, 2022
|
|
Integrin/TGF-β1 inhibitor GLPG-0187 blocks SARS-CoV-2 Delta and Omicron pseudovirus infection of airway epithelial cells which could attenuate disease severity
First Author:
Reviewed: Jan 7, 2022
|
|
Jan 7, 2022
|
|
Mapping the antigenic diversification of SARS-CoV-2
First Author:
Reviewed: Jan 7, 2022
|
|
Jan 7, 2022
|
|
New onset rheumatoid arthritis with refractory hyper-eosinophilia associated with inactivated COVID-19 vaccine
First Author:
Reviewed: Jan 7, 2022
|
|
Jan 7, 2022
|
|
Nonself Mutations in the Spike Protein Suggest an Increase in the Antigenicity and a Decrease in the Virulence of the Omicron Variant of SARS-CoV-2
First Author:
Reviewed: Jan 7, 2022
|
|
Jan 7, 2022
|
|
Statistical and agent-based modelling of the transmissibility of different SARS-CoV-2 variants in England and impact of different interventions
First Author:
Reviewed: Jan 7, 2022
|
|
Jan 7, 2022
|
|
Superior immunity that allows neutralization of all SARS-CoV-2 variants of concern develops in COVID-19 convalescents and naïve individuals after three vaccinations
First Author:
Reviewed: Jan 7, 2022
|
|
Jan 7, 2022
|
|
The hyper-transmissible SARS-CoV-2 Omicron variant exhibits significant antigenic change, vaccine escape and a switch in cell entry mechanism
First Author:
Reviewed: Jan 7, 2022
|
|
Jan 7, 2022
|
|
The SARS-CoV-2 variant, Omicron, shows rapid replication in human primary nasal epithelial cultures and efficiently uses the endosomal route of entry
First Author:
Reviewed: Jan 7, 2022
|
|
Jan 7, 2022
|
|
Vaccines Elicit Highly Cross-Reactive Cellular Immunity to the SARS-CoV-2 Omicron Variant
First Author:
Reviewed: Jan 7, 2022
|
|
Jan 7, 2022
|
|
Wild Type and Omicron SARS-CoV-2 Spike Receptor Binding Domains Bind Similarly to the Human ACE2 Receptor: An MM-GBSA Study
First Author:
Reviewed: Jan 7, 2022
|
|
Jan 7, 2022
|
|
Adequate Immunogenicity And Low Rate of Severe Adverse Events After SARS-CoV-2 mRNA-Based Vaccination In Patients With Solid Malignancies On Active Treatment Starts To Decline 3 Months After Complete Primary Course of Vaccination
First Author:
Reviewed: Jan 6, 2022
|
|
Jan 6, 2022
|
|
Comparative analysis of BNT162b2, mRNA-1273 and ChAdOx1 COVID-19 vaccine induced antibody responses and the 3rd BNT162b2 vaccine induced neutralizing antibodies against Delta and Omicron variants
First Author:
Reviewed: Jan 6, 2022
|
|
Jan 6, 2022
|
|
Comparison of outcomes from COVID infection in pediatric and adult patients before and after the emergence of Omicron
First Author:
Reviewed: Jan 6, 2022
|
|
Jan 6, 2022
|
|
COVID-19 mRNA Booster Vaccines Elicit Strong Protection Against SARS-CoV-2 Omicron Variant in Patients with Cancer
First Author:
Reviewed: Jan 6, 2022
|
|
Jan 6, 2022
|
|
COVID-19 severity prediction based on patient risk factors and number of vaccines received
First Author:
Reviewed: Jan 6, 2022
|
|
Jan 6, 2022
|
|
COVID-19 vaccination is highly effective to prevent SARS-CoV-2 circulation
First Author:
Reviewed: Jan 6, 2022
|
|
Jan 6, 2022
|
|
COVID-19 vaccine effectiveness among immunocompromised populations: a targeted literature review of real-world studies
First Author:
Reviewed: Jan 6, 2022
|
|
Jan 6, 2022
|
|
Cross reactivity of spike glycoprotein induced antibody against Delta and Omicron variants before and after third SARS-CoV-2 vaccine dose
First Author:
Reviewed: Jan 6, 2022
|
|
Jan 6, 2022
|
|
Early estimates of SARS-CoV-2 Omicron variant severity based on a matched cohort study, Ontario, Canada
First Author:
Reviewed: Jan 6, 2022
|
|
Jan 6, 2022
|
|
Early signals of significantly increased vaccine breakthrough, decreased hospitalization rates, and less severe disease in patients with COVID-19 caused by the Omicron variant of SARS-CoV-2 in Houston, Texas
First Author:
Reviewed: Jan 6, 2022
|
|
Jan 6, 2022
|
|
Effectiveness of COVID-19 vaccines against Omicron or Delta infection
First Author:
Reviewed: Jan 6, 2022
|
|
Jan 6, 2022
|
|
Executive dysfunction following SARS-CoV-2 infection: A cross-sectional examination in a population-representative sample
First Author:
Reviewed: Jan 6, 2022
|
|
Jan 6, 2022
|
|
Humoral immune responses against SARS-CoV-2 variants including omicron in solid organ transplant recipients after three doses of a COVID-19 mRNA vaccine
First Author:
Reviewed: Jan 6, 2022
|
|
Jan 6, 2022
|
|
Longitudinal serologic and viral testing post–SARS-CoV-2 infection and post-receipt of mRNA COVID-19 vaccine in a nursing home cohort—Georgia, October 2020‒April 2021
First Author:
Reviewed: Jan 6, 2022
|
|
Jan 6, 2022
|
|
Long-lasting cellular immunity to SARS-CoV-2 following infection or vaccination and implications for booster strategies
First Author:
Reviewed: Jan 6, 2022
|
|
Jan 6, 2022
|
|
Magnitude and breadth of neutralizing antibody responses elicited by SARS-CoV-2 infection or vaccination
First Author:
Reviewed: Jan 6, 2022
|
|
Jan 6, 2022
|
|
Mobility network reveals the impact of spatial vaccination heterogeneity on COVID-19
First Author:
Reviewed: Jan 6, 2022
|
|
Jan 6, 2022
|
|
Mucosal TLR2-activating protein-based vaccination induces potent pulmonary immunity and protection against SARS-CoV-2 in mice
First Author:
Reviewed: Jan 6, 2022
|
|
Jan 6, 2022
|
|
Neutralization of ancestral SARS-CoV-2 and variants Alpha, Beta, Gamma, Delta, Zeta and Omicron by mRNA vaccination and infection-derived immunity through homologous and heterologous variants
First Author:
Reviewed: Jan 6, 2022
|
|
Jan 6, 2022
|
|
Neutralizing antibody titres to SARS-CoV-2 Omicron variant and wild-type virus in those with past infection or vaccinated or boosted with mRNA BNT162b2 or inactivated CoronaVac vaccines
First Author:
Reviewed: Jan 6, 2022
|
|
Jan 6, 2022
|
|
Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles
First Author:
Reviewed: Jan 6, 2022
|
|
Jan 6, 2022
|
|
Omicron outbreak at a private gathering in the Faroe Islands, infecting 21 of 33 triple-vaccinated healthcare workers
First Author:
Reviewed: Jan 6, 2022
|
|
Jan 6, 2022
|
|
Predicting the impact of COVID-19 vaccination campaigns – a flexible age-dependent, spatially-stratified predictive model, accounting for multiple viral variants and vaccines
First Author:
Reviewed: Jan 6, 2022
|
|
Jan 6, 2022
|
|
Preferential expansion upon boosting of cross-reactive “pre-existing” switched memory B cells that recognize the SARS-CoV-2 Omicron variant Spike protein
First Author:
Reviewed: Jan 6, 2022
|
|
Jan 6, 2022
|
|
Preserved recognition of Omicron Spike following COVID-19 mRNA vaccination in pregnancy
First Author:
Reviewed: Jan 6, 2022
|
|
Jan 6, 2022
|
|
Protective effect of BNT162b2 vaccination on aerobic capacity following mild to moderate SARS-CoV-2 infection: a cross sectional study, Israel, March-December 2021
First Author:
Reviewed: Jan 6, 2022
|
|
Jan 6, 2022
|
|
Quantitation of SARS-CoV-2 neutralizing antibodies with a virus-free, authentic test
First Author:
Reviewed: Jan 6, 2022
|
|
Jan 6, 2022
|
|
Transition of antibody titers after the SARS-CoV-2 mRNA vaccine in Japanese healthcare workers
First Author:
Reviewed: Jan 6, 2022
|
|
Jan 6, 2022
|
|
Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants
First Author:
Reviewed: Jan 6, 2022
|
|
Jan 6, 2022
|
|
Vaccine Effectiveness against COVID-19 among Symptomatic Persons Aged ≥12 Years with Reported Contact with COVID-19 Cases, February – September 2021
First Author:
Reviewed: Jan 6, 2022
|
|
Jan 6, 2022
|
- Adults
- Pediatrics/Adolescents
|
Waning of SARS-CoV-2 Antibody levels response to inactivated cellular vaccine over 6 months among healthcare workers
First Author:
Reviewed: Jan 6, 2022
|
|
Jan 6, 2022
|
|
Antigen evolution from D614, to G614, and to Delta subtype of SARS-CoV-2
First Author:
Reviewed: Jan 5, 2022
|
|
Jan 5, 2022
|
|
SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings From The COV-AD Study
First Author:
Reviewed: Jan 5, 2022
|
|
Jan 5, 2022
|
|
A novel assessment method for COVID-19 humoral immunity duration using serial measurements in naturally infected and vaccinated subjects
First Author:
Reviewed: Jan 4, 2022
|
|
Jan 4, 2022
|
|
A Novel CRISPR-Engineered, Stem Cell-Derived Cellular Vaccine
First Author:
Reviewed: Jan 4, 2022
|
|
Jan 4, 2022
|
|
Acceptance of COVID-19 Vaccination and its Related Factors Among HIV/AIDS Patients in Guangxi, China: A Cross-Sectional Survey.
First Author:
Reviewed: Jan 4, 2022
|
|
Jan 4, 2022
|
|
Ancestral SARS-CoV-2-specific T cells cross-recognize Omicron (B.1.1.529)
First Author:
Reviewed: Jan 4, 2022
|
|
Jan 4, 2022
|
|
Assessment of Activity of Chalcone Compounds as Inhibitors of 3-Chymotrypsin Like Protease (3CLPro) of SARS-CoV-2: in Silico Study
First Author:
Reviewed: Jan 4, 2022
|
|
Jan 4, 2022
|
|
Booster vaccines protect hamsters with waning immunity from Delta VOC infection, disease, and transmission
First Author:
Reviewed: Jan 4, 2022
|
|
Jan 4, 2022
|
|
Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody
First Author:
Reviewed: Jan 4, 2022
|
|
Jan 4, 2022
|
|
Control Strategies for the Third wave of COVID-19 infection in India: A Mathematical Model Incorporating Vaccine Effectiveness
First Author:
Reviewed: Jan 4, 2022
|
|
Jan 4, 2022
|
|
Deciphering the quality of SARS-CoV-2 specific T-cell response associated with disease severity, immune memory and heterologous response
First Author:
Reviewed: Jan 4, 2022
|
|
Jan 4, 2022
|
|
Design, immunogenicity, and efficacy of a pan-sarbecovirus dendritic-cell targeting vaccine
First Author:
Reviewed: Jan 4, 2022
|
|
Jan 4, 2022
|
|
Divergent SARS CoV-2 Omicron-specific T- and B-cell responses in COVID-19 vaccine recipients
First Author:
Reviewed: Jan 4, 2022
|
|
Jan 4, 2022
|
|
Effects of Lockdowns And Its Impacts On Age-Specific Transmission Dynamics of SARS-Cov-2 In Georgia, USA
First Author:
Reviewed: Jan 4, 2022
|
|
Jan 4, 2022
|
|
Emergence in Southern France of a new SARS-CoV-2 variant of probably Cameroonian origin harbouring both substitutions N501Y and E484K in the spike protein
First Author:
Reviewed: Jan 4, 2022
|
|
Jan 4, 2022
|
|
Evolutionary trend of SARS-CoV-2 inferred by the homopolymeric
nucleotide repeats
First Author:
Reviewed: Jan 4, 2022
|
|
Jan 4, 2022
|
|
Forecasting COVID-19 infection trends and new hospital admissions in England due to SARS-CoV-2 Variant of Concern Omicron
First Author:
Reviewed: Jan 4, 2022
|
|
Jan 4, 2022
|
|
Functional properties of the spike glycoprotein of the emerging SARS-CoV-2 variant B.1.1.529
First Author:
Reviewed: Jan 4, 2022
|
|
Jan 4, 2022
|
|
Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (BBV152) in children from 2 to 18 years of age: an open-label, age-de-escalation phase 2/3 study
First Author:
Reviewed: Jan 4, 2022
|
|
Jan 4, 2022
|
|
Immunogenicity of heterologous BNT162b2 booster in fully vaccinated individuals with CoronaVac against SARS-CoV-2 variants Delta and Omicron: the Dominican Republic Experience
First Author:
Reviewed: Jan 4, 2022
|
|
Jan 4, 2022
|
|
In contrast to TH2-biased approaches, TH1 COVID-19 vaccines protect Syrian hamsters from severe disease in the absence of dexamethasone-treatable vaccine-associated enhanced respiratory pathology
First Author:
Reviewed: Jan 4, 2022
|
|
Jan 4, 2022
|
|
Increased resistance of SARS-CoV-2 Omicron Variant to Neutralization by Vaccine-Elicited and Therapeutic Antibodies
First Author:
Reviewed: Jan 4, 2022
|
|
Jan 4, 2022
|
|
Molecular probes of spike ectodomain and its subdomains for SARS-CoV-2 variants, Alpha through Omicron
First Author:
Reviewed: Jan 4, 2022
|
|
Jan 4, 2022
|
|
mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2
First Author:
Reviewed: Jan 4, 2022
|
|
Jan 4, 2022
|
|
Neutralizing antibody responses to SARS-CoV-2: a population based seroepidemiological analysis in Delhi, India
First Author:
Reviewed: Jan 4, 2022
|
|
Jan 4, 2022
|
|
Peptide-based epitope design on non-structural proteins of SARS-CoV-2
First Author:
Reviewed: Jan 4, 2022
|
|
Jan 4, 2022
|
|
Preserved T cell reactivity to the SARS-CoV-2 Omicron variant indicates continued protection in vaccinated individuals
First Author:
Reviewed: Jan 4, 2022
|
|
Jan 4, 2022
|
|
Replacement of the Gamma by the Delta variant in Brazil: impact of lineage displacement on the ongoing pandemic
First Author:
Reviewed: Jan 4, 2022
|
|
Jan 4, 2022
|
|
Safety and immunogenicity of BNT162b2 mRNA COVID-19 vaccine in Japanese patients after allogeneic stem cell transplantation
First Author:
Reviewed: Jan 4, 2022
|
|
Jan 4, 2022
|
|
SARS-CoV-2 diverges from other betacoronaviruses in only partially activating the IRE1α/XBP1 ER stress pathway in human lung-derived cells
First Author:
Reviewed: Jan 4, 2022
|
|
Jan 4, 2022
|
|
SARS-CoV-2 Omicron variant: healthcare workers’ perceptions and beliefs of vaccine effectiveness and advocacy: a national survey during the first week of the World Health Organization variant alert
First Author:
Reviewed: Jan 4, 2022
|
|
Jan 4, 2022
|
|
SARS-CoV-2 Omicron-B.1.1.529 Variant leads to less severe disease than Pango B and Delta variants strains in a mouse model of severe COVID-19
First Author:
Reviewed: Jan 4, 2022
|
|
Jan 4, 2022
|
|
SARS-CoV-2 seroprevalence in Delhi, India - September-October 2021 – a population based seroepidemiological study
First Author:
Reviewed: Jan 4, 2022
|
|
Jan 4, 2022
|
|
SARS-CoV-2 spike T cell responses induced upon vaccination or infection remain robust against Omicron
First Author:
Reviewed: Jan 4, 2022
|
|
Jan 4, 2022
|
|
SARS-CoV-2 vaccination induces immunological memory able to cross-recognize variants from Alpha to Omicron
First Author:
Reviewed: Jan 4, 2022
|
|
Jan 4, 2022
|
|
Short-term Projections based on Early Omicron Variant Dynamics in England
First Author:
Reviewed: Jan 4, 2022
|
|
Jan 4, 2022
|
|
Structural and functional characterizations of altered infectivity and immune evasion of SARS-CoV-2 Omicron variant
First Author:
Reviewed: Jan 4, 2022
|
|
Jan 4, 2022
|
|
Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529
First Author:
Reviewed: Jan 4, 2022
|
|
Jan 4, 2022
|
|
Super-immunity by broadly protective nanobodies to sarbecoviruses
First Author:
Reviewed: Jan 4, 2022
|
|
Jan 4, 2022
|
|
Vaccine effectiveness against hospital admission in South African health care workers who received a homologous booster of Ad26.COV2 during an Omicron COVID19 wave: Preliminary Results of the Sisonke 2 Study
First Author:
Reviewed: Jan 4, 2022
|
|
Jan 4, 2022
|
|
Vaccine-breakthrough infection by the SARS-CoV-2 Omicron variant elicits broadly cross-reactive immune responses
First Author:
Reviewed: Jan 4, 2022
|
|
Jan 4, 2022
|
|
Viral population genomics reveals host and infectivity impact on SARS-CoV-2 adaptive landscape
First Author:
Reviewed: Jan 4, 2022
|
|
Jan 4, 2022
|
|
Waning of SARS-CoV-2 booster viral-load reduction effectiveness
First Author:
Reviewed: Jan 4, 2022
|
|
Jan 4, 2022
|
|
Why do people consent to receiving SARS-CoV2 vaccinations? A Representative Survey in Germany
First Author:
Reviewed: Jan 4, 2022
|
|
Jan 4, 2022
|
|
Assessing Immunity by Quantitative Measurement of SARS-CoV-2 IgG Antibodies in Fingerstick Samples
First Author:
Reviewed: Jan 3, 2022
|
|
Jan 3, 2022
|
|
Broad and Long-lasting Immune Response against SARS-CoV-2 Omicron and Other Variants by PIKA-Adjuvanted Recombinant SARS-CoV-2 Spike (S) Protein Subunit Vaccine (YS-SC2-010)
First Author:
Reviewed: Jan 3, 2022
|
|
Jan 3, 2022
|
|
COVID-19: Salient Aspects of Coronavirus Infection, Vaccines and Vaccination Testing and their Implications
First Author:
Reviewed: Jan 3, 2022
|
|
Jan 3, 2022
|
|
Engineered ACE2 counteracts vaccine-evading SARS-CoV-2 Omicron variant
First Author:
Reviewed: Jan 3, 2022
|
|
Jan 3, 2022
|
|
Estimating the impact of implementation and timing of COVID-19 vaccination program in Brazil: a counterfactual analysis
First Author:
Reviewed: Jan 3, 2022
|
|
Jan 3, 2022
|
|
Homologous or Heterologous Booster of Inactivated Vaccine Reduces SARS-CoV-2 Omicron Variant Escape from Neutralizing Antibodies
First Author:
Reviewed: Jan 3, 2022
|
|
Jan 3, 2022
|
|
Modeling COVID-19 Transmission using IDSIM, an Epidemiological-Modelling
Desktop App with Multi-Level Immunization Capabilities
First Author:
Reviewed: Jan 3, 2022
|
|
Jan 3, 2022
|
|
Omicron infection enhances neutralizing immunity against the Delta variant
First Author:
Reviewed: Jan 3, 2022
|
|
Jan 3, 2022
|
|
Preserved Omicron Spike specific antibody binding and Fc-recognition across COVID-19 vaccine platforms
First Author:
Reviewed: Jan 3, 2022
|
|
Jan 3, 2022
|
|
Reduced infectivity but increased immune escape of the new SARS-CoV-2 variant of concern Omicron
First Author:
Reviewed: Jan 3, 2022
|
|
Jan 3, 2022
|
|
SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster
First Author:
Reviewed: Jan 3, 2022
|
|
Jan 3, 2022
|
|
SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-weeks interval between doses
First Author:
Reviewed: Jan 3, 2022
|
|
Jan 3, 2022
|
|
SIR model for assessing the impact of the advent of Omicron and mitigating measures on infection pressure and hospitalization needs
First Author:
Reviewed: Jan 3, 2022
|
|
Jan 3, 2022
|
|
Waning immune responses against SARS-CoV-2 among vaccinees in Hong Kong
First Author:
Reviewed: Jan 3, 2022
|
|
Jan 3, 2022
|
|
Recursive State and Parameter Estimation of COVID-19 Circulating Variants Dynamics
First Author:
Reviewed: Dec 31, 2021
|
|
Dec 31, 2021
|
|
A subset of Memory B-derived antibody repertoire from 3-dose vaccinees is ultrapotent against diverse and highly transmissible SARS-CoV-2 variants, including Omicron
First Author:
Reviewed: Dec 30, 2021
|
|
Dec 30, 2021
|
|
An ultrapotent RBD-targeted biparatopic nanobody neutralizes broad SARS-CoV-2 variants
First Author:
Reviewed: Dec 30, 2021
|
|
Dec 30, 2021
|
|
Analyzing the interaction of human ACE2 and RBD of spike protein of SARS-CoV-2 in perspective of Omicron variant
First Author:
Reviewed: Dec 30, 2021
|
|
Dec 30, 2021
|
|
AstraZeneca ChAdOx1-S COVID-19 Vaccine Can Be Safely Administered in Patients with EDTA Allergy
First Author:
Reviewed: Dec 30, 2021
|
|
Dec 30, 2021
|
|
Attenuated replication and pathogenesis of SARS-CoV-2 B.1.1.529 Omicron
First Author:
Reviewed: Dec 30, 2021
|
|
Dec 30, 2021
|
|
BNT162b2 boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19
First Author:
Reviewed: Dec 30, 2021
|
|
Dec 30, 2021
|
|
Calibrated comparison of SARS-CoV-2 neutralizing antibody levels in response to protein-, mRNA-, and vector-based COVID-19 vaccines
First Author:
Reviewed: Dec 30, 2021
|
|
Dec 30, 2021
|
|
Change in COVID-19 risk over time following vaccination with CoronaVac: A test-negative case-control study
First Author:
Reviewed: Dec 30, 2021
|
|
Dec 30, 2021
|
|
COMPARATIVE ANALYSIS OF ANTIBODY RESPONSES FROM COVID-19 CONVALESCENTS RECEIVING VARIOUS VACCINES REVEALS CONSISTENT HIGH NEUTRALIZING ACTIVITY FOR SARS-CoV-2 VARIANT OF CONCERN OMICRON
First Author:
Reviewed: Dec 30, 2021
|
|
Dec 30, 2021
|
|
Comparison of IgA, IgG and neutralizing antibody responses following immunization with Moderna, BioNTech, AstraZeneca, Sputnik-V, Johnson and Johnson, and Sinopharm’s COVID-19 vaccines.
First Author:
Reviewed: Dec 30, 2021
|
|
Dec 30, 2021
|
|
Convalescence from prototype SARS-CoV-2 protects Syrian hamsters from disease caused by the Omicron variant
First Author:
Reviewed: Dec 30, 2021
|
|
Dec 30, 2021
|
|
COVID-19 vaccination effectiveness rates by week and sources of bias
First Author:
Reviewed: Dec 30, 2021
|
|
Dec 30, 2021
|
|
Designing multi-epitope based peptide vaccine targeting spike protein SARS-CoV-2 B1.1.529 (Omicron) variant using computational approaches
First Author:
Reviewed: Dec 30, 2021
|
|
Dec 30, 2021
|
|
Diversity in antibody titer at an average of 87 days after the second dose of BNT162b2 mRNA coronavirus disease 2019 vaccine: data from a predominantly elderly population in a practice in Tokyo
First Author:
Reviewed: Dec 30, 2021
|
|
Dec 30, 2021
|
|
Effectiveness of BNT162b2 and mRNA-1273 Second Doses and Boosters for SARS-CoV-2 infection and SARS-CoV-2 Related Hospitalizations: A Statewide Report from the Minnesota Electronic Health Record Consortium
First Author:
Reviewed: Dec 30, 2021
|
|
Dec 30, 2021
|
|
Genomic diversification of long polynucleotide fragments is a signature of emerging SARS-CoV-2 variants of concern
First Author:
Reviewed: Dec 30, 2021
|
|
Dec 30, 2021
|
|
Humoral Response among Patients with Interstitial Lung Disease Vaccinated with the BNT162b2 SARS-Cov-2 vaccine - A Prospective Cohort Study
First Author:
Reviewed: Dec 30, 2021
|
|
Dec 30, 2021
|
|
Immunogenicity and Safety Following a Homologous Booster Dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): A Phase 2 Randomized Placebo-Controlled Trial
First Author:
Reviewed: Dec 30, 2021
|
|
Dec 30, 2021
|
|
In vitro evolution predicts emerging CoV-2 mutations with high affinity for ACE2 and cross-species binding
First Author:
Reviewed: Dec 30, 2021
|
|
Dec 30, 2021
|
|
Influenza A H1N1–mediated pre-existing immunity to SARS-CoV-2 predicts COVID-19 outbreak dynamics
First Author:
Reviewed: Dec 30, 2021
|
|
Dec 30, 2021
|
|
Infrared spectroscopy enables rapid, robust, portable COVID-19 saliva screening based on pathophysiological response to SARS-CoV-2
First Author:
Reviewed: Dec 30, 2021
|
|
Dec 30, 2021
|
|
Knowledge, Attitude and Acceptance of a COVID-19 Vaccine in Indian Population : a Cross Sectional Study
First Author:
Reviewed: Dec 30, 2021
|
|
Dec 30, 2021
|
|
Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617
First Author:
Reviewed: Dec 30, 2021
|
|
Dec 30, 2021
|
|
Neutralising antibody activity against SARS-CoV-2 variants, including Omicron, in an elderly cohort vaccinated with BNT162b2
First Author:
Reviewed: Dec 30, 2021
|
|
Dec 30, 2021
|
|
Neutralizing antibodies to SARS-CoV-2 Omicron variant after 3rd mRNA vaccination in health care workers and elderly subjects and response to a single dose in previously infected adults
First Author:
Reviewed: Dec 30, 2021
|
|
Dec 30, 2021
|
|
Population immunity to SARS-CoV-2 in US states and counties due to infection and vaccination, January 2020-November 2021
First Author:
Reviewed: Dec 30, 2021
|
|
Dec 30, 2021
|
|
Risk of myocarditis following sequential COVID-19 vaccinations by age and sex
First Author:
Reviewed: Dec 30, 2021
|
|
Dec 30, 2021
|
|
SARS-CoV-2 vaccine Alpha and Delta variant breakthrough infections are rare and mild, but happen relative early after vaccination
First Author:
Reviewed: Dec 30, 2021
|
|
Dec 30, 2021
|
|
Serum anti-Spike antibody titers before and after heterologous booster with mRNA-1273 SARS-CoV-2 vaccine following two doses of inactivated whole-virus CoronaVac vaccine
First Author:
Reviewed: Dec 30, 2021
|
|
Dec 30, 2021
|
|
Structurally and functionally distinct early antibody responses predict COVID-19 disease trajectory and mRNA vaccine response
First Author:
Reviewed: Dec 30, 2021
|
|
Dec 30, 2021
|
|
The SARS-CoV-2 B.1.1.529 Omicron virus causes attenuated infection and disease in mice and hamsters
First Author:
Reviewed: Dec 30, 2021
|
|
Dec 30, 2021
|
|
Three doses of the BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 B.1.1.529 (Omicron) variant of concern
First Author:
Reviewed: Dec 30, 2021
|
|
Dec 30, 2021
|
|
Two doses of mRNA vaccine elicit cross-neutralizing memory B-cells against SARS-CoV-2 Omicron variant
First Author:
Reviewed: Dec 30, 2021
|
|
Dec 30, 2021
|
|
Acute cardiac side effects after COVID-19 mRNA vaccination, a case series
First Author:
Reviewed: Dec 29, 2021
|
|
Dec 29, 2021
|
|
Construction of a potent pan-vaccine based on the evolutionary tendency of SARS-CoV-2 spike protein
First Author:
Reviewed: Dec 29, 2021
|
|
Dec 29, 2021
|
|
Effect of an Exercise Bout Prior to the Booster Dose of an Inactivated SARS-CoV-2 Vaccine on Immunogenicity in Immunocompromised Patients
First Author:
Reviewed: Dec 29, 2021
|
|
Dec 29, 2021
|
|
Efficacy of antiviral drugs against the omicron variant of SARS-CoV-2
First Author:
Reviewed: Dec 29, 2021
|
|
Dec 29, 2021
|
|
Intranasal inhibitor blocks omicron and other variants of SARS-CoV-2
First Author:
Reviewed: Dec 29, 2021
|
|
Dec 29, 2021
|
|
Modeling The Impact of Vaccination On COVID-19 And Its Delta Variant
First Author:
Reviewed: Dec 29, 2021
|
|
Dec 29, 2021
|
|
mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant
First Author:
Reviewed: Dec 29, 2021
|
|
Dec 29, 2021
|
|
Neutralizing potency of COVID-19 vaccines against the SARS-CoV-2 Omicron (B.1.1.529) variant
First Author:
Reviewed: Dec 29, 2021
|
|
Dec 29, 2021
|
|
Nucleocapsid 203 mutations enhance SARS-CoV-2 immune evasion
First Author:
Reviewed: Dec 29, 2021
|
|
Dec 29, 2021
|
|
Patterns and predictors of COVID-19 occurrence and severity in vaccinated priority groups
First Author:
Reviewed: Dec 29, 2021
|
|
Dec 29, 2021
|
|
Physical Activity Associates with Greater Antibody Persistence through 6 Months after the Second Dose of CoronaVac in Patients with Autoimmune Rheumatic Diseases
First Author:
Reviewed: Dec 29, 2021
|
|
Dec 29, 2021
|
|
Polymerized Porin as a Novel Delivery Platform for Coronavirus Vaccine
First Author:
Reviewed: Dec 29, 2021
|
|
Dec 29, 2021
|
|
Predictors of an Immunogenic Response to the BNT162b2 mRNA COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases Treated with Rituximab: A Multicenter Study
First Author:
Reviewed: Dec 29, 2021
|
|
Dec 29, 2021
|
|
Breakthrough Covid-19 infections during periods of circulating Beta, Delta and Omicron variants of concern, among health care workers in the Sisonke Ad26.COV2.S vaccine trial, South Africa
First Author:
Reviewed: Dec 28, 2021
|
|
Dec 28, 2021
|
|
Engineered High-Affinity ACE2 Peptide Mitigates ARDS and Death Induced by Multiple SARS-CoV-2 Variants
First Author:
Reviewed: Dec 28, 2021
|
|
Dec 28, 2021
|
|
Epistasis at the SARS-CoV-2 RBD Interface and the Propitiously Boring Implications for Vaccine Escape
First Author:
Reviewed: Dec 28, 2021
|
|
Dec 28, 2021
|
|
Immune escape of SARS-CoV-2 Omicron variant from mRNA vaccination-elicited RBD-specific memory B cells
First Author:
Reviewed: Dec 28, 2021
|
|
Dec 28, 2021
|
|
Immune responses following third COVID-19 vaccination are reduced in patients with hematologic malignancies compared to patients with solid cancer
First Author:
Reviewed: Dec 28, 2021
|
|
Dec 28, 2021
|
|
Longitudinal characterisation of phagocytic and neutralisation functions of anti-Spike antibodies in plasma of patients after SARS-CoV-2 infection
First Author:
Reviewed: Dec 28, 2021
|
|
Dec 28, 2021
|
|
mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 Omicron variant
First Author:
Reviewed: Dec 28, 2021
|
|
Dec 28, 2021
|
|
Neutralization against Omicron SARS-CoV-2 from previous non-Omicron infection
First Author:
Reviewed: Dec 28, 2021
|
|
Dec 28, 2021
|
|
Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
First Author:
Reviewed: Dec 28, 2021
|
|
Dec 28, 2021
|
|
Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
First Author:
Reviewed: Dec 28, 2021
|
|
Dec 28, 2021
|
|
Rapid antigen testing as a reactive response to surges in nosocomial SARS-CoV-2 outbreak risk
First Author:
Reviewed: Dec 28, 2021
|
|
Dec 28, 2021
|
|
SARS-CoV-2 Omicron spike mediated immune escape, infectivity and cell-cell fusion
First Author:
Reviewed: Dec 28, 2021
|
|
Dec 28, 2021
|
|
SARS-CoV-2 Omicron variant replication in human respiratory tract ex vivo
First Author:
Reviewed: Dec 28, 2021
|
|
Dec 28, 2021
|
|
Third COVID-19 Vaccine Dose Boosts Neutralizing Antibodies in Poor Responders
First Author:
Reviewed: Dec 28, 2021
|
|
Dec 28, 2021
|
|
Vaccine effectiveness against SARS-CoV-2 infection with the Omicron or Delta variants following a two-dose or booster BNT162b2 or mRNA-1273 vaccination series: A Danish cohort study
First Author:
Reviewed: Dec 28, 2021
|
|
Dec 28, 2021
|
|
Virus-like particles (VLPs) are efficient tools for boosting mRNA-induced antibodies
First Author:
Reviewed: Dec 28, 2021
|
|
Dec 28, 2021
|
|
Interplay between risk perception, behaviour, and COVID-19 spread
First Author:
Reviewed: Dec 23, 2021
|
|
Dec 23, 2021
|
|
Modeling and predicting the overlap of B- and T-cell receptor repertoires in healthy and SARS-CoV-2 infected individuals
First Author:
Reviewed: Dec 23, 2021
|
|
Dec 23, 2021
|
|
Neutralization and Stability of SARS-CoV-2 Omicron Variant
First Author:
Reviewed: Dec 23, 2021
|
|
Dec 23, 2021
|
|
Reduced sera neutralization to Omicron SARS-CoV-2 by both inactivated and protein subunit vaccines and the convalescents
First Author:
Reviewed: Dec 23, 2021
|
|
Dec 23, 2021
|
|
SARS-COV-2 Omicron variant predicted to exhibit higher affinity to ACE-2 receptor and lower affinity to a large range of neutralizing antibodies, using a rapid computational platform
First Author:
Reviewed: Dec 23, 2021
|
|
Dec 23, 2021
|
|
The rise and fall of SARS-CoV-2 variants and the mutational profile of Omicron
First Author:
Reviewed: Dec 23, 2021
|
|
Dec 23, 2021
|
|
Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel
First Author:
Reviewed: Dec 23, 2021
|
|
Dec 23, 2021
|
|
Variable loss of antibody potency against SARS-CoV-2 B.1.1.529 (Omicron)
First Author:
Reviewed: Dec 23, 2021
|
|
Dec 23, 2021
|
|
A machine learning-based approach to determine infection status in recipients of BBV152 whole virion inactivated SARS-CoV-2 vaccine for serological surveys
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
A recurring YYDRxG pattern in broadly neutralizing antibodies to a conserved site on SARS-CoV-2, variants of concern, and related viruses
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
A Single Dose of COVID-19 mRNA Vaccine Induces Airway Immunity in COVID-19 Convalescent Patients
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
A third vaccination with a single T cell epitope protects against SARS-CoV-2 infection in the absence of neutralizing antibodies
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
Amyloidogenesis of SARS-CoV-2 Spike Protein
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by several therapeutic monoclonal antibodies
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
Antibody Responses to 3rd Dose mRNA Vaccines in Nursing Home and Assisted Living Residents
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
Antibody-mediated Immunogenicity against SARS-CoV-2 following priming, boosting and hybrid immunity: insights from 11 months of follow-up of a healthcare worker cohort in Israel, December 2020-October 2021
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
Antigenic and virological properties of an H3N2 variant that will likely dominate the 2021-2022 Northern Hemisphere influenza season
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
Anti-SARS-CoV-2 cellular immunity in 571 vaccinees assessed using an interferon-γ release assay
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
Benefits of integrated screening and vaccination for infection control
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
Changing of therapeutic trends between the 1st and 2nd wave did not reduce COVID-19 related mortality of renal transplant recipients: a national registry study
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
Comparative evaluation of rapid isothermal amplification and antigen assays for screening testing of SARS-CoV-2
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
Comparison of the Immunogenicity of five COVID-19 vaccines in Sri Lanka
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
COVID-19 endgame: from pandemic to endemic? Vaccination, reopening and evolution in a well-vaccinated population
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
COVID-19 vaccination and Guillain-Barré syndrome: analyses using the National Immunoglobulin Database
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
COVID-19 vaccination, from first dose to booster: New insights into the frequency of most common systemic adverse events and possible booster nocebo effects based on a systematic review
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
Data-Driven Real-Time Strategic Placement of Mobile Vaccine Distribution Sites
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
Distinguishing COVID-19 infection and vaccination history by T cell reactivity
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
Dynamics of anti-Spike IgG antibody level after full BNT162b2 COVID-19 vaccination in health care workers
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
Efficacy of COVID-19 vaccine booster doses in older people
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
Emerging from the COVID-19 pandemic: impacts of variants, vaccines, and duration of immunity
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
Ensovibep, a novel trispecific DARPin candidate that protects against SARS-CoV-2 variants
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
Forecasting COVID-19 infection trends in the EU-27 countries, the UK and Switzerland due to SARS-CoV-2 Variant of Concern Omicron
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
Genomic and Virological Characterization of SARS-CoV-2 Variants in a Subset of Unvaccinated and Vaccinated U.S. Military Personnel
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
Geographic Disparities and Determinants of COVID-19 Incidence Risk in the Greater St. Louis Area, Missouri
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
Identification of a promiscuous conserved CTL epitope within the SARS-CoV-2 spike protein
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
Impacts of vaccination and asymptomatic testing on SARS-CoV-2 transmission dynamics in a university setting
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
Mechanistic Models of COVID-19: Insights into Disease Progression,
Vaccines, and Therapeutics
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
mRNA COVID-19 vaccine effectiveness against SARS-CoV-2 infection in a prospective community cohort, rural Wisconsin, November 2020-December 2021
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
Mutagenic distinction between the receptor-binding and fusion subunits of the SARS-CoV-2 spike glycoprotein and its upshot
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
Persistence of immune response in health care workers after two doses BNT162b2 in a longitudinal observational study
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
Projected epidemiological consequences of the Omicron SARS-CoV-2 variant in England, December 2021 to April 2022
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
Pseudotyped SARS-CoV-2 Omicron variant exhibits significant escape from neutralization induced by a third booster dose of vaccination
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
Rapid Face Mask Detection and Person Identification Model based on Deep
Neural Networks
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
REACT-1 round 15 final report: Increased breakthrough SARS-CoV-2 infections among adults who had received two doses of vaccine, but booster doses and first doses in children are providing important protection
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
- Adults
- Pediatrics/Adolescents
|
Real-world data on immune responses following heterologous prime-boost COVID-19 vaccination schedule with Pfizer and AstraZeneca vaccines in England
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
Safety profile of COVID-19 vaccines in pregnant and postpartum women in brazil
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
Safety, Tolerability and Immunogenicity of Oxford-AstraZeneca ChAdOx1 Vaccine Among Polish School-Teachers
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
SARS-CoV-2 lineage dynamics in England from September to November 2021: high diversity of Delta sub-lineages and increased transmissibility of AY.4.2
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
Side Effects After Vaccination Using the Pfizer-Biontech (Bnt162b2) Against Sars-Cov-2 in the Young Adults
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
Syndromic Surveillance-Based Estimates of Vaccine Efficacy Against COVID-Like Illness from Emerging Omicron and COVID-19 Variants
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
The effect of anti-SARS-CoV-2 monoclonal antibody, bamlanivimab, on endogenous immune response to COVID-19 vaccination
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
The importance of superspreaders on the spread of the global COVID-19 pandemic
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
Waning of mRNA-1273 vaccine effectiveness against SARS-CoV-2 infection in Qatar
First Author:
Reviewed: Dec 22, 2021
|
|
Dec 22, 2021
|
|
A qualitative mathematical model of immunocompetence with applications to SARS-CoV-2 immunity
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
A robust prediction from a minimal model of COVID-19 -- Can we avoid the
third wave?
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
A Structure-based B-cell Epitope Prediction Model Through Combing Local and Global Features
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
Age-specific Contribution of Contacts to Transmission of SARS-CoV-2 in Germany
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
Assessing impact of Omicron on SARS-CoV-2 dynamics and public health burden
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
Booster of mRNA-1273 Vaccine Reduces SARS-CoV-2 Omicron Escape from Neutralizing Antibodies
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
Broad anti-SARS-CoV-2 antibody immunity induced by heterologous ChAdOx1/mRNA-1273 prime-boost vaccination
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
Broad antiviral effects of Echinacea purpurea against SARS-CoV-2 variants of concern and potential mechanism of action
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
Characterization of the significant decline in humoral immune response six months post-SARS-CoV-2 mRNA vaccination: A systematic review
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
CHARM: COVID-19 Health Action Response for Marines – association of antigen-specific interferon-gamma and IL2 responses with asymptomatic and symptomatic infections after a positive qPCR SARS-CoV-2 test
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
Considerable escape of SARS-CoV-2 variant Omicron to antibody neutralization
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
COVID-19 in French Nursing Homes during the Second Pandemic Wave: A Mixed-Methods Cross-Sectional Study
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
COVID-19 vaccine effectiveness against laboratory confirmed symptomatic SARS-CoV-2 infection, COVID-19 related hospitalizations and deaths, among individuals aged 65 years or more in Portugal: a cohort study based on data-linkage of national registries February-September 2021
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
Development and Characterization of Recombinant Vesicular Stomatitis Virus (rVSV)-based Bivalent Vaccine Against COVID-19 Delta Variant and Influenza Virus
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
Durability of mRNA-1273 against COVID-19 in the time of Delta: Interim results from an observational cohort study
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
Echinacea purpurea for the Long-term Prevention of Viral Respiratory Tract Infections during COVID-19 Pandemic: A Randomized, Open, Controlled, Exploratory Clinical Study
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
Effectiveness of COVID-19 vaccines against the Omicron (B.1.1.529) variant of concern
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
Epistatic models predict mutable sites in SARS-CoV-2 proteins and epitopes
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
Evaluation of transplacental transfer of mRNA vaccine products and functional antibodies during pregnancy and early infancy
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
Federated Adaptive Causal Estimation (FACE) of Target Treatment Effects
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
Harmonization of SARS CoV-2 antibodies determination. Is it really possible?
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
High correlation between binding IgG (anti-RBD/S) and neutralizing antibodies against SARS-CoV-2 six months after vaccination
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
High temporal resolution transcriptomic profiling delineates distinct patterns of interferon response following Covid-19 mRNA vaccination and SARS-CoV2 infection
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
Human serum from SARS-CoV-2 vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
Humoral and cellular immune responses and their kinetics vary in dependence of diagnosis and treatment in immunocompromised patients upon COVID-19 mRNA vaccination
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
Immunogenic epitope panel for accurate detection of non-cross-reactive T cell response to SARS-CoV-2
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
Immunogenicity and reactogenicity after booster dose with AZD1222 via intradermal route among adult who had received CoronaVac
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
Improved neutralization of the SARS-CoV-2 Omicron variant after Pfizer-BioNTech BNT162b2 COVID-19 vaccine boosting
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
Interdependencies between cellular and humoral immune responses in heterologous and homologous SARS-CoV-2 vaccination
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
Isolation and Characterization of SARS-CoV-2 strains circulating in Eastern India
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
Isolation and comparative analysis of antibodies that broadly neutralize sarbecoviruses
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
Measuring the impact of COVID-19 vaccination and immunity waning: a modelling study for Portugal
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
Metalloproteinase-dependent and TMPRSS2-independnt cell surface entry pathway of SARS-CoV-2 requires the furin-cleavage site and the S2 domain of spike protein
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
Mucosal and systemic responses to SARS-CoV-2 vaccination in infection naïve and experienced individuals
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
Mutations in RBD of SARS-CoV-2 Omicron variant result stronger binding to human ACE2 protein
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
Neutralization of SARS-CoV-2 Omicron variant by sera from BNT162b2 or Coronavac vaccine recipients
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
Plasma neutralization properties of the SARS-CoV-2 Omicron variant
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
Risk of hospitalization and mortality after breakthrough SARS-CoV-2 infection by vaccine type and previous SARS-CoV-2 infection utilizing medical claims data
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
Safety and immunogenicity of a heterologous booster of protein subunit vaccine MVC-COV1901 after two doses of adenoviral vector vaccine AZD1222
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
SARS-CoV-2 Omicron variant escapes neutralization by vaccinated and convalescent sera and therapeutic monoclonal antibodies
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
SARS-CoV-2 T cell responses are expected to remain robust against Omicron
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
SARS-CoV2 variant-specific replicating RNA vaccines protect from disease and pathology and reduce viral shedding following challenge with heterologous SARS-CoV2 variants of concern
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
Simple decision rules to predict local surges in COVID-19 hospitalizations during the winter and spring of 2022
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
Striking Antibody Evasion Manifested by the Omicron Variant of SARS-CoV-2
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
The age-dependent immunogenicity after two doses of MVC-COV1901 vaccine
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
The Omicron variant is highly resistant against antibody-mediated neutralization – implications for control of the COVID-19 pandemic
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
Third BNT162b2 vaccination neutralization of SARS-CoV-2 Omicron infection
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
Vaccine breakthrough and the invasion dynamics of SARS-CoV-2 variants
First Author:
Reviewed: Dec 20, 2021
|
|
Dec 20, 2021
|
|
A Novel Compartmental Approach to Modeling COVID-19 Disease Dynamics and
Analyzing the Effect of Common Preventative Measures
First Author:
Reviewed: Dec 18, 2021
|
|
Dec 18, 2021
|
|
A Routine Sanger Sequencing Target Specific Mutation Assay For SARS-CoV-2 Variants Of Concern And Interest
First Author:
Reviewed: Dec 18, 2021
|
|
Dec 18, 2021
|
|
A SARS-CoV-2 variant of concern triggers Fc effector function with increased cross-reactivity
First Author:
Reviewed: Dec 18, 2021
|
|
Dec 18, 2021
|
|
A study of the benefits of vaccine mandates and vaccine passports for SARS-CoV-2
First Author:
Reviewed: Dec 18, 2021
|
|
Dec 18, 2021
|
|
Association of COVID-19 vaccination with risks of hospitalization due to cardiovascular and other diseases: A study of the UK Biobank
First Author:
Reviewed: Dec 18, 2021
|
|
Dec 18, 2021
|
|
Case Study of High-Throughput Drug Screening and Remote Data Collection for SARS-CoV-2 Main Protease by Using Serial Femtosecond X-ray Crystallography
First Author:
Reviewed: Dec 18, 2021
|
|
Dec 18, 2021
|
|
Cellular and humoral Immune response to mRNA COVID-19 vaccination in subjects with chronic lymphocytic leukemia
First Author:
Reviewed: Dec 18, 2021
|
|
Dec 18, 2021
|
|
COVID-19 management in social care in England: a systematic review of changing policies and newspaper reported staff perspectives
First Author:
Reviewed: Dec 18, 2021
|
|
Dec 18, 2021
|
|
Determinants of pre-vaccination antibody responses to SARS-CoV-2: a population-based longitudinal study (COVIDENCE UK)
First Author:
Reviewed: Dec 18, 2021
|
|
Dec 18, 2021
|
|
Determining international spread of novel B.1.1.523 SARS-CoV-2 lineage
First Author:
Reviewed: Dec 18, 2021
|
|
Dec 18, 2021
|
|
Durability of anti-Spike antibodies in the infant after maternal COVID-19 vaccination
First Author:
Reviewed: Dec 18, 2021
|
|
Dec 18, 2021
|
|
Effective Mathematical Modelling of Health Passes During a Pandemic
First Author:
Reviewed: Dec 18, 2021
|
|
Dec 18, 2021
|
|
Efficient vaccination strategies to reduce the epidemic mortality in
population with heterogeneous fatality rate
First Author:
Reviewed: Dec 18, 2021
|
|
Dec 18, 2021
|
|
Influence of heterogeneous age-group contact patterns on critical vaccination rates for herd immunity to SARS-CoV-2
First Author:
Reviewed: Dec 18, 2021
|
|
Dec 18, 2021
|
|
Machine Learning Based Prediction of COVID-19 Mortality Suggests Repositioning of Anticancer Drug for Treating Severe Cases
First Author:
Reviewed: Dec 18, 2021
|
|
Dec 18, 2021
|
|
Metadichol®, a Novel Nano Lipid Formulation that Inhibits SARS-COV-2 and a Multitude of Pathological Viruses in vitro
First Author:
Reviewed: Dec 18, 2021
|
|
Dec 18, 2021
|
|
Mobility network reveals the impact of spatial vaccination heterogeneity on COVID‐19
First Author:
Reviewed: Dec 18, 2021
|
|
Dec 18, 2021
|
|
Modelling the Effect of Vaccination and Human Behaviour on the Spread of
Epidemic Diseases on Temporal Networks
First Author:
Reviewed: Dec 18, 2021
|
|
Dec 18, 2021
|
|
Prevalence of Antibodies to SARS-CoV-2 following natural infection and vaccination in Irish Hospital Healthcare Workers; changing epidemiology as the pandemic progresses
First Author:
Reviewed: Dec 18, 2021
|
|
Dec 18, 2021
|
|
Should we Mitigate or Suppress the next Pandemic? Time-Horizons and Costs shape optimal Social Distancing Strategies
First Author:
Reviewed: Dec 18, 2021
|
|
Dec 18, 2021
|
|
Simulating the impact of vaccination rates on the initial stages of a COVID-19 outbreak in New Zealand (Aotearoa) with a stochastic model
First Author:
Reviewed: Dec 18, 2021
|
|
Dec 18, 2021
|
|
Synergistic Anti-SARS-CoV-2 Activity of Repurposed Anti-Parasitic Drug Combinations
First Author:
Reviewed: Dec 18, 2021
|
|
Dec 18, 2021
|
|
The influence of risk perceptions on close contact frequency during the SARS-CoV-2 pandemic
First Author:
Reviewed: Dec 18, 2021
|
|
Dec 18, 2021
|
|
The Role of SARS-CoV-2 Testing on Hospitalizations in California
First Author:
Reviewed: Dec 18, 2021
|
|
Dec 18, 2021
|
|
Vaccine effectiveness against COVID-19 related hospital admission in the Netherlands: a test-negative case-control study
First Author:
Reviewed: Dec 18, 2021
|
|
Dec 18, 2021
|
|
Evaluation of transplacental transfer of mRNA vaccine products and functional antibodies during pregnancy and early infancy
First Author:
Reviewed: Dec 16, 2021
|
|
Dec 16, 2021
|
|
The T cell receptor repertoire reflects the dynamics of the immune response to vaccination
First Author:
Reviewed: Dec 16, 2021
|
|
Dec 16, 2021
|
|
A novel bacterial protease inhibitor adjuvant in RBD-based COVID-19 vaccine formulations increases neutralizing antibodies, specific germinal center B cells and confers protection against SARS-CoV-2 infection
First Author:
Reviewed: Dec 15, 2021
|
|
Dec 15, 2021
|
|
Acceptance and hesitancy to receive COVID-19 vaccine among university students in Egypt: a nationwide survey
First Author:
Reviewed: Dec 15, 2021
|
|
Dec 15, 2021
|
|
Changes in Spike Protein Antibody Titer Over 90 Days after the Second Dose of SARS- CoV-2 Vaccine in Japanese Dialysis Patients
First Author:
Reviewed: Dec 15, 2021
|
|
Dec 15, 2021
|
|
Combinatorial mRNA vaccination enhances protection against SARS-CoV-2 delta variant
First Author:
Reviewed: Dec 15, 2021
|
|
Dec 15, 2021
|
|
Delta breakthrough infections elicit potent, broad and durable neutralizing antibody responses
First Author:
Reviewed: Dec 15, 2021
|
|
Dec 15, 2021
|
|
Emergence of the Delta Variant and risk of SARS-CoV-2 infection in secondary school students and staff: prospective surveillance in 18 schools, England
First Author:
Reviewed: Dec 15, 2021
|
|
Dec 15, 2021
|
|
Estimates of reduced vaccine effectiveness against hospitalization, infection, transmission and symptomatic disease of a new SARS-CoV-2 variant, Omicron (B.1.1.529), using neutralizing antibody titers
First Author:
Reviewed: Dec 15, 2021
|
|
Dec 15, 2021
|
|
Glycolytic inhibitor 2-Deoxy-D-glucose attenuates SARS-CoV-2 multiplication in host cells and weakens the infective potential of progeny virions
First Author:
Reviewed: Dec 15, 2021
|
|
Dec 15, 2021
|
|
In Silico study of Wheatgrass constituents against Coronavirus COVID-19 Proteins.
First Author:
Reviewed: Dec 15, 2021
|
|
Dec 15, 2021
|
|
Interferon Resistance of Emerging SARS-CoV-2 Variants
First Author:
Reviewed: Dec 15, 2021
|
|
Dec 15, 2021
|
|
Mutations in the spike RBD of SARS-CoV-2 omicron variant may increase infectivity without dramatically altering the efficacy of current multi-dosage vaccinations
First Author:
Reviewed: Dec 15, 2021
|
|
Dec 15, 2021
|
|
Neutralizing Antibody Activity Against SARS-CoV-2 Variants in Gestational Age-Matched Mother-Infant Dyads
First Author:
Reviewed: Dec 15, 2021
|
|
Dec 15, 2021
|
|
Predicted Symptomatic Effectiveness of Pfizer-BioNTech BNT162b2 Vaccine Against Omicron Variant of SARS-CoV-2
First Author:
Reviewed: Dec 15, 2021
|
|
Dec 15, 2021
|
|
Reactive vaccination of workplaces and schools against COVID-19
First Author:
Reviewed: Dec 15, 2021
|
|
Dec 15, 2021
|
|
Reduced neutralisation of SARS-COV-2 Omicron-B.1.1.529 variant by post-immunisation serum
First Author:
Reviewed: Dec 15, 2021
|
|
Dec 15, 2021
|
|
Reduced Odds of SARS-CoV-2 Reinfection after Vaccination among New York City Adults, June–August 2021
First Author:
Reviewed: Dec 15, 2021
|
|
Dec 15, 2021
|
|
SARS-CoV-2 B.1.1.529 variant (Omicron) evades neutralization by sera from vaccinated and convalescent individuals
First Author:
Reviewed: Dec 15, 2021
|
|
Dec 15, 2021
|
|
The Point Mutations in SARS-CoV-2 Variants Induce Long-Range Dynamical Perturbations in Neutralizing Antibodies
First Author:
Reviewed: Dec 15, 2021
|
|
Dec 15, 2021
|
|
The prevalence of adaptive immunity to COVID-19 and reinfection after recovery – a comprehensive systematic review and meta-analysis
First Author:
Reviewed: Dec 15, 2021
|
|
Dec 15, 2021
|
|
Cell Surface SARS-CoV-2 Nucleocapsid Protein Modulates Innate and Adaptive Immunity
First Author:
Reviewed: Dec 14, 2021
|
|
Dec 14, 2021
|
|
Dynamical clustering of U.S. states reveals four distinct infection
patterns that predict SARS-CoV-2 pandemic behavior
First Author:
Reviewed: Dec 14, 2021
|
|
Dec 14, 2021
|
|
Evaluation of COVID-19 vaccination websites using DISCERN and Quality Evaluation Scoring (QUEST) Tools
First Author:
Reviewed: Dec 14, 2021
|
|
Dec 14, 2021
|
|
Helminths' antigens differentially modulate the activation of SARS-CoV-2-reactive helper and cytotoxic T cells in COVID-19 patients and healthy blood donors
First Author:
Reviewed: Dec 14, 2021
|
|
Dec 14, 2021
|
|
Homogeneous Surrogate Virus Neutralization Assay to Rapidly Assess Neutralization Activity of Anti-SARS-CoV-2 Antibodies
First Author:
Reviewed: Dec 14, 2021
|
|
Dec 14, 2021
|
|
Vaccination is reasonably effective in limiting the spread of COVID-19 infections, hospitalizations and deaths with COVID-19
First Author:
Reviewed: Dec 14, 2021
|
|
Dec 14, 2021
|
|
An antibody-escape calculator for mutations to the SARS-CoV-2 receptor-binding domain
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
Changes in the trajectory of Long Covid symptoms following COVID-19 vaccination: community-based cohort study
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
Clinical and genomic signatures of rising SARS-CoV-2 Delta breakthrough infections in New York
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
COVID-19 Vaccine Hesitancy Among Patients with Inflammatory Bowel Disease on Biologic Therapies; A cross-sectional study
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
Detection of Antibody Responses against SARS-CoV-2 in Plasma and Saliva from Vaccinated and Infected Individuals
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
Elucidating design principles for engineering cell-derived vesicles to inhibit SARS-CoV-2 infection
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
Estimating the proportion of SARS-CoV-2 infections ascertained through diagnostic testing
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
Evaluating COVID-19 booster vaccination strategies in a partially vaccinated population: a modeling study.
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
Facilitating safe discharge through predicting disease progression in moderate COVID-19: a prospective cohort study to develop and validate a clinical prediction model in resource-limited settings
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
Factors influencing COVID-19 Infection in older individuals: History of Alcohol Use Disorder, Major Depressive illness, genetic variation and current use of alcohol
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
Global disparities in SARS-CoV-2 genomic surveillance
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
High seroconversion rate and SARS-CoV-2 Delta neutralization in PLWHIV vaccinated with BNT162b2
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
Humoral and cellular responses to SARS-CoV-2 vaccination in patients with lymphoid malignancies
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
Individual vaccine efficacy variation with time since mRNA BNT162b2 vaccination estimated by rapid, quantitative antibody measurements from a finger-prick sample
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
In-hospital mortality due to breakthrough COVID-19 among recipients of COVISHIELD (ChAdOx nCoV-19) and COVAXIN (BBV152)
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
Insights on the mutational landscape of the SARS-CoV-2 Omicron variant
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
Intranasal immunization with a vaccinia virus vaccine vector expressing pre-fusion stabilized SARS-CoV-2 spike fully protected mice against lethal challenge with the heavily mutated mouse-adapted SARS2-N501YMA30 strain of SARS-CoV-2
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
Loss of Neutralizing Antibody Response to mRNA Vaccination against SARS-CoV-2 Variants: Differing Kinetics and Strong Boosting by Breakthrough Infection
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
Minimal cross-over between mutations associated with Omicron variant of SARS-CoV-2 and CD8+ T cell epitopes identified in COVID-19 convalescent individuals
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
No evidence of fetal defects or anti-syncytin-1 antibody induction following COVID-19 mRNA vaccination
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
Omicron: A heavily mutated SARS-CoV-2 variant exhibits stronger binding to ACE2 and potently escape approved COVID-19 therapeutic antibodies
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
Opening up safely: public health system requirements for ongoing COVID-19 management based on evaluation of Australia’s surveillance system performance
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
Outbreak of COVID-19 among vaccinated and unvaccinated homeless shelter residents — Sonoma County, California, July 2021
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
Population Optimally Immunized after Accounting for Type-Specific COVID-19 Vaccine Waning Intervals: State-Level Prevalence and Trends
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
Post-Vaccination Symptoms after A Third Dose of mRNA SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Disease
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
Predictive profiling of SARS-CoV-2 variants by deep mutational learning
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
Reduced Neutralization of SARS-CoV-2 Omicron Variant by Vaccine Sera and monoclonal antibodies
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
Relative contribution of leaving home for work or education, transport, shopping and other activities on risk of acquiring COVID-19 infection outside the household in the second wave of the pandemic in England and Wales
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
Safety and Immunogenicity of SARS-CoV-2 S-2P Protein Vaccine MVC-COV1901 in People Living with HIV
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
SARS-CoV-2 attack rate and population immunity in southern New England, March 2020 - May 2021
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
SARS-CoV-2 Transmission and Impacts of Unvaccinated-Only Testing in Populations of Mixed Vaccination Status
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
Significantly elevated antibody levels and neutralization titers in nursing home residents after SARS-CoV-2 BNT162b2 mRNA booster vaccination
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
Simultaneous analysis of antigen-specific B and T cells after SARS-CoV-2 infection and vaccination
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
SIR Modeling the Dual Disaster Impacts of Omicron B.1.1.529 and Natural Disaster Events on Simulated 6 Months (December 2021 – May 2022) Healthcare System Resiliences in Fragile SE Asia Ring of Fire Ecosystems
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
Surveillance of COVID-19 vaccine effectiveness – a real-time case-control study in southern Sweden
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
Systematic review of cardiac adverse effects in children and young people under 18 years of age after SARS-CoV-2 vaccination
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
The cellular characterisation of SARS-CoV-2 spike protein in virus-infected cells using Receptor Binding Domain-binding specific human monoclonal antibodies
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
The challenge of limited vaccine supplies: impact of prior infection on anti-spike IgG antibody trajectories after a single COVID-19 vaccination
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
The influence of new SARS-CoV-2 variant Omicron (B.1.1.529) on vaccine efficacy, its correlation to Delta Variants: a computational approach
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
The Persistence of Natural SARS-CoV-2 Antibodies 12 Months Post COVID-19, a Prospective Cohort Study.
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
The structural role of SARS-CoV-2 genetic background in the emergence and success of spike mutations: the case of the spike A222V mutation
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
The T-cell clonal response to SARS-CoV-2 vaccination in inflammatory bowel disease patients is augmented by anti-TNF therapy and often deficient in antibody-responders
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
Vaccine hesitancy for COVID-19 explored in a phenomic study of 259 socio-cognitive-behavioural measures in the UK-REACH study of 12,431 UK healthcare workers
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
Waning antibody levels after vaccination with mRNA BNT162b2 and inactivated CoronaVac COVID-19 vaccines in Hong Kong blood donors
First Author:
Reviewed: Dec 13, 2021
|
|
Dec 13, 2021
|
|
‘Trained immunity’ from Mycobacterium spp. (environmental or BCG) exposure predicts protection from Coronavirus disease 2019 (COVID-19)
First Author:
Reviewed: Dec 10, 2021
|
|
Dec 10, 2021
|
|
COVID-19 infections post-vaccination by HIV status in the United States
First Author:
Reviewed: Dec 10, 2021
|
|
Dec 10, 2021
|
|
COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutants
First Author:
Reviewed: Dec 10, 2021
|
|
Dec 10, 2021
|
|
Durable T cell responses contrast with faster antibody waning in BNT162b2-vaccinated elderly at 6 month
First Author:
Reviewed: Dec 10, 2021
|
|
Dec 10, 2021
|
|
Investigation of Vaccine Breakthrough Infections by Vaccine strategy during the Delta Variant Wave in France
First Author:
Reviewed: Dec 10, 2021
|
|
Dec 10, 2021
|
|
Modeling the trajectory of SARS-CoV-2 spike protein evolution in continuous latent space using a neural network and Gaussian process
First Author:
Reviewed: Dec 10, 2021
|
|
Dec 10, 2021
|
|
Multimodal Pre-Training Model for Sequence-based Prediction of Protein-Protein Interaction
First Author:
Reviewed: Dec 10, 2021
|
|
Dec 10, 2021
|
|
Predictions of the SARS-CoV-2 Omicron Variant (B.1.1.529) Spike Protein Receptor-Binding Domain Structure and Neutralizing Antibody Interactions
First Author:
Reviewed: Dec 10, 2021
|
|
Dec 10, 2021
|
|
Preserved T-cell Response in anti-CD20 Treated Multiple Sclerosis Patients Following SARS-CoV-2 Vaccination
First Author:
Reviewed: Dec 10, 2021
|
|
Dec 10, 2021
|
|
SARS-CoV-2 Herd Immunity of the Kyrgyz Population in 2021
First Author:
Reviewed: Dec 10, 2021
|
|
Dec 10, 2021
|
|
Seroprevalence of SARS-CoV-2 IgG Antibodies After the Second BNT162b2 mRNA Vaccine in Japanese Kidney Transplant Recipients
First Author:
Reviewed: Dec 10, 2021
|
|
Dec 10, 2021
|
|
A kinetic model considering the decline of antibody level and vaccination of COVID-19
First Author:
Reviewed: Dec 9, 2021
|
|
Dec 9, 2021
|
|
Ad26.COV2.S or BNT162b2 Boosting of BNT162b2 Vaccinated Individuals
First Author:
Reviewed: Dec 9, 2021
|
|
Dec 9, 2021
|
|
B.1.1.529 escapes the majority of SARS-CoV-2 neutralizing antibodies of diverse epitopes
First Author:
Reviewed: Dec 9, 2021
|
|
Dec 9, 2021
|
|
Cellular and humoral responses to SARS-CoV-2 vaccination in immunosuppressed patients
First Author:
Reviewed: Dec 9, 2021
|
|
Dec 9, 2021
|
|
Comparative magnitude and persistence of SARS-CoV-2 vaccination responses on a population level in Germany
First Author:
Reviewed: Dec 9, 2021
|
|
Dec 9, 2021
|
|
Epidemiology of myocarditis and pericarditis following mRNA vaccines in Ontario, Canada: by vaccine product, schedule and interval
First Author:
Reviewed: Dec 9, 2021
|
|
Dec 9, 2021
|
|
Glycosylation as a key for enhancing drug recognition into spike glycoprotein of SARS-CoV-2
First Author:
Reviewed: Dec 9, 2021
|
|
Dec 9, 2021
|
|
Guillain-Barré Syndrome after COVID-19 Vaccination in the Vaccine Safety Datalink
First Author:
Reviewed: Dec 9, 2021
|
|
Dec 9, 2021
|
|
Healthcare worker risk of COVID-19: A 20-month analysis of protective measures from vaccination and beyond
First Author:
Reviewed: Dec 9, 2021
|
|
Dec 9, 2021
|
|
Impact of individual-level characteristics and transmission mitigation behaviors on SARS-CoV-2 infection and seroprevalence in a large Northern California Bay Area cohort
First Author:
Reviewed: Dec 9, 2021
|
|
Dec 9, 2021
|
|
Indirect Impact of COVID-19 Vaccination on Weekly Trends in Morbidity and Mortality Indicators in Brazil, 2020 to 2021
First Author:
Reviewed: Dec 9, 2021
|
|
Dec 9, 2021
|
|
Introduction and community transmission of SARS-CoV-2 lineage A.2.5 in Florida with novel spike INDELS
First Author:
Reviewed: Dec 9, 2021
|
|
Dec 9, 2021
|
|
Long Term Humoral Immunity Decline in Hemodialysis Patients Following SARS-CoV-2 Vaccination
First Author:
Reviewed: Dec 9, 2021
|
|
Dec 9, 2021
|
|
Longitudinal study of DNA methylation and epigenetic clocks prior to and following test-confirmed COVID-19 and mRNA vaccination
First Author:
Reviewed: Dec 9, 2021
|
|
Dec 9, 2021
|
|
Mucosal memory T cells in breastmilk are modulated by SARS-CoV-2 mRNA vaccination
First Author:
Reviewed: Dec 9, 2021
|
|
Dec 9, 2021
|
|
Neutralising reactivity against SARS-CoV-2 B.1.617.2 (Delta) variant by vaccination status and pre-exposure
First Author:
Reviewed: Dec 9, 2021
|
|
Dec 9, 2021
|
|
Post-Translational Modifications Optimize the Ability of SARS-CoV-2 Spike for Effective Interaction with Host Cell Receptors
First Author:
Reviewed: Dec 9, 2021
|
|
Dec 9, 2021
|
|
Protection and waning of natural and hybrid COVID-19 immunity
First Author:
Reviewed: Dec 9, 2021
|
|
Dec 9, 2021
|
|
S glycoprotein diversity of the Omicron Variant
First Author:
Reviewed: Dec 9, 2021
|
|
Dec 9, 2021
|
|
Safety and immunogenicity of the third booster dose with inactivated, viral vector, and mRNA COVID-19 vaccines in fully immunized healthy adults with inactivated vaccine
First Author:
Reviewed: Dec 9, 2021
|
|
Dec 9, 2021
|
|
Single immunization with recombinant ACAM2000 vaccinia viruses expressing the spike and the nucleocapsid proteins protect hamsters against SARS-CoV-2 caused clinical disease
First Author:
Reviewed: Dec 9, 2021
|
|
Dec 9, 2021
|
|
The reactogenicity and immunogenicity of a booster dose after the second dose of a protein subunit vaccine MVC-COV1901
First Author:
Reviewed: Dec 9, 2021
|
|
Dec 9, 2021
|
|
Underlying co morbidity reveals unique immune signatures in Type II diabetes patients infected with SARS-CoV2
First Author:
Reviewed: Dec 9, 2021
|
|
Dec 9, 2021
|
|
Viral replication dynamics could critically modulate vaccine
effectiveness and should be accounted for when assessing new SARS-CoV-2
variants
First Author:
Reviewed: Dec 9, 2021
|
|
Dec 9, 2021
|
|
Worldwide routine immunisation coverage regressed during the first year of the COVID-19 pandemic
First Author:
Reviewed: Dec 9, 2021
|
|
Dec 9, 2021
|
|
A public antibody class recognizes a novel S2 epitope exposed on open conformations of SARS-CoV-2 spike
First Author:
Reviewed: Dec 8, 2021
|
|
Dec 8, 2021
|
|
Commitment to protective measures during COVID-19 pandemic in Syria: a nationwide cross-sectional study.
First Author:
Reviewed: Dec 8, 2021
|
|
Dec 8, 2021
|
|
Efficacy and Safety of Ayush-64 as standalone or adjunct to standard care in COVID-19: A Structured Summary of Protocol for a Systematic Review
First Author:
Reviewed: Dec 8, 2021
|
|
Dec 8, 2021
|
|
High viral loads: what drives fatal cases of COVID-19 in vaccinees? – an autopsy study
First Author:
Reviewed: Dec 8, 2021
|
|
Dec 8, 2021
|
|
Influence of Covid-19 Vaccination Coverage on Case Fatality Rate
First Author:
Reviewed: Dec 8, 2021
|
|
Dec 8, 2021
|
|
Omicron and Delta Variant of SARS-CoV-2: A Comparative Computational Study of Spike protein
First Author:
Reviewed: Dec 8, 2021
|
|
Dec 8, 2021
|
|
Possible Interference in Protein – Protein interaction as a new approach in microinhibition of respiratory pathogens on nasal– oral epithelium: An early on-screen study with reference toSARS-Cov-2–ACE2 binding interference
First Author:
Reviewed: Dec 8, 2021
|
|
Dec 8, 2021
|
|
SARS-CoV-2 incidence, transmission and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-2021
First Author:
Reviewed: Dec 8, 2021
|
|
Dec 8, 2021
|
|
Systems immune profiling of variant-specific vaccination against SARS-CoV-2
First Author:
Reviewed: Dec 8, 2021
|
|
Dec 8, 2021
|
|
A New Rapid Test to End COVID
First Author:
Reviewed: Dec 7, 2021
|
|
Dec 7, 2021
|
|
Compartmental and cellular automaton $SEIRS$ epidemiology models for the
COVID-19 pandemic with the effects of temporal immunity and vaccination
First Author:
Reviewed: Dec 7, 2021
|
|
Dec 7, 2021
|
|
COVID-19 Waves: Variant Dynamics and Control
First Author:
Reviewed: Dec 7, 2021
|
|
Dec 7, 2021
|
|
Evaluating COVID-19 booster vaccination strategies in a partially vaccinated population: a modeling study
First Author:
Reviewed: Dec 7, 2021
|
|
Dec 7, 2021
|
|
Humoral responses following SARS-CoV-2 breakthrough infection in COVID-19 vaccinated individuals
First Author:
Reviewed: Dec 7, 2021
|
|
Dec 7, 2021
|
|
Increased risk of SARS-CoV-2 reinfection associated with emergence of the Omicron variant in South Africa
First Author:
Reviewed: Dec 7, 2021
|
|
Dec 7, 2021
|
|
Infection Fatality Rate and Infection Attack Rate of COVID-19 in South American Countries
First Author:
Reviewed: Dec 7, 2021
|
|
Dec 7, 2021
|
|
Third COVID-19 Vaccine Dose Boosts Neutralising Antibodies in Poor Responders
First Author:
Reviewed: Dec 7, 2021
|
|
Dec 7, 2021
|
|
VacSIM: Learning Effective Strategies for COVID-19 Vaccine Distribution
using Reinforcement Learning
First Author:
Reviewed: Dec 7, 2021
|
|
Dec 7, 2021
|
|
A human monoclonal antibody potently pan-neutralizes SARS-CoV-2 VOCs by targeting RBD invariant sites
First Author:
Reviewed: Dec 6, 2021
|
|
Dec 6, 2021
|
|
A recombinant SARS-CoV-2 RBD antigen expressed in insect cells elicits immunogenicity and confirms safety in animal models
First Author:
Reviewed: Dec 6, 2021
|
|
Dec 6, 2021
|
|
Broad human and animal coronavirus neutralisation by SARS-CoV-2 S2-targeted vaccination
First Author:
Reviewed: Dec 6, 2021
|
|
Dec 6, 2021
|
|
Different formulations of inactivated SARS-CoV-2 vaccine candidates in human compatible adjuvants: Potency studies in mice showed different platforms of immune responses
First Author:
Reviewed: Dec 6, 2021
|
|
Dec 6, 2021
|
|
Differential neutralization and inhibition of SARS-CoV-2 variants by antibodies elicited by COVID-19 mRNA vaccines
First Author:
Reviewed: Dec 6, 2021
|
|
Dec 6, 2021
|
|
Effectiveness and durability of protection against future SARS-CoV-2 infection conferred by COVID-19 vaccination and previous infection; findings from the UK SIREN prospective cohort study of healthcare workers March 2020 to September 2021
First Author:
Reviewed: Dec 6, 2021
|
|
Dec 6, 2021
|
|
Effectiveness of a third dose of BNT162b2 or mRNA-1273 vaccine for preventing post-vaccination COVID-19 infection: an observational study
First Author:
Reviewed: Dec 6, 2021
|
|
Dec 6, 2021
|
|
Effectiveness of COVID-19 vaccines against delta variant (B.1.617.2): A meta-analysis
First Author:
Reviewed: Dec 6, 2021
|
|
Dec 6, 2021
|
|
Heterologous Vaccination with SARS-CoV-2 Spike saRNA Prime followed by DNA Dual-Antigen Boost Induces Robust Antibody and T-Cell Immunogenicity against both Wild Type and Delta Spike as well as Nucleocapsid Antigens
First Author:
Reviewed: Dec 6, 2021
|
|
Dec 6, 2021
|
|
Identification of susceptibility loci for adverse events following COVID-19 vaccination in the Japanese population: A web-based genome-wide association study
First Author:
Reviewed: Dec 6, 2021
|
|
Dec 6, 2021
|
|
Main protease mutants of SARS-CoV-2 variants remain susceptible to PF-07321332
First Author:
Reviewed: Dec 6, 2021
|
|
Dec 6, 2021
|
|
Protective immunity of the primary SARS-CoV-2 infection reduces disease severity post re-infection with Delta variants in Syrian hamsters
First Author:
Reviewed: Dec 6, 2021
|
|
Dec 6, 2021
|
|
Safety, tolerability, and immunogenicity of a SARS-CoV-2 recombinant spike protein vaccine: a randomised, double-blind, placebo-controlled, phase 1-2 clinical trial (ABDALA Study)
First Author:
Reviewed: Dec 6, 2021
|
|
Dec 6, 2021
|
|
SARS-CoV-2 Delta derivatives impact on neutralization of Covishield recipient sera
First Author:
Reviewed: Dec 6, 2021
|
|
Dec 6, 2021
|
|
SARS-CoV-2 genomic monitoring in the São Paulo State unveils new sublineages of the AY.43 strain
First Author:
Reviewed: Dec 6, 2021
|
|
Dec 6, 2021
|
|
SARS-CoV-2 variants impact RBD conformational dynamics and ACE2 accessibility
First Author:
Reviewed: Dec 6, 2021
|
|
Dec 6, 2021
|
|
SARS-CoV-2 Virus like Particles produced by a single recombinant baculovirus generate potent neutralizing antibody that protects against variant challenge
First Author:
Reviewed: Dec 6, 2021
|
|
Dec 6, 2021
|
|
Use of heat-not-burn tobacco products, moderate alcohol drinking, and anti-SARS-CoV-2 IgG antibody titers after BNT162b2 vaccination among Japanese healthcare workers
First Author:
Reviewed: Dec 6, 2021
|
|
Dec 6, 2021
|
|
Anticipating future SARS-CoV-2 variants of concern through ab initio quantum mechanical modeling
First Author:
Reviewed: Dec 3, 2021
|
|
Dec 3, 2021
|
|
Incorporating the mutational landscape of SARS-COV-2 variants and case-dependent vaccination rates into epidemic models
First Author:
Reviewed: Dec 3, 2021
|
|
Dec 3, 2021
|
|
Inferring Risks of Coronavirus Transmission from Community Household
Data
First Author:
Reviewed: Dec 3, 2021
|
|
Dec 3, 2021
|
|
LDA2Net: Digging under the surface of COVID-19 topics in scientific
literature
First Author:
Reviewed: Dec 3, 2021
|
|
Dec 3, 2021
|
|
Mathematical modelling of SARS-CoV-2 variant outbreaks reveals their probability of extinction
First Author:
Reviewed: Dec 3, 2021
|
|
Dec 3, 2021
|
|
Modelling the effect of the interaction between vaccination and non-pharmaceutical measures on COVID-19 incidence
First Author:
Reviewed: Dec 3, 2021
|
|
Dec 3, 2021
|
|
Omicron (B.1.1.529): Infectivity, vaccine breakthrough, and antibody
resistance
First Author:
Reviewed: Dec 3, 2021
|
|
Dec 3, 2021
|
|
Prioritizing interventions for preventing COVID-19 outbreaks in military basic training
First Author:
Reviewed: Dec 3, 2021
|
|
Dec 3, 2021
|
|
Seroconversion following the first, second, and third dose of SARS-CoV-2 vaccines in immunocompromised population; A systematic review and meta-analysis
First Author:
Reviewed: Dec 3, 2021
|
|
Dec 3, 2021
|
|
A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the delta variant in kidney transplant recipients
First Author:
Reviewed: Dec 2, 2021
|
|
Dec 2, 2021
|
|
Dendritic cell targeting virus-like particle delivers mRNA for in vivo immunization
First Author:
Reviewed: Dec 2, 2021
|
|
Dec 2, 2021
|
|
Development and Implementation of Dried Blood Spot-based COVID-19 Serological Assays for Epidemiologic Studies
First Author:
Reviewed: Dec 2, 2021
|
|
Dec 2, 2021
|
|
Dosing interval strategies for two-dose COVID-19 vaccination in 13 low- and middle-income countries of Europe: health impact modelling and benefit-risk analysis
First Author:
Reviewed: Dec 2, 2021
|
|
Dec 2, 2021
|
|
First detection of SARS-CoV-2 B.1.617.2 (Delta) variant of concern in a symptomatic cat in Spain
First Author:
Reviewed: Dec 2, 2021
|
|
Dec 2, 2021
|
|
Modelling the interplay of SARS-CoV-2 variants in the United Kingdom
First Author:
Reviewed: Dec 2, 2021
|
|
Dec 2, 2021
|
|
SARS-Cov 2 infection and anti-tuberculosis immunity: temporal association or real protective role?
First Author:
Reviewed: Dec 2, 2021
|
|
Dec 2, 2021
|
|
The immunogenicity and safety of different COVID-19 booster vaccination following CoronaVac or ChAdOx1 nCoV-19 primary series
First Author:
Reviewed: Dec 2, 2021
|
|
Dec 2, 2021
|
|
Vaccination as an Alternative to Non-Drug Interventions to Prevent Local Resurgence of COVID-19
First Author:
Reviewed: Dec 2, 2021
|
|
Dec 2, 2021
|
|
Anatomy of the first six months of COVID-19 Vaccination Campaign in Italy
First Author:
Reviewed: Dec 1, 2021
|
|
Dec 1, 2021
|
|
Appropriate relaxation of non-pharmaceutical interventions minimizes the risk of a resurgence in SARS-CoV-2 infections in spite of the Delta variant
First Author:
Reviewed: Dec 1, 2021
|
|
Dec 1, 2021
|
|
Axillary Adenopathy Secondary to SARS-CoV-2 Vaccination: a Case Report
First Author:
Reviewed: Dec 1, 2021
|
|
Dec 1, 2021
|
|
COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: two prospective observational cohort studies
First Author:
Reviewed: Dec 1, 2021
|
|
Dec 1, 2021
|
|
Covid-19 vaccination coverage and break through infections in urban slums of Bengaluru, India: A cross sectional study
First Author:
Reviewed: Dec 1, 2021
|
|
Dec 1, 2021
|
|
COVID-19 vaccination uptake strongly predicts averted deaths of older people across Europe
First Author:
Reviewed: Dec 1, 2021
|
|
Dec 1, 2021
|
|
Effect of Gender, Age and Vaccine on Reactogenicity and Incapacity to Work after COVID-19 Vaccination: A Survey among Health Care Workers
First Author:
Reviewed: Dec 1, 2021
|
|
Dec 1, 2021
|
|
High Burden of COVID-19 among Unvaccinated Law Enforcement Officers and Firefighters
First Author:
Reviewed: Dec 1, 2021
|
|
Dec 1, 2021
|
|
New Onset Focal Seizure Following COVID-19 Vaccination: Case Report
First Author:
Reviewed: Dec 1, 2021
|
|
Dec 1, 2021
|
|
Online Causal Inference with Application to Near Real-Time Post-Market
Vaccine Safety Surveillance
First Author:
Reviewed: Dec 1, 2021
|
|
Dec 1, 2021
|
|
Primary COVID-19 vaccine cycle and booster doses efficacy: analysis of Italian nationwide vaccination campaign
First Author:
Reviewed: Dec 1, 2021
|
|
Dec 1, 2021
|
|
Rapid evaluation of COVID-19 vaccine effectiveness against VOC/VOIs by genetic mismatch
First Author:
Reviewed: Dec 1, 2021
|
|
Dec 1, 2021
|
|
Recombinant neutralizing secretory IgA antibodies for preventing mucosal carriage and transmission of SARS-CoV-2
First Author:
Reviewed: Dec 1, 2021
|
|
Dec 1, 2021
|
|
Safety of Pfizer-BioNTech COVID-19 mRNA Vaccine in the Elderly
First Author:
Reviewed: Dec 1, 2021
|
|
Dec 1, 2021
|
|
SARS-CoV-2 Convalescent Sera Binding and Neutralizing Antibody Concentrations Compared with COVID-19 Vaccine Efficacy Estimates Against Symptomatic Infection
First Author:
Reviewed: Dec 1, 2021
|
|
Dec 1, 2021
|
|
Tracking SARS-COV-2 Variants Using Nanopore Sequencing in Ukraine in Summer 2021
First Author:
Reviewed: Dec 1, 2021
|
|
Dec 1, 2021
|
|
Synergetic measures needed to control infection waves and contain SARS-CoV-2 transmission
First Author:
Reviewed: Nov 30, 2021
|
|
Nov 30, 2021
|
|
A modified porous silicon microparticle promotes mucosal delivery of SARS-CoV-2 antigen and induction of potent and durable systemic and mucosal T helper 1 skewed protective immunity
First Author:
Reviewed: Nov 29, 2021
|
|
Nov 29, 2021
|
|
A RANDOMIZED CLINICAL TRIAL OF 2-WEEK METHOTREXATE DISCONTINUATION IN RHEUMATOID ARTHRITIS PATIENTS VACCINATED WITH INACTIVATED SARS-COV-2 VACCINE
First Author:
Reviewed: Nov 29, 2021
|
|
Nov 29, 2021
|
|
An immune correlate of SARS-CoV-2 infection and severity of reinfections
First Author:
Reviewed: Nov 29, 2021
|
|
Nov 29, 2021
|
|
Characterization of SARS-CoV-2 public CD4+ αβ T cell clonotypes through reverse epitope discovery
First Author:
Reviewed: Nov 29, 2021
|
|
Nov 29, 2021
|
|
Characterization of the immune resistance of SARS-CoV-2 Mu variant and the immunity induced by Mu infection
First Author:
Reviewed: Nov 29, 2021
|
|
Nov 29, 2021
|
|
Coronavirus Resistance Database (CoV-RDB): SARS-CoV-2 susceptibility to monoclonal antibodies, convalescent plasma, and plasma from vaccinated persons
First Author:
Reviewed: Nov 29, 2021
|
|
Nov 29, 2021
|
|
COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination
First Author:
Reviewed: Nov 29, 2021
|
|
Nov 29, 2021
|
|
COVID-19 vaccination and menstrual cycle changes: A United Kingdom (UK) retrospective case-control study
First Author:
Reviewed: Nov 29, 2021
|
|
Nov 29, 2021
|
|
Effectiveness of BNT162b2 and ChAdOx1 against SARS-CoV-2 household transmission: a prospective cohort study in England
First Author:
Reviewed: Nov 29, 2021
|
|
Nov 29, 2021
|
|
Factors associated with COVID-19 vaccine acceptance and hesitancy among residents of Northern California jails
First Author:
Reviewed: Nov 29, 2021
|
|
Nov 29, 2021
|
|
Genome-wide characterization of SARS-CoV-2 cytopathogenic proteins in the search of antiviral targets
First Author:
Reviewed: Nov 29, 2021
|
|
Nov 29, 2021
|
|
Germany’s low SARS-CoV-2 seroprevalence confirms effective containment in 2020: Results of the nationwide RKI-SOEP study
First Author:
Reviewed: Nov 29, 2021
|
|
Nov 29, 2021
|
|
In vitro, classical complement activation differs by disease severity and between SARS-CoV-2 antigens
First Author:
Reviewed: Nov 29, 2021
|
|
Nov 29, 2021
|
|
Increased risk of infection with SARS-CoV-2 Beta, Gamma, and Delta variant compared to Alpha variant in vaccinated individuals
First Author:
Reviewed: Nov 29, 2021
|
|
Nov 29, 2021
|
|
Invariant in variants
First Author:
Reviewed: Nov 29, 2021
|
|
Nov 29, 2021
|
|
Investigating SARS-CoV-2 breakthrough infections per variant and vaccine type
First Author:
Reviewed: Nov 29, 2021
|
|
Nov 29, 2021
|
|
Neutralization of SARS-CoV-2 variants by rVSV-ΔG-spike-elicited human sera
First Author:
Reviewed: Nov 29, 2021
|
|
Nov 29, 2021
|
|
Pausing methotrexate improves immunogenicity of COVID-19 vaccination in patients with rheumatic diseases
First Author:
Reviewed: Nov 29, 2021
|
|
Nov 29, 2021
|
|
Preclinical efficacy, safety, and immunogenicity of PHH-1V, a second-generation COVID-19 vaccine candidate based on a novel recombinant RBD fusion heterodimer of SARS-CoV-2
First Author:
Reviewed: Nov 29, 2021
|
|
Nov 29, 2021
|
|
Projecting the transition of COVID-19 burden towards the young population while vaccines are rolled out: a modelling study
First Author:
Reviewed: Nov 29, 2021
|
|
Nov 29, 2021
|
|
Reactogenicity of COVID-19 vaccine in hemodialysis patients: a single-center retrospective study
First Author:
Reviewed: Nov 29, 2021
|
|
Nov 29, 2021
|
|
Recurring Spatiotemporal Patterns of COVID-19 in the United States
First Author:
Reviewed: Nov 29, 2021
|
|
Nov 29, 2021
|
|
Reinfection with SARS-CoV-2: outcome, risk factors and vaccine efficacy in a Scottish cohort
First Author:
Reviewed: Nov 29, 2021
|
|
Nov 29, 2021
|
|
Serological responses to COVID-19 booster vaccine in England
First Author:
Reviewed: Nov 29, 2021
|
|
Nov 29, 2021
|
|
Stabilization of the SARS-CoV-2 Receptor Binding Domain by Protein Core Redesign and Deep Mutational Scanning
First Author:
Reviewed: Nov 29, 2021
|
|
Nov 29, 2021
|
|
Test-trace-isolate-quarantine (TTIQ) intervention strategies after symptomatic COVID-19 case identification
First Author:
Reviewed: Nov 29, 2021
|
|
Nov 29, 2021
|
|
The Failures of an Ideal COVID-19 Vaccine: A Simulation Study
First Author:
Reviewed: Nov 29, 2021
|
|
Nov 29, 2021
|
|
Vaccination strategies in structured populations under partial immunity and reinfection
First Author:
Reviewed: Nov 29, 2021
|
|
Nov 29, 2021
|
|
Case Series of Thrombosis with Thrombocytopenia Syndrome following COVID-19 vaccination—United States, December 2020–August 2021
First Author:
Reviewed: Nov 26, 2021
|
|
Nov 26, 2021
|
|
Cost-effectiveness analysis of BNT162b2 COVID-19 booster vaccination in the United States
First Author:
Reviewed: Nov 26, 2021
|
|
Nov 26, 2021
|
|
Finger stick blood test to assess post vaccination SARS-CoV-2 neutralizing antibody response against variants
First Author:
Reviewed: Nov 26, 2021
|
|
Nov 26, 2021
|
|
Maternal immune response and placental antibody transfer after COVID-19 vaccination across trimester and platforms
First Author:
Reviewed: Nov 26, 2021
|
|
Nov 26, 2021
|
|
Using high-resolution contact networks to evaluate SARS-CoV-2 transmission and control in large-scale multi-day events
First Author:
Reviewed: Nov 26, 2021
|
|
Nov 26, 2021
|
|
Antibody titers before and after booster doses of SARS-CoV-2 mRNA vaccines in healthy adults
First Author:
Reviewed: Nov 25, 2021
|
|
Nov 25, 2021
|
|
Anti-SARS-CoV-2 immunogenicity decay and incident cases six months after Sinovac-CoronaVac inactivated vaccine in autoimmune rheumatic diseases patients: phase 4 prospective trial
First Author:
Reviewed: Nov 25, 2021
|
|
Nov 25, 2021
|
|
Comprehensive genomic, immunological and clinical analysis of COVID-19 vaccine breakthrough infections: a prospective, comparative cohort study
First Author:
Reviewed: Nov 25, 2021
|
|
Nov 25, 2021
|
|
Effectiveness of Vaccination against Reported SARS-CoV-2 Infection in United States Coast Guard Personnel between May and August 2021: A Time-Series Analysis
First Author:
Reviewed: Nov 25, 2021
|
|
Nov 25, 2021
|
|
Healthcare workers benefit from second dose of COVID-19 mRNA vaccine: Effects of partial and full vaccination on sick leave duration and symptoms
First Author:
Reviewed: Nov 25, 2021
|
|
Nov 25, 2021
|
|
HLA-A*03:01 is associated with increased risk of fever, chills, and more severe reaction to Pfizer-BioNTech COVID-19 vaccination
First Author:
Reviewed: Nov 25, 2021
|
|
Nov 25, 2021
|
|
Immunogenicity of heterologous prime/boost inactivated and mRNA COVID-19 vaccine
First Author:
Reviewed: Nov 25, 2021
|
|
Nov 25, 2021
|
|
Limited immune responses after three months of BNT162b2 vaccine in SARS-CoV-2 uninfected elders living in long-term care facilities
First Author:
Reviewed: Nov 25, 2021
|
|
Nov 25, 2021
|
|
Longitudinal analysis of antibody trajectories and humoral responses to a third dose of mRNA vaccines against SARS-CoV-2 in patients with a history of anti-CD20 therapy (RituxiVac 2.0)
First Author:
Reviewed: Nov 25, 2021
|
|
Nov 25, 2021
|
|
Modelling optimal vaccination strategies against Covid-19 in a context of Gamma variant predominance in Brazil
First Author:
Reviewed: Nov 25, 2021
|
|
Nov 25, 2021
|
|
mRNA COVID-19 vaccines induce enhanced antibody and cellular responses compared to ChAdOx1 or natural infection in children
First Author:
Reviewed: Nov 25, 2021
|
|
Nov 25, 2021
|
|
Myocarditis and Pericarditis following COVID-19 Vaccination: Rapid Systematic Review of Incidence, Risk Factors, and Clinical Course
First Author:
Reviewed: Nov 25, 2021
|
|
Nov 25, 2021
|
|
Protective characteristics of COVID-19 convalescent and post-vaccination IgG antibodies
First Author:
Reviewed: Nov 25, 2021
|
|
Nov 25, 2021
|
|
Transmission of B.1.617.2 Delta Variant between vaccinated healthcare workers
First Author:
Reviewed: Nov 25, 2021
|
|
Nov 25, 2021
|
|
A Cost-Benefit Analysis of COVID-19 Vaccination in Catalonia
First Author:
Reviewed: Nov 24, 2021
|
|
Nov 24, 2021
|
|
Humoral immune response after COVID-19 infection or BNT162b2 vaccine among older adults: evolution over time and protective thresholds
First Author:
Reviewed: Nov 24, 2021
|
|
Nov 24, 2021
|
|
Identification of vaccine effects when exposure status is unknown
First Author:
Reviewed: Nov 24, 2021
|
|
Nov 24, 2021
|
|
Low neutralizing antibody titers against the Mu variant of SARS-CoV-2 in BNT162b2 vaccinated individuals
First Author:
Reviewed: Nov 24, 2021
|
|
Nov 24, 2021
|
|
Monitoring of SARS-CoV-2 Antibodies Using Dried Blood Spot for At-Home Collection
First Author:
Reviewed: Nov 24, 2021
|
|
Nov 24, 2021
|
|
Pro-Vaccination Attitude and Associated Factors Towards COVID-19 Vaccine among Healthcare Workers and Nonhealthcare Workers: “A Call for Action”-A Systematic Review
First Author:
Reviewed: Nov 24, 2021
|
|
Nov 24, 2021
|
|
Transmission potential of vaccinated and unvaccinated persons infected with the SARS-CoV-2 Delta variant in a federal prison, July—August 2021
First Author:
Reviewed: Nov 24, 2021
|
|
Nov 24, 2021
|
|
Uptake of Covid-19 vaccines among frontline workers in California state prisons
First Author:
Reviewed: Nov 24, 2021
|
|
Nov 24, 2021
|
|
Reduced Incidence of Long-COVID Symptoms Related to Administration of COVID-19 Vaccines Both Before COVID-19 Diagnosis and Up to 12 Weeks After
First Author:
Reviewed: Nov 23, 2021
|
|
Nov 23, 2021
|
|
Vaccine Search Patterns Provide Insights into Vaccination Intent
First Author:
Reviewed: Nov 23, 2021
|
|
Nov 23, 2021
|
|
A 500,000-Person Experiment Evaluating the Impact of Geographically-Targeted, High-Payoff Vaccine Lotteries
First Author:
Reviewed: Nov 22, 2021
|
|
Nov 22, 2021
|
|
A booster dose of an inactivated vaccine increases neutralizing antibodies and T cell responses against SARS-CoV-2
First Author:
Reviewed: Nov 22, 2021
|
|
Nov 22, 2021
|
|
A live attenuated influenza virus-vectored intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2 infection
First Author:
Reviewed: Nov 22, 2021
|
|
Nov 22, 2021
|
|
A Re-Analysis of EU’s COVID-19 Vaccine Procurement Strategy in View of the An-Ticipated Cost-effectiveness of Vaccination
First Author:
Reviewed: Nov 22, 2021
|
|
Nov 22, 2021
|
|
Assessment of breakthrough infections among post-vaccinated healthcare workers in a Tertiary Dental Hospital in New Delhi, India
First Author:
Reviewed: Nov 22, 2021
|
|
Nov 22, 2021
|
|
Attenuation of antibody titres during 3-6 months after the second dose of the BNT162b2 vaccine depends on sex, with age and smoking as risk factors for lower antibody titres at 6 months
First Author:
Reviewed: Nov 22, 2021
|
|
Nov 22, 2021
|
|
Comparative analysis of antibody production by mRNA 1273, AZD 1222 and BBIBP-CorV on elderly people suffering from different co-morbidity in Bangladesh
First Author:
Reviewed: Nov 22, 2021
|
|
Nov 22, 2021
|
|
Comparative effectiveness and safety of homologous two-dose ChAdOx1 versus heterologous vaccination with ChAdOx1 and BNT162b2: a cohort analysis
First Author:
Reviewed: Nov 22, 2021
|
|
Nov 22, 2021
|
|
Continued Effectiveness of COVID-19 Vaccination among Urban Healthcare Workers during Delta Variant Predominance
First Author:
Reviewed: Nov 22, 2021
|
|
Nov 22, 2021
|
|
Could the candidate causal gene (LZTFL1) identified by Oxford University scientists, which doubles the risk of COVID-19-related respiratory failure, be used to boost the Weak immunogenicity of COVID-19 mRNA vaccines in patients with B-cell chronic lymphocytic leukemia (CLL)???. A double edged sward
First Author:
Reviewed: Nov 22, 2021
|
|
Nov 22, 2021
|
|
COVID-19 first and delta waves in relation to ACEI, ARB, Influenza vaccination, and comorbidity in a North Metropolitan Barcelona Health Consortium
First Author:
Reviewed: Nov 22, 2021
|
|
Nov 22, 2021
|
|
COVID-19 in the Republic of Belarus: pandemic features and the interim safety and efficacy assessment of the Gam-COVID-Vac vaccine
First Author:
Reviewed: Nov 22, 2021
|
|
Nov 22, 2021
|
|
COVID-19 vaccination, risk-compensatory behaviours, and contacts in the UK
First Author:
Reviewed: Nov 22, 2021
|
|
Nov 22, 2021
|
|
COVID-19 Vaccine Acceptance and Hesitancy among Singaporean Primary Healthcare Workers
First Author:
Reviewed: Nov 22, 2021
|
|
Nov 22, 2021
|
|
Effectiveness of BNT162b2 (Comirnaty, Pfizer-BioNTech) COVID-19 booster vaccine against covid-19 related symptoms in England: test negative case-control study
First Author:
Reviewed: Nov 22, 2021
|
|
Nov 22, 2021
|
|
Full protection against all four SARS-CoV-2 variants of concern (VOC) in hamsters requires revision of spike antigen used for vaccination
First Author:
Reviewed: Nov 22, 2021
|
|
Nov 22, 2021
|
|
Impact of SARS-CoV-2 Vaccines on Covid-19 Incidence and Mortality in the United States
First Author:
Reviewed: Nov 22, 2021
|
|
Nov 22, 2021
|
|
Inactivated virus vaccine BBV152/Covaxin elicits robust cellular immune memory to SARS-CoV-2 and variants of concern
First Author:
Reviewed: Nov 22, 2021
|
|
Nov 22, 2021
|
|
Predicting SARS-CoV-2 epitope-specific TCR recognition using pre-trained protein embeddings
First Author:
Reviewed: Nov 22, 2021
|
|
Nov 22, 2021
|
|
Quantitative serology for SARS-CoV-2 using self-collected saliva and finger-stick blood
First Author:
Reviewed: Nov 22, 2021
|
|
Nov 22, 2021
|
|
Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme
First Author:
Reviewed: Nov 22, 2021
|
|
Nov 22, 2021
|
|
The effect of COVID-19 vaccination in Italy and perspectives for “living with the virus”
First Author:
Reviewed: Nov 22, 2021
|
|
Nov 22, 2021
|
|
The SARS-CoV-2 spike residues 616/644 and 1138/1169 delineate two antibody epitopes in COVID-19 mRNA COMINARTY vaccine (Pfizer/BioNTech)
First Author:
Reviewed: Nov 22, 2021
|
|
Nov 22, 2021
|
|
Comparative longitudinal variation of total, IgG and IgA anti-SARS-CoV-2 antibodies in recipients of BNT162b2 vaccination
First Author:
Reviewed: Nov 19, 2021
|
|
Nov 19, 2021
|
|
Factors Associated with Low IgG Response to mRNA COVID-19 Vaccine BNT162b2
First Author:
Reviewed: Nov 19, 2021
|
|
Nov 19, 2021
|
|
Immunogenicity of COVID-19 mRNA Vaccines in Immunocompromised Patients: A Systematic Review and Meta-Analysis
First Author:
Reviewed: Nov 19, 2021
|
|
Nov 19, 2021
|
|
Local monitoring of SARS-CoV-2 Variants in Two Large California Counties in 2021
First Author:
Reviewed: Nov 19, 2021
|
|
Nov 19, 2021
|
|
A Misleading Apical Periodontitis Like Symptoms Post COVID-19 Vaccine
First Author:
Reviewed: Nov 17, 2021
|
|
Nov 17, 2021
|
|
A prototype vaccination model for endemic Covid-19 under waning immunity and imperfect vaccine take-up
First Author:
Reviewed: Nov 17, 2021
|
|
Nov 17, 2021
|
|
Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, January – September 2021
First Author:
Reviewed: Nov 17, 2021
|
|
Nov 17, 2021
|
|
Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in infliximab- and vedolizumab-treated patients
First Author:
Reviewed: Nov 17, 2021
|
|
Nov 17, 2021
|
|
Clinical outcomes and cost-effectiveness of COVID-19 vaccination in South Africa
First Author:
Reviewed: Nov 17, 2021
|
|
Nov 17, 2021
|
|
Comparing regional and provincial-wide COVID-19 models with physical
distancing in British Columbia
First Author:
Reviewed: Nov 17, 2021
|
|
Nov 17, 2021
|
|
COVID-19 convalescents exhibit deficient humoral and T cell responses to variant of concern Spike antigens at 12 month post-infection
First Author:
Reviewed: Nov 17, 2021
|
|
Nov 17, 2021
|
|
Long-term persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific and neutralizing antibodies in recovered COVID-19 patients
First Author:
Reviewed: Nov 17, 2021
|
|
Nov 17, 2021
|
|
Myocarditis After mRNA-1273 Vaccination: A Population-Based Analysis of 151 Million Vaccine Recipients Worldwide
First Author:
Reviewed: Nov 17, 2021
|
|
Nov 17, 2021
|
|
Nachhaltige Strategien gegen die COVID-19-Pandemie in Deutschland im
Winter 2021/2022
First Author:
Reviewed: Nov 17, 2021
|
|
Nov 17, 2021
|
|
Neutralization breadth of SARS CoV-2 viral variants following primary series and booster SARS CoV-2 vaccines in patients with cancer
First Author:
Reviewed: Nov 17, 2021
|
|
Nov 17, 2021
|
|
Protection offered by mRNA-1273 versus BNT162b2 vaccines against SARS-CoV-2 infection and severe COVID-19 in Qatar
First Author:
Reviewed: Nov 17, 2021
|
|
Nov 17, 2021
|
|
Quantification and progress over time of specific antibodies against SARS-CoV-2 in breast milk of lactating women vaccinated with BNT162b2 Pfizer-BioNTech COVID-19 vaccine (LacCOVID)
First Author:
Reviewed: Nov 17, 2021
|
|
Nov 17, 2021
|
|
SARS-CoV-2 Delta vaccine breakthrough transmissibility in Alachua, Florida
First Author:
Reviewed: Nov 17, 2021
|
|
Nov 17, 2021
|
|
SARS-CoV-2 Envelope protein (E) binds and activates TLR2: A novel target for COVID-19 interventions
First Author:
Reviewed: Nov 17, 2021
|
|
Nov 17, 2021
|
|
SARS-COV2 Seroprevalence in a Cohort of Perinatally HIV Infected Children and Young Adults From May to December 2020 in Italy
First Author:
Reviewed: Nov 17, 2021
|
|
Nov 17, 2021
|
|
The role of antiviral treatment in curbing the COVID-19 pandemic: a modeling study
First Author:
Reviewed: Nov 17, 2021
|
|
Nov 17, 2021
|
|
A need of COVID19 vaccination for children aged <12 years: Comparative evidence from the clinical characteristics in patients during a recent Delta surge (B.1.617.2)
First Author:
Reviewed: Nov 16, 2021
|
|
Nov 16, 2021
|
|
A self-amplifying mRNA COVID-19 vaccine drives potent and broad immune responses at low doses that protects non-human primates against SARS-CoV-2
First Author:
Reviewed: Nov 16, 2021
|
|
Nov 16, 2021
|
|
Ad26.COV2.S breakthrough infections induce high titers of antibodies capable of neutralizing variants of concern
First Author:
Reviewed: Nov 16, 2021
|
|
Nov 16, 2021
|
|
Affordable and time-effective high throughput screening of SARS-CoV-2 variants using Denaturing High-Performance Liquid Chromatography analysis
First Author:
Reviewed: Nov 16, 2021
|
|
Nov 16, 2021
|
|
Anti-membrane and anti-spike antibodies are long-lasting and together discriminate between past COVID-19 infection and vaccination
First Author:
Reviewed: Nov 16, 2021
|
|
Nov 16, 2021
|
|
Can hesitancy be mitigated by free choice across COVID-19 vaccine types?
First Author:
Reviewed: Nov 16, 2021
|
|
Nov 16, 2021
|
|
ChAdOx1 n-COV-19 Vaccine Side Effects Among Health Care Workers in Trinidad and Tobago
First Author:
Reviewed: Nov 16, 2021
|
|
Nov 16, 2021
|
|
Characterization of the humoral immune response to BNT162b2 in elderly residents of long-term care facilities five to seven months after vaccination
First Author:
Reviewed: Nov 16, 2021
|
|
Nov 16, 2021
|
|
Cohort study of Covid-19 vaccine effectiveness among healthcare workers in Finland, December 2020 - October 2021
First Author:
Reviewed: Nov 16, 2021
|
|
Nov 16, 2021
|
|
Comparative Efficacy over time of the mRNA-1273 (Moderna) vaccine and the BNT162b2 (Pfizer-BioNTech) vaccine
First Author:
Reviewed: Nov 16, 2021
|
|
Nov 16, 2021
|
|
Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: A cohort study from OpenSAFELY
First Author:
Reviewed: Nov 16, 2021
|
|
Nov 16, 2021
|
|
Humoral immune response to Covid-19 vaccination in diabetes: age-dependent but independent of type of diabetes and glycaemic control – the prospective COVAC-DM cohort study
First Author:
Reviewed: Nov 16, 2021
|
|
Nov 16, 2021
|
|
Immunity to COVID-19 in India through vaccination and natural infection
First Author:
Reviewed: Nov 16, 2021
|
|
Nov 16, 2021
|
|
Immunogenicity and adverse events of priming with inactivated whole SARS-CoV-2 vaccine (CoronaVac) followed by boosting the ChAdOx1 nCoV-19 vaccine
First Author:
Reviewed: Nov 16, 2021
|
|
Nov 16, 2021
|
|
Immunogenicity and safety of the homogenous booster shot of a recombinant fusion protein vaccine (V-01) against COVID-19 in healthy adult participants primed with a two-dose regimen
First Author:
Reviewed: Nov 16, 2021
|
|
Nov 16, 2021
|
|
Immunogenicity of COVID-19 vaccines in patients with haematological malignancy: A systematic review and meta-analysis
First Author:
Reviewed: Nov 16, 2021
|
|
Nov 16, 2021
|
|
Montmorillonite-Nasal-Gel, A Prophylactic Measure Against Covid-19
First Author:
Reviewed: Nov 16, 2021
|
|
Nov 16, 2021
|
|
Neutralisation of SARS-CoV-2 Delta sub-lineage AY.4.2 and B.1.617.2+E484K by BNT162b2 mRNA vaccine-elicited sera
First Author:
Reviewed: Nov 16, 2021
|
|
Nov 16, 2021
|
|
Parents’ intention to vaccinate their 5-11 years old children with the COVID-19 vaccine: rates, predictors and the role of incentives
First Author:
Reviewed: Nov 16, 2021
|
|
Nov 16, 2021
|
|
Phage-like particle vaccines are highly immunogenic and protect against pathogenic coronavirus infection and disease
First Author:
Reviewed: Nov 16, 2021
|
|
Nov 16, 2021
|
|
Potent antibody immunity to SARS-CoV-2 variants elicited by a third dose of inactivated vaccine
First Author:
Reviewed: Nov 16, 2021
|
|
Nov 16, 2021
|
|
SARS-CoV-2 Antibody Response is Associated with Age in Convalescent Outpatients
First Author:
Reviewed: Nov 16, 2021
|
|
Nov 16, 2021
|
|
SARS-COV-2 Delta variant displays moderate resistance to neutralizing antibodies and spike protein properties of higher soluble ACE2 sensitivity, enhanced cleavage and fusogenic activity
First Author:
Reviewed: Nov 16, 2021
|
|
Nov 16, 2021
|
|
SARS-CoV-2 specific T cell and humoral immune responses upon vaccination with BNT162b2
First Author:
Reviewed: Nov 16, 2021
|
|
Nov 16, 2021
|
|
Structural basis of main proteases of coronavirus bound to drug candidate PF-07321332
First Author:
Reviewed: Nov 16, 2021
|
|
Nov 16, 2021
|
|
Surveillance of COVID-19 in a Vaccinated Population: A Rapid Literature Review
First Author:
Reviewed: Nov 16, 2021
|
|
Nov 16, 2021
|
|
Third dose vaccine With BNT162b2 and its response on Long COVID after Breakthrough infections
First Author:
Reviewed: Nov 16, 2021
|
|
Nov 16, 2021
|
|
Three doses of COVID-19 mRNA vaccination are safe based on adverse events reported in electronic health records
First Author:
Reviewed: Nov 16, 2021
|
|
Nov 16, 2021
|
|
Transcriptome analysis of SARS-CoV-2 naïve and recovered individuals vaccinated with inactivated vaccine
First Author:
Reviewed: Nov 16, 2021
|
|
Nov 16, 2021
|
|
Understanding COVID-19 trajectories from a nationwide linked electronic health record cohort of 56 million people: phenotypes, severity, waves & vaccination
First Author:
Reviewed: Nov 16, 2021
|
|
Nov 16, 2021
|
|
Vaccine effectiveness of Pfizer-BioNTech and Oxford-AstraZeneca to prevent severe COVID-19 in Costa Rica by September and October 2021: A nationwide, observational study of hospitalisations prevalence
First Author:
Reviewed: Nov 16, 2021
|
|
Nov 16, 2021
|
|
Validation of a rapid and sensitive SARS-CoV-2 screening system developed for pandemic-scale infection surveillance
First Author:
Reviewed: Nov 16, 2021
|
|
Nov 16, 2021
|
|
Waning of SARS-CoV-2 antibodies targeting the Spike protein in individuals post second dose of ChAdOx1 and BNT162b2 COVID-19 vaccines and risk of breakthrough infections: analysis of the Virus Watch community cohort
First Author:
Reviewed: Nov 16, 2021
|
|
Nov 16, 2021
|
|
Waning, Boosting and a Path to Endemicity for SARS-CoV-2
First Author:
Reviewed: Nov 16, 2021
|
|
Nov 16, 2021
|
|
δ subvariants of SARS-COV-2 in Israel, Qatar and Bahrain: Optimal vaccination as an effective strategy to block viral evolution and control the pandemic
First Author:
Reviewed: Nov 16, 2021
|
|
Nov 16, 2021
|
|
(Mis)perceptions and Engagement on Twitter: COVID-19 Vaccine Rumors on
Efficacy and Mass Immunization Effort
First Author:
Reviewed: Nov 11, 2021
|
|
Nov 11, 2021
|
|
Cellular and Humoral Immune Response to SARS-CoV-2 mRNA Vaccines in Patients Treated with either Ibrutinib or Rituximab
First Author:
Reviewed: Nov 11, 2021
|
|
Nov 11, 2021
|
|
LinearTurboFold: Linear-Time Global Prediction of Conserved Structures for RNA Homologs with Applications to SARS-CoV-2
First Author:
Reviewed: Nov 11, 2021
|
|
Nov 11, 2021
|
|
Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccines in healthy adults
First Author:
Reviewed: Nov 11, 2021
|
|
Nov 11, 2021
|
|
Spike protein cleavage-activation mediated by the SARS-CoV-2 P681R mutation: a case-study from its first appearance in variant of interest (VOI) A.23.1 identified in Uganda
First Author:
Reviewed: Nov 11, 2021
|
|
Nov 11, 2021
|
|
The pronounced decline of anti-SARS-CoV-2 spike trimeric IgG and RBD IgG in baseline seronegative individuals 6 months after BNT162b2 vaccination is consistent with the need for vaccine boosters
First Author:
Reviewed: Nov 11, 2021
|
|
Nov 11, 2021
|
|
A Non-Markovian Model to Assess Contact Tracing for the Containment of
COVID-19
First Author:
Reviewed: Nov 10, 2021
|
|
Nov 10, 2021
|
|
A RCT of a third dose CoronaVac or BNT162b2 vaccine in adults with two doses of CoronaVac
First Author:
Reviewed: Nov 10, 2021
|
|
Nov 10, 2021
|
|
Development of a Rapid Point-Of-Care Test that Measures Neutralizing Antibodies to SARS-CoV-2
First Author:
Reviewed: Nov 10, 2021
|
|
Nov 10, 2021
|
|
Distinct evolution of infection-enhancing and neutralizing epitopes in the spike protein of SARS-CoV-2 variants (alpha, beta, gamma, delta, lambda and mu) : a structural and molecular epidemiology study
First Author:
Reviewed: Nov 10, 2021
|
|
Nov 10, 2021
|
|
Downsizing of contact tracing during COVID-19 vaccine roll-out
First Author:
Reviewed: Nov 10, 2021
|
|
Nov 10, 2021
|
|
Effectiveness of COVID-19 Vaccines and Post-vaccination SARS-COV 2 Infection, Hospitalization, and Mortality: a Systematic Review and Meta-analysis of Observational Studies
First Author:
Reviewed: Nov 10, 2021
|
|
Nov 10, 2021
|
|
Immunogenicity and reactogenicity of heterologous Ad26.COV.2 and BNT162b2 vaccination
First Author:
Reviewed: Nov 10, 2021
|
|
Nov 10, 2021
|
|
Neutralizing antibody-independent immunity to SARS-CoV-2 in Syrian hamsters and human ACE-2 transgenic mice immunized with a RBD/Nucleocapsid fusion protein
First Author:
Reviewed: Nov 10, 2021
|
|
Nov 10, 2021
|
|
REACT-1 round 15 interim report: High and rising prevalence of SARS-CoV-2 infection in England from end of September 2021 followed by a fall in late October 2021
First Author:
Reviewed: Nov 10, 2021
|
|
Nov 10, 2021
|
|
Understanding Attitudes and Obstacles To Vaccination Against COVID-19 in Patients With Primary Immunodeficiency
First Author:
Reviewed: Nov 10, 2021
|
|
Nov 10, 2021
|
|
Untangling the changing impact of non-pharmaceutical interventions and vaccination on European Covid-19 trajectories
First Author:
Reviewed: Nov 10, 2021
|
|
Nov 10, 2021
|
|
Waning of the Humoral Response to SARS-CoV-2 in Pregnancy is Variant-Dependent
First Author:
Reviewed: Nov 10, 2021
|
|
Nov 10, 2021
|
|
Anti-SARS-CoV-2 vaccination does not induce the formation of autoantibodies but provides humoral immunity following heterologous and homologous vaccination regimens: Results from a clinical and prospective study within professionals of a German University Hospital
First Author:
Reviewed: Nov 8, 2021
|
|
Nov 8, 2021
|
|
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting: A Note
First Author:
Reviewed: Nov 8, 2021
|
|
Nov 8, 2021
|
|
Comparative genomics and characterization of SARS-CoV-2 P.1 (Gamma) Variant of Concern (VOC) from Amazonas, Brazil
First Author:
Reviewed: Nov 8, 2021
|
|
Nov 8, 2021
|
|
Comparison of Antibody Levels in Response to SARS-CoV-2 Infection and Vaccination Type in a Midwestern Cohort
First Author:
Reviewed: Nov 8, 2021
|
|
Nov 8, 2021
|
|
Efficacy and Safety of SOBERANA 02, a COVID-19 conjugate vaccine in heterologous three doses combination
First Author:
Reviewed: Nov 8, 2021
|
|
Nov 8, 2021
|
|
Emergence and spread of a sub-lineage of SARS-CoV-2 Alpha variant B.1.1.7 in Europe, and with further evolution of spike mutation accumulations shared with the Beta and Gamma variants
First Author:
Reviewed: Nov 8, 2021
|
|
Nov 8, 2021
|
|
Germinal centre-driven maturation of B cell response to SARS-CoV-2 vaccination
First Author:
Reviewed: Nov 8, 2021
|
|
Nov 8, 2021
|
|
Glycan-masking spike antigen in NTD and RBD elicits broadly neutralizing antibodies against SARS-CoV-2 variants
First Author:
Reviewed: Nov 8, 2021
|
|
Nov 8, 2021
|
|
Glycopeptide antibiotic teicoplanin inhibits cell entry of SARS-CoV-2 by suppressing the proteolytic activity of cathepsin L
First Author:
Reviewed: Nov 8, 2021
|
|
Nov 8, 2021
|
|
Kinetics of the SARS-CoV-2 antibody response in immunocompetent convalescent patients: nationwide multicenter 15-month follow-up cohort study
First Author:
Reviewed: Nov 8, 2021
|
|
Nov 8, 2021
|
|
Quantifying the effects of non-pharmaceutical and pharmaceutical interventions against COVID-19 epidemic in the Republic of Korea: Mathematical model-based approach considering age groups and the Delta variant
First Author:
Reviewed: Nov 8, 2021
|
|
Nov 8, 2021
|
|
SARS-CoV-2 mechanistic correlates of protection: insight from modelling response to vaccines
First Author:
Reviewed: Nov 8, 2021
|
|
Nov 8, 2021
|
|
Serological Response to BNT162b2 and ChAdOx1 nCoV-19 Vaccines in Patients with Inflammatory Bowel Disease on Biologic Therapies; A Multi-Center Prospective Study
First Author:
Reviewed: Nov 8, 2021
|
|
Nov 8, 2021
|
|
Underlying factors that influence the acceptance of COVID-19 vaccine in a country with a high vaccination rate
First Author:
Reviewed: Nov 8, 2021
|
|
Nov 8, 2021
|
|
PhyloTransformer: A Discriminative Model for Mutation Prediction Based
on a Multi-head Self-attention Mechanism
First Author:
Reviewed: Nov 4, 2021
|
|
Nov 4, 2021
|
|
A Potential Novel COVID-19 Vaccine With RBD-HR1/HR2 Hexamer Structure
First Author:
Reviewed: Nov 3, 2021
|
|
Nov 3, 2021
|
|
An immunological autobiography: my year as a COVID-19 vaccine trial
participant
First Author:
Reviewed: Nov 3, 2021
|
|
Nov 3, 2021
|
|
Antibody escape and global spread of SARS-CoV-2 lineage A.27
First Author:
Reviewed: Nov 3, 2021
|
|
Nov 3, 2021
|
|
Boosting of Cross-Reactive Antibodies to Endemic Coronaviruses by SARS-CoV-2 Infection but not Vaccination with Stabilized Spike
First Author:
Reviewed: Nov 3, 2021
|
|
Nov 3, 2021
|
|
Can sarcopenia index serve as a predictor of myocarditis from mRNA based COVID-19 vaccine, insights from clustered cases and potential involvement of micro-RNAs in its pathogenesis.
First Author:
Reviewed: Nov 3, 2021
|
|
Nov 3, 2021
|
|
Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID-19 Vaccines in Hong Kong
First Author:
Reviewed: Nov 3, 2021
|
|
Nov 3, 2021
|
|
COVID-19 Vaccine Failure in Chronic Lymphocytic Leukemia and Monoclonal B-Lymphocytosis; Humoral and Cellular Immunity
First Author:
Reviewed: Nov 3, 2021
|
|
Nov 3, 2021
|
|
Designing an evidence-based Bayesian network for estimating the risk versus benefits of AstraZeneca COVID-19 vaccine
First Author:
Reviewed: Nov 3, 2021
|
|
Nov 3, 2021
|
|
Effect of COVID-19 Vaccination on Seizures in Patients With Epilepsy: a Multicenter, Retrospective Study
First Author:
Reviewed: Nov 3, 2021
|
|
Nov 3, 2021
|
|
Head-to-head analysis of immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19-priming and BNT162b2 or mRNA-1273-boosting with homologous COVID-19 vaccine regimens
First Author:
Reviewed: Nov 3, 2021
|
|
Nov 3, 2021
|
|
How many lives do COVID vaccines save? Evidence from Israel
First Author:
Reviewed: Nov 3, 2021
|
|
Nov 3, 2021
|
|
Impact of non-pharmacological interventions on COVID-19 boosting vaccine prioritization and vaccine-induced herd immunity: a population-stratified modelling study
First Author:
Reviewed: Nov 3, 2021
|
|
Nov 3, 2021
|
|
Ocular inflammatory events following COVID-19 vaccination: a multinational case series
First Author:
Reviewed: Nov 3, 2021
|
|
Nov 3, 2021
|
|
Parents’ perceptions and intention to vaccinate their children against COVID-19: Results from a cross-sectional national survey in India
First Author:
Reviewed: Nov 3, 2021
|
|
Nov 3, 2021
|
|
Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults ≥ 65 years of age: a Phase II, open-label study
First Author:
Reviewed: Nov 3, 2021
|
|
Nov 3, 2021
|
|
Time of day of vaccination affects SARS-CoV-2 antibody responses in an observational study of healthcare workers
First Author:
Reviewed: Nov 3, 2021
|
|
Nov 3, 2021
|
|
Vaccination of COVID-19 Convalescent Plasma Donors Increases Binding and Neutralizing Antibodies Against SARS-CoV-2 Variants
First Author:
Reviewed: Nov 3, 2021
|
|
Nov 3, 2021
|
|
Vaccine-induced humoral and cellular immunity against SARS-CoV-2 at 6 months post BNT162b2 vaccination
First Author:
Reviewed: Nov 3, 2021
|
|
Nov 3, 2021
|
|
Weak or No Correlation Between Recent COVID-19 Data and Vaccination Rates in France
First Author:
Reviewed: Nov 3, 2021
|
|
Nov 3, 2021
|
|
A “Made-in-Canada” serology solution for profiling humoral immune responses to SARS-CoV-2 infection and vaccination
First Author:
Reviewed: Nov 2, 2021
|
|
Nov 2, 2021
|
|
Active Surveillance of Adverse Events After COVID-19 and Other Vaccinations: a Feasibility Study as Part of the CoVaKo Project
First Author:
Reviewed: Nov 2, 2021
|
|
Nov 2, 2021
|
|
ADNKA overcomes SARS-CoV2-mediated NK cell inhibition through non-spike antibodies
First Author:
Reviewed: Nov 2, 2021
|
|
Nov 2, 2021
|
|
Assessing the potential impact of immunity waning on the dynamics of COVID-19: an endemic model of COVID-19
First Author:
Reviewed: Nov 2, 2021
|
|
Nov 2, 2021
|
|
Associations between SARS-CoV-2 variants and risk of COVID-19 hospitalization among confirmed cases in Washington State: a retrospective cohort study
First Author:
Reviewed: Nov 2, 2021
|
|
Nov 2, 2021
|
|
Auricular Acupressure for Adverse Events Following Immunization Related To COVID-19 Vaccine Injection: Study Protocol for a Multicenter, Three-Arm, Blinded Randomized Controlled Trial
First Author:
Reviewed: Nov 2, 2021
|
|
Nov 2, 2021
|
|
Boosting of the SARS-CoV-2-specific immune response after vaccination with single-dose Sputnik Light vaccine
First Author:
Reviewed: Nov 2, 2021
|
|
Nov 2, 2021
|
|
Comparative Effectiveness of BNT162b2 versus Ad26.COV2.S for the Prevention of COVID-19 among Dialysis Patients
First Author:
Reviewed: Nov 2, 2021
|
|
Nov 2, 2021
|
|
COVID 19 breakthrough infection risk: a simple physical model describing the dependence on antibody concentration
First Author:
Reviewed: Nov 2, 2021
|
|
Nov 2, 2021
|
|
COVID-19 breakthrough infections and pre-infection neutralizing antibody
First Author:
Reviewed: Nov 2, 2021
|
|
Nov 2, 2021
|
|
COVID-19 Incidence and Hospitalization During the Delta Surge Were Inversely Related to Vaccination Coverage Among the Most Populous U.S. Counties
First Author:
Reviewed: Nov 2, 2021
|
|
Nov 2, 2021
|
|
COVID-19 testing and vaccine willingness: Cross-sectional survey in a culturally diverse community in Sydney, Australia
First Author:
Reviewed: Nov 2, 2021
|
|
Nov 2, 2021
|
|
Dampening of the respiratory cytokine storm is promoted by inhaled budesonide in patients with early COVID-19
First Author:
Reviewed: Nov 2, 2021
|
|
Nov 2, 2021
|
|
Disease waves of SARS-CoV-2 in Iran closely mirror global pandemic trends
First Author:
Reviewed: Nov 2, 2021
|
|
Nov 2, 2021
|
|
Effectiveness of Covid-19 Vaccines in the United States Over 9 Months: Surveillance Data from the State of North Carolina
First Author:
Reviewed: Nov 2, 2021
|
|
Nov 2, 2021
|
|
Global diversity of policy, coverage, and demand of COVID-19 vaccines: a descriptive study
First Author:
Reviewed: Nov 2, 2021
|
|
Nov 2, 2021
|
|
Higher mortality associated with the SARS-CoV-2 Delta variant in the Western Cape, South Africa, using RdRp target delay as a proxy
First Author:
Reviewed: Nov 2, 2021
|
|
Nov 2, 2021
|
|
Immune response to COVID-19 vaccination is attenuated by poor disease control and antimyeloma therapy with vaccine driven divergent T cell response
First Author:
Reviewed: Nov 2, 2021
|
|
Nov 2, 2021
|
|
Kinetics of immune responses to the AZD1222/Covishield vaccine with varying dose intervals in Sri Lankan individuals
First Author:
Reviewed: Nov 2, 2021
|
|
Nov 2, 2021
|
|
Limited impact of Delta variant’s mutations in the effectiveness of neutralization conferred by natural infection or COVID-19 vaccines in a Latino population
First Author:
Reviewed: Nov 2, 2021
|
|
Nov 2, 2021
|
|
Longitudinal Study after Sputnik V Vaccination Shows Durable SARS-CoV-2 Neutralizing Antibodies and Reduced Viral Variant Escape over Time
First Author:
Reviewed: Nov 2, 2021
|
|
Nov 2, 2021
|
|
Modeling the impact of vaccination strategies for nursing homes in the context of increased SARS-CoV-2 community transmission and variants
First Author:
Reviewed: Nov 2, 2021
|
|
Nov 2, 2021
|
|
Nanobodies recognizing conserved hidden clefts of all SARS-CoV-2 spike variants
First Author:
Reviewed: Nov 2, 2021
|
|
Nov 2, 2021
|
|
Neutralizing Antibody Response to Pseudotype SARS-CoV-2 Differs between mRNA-1273 and BNT162b2 COVID-19 Vaccines and by History of SARS-CoV-2 Infection
First Author:
Reviewed: Nov 2, 2021
|
|
Nov 2, 2021
|
|
Nucleocapsid antibody positivity as a marker of past SARS-CoV-2 infection in population serosurveillance studies: impact of variant, vaccination, and choice of assay cut-off
First Author:
Reviewed: Nov 2, 2021
|
|
Nov 2, 2021
|
|
Ongoing use of SSRIs and the hospital course of COVID-19 patients: a retrospective outcome analysis
First Author:
Reviewed: Nov 2, 2021
|
|
Nov 2, 2021
|
|
Outbreak of SARS-CoV-2 B.1.617.2 (Delta) variant in a Nursing Home 28 weeks after two doses of mRNA anti-Covid-19 vaccines: evidence of a waning immunity
First Author:
Reviewed: Nov 2, 2021
|
|
Nov 2, 2021
|
|
Quarantine and testing strategies to ameliorate transmission due to travel during the COVID-19 pandemic
First Author:
Reviewed: Nov 2, 2021
|
|
Nov 2, 2021
|
|
Rapid surveillance platforms for key SARS-CoV-2 mutations in Denmark
First Author:
Reviewed: Nov 2, 2021
|
|
Nov 2, 2021
|
|
Safety and Effectiveness of COVID-19 SPUTNIK V Vaccine in Dialysis Patients
First Author:
Reviewed: Nov 2, 2021
|
|
Nov 2, 2021
|
|
Safety and Immunogenicity of the COVID-19 Vaccine BNT162b2 in Patients Undergoing Chemotherapy for Solid Cancer
First Author:
Reviewed: Nov 2, 2021
|
|
Nov 2, 2021
|
|
Safety Monitoring of mRNA Vaccines Administered During the Initial 6 Months of the U.S. COVID-19 Vaccination Program: Reports to Vaccine Adverse Events Reporting System (VAERS) and v-safe
First Author:
Reviewed: Nov 2, 2021
|
|
Nov 2, 2021
|
|
SARS-CoV-2 Receptor Binding Domain IgG Response to AstraZeneca (AZD1222) COVID-19 Vaccination, Jamaica
First Author:
Reviewed: Nov 2, 2021
|
|
Nov 2, 2021
|
|
SARS-CoV-2 Spike S1-specific IgG kinetic profiles following mRNA- versus vector-based vaccination in the general Dutch population
First Author:
Reviewed: Nov 2, 2021
|
|
Nov 2, 2021
|
|
Six-month sequelae of post-vaccination SARS-CoV-2 infection: a retrospective cohort study of 10,024 breakthrough infections
First Author:
Reviewed: Nov 2, 2021
|
|
Nov 2, 2021
|
|
The Impact of SARS-CoV-2 Lineages (Variants) on the COVID-19 Epidemic in South Africa
First Author:
Reviewed: Nov 2, 2021
|
|
Nov 2, 2021
|
|
The impact of vaccinating adolescents and children on COVID-19 disease outcomes
First Author:
Reviewed: Nov 2, 2021
|
|
Nov 2, 2021
|
|
The Persistence of Neutralising Antibodies up to 11 months after SARS-CoV-2 Infection in the Southern Region of New Zealand
First Author:
Reviewed: Nov 2, 2021
|
|
Nov 2, 2021
|
|
Third doses of COVID-19 vaccines reduce infection and transmission of SARS-CoV-2 and could prevent future surges in some populations
First Author:
Reviewed: Nov 2, 2021
|
|
Nov 2, 2021
|
|
Two-dose SARS-CoV-2 vaccine effectiveness with mixed schedules and extended dosing intervals: test-negative design studies from British Columbia and Quebec, Canada
First Author:
Reviewed: Nov 2, 2021
|
|
Nov 2, 2021
|
|
Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice
First Author:
Reviewed: Oct 29, 2021
|
|
Oct 29, 2021
|
|
Characterization of raloxifene as potential pharmacological agent against SARS-CoV-2 and its variants
First Author:
Reviewed: Oct 28, 2021
|
|
Oct 28, 2021
|
|
Six-month decline of serum anti-spike S1 subunit IgA in SARS-CoV-2 in seronegative healthcare workers after mRNA-based COVID-19 vaccination
First Author:
Reviewed: Oct 28, 2021
|
|
Oct 28, 2021
|
|
A rigorous framework for detecting SARS-CoV-2 spike protein mutational ensemble from genomic and structural features
First Author:
Reviewed: Oct 27, 2021
|
|
Oct 27, 2021
|
|
Analysis of COVID-19 infection waves in Tokyo by Avrami equation
First Author:
Reviewed: Oct 27, 2021
|
|
Oct 27, 2021
|
|
Autoimmune conditions following mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccination: a descriptive cohort study among 1.1 million vaccinated people in Hong Kong
First Author:
Reviewed: Oct 27, 2021
|
|
Oct 27, 2021
|
|
COVID-19 Vaccine Perceptions and Uptake in a National Prospective Cohort of Essential Workers
First Author:
Reviewed: Oct 27, 2021
|
|
Oct 27, 2021
|
|
Cutaneous adverse reactions of COVID-19 vaccines: a systematic review
First Author:
Reviewed: Oct 27, 2021
|
|
Oct 27, 2021
|
|
Differential features of the fifth wave of COVID-19 associated with vaccination and the Delta variant in a reference hospital in Catalonia, Spain
First Author:
Reviewed: Oct 27, 2021
|
|
Oct 27, 2021
|
|
Effectiveness of partial COVID-19 vaccination on the outcome of hospitalized COVID-19 patients during the second pandemic In India
First Author:
Reviewed: Oct 27, 2021
|
|
Oct 27, 2021
|
|
Epidemic Surveillance Models for Containing the Spread of SARS-CoV-2 Variants: Taiwan Experience
First Author:
Reviewed: Oct 27, 2021
|
|
Oct 27, 2021
|
|
High prevalence of an alpha variant lineage with a premature stop codon in ORF7a in Iraq, winter 2020-2021
First Author:
Reviewed: Oct 27, 2021
|
|
Oct 27, 2021
|
|
High SARS-CoV-2 seroprevalence in rural Peru, 2021; a cross-sectional population-based study
First Author:
Reviewed: Oct 27, 2021
|
|
Oct 27, 2021
|
|
Immunogenicity and reactogenicity of booster vaccinations after Ad26.COV2.S priming
First Author:
Reviewed: Oct 27, 2021
|
|
Oct 27, 2021
|
|
Molecular Insights into the Differential Dynamics of SARS-CoV-2 Variants of Concern (VOC)
First Author:
Reviewed: Oct 27, 2021
|
|
Oct 27, 2021
|
|
Nasal prevention of SARS-CoV-2 infection by intranasal influenza-based boost vaccination
First Author:
Reviewed: Oct 27, 2021
|
|
Oct 27, 2021
|
|
Population Based Mean Vitamin-D Levels In 19 European Countries & COVID-19 Mortality
First Author:
Reviewed: Oct 27, 2021
|
|
Oct 27, 2021
|
|
REACT-1 study round 14: High and increasing prevalence of SARS-CoV-2 infection among school-aged children during September 2021 and vaccine effectiveness against infection in England
First Author:
Reviewed: Oct 27, 2021
|
|
Oct 27, 2021
|
|
The Mask-Wearing Bias In The Estimates Of Vaccine Efficacy
First Author:
Reviewed: Oct 27, 2021
|
|
Oct 27, 2021
|
|
A novel Pan-viral prophylaxis strategy using vaccine adjuvant CAF09b protects against influenza virus infection
First Author:
Reviewed: Oct 26, 2021
|
|
Oct 26, 2021
|
|
Effect of the third dose of BNT162b2 vaccine in quantitative SARS-CoV-2 spike 1-2 IgG antibody titers in healthcare workers
First Author:
Reviewed: Oct 26, 2021
|
|
Oct 26, 2021
|
|
Impaired Neutralizing Antibody Response to COVID-19 mRNA Vaccines in Cancer Patients
First Author:
Reviewed: Oct 26, 2021
|
|
Oct 26, 2021
|
|
Who Are the `Silent Spreaders'?: Contact Tracing in Spatio-Temporal
Memory Models
First Author:
Reviewed: Oct 26, 2021
|
|
Oct 26, 2021
|
|
‘Subacute’ Onset of Guillain Barré Syndrome Post mRNA-1273 Vaccination: A Case Report
First Author:
Reviewed: Oct 25, 2021
|
|
Oct 25, 2021
|
|
An intranasally administrated SARS-CoV-2 beta variant subunit booster vaccine prevents beta variant viral replication in rhesus macaques
First Author:
Reviewed: Oct 25, 2021
|
|
Oct 25, 2021
|
|
Comparative effectiveness of allocation strategies of COVID-19 vaccines and antivirals against emerging SARS-CoV-2 variants of concern in East Asia and Pacific region
First Author:
Reviewed: Oct 25, 2021
|
|
Oct 25, 2021
|
|
COVID-19 Vaccine Acceptance in Mukalla City, Yemen
First Author:
Reviewed: Oct 25, 2021
|
|
Oct 25, 2021
|
|
Effects of Vaccine Health and Safety Perceptions on COVID-19 Vaccine Uptake in Ghana: Implications for Implementing Rollout Programs
First Author:
Reviewed: Oct 25, 2021
|
|
Oct 25, 2021
|
|
Elevated antibody titers in Abdala vaccinees evaluated by Elecsys® anti-SARS-CoV-2 S highly correlate with UMELISA SARS-CoV-2 ANTI RBD, ACE-2 binding inhibition and viral neutralization assays
First Author:
Reviewed: Oct 25, 2021
|
|
Oct 25, 2021
|
|
Evidence of transmission from fully vaccinated individuals in a large outbreak of the SARS-CoV-2 Delta variant in Provincetown, Massachusetts
First Author:
Reviewed: Oct 25, 2021
|
|
Oct 25, 2021
|
|
Immune Responses in Fully Vaccinated Individuals Following Breakthrough Infection with the SARS-CoV-2 Delta Variant in Provincetown, Massachusetts
First Author:
Reviewed: Oct 25, 2021
|
|
Oct 25, 2021
|
|
Immunogenicity of BNT162b2 Vaccine in Patients with Inflammatory Bowel Disease on Infliximab Combination Therapy: A Multicenter Prospective Study
First Author:
Reviewed: Oct 25, 2021
|
|
Oct 25, 2021
|
|
Immunogenicity of The BNT162b2 mRNA COVID-19 Vaccine in Patients With Primary Brain Tumors: A Prospective Cohort Study
First Author:
Reviewed: Oct 25, 2021
|
|
Oct 25, 2021
|
|
Impact of SARS-CoV-2 infection on longitudinal vaccine immune responses
First Author:
Reviewed: Oct 25, 2021
|
|
Oct 25, 2021
|
|
Impacts of vaccination and Severe Acute Respiratory Syndrome Coronavirus 2 variants Alpha and Delta on Coronavirus Disease 2019 transmission dynamics in the 15 most populous metropolitan statistical areas in the United States
First Author:
Reviewed: Oct 25, 2021
|
|
Oct 25, 2021
|
|
Intensive Single Cell Analysis Reveals Immune Cell Diversity among Healthy Individuals
First Author:
Reviewed: Oct 25, 2021
|
|
Oct 25, 2021
|
|
Longitudinal and comparative analysis of humoral response upon COVID-19 vaccination
First Author:
Reviewed: Oct 25, 2021
|
|
Oct 25, 2021
|
|
Monoclonal Antibody Treatment of Breakthrough COVID-19 in Fully Vaccinated Individuals with High-Risk Comorbidities
First Author:
Reviewed: Oct 25, 2021
|
|
Oct 25, 2021
|
|
Neutralization of Mu and C.1.2 SARS-CoV-2 Variants by Vaccine-elicited Antibodies in Individuals With and Without Previous History of Infection
First Author:
Reviewed: Oct 25, 2021
|
|
Oct 25, 2021
|
|
Nowcasting transmission and suppression of the Delta variant of
SARS-CoV-2 in Australia
First Author:
Reviewed: Oct 25, 2021
|
|
Oct 25, 2021
|
|
On the association between COVID-19 vaccination levels and incidence and
lethality rates at a regional scale in Spain
First Author:
Reviewed: Oct 25, 2021
|
|
Oct 25, 2021
|
|
One-dose ChAdOx1 nCoV-19 Vaccine Effectiveness Against Symptomatic COVID-19 in a vulnerable community in Rio de Janeiro, Brazil: test-negative design study
First Author:
Reviewed: Oct 25, 2021
|
|
Oct 25, 2021
|
|
Preparation of ingestible antibodies to neutralize the binding of SarsCoV2 RBD (receptor binding domain) to human ACE2 Receptor
First Author:
Reviewed: Oct 25, 2021
|
|
Oct 25, 2021
|
|
Response to Tozinameran (BNT162b2) booster in twice-vaccinated kidney transplant and maintenance dialysis patients
First Author:
Reviewed: Oct 25, 2021
|
|
Oct 25, 2021
|
|
SARS-CoV-2 variants associated with vaccine breakthrough in the Delaware Valley through summer 2021
First Author:
Reviewed: Oct 25, 2021
|
|
Oct 25, 2021
|
|
A cohort of 222 anti-CD20 treated patients with multiple sclerosis followed through the COVID-19 pandemic: Attenuated humoral but robust cellular immune responses after vaccination and infection
First Author:
Reviewed: Oct 24, 2021
|
|
Oct 24, 2021
|
|
A high content microscopy-based platform for detecting antibodies to the nucleocapsid, spike and membrane proteins of SARS-CoV-2
First Author:
Reviewed: Oct 24, 2021
|
|
Oct 24, 2021
|
|
Acquisition of resistance to wild-type spike-immune sera by emerging SARS-CoV-2 variants
First Author:
Reviewed: Oct 24, 2021
|
|
Oct 24, 2021
|
|
Comparative effectiveness of ChAdOx1 versus BNT162b2 COVID-19 vaccines in Health and Social Care workers in England: a cohort study using OpenSAFELY
First Author:
Reviewed: Oct 24, 2021
|
|
Oct 24, 2021
|
|
Covid-19 Cases Surge in a Security Compromised Region of Cameroon
First Author:
Reviewed: Oct 24, 2021
|
|
Oct 24, 2021
|
|
Durability of antibody responses and frequency of clinical and subclinical SARS-CoV-2 infection six months after BNT162b2 COVID-19 vaccination in healthcare workers
First Author:
Reviewed: Oct 24, 2021
|
|
Oct 24, 2021
|
|
Efficacy and safety of a third SARS-CoV-2 vaccination in multiple sclerosis vaccine non-responders
First Author:
Reviewed: Oct 24, 2021
|
|
Oct 24, 2021
|
|
How frequent are acute reactions to COVID-19 vaccination and who is at risk?
First Author:
Reviewed: Oct 24, 2021
|
|
Oct 24, 2021
|
|
Long-term predictions of humoral immunity after two doses of BNT162b2 and mRNA-1273 vaccines based on dosage, age and sex
First Author:
Reviewed: Oct 24, 2021
|
|
Oct 24, 2021
|
|
Minimum manufacturing costs, national prices and estimated global availability of new repurposed therapies for COVID-19
First Author:
Reviewed: Oct 24, 2021
|
|
Oct 24, 2021
|
|
Modeling the influence of vaccine administration on COVID-19 testing strategies
First Author:
Reviewed: Oct 24, 2021
|
|
Oct 24, 2021
|
|
Persistence of antibody and T cell responses to the Sinopharm/BBIBP-CorV vaccine in Sri Lankan individuals
First Author:
Reviewed: Oct 24, 2021
|
|
Oct 24, 2021
|
|
Plant-based production of SARS-CoV-2 antigens for use in a subunit vaccine
First Author:
Reviewed: Oct 24, 2021
|
|
Oct 24, 2021
|
|
Predicting COVID-19 Vaccine Efficacy from Neutralizing Antibody Levels
First Author:
Reviewed: Oct 24, 2021
|
|
Oct 24, 2021
|
|
Reduced seroconversion in children compared to adults with mild COVID-19
First Author:
Reviewed: Oct 24, 2021
|
|
Oct 24, 2021
|
|
SARS-CoV-2 Pandemic Preventive Methods Efficacy - A Simulation Case Study
First Author:
Reviewed: Oct 24, 2021
|
|
Oct 24, 2021
|
|
Self-reported safety of the BBIBP-CorV (Sinopharm) COVID-19 vaccine among Iranian people with multiple sclerosis
First Author:
Reviewed: Oct 24, 2021
|
|
Oct 24, 2021
|
|
The association between immunosuppressants use and COVID-19 adverse outcomes: National COVID-19 cohort in South Korea
First Author:
Reviewed: Oct 24, 2021
|
|
Oct 24, 2021
|
|
The Contribution of Periodic Intensification of Routine Immunization to Vaccination Coverage and Disease Surveillance in the South West Region of Cameroon amid Sociopolitical Crisis and Covid-19 Outbreak in 2020
First Author:
Reviewed: Oct 24, 2021
|
|
Oct 24, 2021
|
|
Time-varying effectiveness of the mRNA-1273, BNT162b2 and Ad26.COV2.S vaccines against SARS-CoV-2 infections and COVID-19 hospitalizations and deaths: an analysis based on observational data from Puerto Rico
First Author:
Reviewed: Oct 24, 2021
|
|
Oct 24, 2021
|
|
Vaccine effectiveness of Ad26.COV2.S against symptomatic COVID-19 and clinical outcomes in Brazil: a test-negative study design
First Author:
Reviewed: Oct 24, 2021
|
|
Oct 24, 2021
|
|
A Review on Potentials of Artificial Intelligence Approaches to Forecasting COVID-19 Spreading
First Author:
Reviewed: Oct 20, 2021
|
|
Oct 20, 2021
|
|
Development and Validation of a Multi-lingual Online Questionnaire for Surveying the COVID-19 Prevention and Control Measures used in Global Workplaces
First Author:
Reviewed: Oct 20, 2021
|
|
Oct 20, 2021
|
|
Development, Analyze and Preclinical Evaluation of Inactivated Vaccine Candidate For Prevention of COVID-19 Disease
First Author:
Reviewed: Oct 20, 2021
|
|
Oct 20, 2021
|
|
Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2
First Author:
Reviewed: Oct 20, 2021
|
|
Oct 20, 2021
|
|
Factors influencing COVID-19 vaccines hesitancy in rural and urban West Africa: Implications for vaccination strategies
First Author:
Reviewed: Oct 20, 2021
|
|
Oct 20, 2021
|
|
Memory B cell and humoral responses elicited by Sputnik V in naïve and COVID-19-recovered vaccine recipients
First Author:
Reviewed: Oct 20, 2021
|
|
Oct 20, 2021
|
|
Potent Anti-Delta Effect By a Booster Third-Dose of UB-612, a Precision-Designed SARS-CoV-2 Multitope Protein-Peptide Vaccine
First Author:
Reviewed: Oct 20, 2021
|
|
Oct 20, 2021
|
|
Risk Factors of SARS-CoV-2 and Follow-up in Patients with Common Underlying Diseases on the Dynamic Changes of Antibodies: A Cross-sectional Study
First Author:
Reviewed: Oct 20, 2021
|
|
Oct 20, 2021
|
|
SARS-COV-2 δ variant drives the pandemic in the USA through two subvariants
First Author:
Reviewed: Oct 20, 2021
|
|
Oct 20, 2021
|
|
Shedding of Infectious SARS-CoV-2 Despite Vaccination
First Author:
Reviewed: Oct 20, 2021
|
|
Oct 20, 2021
|
|
Tracking the kinetics and phenotype of spike epitope-specific CD4 T cell immunity in the context of SARS-CoV-2 infection and vaccination
First Author:
Reviewed: Oct 20, 2021
|
|
Oct 20, 2021
|
|
A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses
First Author:
Reviewed: Oct 18, 2021
|
|
Oct 18, 2021
|
|
A Novel Systems Model to Simulate the Dynamics for the Analytical Study of the Proliferation of COVID-19
First Author:
Reviewed: Oct 18, 2021
|
|
Oct 18, 2021
|
|
A Rapid Bead-Based Assay For Screening Of SARS-CoV-2 Neutralising Antibodies
First Author:
Reviewed: Oct 18, 2021
|
|
Oct 18, 2021
|
|
A spatial vaccination strategy to reduce the risk of vaccine-resistant variants
First Author:
Reviewed: Oct 18, 2021
|
|
Oct 18, 2021
|
|
A Third Dose of SARS-CoV-2 Vaccine Increases Neutralizing Antibodies Against Variants of Concern in Solid Organ Transplant Recipients
First Author:
Reviewed: Oct 18, 2021
|
|
Oct 18, 2021
|
|
An objective systematic comparison of the most common adverse events of COVID-19 vaccines
First Author:
Reviewed: Oct 18, 2021
|
|
Oct 18, 2021
|
|
Breakthrough SARS-CoV-2 Infections after Vaccination in North Carolina
First Author:
Reviewed: Oct 18, 2021
|
|
Oct 18, 2021
|
|
Breakthrough SARS-CoV-2 infections in 620,000 U.S. Veterans, February 1, 2021 to August 13, 2021
First Author:
Reviewed: Oct 18, 2021
|
|
Oct 18, 2021
|
|
Breastfeeding infants receive neutralizing antibodies and cytokines from mothers immunized with a COVID-19 mRNA vaccine
First Author:
Reviewed: Oct 18, 2021
|
|
Oct 18, 2021
|
|
Comparative immunogenicity and effectiveness of mRNA-1273, BNT162b2 and Ad26.COV2.S COVID-19 vaccines
First Author:
Reviewed: Oct 18, 2021
|
|
Oct 18, 2021
|
|
Covid-19 genomic analysis reveals clusters of emerging sublineages within the delta variant
First Author:
Reviewed: Oct 18, 2021
|
|
Oct 18, 2021
|
|
Deep phylogenetic-based clustering analysis uncovers new and shared mutations in SARS-CoV-2 variants as a result of directional and convergent evolution
First Author:
Reviewed: Oct 18, 2021
|
|
Oct 18, 2021
|
|
Detection of neutralizing antibodies against SARS-CoV-2 by using a commercial surrogate virus neutralization ELISA: can it substitute the classical neutralization test?
First Author:
Reviewed: Oct 18, 2021
|
|
Oct 18, 2021
|
|
Differential anchoring effects of vaccination comparator selection: characterizing a potential bias due to healthcare utilization in COVID-19 versus influenza
First Author:
Reviewed: Oct 18, 2021
|
|
Oct 18, 2021
|
|
Differential immunogenicity of homologous versus heterologous boost in Ad26.COV2.S vaccine recipients
First Author:
Reviewed: Oct 18, 2021
|
|
Oct 18, 2021
|
|
Differentiation of SARS-CoV-2 naturally infected and vaccinated individuals in an inner-city emergency department
First Author:
Reviewed: Oct 18, 2021
|
|
Oct 18, 2021
|
|
Disparities in SARS-CoV-2 exposure: evidence from a citywide seroprevalence study in Holyoke, Massachusetts, USA
First Author:
Reviewed: Oct 18, 2021
|
|
Oct 18, 2021
|
|
Effect of heterologous vaccination regimen with Ad5-nCoV CanSinoBio and BNT162b2 Pfizer in SARS-CoV-2 IgG antibodies titers
First Author:
Reviewed: Oct 18, 2021
|
|
Oct 18, 2021
|
|
Effect of SARS-CoV-2 vaccination on symptoms from post-acute COVID syndrome: results from the national VAXILONG survey
First Author:
Reviewed: Oct 18, 2021
|
|
Oct 18, 2021
|
|
Effectiveness of the BNT162b2 (Pfizer-BioNTech) and the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccines for reducing susceptibility to infection with the Delta variant (B.1.617.2) of SARS-CoV-2
First Author:
Reviewed: Oct 18, 2021
|
|
Oct 18, 2021
|
|
Effects of Age, Sex, Serostatus and Underlying Comorbidities on Humoral Response Post-SARS-CoV-2 Pfizer-BioNTech Vaccination – A Systematic Review
First Author:
Reviewed: Oct 18, 2021
|
|
Oct 18, 2021
|
|
Heterologous SARS-CoV-2 Booster Vaccinations – Preliminary Report
First Author:
Reviewed: Oct 18, 2021
|
|
Oct 18, 2021
|
|
Immunity to SARS-CoV-2 up to 15 months after infection
First Author:
Reviewed: Oct 18, 2021
|
|
Oct 18, 2021
|
|
Immunogenicity of SARS-CoV-2 trimetric spike protein associated to Poly(I:C) plus Alum
First Author:
Reviewed: Oct 18, 2021
|
|
Oct 18, 2021
|
|
Modelling airborne transmission of SARS-CoV-2 using CARA: Risk assessment for enclosed spaces
First Author:
Reviewed: Oct 18, 2021
|
|
Oct 18, 2021
|
|
One-shot immunization with Sputnik Light (the first component of Sputnik V vaccine) is effective against SARS-CoV-2 Delta variant: efficacy data on the use of the vaccine in civil circulation in Moscow
First Author:
Reviewed: Oct 18, 2021
|
|
Oct 18, 2021
|
|
Phase 2 Randomized Trial of an AS03 Adjuvanted Plant-Based Virus-Like Particle Vaccine for Covid-19 in Healthy Adults, Older Adults and Adults with Comorbidities
First Author:
Reviewed: Oct 18, 2021
|
|
Oct 18, 2021
|
|
Public T-cell epitopes shared among SARS-CoV-2 variants are presented on prevalent HLA class I alleles
First Author:
Reviewed: Oct 18, 2021
|
|
Oct 18, 2021
|
|
Resource Allocation for Different Types of Vaccines against COVID-19: Tradeoffs and Synergies between Efficacy and Reach
First Author:
Reviewed: Oct 18, 2021
|
|
Oct 18, 2021
|
|
Safely return to schools and offices: early and frequent screening with high sensitivity antigen tests effectively identifies COVID-19 patients
First Author:
Reviewed: Oct 18, 2021
|
|
Oct 18, 2021
|
|
SARS-CoV-2 vaccine antibody response and breakthrough infection in dialysis
First Author:
Reviewed: Oct 18, 2021
|
|
Oct 18, 2021
|
|
SARS-CoV-2 variants exhibit increased kinetic stability of open spike conformations as an evolutionary strategy
First Author:
Reviewed: Oct 18, 2021
|
|
Oct 18, 2021
|
|
The adenosine analogue prodrug ATV006 is orally bioavailable and has potent preclinical efficacy against SARS-CoV-2 and its variants
First Author:
Reviewed: Oct 18, 2021
|
|
Oct 18, 2021
|
|
The impact of mandatory COVID-19 certificates on vaccine uptake: Synthetic Control Modelling of Six Countries
First Author:
Reviewed: Oct 18, 2021
|
|
Oct 18, 2021
|
|
Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), August-September 2021, the Netherlands
First Author:
Reviewed: Oct 18, 2021
|
|
Oct 18, 2021
|
|
Willingness to take the Covid-19 vaccines and associated factors at a tertiary institution community in Johannesburg, South Africa
First Author:
Reviewed: Oct 18, 2021
|
|
Oct 18, 2021
|
|
Cellular and Antibody Immunity after COVID-19 Vaccination at >4-Month Follow Up in Immunocompetent and Immunocompromised Subjects
First Author:
Reviewed: Oct 15, 2021
|
|
Oct 15, 2021
|
|
DECREASED BREADTH OF THE ANTIBODY RESPONSE TO THE SPIKE PROTEIN OF SARS-CoV-2 AFTER REPEATED VACCINATION
First Author:
Reviewed: Oct 15, 2021
|
|
Oct 15, 2021
|
|
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico
First Author:
Reviewed: Oct 15, 2021
|
|
Oct 15, 2021
|
|
Integrating Health Belief model to determine factors associated with COVID-19 Vaccine Acceptance in Lebanon: Differences between health care workers and non-healthcare workers
First Author:
Reviewed: Oct 15, 2021
|
|
Oct 15, 2021
|
|
Quantum Optical Immunoassay: Upconversion Nanoparticle-based
Neutralizing Assay for COVID-19
First Author:
Reviewed: Oct 15, 2021
|
|
Oct 15, 2021
|
|
Safety and immunogenicity of a SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in healthy adults: interim findings from a phase 2, randomised, dose-finding, multi-centre study
First Author:
Reviewed: Oct 15, 2021
|
|
Oct 15, 2021
|
|
SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial
First Author:
Reviewed: Oct 15, 2021
|
|
Oct 15, 2021
|
|
DeepABM: Scalable, efficient and differentiable agent-based simulations
via graph neural networks
First Author:
Reviewed: Oct 14, 2021
|
|
Oct 14, 2021
|
|
LinearDesign: Efficient Algorithms for Optimized mRNA Sequence Design
First Author:
Reviewed: Oct 14, 2021
|
|
Oct 14, 2021
|
|
A Retrospective Analysis of COVID-19 mRNA Vaccine Breakthrough Infections – Risk Factors and Vaccine Effectiveness
First Author:
Reviewed: Oct 13, 2021
|
|
Oct 13, 2021
|
|
A twelve-month projection to September 2022 of the Covid-19 epidemic in the UK using a Dynamic Causal Model
First Author:
Reviewed: Oct 13, 2021
|
|
Oct 13, 2021
|
|
A universal TLR7-nanoparticle adjuvant promotes broad immune responses against heterologous strains of Influenza and SARS-CoV-2
First Author:
Reviewed: Oct 13, 2021
|
|
Oct 13, 2021
|
|
Active immunization by COVID-19 mRNA vaccine results in rapid antibody response and virus reduction in breakthrough infection by Delta (B.1.617.2)
First Author:
Reviewed: Oct 13, 2021
|
|
Oct 13, 2021
|
|
An Ultrapotent Neutralizing Bispecific Antibody with Broad Spectrum Against SARS-CoV-2 Variants
First Author:
Reviewed: Oct 13, 2021
|
|
Oct 13, 2021
|
|
Antigen receptor stimulation drives selection against pathogenic mtDNA variants that dysregulate lymphocyte responses
First Author:
Reviewed: Oct 13, 2021
|
|
Oct 13, 2021
|
|
Characterizing the spatiotemporal heterogeneity of the COVID-19 vaccination landscape
First Author:
Reviewed: Oct 13, 2021
|
|
Oct 13, 2021
|
|
Comparison of antibody immune responses between BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines in naïve and previously infected individuals
First Author:
Reviewed: Oct 13, 2021
|
|
Oct 13, 2021
|
|
Comprehensive antibody profiling of mRNA vaccination in children
First Author:
Reviewed: Oct 13, 2021
|
|
Oct 13, 2021
|
|
Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein after infection and/or vaccination
First Author:
Reviewed: Oct 13, 2021
|
|
Oct 13, 2021
|
|
COVID-19 Vaccine Effectiveness by Product and Timing in New York State
First Author:
Reviewed: Oct 13, 2021
|
|
Oct 13, 2021
|
|
Covid-19 vaccine perceptions in Senegal and in Mali: a mixed approach
First Author:
Reviewed: Oct 13, 2021
|
|
Oct 13, 2021
|
|
Defective neutralizing antibody response to SARS-CoV-2 in vaccinated dialysis patients
First Author:
Reviewed: Oct 13, 2021
|
|
Oct 13, 2021
|
|
Estimating the effectiveness of first dose of COVID-19 vaccine against mortality in England: a quasi-experimental study
First Author:
Reviewed: Oct 13, 2021
|
|
Oct 13, 2021
|
|
Evolution of SARS-CoV-2 immune responses in nursing home residents following full dose of the Comirnaty® COVID-19 vaccine
First Author:
Reviewed: Oct 13, 2021
|
|
Oct 13, 2021
|
|
Illness characteristics of COVID-19 in children infected with the SARS-CoV-2 Delta variant
First Author:
Reviewed: Oct 13, 2021
|
|
Oct 13, 2021
|
|
Inactivated Poliovirus Vaccine Induces Antibodies that Inhibit RNA Synthesis of SARS-CoV-2: An open-label, pre-post vaccine clinical trial
First Author:
Reviewed: Oct 13, 2021
|
|
Oct 13, 2021
|
|
Minority and Rural Coronavirus Insights Study (MRCIS): The Need for Targeted SARS CoV-2 Vaccination Efforts in Minority Populations
First Author:
Reviewed: Oct 13, 2021
|
|
Oct 13, 2021
|
|
Neutralizing antibodies against SARS-CoV-2 variants of concern elicited by the Comirnaty® COVID-19 vaccine in nursing home residents
First Author:
Reviewed: Oct 13, 2021
|
|
Oct 13, 2021
|
|
Poking COVID-19: insights on genomic constraints among immune-related genes between Qatari and Italian populations
First Author:
Reviewed: Oct 13, 2021
|
|
Oct 13, 2021
|
|
Preclinical Immunological Evaluation of an Intradermally Administered Heterologous Vaccine Against SARS-CoV-2 Variants
First Author:
Reviewed: Oct 13, 2021
|
|
Oct 13, 2021
|
|
Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California
First Author:
Reviewed: Oct 13, 2021
|
|
Oct 13, 2021
|
|
Protection Across Age Groups of BNT162b2 Vaccine Booster against Covid-19
First Author:
Reviewed: Oct 13, 2021
|
|
Oct 13, 2021
|
|
Quantifying the COVID19 infection risk due to droplet/aerosol inhalation
First Author:
Reviewed: Oct 13, 2021
|
|
Oct 13, 2021
|
|
Randomised Controlled Trial of Intravenous Nafamostat Mesylate in COVID pneumonitis: Phase 1b/2a Experimental Study to Investigate Safety, Pharmacokinetics and Pharmacodynamics
First Author:
Reviewed: Oct 13, 2021
|
|
Oct 13, 2021
|
|
Safety and Immunogenicity of CoronaVac and ChAdOx1 Against the SARS-CoV-2 Circulating Variants of Concern (Alpha, Delta, Beta) in Thai Healthcare Workers
First Author:
Reviewed: Oct 13, 2021
|
|
Oct 13, 2021
|
|
SARS-COV-2 Neutralizing Activity in Serum Collected from Recovered and Vaccinated Health Care Workers
First Author:
Reviewed: Oct 13, 2021
|
|
Oct 13, 2021
|
|
Seropositivity to Nucleoprotein to detect SARS-CoV-2 infections: a tool to detect breakthrough infections after COVID-19 vaccination
First Author:
Reviewed: Oct 13, 2021
|
|
Oct 13, 2021
|
|
Serum but not mucosal antibody responses are predicted by pre-existing SARS-CoV-2 spike cross-reactive CD4+ T cells following BNT162b2 vaccination in the elderly
First Author:
Reviewed: Oct 13, 2021
|
|
Oct 13, 2021
|
|
Structural inequalities in the pathway to COVID-19 immunity
First Author:
Reviewed: Oct 13, 2021
|
|
Oct 13, 2021
|
|
Markers of memory CD8 T cells depicting the effect of the BNT162b2 mRNA COVID-19 vaccine in Japan
First Author:
Reviewed: Oct 12, 2021
|
|
Oct 12, 2021
|
|
A randomized, double-blind phase I clinical trial of two recombinant dimeric RBD COVID-19 vaccine candidates: safety, reactogenicity and immunogenicity
First Author:
Reviewed: Oct 8, 2021
|
|
Oct 8, 2021
|
|
Adverse events following COVID-19 vaccination in young Japanese people: A case-control study of the risk of systemic adverse events by a questionnaire survey
First Author:
Reviewed: Oct 8, 2021
|
|
Oct 8, 2021
|
|
Adverse events of special interest for COVID-19 vaccines - background incidences vary by sex, age and time period and are affected by the pandemic
First Author:
Reviewed: Oct 8, 2021
|
|
Oct 8, 2021
|
|
B.1.617.3 SARS CoV-2 spike E156G/Δ157-158 mutations contribute to reduced neutralization sensitivity and increased infectivity
First Author:
Reviewed: Oct 8, 2021
|
|
Oct 8, 2021
|
|
Can high SARS-CoV-2 adult vaccination rates help protect unvaccinated children? Evidence from a unique rapid mass vaccination campaign
First Author:
Reviewed: Oct 8, 2021
|
|
Oct 8, 2021
|
|
Clinical utility of Elecsys Anti-SARS-CoV-2 S assay in COVID-19 vaccination: An exploratory analysis of the mRNA-1273 phase 1 trial
First Author:
Reviewed: Oct 8, 2021
|
|
Oct 8, 2021
|
|
COVID-19 Vaccine: Newspaper Coverage of the side effects of the vaccine in Nigeria
First Author:
Reviewed: Oct 8, 2021
|
|
Oct 8, 2021
|
|
Dynamical Regulations On Mobility and Vaccinations To Control Covid19 Spread
First Author:
Reviewed: Oct 8, 2021
|
|
Oct 8, 2021
|
|
Frequency of surveillance testing necessary to reduce transmission of SARS-CoV-2
First Author:
Reviewed: Oct 8, 2021
|
|
Oct 8, 2021
|
|
Full vaccination against COVID-19 suppresses SARS-CoV-2 delta variant and spike gene mutation frequencies and generates purifying selection pressure
First Author:
Reviewed: Oct 8, 2021
|
|
Oct 8, 2021
|
|
Humoral immune responses to COVID-19 vaccination in people living with HIV on suppressive antiretroviral therapy
First Author:
Reviewed: Oct 8, 2021
|
|
Oct 8, 2021
|
|
Humoral response to the BBIBP-CorV vaccine over time in healthcare workers with or without exposure to SARS-CoV-2
First Author:
Reviewed: Oct 8, 2021
|
|
Oct 8, 2021
|
|
Improving vaccination coverage and offering vaccine to all school-age children will allow uninterrupted in-person schooling in King County, WA: Modeling analysis
First Author:
Reviewed: Oct 8, 2021
|
|
Oct 8, 2021
|
|
In Vitro Activity of Cysteamine Against SARS-CoV-2 Variants Alpha, Beta,Gamma and Delta
First Author:
Reviewed: Oct 8, 2021
|
|
Oct 8, 2021
|
|
Longitudinal analysis of antibody responses to the Pfizer BNT162b2 vaccine in Patients Undergoing Maintenance Hemodialysis
First Author:
Reviewed: Oct 8, 2021
|
|
Oct 8, 2021
|
|
Non-pharmaceutical interventions and vaccinating school children required to contain SARS-CoV-2 Delta variant outbreaks in Australia: a modelling analysis
First Author:
Reviewed: Oct 8, 2021
|
|
Oct 8, 2021
|
|
Oral and intranasal Ad5 SARS-CoV-2 vaccines decrease disease and viral transmission in a golden hamster model
First Author:
Reviewed: Oct 8, 2021
|
|
Oct 8, 2021
|
|
Population Changes in Seroprevalence among a Statewide Sample in the United States
First Author:
Reviewed: Oct 8, 2021
|
|
Oct 8, 2021
|
|
SARS-CoV-2 multi-variant graphene biosensor based on engineered dimeric ACE2 receptor
First Author:
Reviewed: Oct 8, 2021
|
|
Oct 8, 2021
|
|
Structure-selected RBM immunogens prime polyclonal memory responses that neutralize SARS-CoV-2 variants of concern
First Author:
Reviewed: Oct 8, 2021
|
|
Oct 8, 2021
|
|
Towards the global equilibrium of COVID-19: statistical analysis of country–level data
First Author:
Reviewed: Oct 8, 2021
|
|
Oct 8, 2021
|
|
Appearance of IgG to SARS-CoV-2 in saliva effectively indicates seroconversion in mRNA vaccinated immunocompromised individuals
First Author:
Reviewed: Oct 7, 2021
|
|
Oct 7, 2021
|
|
Assessing the Burden of COVID-19 in Developing Countries: Systematic Review, Meta-Analysis, and Public Policy Implications
First Author:
Reviewed: Oct 7, 2021
|
|
Oct 7, 2021
|
|
Comparison of Plaque Size, Thermal Stability, and Replication Rate among SARS-CoV-2 Variants of Concern
First Author:
Reviewed: Oct 7, 2021
|
|
Oct 7, 2021
|
|
COVID-19 Neutralizing Antibody Surveillance Testing for Fully Vaccinated Individuals During Delta Variant Spread
First Author:
Reviewed: Oct 7, 2021
|
|
Oct 7, 2021
|
|
Disproportionality analysis of adverse neurological and psychiatric reactions with the ChAdOx1 (Oxford-AstraZeneca) and BNT162b2 (Pfizer-BioNTech) COVID-19 vaccines in the United Kingdom
First Author:
Reviewed: Oct 7, 2021
|
|
Oct 7, 2021
|
|
Effectiveness of mRNA-1273 against Delta, Mu, and other emerging variants
First Author:
Reviewed: Oct 7, 2021
|
|
Oct 7, 2021
|
|
Efficacy of COVID-19 vaccines in immunocompromised patients: A systematic review and meta-analysis
First Author:
Reviewed: Oct 7, 2021
|
|
Oct 7, 2021
|
|
Endemic Seasonal Coronavirus Neutralisation and COVID-19 severity
First Author:
Reviewed: Oct 7, 2021
|
|
Oct 7, 2021
|
|
Humoral and cellular immune responses upon SARS-CoV-2 vaccines in patients with anti-CD20 therapies: A systematic review and meta-analysis of 1342 patients
First Author:
Reviewed: Oct 7, 2021
|
|
Oct 7, 2021
|
|
Immune Memory Response After a Booster Injection of mRNA-1273 for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
First Author:
Reviewed: Oct 7, 2021
|
|
Oct 7, 2021
|
|
Importation Risk Stratification for COVID19 using Quantitative Serology
First Author:
Reviewed: Oct 7, 2021
|
|
Oct 7, 2021
|
|
Longitudinal SARS-CoV-2 testing is punctuated by intermittent positivity and variable rates of cycle-threshold decline
First Author:
Reviewed: Oct 7, 2021
|
|
Oct 7, 2021
|
|
Rapid System to Detect the Main Variants of SARS-CoV-2 in Biological Specimens
First Author:
Reviewed: Oct 7, 2021
|
|
Oct 7, 2021
|
|
Recombinant adjuvanted zoster vaccine and reduced risk of COVID-19 diagnosis and hospitalization in older adults
First Author:
Reviewed: Oct 7, 2021
|
|
Oct 7, 2021
|
|
Risk-benefit analysis of the AstraZeneca COVID-19 vaccine in Australia using a Bayesian network modelling framework
First Author:
Reviewed: Oct 7, 2021
|
|
Oct 7, 2021
|
|
SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared to SARS-CoV-2 mRNA vaccinations
First Author:
Reviewed: Oct 7, 2021
|
|
Oct 7, 2021
|
|
A mixture model for determining SARS-Cov-2 variant composition in pooled
samples
First Author:
Reviewed: Oct 6, 2021
|
|
Oct 6, 2021
|
|
Assessing the impact of SARS-CoV-2 prevention measures in Austrian schools by means of agent-based simulations calibrated to cluster tracing data
First Author:
Reviewed: Oct 6, 2021
|
|
Oct 6, 2021
|
|
Calibrating an SIR model for South Korea COVID-19 infections and predicting vaccination impact
First Author:
Reviewed: Oct 6, 2021
|
|
Oct 6, 2021
|
|
CD19+IgD+CD27- naïve B Cells as predictors of humoral response to COVID-19 mRNA vaccination in immunocompromised patients
First Author:
Reviewed: Oct 6, 2021
|
|
Oct 6, 2021
|
|
Classifying COVID-19 Spike Sequences from Geographic Location Using Deep
Learning
First Author:
Reviewed: Oct 6, 2021
|
|
Oct 6, 2021
|
|
Durability of ChAdOx1 nCov-19 (AZD1222) vaccination in people living with HIV - responses to SARS-CoV-2, variants of concern and circulating coronaviruses
First Author:
Reviewed: Oct 6, 2021
|
|
Oct 6, 2021
|
|
Frequency of surveillance testing necessary to reduce transmission of
SARS-CoV-2
First Author:
Reviewed: Oct 6, 2021
|
|
Oct 6, 2021
|
|
Initial Analysis of Viral Dynamics and Circulating Viral Variants During the mRNA-1273 Phase 3 COVE Trial
First Author:
Reviewed: Oct 6, 2021
|
|
Oct 6, 2021
|
|
No Significant Difference in Viral Load Between Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Groups Infected with SARS-CoV-2 Delta Variant
First Author:
Reviewed: Oct 6, 2021
|
|
Oct 6, 2021
|
|
Predictors of parents’ intention to vaccinate their children against the COVID-19 in Greece: a cross-sectional study
First Author:
Reviewed: Oct 6, 2021
|
|
Oct 6, 2021
|
|
Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibody in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study): prospective cohort study
First Author:
Reviewed: Oct 6, 2021
|
|
Oct 6, 2021
|
|
Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant dependent manner
First Author:
Reviewed: Oct 6, 2021
|
|
Oct 6, 2021
|
|
Protection of Hamsters Challenged with SARS-CoV-2 Variants of Concern by Two Doses of MVC-COV1901 Vaccine Followed by a Single Dose of Beta Variant Version of MVC-COV1901
First Author:
Reviewed: Oct 6, 2021
|
|
Oct 6, 2021
|
|
Reduced antibody activity against SARS-CoV-2 B.1.617.2 Delta virus in serum of mRNA-vaccinated patients receiving TNF-α inhibitors
First Author:
Reviewed: Oct 6, 2021
|
|
Oct 6, 2021
|
|
SARS-Cov-2 Infection versus Vaccine-Induced Immunity among Veterans
First Author:
Reviewed: Oct 6, 2021
|
|
Oct 6, 2021
|
|
SARS-CoV-2 vaccine effectiveness and breakthrough infections in maintenance dialysis patients
First Author:
Reviewed: Oct 6, 2021
|
|
Oct 6, 2021
|
|
Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody
First Author:
Reviewed: Oct 6, 2021
|
|
Oct 6, 2021
|
|
The impact of SARS-CoV-2 vaccination on Alpha & Delta variant transmission
First Author:
Reviewed: Oct 6, 2021
|
|
Oct 6, 2021
|
|
Use of eVLP-based vaccine candidates to broaden immunity against SARS-CoV-2 variants
First Author:
Reviewed: Oct 6, 2021
|
|
Oct 6, 2021
|
|
A novel B.1.1.523 SARS-CoV-2 variant that combines many spike mutations linked to immune evasion with current variants of concern
First Author:
Reviewed: Oct 5, 2021
|
|
Oct 5, 2021
|
|
A novel mechanism for the loss of mRNA activity in lipid nanoparticle delivery systems
First Author:
Reviewed: Oct 5, 2021
|
|
Oct 5, 2021
|
|
A Rapid Antibody Screening Haemagglutination Test for Predicting Immunity to Sars CoV-2 Variants of Concern
First Author:
Reviewed: Oct 5, 2021
|
|
Oct 5, 2021
|
|
Bayesian Inference of State-Level COVID-19 Basic Reproduction Numbers across the United States
First Author:
Reviewed: Oct 5, 2021
|
|
Oct 5, 2021
|
|
Can Tracking Mobility be used as a Public Health Tool Against COVID-19 Following the Expiration of Stay-at-Home Mandates?
First Author:
Reviewed: Oct 5, 2021
|
|
Oct 5, 2021
|
|
ChAdOx1 nCoV-19 (AZD1222) vaccine elicits monoclonal antibodies with potent cross-neutralizing activity against SARS-CoV-2 viral variants
First Author:
Reviewed: Oct 5, 2021
|
|
Oct 5, 2021
|
|
Children develop robust and sustained cross-reactive spike-specific immune responses following SARS-CoV-2 infection
First Author:
Reviewed: Oct 5, 2021
|
|
Oct 5, 2021
|
|
Computational systematics of nutritional support of vaccination against viral and bacterial pathogens as prolegomena to vaccinations against COVID-19
First Author:
Reviewed: Oct 5, 2021
|
|
Oct 5, 2021
|
|
COVID-19 Vaccination Strategies Considering Hesitancy Using Particle-Based Epidemic Simulation
First Author:
Reviewed: Oct 5, 2021
|
|
Oct 5, 2021
|
|
Dichotomy between the humoral and cellular responses elicited by mRNA and adenoviral vector vaccines against SARS-CoV-2
First Author:
Reviewed: Oct 5, 2021
|
|
Oct 5, 2021
|
|
Effectiveness of the mRNA BNT162b2 vaccine against SARS-CoV-2 severe infections in the Israeli over 60 population: a temporal analysis done by using the national surveillance data
First Author:
Reviewed: Oct 5, 2021
|
|
Oct 5, 2021
|
|
Ensemble Forecast of COVID-19 for Vulnerability Assessment and Policy Interventions
First Author:
Reviewed: Oct 5, 2021
|
|
Oct 5, 2021
|
|
Equivalency of Protection from Natural Immunity in COVID-19 Recovered Versus Fully Vaccinated Persons: A Systematic Review and Pooled Analysis
First Author:
Reviewed: Oct 5, 2021
|
|
Oct 5, 2021
|
|
Estimates of presumed population immunity to SARS-CoV-2 by state in the United States, August 2021
First Author:
Reviewed: Oct 5, 2021
|
|
Oct 5, 2021
|
|
Estrogen Hormone Is an Essential Sex Factor Inhibiting Inflammation and Immune Response in COVID-19
First Author:
Reviewed: Oct 5, 2021
|
|
Oct 5, 2021
|
|
Four SARS-CoV-2 vaccines induce quantitatively different antibody responses against SARS-CoV-2 variants
First Author:
Reviewed: Oct 5, 2021
|
|
Oct 5, 2021
|
|
IL13Pred: A method for predicting immunoregulatory cytokine IL-13 inducing peptides for managing COVID-19 severity
First Author:
Reviewed: Oct 5, 2021
|
|
Oct 5, 2021
|
|
Immune Features of COVID-19 Convalescent Individuals Revealed by a Single-cell RNA Sequencing
First Author:
Reviewed: Oct 5, 2021
|
|
Oct 5, 2021
|
|
Induction of robust neutralizing antibodies against the COVID-19 Delta variant with ChAdOx1 nCoV-19 or BNT162b2 as a booster following a primary vaccination series with CoronaVac
First Author:
Reviewed: Oct 5, 2021
|
|
Oct 5, 2021
|
|
Large-scale seroepidemiologic surveillance of COVID-19 - Cross-sectional study in Hyogo prefecture of Japan in August, 2021
First Author:
Reviewed: Oct 5, 2021
|
|
Oct 5, 2021
|
|
Methods for Estimation of SARS-CoV-2 Seroprevalence and Reported COVID-19 Cases in U.S. Children, August 2020—May 2021
First Author:
Reviewed: Oct 5, 2021
|
|
Oct 5, 2021
|
|
Modeling of COVID-19 Transmission Dynamics on US Population: Inter-transfer Infection in Age Groups, Mutant Variants and Vaccination Strategies
First Author:
Reviewed: Oct 5, 2021
|
|
Oct 5, 2021
|
|
NETosis and thrombosis in vaccine-induced immune thrombotic thrombocytopenia
First Author:
Reviewed: Oct 5, 2021
|
|
Oct 5, 2021
|
|
Novel neutralization mechanism of a human antibody with pan-coronavirus reactivity
First Author:
Reviewed: Oct 5, 2021
|
|
Oct 5, 2021
|
|
Optimized Post-Vaccination Strategies and Preventative Measures for SARS-CoV-2
First Author:
Reviewed: Oct 5, 2021
|
|
Oct 5, 2021
|
|
Predictors of COVID-19 Vaccine Acceptability Among Health Professions Students in Vietnam
First Author:
Reviewed: Oct 5, 2021
|
|
Oct 5, 2021
|
|
Prior Covid-19 and high RBD-IgG levels correlate with protection against VOC-δ SARS-CoV-2 infection in vaccinated nursing home residents
First Author:
Reviewed: Oct 5, 2021
|
|
Oct 5, 2021
|
|
Quantifying the role of naturally- and vaccine-derived neutralizing antibodies as a correlate of protection against COVID-19 variants
First Author:
Reviewed: Oct 5, 2021
|
|
Oct 5, 2021
|
|
Real-world serologic responses to Extended-interval and Heterologous COVID-19 mRNA vaccination in Frail Elderly - Interim report from a prospective observational cohort study
First Author:
Reviewed: Oct 5, 2021
|
|
Oct 5, 2021
|
|
The BNT162b2 mRNA vaccine induces polyfunctional T cell responses with features of longevity
First Author:
Reviewed: Oct 5, 2021
|
|
Oct 5, 2021
|
|
The Impact of Vaccinations on COVID-19 Case Rates at the State Level
First Author:
Reviewed: Oct 5, 2021
|
|
Oct 5, 2021
|
|
The Kinetics of COVID-19 Vaccine Response in a Community Vaccinated Population
First Author:
Reviewed: Oct 5, 2021
|
|
Oct 5, 2021
|
|
The longitudinal kinetics of antibodies in COVID-19 recovered patients over 14 months
First Author:
Reviewed: Oct 5, 2021
|
|
Oct 5, 2021
|
|
Vaccine effectiveness and duration of protection of Comirnaty, Vaxzevria and Spikevax against mild and severe COVID-19 in the UK
First Author:
Reviewed: Oct 5, 2021
|
|
Oct 5, 2021
|
|
Vaccine efficacy and SARS CoV 2 control in California and USA during the
session 2020 2026: A modeling study
First Author:
Reviewed: Oct 5, 2021
|
|
Oct 5, 2021
|
|
A multiplex serological assay for the characterization of IgG immune response to SARS-CoV-2
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
A system biology approach identifies candidate drugs to reduce mortality in severely ill COVID-19 patients
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
A systematic review of COVID-19 vaccine efficacy and effectiveness against SARS-CoV-2 infection and disease
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
Antibody titers against the Alpha, Beta, Gamma, and Delta variants of SARS-CoV-2 induced by BNT162b2 vaccination measured using automated chemiluminescent enzyme immunoassay
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
Anti-PF4 VITT antibodies are oligoclonal and variably inhibited by heparin
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
Broad ultra-potent neutralization of SARS-CoV-2 variants by monoclonal antibodies specific to the tip of RBD
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
Comparison of adverse events between COVID-19 and Flu vaccines
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
COVID-19 in low-tolerance border quarantine systems: impact of the Delta
variant of SARS-CoV-2
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
Covid-19 in the Phase 3 Trial of mRNA-1273 During the Delta-variant Surge
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
COVID-19 mortality risk correlates inversely with vitamin D3 status, and a mortality rate close to zero could theoretically be achieved at 50 ng/ml 25(OH)D3: Results of a systematic review and meta-analysis
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
COVID-19 Vaccine Breakthrough Infections in Veterans Health Administration
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
COVID-19 vaccine hesitancy and vaccine passports: Vaccination or restriction?
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
Cytotoxic T-cell-based vaccine against SARS-CoV2: a hybrid immunoinformatic approach
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
Demographic characteristics of SARS-CoV-2 B.1.617.2 (Delta) variant infections in Indian population
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
Design of Peptide Vaccine for COVID19: CD8+ and CD4+ T cell epitopes from SARS-CoV-2 open-reading-frame protein variants
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
Determinants of COVID-19 Vaccine Behaviour Intentions Among The Youth In Kenya: A Vaccine Pre-Introduction Study
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
Development and evaluation of a machine learning-based in-hospital COvid-19 Disease Outcome Predictor (CODOP): a multicontinental retrospective study
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
Development of lipidoid nanoparticles for siRNA delivery to neural cells
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
Divergence of delta and beta variants and SARS-CoV-2 evolved in prolonged infection into distinct serological phenotypes
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
Effectiveness of vaccination in preventing severe SARS CoV-2 infection in South India-a hospital-based cross-sectional study
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
Efficacy and Safety of ACEIs/ARBs in Patients with COVID-19 Combined with Chronic Kidney Disease: a Protocol for Systematic Review and Meta-analysis
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
Emergence and phenotypic characterization of C.1.2, a globally detected lineage that rapidly accumulated mutations of concern
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
Equitable vaccine distribution promotes socioeconomic benefits globally
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
Estimating vaccine confidence levels among healthcare staff and students of a tertiary institution in South Africa
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
Genomic analysis of SARS-CoV-2 breakthrough infections from Varanasi, India
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
Identification of HLA-A*24:02-restricted CTL candidate epitopes derived from the non-structural polyprotein 1a of SARS-CoV-2 and analysis of their conservation using the mutation database of SARS-CoV-2 variants
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
Immune profile and responses of a novel Dengue DNA vaccine encoding EDIII-NS1 consensus design based on Indo-African sequences
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
Impact of prior SARS-CoV-2 infection on post-vaccination SARS-CoV-2 spike IgG antibodies in a longitudinal cohort of healthcare workers
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
Information-Sharing Reduces Anxiety Towards Vaccines for SARS-CoV-2 in Patients With Autoimmune Liver Disease
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
Long Term Accuracy of SARS-CoV-2 Interferon-γ Release Assay and its Application in Household Investigation
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
Modeling the transmission of the SARS-CoV-2 delta variant in a partially vaccinated population
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
Multiple Sites of Thrombosis Without Thrombocytopenia After a Second Dose of Pfizer-BioNTech COVID-19 Vaccine
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
Networks of Necessity: Simulating COVID-19 Mitigation Strategies for
Disabled People and Their Caregivers
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
Neutralizing efficacy of vaccines against the SARS-CoV-2 Mu variant
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
On the parametrization of epidemiologic models -- lessons from modelling
COVID-19 epidemic
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
Optimal vaccine roll-out strategies with respect to social distancing
measures for SARS-CoV-2 pandemic
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
Pandemic Policy Design Via Feedback: A Modelling Study
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
Persistent while declined neutralizing antibody responses in the convalescents of COVID-19 across clinical spectrum during the 16 months follow up
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
Personal care formulations demonstrate virucidal efficacy against multiple SARS-CoV-2 variants of concern: implications for hand hygiene
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
Profiles of US Hispanics Unvaccinated for COVID-19
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
Projecting the Impact of Covid-19 Variants and Vaccination Strategies in
Disease Transmission using a Multilayer Network Model in Costa Rica
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
Rapid semi-quantitative point of care diagnostic test for post vaccination antibody monitoring
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
Risk Factors for Low Humoral Response to BNT-162b2 In Hemodialysis Patients
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
Successive pandemic waves with more virulent strains, and the effects of vaccination for SARS-CoV-2
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
The evolution of COVID-19 pandemic wave and optimal levels of vaccination to reduce negative effects in society
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
The Impact of New SARS-CoV-2 Variants on Vaccine Breakthrough: A Pilot Study on Spreading Infection in the Communities
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
The importance of sustained compliance with physical distancing during COVID-19 vaccination rollout
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
Thrombotic adverse events reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 vaccines: comparison of occurrence and clinical outcomes in the EudraVigilance database
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
Toward Using Twitter Data to Monitor Covid-19 Vaccine Safety in Pregnancy
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
Vaccine Induced Thrombotic Thrombocytopenia (VITT): First report from India and utility of risk score for diagnosis in resource limited settings.
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
Viral loads and profile of the patients infected with SARS-CoV-2 Delta, Alpha or R.1 variants in Tokyo
First Author:
Reviewed: Oct 4, 2021
|
|
Oct 4, 2021
|
|
Analysis of the Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine in Breast Cancer Patients Treated With Cyclin-Dependent Kinases 4 and 6 Inhibitors (CDKi): Limited T-Cell Immunity Despite Satisfactory Humoral Response.
First Author:
Reviewed: Sep 30, 2021
|
|
Sep 30, 2021
|
|
Efficacy and Effectiveness of SARS-CoV-2 vaccine: A systematic review and a meta-analysis.
First Author:
Reviewed: Sep 30, 2021
|
|
Sep 30, 2021
|
|
Comparative analysis of human immune responses following SARS-CoV-2 vaccination with BNT162b2, mRNA-1273, or Ad26.COV2.S
First Author:
Reviewed: Sep 28, 2021
|
|
Sep 28, 2021
|
|
Comparative single-dose mRNA and ChAdOx1 vaccine effectiveness against SARS-CoV-2, including early variants of concern: a test-negative design, British Columbia, Canada
First Author:
Reviewed: Sep 28, 2021
|
|
Sep 28, 2021
|
|
Effectiveness of COVID-19 Vaccines: Eight Months Post Single Dose Vaccination
First Author:
Reviewed: Sep 28, 2021
|
|
Sep 28, 2021
|
|
Human Milk Antibodies Elicited by BNT162b2 Vaccination have reduced activity against SARS-CoV-2 Variants of Concern
First Author:
Reviewed: Sep 28, 2021
|
|
Sep 28, 2021
|
|
HUMORAL AND CELLULAR IMMUNOGENICITY and SAFETY UP TO 4 MONTHS AFTER VACCINATION WITH BNT162B2 mRNA COVID-19 VACCINE IN HEART AND LUNG TRANSPLANTED YOUNG ADULTS
First Author:
Reviewed: Sep 28, 2021
|
|
Sep 28, 2021
|
|
Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine in people living with HIV-1
First Author:
Reviewed: Sep 28, 2021
|
|
Sep 28, 2021
|
|
mRNA-1273 vaccine (Moderna): a better option than BNT162b2 (Pfizer) in kidney transplant recipients and dialysis patients?
First Author:
Reviewed: Sep 28, 2021
|
|
Sep 28, 2021
|
|
Real-world Effectiveness of 2-dose SARS-CoV-2 Vaccination in Kidney Transplant Recipients
First Author:
Reviewed: Sep 28, 2021
|
|
Sep 28, 2021
|
|
The Delta Variant Had Negligible Impact on COVID-19 Vaccine Effectiveness in the USA
First Author:
Reviewed: Sep 28, 2021
|
|
Sep 28, 2021
|
|
The slower antibody response in myelofibrosis patients after two doses of mRNA SARS-CoV-2 vaccine calls for a third dose
First Author:
Reviewed: Sep 28, 2021
|
|
Sep 28, 2021
|
|
Two doses of the mRNA BNT162b2 vaccine reduce severe outcomes, viral load and secondary attack rate: evidence from a SARS-CoV-2 Alpha outbreak in a nursing home in Germany, January-March 2021
First Author:
Reviewed: Sep 28, 2021
|
|
Sep 28, 2021
|
|
Virological and Serological Characterization of SARS-CoV-2 Infections Diagnosed After mRNA BNT162b2 Vaccination
First Author:
Reviewed: Sep 28, 2021
|
|
Sep 28, 2021
|
|
Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomized controlled trial
First Author:
Reviewed: Sep 27, 2021
|
|
Sep 27, 2021
|
|
Durability analysis of the highly effective BNT162b2 vaccine against COVID-19
First Author:
Reviewed: Sep 27, 2021
|
|
Sep 27, 2021
|
|
Effectiveness of the mRNA BNT162b2 vaccine six months after vaccination: findings from a large Israeli HMO
First Author:
Reviewed: Sep 27, 2021
|
|
Sep 27, 2021
|
|
Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals
First Author:
Reviewed: Sep 27, 2021
|
|
Sep 27, 2021
|
|
Immunogenicity of a third dose viral-vectored COVID-19 vaccine after receiving two-dose inactivated vaccines in healthy adults
First Author:
Reviewed: Sep 27, 2021
|
|
Sep 27, 2021
|
|
Immunogenicity of Pfizer mRNA COVID-19 vaccination followed by J&J adenovirus COVID-19 vaccination in two CLL patients
First Author:
Reviewed: Sep 27, 2021
|
|
Sep 27, 2021
|
|
Ineffective neutralization of the SARS-CoV-2 Mu variant by convalescent and vaccine sera
First Author:
Reviewed: Sep 27, 2021
|
|
Sep 27, 2021
|
|
SARS-CoV-2 epidemic in the South American Southern cone: can combined immunity from vaccination and infection prevent the spread of Gamma and Lambda variants while easing restrictions?
First Author:
Reviewed: Sep 27, 2021
|
|
Sep 27, 2021
|
|
Single-Dose SARS-CoV-2 Vaccination With BNT162b2 and AZD1222 Induce Disparate Th1 Responses and IgA Production
First Author:
Reviewed: Sep 27, 2021
|
|
Sep 27, 2021
|
|
Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a sixteen-week interval between doses
First Author:
Reviewed: Sep 27, 2021
|
|
Sep 27, 2021
|
|
A thermostable oral SARS-CoV-2 vaccine induces mucosal and protective immunity
First Author:
Reviewed: Sep 24, 2021
|
|
Sep 24, 2021
|
|
Antibody responses to BNT162b2 mRNA vaccine: infection-naïve individuals with abdominal obesity warrant attention
First Author:
Reviewed: Sep 24, 2021
|
|
Sep 24, 2021
|
|
Anti-SARS-CoV-2 IgG and IgA antibodies in COVID-19 convalescent plasma do not facilitate antibody-dependent enhance of viral infection
First Author:
Reviewed: Sep 24, 2021
|
|
Sep 24, 2021
|
|
BNT162b2-Elicited Neutralization of Delta Plus, Lambda, and Other Variants
First Author:
Reviewed: Sep 24, 2021
|
|
Sep 24, 2021
|
|
Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variants
First Author:
Reviewed: Sep 24, 2021
|
|
Sep 24, 2021
|
|
Controlling simulated outbreaks of new SARS-CoV-2 variants
First Author:
Reviewed: Sep 24, 2021
|
|
Sep 24, 2021
|
|
Correlates of COVID-19 vaccine acceptance, hesitancy and refusal among employees of a safety net California county health system with an early and aggressive vaccination program: Results from a cross-sectional survey
First Author:
Reviewed: Sep 24, 2021
|
|
Sep 24, 2021
|
|
COVID-19 Vaccine Concerns about Safety, Effectiveness and Policies in the United States, Canada, Sweden, and Italy among Unvaccinated Individuals
First Author:
Reviewed: Sep 24, 2021
|
|
Sep 24, 2021
|
|
Differential antibody dynamics to SARS-CoV-2 infection and vaccination
First Author:
Reviewed: Sep 24, 2021
|
|
Sep 24, 2021
|
|
EFFICACY OF THE MEASLES-MUMPS-RUBELLA (MMR) VACCINE IN THE REDUCING THE SEVERITY OF COVID-19: AN INTERIM ANALYSIS OF A RANDOMISED CONTROLLED CLINICAL TRIAL
First Author:
Reviewed: Sep 24, 2021
|
|
Sep 24, 2021
|
|
ESC - a comprehensive resource for SARS-CoV-2 immune escape variants
First Author:
Reviewed: Sep 24, 2021
|
|
Sep 24, 2021
|
|
Evolution of COVID-19 mortality over time: results from the Swiss hospital surveillance system (CH-SUR)
First Author:
Reviewed: Sep 24, 2021
|
|
Sep 24, 2021
|
|
Expert Opinion on COVID-19 Vaccination and the Use of Cladribine Tablets in Clinical Practice
First Author:
Reviewed: Sep 24, 2021
|
|
Sep 24, 2021
|
|
Herd immunity induced by COVID-19 vaccination programs and suppression of epidemics caused by the SARS-CoV-2 Delta variant in China
First Author:
Reviewed: Sep 24, 2021
|
|
Sep 24, 2021
|
|
Impact of multiple sclerosis disease-modifying therapies on SARS-CoV-2 vaccine-induced antibody and T cell immunity
First Author:
Reviewed: Sep 24, 2021
|
|
Sep 24, 2021
|
|
Induction of trained immunity by influenza vaccination - impact on COVID-19
First Author:
Reviewed: Sep 24, 2021
|
|
Sep 24, 2021
|
|
Infectious SARS-CoV-2 in Exhaled Aerosols and Efficacy of Masks During Early Mild Infection
First Author:
Reviewed: Sep 24, 2021
|
|
Sep 24, 2021
|
|
Intranasal administration of a VLP-based vaccine against COVID-19 induces neutralizing antibodies against SARS-CoV-2 and Variants of Concerns
First Author:
Reviewed: Sep 24, 2021
|
|
Sep 24, 2021
|
|
Maintenance of Broad Neutralising Antibodies and Memory B Cells 12 Months Post-Infection Is Predicted by SARS-CoV-2 Specific CD4+ T Cell Responses
First Author:
Reviewed: Sep 24, 2021
|
|
Sep 24, 2021
|
|
Masking significantly reduces, but does not eliminate COVID-19 infection in a spatial agent-based simulation of a University dormitory floor
First Author:
Reviewed: Sep 24, 2021
|
|
Sep 24, 2021
|
|
Monitoring and forecasting the SARS-CoV-2 pandemic in France
First Author:
Reviewed: Sep 24, 2021
|
|
Sep 24, 2021
|
|
Quantitative measurement of infectious virus in SARS-CoV-2 Alpha, Delta and Epsilon variants reveals higher infectivity (viral titer:RNA ratio) in clinical samples containing the Delta and Epsilon variants
First Author:
Reviewed: Sep 24, 2021
|
|
Sep 24, 2021
|
|
REACT-1 round 13 final report: exponential growth, high prevalence of SARS-CoV-2 and vaccine effectiveness associated with Delta variant in England during May to July 2021
First Author:
Reviewed: Sep 24, 2021
|
|
Sep 24, 2021
|
|
Reports of myocarditis and pericarditis following mRNA COVID-19 vaccines: A review of spontaneously reported data from the UK, Europe, and the US
First Author:
Reviewed: Sep 24, 2021
|
|
Sep 24, 2021
|
|
Safety and Immunogenicity of an Inactivated Recombinant Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomised, Placebo-Controlled, Phase 1/2 Trial
First Author:
Reviewed: Sep 24, 2021
|
|
Sep 24, 2021
|
|
Self-reported and physiological reactions to the third BNT162b2 mRNA COVID-19 (booster) vaccine dose
First Author:
Reviewed: Sep 24, 2021
|
|
Sep 24, 2021
|
|
Seroprevalence of anti-SARS-CoV-2 IgG and IgA antibodies before the launch of COVID-19 vaccination in Kazakhstan
First Author:
Reviewed: Sep 24, 2021
|
|
Sep 24, 2021
|
|
Y380Q novel mutation in receptor-binding domain of SARS-CoV-2 spike protein together with C379W interfere in the neutralizing antibodies interaction
First Author:
Reviewed: Sep 24, 2021
|
|
Sep 24, 2021
|
|
A bacterial extracellular vesicle-based intranasal vaccine against SARS-CoV-2 protects against disease and elicits neutralizing antibodies to wild-type virus and Delta variant
First Author:
Reviewed: Sep 23, 2021
|
|
Sep 23, 2021
|
|
Adverse reactions to BNT162b2 mRNA COVID-19 vaccine in medical staffs with a history of allergy
First Author:
Reviewed: Sep 23, 2021
|
|
Sep 23, 2021
|
|
Characteristics associated with COVID-19 vaccine uptake among adults in England (08 December – 17 May 2021)
First Author:
Reviewed: Sep 23, 2021
|
|
Sep 23, 2021
|
|
Effectiveness of COVID-19 Vaccines Against SARS-CoV-2 Infection During a Delta Variant Epidemic Surge in Multnomah County, Oregon, July 2021
First Author:
Reviewed: Sep 23, 2021
|
|
Sep 23, 2021
|
|
Efficacy of two doses of COVID-19 vaccine against severe COVID-19 in those with risk conditions and residual risk to the clinically extremely vulnerable: the REACT-SCOT case-control study
First Author:
Reviewed: Sep 23, 2021
|
|
Sep 23, 2021
|
|
High Seroconversion Rates Amongst Black and Hispanics With Hematologic Malignancies after SARS-CoV-2 Vaccination
First Author:
Reviewed: Sep 23, 2021
|
|
Sep 23, 2021
|
|
Humoral immune responses against seasonal coronaviruses predict efficiency of SARS-CoV-2 spike targeting, FcγR activation, and corresponding COVID-19 disease severity
First Author:
Reviewed: Sep 23, 2021
|
|
Sep 23, 2021
|
|
mRNA COVID-19 Vaccination and Development of CMR-confirmed Myopericarditis
First Author:
Reviewed: Sep 23, 2021
|
|
Sep 23, 2021
|
|
Neutralizing antibody-independent immunity to SARS-CoV-2 in hamsters and hACE-2 transgenic mice immunized with a RBD/Nucleocapsid fusion protein
First Author:
Reviewed: Sep 23, 2021
|
|
Sep 23, 2021
|
|
Platelet polyphosphate and SARS-Cov-2 mRNA-vaccine-induced inflammatory side effects: a pilot study
First Author:
Reviewed: Sep 23, 2021
|
|
Sep 23, 2021
|
|
Real-World Effectiveness of the mRNA-1273 Vaccine Against COVID-19: Interim Results from a Prospective Observational Cohort Study
First Author:
Reviewed: Sep 23, 2021
|
|
Sep 23, 2021
|
|
Reduced levels of convalescent neutralizing antibodies against SARS-CoV-2 B.1+L249S+E484K lineage
First Author:
Reviewed: Sep 23, 2021
|
|
Sep 23, 2021
|
|
Social Capital Dimensions are Differentially Associated with COVID-19 Vaccinations, Masks, and Physical Distancing *
First Author:
Reviewed: Sep 23, 2021
|
|
Sep 23, 2021
|
|
The Impact of COVID-19 Vaccine on Rate of Hospitalization and Outcome of COVID-19 Infection in a Single Center in the Eastern Province of Saudi Arabia
First Author:
Reviewed: Sep 23, 2021
|
|
Sep 23, 2021
|
|
An adjuvanted subunit SARS-CoV-2 spike protein vaccine provides protection against Covid-19 infection and transmission
First Author:
Reviewed: Sep 22, 2021
|
|
Sep 22, 2021
|
|
Assessing the impact of long-term exposure to nine outdoor air pollutants on spatial spread of Covid-19: evidence from 107 Italian provinces
First Author:
Reviewed: Sep 22, 2021
|
|
Sep 22, 2021
|
|
Attitudes, Perceptions, and Experiences of Side Effects of COVID-19 Vaccines in Malaysia: Do Age, Gender and Vaccine Type Matter?
First Author:
Reviewed: Sep 22, 2021
|
|
Sep 22, 2021
|
|
New Unknown Sars-Cov-2 Virus Variants and Hidden Pandemics Within Them in Developing Countries
First Author:
Reviewed: Sep 22, 2021
|
|
Sep 22, 2021
|
|
SARS-CoV-2 preS dTM vaccine booster candidates increase functional antibody responses and cross-neutralization against SARS-CoV-2 variants of concern in non-human primates
First Author:
Reviewed: Sep 22, 2021
|
|
Sep 22, 2021
|
|
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE study
First Author:
Reviewed: Sep 21, 2021
|
|
Sep 21, 2021
|
|
Does Good National Governance Boost COVID-19 Vaccination? Cross-Country Evidence
First Author:
Reviewed: Sep 21, 2021
|
|
Sep 21, 2021
|
|
Multimorbidity and adverse events of special interest associated with CoronaVac (Sinovac) and Comirnaty (Pfizer-BioNTech)
First Author:
Reviewed: Sep 21, 2021
|
|
Sep 21, 2021
|
|
SARS-CoV-2 Neutralization in Convalescent Plasma and Commercial Lots of Plasma-derived Immunoglobulin
First Author:
Reviewed: Sep 21, 2021
|
|
Sep 21, 2021
|
|
Seroresponse to SARS-CoV-2 vaccines among maintenance dialysis patients over six months
First Author:
Reviewed: Sep 21, 2021
|
|
Sep 21, 2021
|
|
The nuts and bolts of SARS-CoV-2 Spike Receptor Binding Domain heterologous expression
First Author:
Reviewed: Sep 21, 2021
|
|
Sep 21, 2021
|
|
A genetic trap in yeast for inhibitors of SARS-CoV-2 main protease
First Author:
Reviewed: Sep 20, 2021
|
|
Sep 20, 2021
|
|
Antibody response to a fourth mRNA Covid-19 vaccine boost in weak responder kidney transplant recipients
First Author:
Reviewed: Sep 20, 2021
|
|
Sep 20, 2021
|
|
Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications in Australia
First Author:
Reviewed: Sep 20, 2021
|
|
Sep 20, 2021
|
|
Autoantibodies against Progranulin and IL-1 receptor antagonist due to immunogenic posttranslational isoforms contribute to hyperinflammation in critically ill COVID-19
First Author:
Reviewed: Sep 20, 2021
|
|
Sep 20, 2021
|
|
COVID-19 Vaccine Acceptability: A Cross-Sectional Mixed Methods Study in Sierra Leone
First Author:
Reviewed: Sep 20, 2021
|
|
Sep 20, 2021
|
|
Distinct immune cell dynamics mark adverse events and antibody responses of SARS-CoV-2 mRNA vaccine
First Author:
Reviewed: Sep 20, 2021
|
|
Sep 20, 2021
|
|
Early immunologic response to mRNA COVID-19 vaccine in patients receiving biologics and/or immunomodulators
First Author:
Reviewed: Sep 20, 2021
|
|
Sep 20, 2021
|
|
Effectiveness of Mass Vaccination in Brazil against Severe COVID-19 Cases
First Author:
Reviewed: Sep 20, 2021
|
|
Sep 20, 2021
|
|
Efficacy of vaccination against severe COVID-19 in relation to Delta variant and time since second dose: the REACT-SCOT case-control study
First Author:
Reviewed: Sep 20, 2021
|
|
Sep 20, 2021
|
|
Evaluation of commercially available high-throughput SARS-CoV-2 serological assays for serosurveillance and related applications
First Author:
Reviewed: Sep 20, 2021
|
|
Sep 20, 2021
|
|
Induction of robust cellular and humoral immunity against SARS-CoV-2 after a third dose of BNT162b2 vaccine in previously unresponsive elderly
First Author:
Reviewed: Sep 20, 2021
|
|
Sep 20, 2021
|
|
Mask Interventions in K12 Schools Can Also Reduce Community Transmission in Fall 2021
First Author:
Reviewed: Sep 20, 2021
|
|
Sep 20, 2021
|
|
Predicting the effects of waning vaccine immunity against COVID-19
through high-resolution agent-based modeling
First Author:
Reviewed: Sep 20, 2021
|
|
Sep 20, 2021
|
|
Predictors of real-world parents’ acceptance to vaccinate their children against the COVID-19
First Author:
Reviewed: Sep 20, 2021
|
|
Sep 20, 2021
|
|
Review of the mechanisms of SARS-CoV-2 evolution and transmission
First Author:
Reviewed: Sep 20, 2021
|
|
Sep 20, 2021
|
|
Robust induction of B cell and T cell responses by a third dose of inactivated SARS-CoV-2 vaccine
First Author:
Reviewed: Sep 20, 2021
|
|
Sep 20, 2021
|
|
Safety, Immunogenicity, and Efficacy of COVID-19 Vaccine in Children and Adolescents: A Systematic Review
First Author:
Reviewed: Sep 20, 2021
|
|
Sep 20, 2021
|
|
SARS-CoV-2 anti-spike IgG antibody responses after second dose of ChAdOx1 or BNT162b2 in the UK general population
First Author:
Reviewed: Sep 20, 2021
|
|
Sep 20, 2021
|
|
Spike Protein NTD mutation G142D in SARS-CoV-2 Delta VOC lineages is associated with frequent back mutations, increased viral loads, and immune evasion
First Author:
Reviewed: Sep 20, 2021
|
|
Sep 20, 2021
|
|
Spread of Gamma (P.1) sub-lineages carrying Spike mutations close to the furin cleavage site and deletions in the N-terminal domain drives ongoing transmission of SARS-CoV-2 in Amazonas, Brazil
First Author:
Reviewed: Sep 20, 2021
|
|
Sep 20, 2021
|
|
Trends in COVID-19 Vaccine Intentions during the COVID-19 Pandemic; a Systematic Review and Meta-Analysis of Cross-Sectional Studies
First Author:
Reviewed: Sep 20, 2021
|
|
Sep 20, 2021
|
|
Vaccine-induced immune thrombotic thrombocytopenia and spike protein
First Author:
Reviewed: Sep 20, 2021
|
|
Sep 20, 2021
|
|
What pushed Israel out of herd immunity? Modeling COVID-19 spread of Delta and Waning immunity
First Author:
Reviewed: Sep 20, 2021
|
|
Sep 20, 2021
|
|
“Association between COVID-19 vaccination, infection, and risk of Guillain-Barre syndrome, Bell’s palsy, encephalomyelitis and transverse myelitis: a population-based cohort and self-controlled case series analysis”
First Author:
Reviewed: Sep 17, 2021
|
|
Sep 17, 2021
|
|
Change in Measles Vaccine Coverage and Estimated Impact on Measles Mortality in Low and Middle Income Countries, 2020: An Investigation into Secondary Public Health Effects of the COVID-19 Pandemic Using the Lives Saved Tool
First Author:
Reviewed: Sep 17, 2021
|
|
Sep 17, 2021
|
|
Design of T cell epitope-based vaccine candidate for SARS-CoV-2 targeting spike and nucleocapsid protein escape variants
First Author:
Reviewed: Sep 17, 2021
|
|
Sep 17, 2021
|
|
Determinants of early antibody responses to COVID-19 mRNA vaccines in exposed and naive healthcare workers
First Author:
Reviewed: Sep 17, 2021
|
|
Sep 17, 2021
|
|
Effectiveness of the Single-Dose Ad26.COV2.S COVID Vaccine
First Author:
Reviewed: Sep 17, 2021
|
|
Sep 17, 2021
|
|
Elicitation of potent SARS-CoV-2 neutralizing antibody responses through immunization using a versatile adenovirus-inspired multimerization platform
First Author:
Reviewed: Sep 17, 2021
|
|
Sep 17, 2021
|
|
Elucidation of the interactions between SARS-CoV-2 Spike protein and wild and mutant types of IFITM proteins by in silico methods
First Author:
Reviewed: Sep 17, 2021
|
|
Sep 17, 2021
|
|
Exposures to different SARS-CoV-2 spike variants elicit neutralizing antibody responses with differential specificity towards established and emerging strains
First Author:
Reviewed: Sep 17, 2021
|
|
Sep 17, 2021
|
|
Incidence of COVID-19 reinfection among Midwestern healthcare employees
First Author:
Reviewed: Sep 17, 2021
|
|
Sep 17, 2021
|
|
Low dose prime and delayed boost can improve COVID-19 vaccine efficacies by increasing B cell selection stringency in germinal centres
First Author:
Reviewed: Sep 17, 2021
|
|
Sep 17, 2021
|
|
Pharmacological perturbation of intracellular dynamics as a SARS-CoV-2 antiviral strategy
First Author:
Reviewed: Sep 17, 2021
|
|
Sep 17, 2021
|
|
Phylogenetic evidence for asparagine to aspartic acid protein editing of N-glycosylated SARS-CoV-2 viral proteins by NGLY1 deglycosylation/deamidation suggests an unusual vaccination strategy
First Author:
Reviewed: Sep 17, 2021
|
|
Sep 17, 2021
|
|
Predicting the Effectiveness of the Pfizer-BioNTech BNT162b2 Vaccine from SARS-CoV-2 Variants Neutralisation Data
First Author:
Reviewed: Sep 17, 2021
|
|
Sep 17, 2021
|
|
Reduced magnitude and durability of humoral immune responses by COVID-19 mRNA vaccines among older adults
First Author:
Reviewed: Sep 17, 2021
|
|
Sep 17, 2021
|
|
Serial evaluation of anti-SARS-CoV-2 IgG antibody and breakthrough infections in BNT162b2 Vaccinated migrant workers from Bangladesh
First Author:
Reviewed: Sep 17, 2021
|
|
Sep 17, 2021
|
|
Therapeutic efficacy of an oral nucleoside analog of remdesivir against SARS-CoV-2 pathogenesis in mice
First Author:
Reviewed: Sep 17, 2021
|
|
Sep 17, 2021
|
|
Vaccinations or Non-Pharmaceutical Interventions: Safe Reopening of Schools in England
First Author:
Reviewed: Sep 17, 2021
|
|
Sep 17, 2021
|
|
Alternative Vaccination Politics
First Author:
Reviewed: Sep 16, 2021
|
|
Sep 16, 2021
|
|
Geographical Prevalence of SARS-CoV-2 Variants, August 2020 to July 2021.
First Author:
Reviewed: Sep 16, 2021
|
|
Sep 16, 2021
|
|
Immunogenicity of SCB-2019 COVID-19 Vaccine Compared to Four Approved Vaccines
First Author:
Reviewed: Sep 16, 2021
|
|
Sep 16, 2021
|
|
Robust immune response to the BNT162b mRNA vaccine in an elderly population vaccinated 15 months after recovery from COVID-19
First Author:
Reviewed: Sep 16, 2021
|
|
Sep 16, 2021
|
|
Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial
First Author:
Reviewed: Sep 16, 2021
|
|
Sep 16, 2021
|
|
Vaccination strategies and transmission of COVID-19: evidence across
leading countries
First Author:
Reviewed: Sep 16, 2021
|
|
Sep 16, 2021
|
|
Exposing Structural Variations in SARS-CoV-2 Evolution
First Author:
Reviewed: Sep 14, 2021
|
|
Sep 14, 2021
|
|
The COVID-19 Hospitalization Metric in the Pre- and Post-vaccination Eras as a Measure of Pandemic Severity: A Retrospective, Nationwide Cohort Study
First Author:
Reviewed: Sep 14, 2021
|
|
Sep 14, 2021
|
|
The second wave of COVID-19 in South and Southeast Asia and vaccination effects
First Author:
Reviewed: Sep 14, 2021
|
|
Sep 14, 2021
|
|
Acute cardiac events following ChAdOx1 nCoV-19 corona virus vaccine (recombinant)
First Author:
Reviewed: Sep 13, 2021
|
|
Sep 13, 2021
|
|
Antibody response induced by the boost overdose during COVID-19 heterologous prime-boost vaccination strategy: A four-case study
First Author:
Reviewed: Sep 13, 2021
|
|
Sep 13, 2021
|
|
Emerging vaccine-breakthrough SARS-CoV-2 variants
First Author:
Reviewed: Sep 13, 2021
|
|
Sep 13, 2021
|
|
Epidemiology: Gray Immunity Model Gives Qualitatively Different Predictions
First Author:
Reviewed: Sep 13, 2021
|
|
Sep 13, 2021
|
|
Persistence of antibodies against Spike glycoprotein of SARS-CoV-2 in health care workers post double dose of BBV-152 and AZD1222 vaccines
First Author:
Reviewed: Sep 13, 2021
|
|
Sep 13, 2021
|
|
The Impact of Health Status of Academic Staff on Attitudes towards COVID-19 Vaccination
First Author:
Reviewed: Sep 13, 2021
|
|
Sep 13, 2021
|
|
A Quantitative Exploration of Continuous Vaccination of the COVID-19 Vaccine: an Empirical Study From China
First Author:
Reviewed: Sep 10, 2021
|
|
Sep 10, 2021
|
|
A Sigh of Relief: Vaccine-Associated Hypermetabolic Iymphadenopathy Following the Third Covid-19 Vaccine Dose is Short in Duration and Uncommonly Interferes with the Interpretation of [18F]FDG PET-CT Studies Performed in Oncologic Patients
First Author:
Reviewed: Sep 10, 2021
|
|
Sep 10, 2021
|
|
A third dose of inactivated vaccine augments the potency, breadth, and duration of anamnestic responses against SARS-CoV-2
First Author:
Reviewed: Sep 10, 2021
|
|
Sep 10, 2021
|
|
Comparative quantitative analysis of SARS- CoV-2 Spike neutralizing antibody titers following two anti COVID-19 vaccines in India
First Author:
Reviewed: Sep 10, 2021
|
|
Sep 10, 2021
|
|
COVID-19 Vaccine Efficacy in a Diverse Urban Healthcare Worker Population
First Author:
Reviewed: Sep 10, 2021
|
|
Sep 10, 2021
|
|
Development and validation of an enzyme immunoassay for detection and quantification of SARS-CoV-2 salivary IgA and IgG
First Author:
Reviewed: Sep 10, 2021
|
|
Sep 10, 2021
|
|
Expected Rates of Select Adverse Events following Immunization for COVID-19 Vaccine Safety Monitoring
First Author:
Reviewed: Sep 10, 2021
|
|
Sep 10, 2021
|
|
Heterologous prime-boost immunization with CoronaVac and Convidecia
First Author:
Reviewed: Sep 10, 2021
|
|
Sep 10, 2021
|
|
Immunogenicity and Safety of the inactivated SARS-CoV-2 vaccine (BBIBP-CoV) in patients with malignancy
First Author:
Reviewed: Sep 10, 2021
|
|
Sep 10, 2021
|
|
Immunogenicity, Safety and Antiphospholipid Antibodies After SARS-CoV-2 Vaccine in Patients With Primary Antiphospholipid Syndrome
First Author:
Reviewed: Sep 10, 2021
|
|
Sep 10, 2021
|
|
MITIGATING THE 4th WAVE OF THE COVID-19 PANDEMIC IN ONTARIO
First Author:
Reviewed: Sep 10, 2021
|
|
Sep 10, 2021
|
|
Monitoring populations at increased risk for SARS-CoV-2 infection in the community
First Author:
Reviewed: Sep 10, 2021
|
|
Sep 10, 2021
|
|
No difference in risk of hospitalisation between reported cases of the SARS-CoV-2 Delta variant and Alpha variant in Norway
First Author:
Reviewed: Sep 10, 2021
|
|
Sep 10, 2021
|
|
The comparability of Anti-Spike SARS-CoV-2 antibody tests is time-dependent: a prospective observational study
First Author:
Reviewed: Sep 10, 2021
|
|
Sep 10, 2021
|
|
Vaccines against Covid-19, venous thromboembolism, and thrombocytopenia. A population-based retrospective cohort study
First Author:
Reviewed: Sep 10, 2021
|
|
Sep 10, 2021
|
|
Effectiveness of inactive COVID-19 vaccines against severe illness in B.1.617.2 (Delta) variant-infected patients in Jiangsu, China
First Author:
Reviewed: Sep 8, 2021
|
|
Sep 8, 2021
|
|
COVID-19 Projections for K12 Schools in Fall 2021: Significant Transmission without Interventions
First Author:
Reviewed: Sep 7, 2021
|
|
Sep 7, 2021
|
|
COVID-19 scenarios for comparing the effectiveness of age-specific vaccination regimes, exemplified for the city of Aschaffenburg (Germany)
First Author:
Reviewed: Sep 7, 2021
|
|
Sep 7, 2021
|
|
Covid-19 Vaccine Effectiveness in Healthcare Personnel in six Israeli Hospitals (CoVEHPI)
First Author:
Reviewed: Sep 7, 2021
|
|
Sep 7, 2021
|
|
COVID-19 Vaccine Hesitancy and Information Diffusion: An Agent-based
Modeling Approach
First Author:
Reviewed: Sep 7, 2021
|
|
Sep 7, 2021
|
|
COVID-eVax, an electroporated plasmid DNA vaccine candidate encoding the SARS-CoV-2 Receptor Binding Domain, elicits protective immune responses in animal models of COVID-19
First Author:
Reviewed: Sep 7, 2021
|
|
Sep 7, 2021
|
|
Distinct neutralizing kinetics and magnitudes elicited by different SARS-CoV-2 variant spikes
First Author:
Reviewed: Sep 7, 2021
|
|
Sep 7, 2021
|
|
Early versus late third trimester maternal SARS-CoV-2 BNT162b2 mRNA immunization maximizes transplacental antibody transfer and neonatal neutralizing antibody levels
First Author:
Reviewed: Sep 7, 2021
|
|
Sep 7, 2021
|
|
Emergence of Two Distinct Variants of SARS-CoV-2 and Explosive Second Wave of COVID-19: An Experience From A Tertiary Care Hospital, Pune, India
First Author:
Reviewed: Sep 7, 2021
|
|
Sep 7, 2021
|
|
Ensemble forecast of COVID-19 in Karnataka for vulnerability assessment and policy interventions
First Author:
Reviewed: Sep 7, 2021
|
|
Sep 7, 2021
|
|
Estimation of Vaccine Efficacy for Variants that Emerge After the Placebo Group Is Vaccinated
First Author:
Reviewed: Sep 7, 2021
|
|
Sep 7, 2021
|
|
Health impact and cost of COVID-19 prophylaxis with monoclonal antibodies
First Author:
Reviewed: Sep 7, 2021
|
|
Sep 7, 2021
|
|
High diversity in Delta variant across countries revealed via genome-wide analysis of SARS-CoV-2 beyond the Spike protein
First Author:
Reviewed: Sep 7, 2021
|
|
Sep 7, 2021
|
|
High-Throughput Adaptable SARS-CoV-2 Screening for Rapid Identification of Dominant and Emerging Regional Variants
First Author:
Reviewed: Sep 7, 2021
|
|
Sep 7, 2021
|
|
How control and relaxation interventions and virus mutations influence the resurgence of COVID-19
First Author:
Reviewed: Sep 7, 2021
|
|
Sep 7, 2021
|
|
Impact of Vaccine Prioritization Strategies on Mitigating COVID-19: An Agent-Based Simulation Study using an Urban Region in the United States
First Author:
Reviewed: Sep 7, 2021
|
|
Sep 7, 2021
|
|
Longitudinal analysis of SARS-CoV-2 vaccine breakthrough infections reveal limited infectious virus shedding and restricted tissue distribution
First Author:
Reviewed: Sep 7, 2021
|
|
Sep 7, 2021
|
|
Multimodal Detection of COVID-19 Symptoms using Deep Learning &
Probability-based Weighting of Modes
First Author:
Reviewed: Sep 7, 2021
|
|
Sep 7, 2021
|
|
Multiscale affinity maturation simulations to elicit broadly neutralizing antibodies against HIV
First Author:
Reviewed: Sep 7, 2021
|
|
Sep 7, 2021
|
|
Nanobody-Functionalized Cellulose for Capturing and Containing SARS-CoV-2
First Author:
Reviewed: Sep 7, 2021
|
|
Sep 7, 2021
|
|
Pandemic-response adenoviral vector and RNA vaccine manufacturing
First Author:
Reviewed: Sep 7, 2021
|
|
Sep 7, 2021
|
|
Pre-existing antibodies targeting a linear epitope on SARS-CoV-2 S2 cross-reacted with commensal gut bacteria and shaped vaccine induced immunity
First Author:
Reviewed: Sep 7, 2021
|
|
Sep 7, 2021
|
|
Projected resurgence of COVID-19 in the United States in July—December 2021 resulting from the increased transmissibility of the Delta variant and faltering vaccination
First Author:
Reviewed: Sep 7, 2021
|
|
Sep 7, 2021
|
|
SARS-CoV-2 Variant Tracking and Mitigation: Strategies and Results from In-Person Learning at a Midwestern University in the 2020/2021 School Year
First Author:
Reviewed: Sep 7, 2021
|
|
Sep 7, 2021
|
|
Sero-survey on Long-term Care Facility Residents Reveals Increased Risk of Sub-optimal Antibody Response to BNT162B2: Implications for Breakthrough Prevention
First Author:
Reviewed: Sep 7, 2021
|
|
Sep 7, 2021
|
|
Sex–associated differences between body mass index and SARS-CoV-2 antibody titers following the BNT162b2 vaccine among 2,435 healthcare workers in Japan
First Author:
Reviewed: Sep 7, 2021
|
|
Sep 7, 2021
|
|
Structural and Biochemical Rationale for Enhanced Spike Protein Fitness in Delta and Kappa SARS-CoV-2 Variants
First Author:
Reviewed: Sep 7, 2021
|
|
Sep 7, 2021
|
|
The anti-SARS-CoV-2 immunoglobulin G levels and neutralising capacities against alpha and delta virus variants of concern achieved after initial immunisation with vector vaccine followed by mRNA vaccine boost are comparable to those after double immunisation with mRNA vaccines
First Author:
Reviewed: Sep 7, 2021
|
|
Sep 7, 2021
|
|
Total Anti-SARS-CoV-2 Antibodies Measured 6 Months After Pfizer-BioNTech COVID-19 Vaccination in Healthcare Workers
First Author:
Reviewed: Sep 7, 2021
|
|
Sep 7, 2021
|
|
Two new compartmental epidemiological models and their equilibria
First Author:
Reviewed: Sep 7, 2021
|
|
Sep 7, 2021
|
|
Waning of IgG, total and neutralizing antibodies 6 months post-vaccination with BNT162b2 in healthcare workers
First Author:
Reviewed: Sep 7, 2021
|
|
Sep 7, 2021
|
|
Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine Evaluation
First Author:
Reviewed: Sep 3, 2021
|
|
Sep 3, 2021
|
|
Coagulapathies after vaccination against SARS-CoV-2 may be derived from
a combination effect of SARS-CoV-2 spike protein and adenovirus
vector-triggered signaling pathways
First Author:
Reviewed: Sep 2, 2021
|
|
Sep 2, 2021
|
|
Comparative cost-effectiveness of SARS-CoV-2 vaccine dose fractionation in India: a modelling study
First Author:
Reviewed: Sep 2, 2021
|
|
Sep 2, 2021
|
|
COVID-19 Vaccine Hesitancy in Eight European Countries:
Prevalence, Determinants and Heterogeneity
First Author:
Reviewed: Sep 2, 2021
|
|
Sep 2, 2021
|
|
A Population-Based Threshold of Protection for COVID-19 Vaccines
First Author:
Reviewed: Sep 1, 2021
|
|
Sep 1, 2021
|
|
Systemic COVID-19 vaccination also enhances the humoral immune response after SARS CoV-2 infection. An approach to criteria for COVID-19 re-immunization is needed. Do we need a third dose?
First Author:
Reviewed: Sep 1, 2021
|
|
Sep 1, 2021
|
|
A rapid real-time polymerase chain reaction-based live virus microneutralization assay for detection of neutralizing antibodies against SARS-CoV-2 in blood/serum
First Author:
Reviewed: Aug 31, 2021
|
|
Aug 31, 2021
|
|
Adverse Events of Inactivated COVID-19 Vaccine in HIV-Infected Adults
First Author:
Reviewed: Aug 31, 2021
|
|
Aug 31, 2021
|
|
Cost-Effectiveness Analysis (CEA) of Preventive COVID-19 Vaccines by Quality-Adjusted Life Years (QALYs)
First Author:
Reviewed: Aug 31, 2021
|
|
Aug 31, 2021
|
|
Introductory models of COVID-19 in the United States
First Author:
Reviewed: Aug 31, 2021
|
|
Aug 31, 2021
|
|
Agent-based Investigation of the Impact of Low Rates of Influenza on Next Season Influenza Infections
First Author:
Reviewed: Aug 30, 2021
|
|
Aug 30, 2021
|
|
An Intranasal OMV-based vaccine induces high mucosal and systemic protecting immunity against a SARS-CoV-2 infection
First Author:
Reviewed: Aug 30, 2021
|
|
Aug 30, 2021
|
|
Durability of antibody responses elicited by a single dose of Ad26.COV2.S and substantial increase following late boosting
First Author:
Reviewed: Aug 30, 2021
|
|
Aug 30, 2021
|
|
Evaluation of commercial anti-SARS-CoV-2 antibody assays and comparison of standardized titers in vaccinated healthcare workers
First Author:
Reviewed: Aug 30, 2021
|
|
Aug 30, 2021
|
|
Longevity of SARS-CoV-2 Antibody in Health Care Workers: 6-Months Follow Up
First Author:
Reviewed: Aug 30, 2021
|
|
Aug 30, 2021
|
|
Long-term immunogenicity of BNT162b2 vaccination in the elderly and in younger health care workers
First Author:
Reviewed: Aug 30, 2021
|
|
Aug 30, 2021
|
|
Low risk of SARS-CoV-2 transmission via fomite, even in cold-chain
First Author:
Reviewed: Aug 30, 2021
|
|
Aug 30, 2021
|
|
Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains
First Author:
Reviewed: Aug 30, 2021
|
|
Aug 30, 2021
|
|
Recent COVID-19 vaccination is associated with modest increases in the physiological demands to graded exercise
First Author:
Reviewed: Aug 30, 2021
|
|
Aug 30, 2021
|
|
Structural remodeling of SARS-CoV-2 spike protein glycans reveals the regulatory roles in receptor binding affinity
First Author:
Reviewed: Aug 30, 2021
|
|
Aug 30, 2021
|
|
The Lambda variant of SARS-CoV-2 has a better chance than the Delta variant to escape vaccines
First Author:
Reviewed: Aug 30, 2021
|
|
Aug 30, 2021
|
|
Time trends, factors associated with, and reasons for COVID-19 vaccine hesitancy in US adults: January-May 2021
First Author:
Reviewed: Aug 30, 2021
|
|
Aug 30, 2021
|
|
Association of COVID-19 vaccines ChAdOx1 and BNT162b2 with major venous, arterial, and thrombocytopenic events: whole population cohort study in 46 million adults in England
First Author:
Reviewed: Aug 27, 2021
|
|
Aug 27, 2021
|
|
Estimating Vaccination Effects and Variant Strains on COVID-19 outbreak course in Japan, as of August, 2021
First Author:
Reviewed: Aug 27, 2021
|
|
Aug 27, 2021
|
|
Evidence for the dependence of the SARS-Cov-2 Delta high diffusivity on the associated N:G215C nucleocapsid mutation
First Author:
Reviewed: Aug 27, 2021
|
|
Aug 27, 2021
|
|
Intra-host SARS-CoV-2 evolution in the gut of mucosally-infected Chlorocebus aethiops (African green monkeys)
First Author:
Reviewed: Aug 27, 2021
|
|
Aug 27, 2021
|
|
Model-based assessment of SARS-CoV-2 Delta variant transmission dynamics within partially vaccinated K-12 school populations
First Author:
Reviewed: Aug 27, 2021
|
|
Aug 27, 2021
|
|
mRNA Vaccination Induces Durable Immune Memory to SARS-CoV-2 with Continued Evolution to Variants of Concern
First Author:
Reviewed: Aug 27, 2021
|
|
Aug 27, 2021
|
|
Reduced T cell and antibody responses to inactivated coronavirus vaccine among males and individuals above 55 years old
First Author:
Reviewed: Aug 27, 2021
|
|
Aug 27, 2021
|
|
SARS-CoV-2 mRNA vaccine elicits a potent adaptive immune response in the absence of IFN-mediated inflammation observed in COVID-19
First Author:
Reviewed: Aug 27, 2021
|
|
Aug 27, 2021
|
|
The SARS-CoV-2 Delta variant is poised to acquire complete resistance to wild-type spike vaccines
First Author:
Reviewed: Aug 27, 2021
|
|
Aug 27, 2021
|
|
Using outbreak data to estimate the dynamic COVID-19 landscape in Eastern Africa
First Author:
Reviewed: Aug 27, 2021
|
|
Aug 27, 2021
|
|
Vaccine Effectiveness against Referral to Hospital and Severe Lung Injury Associated with COVID-19: A Population-based Case-control Study in St. Petersburg, Russia
First Author:
Reviewed: Aug 27, 2021
|
|
Aug 27, 2021
|
|
A k-mer Based Approach for SARS-CoV-2 Variant Identification
First Author:
Reviewed: Aug 26, 2021
|
|
Aug 26, 2021
|
|
Anticipating the hospital burden of future COVID-19 epidemic waves
First Author:
Reviewed: Aug 26, 2021
|
|
Aug 26, 2021
|
|
Delayed interval BNT162b2 mRNA COVID-19 vaccination provides robust immunity
First Author:
Reviewed: Aug 26, 2021
|
|
Aug 26, 2021
|
|
Dynamics of SARS-CoV-2 exposure in Malawian blood donors: a retrospective seroprevalence analysis between January 2020 and February 2021
First Author:
Reviewed: Aug 26, 2021
|
|
Aug 26, 2021
|
|
Effective and scalable clustering of SARS-CoV-2 sequences
First Author:
Reviewed: Aug 26, 2021
|
|
Aug 26, 2021
|
|
Fabrication of chitosan-coated mixed spinel ferrite integrated with graphene oxide (GO) for magnetic extraction of viral RNA for potential detection of SARS-CoV-2
First Author:
Reviewed: Aug 26, 2021
|
|
Aug 26, 2021
|
|
Factors that impact acceptance of COVID-19 vaccination in different community-dwelling populations in China
First Author:
Reviewed: Aug 26, 2021
|
|
Aug 26, 2021
|
|
Hesitancy Towards COVID-19 Vaccine Among Older People in Luzhou, China: A Cross-sectional Study
First Author:
Reviewed: Aug 26, 2021
|
|
Aug 26, 2021
|
|
Immunogenicity of heterologous prime/booster-inactivated and adenoviral-vectored COVID-19 vaccine: real-world data
First Author:
Reviewed: Aug 26, 2021
|
|
Aug 26, 2021
|
|
Morbidity and mortality from COVID-19 post-vaccination breakthrough infections in association with vaccines and the emergence of variants in Bahrain
First Author:
Reviewed: Aug 26, 2021
|
|
Aug 26, 2021
|
|
Mutational signatures and transmissibility of SARS-CoV-2 Gamma and Lambda variants
First Author:
Reviewed: Aug 26, 2021
|
|
Aug 26, 2021
|
|
One-Year Prospective Study of Occupational Health in the Intensivists of a COVID-19 Hub Hospital
First Author:
Reviewed: Aug 26, 2021
|
|
Aug 26, 2021
|
|
Prediction of Second Wave of COVID-19 in India using the Modified SEIR Model
First Author:
Reviewed: Aug 26, 2021
|
|
Aug 26, 2021
|
|
Studies on the level of neutralizing antibodies produced by inactivated COVID-19 vaccines in the real world
First Author:
Reviewed: Aug 26, 2021
|
|
Aug 26, 2021
|
|
Phase I Trial of a Multi-Peptide COVID-19 Vaccine for the Induction of SARS-CoV-2 T-Cell Immunity
First Author:
Reviewed: Aug 23, 2021
|
|
Aug 23, 2021
|
|
Clinical Characteristics of Healthcare Workers with SARS-CoV-2 Infection after Vaccination with BNT162b2 Vaccine
First Author:
Reviewed: Aug 18, 2021
|
|
Aug 18, 2021
|
|
Do Vaccinated People Reduce Their Precautionary Behaviours? A Test on a British Cohort
First Author:
Reviewed: Aug 18, 2021
|
|
Aug 18, 2021
|
|
Novel lipid nanoparticle provides potent SARS-CoV-2 mRNA vaccine at low dose with low local reactogenicity, high thermostability and limited systemic biodistribution
First Author:
Reviewed: Aug 18, 2021
|
|
Aug 18, 2021
|
|
SARS-CoV-2 spike protein-induced platelet activation: Mechanism for virus and vaccine-induced thrombotic thrombocytopenia
First Author:
Reviewed: Aug 18, 2021
|
|
Aug 18, 2021
|
|
COVID-19 vaccine hesitancy in Africa: A scoping review
First Author:
Reviewed: Aug 17, 2021
|
|
Aug 17, 2021
|
|
Investigating the Intention to Receive the COVID-19 Vaccination in Macao: Implications for Vaccination Strategies
First Author:
Reviewed: Aug 17, 2021
|
|
Aug 17, 2021
|
|
The influence of SARS-CoV-2 variants on national case fatality rates
First Author:
Reviewed: Aug 17, 2021
|
|
Aug 17, 2021
|
|
Acceptance of COVID-19 Vaccines Among Physicians in Mid Delta Region of Egypt: A Cross-Sectional Study
First Author:
Reviewed: Aug 16, 2021
|
|
Aug 16, 2021
|
|
Adaptive combination of interventions required to reach population immunity due to stochastic community dynamics and limited vaccination
First Author:
Reviewed: Aug 16, 2021
|
|
Aug 16, 2021
|
|
COVID-VAC: The second global study of COVID-19 vaccine acceptance
First Author:
Reviewed: Aug 16, 2021
|
|
Aug 16, 2021
|
|
High individual heterogeneity of neutralizing activities against the original strain and 9 different variants of SARS-CoV-2
First Author:
Reviewed: Aug 16, 2021
|
|
Aug 16, 2021
|
|
Neutralization of the emerging SARS-CoV-2 variant Lambda by antibodies elicited by inactivated virus and mRNA vaccines
First Author:
Reviewed: Aug 16, 2021
|
|
Aug 16, 2021
|
|
A booster dose is immunogenic and will be needed for older adults who have completed two doses vaccination with CoronaVac: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
A mucosal antibody response is induced by intra-muscular SARS-CoV-2 mRNA vaccination
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
A single intramuscular injection of monoclonal antibody MAD0004J08 induces in healthy adults SARS-CoV-2 neutralising antibody titres exceeding those induced by infection and vaccination
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
Age and smoking predict antibody titres at 3 months after the second dose of the BNT162b2 COVID-19 vaccine
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
An Epidemiological Cohort Study of SARS-CoV-2 and COVID-19 in German Healthcare Workers � Interim Analysis after Six Months of Follow-up
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
Assessing unused residual Pfizer-BioNTech COVID-19 vaccine: a community observational study
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
Association of E484K and L452R spike protein mutations with SARS-CoV-2 infection in vaccinated persons---Maryland, January � May 2021
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
Booster and anergic effects of the Covishield vaccine among healthcare workers in South India
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
Comparable neutralization of SARS-CoV-2 Delta AY.1 and Delta in individuals sera vaccinated with BBV152
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
Comparative analysis of post-vaccination anti-spike IgG antibodies in old Nursing Home Residents and in middle-aged Healthcare workers
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
Comparison between one and two dose SARS-CoV-2 vaccine prioritisation for a fixed number of vaccine doses
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
Comparison of Neutralizing Antibody Titers Elicited by mRNA and Adenoviral Vector Vaccine against SARS-CoV-2 Variants
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
Contribution of single mutations to selected SARS-CoV-2 emerging variants Spike antigenicity
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
COVID-19 mRNA Vaccination in Lactation: Assessment of adverse effects and transfer of anti-SARS-CoV2 antibodies from mother to child
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
COVID-19 pandemic in Saint Petersburg, Russia: combining surveillance and population-based serological study data in May, 2020�April, 2021
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
Data-driven Testing Program Improves Detection of COVID-19 Cases and Reduces Community Transmission
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
Delta variants of SARS-CoV-2 cause significantly increased vaccine breakthrough COVID-19 cases in Houston, Texas
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
Dominance of Alpha and Iota variants in SARS-CoV-2 vaccine breakthrough infections in New York City
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
Emergence and Expansion of the SARS-CoV-2 Variant B.1.526 Identified in New York
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
Epidemiological characteristics of the B.1.526 SARS-CoV-2 variant
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
Estimated pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
Herd immunity thresholds for SARS-CoV-2 estimated from unfolding epidemics
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
High genetic barrier to escape from human polyclonal SARS-CoV-2 neutralizing antibodies
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
High vaccine effectiveness against COVID-19 infection and severe disease among residents and staff of long-term care facilities in Norway, November � June 2021
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
Immunogenicity of BNT162b2 vaccine Against the Alpha and Delta Variants in Immunocompromised Patients
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
Individual variation in susceptibility or exposure to SARS-CoV-2 lowers the herd immunity threshold
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
Inequality in Access to COVID-19 Vaccines: Evidence from the Household Heads and Household Helps from Dhaka City
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
Limited variation between SARS-CoV-2-infected individuals in domain specificity and relative potency of the antibody response against the spike glycoprotein
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
Low SARS-CoV-2 infection rate and high vaccine-induced immunity among German healthcare workers at the end of the third wave of the COVID-19 pandemic
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
More rapid, robust and sustainable antibody responses to mRNA COVID-19 vaccine in convalescent COVID-19 individuals
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
Neuro-COVID long-haulers exhibit broad dysfunction in T cell memory generation and responses to vaccination
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
Neutralizing antibody responses to SARS-CoV-2 variants in vaccinated Ontario long-term care home residents and workers
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
Occupational risk of SARS-CoV-2 infection and reinfection during the second pandemic surge: a cohort study
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
Outbreak of SARS-CoV-2 in a prison: Low effectiveness of a single dose of the adenovirus vector ChAdOx1 vaccine in recently vaccinated inmates
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
Progressive Increase in Virulence of Novel SARS-CoV-2 Variants in Ontario, Canada
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic RNA-mucosal adenoviral vector immunization
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
Risk of COVID-19 Introduction into the Scottish Hebrides and Strategies for Control
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
Robust antibody levels in both diabetic and non-diabetic individuals after BNT162b2 mRNA COVID-19 vaccination
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
Safety and Immunogenicity of CpG 1018 and Aluminium Hydroxide-Adjuvanted SARS-CoV-2 S-2P Protein Vaccine MVC-COV1901: A Large-Scale Double-Blind, Randomised, Placebo-Controlled Phase 2 Trial
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine in High-Risk Occupational Population: a randomized, parallel, controlled clinical trial
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
SARS-CoV-2 antibody changes in patients receiving COVID-19 convalescent plasma from normal and vaccinated donors
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
SARS-CoV-2 Breakthrough Infections among the Healthcare Workers Post-Vaccination with ChAdOx1 nCoV-19 Vaccine in the South Indian State of Kerala
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
SARS-CoV-2-specific Humoral and Cell-mediated Immune Responses after Immunization with Inactivated COVID-19 Vaccine in Kidney Transplant Recipients (CVIM 1 Study)
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
Serendipitous COVID-19 Vaccine-Mix in Uttar Pradesh, India: Safety and Immunogenicity Assessment of a Heterologous Regime
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
Structural Basis and Mode of Action for Two Broadly Neutralizing Antibodies Against SARS-CoV-2 Emerging Variants of Concern
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
The potential impact of delta variant of SARS-CoV-2 in the context of limited vaccination coverage and increasing social mixing in Bogot�, Colombia
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2: a population-based cohort analysis
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
Viral and Immunological Characteristics of COVID-19 Vaccine Breakthrough Infections
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
When do elementary students need masks in school? Model-estimated risk of in-school SARS-CoV-2 transmission and related infections among household members before and after student vaccination
First Author:
Reviewed: Aug 15, 2021
|
|
Aug 15, 2021
|
|
Individual Preparedness for Distant Wildfires and the Delta Variant in the United States: A Survey of 2,250 US Residents
First Author:
Reviewed: Aug 12, 2021
|
|
Aug 12, 2021
|
|
COVID-19 Vaccine Hesitancy Among Different Population Groups in China: a National Multi-Center Online Survey
First Author:
Reviewed: Aug 11, 2021
|
|
Aug 11, 2021
|
|
Evaluation of antibody response to BNT162b2 mRNA COVID-19 vaccine in patients affected by immune-mediated inflammatory diseases up to 5 months after vaccination
First Author:
Reviewed: Aug 11, 2021
|
|
Aug 11, 2021
|
|
Immunogenicity and efficacy of heterologous ChadOx1/BNT162b2 vaccination
First Author:
Reviewed: Aug 11, 2021
|
|
Aug 11, 2021
|
|
Real-time Updating of Dynamic Social Networks for COVID-19 Vaccination
Strategies
First Author:
Reviewed: Aug 11, 2021
|
|
Aug 11, 2021
|
|
Physical activity associates with enhanced immunogenicity of an inactivated virus vaccine against SARS-CoV-2 in patients with autoimmune rheumatic diseases
First Author:
Reviewed: Aug 10, 2021
|
|
Aug 10, 2021
|
|
Receipt of mRNA COVID-19 vaccines preconception and during pregnancy and risk of self-reported spontaneous abortions, CDC v-safe COVID-19 Vaccine Pregnancy Registry 2020-21
First Author:
Reviewed: Aug 10, 2021
|
|
Aug 10, 2021
|
|
Surveillance genome sequencing reveal multiple SARS-CoV-2 variants circulating in the central Texas, USA with a predominance of Delta variant and review of vaccine breakthrough cases
First Author:
Reviewed: Aug 10, 2021
|
|
Aug 10, 2021
|
|
SARS-CoV-2 Delta Variant Predominant at a Tertiary-Care Hospital in Saudi Arabia
First Author:
Reviewed: Aug 9, 2021
|
|
Aug 9, 2021
|
|
The Preclinical Evaluation of Self-Replicating RNA Oral Vaccine to Simultaneously Neutralize Both SARS-CoV-2 Delta and Alpha Variants
First Author:
Reviewed: Aug 6, 2021
|
|
Aug 6, 2021
|
|
A novel approach for evaluating antibodies against SARS-CoV-2 using menstrual blood collected from sanitary napkins before and after vaccination and evaluation of the visual napkin score
First Author:
Reviewed: Aug 5, 2021
|
|
Aug 5, 2021
|
|
TaffiX® nasal powder spray forms an effective barrier against infectious new variants of SARS-CoV-2 (Alpha, Beta and Delta)
First Author:
Reviewed: Aug 5, 2021
|
|
Aug 5, 2021
|
|
The Dynamics of Neutralizing Antibody Level in One Year After SARS-CoV-2 Infection
First Author:
Reviewed: Aug 5, 2021
|
|
Aug 5, 2021
|
|
Application of Ultrasonography to Neuro-COVID-19
First Author:
Reviewed: Aug 4, 2021
|
|
Aug 4, 2021
|
|
Clinical features and laboratory findings first case of B. 1.617.2 (delta) variant concern (VOC) in Iraq
First Author:
Reviewed: Aug 4, 2021
|
|
Aug 4, 2021
|
|
Correlates of Neutralizing/SARS-CoV-2-S1-binding Antibody Response with Adverse Effects and Immune Kinetics in BNT162b2-Vaccinated Individuals
First Author:
Reviewed: Aug 3, 2021
|
|
Aug 3, 2021
|
|
Covid-19 vaccine-induced antibodies are attenuated and decay rapidly in infliximab treated patients
First Author:
Reviewed: Aug 3, 2021
|
|
Aug 3, 2021
|
|
Effects of Various Policy Options on COVID-19 Cases in Nova Scotia including Vaccination Rollout Schedule: A Modelling Study
First Author:
Reviewed: Aug 3, 2021
|
|
Aug 3, 2021
|
|
Estimates of Single Dose and Full Dose BNT162b2 Vaccine Effectiveness among USAF Academy cadets, 1 Mar - 1 May 2021
First Author:
Reviewed: Aug 3, 2021
|
|
Aug 3, 2021
|
|
Genetic and Epigenetic Variations of SARS-Cov-2 and Host Genes and Their Impact in Covid-19 Pandemic
First Author:
Reviewed: Aug 3, 2021
|
|
Aug 3, 2021
|
|
Identification and characterization of novel mutants of Nsp13 protein among Indian SARS-CoV-2 isolates
First Author:
Reviewed: Aug 3, 2021
|
|
Aug 3, 2021
|
|
Identification of Promising CD8 and CD4 T-cell Epitopes for Peptide Vaccine Formulation Against SARS-CoV-2
First Author:
Reviewed: Aug 3, 2021
|
|
Aug 3, 2021
|
|
Impact of B.1.351 (beta) SARS-CoV-2 variant on BNT162b2 mRNA vaccine effectiveness in long-term care facilities of eastern France: a retrospective cohort study
First Author:
Reviewed: Aug 3, 2021
|
|
Aug 3, 2021
|
|
Occurrence of COVID-19 in priority groups receiving ChAdOx1 nCoV-19 coronavirus vaccine (recombinant): a preliminary analysis from north India
First Author:
Reviewed: Aug 3, 2021
|
|
Aug 3, 2021
|
|
Potential 3rd COVID Wave in Mumbai: Scenario Analysis
First Author:
Reviewed: Aug 3, 2021
|
|
Aug 3, 2021
|
|
Predictors of COVID-19 vaccination uptake and reasons for decline of vaccination: a systematic review
First Author:
Reviewed: Aug 3, 2021
|
|
Aug 3, 2021
|
|
Structural basis for recognition of two HLA-A2-restricted SARS-CoV-2 spike epitopes by public and private T cell receptors
First Author:
Reviewed: Aug 3, 2021
|
|
Aug 3, 2021
|
|
A Successful Venous Thromboprophylaxis in a Patient with Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT): a case report of the first reported case in Thailand
First Author:
Reviewed: Jul 29, 2021
|
|
Jul 29, 2021
|
|
Immunodominant NP105-113-B*0702 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease
First Author:
Reviewed: Jul 29, 2021
|
|
Jul 29, 2021
|
|
Novel sites for Cathepsin L cleavage in SARS-CoV-2 spike guide treatment strategies
First Author:
Reviewed: Jul 29, 2021
|
|
Jul 29, 2021
|
|
Pharmacists as Immunizers in Lebanon: A National Survey of Community Pharmacists’ Willingness and Readiness to Administer Adult Immunization
First Author:
Reviewed: Jul 29, 2021
|
|
Jul 29, 2021
|
|
Acceptability of COVID-19 Vaccination among Healthcare Workers in Sudan: A Cross Sectional Survey
First Author:
Reviewed: Jul 27, 2021
|
|
Jul 27, 2021
|
|
Healthcare workers' Attitude and Knowledge Towards the Safety of Nucleotide-Based Vaccines.
First Author:
Reviewed: Jul 27, 2021
|
|
Jul 27, 2021
|
|
Neural message passing for joint paratope-epitope prediction
First Author:
Reviewed: Jul 27, 2021
|
|
Jul 27, 2021
|
|
Social network-based ethical analysis of COVID-19 vaccine supply policy in three Central Asian countries
First Author:
Reviewed: Jul 27, 2021
|
|
Jul 27, 2021
|
|
The effects of rapid mass vaccination against SARS-CoV-2 and its Variants-of-Concern: Evidence from an early VoCs hotspot
First Author:
Reviewed: Jul 27, 2021
|
|
Jul 27, 2021
|
|
Structural Analysis And Molecular Characteristics of SARSCoV-2 Spike Protein Following S494P Point Mutation: Molecular Dynamics Study
First Author:
Reviewed: Jul 26, 2021
|
|
Jul 26, 2021
|
|
Impact of B.1.617 and RBD SARS-CoV-2 Variants on Vaccine Efficacy: An In-silico Approach
First Author:
Reviewed: Jul 23, 2021
|
|
Jul 23, 2021
|
|
Study on the effects of the restrictive measures for containment of the COVID-19 pandemic on the reproduction number $R_t$ in Italian regions
First Author:
Reviewed: Jul 23, 2021
|
|
Jul 23, 2021
|
|
Differential Immunogenicity of BNT162b2 or ChAdOx1 Vaccines After Extended-Interval Homologous Dual Vaccination in Older People
First Author:
Reviewed: Jul 22, 2021
|
|
Jul 22, 2021
|
|
Immunity to SARS-CoV-2 in a Dialyzed Patient Who Developed COVID-19 Twenty Days After the Second Dose of BNT162b2 Vaccine: a Case Report
First Author:
Reviewed: Jul 22, 2021
|
|
Jul 22, 2021
|
|
Linked Nosocomial COVID-19 Outbreak in Three Facilities for People with Intellectual and Developmental Disabilities Due to SARS-CoV-2 Variant B.1.1.519 with Spike Mutation T478K in the Netherlands
First Author:
Reviewed: Jul 22, 2021
|
|
Jul 22, 2021
|
|
mRNA Vaccine-Induced Antibodies More Effective than Natural Immunity in Neutralizing SARS-CoV-2 and its High Affinity Variants
First Author:
Reviewed: Jul 22, 2021
|
|
Jul 22, 2021
|
|
Optimal control and comprehensive cost-effectiveness analysis for COVID-19
First Author:
Reviewed: Jul 21, 2021
|
|
Jul 21, 2021
|
|
Side Effects and Immunogenicity Following Administration of The Sputnik V COVID-19 Vaccine Among Health Care Workers; An Observational Study in Iran
First Author:
Reviewed: Jul 21, 2021
|
|
Jul 21, 2021
|
|
Subcutaneous Uptake on [18F]Florbetaben PET/CT: a Possible Immune-Induced Amyloid-Beta Deposition after COVID-19 Vaccination
First Author:
Reviewed: Jul 21, 2021
|
|
Jul 21, 2021
|
|
Cross neutralization of emerging SARS-CoV-2 variants of concern by antibodies targeting distinct epitopes on spike
First Author:
Reviewed: Jul 20, 2021
|
|
Jul 20, 2021
|
|
How will mass-vaccination change COVID-19 lockdown requirements in
Australia?
First Author:
Reviewed: Jul 20, 2021
|
|
Jul 20, 2021
|
|
Self and Nonself Short Constituent Sequences of Amino Acids in The SARS-CoV-2 Proteome for Vaccine Development
First Author:
Reviewed: Jul 20, 2021
|
|
Jul 20, 2021
|
|
Where to locate COVID-19 mass vaccination facilities?
First Author:
Reviewed: Jul 20, 2021
|
|
Jul 20, 2021
|
|
Cellular Immune Responses are Preserved and May Contribute to Chadox1 ChAdOx1 nCoV-19 Vaccine Effectiveness Against Infection Due to SARS-CoV-2 B·1·617·2 Delta Variant Despite Reduced Virus Neutralisation
First Author:
Reviewed: Jul 19, 2021
|
|
Jul 19, 2021
|
|
Refractory vaccine-induced thrombotic thrombocytopenia (VITT) managed with delayed therapeutic plasma exchange (TPE)
First Author:
Reviewed: Jul 19, 2021
|
|
Jul 19, 2021
|
|
Release of endogenous chondroitin sulfate and heparin as consequence of dysregulated proteolysis in COVID-19
First Author:
Reviewed: Jul 19, 2021
|
|
Jul 19, 2021
|
|
Neutral Electrolyzed Water (SES) for Nasopharyngeal and Oropharyngeal Rinses Prevented COVID-19 in Front-Line Health Professionals: A Randomized, Open-Label, Controlled Trial in a General Hospital in Mexico City.
First Author:
Reviewed: Jul 16, 2021
|
|
Jul 16, 2021
|
|
Development and Large-Scale Validation of A Highly Accurate SARS-COV-2 Serological Test Using Regular Test Strips for Autonomous and Affordable Finger-Prick Sample Collection, Transportation, and Storage
First Author:
Reviewed: Jul 15, 2021
|
|
Jul 15, 2021
|
|
Emergence of a putative novel SARS-CoV-2 P.X lineage harboring N234P and E471Q spike protein mutations in Southern Brazil
First Author:
Reviewed: Jul 15, 2021
|
|
Jul 15, 2021
|
|
Determinants of Participation in Immunization against COVID-19 before Distribution of Vaccine in Iran
First Author:
Reviewed: Jul 14, 2021
|
|
Jul 14, 2021
|
|
Infectivity and Antigenicity of SARS-CoV-2 Strains in Portugal
First Author:
Reviewed: Jul 14, 2021
|
|
Jul 14, 2021
|
|
Long-term follow-up of SARS-CoV-2 convalescents reveals distinct magnitude of spike-specific immunity after viral re-exposure and vaccination
First Author:
Reviewed: Jul 14, 2021
|
|
Jul 14, 2021
|
|
Spirituality and other factors associated with COVID-19 Vaccine Acceptance amongst Healthcare Workers in Cameroon
First Author:
Reviewed: Jul 14, 2021
|
|
Jul 14, 2021
|
|
Antibody and T cell memory immune response after two doses of the BNT162b2 mRNA vaccine in older adults with and without prior SARS-CoV-2 infection
First Author:
Reviewed: Jul 13, 2021
|
|
Jul 13, 2021
|
|
Antibody response to SARS-CoV-2 infection and BNT162b2 vaccine in Israel
First Author:
Reviewed: Jul 13, 2021
|
|
Jul 13, 2021
|
|
BNT162b2 vaccine-induced humoral and cellular responses against SARS-CoV-2 variants in Systemic Lupus Erythematosus
First Author:
Reviewed: Jul 13, 2021
|
|
Jul 13, 2021
|
|
Commercialized kit to assess T-cell responses against SARS-CoV-2 S peptides. A pilot study in Health Care Workers
First Author:
Reviewed: Jul 13, 2021
|
|
Jul 13, 2021
|
|
COVID-19 deaths and hospitalizations averted by rapid vaccination rollout in the United States
First Author:
Reviewed: Jul 13, 2021
|
|
Jul 13, 2021
|
|
Differences in the concentration of anti-SARS-CoV-2 IgG antibodies post-COVID-19 recovery or post-vaccination
First Author:
Reviewed: Jul 13, 2021
|
|
Jul 13, 2021
|
|
Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States
First Author:
Reviewed: Jul 13, 2021
|
|
Jul 13, 2021
|
|
Effectiveness of the BNT162b2 mRNA COVID-19 Vaccine in Pregnancy
First Author:
Reviewed: Jul 13, 2021
|
|
Jul 13, 2021
|
|
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil; an exploratory analysis of a randomised controlled trial
First Author:
Reviewed: Jul 13, 2021
|
|
Jul 13, 2021
|
|
Incidence of Severe Acute Respiratory Syndrome Coronavirus-2 infection among previously infected or vaccinated employees
First Author:
Reviewed: Jul 13, 2021
|
|
Jul 13, 2021
|
|
Insights into the mutation T1117I in the spike and the lineage B.1.1.389 of SARS-CoV-2 circulating in Costa Rica
First Author:
Reviewed: Jul 13, 2021
|
|
Jul 13, 2021
|
|
REACT-1 round 13 interim report: acceleration of SARS-CoV-2 Delta epidemic in the community in England during late June and early July 2021
First Author:
Reviewed: Jul 13, 2021
|
|
Jul 13, 2021
|
|
Reduced neutralization of SARS-CoV-2 B.1.617 variant by inactivated and RBD-subunit vaccine
First Author:
Reviewed: Jul 13, 2021
|
|
Jul 13, 2021
|
|
Symptomatic, Presymptomatic, and Asymptomatic Transmission of SARS-CoV-2
First Author:
Reviewed: Jul 13, 2021
|
|
Jul 13, 2021
|
|
Transmission event of SARS-CoV-2 Delta variant reveals multiple vaccine breakthrough infections
First Author:
Reviewed: Jul 13, 2021
|
|
Jul 13, 2021
|
|
Detection and Quantification of SARS-CoV-2 Receptor Binding Domain Neutralization by a Sensitive Competitive ELISA Assay
First Author:
Reviewed: Jul 9, 2021
|
|
Jul 9, 2021
|
|
Fighting the SARS CoV-2 (COVID-19) Pandemic with Soap
First Author:
Reviewed: Jul 8, 2021
|
|
Jul 8, 2021
|
|
A national cohort study of COVID-19 in-hospital mortality in South Africa: the intersection of communicable and non-communicable chronic diseases in a high HIV prevalence setting
First Author:
Reviewed: Jul 7, 2021
|
|
Jul 7, 2021
|
|
BNT162b2 mRNA Vaccine Effectiveness Given Confirmed Exposure; Analysis of Household Members of COVID-19 Patients
First Author:
Reviewed: Jul 7, 2021
|
|
Jul 7, 2021
|
|
Effectiveness of COVID-19 vaccines against variants of concern, Canada
First Author:
Reviewed: Jul 7, 2021
|
|
Jul 7, 2021
|
|
Fighting the SARS CoV-2 (COVID-19) Pandemic with Soap
First Author:
Reviewed: Jul 7, 2021
|
|
Jul 7, 2021
|
|
PERFORMANCE AND UTILITY OF AN ORAL FLUID-BASED RAPID POINT-OF-CARE TEST FOR SARS-COV-2 ANTIBODY RESPONSE FOLLOWING COVID-19 INFECTION OR VACCINATION
First Author:
Reviewed: Jul 7, 2021
|
|
Jul 7, 2021
|
|
SARS-CoV-2 Lambda Variant Remains Susceptible to Neutralization by mRNA Vaccine-elicited Antibodies and Convalescent Serum
First Author:
Reviewed: Jul 7, 2021
|
|
Jul 7, 2021
|
|
SARS-CoV-2 vaccine breakthrough infections are asymptomatic or mildly symptomatic and are infrequently transmitted
First Author:
Reviewed: Jul 7, 2021
|
|
Jul 7, 2021
|
|
The SARS-CoV-2 receptor-binding domain expressed in Pichia pastoris as a candidate vaccine antigen
First Author:
Reviewed: Jul 7, 2021
|
|
Jul 7, 2021
|
|
Which children and young people are at higher risk of severe disease and death after SARS-CoV-2 infection: a systematic review and individual patient meta-analysis
First Author:
Reviewed: Jul 7, 2021
|
|
Jul 7, 2021
|
|
A look into the future of the COVID-19 pandemic in Europe: an expert
consultation
First Author:
Reviewed: Jul 6, 2021
|
|
Jul 6, 2021
|
|
A phase 1/2 randomized, double-blinded, placebo controlled ascending dose trial to assess the safety, tolerability and immunogenicity of ARCT-021 in healthy adults
First Author:
Reviewed: Jul 6, 2021
|
|
Jul 6, 2021
|
|
Acceptance of COVID-19 Vaccine in Pakistan Among Health Care Workers
First Author:
Reviewed: Jul 6, 2021
|
|
Jul 6, 2021
|
|
Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers
First Author:
Reviewed: Jul 6, 2021
|
|
Jul 6, 2021
|
|
Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages
First Author:
Reviewed: Jul 6, 2021
|
|
Jul 6, 2021
|
|
Communicating about COVID-19 vaccine development and safety
First Author:
Reviewed: Jul 6, 2021
|
|
Jul 6, 2021
|
|
Efficacy, safety, and lot to lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): a, double-blind, randomised, controlled phase 3 trial
First Author:
Reviewed: Jul 6, 2021
|
|
Jul 6, 2021
|
|
Evolution of Anti-SARS-CoV-2 IgG Antibody and IgG Avidity Post Pfizer and Moderna mRNA Vaccinations
First Author:
Reviewed: Jul 6, 2021
|
|
Jul 6, 2021
|
|
Neutralization of Delta variant with sera of Covishield vaccinees and COVID-19 recovered vaccinated individuals
First Author:
Reviewed: Jul 6, 2021
|
|
Jul 6, 2021
|
|
Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples
First Author:
Reviewed: Jul 6, 2021
|
|
Jul 6, 2021
|
|
SARS-CoV-2 variants of concern dominate in Lahore, Pakistan in April 2021
First Author:
Reviewed: Jul 6, 2021
|
|
Jul 6, 2021
|
|
Self-assessment of COVID-19 vaccination efficacy using a lateral flow tests for SARS-CoV-2 S1 protein antibody
First Author:
Reviewed: Jul 6, 2021
|
|
Jul 6, 2021
|
|
The acceptance of covid-19 vaccines in Sub-Saharan Africa: Evidence from 6 national phone surveys
First Author:
Reviewed: Jul 6, 2021
|
|
Jul 6, 2021
|
|
Transmissibility of COVID-19 among Vaccinated Individuals: A Rapid Literature Review - Update #1
First Author:
Reviewed: Jul 6, 2021
|
|
Jul 6, 2021
|
|
A Newcastle disease virus-vector expressing a prefusion-stabilized spike protein of SARS-CoV-2 induces protective immune responses against prototype virus and variants of concern in mice and hamsters
First Author:
Reviewed: Jul 5, 2021
|
|
Jul 5, 2021
|
|
Ad26.COV2.S elicited neutralizing activity against Delta and other SARS-CoV-2 variants of concern
First Author:
Reviewed: Jul 5, 2021
|
|
Jul 5, 2021
|
|
Community-Based Phenotypic Study of Safety, Tolerability, Reactogenicity and Immunogenicity of Emergency-Use-Authorized Vaccines Against COVID-19 and Viral Shedding Potential of Post-Vaccination Infections: Protocol for a prospective study
First Author:
Reviewed: Jul 5, 2021
|
|
Jul 5, 2021
|
|
COVID-19 vaccines and evidence-based medicine
First Author:
Reviewed: Jul 5, 2021
|
|
Jul 5, 2021
|
|
Impact of Vaccination on the COVID-19 Pandemic: Evidence from U.S. States
First Author:
Reviewed: Jul 5, 2021
|
|
Jul 5, 2021
|
|
Infectivity and immune escape of the new SARS-CoV-2 variant of interest Lambda
First Author:
Reviewed: Jul 5, 2021
|
|
Jul 5, 2021
|
|
Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2 infection
First Author:
Reviewed: Jul 5, 2021
|
|
Jul 5, 2021
|
|
SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey
First Author:
Reviewed: Jul 5, 2021
|
|
Jul 5, 2021
|
|
Side Effects and Perceptions Following Sinopharm COVID-19 Vaccination
First Author:
Reviewed: Jul 5, 2021
|
|
Jul 5, 2021
|
|
Trajectories of hospitalisation for patients infected with SARS-CoV-2 variant B.1.1.7 in Norway, December 2020 – April 2021
First Author:
Reviewed: Jul 5, 2021
|
|
Jul 5, 2021
|
|
Use of recently vaccinated individuals to detect bias in test-negative case-control studies of COVID-19 vaccine effectiveness
First Author:
Reviewed: Jul 5, 2021
|
|
Jul 5, 2021
|
|
Antibody Development after SARS-CoV-2 Vaccinations in Elderly Patients with Autoimmune Diseases: Data From a Prospective Controlled Cohort Study
First Author:
Reviewed: Jun 30, 2021
|
|
Jun 30, 2021
|
|
Cellular and humoral immunogenicity of a candidate DNA Vaccine Expressing SARS-CoV-2 Spike Subunit 1
First Author:
Reviewed: Jun 30, 2021
|
|
Jun 30, 2021
|
|
Messages That Increase COVID-19 Vaccine Willingness: Evidence From Online Experiments in Six Latin American Countries
First Author:
Reviewed: Jun 30, 2021
|
|
Jun 30, 2021
|
|
Public Health Management of COVID-19: The Role of Belief Disagreement in Virus Spread, Vaccine Resistance, and Closure Response
First Author:
Reviewed: Jun 30, 2021
|
|
Jun 30, 2021
|
|
Seroconversion panels demonstrate anti-SARS-CoV-2 antibody development after administration of the mRNA-1273 vaccine
First Author:
Reviewed: Jun 30, 2021
|
|
Jun 30, 2021
|
|
The evaluation of factors affecting antibody response after administration of the BNT162b2 vaccine: A prospective study in Japan
First Author:
Reviewed: Jun 30, 2021
|
|
Jun 30, 2021
|
|
Tolerability and Immunogenicity After a Late Second Dose or a Third Dose of ChAdOx1 nCoV-19 (AZD1222)
First Author:
Reviewed: Jun 30, 2021
|
|
Jun 30, 2021
|
|
A New Saliva-Based Lateral-Flow SARS-CoV-2 IgG Antibody Test for mRNA Vaccination
First Author:
Reviewed: Jun 29, 2021
|
|
Jun 29, 2021
|
|
A novel bivalent DNA vaccine encoding both spike protein receptor-binding domain and nucleocapsid protein of SARS-CoV-2 to elicit T cell and neutralising antibody responses that cross react with variants
First Author:
Reviewed: Jun 29, 2021
|
|
Jun 29, 2021
|
|
Analysis of host immunological response of adenovirus-based COVID-19 vaccines
First Author:
Reviewed: Jun 29, 2021
|
|
Jun 29, 2021
|
|
Antibody neutralization to SARS-CoV-2 and variants after one year in Wuhan
First Author:
Reviewed: Jun 29, 2021
|
|
Jun 29, 2021
|
|
Assessing the level and determinants of COVID-19 Vaccine Confidence in Kenya
First Author:
Reviewed: Jun 29, 2021
|
|
Jun 29, 2021
|
|
Hidden fraction of Polish population immune to SARS-CoV-2 in May 2021
First Author:
Reviewed: Jun 28, 2021
|
|
Jun 28, 2021
|
|
Pfizer-BioNTech Vaccine Effectiveness Against SARS-CoV-2 Infection: Findings From a Large Observational Study in Israel
First Author:
Reviewed: Jun 28, 2021
|
|
Jun 28, 2021
|
|
What Can We Learn from COVID-19 Data by Using Epidemic Models with Unidentified Infectious Cases?
First Author:
Reviewed: Jun 28, 2021
|
|
Jun 28, 2021
|
|
Awareness and Acceptance of COVID-19 Vaccines among Pharmacy Students in Zambia: The Implications for Addressing Vaccine Hesitancy
First Author:
Reviewed: Jun 25, 2021
|
|
Jun 25, 2021
|
|
COVID-19 Vaccine Acceptance in the US and UK in the Early Phase of the
Pandemic: AI-Generated Vaccines Hesitancy for Minors, and the Role of
Governments
First Author:
Reviewed: Jun 25, 2021
|
|
Jun 25, 2021
|
|
Breakthrough SARS-CoV-2 infections in an eastern state of India: A preliminary report
First Author:
Reviewed: Jun 24, 2021
|
|
Jun 24, 2021
|
|
Antigenic minimalism of SARS-CoV-2 is linked to surges in COVID-19 community transmission and vaccine breakthrough infections
First Author:
Reviewed: Jun 23, 2021
|
|
Jun 23, 2021
|
|
COVID-19 Vaccination Program in China: a Subnational Descriptive Analysis on Target Population Size and Current Progress
First Author:
Reviewed: Jun 23, 2021
|
|
Jun 23, 2021
|
|
Effectiveness of the SARS-CoV-2 mRNA Vaccines in Pregnant Women
First Author:
Reviewed: Jun 23, 2021
|
|
Jun 23, 2021
|
|
Preliminary Evaluation of QuantiFERON SARS-CoV-2 and QIAreach Anti-SARS-CoV-2 Total Test in Recently Vaccinated Individuals
First Author:
Reviewed: Jun 23, 2021
|
|
Jun 23, 2021
|
|
SARS-CoV-2 B.1.617.2 Delta variant emergence and vaccine breakthrough
First Author:
Reviewed: Jun 23, 2021
|
|
Jun 23, 2021
|
|
Antibody Responses to SARS-CoV-2 after Infection or Vaccination in Children and Young Adults with Inflammatory Bowel Disease
First Author:
Reviewed: Jun 22, 2021
|
|
Jun 22, 2021
|
|
Assessment of anti-SARS-CoV-2 antibodies post-Coronavac Vaccine in the Amazon region of Brazil
First Author:
Reviewed: Jun 22, 2021
|
|
Jun 22, 2021
|
|
Humoral Response to BNT162b2 mRNA Covid19 Vaccine in Peritoneal and Hemodialysis Patients: a Comparative Study
First Author:
Reviewed: Jun 22, 2021
|
|
Jun 22, 2021
|
|
Investigating the intention to receive the COVID-19 vaccination in Macao: implications for vaccination strategies
First Author:
Reviewed: Jun 22, 2021
|
|
Jun 22, 2021
|
|
Managing Two-Dose COVID-19 Vaccine Rollouts with Limited Supply
First Author:
Reviewed: Jun 22, 2021
|
|
Jun 22, 2021
|
|
Memory B cells control SARS-CoV-2 variants upon mRNA vaccination of naive and COVID-19 recovered individuals
First Author:
Reviewed: Jun 22, 2021
|
|
Jun 22, 2021
|
|
Study on the mucosal and serological immune response to the Novel Coronavirus (SARS-CoV-2) vaccines
First Author:
Reviewed: Jun 22, 2021
|
|
Jun 22, 2021
|
|
Efficacy of the CoronaVac® Vaccine in a Region of the Colombian Amazon, Was Herd Immunity Achieved?
First Author:
Reviewed: Jun 21, 2021
|
|
Jun 21, 2021
|
|
Phylogenomics and population genomics of SARS-CoV-2 in Mexico during the pre-vaccination stage reveals variants of interest B.1.1.28.4, B.1.1.222 or B.1.1.519 and B.1.243 with mutations in the Spike protein and the Nucleocapsid
First Author:
Reviewed: Jun 21, 2021
|
|
Jun 21, 2021
|
|
Association of HLA and Mutated CCR5 With the Clinical Course of the Disease in Subjects With mild / moderate disease following COVID-19 infection
First Author:
Reviewed: Jun 17, 2021
|
|
Jun 17, 2021
|
|
Cycle Threshold Probability Score for Immediate and Sensitive Detection of B.1.351 SARS-CoV-2 Lineage
First Author:
Reviewed: Jun 17, 2021
|
|
Jun 17, 2021
|
|
Divergent trajectories of antiviral memory after SARS-Cov-2 infection
First Author:
Reviewed: Jun 17, 2021
|
|
Jun 17, 2021
|
|
A Review of SARS-CoV-2, Responsible for COVID-19: History, Biology, Infection Mechanism, Antigenic Vaccines, their Risks and How an Alternate RBD Vaccine is Safer?
First Author:
Reviewed: Jun 16, 2021
|
|
Jun 16, 2021
|
|
Age- and gender-dependent differences in attitudes towards COVID-19 vaccination and underlying psychological processes
First Author:
Reviewed: Jun 16, 2021
|
|
Jun 16, 2021
|
|
Complete protection by a single dose skin patch delivered SARS-CoV-2 spike vaccine
First Author:
Reviewed: Jun 16, 2021
|
|
Jun 16, 2021
|
|
Correlation of vaccine-elicited antibody levels and neutralizing activities against SARS-CoV-2 and its variants
First Author:
Reviewed: Jun 16, 2021
|
|
Jun 16, 2021
|
|
COVID-19 vaccine uptake in United States counties: geospatial vaccination patterns and trajectories towards herd immunity
First Author:
Reviewed: Jun 16, 2021
|
|
Jun 16, 2021
|
|
A single dose of SARS-CoV-2 FINLAY-FR-1A dimeric-RBD recombinant vaccine enhances neutralization response in COVID-19 convalescents, with excellent safety profile. A preliminary report of an open-label phase 1 clinical trial
First Author:
Reviewed: Jun 15, 2021
|
|
Jun 15, 2021
|
|
BANCOVID, the first D614G variant mRNA-based vaccine candidate against SARS-CoV-2 elicits neutralizing antibody and balanced cellular immune response
First Author:
Reviewed: Jun 15, 2021
|
|
Jun 15, 2021
|
|
Impact of age, gender, ethnicity and prior disease status on immunogenicity following administration of a single dose of the BNT162b2 mRNA Covid-19 Vaccine: real-world evidence from Israeli healthcare workers, December-January 2020
First Author:
Reviewed: Jun 15, 2021
|
|
Jun 15, 2021
|
|
Interim results of the safety and immune-efficacy of 1 versus 2 doses of COVID-19 vaccine BNT162b2 for cancer patients in the context of the UK vaccine priority guidelines
First Author:
Reviewed: Jun 15, 2021
|
|
Jun 15, 2021
|
|
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
First Author:
Reviewed: Jun 15, 2021
|
|
Jun 15, 2021
|
|
Personalized-Dose COVID-19 Vaccination in a Wave of Virus Variants of Concern: Trading Individual Efficacy for Societal Benefit
First Author:
Reviewed: Jun 15, 2021
|
|
Jun 15, 2021
|
|
Safety and effectiveness of dose-sparing strategies for seasonal influenza vaccine
First Author:
Reviewed: Jun 15, 2021
|
|
Jun 15, 2021
|
|
Safety and efficacy of the ChAdOx1 nCoV-19 (AZD1222) Covid-19 vaccine against the B.1.351 variant in South Africa
First Author:
Reviewed: Jun 15, 2021
|
|
Jun 15, 2021
|
|
Safety and Immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC-COV1901) Adjuvanted With CpG 1018 and Aluminum Hydroxide in Healthy Adults: A Phase 1, Dose-Escalation Study
First Author:
Reviewed: Jun 15, 2021
|
|
Jun 15, 2021
|
|
Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: a randomised, placebo-controlled, dose-ranging study
First Author:
Reviewed: Jun 15, 2021
|
|
Jun 15, 2021
|
|
Safety, Tolerability and Immunogenicity of a Recombinant Adenovirus Type 5 Vectored COVID-19 Vaccine in Healthy Adults in China: Preliminary Report of a First-In Human Single-Center, Open-Label, Dose-Escalating Clinical Trial
First Author:
Reviewed: Jun 15, 2021
|
|
Jun 15, 2021
|
|
Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine
First Author:
Reviewed: Jun 15, 2021
|
|
Jun 15, 2021
|
|
The effectiveness of the first dose of BNT162b2 vaccine in reducing SARS-CoV-2 infection 13-24 days after immunization: real-world evidence
First Author:
Reviewed: Jun 15, 2021
|
|
Jun 15, 2021
|
|
Two doses of SARS-CoV-2 vaccination induce more robust immune responses to emerging SARS-CoV-2 variants of concern than does natural infection.
First Author:
Reviewed: Jun 15, 2021
|
|
Jun 15, 2021
|
|
COVID-19 infections in day care centres in Germany: Social and organizational determinants of infections in children and staff in the second and third wave of the pandemic
First Author:
Reviewed: Jun 14, 2021
|
|
Jun 14, 2021
|
|
COVID-19 vaccination in Sindh Province, Pakistan: a modelling study of health impact and cost-effectiveness
First Author:
Reviewed: Jun 14, 2021
|
|
Jun 14, 2021
|
|
Factors That Impact Acceptance of COVID-19 Vaccination in Different Community-Dwelling Populations in China
First Author:
Reviewed: Jun 14, 2021
|
|
Jun 14, 2021
|
|
Infectivity and antigenicity of SARS-CoV-2 B.1.617 variants
First Author:
Reviewed: Jun 14, 2021
|
|
Jun 14, 2021
|
|
Neutralizing antibodies elicited by the Ad26.COV2.S COVID-19 vaccine show reduced activity against 501Y.V2 (B.1.351), despite protection against severe disease by this variant
First Author:
Reviewed: Jun 14, 2021
|
|
Jun 14, 2021
|
|
Poor antibody response to BioNTech/Pfizer COVID-19 vaccination in SARS-CoV-2 naïve residents of nursing homes
First Author:
Reviewed: Jun 14, 2021
|
|
Jun 14, 2021
|
|
Possible future waves of SARS-CoV-2 infection generated by variants of concern with a range of characteristics
First Author:
Reviewed: Jun 14, 2021
|
|
Jun 14, 2021
|
|
Single-dose mRNA vaccine effectiveness against SARS-CoV-2, including P.1 and B.1.1.7 variants: a test-negative design in adults 70 years and older in British Columbia, Canada
First Author:
Reviewed: Jun 14, 2021
|
|
Jun 14, 2021
|
|
The association of vaccination and the incidence of new cases of COVID-19 among health care workers, December 16, 2020 through May 4, 2021
First Author:
Reviewed: Jun 14, 2021
|
|
Jun 14, 2021
|
|
The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 B.1.351 and other variants of concern in preclinical studies
First Author:
Reviewed: Jun 14, 2021
|
|
Jun 14, 2021
|
|
The importance of time post-vaccination in determining the decrease in vaccine efficacy against SARS-CoV-2 variants of concern
First Author:
Reviewed: Jun 14, 2021
|
|
Jun 14, 2021
|
|
Immune Responses to COVID-19 mRNA Vaccines in Patients with Solid Tumors on Active, Immunosuppressive Cancer Therapy
First Author:
Reviewed: Jun 11, 2021
|
|
Jun 11, 2021
|
|
Immunogenicity of the ChAdOx1 nCoV-19 and the BBV152 Vaccines in Patients with Autoimmune Rheumatic Diseases
First Author:
Reviewed: Jun 11, 2021
|
|
Jun 11, 2021
|
|
In Vitro Neutralizing Activity of BNT162b2 mRNA-Induced Antibodies Against B.1.351 SARS-CoV-2 Variant in Pre-Exposed and Non-Pre-Exposed Vaccinees
First Author:
Reviewed: Jun 11, 2021
|
|
Jun 11, 2021
|
|
Infections, Hospitalizations, and Deaths Averted Via Direct Effects of the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine in a Nationwide Vaccination Campaign, Israel
First Author:
Reviewed: Jun 11, 2021
|
|
Jun 11, 2021
|
|
Meta-Analysis of Risk of Vaccine-Induced Immune Thrombotic Thrombocytopenia Following ChAdOx1-S Recombinant Vaccine
First Author:
Reviewed: Jun 11, 2021
|
|
Jun 11, 2021
|
|
Non-neutralizing secretory IgA and T cells targeting SARS-CoV-2 spike protein are transferred to the breastmilk upon BNT162b2 vaccination
First Author:
Reviewed: Jun 11, 2021
|
|
Jun 11, 2021
|
|
Rapid and stable mobilization of fully functional spike-specific CD8+ T cells preceding a mature humoral response after SARS-CoV-2 mRNA vaccination
First Author:
Reviewed: Jun 11, 2021
|
|
Jun 11, 2021
|
|
Real-World Effectiveness of Ad26.COV2.S Adenoviral Vector Vaccine for COVID-19
First Author:
Reviewed: Jun 11, 2021
|
|
Jun 11, 2021
|
|
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity
First Author:
Reviewed: Jun 11, 2021
|
|
Jun 11, 2021
|
|
Short-term effects of BNT162b2 mRNA COVID-19 vaccination on physiological measures: a prospective study
First Author:
Reviewed: Jun 11, 2021
|
|
Jun 11, 2021
|
|
A Combination Adjuvant for the Induction of Potent Antiviral Immune Responses for a Recombinant SARS-CoV-2 Protein Vaccine
First Author:
Reviewed: Jun 10, 2021
|
|
Jun 10, 2021
|
|
A Highly Potent Antibody Effective Against SARS-CoV-2 Variants of Concern
First Author:
Reviewed: Jun 10, 2021
|
|
Jun 10, 2021
|
|
Breadth of neutralising antibody responses to SARS-CoV-2 variants of concern is augmented by vaccination following prior infection: studies in UK healthcare workers and immunodeficient patients
First Author:
Reviewed: Jun 10, 2021
|
|
Jun 10, 2021
|
|
Cellular immunity predominates over humoral immunity after the first dose of COVID-19 vaccines in solid organ transplant recipients
First Author:
Reviewed: Jun 10, 2021
|
|
Jun 10, 2021
|
|
COVID-19 vaccine-associated cerebral venous thrombosis in Germany
First Author:
Reviewed: Jun 10, 2021
|
|
Jun 10, 2021
|
|
Differential Effects of the Second SARS-CoV-2 mRNA Vaccine Dose on T Cell Immunity in Naïve and COVID-19 Recovered Individuals
First Author:
Reviewed: Jun 10, 2021
|
|
Jun 10, 2021
|
|
Genomic Analysis of SARS-CoV-2 Variants of Concern Circulating in Hawai’i to Facilitate Public-Health Policies
First Author:
Reviewed: Jun 10, 2021
|
|
Jun 10, 2021
|
|
A Computational and Literature-Based Evaluation for a Combination of Chiral Anti-CoV Drugs to Block and Eliminate SARS-CoV-2 Safely
First Author:
Reviewed: Jun 9, 2021
|
|
Jun 9, 2021
|
|
Assessment of influence of social media and peer groups on increasing the prevalence of vaccine hesitancy in India: a prospective cross-sectional survey
First Author:
Reviewed: Jun 9, 2021
|
|
Jun 9, 2021
|
|
Confounding Factors Influencing the Kinetic and the Magnitude of Serological Response Following Administration of BNT162b2
First Author:
Reviewed: Jun 9, 2021
|
|
Jun 9, 2021
|
|
Effectiveness of mRNA COVID-19 Vaccines among Employees in an American Healthcare System
First Author:
Reviewed: Jun 9, 2021
|
|
Jun 9, 2021
|
|
Safety and Efficacy of Autologous Non-Hematopoietic Enriched Stem Cell Nebulization in Covid-19 Patients. A Randomized Clinical Trial, Abu Dhabi 2020.
First Author:
Reviewed: Jun 9, 2021
|
|
Jun 9, 2021
|
|
Antibody Response after Second-dose of ChAdOx1-nCOV (Covishield™®) and BBV-152 (Covaxin™®) among Health Care Workers in India: Final Results of Cross-sectional Coronavirus Vaccine-induced Antibody Titre (COVAT) study
First Author:
Reviewed: Jun 8, 2021
|
|
Jun 8, 2021
|
|
Association of Convalescent Plasma Treatment with Reduced Mortality and Improved Clinical Trajectory in Patients Hospitalized with COVID-19 in the Community Setting
First Author:
Reviewed: Jun 8, 2021
|
|
Jun 8, 2021
|
|
Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccination
First Author:
Reviewed: Jun 8, 2021
|
|
Jun 8, 2021
|
|
Genomic characterization and Epidemiology of an emerging SARS-CoV-2 variant in Delhi, India
First Author:
Reviewed: Jun 8, 2021
|
|
Jun 8, 2021
|
|
Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity
First Author:
Reviewed: Jun 8, 2021
|
|
Jun 8, 2021
|
|
Population homogeneity for the antibody response to COVID-19 BNT162b2 / Comirnaty vaccine is only reached after the second dose, across all adult age ranges
First Author:
Reviewed: Jun 8, 2021
|
|
Jun 8, 2021
|
|
Prevention and Attenuation of COVID-19 by BNT162b2 and mRNA-1273 Vaccines
First Author:
Reviewed: Jun 8, 2021
|
|
Jun 8, 2021
|
|
Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1-nCoV19 and BNT162b2: a prospective cohort study
First Author:
Reviewed: Jun 8, 2021
|
|
Jun 8, 2021
|
|
SARS-CoV-2 Spreads through Cell-to-Cell Transmission
First Author:
Reviewed: Jun 8, 2021
|
|
Jun 8, 2021
|
|
Vaccine effectiveness of the BNT162b2 mRNA COVID-19 vaccine against RT-PCR confirmed SARS-CoV-2 infections, hospitalisations and mortality in prioritised risk groups
First Author:
Reviewed: Jun 8, 2021
|
|
Jun 8, 2021
|
|
Safety and immunogenicity of a recombinant DNA COVID-19 vaccine containing the coding regions of the spike and nucleocapsid proteins: Preliminary results from an open-label, phase 1 trial in healthy adults aged 19–55 years
First Author:
Reviewed: Jun 7, 2021
|
|
Jun 7, 2021
|
|
SARS-CoV-2 new infections among health care workers after the first dose of the BNT162b2 mRNA Covid-19 Vaccine
First Author:
Reviewed: Jun 7, 2021
|
|
Jun 7, 2021
|
|
Variant-of-concern-attributable health and health system-related outcomes: a population-level propensity-score matched cohort study
First Author:
Reviewed: Jun 7, 2021
|
|
Jun 7, 2021
|
|
Virologic features of SARS-CoV-2 infection in children
First Author:
Reviewed: Jun 7, 2021
|
|
Jun 7, 2021
|
|
Whole blood-based measurement of SARS-CoV-2-specific T cell responses reveals asymptomatic infection and vaccine efficacy in healthy subjects and patients with solid organ cancers
First Author:
Reviewed: Jun 7, 2021
|
|
Jun 7, 2021
|
|
COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies
First Author:
Reviewed: Jun 4, 2021
|
|
Jun 4, 2021
|
|
Functional and quantitative evaluation of BNT162b2 SARS-CoV-2 vaccine-induced immunity
First Author:
Reviewed: Jun 4, 2021
|
|
Jun 4, 2021
|
|
Immune transcriptomes from hospitalized patients infected with the SARS-CoV-2 variants B.1.1.7 and B.1.1.7 carrying the E484K escape mutation
First Author:
Reviewed: Jun 4, 2021
|
|
Jun 4, 2021
|
|
The Impact of SARS-COV-2 Variants on Vaccine Efficacy Amongst Healthcare Workers During India’s Second Wave
First Author:
Reviewed: Jun 4, 2021
|
|
Jun 4, 2021
|
|
Adaptive and optimized COVID-19 vaccination strategies across
geographical regions and age groups
First Author:
Reviewed: Jun 1, 2021
|
|
Jun 1, 2021
|
|
Addressing anti-syncytin antibody levels, and fertility and breastfeeding concerns, following BNT162B2 COVID-19 mRNA vaccination
First Author:
Reviewed: Jun 1, 2021
|
|
Jun 1, 2021
|
|
Co-circulation of two viral populations under vaccination
First Author:
Reviewed: Jun 1, 2021
|
|
Jun 1, 2021
|
|
COVID19 Vaccine Intentions in South Africa: Health Communication Strategy to Address Vaccine Hesitancy
First Author:
Reviewed: Jun 1, 2021
|
|
Jun 1, 2021
|
|
Decomposition of the SARS-CoV-2-ACE2 interface reveals a common trend among emerging viral variants
First Author:
Reviewed: Jun 1, 2021
|
|
Jun 1, 2021
|
|
Does immune recognition of SARS-CoV2 epitopes vary between different ethnic groups?
First Author:
Reviewed: Jun 1, 2021
|
|
Jun 1, 2021
|
|
Non-pharmaceutical interventions and the emergence of pathogen variants
First Author:
Reviewed: Jun 1, 2021
|
|
Jun 1, 2021
|
|
Prevention of COVID-19 by mRNA-based vaccines within the general population of California
First Author:
Reviewed: Jun 1, 2021
|
|
Jun 1, 2021
|
|
Reduced sensitivity of infectious SARS-CoV-2 variant B.1.617.2 to monoclonal antibodies and sera from convalescent and vaccinated individuals
First Author:
Reviewed: Jun 1, 2021
|
|
Jun 1, 2021
|
|
Single-dose SARS-CoV-2 vaccine in a prospective cohort of COVID-19 patients
First Author:
Reviewed: Jun 1, 2021
|
|
Jun 1, 2021
|
|
The indirect effect of mRNA-based Covid-19 vaccination on unvaccinated household members
First Author:
Reviewed: Jun 1, 2021
|
|
Jun 1, 2021
|
|
Vaccine-Hesitant Parents’ Considerations Regarding Covid-19 Vaccination of Adolescents
First Author:
Reviewed: Jun 1, 2021
|
|
Jun 1, 2021
|
|
Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State
First Author:
Reviewed: Jun 1, 2021
|
|
Jun 1, 2021
|
|
Effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe COVID-19 outcomes in Ontario, Canada
First Author:
Reviewed: May 31, 2021
|
|
May 31, 2021
|
|
Impact of Glycosylation on SARS-CoV-2 Infection and Broadly Protective Vaccine Design
First Author:
Reviewed: May 31, 2021
|
|
May 31, 2021
|
|
Infection control, occupational and public health measures including mRNA-based vaccination against SARS-CoV-2 infections to protect healthcare workers from variants of concern: a 14-month observational study using surveillance data
First Author:
Reviewed: May 31, 2021
|
|
May 31, 2021
|
|
Interpreting vaccine efficacy trial results for infection and transmission
First Author:
Reviewed: May 31, 2021
|
|
May 31, 2021
|
|
“Vaccine-Induced Covid-19 Mimicry” Syndrome:Splice reactions within the SARS-CoV-2 Spike open reading frame result in Spike protein variants that may cause thromboembolic events in patients immunized with vector-based vaccines
First Author:
Reviewed: May 28, 2021
|
|
May 28, 2021
|
|
A Rapid and Consistent Method to Identify SARS-CoV-2 Variants by RT-PCR
First Author:
Reviewed: May 28, 2021
|
|
May 28, 2021
|
|
Airway antibodies emerge according to COVID-19 severity and wane rapidly but reappear after SARS-CoV-2 vaccination
First Author:
Reviewed: May 28, 2021
|
|
May 28, 2021
|
|
Effect of a single-dose of BBV-152 and AZD1222 on Spike antibody titre among healthcare workers previously infected with SARS-CoV-2
First Author:
Reviewed: May 28, 2021
|
|
May 28, 2021
|
|
Emergence and spread of the potential variant of interest (VOI) B.1.1.519 predominantly present in Mexico
First Author:
Reviewed: May 28, 2021
|
|
May 28, 2021
|
|
Emergence of SARS-CoV-2 variants of concern in the pediatric population of the United States
First Author:
Reviewed: May 28, 2021
|
|
May 28, 2021
|
|
Epidemiological characteristics of three SARS-CoV-2 variants of concern and implications for future COVID-19 pandemic outcomes
First Author:
Reviewed: May 28, 2021
|
|
May 28, 2021
|
|
Immunogenicity and safety of an inactivated virus vaccine against SARS-CoV-2 in patients with autoimmune rheumatic diseases
First Author:
Reviewed: May 28, 2021
|
|
May 28, 2021
|
|
Integrating health behavior theories to predict COVID-19 vaccine acceptance: differences between medical students and nursing students in Israel
First Author:
Reviewed: May 28, 2021
|
|
May 28, 2021
|
|
Measurement of multiple SARS-CoV-2 antibody titer after vaccination represents individual vaccine response and contributes to individually appropriate vaccination schedules
First Author:
Reviewed: May 28, 2021
|
|
May 28, 2021
|
|
Mechanistic model calibration and the dynamics of the COVID-19 epidemic in the UK (the past, the present and the future)
First Author:
Reviewed: May 28, 2021
|
|
May 28, 2021
|
|
Neutralization of SARS-CoV-2 variants B.1.617.1 and B.1.525 by BNT162b2-elicited sera
First Author:
Reviewed: May 28, 2021
|
|
May 28, 2021
|
|
Neutralizing activity of BBIBP-CorV vaccine-elicited sera against multiple SARS-CoV-2 variants of concern
First Author:
Reviewed: May 28, 2021
|
|
May 28, 2021
|
|
Peter Chew Formular for calculate Covid-19 Vaccine efficiency
First Author:
Reviewed: May 28, 2021
|
|
May 28, 2021
|
|
Rapid And high throughput RT-qPCR assay for identification and differentiation between SARS-CoV-2 variants B.1.1.7 and B.1.351
First Author:
Reviewed: May 28, 2021
|
|
May 28, 2021
|
|
SARS-CoV-2 infection of BNT162b2(mRNA)-vaccinated individuals is not restricted to variants of concern or high-risk exposure environments
First Author:
Reviewed: May 28, 2021
|
|
May 28, 2021
|
|
Seroconversion following SARS-CoV-2 Infection or Vaccination in Pediatric IBD Patients
First Author:
Reviewed: May 28, 2021
|
|
May 28, 2021
|
|
Single-dose AAV-based vaccine induces a high level of neutralizing antibodies and provides long-term protection against SARS-CoV-2 in rhesus macaques
First Author:
Reviewed: May 28, 2021
|
|
May 28, 2021
|
|
Single-dose immunisation with a multimerised SARS-CoV-2 receptor binding domain (RBD) induces an enhanced and protective response in mice
First Author:
Reviewed: May 28, 2021
|
|
May 28, 2021
|
|
T-cell and antibody immunity after COVID-19 mRNA vaccines in healthy and immunocompromised subjects-An exploratory study
First Author:
Reviewed: May 28, 2021
|
|
May 28, 2021
|
|
The Structure of ChAdOx1/AZD-1222 Reveals Interactions with CAR and PF4 with Implications for Vaccine-induced Immune Thrombotic Thrombocytopenia
First Author:
Reviewed: May 28, 2021
|
|
May 28, 2021
|
|
Towards Internationally standardised humoral Immune Correlates of Protection from SARS-CoV-2 infection and COVID-19 disease
First Author:
Reviewed: May 28, 2021
|
|
May 28, 2021
|
|
Unusually high risks of COVID-19 mortality with age-related comorbidities: An adjusted method to improve the risk assessment of mortality using the comorbid mortality data
First Author:
Reviewed: May 28, 2021
|
|
May 28, 2021
|
|
COVseq is a cost-effective workflow for mass-scale SARS-CoV-2 genomic surveillance
First Author:
Reviewed: May 27, 2021
|
|
May 27, 2021
|
|
Effectiveness of COVID-19 vaccines against the B.1.617.2 variant
First Author:
Reviewed: May 27, 2021
|
|
May 27, 2021
|
|
Effectiveness of the CoronaVac vaccine in the elderly population during a P.1 variant-associated epidemic of COVID-19 in Brazil: A test-negative case-control study
First Author:
Reviewed: May 27, 2021
|
|
May 27, 2021
|
|
Vaccinate Early and Vaccinate Broadly: On the health and Economic Effects of COVID-19 Vaccines
First Author:
Reviewed: May 27, 2021
|
|
May 27, 2021
|
|
A Case of Immune Thrombocytopenia After COVID-19 Vaccination: Coincidental or Causal Effect? Running Title: ITP After COVID-19 Vaccination
First Author:
Reviewed: May 26, 2021
|
|
May 26, 2021
|
|
Efficacy Estimates for Various COVID-19 Vaccines: What we Know from the Literature and Reports
First Author:
Reviewed: May 26, 2021
|
|
May 26, 2021
|
|
Heterologous vaccination strategy for containing COVID-19 pandemic
First Author:
Reviewed: May 26, 2021
|
|
May 26, 2021
|
|
In Silico Molecular-Based Rationale for SARS-CoV-2 Spike Circulating Mutations Able to Escape Bamlanivimab and Etesevimab Monoclonal Antibodies
First Author:
Reviewed: May 26, 2021
|
|
May 26, 2021
|
|
Public Health and Health Systems Impacts of SARS-CoV-2 Variants of Concern: A Rapid Scoping Review
First Author:
Reviewed: May 26, 2021
|
|
May 26, 2021
|
|
Agent-based simulations for protecting nursing homes with prevention and
vaccination strategies
First Author:
Reviewed: May 25, 2021
|
|
May 25, 2021
|
|
An AAV-ie based Vaccine effectively protects against SARS-CoV-2 and Circulating Variants
First Author:
Reviewed: May 25, 2021
|
|
May 25, 2021
|
|
An intranasal ASO therapeutic targeting SARS-CoV-2
First Author:
Reviewed: May 25, 2021
|
|
May 25, 2021
|
|
Asymptomatic COVID-19 screening tests to facilitate full-time school attendance: model-based analysis of cost and impact
First Author:
Reviewed: May 25, 2021
|
|
May 25, 2021
|
|
Broad neutralization against SARS-CoV-2 variants induced by a modified B.1.351 protein-based COVID-19 vaccine candidate
First Author:
Reviewed: May 25, 2021
|
|
May 25, 2021
|
|
Implications Derived from S-Protein Variants of SARS-CoV-2 from Six Continents
First Author:
Reviewed: May 25, 2021
|
|
May 25, 2021
|
|
Inhibitor screening of Spike variants reveals the heterogeneity of neutralizing antibodies to COVID-19 infection and vaccination
First Author:
Reviewed: May 25, 2021
|
|
May 25, 2021
|
|
Modeling waning and boosting of COVID-19 in Canada with vaccination
First Author:
Reviewed: May 25, 2021
|
|
May 25, 2021
|
|
The specter of Manaus: the risks of a rapid return to pre-pandemic conditions after COVID-19 vaccine rollout
First Author:
Reviewed: May 25, 2021
|
|
May 25, 2021
|
|
A quantitative risk-benefit analysis of ChAdOx1 nCoV-19 vaccine among people under 60 in Italy
First Author:
Reviewed: May 21, 2021
|
|
May 21, 2021
|
|
Adherence and sustainability of interventions informing optimal control against COVID-19 pandemic
First Author:
Reviewed: May 21, 2021
|
|
May 21, 2021
|
|
Anti-SARS-CoV-2 Antibodies Persist for up to 13 Months and Reduce Risk of Reinfection
First Author:
Reviewed: May 21, 2021
|
|
May 21, 2021
|
|
Association between ChAdOx1 nCoV-19 vaccination and bleeding episodes: large population-based cohort study
First Author:
Reviewed: May 21, 2021
|
|
May 21, 2021
|
|
Characterization of the emerging B.1.621 variant of interest of SARS-CoV-2
First Author:
Reviewed: May 21, 2021
|
|
May 21, 2021
|
|
Comparative docking of SARS-CoV-2 receptors antagonists from repurposing drugs
First Author:
Reviewed: May 21, 2021
|
|
May 21, 2021
|
|
Expansion of tissue-resident CD8+ T cells and CD4+ Th17 cells in the nasal mucosa following mRNA COVID-19 vaccination
First Author:
Reviewed: May 21, 2021
|
|
May 21, 2021
|
|
Impact of BNT162b first vaccination on the immune transcriptome of elderly patients infected with the B.1.351 SARS-CoV-2 variant
First Author:
Reviewed: May 21, 2021
|
|
May 21, 2021
|
|
Infection and vaccine-induced neutralizing antibody responses to the SARS-CoV-2 B.1.617.1 variant
First Author:
Reviewed: May 21, 2021
|
|
May 21, 2021
|
|
Live virus neutralisation testing in convalescent patients and subjects vaccinated against 19A, 20B, 20I/501Y.V1 and 20H/501Y.V2 isolates of SARS-CoV-2
First Author:
Reviewed: May 21, 2021
|
|
May 21, 2021
|
|
Mechanism of a COVID-19 nanoparticle vaccine candidate that elicits a broadly neutralizing antibody response to SARS-CoV-2 variants
First Author:
Reviewed: May 21, 2021
|
|
May 21, 2021
|
|
mRNA vaccine-induced SARS-CoV-2-specific T cells recognize B.1.1.7 and B.1.351 variants but differ in longevity and homing properties depending on prior infection status
First Author:
Reviewed: May 21, 2021
|
|
May 21, 2021
|
|
Neutralization potential of Covishield vaccinated individuals against B.1.617.1
First Author:
Reviewed: May 21, 2021
|
|
May 21, 2021
|
|
Neutralizing response against E484K variant after original SARS-CoV-2 infection
First Author:
Reviewed: May 21, 2021
|
|
May 21, 2021
|
|
Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: a preliminary report of a randomized, blinded, placebo-controlled, Phase 2 clinical trial in adults at high risk of viral exposure
First Author:
Reviewed: May 21, 2021
|
|
May 21, 2021
|
|
SARS-CoV-2 B.1.617 emergence and sensitivity to vaccine-elicited antibodies
First Author:
Reviewed: May 21, 2021
|
|
May 21, 2021
|
|
SARS-CoV-2 naïve and recovered individuals show qualitatively different antibody responses following mRNA vaccination
First Author:
Reviewed: May 21, 2021
|
|
May 21, 2021
|
|
SARS-COV-2 Recombinant Receptor-Binding-Domain (RBD) Induces Neutralising Antibodies Against Variant Strains of SARS-CoV-2 and SARS-CoV-1
First Author:
Reviewed: May 21, 2021
|
|
May 21, 2021
|
|
Vaccination boosts naturally enhanced neutralizing breadth to SARS-CoV-2 one year after infection
First Author:
Reviewed: May 21, 2021
|
|
May 21, 2021
|
|
Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient: a source of immune escape variants
First Author:
Reviewed: May 21, 2021
|
|
May 21, 2021
|
|
Development of Potent and Effective Synthetic SARS-CoV-2 Neutralizing Nanobodies
First Author:
Reviewed: May 20, 2021
|
|
May 20, 2021
|
|
Evaluation of SARS-CoV-2 spike antibody levels among Sputnik V first dose vaccinated people in Pakistan: formulation of national anti-COVID-19 mass vaccination strategy.
First Author:
Reviewed: May 20, 2021
|
|
May 20, 2021
|
|
Fatal breakthrough infection after anti-BCMA CAR-T therapy highlights suboptimal immune response to SARS-CoV-2 vaccination in myeloma patients
First Author:
Reviewed: May 20, 2021
|
|
May 20, 2021
|
|
Meta-Analysis and Structural Dynamics of the Emergence of Genetic Variants of SARS-CoV-2
First Author:
Reviewed: May 20, 2021
|
|
May 20, 2021
|
|
Preliminary Analysis of Safety and Immunogenicity of a SARS-CoV-2 Variant Vaccine Booster
First Author:
Reviewed: May 20, 2021
|
|
May 20, 2021
|
|
A new SARS-CoV-2 variant poorly detected by RT-PCR on nasopharyngeal samples, with high lethality
First Author:
Reviewed: May 19, 2021
|
|
May 19, 2021
|
|
Design and immunogenicity of a Pan-SARS-CoV-2 synthetic DNA vaccine
First Author:
Reviewed: May 19, 2021
|
|
May 19, 2021
|
|
Driving potent neutralization of a SARS-CoV-2 Variant of Concern with a heterotypic boost
First Author:
Reviewed: May 19, 2021
|
|
May 19, 2021
|
|
Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.1.7 Variant
First Author:
Reviewed: May 19, 2021
|
|
May 19, 2021
|
|
Estimating SARS-CoV-2 Spike Antibody Levels Among Sputnik V First Dose Vaccinated People in Pakistan: Formulation of Anti-COVID-19 National Mass Vaccination Strategy.
First Author:
Reviewed: May 19, 2021
|
|
May 19, 2021
|
|
Impact of vaccination on the COVID-19 pandemic: Evidence from U.S. states
First Author:
Reviewed: May 19, 2021
|
|
May 19, 2021
|
|
Isolation and characterization of SARS-CoV-2 VOC, 20H/501Y.V2, from UAE travelers
First Author:
Reviewed: May 19, 2021
|
|
May 19, 2021
|
|
Methotrexate Hampers Immunogenicity to BNT162b2 mRNA COVID-19 Vaccine in Immune-Mediated Inflammatory Disease
First Author:
Reviewed: May 19, 2021
|
|
May 19, 2021
|
|
Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B
First Author:
Reviewed: May 19, 2021
|
|
May 19, 2021
|
|
Rapid detection of neutralizing antibodies to SARS-CoV-2 variants in post-vaccination sera
First Author:
Reviewed: May 19, 2021
|
|
May 19, 2021
|
|
Rapid inactivation of SARS-CoV-2 variants by continuous and intermittent irradiation with a deep-ultraviolet light-emitting diode (DUV-LED) device
First Author:
Reviewed: May 19, 2021
|
|
May 19, 2021
|
|
SARS-CoV-2 Variant of Concern Substitutions Alter Spike Glycoprotein Receptor Binding Domain Structure and Stability
First Author:
Reviewed: May 19, 2021
|
|
May 19, 2021
|
|
Severity assessment of single dose Oxford–AstraZeneca vaccinated individuals infected with SARS CoV-2 in the Southeast Bangladesh
First Author:
Reviewed: May 19, 2021
|
|
May 19, 2021
|
|
Antibody Responses After a Single Dose of ChAdOx1 nCoV-19 Vaccine in Healthcare Workers Previously Infected with SARS-CoV-2
First Author:
Reviewed: May 18, 2021
|
|
May 18, 2021
|
|
Intra-host evolution provides for continuous emergence of SARS-CoV-2 variants
First Author:
Reviewed: May 18, 2021
|
|
May 18, 2021
|
|
Magnetofluidic platform for rapid multiplexed screening of SARS-CoV-2 variants and respiratory pathogens
First Author:
Reviewed: May 18, 2021
|
|
May 18, 2021
|
|
Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms
First Author:
Reviewed: May 18, 2021
|
|
May 18, 2021
|
|
Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals
First Author:
Reviewed: May 10, 2021
|
|
May 10, 2021
|
|
Convergent evolution of SARS-CoV-2 spike mutations, L452R, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, India
First Author:
Reviewed: May 10, 2021
|
|
May 10, 2021
|
|
Impaired T-cell and antibody immunity after COVID-19 infection in chronically immunosuppressed transplant recipients
First Author:
Reviewed: May 10, 2021
|
|
May 10, 2021
|
|
SARS -CoV-2 T-cell immunity to variants of concern following vaccination
First Author:
Reviewed: May 10, 2021
|
|
May 10, 2021
|
|
SARS-CoV-2 antibodies remain detectable 12 months after infection and antibody magnitude is associated with age and COVID-19 severity
First Author:
Reviewed: May 10, 2021
|
|
May 10, 2021
|
|
SARS-CoV-2 variant B.1.617 is resistant to Bamlanivimab and evades antibodies induced by infection and vaccination
First Author:
Reviewed: May 10, 2021
|
|
May 10, 2021
|
|
Serological Response in Lung Transplant Recipients after Two Doses of SARS-CoV-2 mRNA Vaccines
First Author:
Reviewed: May 10, 2021
|
|
May 10, 2021
|
|
The Physiologic Response to COVID-19 Vaccination
First Author:
Reviewed: May 10, 2021
|
|
May 10, 2021
|
|
Comprehensive mapping of neutralizing antibodies against SARS-CoV-2 variants induced by natural infection or vaccination
First Author:
Reviewed: May 7, 2021
|
|
May 7, 2021
|
|
Modeling and Predicting Antibody Durability for mRNA-1273 Vaccine for SARS-CoV-2 Variants
First Author:
Reviewed: May 7, 2021
|
|
May 7, 2021
|
|
Population Vaccine Effectiveness and its Implication for Control of the Spread of COVID-19 in the US
First Author:
Reviewed: May 7, 2021
|
|
May 7, 2021
|
|
A novel highly potent inhibitor of TMPRSS2-like proteases blocks SARS-CoV-2 variants of concern and is broadly protective against infection and mortality in mice
First Author:
Reviewed: May 5, 2021
|
|
May 5, 2021
|
|
Evolution of case fatality rates in the second wave of coronavirus in England: effects of false positives, a Variant of Concern and vaccination
First Author:
Reviewed: May 4, 2021
|
|
May 4, 2021
|
|
Impact of vaccination on SARS-CoV-2 cases in the community: a population-based study using the UK’s COVID-19 Infection Survey
First Author:
Reviewed: May 4, 2021
|
|
May 4, 2021
|
|
LY-CoV1404 potently neutralizes SARS-CoV-2 variants
First Author:
Reviewed: May 4, 2021
|
|
May 4, 2021
|
|
Post-vaccination SARS-CoV-2 infections and incidence of the B.1.427/B.1.429 variant among healthcare personnel at a northern California academic medical center
First Author:
Reviewed: May 4, 2021
|
|
May 4, 2021
|
|
Rapid induction of antigen-specific CD4+ T cells guides coordinated humoral and cellular immune responses to SARS-CoV-2 mRNA vaccination
First Author:
Reviewed: May 4, 2021
|
|
May 4, 2021
|
|
A broadly neutralizing antibody protects against SARS-CoV, pre-emergent bat CoVs, and SARS-CoV-2 variants in mice
First Author:
Reviewed: May 3, 2021
|
|
May 3, 2021
|
|
Effectiveness of CoronaVac in the setting of high SARS-CoV-2 P.1 variant transmission in Brazil: A test-negative case-control study
First Author:
Reviewed: May 3, 2021
|
|
May 3, 2021
|
|
The natural stilbenoid (-)-hopeaphenol inhibits cellular entry of SARS-CoV-2 USA-WA1/2020, B.1.1.7 and B.1.351 variants
First Author:
Reviewed: May 3, 2021
|
|
May 3, 2021
|
|
Therapeutic effect of CT-P59 against SARS-CoV-2 South African variant
First Author:
Reviewed: May 3, 2021
|
|
May 3, 2021
|
|
Antibody response after COVID-19 mRNA vaccination in relation to age, sex, and side effects
First Author:
Reviewed: Apr 30, 2021
|
|
Apr 30, 2021
|
|